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Oral Abstracts
Scientific Session 1: Advances in Cardiac Tissue
Engineering & Bioengineered Valves for Vascular Repair
Monday, December 4, 2017, 10:00 AM - 11:30 AM
1
Tissue-engineered Cardiobundles for In Vitro Development
of Heart Regeneration Therapies
C. P. Jackman, S. Heo, N. Bursac;
Biomedical Engineering, Duke University, Durham, NC.
Cardiomyocytes (CM) in the adult mammalian heart have limited
capacity to proliferate following injury. Thus, therapies to induce
endogenous regeneration of the heart would significantly improve
cardiac function in the setting of heart disease. We have previously
engineered 3-dimensional cylindrical tissues (‘‘cardiobundles’’) made
from neonatal rat CM embedded in fibrin-based hydrogel (*16 car-
diobundles derived from 1 neonatal heart), which accurately mimic the
dense and anisotropic cellular structure of native myocardium while
also displaying tissue-level functional properties comparable to the
adult or adolescent heart [1]. Here, we show that CM in cardiobundles
stop proliferating (<1% turnover per day) after 2 weeks in standard
culture conditions, representing a high-fidelity in vitro model to test
potential therapies for re-activation of the cell cycle in post-mitotic
myocardium. Furthermore, we establish various injury methods (e.g.,
cardiotoxin, hydrogen peroxide, calcium ionophores) that result in CM
death and a 60-80% decline in the cardiobundles’ active contractile
force, enabling studies of CM regeneration and functional recovery
after cardiac injury. Electrical stimulation of injured cardiobundles
results in partial yet incomplete regeneration and recovery of con-
tractile force. The cardiobundle injury model is thus a realistic 3-D
system to test new small molecule and gene therapies targeting CM
regeneration in the terminally differentiated heart, with higher
throughput than in vivo studies on the intact heart.
Acknowledgments: NIH grant HL134764, Foundation Leducq
grant, NSFGRF # 2013126035. [1] Jackman CP, Carlson AL, Bursac
N. Biomaterials 111:66-79 (2016).
2
Engineering Electroconductive Scaffolds for Cardiac Tissue
Regeneration
B. W. Walker, 021151, C. H. Yu1, E. Shirzaei Sani1, W. Kimball1,
N. Annabi1,2,3;
1Chemical Engineering, Northeastern University, Boston, MA,
2Biomaterials Innovation Research Center, Harvard Medical School,
Cambridge, MA, 3Massachusetts Institute of Technology,
Cambridge, MA.
Heart failure following myocardial infarction (MI) is a leading
cause of death in the United States. This issue is due to the inability of
myocardium to regenerate, leaving behind a fibrous scar tissue that is
unable to contract or propagate electrical impulses. Tissue engineering
(TE) approaches utilize different natural and synthetic materials to
develop scaffolds for cardiac tissue regeneration. Here, we engineered
highly biocompatible and conductive hydrogels for cardiac tissue re-
generation by combining gelatin methacryloyl (GelMA) prepolymer
and a choline-based bio-ionic liquid (Bio-IL). GelMA, a naturally
derived photocrosslinkable biopolymer, was selected due to its tunable
mechanical properties, favorable biodegradation, and the presence of
cell binding sites, which promote cell adhesion and proliferation. Bio-
IL, an organic salt high water solubility and ionic conductivity, and
electrochemical stability, was also used due to its biocompatibility and
conductivity. In this study, the electroconductive scaffolds were fab-
ricated using two techniques: i) bulk fabrication through photo-
polymerization and ii) electrospinning. Our results exhibited that the
scaffolds possessed high conductivity in vitro and ex vivo as well as
remarkable mechanical stability and strength. The in vitro 2D and 3D
culture of primary rat cardiomyocytes (CMs) showed that the en-
gineered hydrogels were highly biocompatible and could promote CM
growth and function. The subcutaneous implantation of the engineered
scaffolds in rats exhibited high biocompatibility and biodegradation
in vivo. Taken together, this study showed that GelMA/Bio-IL scaf-
folds could be readily tailored to different tissue engineering appli-
cations particularly cardiac tissue regeneration.
Scientific Session 1: Biomaterial Scaffolds 1
Monday, December 4, 2017, 10:00 AM - 11:30 AM
3
Engineering Silk Biomaterials for Cancer Therapy
S. Sapru1, D. Naskar1, B. Kundu2, A. K. Ghosh1, M. Mandal3,
R. L. Reis2, S. C. Kundu1,2;
1Department of Biotechnology, Indian Institute of Technology
Kharagpur, Kharagpur, INDIA, 23B’s Research Group, University of
Minho, Guimaraes, PORTUGAL, 3School of Medical Science and
Technology, Indian Institute of Technology Kharagpur, Kharagpur,
INDIA.
2D models are failing to predict the accuracy and efficiency of
cancer therapeutics. Thus 3D culture systems are adapted to unwind
true structural and functional cancerous microenvironment. In situ,
cancer microenvironment contains extracellular matrix (ECM) and
diverse cells (stem and immune cells). The most abundant cancerous
ECM is collagen, playing critical role in cancermetastasis. Silk protein
fibroin is structurally homologous with collagen. Structural homology
with naı¨ve disease ECM and ability to adapt different morphologies as
per prerequisites of application, enhances its prospect to be explored
for cancer modelling and therapy. Porous silk sponges are able to serve
as ECM support for breast and liver carcinoma, leading to develop-
ment of functional solid hypoxic tumors with drug sensitivity. This
improves the understanding of cell-ECM interaction in disease pro-
gression and therapeutic response. Stem cells are further incorporated
within this hypoxic model to unwind the role of cellular cross-talk in
cancer metastasis to secondary sites such as bone. Further, the struc-
tural diversity of silk biomaterials allows to deliver anti-cancer ther-
apeutics by means of nanoparticle with target specificity imparted by
folate conjugation. However, the exploitation of potential biopolymer
like silk in cancer is at neonatal stage. Foreseen applications include
mimicking of mechano-transducing cancerous ECM using flexibility
and mechanical robustness of silk, designing of organ-on-a-chip and
micro-tumors using silk. (Supported by Department of Biotechnology
[BT/PR10941/MED/32/333/2014], Indian Council of Medical Re-
search [5/13/12/2010/NCD-III], Govt. of India. SCK currently holds
ERA Chair under EU Framework Programme for Research and In-
novation Horizon 2020 FoReCaST - agreement number n 668983)
4
Advances in Biomaterials for Tissue Regeneration:
Functionalization, Processing and Applications
J. M. Oliveira, Sr., R. L. Reis;
UMinho, Braga, PORTUGAL.
Scientists can now envision a wide range of possibilites when ad-
dressing tissue and organ regeneration due to the great developments
TISSUE ENGINEERING: Part A
Volume 23, Supplement 1, 2017
ª Mary Ann Liebert, Inc.
DOI: 10.1089/ten.tea.2017.29003.abstracts
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in the biomaterials field. At the 3B’s Research Group, we have been
developing several natural-based biomaterials (e.g. chitosan, gellan
gum, silk fibroin, alginates, and kefiran) with the required function-
alities for further processing as micro- and nano-particles, hydrogels,
membranes, capsules, scaffolds, and bioinks. Herein, themost relevant
advances of biomaterials functionalization and processingmethods for
further application in musculoskeletal, neurosciences and cancer re-
search will be presented.
5
Self-healing and Adhesive Chitosan/Graphene Oxide Composite
Hydrogel based on Mussel-inspired Chemistry for Electroactive
Tissue Engineering
X. Jing1,2, H. Mi, 537051,2, L. Turng1,2;
1Wisconsin Institutes for Discovery, Madison, WI, 2Department
of Mechanical Engineering, Madison, WI.
Hydrogels currently used in electroactive tissues, such as skin and
cardiac tissues, have certain shortcomings, such as a lack of electrical
conductivity and adhesiveness, which play a key role in the success
of hydrogels in biomedical applications. In this study, chitosan (CS)/
graphene oxide (GO) composite hydrogels that are self-adhesive,
self-healing, and conductive were prepared by the incorporation of
mussel-inspired protein polydopamine (PDA). During the oxidizing
process of dopamine (DA), graphene oxide was reduced by PDA and
dispersed into the hydrogel networks to form electronic pathways.
The covalent bonds, supramolecular interactions, hydrogen bonding,
and p-p stacking enabled the chitosan/GO composite hydrogels to
have better stability, stronger mechanical behavior, and good adhe-
sive properties, as well as self-healing and fast recoverability char-
acteristics. The self-healed test samples, which were recovered from
dissected pieces and reassembled into a whole, healed piece, ex-
hibited almost the same performance and properties as the original
whole samples. The electrical conductivity of the CS/GO reached
1.22 mS/cm and the adhesive strength of the composite hydrogel was
increased by 300% compared to CS-DA hydrogels. HEF1 and car-
diomyocyte cells derived from human embryonic stem cells showed
better biological behavior, such as cell viability and proliferation,
compared to the CS-DA hydrogels. Moreover, cardiomyocytes
showed a faster spontaneous beating rate than those on the control
groups. Our work pointed to a cost-effective and scalable approach to
fabricating polydopamine-based hydrogels that are adhesive, con-
ductive, self-healing, and have fast recovery rates. These hydrogels
have potential applications in electroactive tissue engineering.
6
Gellan Gum Spongy-like Hydrogels Reinforced with
Hydroxyapatite for Bone Tissue Engineering Applications
F. R. Maia1,2, D. S. Musson3, D. Naot3, L. P. da Silva1,2,
A. R. Bastos1,2, J. B. Costa1,2, J. M. Oliveira1,2, V. M. Correlo1,2,
R. L. Reis1,2, J. Cornish3;
13B’s Research Group - Biomaterials, Biodegradables
and Biomimetics, Guimara˜es, PORTUGAL, 2ICVS/3B’s - PT
Government Associated Laboratory, Braga, PORTUGAL,
3Department of Medicine, University of Auckland, Auckland,
NEW ZEALAND.
Bone tissue engineering with cell-laden-hydrogels has been at-
tracting attention worldwide. In fact, they can resemble in some
aspects the extracellular matrix, as high water content. In a forward
thinking manner, our group engineered gellan gum (GG) spongy-like
hydrogels where cells adhered and proliferated without the need of
any modification. Moreover, we took advantage of these character-
istics and combined it with hydroxyapatite to reinforce the GG (GG-
HAp) spongy-like hydrogels. Since there is limited knowledge about
the interaction of osteoclasts with biomaterials, we assessed the
ability of developed matrices to support osteoclastogenesis. After
mechanical and morphological characterization, bone marrow cells
were seeded and treated with 1,25-dihydroxyvitamin D3 (Vitamin
D3) to promote osteoclastogenesis. After 7 days, cell viability and
differentiation was assessed. It was shown that the addition of HAp to
GG spongy-like hydrogels enable the formation of lager pores and
thicker walls and the improvement of the mechanical properties
(stiffness). Additionally, cells were viable and metabolically active.
Finally, it was observed that the GG-HAp spongy-like hydrogels
supported cell differentiation into pre-osteoclasts, as suggested by
the presence of aggregates of TRAP-stained cells, and the expression
of DC-Stamp and Cathepsin K, necessary for cell fusion and re-
sorption capacity, respectively. Overall, GG-HAp spongy-like hy-
drogels showed to support osteoclastogenesis, an important feature
when establishing new biomaterials for bone tissue applications.
Acknowledgments: The authors thank the funds provided by
FROnTHERA (NORTE-01-0145-FEDER-0000232). FRM ac-
knowledges FCT (SFRH/BPD/117492/2016) and ERC-2012-ADG
20120216-321266 (ComplexiTE), LPS thanks FCT (SFRH/BD/
78025/2011), JMO and VMC thanks FCT Investigator program (IF/
01285/2015 and IF/01214/2014).
7
Nanomaterial-Based Electrochemical Stem Cell Differentiations
A. Orza;
Emory University, Atlanta, GA.
Tunable Nano-Bio-Scaffolds (NB-Scaffolds) that direct the Stem
Cell differentiation is critical for stem cell-based regeneration. The
impact of the chemical composition, surface topography, and stiffness
on the stem cell behavior was highly explored and their importance is
notable. However, the impact of the NB-Scaffolds-dynamic stimuli
to stem cell fate is still unclear. Herein, we will present the synthesis
of various scaffold compositions and show/compare that their elec-
trochemical stimuli are inducing the surface adhesion and differen-
tiation of various stem cell types to neuronal and cardiac progenitors.
These electrochemical induced NB-scaffolds provide an alternative
to the classical culture substrates for a faster and more efficient way
of regulating stem cell behavior.
Scientific Session 1: CNS Neural Tissue Repair,
Regeneration, Derivation, and Engineering
of In Vitro Models
Monday, December 4, 2017, 10:00 AM - 11:30 AM
8
Regional Patterning and Engraftment of hPSC-Derived
Posterior Central Nervous System Tissue
N. Iyer, M. Estevez, A. Sreeram, S. Cuskey, N. Fedorchak,
R. Ashton;
Wisconsin Institutes for Discovery, University of Wisconsin
Madison, Madison, WI.
In vitro modeling of the human central nervous system (CNS) is
complicated by the diversity of constituent cell phenotypes. This
diversity arises from neural stem cells (NSCs) that are regionally
patterned along both the rostrocaudal (R/C) and dorsoventral (D/V)
axes during early neural tube development. Recapitulating this pat-
terning with chemically defined, scalable protocols using human
pluripotent stem cells (hPSCs) is necessary to optimally model CNS
disorders, screen potential drug therapies, and develop cell replace-
ment strategies for regeneration. We have previously reported
methods to efficiently differentiate hPSCs to Pax6+/Sox2+ NSCs and
to deterministically pattern their regional phenotype, generating
discrete R/C HOX profiles that span the hindbrain through spinal
cord. Here, we optimize D/V patterning conditions by modulating
Shh, Wnt/b-catenin, BMP, and TGF-b signaling pathways. qRT-
PCR of differentiated hESCs demonstrates a shift in expression of
dorsally expressed transcription factors in response to Wnt/b-
catenin, BMP, and TGF-b signaling to ventrally expressed tran-
scription factors in response to Shh signaling. Immunocytochemistry
ORAL ABSTRACTS S-3
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and RNA-seq confirm enrichment of NSC and neuronal populations
reflective of appropriate phenotypes. To investigate whether regional
specificity impacts integration into circuits in vivo, hESC-derived
motor neurons (MNs) were transplanted into developing chick em-
bryos. Quantification shows cervical MNs are able to selectively
engraft into the appropriate region of the developing chick neural
tube about the cervical/thoracic border. Optimization and charac-
terization ofmature neuronal populations are ongoing. Having access
to this hCNS model with organotypic cell phenotype diversity and a
comprehensive transcriptomic time-course will be a valuable re-
source for hindbrain and spinal cord regenerative medicine.
9
Nanofiber Scaffold-mediated Non-viral Delivery of microRNA-
219/-338 Protects Survival and Stimulates Oligodendrocyte
Precursor Cell Maturation After Spinal Cord Injury
S. Chew, U. Milbreta, C. Pinese;
School of Chemical & Biomedical Engineering, Nanyang
Technological University, Singapore, SINGAPORE.
Following spinal cord injury (SCI), oligodendrocytes (OL) adja-
cent to the lesion site die and cause axonal demyelination. The aim of
this study was to use a scaffold-mediated non-viral microRNA de-
livery approach to enhance remyelination by promoting the differ-
entiation and maturation of endogenous oligodendrocyte precursor
cells (OPC) after SCI. We developed a biodegradable electrospun
nanofiber-hydrogel scaffold that delivers miR-219/-338 in a sus-
tained manner for up to 20 days in vitro. After 1 and 2 weeks post-
implantation (WPI), the total number of cells per peri-lesional area
was similar with and without miR-219/-338 treatment (miR-219/-
338). MiR-219/-338 retained the number of oligodendroglial lineage
(Olig2+) cells at 1 and 2WPI. Conversely, scrambledmiR (Neg-miR)
showed a significant decrease in cell number (p< 0.05). PDGFRa+
OPCs showed a larger cell number decrease in miR-219/-338 (0.39-
fold change) compared to Neg-miR (0.37-fold change). Corre-
spondingly, by 2WPI, miR-219/-338 showed a significant increase in
mature OL (CC1+) numbers as compared to Neg-miR (1.47– 0.27
CC1+ cells/area in miR-219/-338 vs 1.1– 0.21 CC1+ cells/area in
Neg-miR, p < 0.05). These results indicate that scaffold-mediated
non-viral delivery of miR-219/-338 protected the survival of OPC/
OL and significantly increased the number of mature OL after SCI.
10
Neuron-Glia Interactions Recapitulated in a 3D Organotypic
Human Alzheimer’s Disease Brain Model
J. Park, I. Wetzel, H. Cho;
Mechanical Engineering and Engineering Science, UNC Charlotte,
Charlotte, NC.
Alzheimer’s disease (AD) is characterized by amyloid beta (A-beta)
accumulation, hyper-activation of glial cells, tau tangle formation,
and neuronal loss, which eventually leads to neurodegeneration.
The underlying mechanisms of AD pathogenesis, however, remain
poorly understood partially due to the absence of relevant models
that can comprehensively recapitulate pathogenic cascades of
human AD brains. Here, we present a new 3D organotypic human
cellular AD brain model by tri-culturing human AD neurons, as-
trocytes, and adult microglia in a 3D microfluidic platform (3D
NeuroGliAD). Our model provided representative AD signatures of
pathological accumulation of A-beta, phosphorylated tau (pTau),
neurofibrillary tangle (NFT)-like structure formation inside neu-
rons, and interferon-gamma (IFN-g) production from astrocytes. In
addition, the model reconstituted microglial inflammatory activi-
ties and elicited neuronal loss mediated by nitric oxide synthase
(iNOS) expression and cytotoxic NO release via TLR4 and IFN-g
receptors, respectively. We envision that our 3D organotypic
human multicellular brain model can represent critical features in
human neuroinflammatory diseases and compromise the limitation
of animal models for the better understanding of pathogenic neuron-
glia interactions in neurodegenerative diseases and serve as a valid
drug-screening platform at a high throughput.
11
Tissue Engineered Bioelectronics for Brain-Machine Interfaces
L. A. Poole-Warren1, U. Aregueta Robles1, A. Gilmour1,
J. Goding2, N. H. Lovell1, P. J. Martens1, R. A. Green2;
1Biomedical Engineering, UNSW Sydney, Sydney, AUSTRALIA,
2Bioengineering, Imperial College London, London, UNITED
KINGDOM.
Communication across neural interfaces typically relies on con-
ventional metal electrodes and their in vivo electrical and biological
performance is restricted by fibrosis. The hypothesis driving this
research was that neural cell loaded coatings provide a more physi-
ological interface, able to integrate electrodes with the neural tissue
and improve performance. The study aimed to develop tissue-
engineered, living electrode (LE) coatings for brain-machine inter-
faces and evaluate in vitro and in vivo function. LE fabrication was
achieved by coating the electrode with conductive hydrogel (CH) and
overlaying the CH with primary neural progenitor cells encapsulated
in 3D biosynthetic hydrogels. In vitro studies confirmed that charge
storage capacity (CSC) and frequency dependent electrochemical
impedance were similar in LE and CH. Mass loss and swelling of the
LE and CH were also similar, suggesting that material performance
of the LEwas comparable to the CH alone. Implantation of LE coated
and uncoated platinum control electrodes in a rat brain model con-
firmed that the LE did not cause any adverse events over 8 week
implantation. LE had significantly improved signal to noise ratio and
further research will examine the tissue response to understand the
mechanisms for this observation. These results demonstrate the po-
tential for a tissue-engineered electrode to support development of
more robust neural interfaces in vivo.
Acknowledgments: The research was supported by the Defense
Advanced Research Projects Agency (DARPA) under contract
number HR0011-16-C-0032. Experiments were approved by UNSW
Animal Care and Ethics Committee approval (15/145B).
12
Treatment of Focal Neurological Deficits Using Strategic
Generation of Stem Cell-Derived Neurons
L. Zirretta1, D. Stapp1, S. Grundeen2, A. Doyle3;
1Neuroscience Research Institute, University of California Santa
Barbara, Santa Barbara, CA, 2Dept. of Electrical and Computer
Engineering, University of California Santa Barbara, Santa Barbara,
CA, 3Neuroscience Research Institute & Center for Bioengineering,
University of California Santa Barbara, Santa Barbara, CA.
Restoring function to localized neural tissue provides an attractive
target for cell-based regenerative medicine therapies estimated to
benefit millions of patients annually (WHO, CDC). However, con-
trollably generating specific neuron subtypes to replace damaged
cells remains a substantial technical and translational challenge. To
address this objective, we used a two-pronged approach. First, we
systematically reviewed primary literature to identify promising
paths and rate limiting factors in clinical and commercial adoption of
stem cell-based neuronal therapies. Second, we designed and applied
a paired novel computational model with an in vitro embryonic stem
cell culture platform to iteratively improve design rationale for ex-
citatory and inhibitory neuron production from stem cells. Results
from this work (1) prioritize target patient populations most likely to
benefit from options for excitatory and inhibitory neuron therapeutic
cells, (2) provide a consensus and evidence-based assessment of the
potential use of cell therapies to treat focal neural disorders, (3) yield
a quantitative, tuneable system for tracking stem cell commitment to
neural and neuronal subtype cells, and (4) demonstrates the relative
kinetics of excitatory and inhibitory neuron differentiation, includ-
ing identification of novel biomarkers for cell fate choice that are
>99% predictive of GABAergic or glutamatergic cell fate choice at
S-4 ORAL ABSTRACTS
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significantly earlier time points than currently used markers of fate
choice. This work advances technical and quantitative science about
on-demand neuron subtypes for regenerative therapies, and provides
insight into design choices that may promote faster and more feasible
clinical translation and commercialization of regenerative medicine
stem cell therapies for focal neural deficits.
13
Modeling Neurogenesis and Vascularization in 3D
J. M. Grasman, D. L. Kaplan;
Biomedical Engineering, Tufts University, Medford, MA.
Understanding how neural and vascular networks spontaneously
regenerate in small injuries is critical to enhance material-based in-
terventions to regenerate large traumatic injuries; which are limited
by the development of these networks. During embryogenesis, neural
and vascular tissues form interconnected, complex networks as a
result of signaling between these tissues. In this study, we report on
our efforts to recreate signaling conditions found in development to
generate a model tissue-like system to study the co-development of
vascular and neural networks in order to understand and exploit this
crosstalk towards improved regenerative medicine outcomes. Spe-
cifically, we investigated how human umbilical vein endothelial cells
(HUVECs) and chicken dorsal root ganglia (DRG) interacted in a
series of neighboring channels within a collagen gel. HUVECs see-
ded in channels maintained CD31 expression for at least 7 days.
Axons grew towards and along HUVEC-seeded channels, regardless
of whether or not the DRGs were seeded near these channels, dem-
onstrating that this system was able to direct axonal growth towards
specific stimuli. These data suggest that HUVEC-seeded constructs
direct axonal growth, and support our hypothesis that hollow channel
collagen gels provide a facile 3D model to study the interactions
between neural and vascular systems. Current work is focused on
seeding explants prior to HUVEC incorporation into the model to
simulate the co-development of these networks. This co-culture tis-
sue model will allow for the study of neurogenesis and angiogenesis
and will be used to inform targeted innervation strategies and ulti-
mately improve remodeling of large tissue defects.
Scientific Session 1: Skin, Inflammation and Wound
Healing General Session
Monday, December 4, 2017, 10:00 AM - 11:30 AM
14
Autologous Mesenchymal Stem Cells (MSCs) at the Early
Passages Accelerate Diabetic Wounds Re-epithelialization:
Clinical Case Study
N. V. Maximova, M. E. Krasheninnikov, I. D. Klabukov,
I. A. Pomytkin, A. V. Lyundup;
Institute for regenerative medicine, Sechenov First Moscow State
Medical University, Moscow, RUSSIAN FEDERATION.
Diabetic foot ulcers (DFUs) are major complication of diabetes and
the common cause of non-traumatic amputation. A pathologically low
rate of wound closure is a hallmark of non-healing DFUs. Mesench-
ymal stem cells (MSCs) (‡1·106 cells/cm2) have emerged as a
promising tool for the treatment of diabetic wounds, while optimal
regime of MSCs use is yet to be established. In the present three-case
clinical study, we explored effect of the early passage MSCs with a
purpose to select optimal dosage regimen prior to the large scale in-
vestigation. We found that the topical application of autologous early
passage MSCs (p£ 2) at dose of 4x104 cells per cm2 of wound surface
resulted in a significant 2.2-fold increase of average rates of re-
epithelialization until complete neuropathic wound closure as com-
pared to rate values at baseline (0.20– 0.04 vs. 0.09– 0.01 cm2/day
respectively, p= 0.0044, n= 3). A maximum 8-fold increase in rates of
wound closure was observed within the first week after MSCs appli-
cations (p= 0.037). Then re-epithelialization rates began to slow, while
were still significantly higher than at baseline at any time point. All
three wounds were closed successfully. Together, these study provides
the first evidence of clinical efficacy of the early passage MSCs (p£ 2)
in the treatment of diabetic wounds. Furthermore, a long-term culti-
vation in vitro to yield large amounts of MSCs is not required and
clinical effectiveness in DFUs treatment can be achieved at much less
doses than those reported previously with the early passage MSCs.
15
Hollow Microgels for Enhanced Wound Repair
E. P. Sproul1,2, S. Nandi1,2, C. A. Roosa1, A. C. Brown1,2;
1Joint Department of Biomedical Engineering, North Carolina State
University & The University of North Carolina at Chapel Hill,
Raleigh, NC, 2Comparative Medicine Institute, Raleigh, NC.
Wound repair initiates with the formation of a provisional fibrin
mesh to stop bleeding. Subsequent platelet-mediated clot contraction
increases fibrin matrix density/stability which promotes healing.
Synthetic platelet-like particles (PLPs)1, which are comprised of
pNIPAm microgels coupled to fibrin-binding antibodies, induce clot
collapse and indicate potential for enhancing wound healing outcomes.
To facilitate fine control over particle-mediated fibrin network col-
lapse/stiffening, we have constructed hollow microgel architectures
with varying degrees of deformability (a critical feature for PLP-clot
collapse) by varying crosslinking density. Microgels are then coupled
to a fibrin-binding antibody with EDC/NHS chemistry. We hypothe-
sized that increased particle deformability would correlate with in-
creased clot collapse and improvedwound healing outcomes.Microgel
size was assessed with dynamic light scattering and microgel de-
formability (i.e particle spreading) was determined with atomic force
microscopy (AFM). In vitro clot collapse in the presence of fibrin-
binding particles was visualized with confocal microscopy, and wound
healing and inflammatory responses were assessed in vivo through
analysis of wound size and histology after topical application of mi-
crogels in a murine dermal wound model. Particle deformability and
particle-mediated collapse were inversely correlated with hollow
particle crosslinking. In vivo results displayed enhanced wound repair
in the presence of deformable microgel treatments as compared to
controls. These results indicate that hollow, fibrin-binding microgels
induce fibrin network collapse and enhance wound repair.
References: 1. Brown, A. et al. Nat. Mater. 13, 1108-1114 (2014).
Acknowledgments: AHA Scientist Development Grant
16SDG29870005Abrams Undergraduate Research Award.
16
Novel Porcine Model of Delayed Wound Healing Aimed
at Modulating the Rate of Wound Closure
A. Kharge1, A. Gandhi1, P. Attar2, S. Korn2, K. Lam2, S. Saini1;
1Integra LifeSciences, Plainsboro, NJ, 2BRIDGE PTS, Inc., San
Antonio, TX.
Background: Previously1, we demonstrated a model to simulate
healing impairment in chronic wounds such as diabetic ulcers caused
by glycosylation of collagen resulting from extended exposure to
hyperglycemia2. In this follow-up study, we evaluated (i) if the in-
tensity of healing impairment could be modulated by varying the
concentration of the chemical crosslinker and (ii) if surgical de-
bridement of crosslinked wounds would impact healing time.
Methods: Twenty full-thickness wounds (2 cm diameter) were
created on the dorsum of three Yorkshire pigs. To rapidly simulate
glycosylation of collagen, wounds were immediately treated with 0.1
to 1% (v/v) glutaraldehyde for 5 minutes to crosslink collagen.
Wounds were surgically debrided on Day 3.
Results: In the glutaraldehyde-treated wounds, there was a dose
dependent response with respect to wound closure—higher con-
centrations of glutaraldehyde correlated with delayed wound closure.
At day 14, 90% closure or better was attained by 18 of 20 control
(untreated) wounds, 14 of 20 of 0.1% (v/v) glutaraldehyde-treated
wounds and zero of 20 of the 1% (v/v) glutaraldehyde-treated
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wounds. Healing was significantly delayed in all glutaraldehyde-
treated wounds at days 1, 3, 7, 11 and 14 (t-test vs. control, p < 0.001).
Further, all glutaraldehyde-treated wounds regardless of debride-
ment experienced delayed healing compared to the control.
Conclusion: Glutaraldehyde-treatment of dermal tissue can sig-
nificantly delay wound healing in vivo and the degree of wound closure
can be modulated by varying the concentration of glutaraldehyde.
References:
1. Kharge A et al. Abstract#1390, TERMIS-AM, Dec 2016.
2. Hennessey PJ et al. J Pediatr Surg. 25(1):75-8, Jan 1990.
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Targeted and Sustained Delivery of Polyphosphate Suppresses
Bacterial Collagenase for Promotion of Post-Surgical
Intestinal Healing
D. Nichols1, S. Hyoju2, O. Zaborina2, J. Alverdy2, F. Teymour3,
G. Papavasiliou1;
1Biomedical Engineering, Illinois Institute of Technology, Chicago,
IL, 2Department of Surgery, University of Chicago, Chicago, IL,
3Chemical Engineering, Illinois Institute of Technology, Chicago, IL.
Wound healing and repair of the intestinal tract is a complex
process due to the presence of intestinal microbiota which can impair
or enhance the healing process. Previous studies indicate that under
phosphate depleted conditions certain bacteria (E. faecalis, S. mar-
cescens, P. aeruginosa) secrete high levels of collagenase, a key
phenotype involved in healing impairment. Drug delivery ap-
proaches focused on sustained release of compounds that could
suppress collagenase production by pathogens while allowing com-
mensal bacteria to proliferate normally offer a major advantage for
prevention and treatment of these problems. We have previously
developed a drug delivery approach involving the use of hydrogel
nanoparticles that provide prolonged polyphosphate release, and
which suppress the in vitro virulence of intestinal pathogens while
maintaining bacterial survival. Polyphosphate (PPi), was encapsu-
lated in poly(ethylene) glycol hydrogel nanoparticles (NP-PPi)
formed using inverse miniemulsion polymerization. Free PPi and
NP-PPi reduce in vitro collagenase levels in gram-negative patho-
gens (P. aeruginosa and S. marcescens) while maintaining bacterial
survival. Mice subjected to colonic anastomosis exhibited normal
healing (n= 5) whereas mice subjected to both anastomosis and in-
testinal bacterial inoculation exhibited adhesions and inflammation
(n= 4). Furthermore, mice subjected to anastomosis, bacterial inoc-
ulation, and antibiotic treatment exhibited severe inflammation and
in some cases, gross leaks (n= 10). Mice subjected to colonic anas-
tomosis and bacterial inoculation treated with PPi dosed drinking
water exhibited attenuation in S. marcescens colonization and pre-
vention of healing complications (n= 10). Current studies are being
performed to test the effectiveness of NP-PPi in preventing healing
complications in mice subjected to intestinal injury.
Scientific Session 1: Biofabrication and Bioreactors 1
Monday, December 4, 2017, 10:00 AM - 11:30 AM
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Laser-based Biofabrication Methods
R. Narayan;
North Carolina State University, Raleigh, NC.
Laser-fabricated structures, such as tissue engineering scaffolds,
implantable sensors, and drug delivery devices, will become important
tools for medical diagnosis and treatment over the coming decades.
Over the past decade, we have examined use of several laser tech-
nologies, including pulsed laser deposition, matrix assisted pulsed laser
evaporation,matrix assisted pulsed laser evaporation-direct write, laser
micromachining, and two photon polymerization, to process micro-
structured and nanostructured materials for medical applications. For
example, we have shown that a laser-based approach known as two
photon polymerization may be used to process a variety of photosen-
sitive materials, including acrylate-based polymers, hydrogels, and
organically-modified ceramic materials, into medically-relevant
structures. Two photon polymerization involves an application of the
multi-photon absorption phenomenon for 3D printing at sub-
micrometer length scales. This technique involves nearly simultaneous
absorption of two photons by a small volume of a photosensitive
material, leading to highly localized polymerization and hardening of
the material. We have prepared structures with complex microscale
geometries out of photosensitive materials using two photon poly-
merization; cell interactions with these structures were examined using
a variety of in vitro studies. Micromolding can be used to replicate two
photon polymerization-prepared patterns. Current efforts to improve
the biocompatibility of laser biomaterials andmodify laser methods for
clinical translation will also be considered.
19
Lab-on-a-PrinterTM - a Multi-Material 3D Bioprinting
Platform for Building Living Tissues on Demand
S. Wadsworth, S. Beyer, K. Walus, K. Thain, S. Pan, T. Mohamed;
Aspect Biosystems, Vancouver, BC, CANADA.
Recreating the complex heterogeneity and microstructure of bi-
ological tissues is a challenge. To address this, we have developed
a novel 3D bioprinting system based on a paradigm called Lab-on-
a-PrinterTM (LOP). LOPTM printheads integrate microfluidics and
filament deposition technology enabling rapid switching between
different cell-containing bioink compositions in a single printhead.
Custom software tools precisely coordinate material switching with
printer toolpaths to enable rapid fabrication of heterogenous living
3D tissues. In generating the cell-laden hydrogel fiber, we utilize
co-axial flow focusing, a method that protects printed cells from
damaging shear stress within sub-100 mm hydrogel fibres which are
generated with very high cell density (from 0 to >100x106 cells/mL),
printed at high speeds (100mm/sec) and maintain high cell viability
(>95%). The LOPTM system can print fibres containing multiple
extracellular matrix factors, growth factors, and other bioactive
compounds. Selective customisation of the cellular microenviron-
ment enables us to print a variety of cell types and produce func-
tional tissues: The 3DBioRingTM Airway tissue contains primary
human airway smooth muscle cells printed in a proprietary biological
matrix. The cells are viable for over 2 weeks post-printing, form in-
terconnected networks and are functionally contractile, exhibiting a
physiological bronchoconstriction-like response to histamine (EC50=
0.60mM) and a pharmacologically-appropriate relaxation to salbuta-
mol (EC50= 39nM). The LOPTM system is broadly applicable for
printing a variety of cell types including, adherent primary cells (eg.
dermal fibroblasts), non-adherent immune cells (eg. cord-blood de-
rived mast cells), and multiple cell lines (eg. HepG2 hepatocytes).
20
A 3D Printed Microfluidic Bioreactor to Engineering
Biphasic Construct
G. De Riccardis1, P. G. Alexander2, M. T. Raimondi3,
R. S. Tuan2, R. Gottardi2;
1Department of Chemistry, Materials and Chemical Engineering ‘‘G.
Natta’’, Politecnico di Milano, Milano, ITALY, 2Department of
Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA,
3Department of Chemistry, Materials and Chemical Engineering,
Politecnico di Milano, Milano, ITALY.
Introduction: Tissue engineered constructs coupled with high-
throughput bioreactors can be used as innovative in vitro preclinical
models of tissue functions and disease pathogenesis for drug
screening and toxicity assessment [1]. Here, we present an innovative
3D printed bioreactor for biphasic constructs, enabled with optical
access for direct monitoring of cellular responses.
Materials and Methods: Two different fluid circuits for the
bioreactor were tested using food coloring and the degree of mixing
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in the outlets was quantified with a plate reader. Bone marrow de-
rived human mesenchymal stem cells (BM-hMSCs) were suspended
(1 million cells/ml) in 8%methacrylated gelatin (GelMA), UV cross-
linked in situ in the bioreactors [2], and perfused with an inlet flow-
rate of 1ml/day. A Dynamic Live Assays was performed adding
Calcein-AM to the medium stream and imaging constructs in 3D. A
Dynamic Metabolic Assay was similarly performed using Alamar-
Blue and analyzing the output media every 42h.
Results and Discussion: Cells were successfully stained and im-
aged by the dynamic live assay within the bioreactors where they
maintained viability and activemetabolism, confirming the possibility of
non-destructive monitoring within the system. For the biphasic biore-
actor, experimental tests confirmed modelling predictions [3], showing
minimal mixing in the media stream for each tissue component.
Conclusions: The successful dynamic staining of the constructs
validates the use of the bioreactors to perform a continuous, non-
destructive, real-time monitoring of cellular responses without
breaking sterility. This is especially relevant for biphasic constructs
that require specific media for each component [4].
21
A Fluidic Bioreactor Platform for Spatially Patterned Cell
Growth, Differentiation, and Cocultures
J. Lembong1, M. J. Lerman2, T. J. Kingsbury3,
C. I. Civin3, J. P. Fisher1;
1Fischell Department of Bioengineering, University of Maryland,
College Park, MD, 2Department of Materials Science and
Engineering, University of Maryland, College Park, MD, 3Center
for Stem Cell Biology & Regenerative Medicine, Departments
of Pediatrics and Physiology, University of Maryland School
of Medicine, Baltimore, MD.
Perfusion bioreactors have been used widely in the past decade to
enhance in vitro culture of stem cells. We develop a pillar-based
fluidic bioreactor chamber for dynamic stem cell culture, with em-
phasis on controlling cellular interactions in a three-dimensional
environment via flow and substrate curvature, which are physiolog-
ically relevant to natural tissues. We utilize shear stress of up to 15
mPa on cell surfaces to enhance growth of humanmesenchymal stem
cells (hMSCs), resulting in 5-fold expansion within 7 days, ex-
ceeding the 3-fold expansion in static two-dimensional culture plates.
The pillar geometry in the bioreactors dictates cell spatial patterning
through preferential initial cell localization within *300mm radius
from the pillars, potentially due to cell affinity for local negative cur-
vatures. Fluid flow overcomes this localization, creating homogeneous
cell distribution throughout the bioreactor within 24 hours. Flow-
enhanced osteogenic differentiation is evidenced by 10-fold enhance-
ment of alkaline phosphatase (ALP) expression within 7 days, where
local ALP expression positively correlates with local shear stress pro-
files caused by the flow past the pillars. Additionally, cell localization in
the bioreactor enables patterning of hMSCs and endothelial cells in
cocultures, potentially modulating the signaling between the two es-
sential cell types in the bone marrow microenvironment. Overall, we
have developed a fluidic bioreactor platform for dynamic stem cell
culture, with demonstrated capabilities to create spatially patterned cell
growth and osteogenic differentiation through flow patterning. The
platform’s scalability, adjustability, and capability of forming three-
dimensional tissue structures allow for integration into large-scale
perfusion bioreactor systems for tissue engineering applications.
22
Effects of 3D Printing on Flow-Induced Shear Distributions
M. Felder, C. Williams, V. Sikavitsas;
The University of Oklahoma, Norman, OK.
As 3D printing gains more exposure as the future of scaffold fab-
rication for tissue and tumor engineering, the ability to preemptively
model the constructs microenvironment becomes of vital importance.
Particularly when using perfusion based bioreactor systems, the most
important properties to obtain are the fluid flow and wall shear fields
that potential cells will experience during and after seeding. Tradi-
tionally, 3D printing has given users the impression that the scaffold
obtained after printing will exhibit the same, or closely similar, ar-
chitecture as the designed model. While this may be the case in terms
of the macrostructure, we hypothesized that the local fluid dynamic
environment would differ greatly. The intention of this studywas to 3D
print scaffolds of various pore size gradients, image these constructs
utilizing micro-computed tomography, and perform computational
fluid dynamic simulations on the resulting reconstructions and the
initial designs in order to compare the average shear on the fibers,
where the cells would be adhered. As a determining factor, the prob-
ability density function (p.d.f.) of each was compared to not only
highlight the major differences, but also to show the reproducibility of
the printing process. The results presented in this manuscript give users
the knowledge of how the 3D printing process may alter the intended
fluid environment they designed, and how to, in spite of that fact,
produce repeatable results.
Scientific Session 2: Strategies for Respiratory,
Urologic and Gastrointestinal Engineering
Monday, December 4, 2017, 12:45 PM - 2:15 PM
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Engineered diaphragma
M. Komura1, K. Suzuki1, H. Komura2;
1Saitama Medical University, Saitama prefecture, JAPAN,
2Tokyo University, Tokyo, JAPAN.
Background: In repair of congenital diaphragmatic herniawith large
defects, prosthetic patches can cause infection, recurrence, and thoracic
deformity. Biosheets (collagenous connective tissue membranes) are
reportedly useful in regenerative medicine.We evaluated the efficacy of
biosheets in regeneration and repair of diaphragm in a rabbit model.
Methods: Biosheets were prepared by embedding silicone plates
in dorsal subcutaneous pouches of rabbits for 4 weeks. In group 1
(n= 11), Gore-Tex sheets (1.8 · 1.8 cm) were implanted into the
diaphragmatic defects. In group 2 (n= 11), SEAMDURA, a
bioabsorbable artificial dural substitute, was implanted in the same
manner. In group 3 (n= 14), biosheets were autologously trans-
planted into the diaphragmatic defects. All rabbits were euthanized 3
months after transplantation to evaluate their graft status.
Principal results: Herniation of liver was observed in 5 rabbits
(45%) in group 1, 8 (73%) in group 2, and 3 (21%) in group 3. A
significant difference was noted between groups 2 and 3 (p= 0.03).
Biosheets had equivalent burst strength and modulus of elasticity as
native diaphragm. Muscular tissue regeneration in transplanted
biosheets in group 3 was confirmed histologically.
Conclusion: Biosheets may be applied to diaphragmatic repair
and engineering of diaphragmatic muscular tissue
24
Assessment of Injected vs. Native Cells in Urinary Sphincter
Regeneration of Nonhuman Primates with Urinary Sphincter
Deficiency
J. K. Williams, S. K. Lankford, 27101, K. Andersson;
Regenerative Medicine, Wake Forest University, Winston-
Salem, NC.
Objective: A major question remaining in the development of tis-
sue engineering medicine approaches to tissue and organ replacement
is the role of injected vs. native cells in tissue regeneration. The goal of
this study was to develop a method to label and then identify injected
autologous muscle precursor cells (skMPC) vs. native bone marrow
cells (BMCs), labeled with different colored lentivirus promoters.
Methods: Ten female cynomolgus monkeys had surgically-
induced urinary sphincter muscle deficiency. A muscle biopsy was
taken to isolate and label (using a lentivirus-delivered M-cherry
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promoter) skMPCs. Five weeks later, BMCs were collected by biopsy
and adherent stromal cells labeled with a lentivirus GFP promoter. 20
million BMCs were injected intravenously 4 days following the
monkeys receiving 3 intravenous injections of the bone marrow sup-
pressant busulfan (1mg/kg/day). One week later, 5 million M-cherry
labeled skMPCs were injected directly into the urinary sphincter.
Results: Transduction produced 40%m-cherry positive skMPCs and
60% GFP positive BMCs. Fluorescent antibody cell sorting indicated
that injected skMPCs were strongly skeletal muscle actin and MyoD
positive and the BMCs were strongly CD133, CD117 and CD34 posi-
tive. Once injected, GFP-labeled cells constituted 40% of the bone
marrow cells and could be readily found in the muscle layer and lamina
propria of the sphincter complex. M-cherry labeled skMPC were more
scarce (5% of cells) and more commonly found in the muscle layers.
Conclusion: It is concluded that this is an effective method to
assess the relative contribution of injected vs. mobilized cells in
tissue regeneration.
25
Intestine Re-endothelialization ForWholeOrgan Bioengineering
A. F. Pellegata1, A. M. Tedeschi1, A. Gjinovci1, S. Russo2,
C. Camilli1, G. Cossu3, S. Mantero2, P. De Coppi1;
1Institute of Child Health, University College London, London,
UNITED KINGDOM, 2DCMIC, Politecnico di Milano, Milan,
ITALY, 3University of Manchester, Manchester, UNITED
KINGDOM.
Short-bowel-syndrome remains an unmet clinical need. To address
this issue, transplantation with engineered whole organs would an ideal
solution. However, regeneration of the vascular network is a major
limitation to engineered tissue survival and scaling-up for clinical use.
The aim of this study is to regenerate a functional vascular network
composed of endothelial and perivascular cells within decellularised rat
intestine. Small intestine segments were harvested from rats preserving
the mesenteric vascular plexus via cannulation, obtaining a segment
suitable for orthotopic transplantation and decellularised according to a
detergent-enzymatic protocol previously developed that preserves the
integrity of the vascular network. Adult and iPSC-derived endothelial
and perivascular cells were perfusion-seeded in the vasculature and
cultured in specific growth condition, in order to promote the prolif-
eration and stabilisation of the regenerated endothelium. Culture was
performed inside a custom-made bioreactor specifically designed to
provide perfusion through the blood vessels and the lumen of the in-
testinal scaffold. After 7 days in culture, the blood vessels patency was
confirmedwith fluorescent dextran assay. Immunofluorescence staining
performed on whole mounts showed that endothelial cells engrafted till
the very distal capillaries of the intestinal scaffold with considerable
lumen coverage, expressing functional markers and showing develop-
ment of a mature barrier function by formation of tight junctions. These
findings represent a crucial step in the engineering and scale-up of a
whole intestine. The functional vascular network will be essential for
the survival of the graft in-vivo.
26
An Acellular Regenerative Medicine Approach for Ulcerative
Colitis
M. C. Cramer1, S. F. Badylak2;
1Bioengineering, University of Pittsburgh, Pittsburgh, PA, 2Surgery,
University of Pittsburgh, Pittsburgh, PA.
Ulcerative colitis (UC) is the most common form of inflammatory
bowel disease, affecting approximately 900,000 patients in the US. Al-
though the exact etiology of UC is unknown, a damaged epithelial layer
and an aberrant pro-inflammatory immune response to commensal mi-
croflora is characteristic of the disease. In a pre-clinical study of dextran
sulfate sodium (DSS)-induced colitis in rats, extracellular matrix (ECM)
hydrogel treatment rapidly resolved clinical signs of the disease, restored
the epithelial barrier, and mitigated the pro-inflammatory state of resi-
dent tissue macrophages. Matrix bound nanovesicles (MBV) containing
microRNA (miR) and protein cargo have been isolated from the ECM
and are thought to be a potent vector of bioactivity. MiR-143/145 are
highly expressed in MBV, down-regulated in UC patients, and essential
for epithelial regeneration followingDSS injury.MiR-143/145 knockout
mice were used as a tool to identify the specific role of miR-143/145 in
ECM-based UC therapy. ECM was isolated from the intestine of wild-
type and knockoutmice to produce ECMbioscaffolds that contain either
physiologic levels or complete lack of expression of miR-143/145, re-
spectively. In vitro, macrophages treated with wild-type and knockout
ECM displayed differential activation states. Colitic mice treated with
knockout mouse-derived ECM showed a prolonged pro-inflammatory
state and impaired epithelial carrier as compared to wild-type ECM
treated animals, suggesting the importance of miR-143/145 in ECM-
mediated therapeutic effects. In conclusion, an acellular regenerative
medicine approach based upon inductive signals delivered by MBV
within ECM can restore homeostatic macrophage function and facilitate
mucosal healing in a rodent model of ulcerative colitis.
27
Restoration of Fecal Continence in a Large Animal Model:
Long Term Follow-up
E. Zakhem1,2, J. Bohl3, R. Tamburrini4,5, P. Dadhich1, K. Bitar1,2,6;
1Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC, 2Program in Neuro-Gastroenterology andMotility, Wake Forest
School of Medicine, Winston Salem, NC, 3Department of General
Surgery, Wake Forest School of Medicine, Winston Salem, NC,
4Wake Forest School of Medicine, Winston Salem, NC, 5Department
of General Surgery, University of Pavia, Pavia, ITALY, 6Section on
Gastroenterology,Wake Forest School ofMedicine,Winston Salem,NC.
Introduction: Fecal continence is primarily maintained by the
internal anal sphincter (IAS). Loss of IAS integrity or functionality
leads to passive fecal incontinence. Our previous studies have shown
restoration of fecal continence in rabbits following implantation of
engineered autologous IAS Biosphincters for up to 3 months.
Objective: Here, we studied a longer follow up (12 months) of
restoration of fecal continence using IAS Biosphincters.
Methods: Fecal incontinence was induced in rabbits as described
before. Rabbits were assigned to 3 groups: (i) non-treated group (n= 4),
(ii) treated group (n= 7) that received implantation of Biosphincters
and (iii) sham group (n= 5). Anorectal manometry (resting pressure
and RectoAnal Inhibitory Reflex, RAIR) was followed regularly for up
to 12 months. Histological and pathological analyses were performed.
Results: Incontinence in rabbits was evident by their lack of fecal
hygiene and by significant reduction in resting pressure and RAIR
(26 – 7mmHg and 19 – 6%) compared to baseline (38– 2mmHg and
62 – 5%). Resting pressures and RAIR were restored and maintained
in the treated group (32– 3mmHg and 63 – 6%) and were signifi-
cantly higher than those in the non-treated group at 12 months.
Resting pressures and RAIR were not significantly different between
non-treated and sham groups.
Conclusion: This study provides a promising tissue engineering
and regenerative medicine approach to treat passive fecal inconti-
nence using engineered Biosphincters. Our long term follow up study
(12 months) indicated the sustained long-term effect of Biosphincters
implantation on restoration of continence.
28
Cell Therapy for Neo-Innervation and Restoration of Neural
Function in the Gut
P. Dadhich1, E. M. Petran2, E. Zakhem1,3, K. N. Bitar1,3,4;
1Wake Forest Institute for Regenerative Medicine, Wake Forest
Institute for Regenerative Medicine, Winston salem, NC, 2Summer
Scholar Program, Wake Forest Institute for Regenerative Medicine,
Winston salem, NC, 3Program in Neuro-Gastroenterology and
Motility, Wake Forest School of Medicine, Winston-Salem, NC,
4Section on Gastroenterology, Wake Forest School of Medicine,
Winston-Salem, NC.
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Background: Neuro-degenerative diseases can result in loss of
innervation of the pyloric sphincter. Replenishing of neurons in the
pylorus via direct injection of neural-progenitor cells (NPCs) pro-
vides a possible approach for long-term treatment.
Aim: The objective of this study was to inject gut-derived NPCs
into denervated pylorus explants for re-innervation and reinstatement
of function.
Methods: Pylorus tissue was harvested from rats and prepared
for ex-vivo model of denervated pylorus. Explants were then either
injected with fluorescently tagged NPCs or with PBS. Non-treated
explants served as control. Neo-innervation and restoration of
function were assessed by immunohistochemistry, qPCR and phys-
iological analysis.
Results: Fluorescence microscopy confirmed presence of red
fluorescing neurons in the submucosa and muscularis mucosae of the
explants injected with NPCs, indicating the success of the injection
process. Explants injected with tagged NPCs stained positive for
nitric-oxide-synthase neurons (nNOS), indicating the differentiation
of tagged NPCs. qPCR studies confirmed the presence of differen-
tiated neurons in the explants injected with NPCs. Electrical field
stimulation showed 87% regain of relaxation in the explants injected
with NPCs compared to control and PBS-injected explants. With
nNOS inhibitor, relaxation diminished (* 51%) similar to control,
which further validated differentiation of injected NPCs into nNOS
neurons.
Conclusion: This study demonstrated that injection of NPCs into
denervated pylorus tissues ex vivo resulted in neo-innervation of the
tissue. Injected NPCs integrated into the pylorus, differentiated into
functional neurons and reinstated its function. These findings sug-
gest that NPCs cell therapy can be used to treat neurodegenerative
diseases of the gut.
Scientific Session 2: Tissue Engineering Approaches
for Musculoskeletal Defects Session 1
Monday, December 4, 2017, 12:45 PM - 2:15 PM
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Skeletal Muscle-Macrophage Platform for Modeling
Tissue Regeneration
M. Juhas, N. O. Abutaleb, J. T. Wang, N. Bursac;
Biomedical Engineering, Duke University, Durham, NC.
In response to injury, adult skeletal muscle shows robust capacity
for self-repair enabled by an intricate interplay between muscle stem
cells and the immune system. Generating high-fidelity in vitro
models of self-regenerative muscle could facilitate basic studies of
muscle regeneration and enable screening and discovery of factors to
enhance muscle repair and function in various pathologies. Here, we
show that functional muscle tissues engineered from adult rat myo-
genic progenitor cells fail to properly self-repair in vitro following
injury with cardiotoxin despite the presence of Pax7+muscle satellite
cell (MuSC) pool and treatment with known pro-regenerative cyto-
kines (IGF-1, CTGF, IL10). Remarkably, incorporation of bone
marrow-derived macrophages (BMDMs) into the engineered muscle
enabled near-complete structural and functional repair after injury.
Notably, the BMDMs proved capable of significantly attenuating
injury-induced myofiber apoptosis which enabled MuSCs within the
engineered muscle to activate, proliferate, and differentiate to rebuild
muscle mass. Shared-media experiments, immunostaining, and cy-
tokine analysis further suggested a role of the immune cells in
stimulating the transition from a pro- to an anti-inflammatory envi-
ronment post-injury supported by the reduction of muscle death with
direct TNFa inhibition. In vivo, BMDMs within implanted en-
gineered tissues augment blood vessel ingrowth, cell survival,
muscle regeneration and contractile function. Our studies reveal
requisite roles of macrophages in engineering adult-derived muscle
tissues with capacity for self-regeneration and inspire future devel-
opment of biomimetic in vitro platforms for modeling and treatment
of degenerative muscle injury and disease. This study was supported
by grant AR070543 from NIAMS to N. Bursac.
30
In situ 3D Bioprinting for cartilage regeneration
C. Di Bella1, C. O’Connell2, R. Blanchard1, S. Duchi1,
S. Ryan3, Z. Yue4, C. Onofrillo1, G. Wallace4, P. Choong5;
1Department of Surgery, University of Melbourne, Melbourne,
AUSTRALIA, 2Biofab3D, Melbourne, AUSTRALIA, 3University
of Melbourne, Werribee, AUSTRALIA, 4University of Wollongong,
Wollongong, AUSTRALIA, 5University of Melbourne, Melbourne,
AUSTRALIA.
Objectives: In-situ 3D printing is an exciting bio-fabrication
technology to deliver tissue-engineering techniques by the surgeon at
the time and location of need. We have created a hand-held extrusion
ink-jet printing device (Biopen) that allows the simultaneous and co-
axial extrusion of Bioscaffold and cultured cells directly into the
defect that needs to be repaired. This pilot study aimed at assessing
the use of the Biopen in vivo to repair a full thickness chondral defect
in a large animal model.
Methodology: An 8-mm circular critical sized full thickness
chondral defect has been created in the weight-bearing surface of the
lateral and medial condyles of both femurs of 8 sheep. Each defect
has been treated with either (i) hand-held in situ 3D printed bios-
caffold using the Biopen (HH group), (ii) pre-constructed bench-
based printed bioscaffolds (BB group), (iii) micro-fractures (Clinical
Group) or (iv) left untreated (Negative Control Group). Histology
and IHC have been performed in the retrieved condyles (O’Driscoll
score) and biomechanical indentation tests have been performed to
assess the physical properties of the regenerated cartilage tissue.
Results: The HH printed scaffolds (i) remained in place for the
duration of the experiment (8 weeks), (ii) do not induce inflammatory
reaction, (iii) allow early cartilage formation which shows superior
macroscopic andmicroscopic score when compared tomicro fractures.
Significance: This pilot study shows that direct in-situ bioprinting
can be used to regenerate articular cartilage with superior results
when compared to the clinically available surgical techniques.
31
Repair Of Segmental Bone Defect Using Totally Vitalized Tissue
Engineered Bone Graft By A Combined Perfusion Seeding
& Culture System
l. wang;
Department of Orthopaedics, Xijing Hospital, Fourth Military
Medical University, Xi’an, CHINA.
In this study, we proposed the ‘‘Totally Vitalized TEBG’’ (TV-
TEBG) which was characterized by abundant and homogenously
distributed cells with enhanced cell proliferation and differentiation
and further investigated its biological performance in repairing
segmental bone defect.
Methods: In this study, we constructed the TV-TEBG with the
combination of customized flow perfusion seeding/culture system and
beta-tricalcium phosphate (beta-TCP) scaffold fabricated by Rapid
Prototyping (RP) technique. We systemically compared three kinds of
TEBG constructed by perfusion seeding and perfusion culture (PSPC)
method, static seeding and perfusion culture (SSPC)method, and static
seeding and static culture (SSSC)method for their in vitro performance
and bone defect healing efficacy with a rabbit model.
Results: Our study has demonstrated that TEBG constructed by
PSPCmethod exhibited better biological properties with higher daily
D-glucose consumption, increased cell proliferation and differenti-
ation, and better cell distribution, indicating the successful con-
struction of TV-TEBG. After implanted into rabbit radius defects for
12 weeks, PSPC group exerted higher X-ray score close to autograft,
much greater mechanical property evidenced by the biomechanical
testing and significantly higher new bone formation as shown by
histological analysis compared with the other two groups, and
eventually obtained favorable healing efficacy of the segmental bone
defect that was the closest to autograft transplantation.
Conclusion: This study demonstrated the feasibility of TV-TEBG
construction with combination of perfusion seeding, perfusion culture
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and RP technique which exerted excellent biological properties. The
application of TV-TEBG may become a preferred candidate for seg-
mental bone defect repair in orthopedic and maxillofacial fields.
32
Novel Coupled Framework of In Situ and In Silico Analysis
to Accelerate Development of Muscle Tissue Engineering
Therapeutics
A. Meppelink, D. Remer, X. Hu, S. S. Blemker, G. J. Christ;
Biomedical Engineering, University of Virginia, Charlottesville,
VA.
Regenerative medicine approaches for volumetric muscle loss
(VML) injuries have generated partial recovery of muscle force in
biologically relevant rodent models. However, the mechanisms re-
sponsible are poorly understood. We present a novel coupled
framework of in-silico and in-situ methods to address knowledge
gaps and identify opportunities for improved therapeutics.
A 3D finite element model of the rat latissimus dorsi (LD) was
created in-silico. The muscle was modeled as a transversely isotro-
pic, hyperelastic and quasi-incompressible material. Six distinct
VML injuries were simulated in the model, and used to predict LD
contractile forces. From these results, two different VML injuries
were created in the LD of rats and muscle function was immediately
assessed in-situ. The distal tendon of the LD was attached to a lever
arm and peak isometric contractions were measured via electrical
stimulation of the motor nerve.
In-silico predictions were confirmed experimentally using in-situ
testing. In the intact computational model with in-situ conditions, the
pennate portion of the LD generated two times more force than the
longitudinal portion. With only the longitudinal portion anchored,
force was just 60% smaller indicative of lateral force transmission.
Functional deficits from VML injuries vary widely. Thus, regen-
erative technologies would be more effectively targeted if they were
injury-based and muscle-specific. To this end, we illustrate how
understanding of VML injuries may be improved using a coupled
framework of computational and experimental methods to identify
relevant biomechanical mechanisms of muscle function. This ap-
proach should accelerate development of more effective technolo-
gies for functional recovery from VML injury.
Scientific Session 2: Ophthalmology & Soft Tissue
Monday, December 4, 2017, 12:45 PM - 2:15 PM
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Magnetic Nanoparticles For Targeted Corneal Endothelial
Transplantation
L. Cornell, J. McDaniel, B. Lund, D. Zamora;
Ocular Trauma, USAISR, Fort Sam Houston, TX.
Purpose:The corneal endothelial cell layer poses great challenges
due to its lack of regenerative potential and reducing cell population
with age. This study investigates human corneal endothelial cells
(HCEC), loaded with iron-based nanoparticles, being magnetically-
directed to injured regions of the cornea.
Methods: HCECs were grown and exposed to 50nm dextran-
coated biotin conjugated super paramagnetic iron oxide nano-
particles (SPIONP) at 37C for up to 72 hrs. SPIONP uptake was
evaluated via Atomic Emission Spectroscopy (ICP). Mathematical
modeling based upon stokes law, gravity, and magnetic field strength
was used to determine optimum SPIONP cell loading in relation to
magnetic field strength for induced cellular movement within the
aqueous chamber. Mathematical modeling efficacy was then evalu-
ated by injecting SPIONP loaded HCECs onto a denuded human
corneal endothelium in the presence of an applied magnetic field.
Results: HCEC were cultured and maintained their in-vivo cell-
specific marker expression of CD200 and Glypican-4, confirming
their endothelial lineage. ICP analysis revealed that SPIONP inter-
nalization by HCECwas increased bymagnetic exposure during cell-
MNP loading. When SPIONP loaded-HCEC were placed in solution
with the denuded cornea, up to 1 million cells/mL, the cells showed
targeted movement through the solution towards the externally ap-
plied magnetic field of 1.23 Tesla.
Conclusions: Proof of concept studies performed here indicate
that cells with internally-loaded SPIONP can be directed through an
aqueous solution to a predetermined area when a magnetic field is
applied. Results of this study may lead to the development of a non-
surgical technique to replenish this vital cell layer.
34
Local Affinity Release to the Retina
V. Delplace, N. Mitrousis, J. Parker, M. Pakulska, M. S. Shoichet;
University of Toronto, Toronto, ON, CANADA.
Introduction: Blindness and visual impairment are largely caused
by irreversible loss of photoreceptors and retinal pigment epithelium
cells in the retina. Pro-survival therapeutic proteins can improve retinal
cell survival in damaged retina, but require controlled delivery systems
due to their short half-lives and rapid clearance. To achieve local
controlled release, we designed an affinity-based system that sustains
the release of proteins from an injectable, hyaluronan-based hydrogel.
Materials and methods: In this strategy, we exploit the interaction
of an intracellular protein, Src homology 3 (SH3), with its binding
peptides. By expressing fusion proteins of SH3 with the protein of
interest and modifying a hyaluronan–methylcellulose (HAMC) hydro-
gel with the corresponding binding peptides, the release can be adjusted.
The rate of release can be tuned by varying either the binding strength of
the SH3-protein/peptide pair or the peptide concentration. Two fusion
proteins, SH3-IGF-1 and SH3-CNTF, were successfully expressed.
Their controlled release from modified HAMC were investigated
in vitro as potential candidates for local affinity release to the retina.
Results and discussion: Reflecting the difference in binding equi-
librium between the binding peptides, we showed that the strongest
binder released SH3-IGF-1 more slowly. Furthermore, RPEs in the
HAMC/SH3-IGF-1 release system had higher cell viability than cells
cultured in the absence of the slow release IGF-1 system.Moreover, we
validated the prediction of our mathematical model for the controlled
release of SH3-CNTF from weak-binding HAMC, and demonstrated
bioactivity of released SH3-CNTF. This system lays the foundation for
future in vivo studies combining cell and biomolecule delivery.
35
Neuroprotective Factors Secreted By Retinal Progenitors
Derived From Induced Pluripotent Stem Cells
J. Rebeles1, T. A. Burke2, W. A. Greene2, R. R. Kaini2, H. Wang2;
1Ocular Trauma, U.S. Army Institute of Surgical Research, JBSA
Fort Sam Houston, TX, 2Ocular Trauma, US Army Institute of
Surgical Research, JBSA Fort Sam Houston, TX.
Purpose: We hypothesize that secreted factors by retinal pro-
genitors derived from induced pluripotent stem (iPS) cells offer
neuroprotective and neuroregenerative functions. In this study, we
investigated the secreted factors by retinal progenitors derived from
iPS cells.
Methods: 3D1 iPS cells were differentiated toward retinal line-
age. Embryoid bodies (EBs) of 9000 cells were generated using
Aggrewells. EBs were transitioned to neurons by adding neural in-
duction medium andmaintained in a three-dimension (3D) culture. On
Day17, neuro-rosettes were selected. Fifty rosettes were in eachwell of
ultralow attachment plate with 2ml media. Conditioned media was
harvested every 72 hours and replaced with fresh media. Stepwise
differentiation was confirmed by immunofluorescence analysis of
neural (OTX 2, SOX1), eye field (LHX2, SIX6), and retinal progenitor
markers (CHX10, PAX6). Multiplex luminex Immunoassays were
performed to simultaneously measure multiple factors.
Results: EBs derived from 3D1 cells expressed neural, eye field and
retinal progenitor markers at different time points constant with previous
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studies. Expressions of retinal progenitor markers started on Day21 and
peaked on Day30 of differentiations. Neuroprotective factors detected
from retinal progenitors includedOsteopontin, Hepatocyte growth factor
(HGF), Stromal cell-derived factor 1 (SDF-1), Insulin-like growth factor
1 (IGF-1), Monocyte chemoattractant protein-1 (MCP-1) and Me-
sencephalic astrocyte-derived neurotrophic factor (MANF).
Conclusions: We observed that retinal progenitors derived from
iPS cells secret several neuroprotective factors. This study suggests
that conditioned media from retinal progenitors derived from iPS cells
may be a novel treatment for retinal degeneration and retinal injury.
36
3D Bioprinting of IPSCs to Generate Cartilage Like Tissue
Using Laminin Bioconjugated Cell-instructive Bioink
P. Gatenholm1, E. Romberg1, R. Castro Vin˜ualas2, E. Karabulut1,
A. Forsman2, A. Lindahl2, S. Simonsson2;
1Chemical and Biological Engineering, Chalmers University
of Technology, Goteborg, SWEDEN, 2Department of Clinical
Chemistry and Transfusion Medicine, Institute of Biomedicine
at Sahlgrenska Academy, Goteborg, SWEDEN.
Cartilage lesions can develop into osteoarthritis (OA) and are a
worldwide burden. As a prospective treatment for such lesions, we
show that human-derived induced pluripotent stem cells (iPSCs) can be
3D bioprinted and directed to form cartilage-mimics (1). The benefits
by using an established iPSC line are unlimited cell source with re-
generation capacity. The objective of this study is to develop a cartilage
prototype by 3Dbioprinting of human chondrocyte derived iPSCs using
novel cell-instructive bioink composed of laminin-conjugated nano-
cellulose fibrils. We bioprinted iPSCs in nanocellulose/alginate bioink
and compared with nanocellulose/alginate bioink which was bio-
conjugated with laminin, to resemble the microenvironment found in
cartilage tissue. Designing protocols that generates hyaline cartilage
from pluripotent cells in vitro is still a challenge, due to that joint
formation are late in development and far from the pluripotent state.We
used a protocol for hyaline-like cartilage generation from iPSCs using
combinations of growth factors or co-culture with irradiated chon-
drocytes. The 2-photon-fluorescence-microscopy results showed an
increased cell density within the cartilaginous-like tissue, indicating the
importance for good cell survival during bioprinting. Collagen type 2
could be detected and the pluripotency marker Oct4 was lost in the
cartilage mimics. Improved cartilage generation was achieved in the
cell-instructive bioink. 1. D. Nguyen et al. Scientific Reports, 2017, 7:
658 j DOI:10.1038/s41598-017-00690-y
37
Platelet-Like-Particles Mediate Matrix Properties to Promote
Cell Migration in a Hemophilia Wound Healing Model
S. Nandi1,2, E. P. Sproul1,2, L. Sommerville3, D. M. Monroe, III4,
M. R. Hoffman3, A. C. Brown1,2;
1Joint Department of Biomedical Engineering, North Carolina State
University/University of North Carolina - Chapel Hill, Raleigh, NC,
2Comparative Medicine Institute, Raleigh, NC, 3Department of
Pathology, Duke University, Durham, NC, 4Division of Hematology/
Oncology, University of North Carolina - Chapel Hill, Chapel Hill, NC.
Coagulation is the initial step in the wound repair process.1 In situ-
ations in which coagulation is impaired, such as hemophilia, subsequent
wound healing has been shown to be significantly impaired. To that end,
we have created synthetic platelets capable of augmenting healing and
improving wound repair via application of these platelet-like-particles
(PLPs) to enhance clot stability and stiffness.2 Increased clot stabiliza-
tion and stiffness subsequently leads to improved cell migration into and
within the wound environment.We characterized these clot stabilization
effects via cryogenic SEM and fibrinolysis assays, which indicated that
PLP-laden clots have decreased porosity and increased stability relative
to standard clots.We then used our PLPs in in vitro cell migration assays
modeling hemophilia and normal wound repair conditions. PLPs were
shown to enhance cell migration in hemophilia conditions. Additionally,
application of PLPs in vivo in a mouse model of wound repair demon-
strated a dose dependent increase in wound closure rates.
References:
1. Nandi, S. & Brown, A. C.Exp. Biol. Med. 241, 1138-1148 (2016).
2. Brown, A. C. et al. Nat. Mater. 13, 1108-1114 (2014).
Acknowledgments: Duke/NCSU Translational Collaborative Re-
search Program; American Heart Association Grant 16SDG29870005;
North Carolina State University Analytical Instrumentation Facility
38
Characterization of a Newly Developed Dermal Sponge
for Soft Tissue Replacement
A. Johnson, D. Softic, X. Qin;
LifeNet Health, Virginia Beach, VA.
Introduction: A macroporous, moldable acellular dermal sponge
was developed as a soft tissue filler to address clinical needs for
breast reconstruction following lumpectomy or for deep and tun-
neling wounds.
Methods: Dermal sponges were produced from decellularized
human dermis from donors with research authorization. Sponges
were evaluated for adipoconductivity by seeding adipose derived
stem cells (ASC) and inducing adipogenic differentiation. Sponges
were also assessed for their regenerative and degenerative properties
in a subcutaneous athymic mouse implantation model in comparison
with an acellular dermis and Helistat collagen sponge at 6, 12, and
24 weeks. Cellular infiltration, neovascularization and inflammatory
response were evaluated histologically. Adipogenic remodeling and
implant size were quantified from their cross-sectional area.
Results: Dermal sponges supported ASC attachment, proliferation
and differentiation to adipocytes demonstrated by perilipin-A staining
and enhanced adiponectin levels in culture media. Dermal sponges
showed significantly enhanced fibroblast infiltration and neovascu-
larization over acellular dermis and Helistat at week 6 (p&lt0.05). No
significant inflammatory cell infiltration or fibrous capsule formation
was observed. Sponges showed three times the level of adipogenic
remodeling over acellular dermis and Helistat by week 12. Fromweek
6 to week 24, neither dermal sponges nor acellular dermis showed a
significant decrease in cross-sectional area, while the cross-sectional
area of Helistat sponges was reduced significantly (p&lt0.01).
Significance: The shapeable, space-filling dermal sponge may be
an effective matrix for breast reconstruction and wound healing as it
allows for rapid cellular infiltration and angiogenesis while main-
taining its volume over 18 weeks in the subcutaneous pocket.
Scientific Session 2: Stem Cells and Microenvironments
for Dental and Craniofacial Tissue Regeneration
Monday, December 4, 2017, 12:45 PM - 2:15 PM
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Microrna-200a Inhibitor Promotes Bone Regeneration
at Calvarial Defects Of Rats
L. Hong, A. Akkouch, S. Eliason, B. Amendt;
University of Iowa, Iowa City, IA.
MicroRNA (miR)-200a suppresses b-catenin/Wnt signaling and
TGF-b2 /Smad pathway and inhibits BMP-2-induced differentiation
by targeting Dlx-5.
Objectives: This project is to test whether we can promote oste-
ogenic differentiation and bone regeneration by inhibiting miR-200a.
Methods: Plasmid-based miR-200a inhibitor system (PMIS-miR-
200a) was transfected into human bonemarrowMSCs. The cells with
miR-200a inhibition were subsequently exposed to osteogenic dif-
ferentiation media for up to 4 weeks. The biomarkers of osteogenic
differentiation were quantitatively measured at different time points.
In addition, PMIS-miR-200a at different doses were loaded into
collagen sponge and implanted into calvarial defects at a rat model.
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The bone regeneration with different treatments were analyzed using
mCT and histology.
Results: The expression of PMIS-miR-200a in human bone
marrow MSCs was confirmed using real-time PCR after the PMIS-
miR-200a were treated. The osteogenic differentiation were up-
regulated in the cells treated with PMIS-miR-200a, compared to the
cell without treatment or the cells treated with empty vectors. The
bone regeneration measured using mCT in the defects treated with
PMIS-miR-200a is twice higher than controls.
Conclusions: These data demonstrated that inhibition of miR-
200a potently improves osteogenic differentiation of human MSCs
and promote bone formation, which indicating the potential of PMIS-
miR-200a to be used for oral and craniofacial bone regeneration.
40
Development of a PDGF-BB Delivery System to Enhance
Adipose-Derived Stem Cell-Mediated Cranial Bone
Regeneration
A. N. Rindone1,2, W. L. Grayson1,2;
1Biomedical Engineering, Johns Hopkins University School of
Medicine, Baltimore, MD, 2Translational Tissue Engineering Center,
Johns Hopkins University School of Medicine, Baltimore, MD.
Critical-sized bone defects require treatment with bone grafts to fa-
cilitate complete healing. Adipose-derived stem cells (ASCs) are a
promising cell source for engineering biologically-functional bone
grafts. Recently, our group demonstrated that physiological concentra-
tions of platelet-derived growth factor-BB (PDGF) significantly en-
hanced osteogenesis of ASCs. To capitalize on this unique feature of
ASCs, we developed a novel heparin-conjugated, decellularized bone
matrix (HC-DCB) particle system to deliver PDGF to ASCs within bone
grafts. Here, we assessed the loading efficiency of 100ng of PDGF and
release kinetics over 21 days from non-conjugated DCB and HC-DCB.
Using ELISA, we found that HC-DCB particles had a higher loading
efficiency (97.5%vs. 83.5%), and released less PDGF over 21 days (3.25
vs. 14.48ng) compared to DCB particles. We evaluated the os-
teoinductive effects of PDGF on ASCs using DCB and HC-DCB with
and without PDGF. Particles were incubated with PDGF in fibrinogen
overnight, combined with ASCs and thrombin, and infused into porous
polycaprolactone scaffolds. Grafts were cultured in vitro for 21 days in
osteogenic medium or directly implanted into critical-sized murine
calvarial defects. Consistent with our prior findings, grafts with PDGF
had roughly five times higher calcium deposition, while there was no
difference in calciumcontent betweenHC-DCB-PDGFandDCB-PDGF
in vitro. However, osteocalcin expression was three times higher in HC-
DCB-PDGF versus DCB-PDGF. In vivo, HC-DCB-PDGF regenerated
150% greater bone volume at Week 4 than DCB-PDGF (p=0.17).
Together these data demonstrate a significant potential of delivering
PDGF using HC-DCB for ASC-mediated cranial bone regeneration.
41
Bioengineered Tooth Bud Model Recapitulates Significant
Features of Natural Tooth Buds
E. E. Smith1, S. Angstadt2, N. Monteiro2, W. Zhang2,
A. Khademhosseini3, P. C. Yelick4,1,2;
1Sackler School of Graduate Biomedical Sciences, Tufts University
School of Medicine, Boston, MA, 2Orthodontics, Tufts University
School of Dental Medicine, Boston, MA, 3Division of Health
Science and Technology, Havard Medical School, Cambridge, MA,
4Biomedical Engineering, Tufts University, Boston, MA.
Our long-term goal is to enhance the quality of dental and oral health
for those suffering from tooth loss by creating bioengineered func-
tional, living replacement teeth as a superior alternative to currently
used synthetic dental implants. For this study, we co-encapsulated
postnatal dental cells and endothelial cells within GelMA hydrogel
scaffolds to fabricate tooth bud constructs. After 2 weeks of subcuta-
neous implantation, bioengineered tooth bud constructs exhibited
proliferating dental epithelial (DE) rosette structures that expressed
Sox2 and LEF-1, markers of the DE stem cell (DESC) niche. The
putative bioengineered DESC also exhibited canonical Wnt signaling
activation as demonstrated by robust Beta-Catenin and Sonic Hedge-
hog (Shh) expression and a co-expressed Shh and FGF3 signaling
center resembling the natural enamel knot. The putative DESC niche
was surrounded by a distinct basement membrane, and condensed
dental mesenchymal cells that expressed Fibroblast Growth Factor 3
(FGF3) and de novo Fibrillin-2 expression, all hallmarks of naturally
developing tooth buds. After 4W of in vivo growth, GelMA tooth bud
constructs exhibited robust mineralized tissue formation that adopted
the size and shape of the construct. These high impact results are the
first to recapitulate the natural DESC niche and other features of natural
tooth development using postnatal dental cells. These results are an-
ticipated to improve the quality of dental and oral health for people
suffering from tooth loss, and facilitate a variety of regenerative
medicine approaches to bioengineer functional organs and tissues.
42
3-D Topographical Controls to Angularly Organize
Periodontal Ligaments
C. PARK1, J. Huh2, W. V. Giannobile3, Y. Lee4, Y. Seol4;
1Seoul National Univeristy, Seoul, KOREA, REPUBLIC OF,
2Prosthodontics, Pusan National University, Yangsan, KOREA,
REPUBLIC OF, 3Periodontics and Oral Medicine, University
of Michigan, Ann Arbor, MI, 4Periodontology, Seoul National
Univeristy, Seoul, KOREA, REPUBLIC OF.
Objective: For tooth-supportive functions under occlusal/masti-
catory loadings, specific orientations of periodontal ligament (PDL)
to tooth-root surfaces are important. However, angular orientations
in PDL regeneration is currently challenging in periodontal tissue
engineering. Here, we investigated 3-D architectures, which can
spatiotemporally organize PDL in 3-D printing technology.
Methodology: The programmed slicing with three different an-
gulations is the key step to create oriented microgroove-patterns on
3-D scaffold surfaces. The spatial scaffold for PDL regeneration was
designed using CAD and waxmolds were manufactured with the 3-D
wax printer. The poly-e-caprolactone was casted into 3-D printed
molds and surfaces were analyzed by micro-CT, SEM, and confocal
microscope. After in-vitro human PDL cell cultures, cell orientations
were statistically analyzed using fluorescence staining of cell nuclei.
In-vivo subcutaneous experiments are performed to evaluate PDL
cell/tissue alignments and collagen formation.
Results: Individually different microgroove-patterns on the
scaffold were analyzed and each topography had high reproducibil-
ity and predictability by 3-D printing technology. Promisingly,
microgroove-patterned scaffolds provided more predictable cell
alignments and cell orientations were significantly angular-
controllable with statistical difference in in-vitro and in-vivo.
Significance: It is still challenging to spatiotemporally control
orientations of PDL for physiological functioning restorations in
periodontal complexes. Here, we demonstrated the different angu-
lated microgroove-patterns on scaffolds can spatiotemporally con-
trol orientation of ligaments with high reproducibility. This simple
strategy provide topographical platforms to precisely form periodontal-
mimetic architectures for PDL organizations. Furthermore, ligament-
guiding architectures can integrate designed bone compartments for
ligament-bone constructs and the multi-compartmentalization can lead
to tissue-functioning restoration in biomedical applications.
Scientific Session 3: Rapid Fire Session 1
Monday, December 4, 2017, 4:15 PM - 5:45 PM
43
Hyaluronan-Collagen Type-I Hybrid Bioink for 3D Printed
Microenvironments
A. Mazzocchi, S. Soker, A. Skardal;
Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC.
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Current in vitro 3D tissue constructs are restricted by the ma-
terials in which they are grown and the inability to create physio-
logically accurate extracellular matrix (ECM) micro-architecture.
These restrictions have thus far prevented optimization of true
ECM microenvironments that mimic the composition and structure
of in vivo tissues. Consequently, this artificial nature can affect
cellular phenotype and behaviors in in vitro model-based studies
such as drug screens. Collagen type-1 is the major structural
component in the ECM, and is widely used as a 3D hydrogel, but is
not easy to use as a bioink for 3D bioprinting due to low viscosity
and slow crosslinking properties. We have developed a novel, yet
simple bioink formulation that combines thiol-modified hyaluronic
acid with methacrylated collagen type-1. The resulting bioink has
the properties needed for extrusion bioprinting and cell-driven in-
ternal micro-architecture formation. In validation studies, we de-
veloped three bioink formulations, verified viscoelastic behavior
and printability in extrusion bioprinters, and have employed a panel
of cell types to verify biocompatibility and cell-driven reorgani-
zation of collagen fibrils into fiber-based micro-architectures.
Viscoelastic properties were measured using rheology and collagen
reorganization was characterized with picrosirus red and trichrome
staining. Cell viability of multiple cell lines was confirmed using
MTS proliferation assays and quantification of LIVE/DEAD
staining in comparison to current on-the-market 3D hydrogels.
Combined, we have been able to create a simple bioink with ideal,
tunable elements for 3D cell culture leading to optimized formu-
lation of 3D printing of functional bioengineered liver constructs
and primary tumor organoids.
44
MRI-informed Biomimetic Design of Artificial Intervertebral
Disc Scaffolds using 3D Bioplotting
E. Hodder1, D. Covill2, P. Bush2, M. Cercignani3, N. Dowell3,
A. Overall2, M. Gelinsky4, A. Lode5, S. Duin5;
1University of Brighton, Sussex University, Brighton, UNITED
KINGDOM, 2University of Brighton, Brighton, UNITED
KINGDOM, 3Sussex University, Brighton, UNITED KINGDOM,
4Centre for Translational Bone, Joint and Soft Tissue Research,
Technische Universita¨t Dresden, Dresden, GERMANY, 5Centre
for Translational Bone, Joint and Soft Tissue Research, Dresden
University of Technology, Dresden, GERMANY.
Introduction: Damage to intervertebral discs (IVD’s) is a
major health concern. However, current artificial disk replacement
are associated with an inability to absorb compressive forces and
debris release. This investigation aims to address this issue using
3D bioplotting of alginate methylcellulose (alg/MC) with pri-
mary bovine articular chondrocytes (pBAC), to replicate native
disc tissue.
Methods: Magnetic resonance imaging (MRI) IVDs provided
the dimensions for the alg/MC scaffolds with pBACs (5x106). Cell
viability was measured by fluorescent imaging (CMFDA-green
and ethidium bromide), and phenotype by PCR gene expression
analysis of collagen type I & II, and histological imaging of pro-
teoglycan. Scaffolds were assessed using quantitative (qMRI);
T2* for water content, spectroscopy for proteoglycan and MTR for
collagen.
Results: The gene expression ratio of collagen type I to II in 14-
day growth samples was 4:96, and mimics freshly isolated chon-
drocytes (100% collagen II). Safranin-O staining of proteoglycans
demonstrated significant increasing content with longer culture time
(1,7,14 days). qMRI techniques were successfully applied to achieve
measurements of water, collagen, and proteoglycan contents in both
healthy disc tissues and day 21 scaffolds. High cell survival of 80%
was recorded throughout, and was improved by the variation of print
parameters and material sterilisation procedures.
Conclusions: 3D bioplotting using alg/MC represents a promising
new material capable of supporting appropriate chondrocyte phe-
notype and extracellular matrix synthesis. Mechanical stimulation
and testing during growth is the next stage in experiments, to further
encourage proteoglycan production and monitor scaffold physical
properties.
45
Decellularized Xenograft Bone Scaffold is Superior
to Demineralized Bone Matrix in Healing of Critical Bone
Defects in Rat Femurs
A. H. Jinnah1, D. N. Bracey1, T. D. Luo1, J. S. Willey2,
B. E. Collins3, T. L. Smith1;
1Orthopaedic Surgery, Wake Forest School of Medicine, Winston
Salem, NC, 2Radiation Oncology, Wake Forest School of Medicine,
Winston Salem, NC, 3North Carolina A&T University,
Greensboro, NC.
Approximately 5.2 million musculoskeletal surgeries are per-
formed every year in the United States, nearly half of these utilizing
bone grafts. The economic and clinical implications of bone grafting
are enormous, and tissue-engineered bone graft substitutes have
garnered considerable attention in recent years. Using novel decel-
lularization protocols developed in our laboratory, a porcine bone
scaffold was developed. Previous work demonstrated that this pro-
tocol significantly reduced nuclear material within the xenograft
suggesting that the scaffold was effectively decellularized compared
to the starting material. Furthermore, the native bony architechture
was maintained. We hypothesized that the decellularized construct
would be superior to demineralized bone matrix (DBM) in repairing
a critical size bone defect. The purpose of this study was to compare
osteointegration of this novel xenograft to a DBM commercial
product in a segmental bone defect using micro-computerized to-
mography (CT) and histological analysis. An 8mm segmental bone
defect created in 13 week old Sprague-Dawley rats (n = 3/group)
beneath a polysulfone plate attached to the femur. This defect was
filled with xenograft scaffold or DBM, for 16 weeks. Histology of the
explanted femurs demonstrated newly formed collagen within the
scaffold. Disorganized fibrous growth was observed within the DBM
group. Micro-CT demonstrated host osteointegration into the xeno-
graft while DBM failed to integrate in the defect site. These pre-
liminary results demonstrate superior osteointegration with a
xenograft scaffold in a rat femoral critical defect when compared to
DBM. Further work must be done with larger group sizes to confirm
our findings.
46
3D Bioprinting of BMP-2 Gene-Activated and Stem
Cell-Encapsulated Gelatin Scaffold: Efficacious in situ
Transduction and Robust Osteogenesis for Bone Regeneration
H. Lin, Y. Tang, T. Lozito, B. Wang, R. Tuan;
University of Pittsburgh School of Medicine, Pittsburgh, PA.
Objective: Currently, sustained in vivo delivery of active bone
morphogenetic protein-2 (BMP-2) protein to responsive target cells,
such as bone marrow-derived mesenchymal stem cells (BMSCs),
remains challenging. Ex vivo gene transfer, while efficient, requires
additional in vitro cell culture. In this study, we incorporated lenti-
viral vector encoding BMP-2 gene (Lv-BMP, BMP group) or GFP
gene (Lv-GFP, GFP group) and human BMSCs into photo-
crosslinkable gelatin solution, and encapsulated them into gelatin
hydrogel scaffolds with porous infrastructure in a single step, using a
visible light-based projection stereolithographic (VL-PSL) 3D
printing technology. We hypothesize that the Lv-BMP-activated,
BMSC-laden constructs would independently form bony tissue
without extra BMP-2 administration.
Methods: hBMSCs were isolated and expanded with IRB ap-
proval. In vivo bone formation was examined by implanting con-
structs into SCID mice with IACUC approval.
Results: Upon in vitro culture, compared to the GFP group, cells
from BMP group showed >1,000-fold higher BMP-2 release, and the
majority of them stained intensely for alkaline phosphatase (ALP)
activity. Real-time RT-PCR also showed dramatically increased
expression of osteogenesis marker genes only in the BMP group. Post
implantation into SCID mice, the micro-computed tomography im-
aging showed bone formation only in the BMP group, which was
restricted within the scaffolds locally. Alizarin red staining and
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immunohistochemistry of GFP and osteocalcin further indicated that
the grafted hBMSCs, not host cells, contributed primarily to the
newly formed bone.
Significance: This novel one-step, gene-activated and live cell
encapsulated scaffold fabrication procedure developed in this study
is potentially applicable for point-of-care treatment of bone defect.
47
Involvement of FAK-BMP-2/Smad Pathway in Mediating
Osteoblast Adhesion &Differentiation on Nano-Hydroxyapatite/
Chitosan Composite Coated Titanium Implant under Diabetes
F. Yafei;
Department of Orthopaedics, Xijing Hospital, Fourth Military
Medical University, Xi‘an, Shaanxi, CHINA.
Chitosan (CS)-based hydroxyapatite (HA) composite emerges as a
novel strategy for promoting bone regeneration. Here the nanophase
HA/CS composite coated porous titanium implant (nCT) was fabricated
& its biological behavior under diabetic conditions was investigated.We
proposed that focal adhesion kinase (FAK)-mediated BMP-2/Smad
pathway played a role in mediating the promotive effect of nCT on
osteoblast adhesion and differentiation under diabetes-induced high re-
active oxygen species (ROS) condition. To confirm the hypothesis, rat
osteoblasts on bare titanium implant (Ti) or nCT were subjected to
normal serum (NS), diabetic serum (DS), DS + NAC (a potent ROS
inhibitor) & DS + cytochalasin D (a FAK inhibitor). In vivo study was
performed on diabetic sheep implanted with Ti or nCT with or without
NAC administration. Results showed that diabetes-induced ROS over-
production impaired osteoblast adhesion evidenced by immunostaining
of F-actin and vinculin, &morphological observation through inhibition
of FAK phosphorylation, which contributed to suppressed BMP-2-
dependent Smad1/5/8 phosphorylation. nCT substrate reactivated FAK-
BMP-2/Smad pathway, thus reversed osteoblast dysfunction, which
exerted similar effect toNAC treatment on Ti. These effects were further
confirmed by the improved osseointegration within nCT in diabetic
sheep evidenced by Micro-CT & histological examinations. Our study
demonstrated reactivation of FAK-BMP-2/Smad pathway was involved
in improving osteoblast adhesion & differentiation by nano-HA/CS
composite coating, hopefully directing biomaterial modification &
biofunctionalization under diabetic conditions.
48
Quantitative Assessment of Cell and Progenitor Population
Resident in Different Zones of Human Cartilage Tissue
and its Correlation with Tissue Health
V. Mantripragada1, C. Boehm1, W. Bova1, N. Piuzzi1,
N. Obuchowski2, R. Midura1, G. Muschler1;
1Biomedical Engineering, Cleveland Clinic, Cleveland, OH,
2Quantitative Health Science, Cleveland Clinic, Cleveland, OH.
A rational development of cell-based therapy for cartilage regener-
ation requires knowledge of the number and functional attributes of the
chondrogenic connective tissue progenitors (CTP-Cs) resident in po-
tential source tissues. The concentration, prevalence and biological
performance of cells in the superficial (Csp, top 500mm thickness) and
deep cartilage (Cdp, remainder of cartilage excluding the calcified
cartilage zone) were compared. The lateral femoral condyle of patients
undergoing total knee arthroplasty in varus knees with osteoarthritis
(OA) was used. Cell and CTP data, histological grade, and patient
variables were assessed. Colony formation was assessed using auto-
mated quantitative image analysis methods, ColonyzeTM. Cell con-
centration (cells/mg) in Csp (Median: 7280; Range: 3440,17600) was
significantly higher than Cdp (Median: 5686; Range: 3393,9660),
p= 0.039. Prevalence of CTPs (CTPs/million cells plated) was similar
between Csp (Median: 1274; Range: 0,3898) and Cdp (Median: 1365;
Range: 0,6330), p=0.42. The biological potential of CTPs varies
widely, within and between patients, manifest by variation in colony
size and morphology. Early stages of cartilage degradation were asso-
ciated with an increase in cell and CTP concentration in Csp (p<0.05),
whereas later stages of matrix degradation were associated with a de-
crease in cell and CTP concentration in Cdp (p<0.05). Overall these
findings provide systematic quantification of stem and progenitor cells
in different zones of cartilage and their correlation to various histo-
pathological features observed during idiopathic OA progression.
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Mechanically Functional 3D-Printed Bioresorbable Vascular
Scaffolds
B. Akar1, H. M. Ware2, A. C. Farsheed2, C. Duan1, X. Cheng2,
C. Sun1, G. Ameer1;
1Biomedical Engineering Department, Northwestern University,
Evanston, IL, 2Mechanical Engineering Department, Northwestern
University, Evanston, IL.
Mechanically Functional 3D-Printed Bioresorbable Vascular
Scaffolds
Banu Akar1, Henry Oliver T. Ware1, Adam C Farsheed1,
Chongwen Duan1, Xiangfan Chen1, Cheng Sun1, Guillermo Ameer1
1Northwestern University, Evanston, IL, USA
It is estimated that over 15 million people and approximately 8-12
million people in the United States have atherosclerotic coronary artery
disease (CAD) and peripheral artery disease (PAD), respectively.1
Problems (e.g. restenosis, thrombosis, and impaired vasomotion) as-
sociated with bare and drug-eluting metal stents have prompted the
development of bioresorbable vascular scaffolds (BVS). However,
current BVSs do not meet the mechanical properties of metal stents
(nitinol) and their increased strut thickness and width increases the risk
of thrombosis. The objective of this study is to develop a biomaterial ink
(B-InkTM) formulation that will enable 3D printing of a biocompatible,
mechanically functional BVS to overcome the above challenges.
In this study, we fabricated BVS with strut width and thickness of
155 mm, which is comparable to the dimensions of a polymer-based
BVS approved by the U.S. Food & Drug Administration. Con-
centrations of B-InkTM components (e.g. prepolymer: methacrylated
poly(1-12 dodecamethylene citrate; co-photoinitiator: Ethyl 4-
dimethylamino benzoate) had significant effects on the final me-
chanical properties of the printed BVSs and allowed the BVS to meet
the mechanical properties of nitinol stents. This work is a step for-
ward toward the development of patient-specific 3D-printed BVSs.
References: 1. Fowkes FGR. et al. Lancet, 2013; 382: 1329-40.
Acknowledgments: This work was supported by the National
Science Foundation (NSF, EEC-1530734) and The Farley Foundation.
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Design and Synthesis of Cell Instructive Bioinks for Controlling
Cell Fate and Functions in 3D Bioprinted Soft Tissue
P. Gatenholm, E. Karabulut, L. Strid Orrhult;
Chemical and Biological Engineering, Chalmers University
of Technology, Goteborg, SWEDEN.
3D Bioprinting is an emerging technology which will revolu-
tionize the field of tissue engineering and regenerative medicine. 3D
Bioprinting can replicate any tissue or organ by building biological
material layer by layer using 3D bioprinter, bioink and cells. The
function of bioink is to facilitate viable cell deposition in pre-
determined pattern and then become the scaffold when cells are
cultured in vitro or in vivo. Among the most important properties of
bionks are rheological properties. We have developed bioinks with
excellent printability using polysaccharide nanofibrils (such as cel-
lulose, CNF) and these bioinks have been successfully commer-
cialized and are available on the market under trade name CELLINK.
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The hydrophilic nature of the CNF surfaces covered by water prevent
them from protein adsorption and make them bioinert. Cells do not
recognize CNF surfaces which is a big advantage when it comes to
biocompatibility. In this presentation we introduce the new genera-
tion of cell instructive bioinks for controlling cell fate and functions
of cells forming soft tissue. Cellulose nanofibrils were bioconjugated
with extracellular matrix components such as collagen, fibronectin,
peptide motifs such as RGD or GRGDSP, laminin and growth factors
such as TGFBeta and BMP7 and then used as bioinks. We have seen
remarkable effects of bioink - cell interactions on cell adhesion,
proliferation and also cell differentiation. The results from in vitro
and in vivo studies using human chondrocytes, fibroblasts and adi-
pose derived stem cells as well as iPSC will be presented.
52
A Novel Strategy for Vocal Fold Tissue Engineering to Promote
Cell Attachments and Migration
N. Latifi, M. Asgari, R. Gopinath, M. Toufaili, L. Mongeau;
McGill University, Montreal, QC, CANADA.
Injectable hydrogels are under investigation for vocal fold (VF)
engineering to regenerate extracellular matrix in the VF lamina propria
or to restore viscoelastic functions of the damaged tissue. The hydro-
gels should thus be biocompatible, biodegradable, and offer a tissue-
mimetic micro-environment to support cell culture and implantation in
terms of cell attachments and migration. In the present study, a novel
injectable hydrogel composed of collagen fibrils in a glycol-chitosan
matrix was developed and characterized. A recombinant human epi-
dermal growth factor (EGF) with four target concentrations of 125,
250, 375 and 500 ng/mL was encapsulated within the cell-seeded hy-
drogels. Samples without EGF were used as negative controls. The
proposed hydrogel was shown to be biocompatible, biodegradable and
possess a fibrillar porous micro-structure. The hydrogel was found to
be mechanically stable under phonation-induced stimulations using a
previously described phono-mimetic bioreactor (1). The hydrogel also
supports cell attachments due to the presence of collagen fibrils. It was
also found that the addition of 375 ng/mL EGF promotes VF fibro-
blasts migration significantly. To investigate the gradual release of
EGF, glycol-chitosan micro-particles were fabricated and character-
ized. The particles were loadedwith EGF, and encapsulated in the bulk
hydrogels. The two biomaterial models were then compared in terms
of cell-biomaterial interactions.
1. Latifi N, et al., Tissue Engineering Part C: Methods 22(9), 823,
2016.
Acknowledgments: NIH R01-DC005788 (Mongeau, L.).
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Ovarian ECM-Derived Hydrogels Provide a Bioactive Scaffold
for Follicle Maturation
M. J. Buckenmeyer1, Z. Xian1, Y. Ren2, A. Rajkovic2,
B. N. Brown1;
1Bioengineering, University of Pittsburgh, McGowan Institute for
RegenerativeMedicine, Pittsburgh, PA, 2Obstetrics, Gynecology and
Reproductive Science, Magee-Womens Research Institute,
Pittsburgh, PA.
A large percentage of female cancer survivors lose reproductive
function due to the deleterious effects of treatment on ovarian tissues
and cells. In vitro follicle maturation (IVM) has been suggested as a
safer option to help restore fertility by isolating follicles from the
stroma to obtain mature oocytes devoid of malignant cells. In an
effort to improve current IVM outcomes, our group has developed a
bioactive ECM hydrogel derived from decellularized porcine ovarian
tissues to mimic the ovarian microenvironment. Ovarian tissues were
treated with mild detergents to remove immunogenic components,
then lyophilized and milled into a fine ECM powder. The hydrogel
scaffolds were formed from solubilized ECM powder at 37C after
neutralizing pH and balancing the salt concentration. Sohlh1-
mCherry newborn mouse ovaries were cultured on top of the ovarian
scaffolds at increasing ECM concentrations to determine the effects
of the hydrogel on primordial follicle populations. A volumetric
analysis of confocal images showed no significant difference be-
tween the number of Sohlh1+ cells in native day 7 and hydrogel-
cultured ovaries. This result was confirmed using immunohisto-
chemistry (NOBOX) and immunofluorescence (Sohlh1/2) staining,
showing morphologically healthy oocytes throughout the ovaries
after seven days. Ovaries cultured on higher ECM concentrated
scaffolds showed a decrease in the total follicle population, which
may suggest that increasing mechanical stiffness could drive follicle
activation. Finally, ovarian follicles were enzymatically isolated
from 6-14 day mice and successfully embedded in ovarian ECM
scaffolds demonstrating the potential of ovarian hydrogels as an al-
ternative biomaterial for fertility preservation.
54
Nanovesicles within ECM Bioscaffolds as Regulators
of the Strength of Soft Tissue Repair
G. S. Hussey, S. F. Badylak;
McGowan Institute for Regenerative Medicine, Pittsburgh, PA.
Bioscaffolds derived from mammalian extracellular matrix (ECM)
are widely used clinically as templates of inductive tissue remodeling
in multiple anatomic sites. Constructive tissue remodeling facili-
tated by ECM-scaffolds is largely attributed to the degradation of
the scaffold material and subsequent release of bioactive components
including matrix-bound-nanovesicles (MBV). However, the mecha-
nisms by which MBV regulate the functional and mechanical prop-
erties of remodeled tissue is only partially understood. The present
study shows that Lysyl Oxidase (LOX) isoforms are functional MBV
surface proteins. The heterogeneous family of LOX extracellular en-
zymes are responsible for collagen cross-link formation and stabili-
zation of collagen fibrils. Although there has been much interest in
utilizing LOX proteins in tissue engineering applications, these efforts
have been confounded by the inherently low solubility of LOX, which
obviates effective clinical translation. Our finding that LOX is asso-
ciated with MBV provides not only a feasible method for purifying
functional LOX proteins for therapeutic applications, but also a con-
ceptual model for how LOX is incorporated into ECMof native tissues
as part of the homeostatic process. Moreover, emerging evidence
suggests that secreted LOX can re-enter cells and rapidly concentrate
in the cell nucleus, resulting in increased promoter activity of the
collagen alpha-1(III) gene, and upregulation of elastin mRNA. Stated
differently, the in-vivo degradation of ECM-bioscaffolds and associ-
ated release of MBV can serve as a feedback loop to instruct cells to
coordinate the synthesis and deposition of matrix components. MBV
represent an attractive potential tissue engineering strategy to enhance
the biomechanical properties of injured soft tissue.
55
Fabrication of 3D Biomaterial Scaffolds for Bone Tissue
Engineering Applications using Additive Manufacturing
Technology
J. Kim, M. Sa;
Department of Mechanical Engineering, Andong National
University, Andong-si, KOREA, REPUBLIC OF.
In bone tissue engineering, polymers and ceramics are used as
essential materials for the fabrication of scaffolds in recent years.
Poly (e-caprolactone) (PCL) is one of the most flexible among the
bioresorbable polymers, which is commonly used as basic material to
fabricate three-dimensional (3D) composite scaffolds based on a 3D
printing technique. Calcium phosphate-based bio-ceramics are being
widely used in bone tissue regeneration due to their excellent bio-
compatibility and osteoconductivity. In our laboratory, we fabricated
3D hybrid polymers and ceramics scaffolds with designed pore
structures using various additive manufacturing technologies.
The morphology and characterization of the fabricated scaffolds
were evaluated. These results suggest that the 3D scaffolds with
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interconnected pores could be a suitable candidate for bone repair
and regeneration. In this presentation, self-developed scaffold
fabrication techniques will be introduced.
56
In Vitro Chondrogenesis in 3D Bioprinted Human Cell-laden
Hydrogel Constructs
S. Schwarz1, L. Strid Orrhult2, E. Karabulut2, C. Goegele1,
K. Stoelzel3, G. Schulze-Tanzil1, P. Gatenholm2;
1Paracelsus Medical University, Department of Anatomy,
Nuremberg, GERMANY, 2Chalmers University of Technology,
3D Bioprinting Center, Gothenburg, SWEDEN, 3Charite´-
Universita¨tsmedizin Berlin, Campus Charite´ Mitte, Department
of Otorhinolaryngology, Berlin, GERMANY.
A fundamental challenge of cartilage tissue engineering is the de-
differentiation of chondrocytes resulting in the loss of chondrogenic
phenotype. TGF-b1 plays a crucial role in initiating and maintaining
chondrogenesis of chondrocytes, mesenchymal precursor cells and
deposition of cartilage-specific ECM molecules. The aim of the study
was to control the chondrogenic differentiation of human chondrocytes
(hNC) and human adipose derived stem cells (hASC) by conjugating a
bioink with TGF-b1 and 3D Bioprinting constructs.
For cartilage reconstruction, we evaluated the biological func-
tionality of a bioink consisting of nano-fibrillated cellulose conju-
gated with TGF-b1 and supplemented with alginate. We loaded
the nano-fibrillated bioink with and without TGF-b1 with hNC as
well as co-cultures of hNCs with hASC (ratio 20:80). Constructs
were produced by 3D bioprinting and cultured for up to 21 days.
The chondrogenic phenotype of hNCs as well as the effect on
chondrogenic differentiation processes in hNC:hASC co-cultures
and neo-synthesis of cartilage specific components were examined
on protein- and gene-expression level.
3D printing with both bioinks facilitated the production of cell-
laden implants with a high cell density and a homogenous cell dis-
tribution. Both inks provided an optimal nutrition supply of the
embedded hNCs and hNC:hASC, confirmed by high cell vitality
during 7d 3D culture. All constructs exhibited excellent shape and
size stability. Conjugation with TGF-b1 did not change 3D stability
and viability of cells. Data of histological, immunohistochemical
and biochemical analyses for evaluation of redifferentiation and
chondrogenesis of hNCs as well as hNC:hASC co-cultures will be
presented.
57
Effects of 3D Printing on Flow-Induced Shear
Stress Distributions
M. Felder, C. Williams, V. Sikavitsas;
Stephenson School of Biomedical Engineering, University
of Oklahoma, Norman, OK.
As 3D printing gains more exposure as the future of scaffold
fabrication for tissue and tumor engineering, the ability to preemp-
tively model the constructs microenvironment becomes of vital im-
portance. Particularly when using perfusion based bioreactor
systems, the most important properties to obtain are the fluid flow and
wall shear fields that potential cells will experience during and after
seeding. Traditionally, 3D printing has given users the impression
that the scaffold obtained after printing will exhibit the same, or
closely similar, architecture as the designed model. While this may
be the case in terms of the macrostructure, we hypothesized that the
local fluid dynamic environment would differ greatly. The intention
of this study was to 3D print scaffolds of various pore size gradients,
image these constructs utilizing micro-computed tomography, and
perform computational fluid dynamic simulations on the resulting
reconstructions and the initial designs in order to compare the av-
erage shear on the fibers, where the cells would be adhered. As a
determining factor, the probability density function (p.d.f.) of each
was compared to not only highlight the major differences, but also to
show the reproducibility of the printing process. The results pre-
sented in this manuscript give users the knowledge of how the 3D
printing process may alter the intended fluid environment they de-
signed, and how to, in spite of that fact, produce repeatable results.
58
Low Intensity Ultrasound Prolongs Lifetimes of Mesenchymal
Stromal Cell Transplants in Skeletal Muscle
S. R. Burks, M. E. Nagle, J. A. Frank;
NIH Clinical Center, Bethesda, MD.
Mesenchymal stromal cells (MSC) are the most clinically-
applicable stem cell for transplantation.MSCs are considered immune-
privileged, but typically do not engraft into host tissue, dying within
3-10 days post-transplantation. We have extensively studied image-
guided focused ultrasound tissue molecular responses and sought un-
focused therapeutic ultrasound (TUS) as a cost-effective mechanism to
produce similar results. Daily TUS (10min; 2W/cm2; 10% duty cycle)
to mouse hamstrings following implantation of 106 luciferase-
transfected bone marrow MSCs prolonged MSC survival. Luciferase
was detectable in treated legs for 6 days compared to 4 days in un-
treated legs. TUS resulted in mild hypoxia in hamstrings, indicated by
pimonidazole accumulation. Furthermore, increased muscle levels of
hypoxia-inducible factor-1a (HIF-1a), nuclear factor kB (NFkB),
cyclooxygenase-2 (COX2), vascular endothelial growth factor
(VEGF), interleukin-10, fibroblast growth factor (FGF), intercellular
adhesion molecule (ICAM), and vascular cell adhesion molecule
(VCAM) were detected, consistent with mild or transient hypoxia.
While hypoxia-driven factors (e.g. VEGF, FGF, IL-10) are pro-growth
and could promote cell survival, hypoxia itself is known to enhance
MSC survival and potency. Further mechanistic investigations into
TUS exposures are necessary to elucidate which specific TUS effects
are beneficial (i.e. on host tissue and/or transplants). Prolonging life-
times with TUS has profound implications for a wide range of MSC
therapies because TUS is noninvasive, safe, and inexpensive. There-
fore, utilizing a straightforward clinically-approved modality (TUS)
toward transplanted MSCs could increase longevity and function of
transplanted cells, reduce the number of transplantations/injections
required to treat disease, and ultimately improve cellular therapy.
Scientific Session 3: Imaging Tissue Engineering
Therapies
Monday, December 4, 2017, 4:15 PM - 5:45 PM
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Design and Testing of a Non-Invasive 3D Imaging System
for Cell Mapping Within Bioengineered Tissue
G. O’Connell1, J. Tsuruta2, W. Zhang2, T. Czernuszewicz1,
P. A. Dayton2, L. Reid2, R. Gessner1;
1SonoVol, Inc., Research Triangle Park, NC, 2UNC Chapel Hill and
NCSU Joint Dept of BME, Chapel Hill, NC.
Background: Many tissue engineering laboratories are working
to develop bioengineered organs from either printed or decellularized
scaffolds. These functionalized platforms could address significant
clinical transplant scarcities. Clinical translation of bioengineered
organs would be accelerated with more precise feedback and control
of the microenvironment within engineered tissues. For instance, it is
currently very challenging to acquire noninvasive 3D images of
developing organs or quantitatively assess the seeding and growth of
cells within developing organs. These parameters can only be eval-
uated destructively by histology or by rudimentary input/output as-
says with no spatial sensitivity. This slows down the experimental
feedback loop and increases the costs of R&D.
Methods: To address this problem, we have constructed a robotic
3D organ imaging system. The system uses high resolution ultrasound
to image tissue (b-mode), vasculature/microvasculature (Acoustic An-
giography), and cellular maps within the organ (targeted microbubble
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contrast). The system’s spatial resolution is *100 um, can image
*2 cm into tissue, and is sensitive to a single microbubble (smaller than
a blood cell).
Results: We have collected 3D images of different species and or-
gans, including mouse (liver), rat (liver), and pig (kidney+lung). En-
dothelial cell mapping has been achieved using microbubbles targeted
against CD-31. An image fusion algorithm has been written to allow
seamless blending across an entire field of view as large as 7·7cm.
Next steps: To allow cells beyond the lumen to be mapped, na-
noparticle contrast agents will be explored. Additionally, hardware
developments are underway to improve ease of use and maximize
study consistency.
60
Quantitative nano-mechanical characterization
of biomaterialsand living cell samples using atomic
force microscopy
T. Mueller1, H. Haschke1, S. Kaemmer2, T. Jaehnke1;
1JPK Instruments AG, Berlin, GERMANY, 2JPKInstruments USA
Inc., Carpinteria, CA.
The determination of the biophysical parameters and mechanical
properties of biomaterials such as structural and physico-chemical
composition, topography, roughness and adhesiveness is gaining sig-
nificant recognition in biomedical applications. These factors strongly
affect cell development, tissue formation and also influence the healing
capacity of the human body. Atomic Force Microscopy (AFM) is a
versatile tool suitable for measuring all of these characteristics with
nanometer scale resolution under physiological conditions. We have
developed a multipurpose AFM device which allows the compre-
hensive characterization of biological samples such as live cells, tis-
sues and biomaterials in the nanoscale. Our Quantitative Imaging
(QI) mode acquires real force distance curves at every pixel of an
image in order to simultaneously obtain topographic, nano-mechanical
and adhesive sample properties. To get those quantitative data, such as
Young’s modulus images and topography at different indentation
forces, experiments on from living cells, skin tissue and hydrogels
were performed. Micro-rheology can be used to characterize the visco-
elastic properties of the same sample. Oscillatory measurements (Hz-
1000Hz, amplitude 5-20nm) were carried out to calculate the dynamic
storage and loss modulus (E’, E’’) distribution on living fibroblast
cells. Furthermore, we have developed a complimentary device which
enables tensile stretching with AFM. This comprehensive toolbox al-
lows applying sample deformation in the sample plane, which can then
be investigated in detail by the AFM. The potential of the combination
of QI mode and tensile stretcher is demonstrated with a study of an
elastic film during and after the tensile load
61
Multi Target Labeling To Monitor Myoblast Differentiation
E. SAPOZNIK1, Y. Zhou2, I. Ashry3, Y. Xu3, S. Soker1;
1Biomedical Engineering, Wake Forest Institute for Regenerative
Medicine, WINSTON SALEM, NC, 2Wake Forest Institute for
Regenerative Medicine, WINSTON SALEM, NC, 3Virginia Tech,
Blacksburg, VA.
Introduction: Better non-invasive assessment tools for tissue mat-
uration and development are necessary to advance the field of regen-
erative medicine into the clinic. We have previously described a novel
fiber based imaging tool capable of real-time non-invasive monitoring.
The goal of the current study was to adapt this system to assess skeletal
muscle development. Specifically, we have determined the necessary
cell labeling parameters to allow high resolution imaging.
Materials and methods: Fluorescently labeled C2C12 myoblast
cells were used as a cell model. GFPH2BmCherry cells were labeled
via lentiviral infection and sorted for highest expressing cells. The
labeling of cells was compared with sacrificial tools of im-
munostaining and RT-qPCR. Cell fusion was assessed on plastic and
electrospun PCL/Collagen scaffold with and without protein coating.
Results: Fluorescent labeling of both the nucleus and cytoplasm in
C2C12 enabled a quantitative measure for differentiation level. The live
cell fusion was comparable to immunostaining and mRNA levels ex-
pression typical of myoblast differentiation. Geltain coating of plastic
had no significant impact onmyoblast fusion,while collagen film coating
of the scaffold improved cell differentiation with higher fusion index.
Discussion and conclusions: The labeling approach developed in
this study offers a new way to monitor myoblast differentiation
quantitatively in real time. The application of the labeled cells shows
the promise in using this approach to assess cell morphology non-
invasively. Future studies will measure skeletal muscle cell differ-
entiation on different scaffolding types and in response to drugs.
62
Real-time MRI of Intrathecal Transplantation of Hydrogel-
Embedded Glial Progenitors in Dogs Suffering from ALS-like
Disease
I. Małysz-Cymborska1, D. Gołubczyk1, L. Kalkowski1,
M. Janowski2,3,4, J. Sanford5, K. Olbrych6, P. Holak7,
W. Maksymowicz1, P. Walczak2,3,8;
1Department of Neurology and Neurosurgery, University of Warmia
and Mazury, Olsztyn, POLAND, 2Russell H. Morgan Dept. of
Radiology and Radiological Science, Johns Hopkins University,
Baltimore, MD, 3Cellular Imaging Section and Vascular Biology
Program, Institute for Cell Engineering, Johns Hopkins University,
Baltimore, MD, 4NeuroRepair Department, Polish Academy of
Sciences, Warsaw, POLAND, 5Vet Regen, Warsaw, POLAND,
6Department of Morphological Sci, University of Life Sciences –
SGGW, Warsaw, POLAND, 7Department of Surgery and Roentgen,
University of Warmia andMazury, Olsztyn, POLAND, 8Department
of Radiology, University of Warmia and Mazury, Olsztyn,
POLAND.
Stem cell-based regenerative medicine is an attractive approach for
the treatment of neurodegenerative diseases. Disorders with global
pathology such as ALS require broad cell distribution hence, cerebro-
spinal fluid-filled spaces are attractive gateways for cell transplantation.
To prevent sedimentation, we propose to embed cells in hydrogel for
intrathecal injection. The goal of this study was to investigate the ap-
plicability of injectable hydrogels for intrathecal transplantation of glial
restricted precursors (GRPs) in dogs suffering from ALS-like disease
degenerative myelopathy (DM). Canine GRPs (6-7x106/ml) were la-
beled with superparamagnetic iron oxide nanoparticles (SPIO;Biopal).
Immediately prior to injection, hydrogel components were mixed
(EsiBio). Dogs suffering from DM (n=4) were subjected to X-ray
guided catheter placement within thoracic spinal cord. Next, hydrogel
containing SPIO-labeled GRPs was injected under MRI with acquisi-
tion of dynamic T2*-weighted images. Tissue from two dogs that
succumb to the disease was processed for ex vivo MRI and histopa-
thology (Prussian blue). Dynamic imaging during hydrogel infusion
revealed hypointensity in the area of catheter tip extending rostrally and
caudally. The rostral-caudal distance, covered by hydrogel ranged be-
tween 42-168mm. Ex vivo MRI of spinal cord revealed hypointense
regions in the thoracic part, that correlated with in vivo MRI scans
during hydrogel injection. Prussian blue staining detected iron particles
within hydrogel confirming presence of SPIO-labeled GRPs. MRI-
guided, intrathecal injection of hydrogel-embedded cells in DM dogs is
safe and feasible. Embedding cells in the injectable hydrogels prevents
sedimentation and facilitates attachment of cells to spinal cord surface
tissue setting the stage for their migration and engraftment.
63
Labeling Of Hyaluronan-based Hydrogels Using Fluorine
Nanoemulsions
M. Piejko1,2, P. Walczak1,3, X. Li1, J. W. Bulte1, M. Janowski1,4;
1Johns Hopkins University, Baltimore, MD, 2Jagiellonian
University, Cracow, POLAND, 3University of Warmia and Mazury,
Olsztyn, POLAND, 4Mossakowski Medical Research Centre,
Warsaw, POLAND.
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Hydrogels can serve as injectable scaffolds for transplanted stem
cells, but the precision of hydrogel injections, as well as monitoring of
gel biodegradation, remains challenging. We studied the feasibility of
using a fluorine nanoemulsion to label and image hyaluronan-based
hydrogels with 19F MRI. We studied three hydrogels with various V-
sense (CelSense, Inc.) to HA (Hystem, Inc.) volumetric ratios (1:50,
1:10, and 1:5). Gelation time and elasticity were measured by oscil-
latory stress at 1h and 7d using an ARES 2 rheometer. Diffusion of
fluorine from the hydrogel was evaluated through acquisition of 1H and
19F MRI scans at until 2 months after hydrogel preparation using a
Bruker Ascend 750 scanner. The viability of glial restricted precursors
(GRPs) embedded within hydrogels was assessed in vitro and in vivo.
We found that increasing concentrations of fluorine gradually elon-
gated the gelation time from 194 s for controls to 304 s for 1/5V-sense/
HA hydrogels, while their elastic properties slightly decreased, from
183 Pa for the control to 95.3 Pa for 1/5V-sense/HA hydrogel at day 0,
and from 870 Pa for the control to 588 Pa for 1/5V-sense/HA hydrogel
for day 7. There was no release of fluorine nanoemulsion from hy-
drogels. No negative influence of V-sense on the proliferation/viability
of GRPs was also observed either in vitro or in vivo, and, at some time
points, the presence of fluorine seemed to have a beneficial effect.
Thus, fluorination of hydrogels appears promising to follow the loca-
tion of scaffolded cells non-invasively with MRI.
Scientific Session 3: Regenerative Pharmacology
Monday, December 4, 2017, 4:15 PM - 5:45 PM
63A
Developing a Novel Small Molecule Based Therapy to Restore
Hearing and Balance
G. Kulkarni, C. Clouse, I. Kim, B. Lu, J. Jackson, J. Yoo, A. Atala;
Wake Forest Institute For Regenerative Medicine, Winston-Salem,
NC.
Hair cells in the inner ear are essential for hearing and balance that
are lost due to aging, medications or loud sounds. The adult mam-
malian inner ear fails to regenerate hair cells resulting in permanent
deficits. During development, supporting cells within inner ear sen-
sory epithelia can self-renew to give rise to new hair cells; however
they become quiescent postnatally. Previously, we have shown that
in vivo gene delivery of c-Myc (c-MycT58A) into the inner ear
stimulated reprogramming of supporting cells in adult mice utricles
leading to formation of few new hair cells. Based on this, we have
developed a small molecule based therapy to induce in situ repro-
gramming of supporting cells for proliferation and regeneration
of inner ear hair cells. In order to select potential c-Myc activators,
we screened several small molecules synthesized in our laboratory
using a Luciferase based assay. Few potential c-Myc activators
were further tested on adult mice utricle cultures. Supporting cell
proliferation and hair cell regeneration were analyzed using EdU
(Ethynyl-2’-Deoxyuridine) along with supporting(SOX2) and hair
cell(MYO7) specific markers. For in vivo studies, the most potential
small molecule candidate was injected into the mouse inner ear via
Canalostomy along with multiple EdU-IP injections. We have thus
identified a novel small molecule drug candidate which can induce
supporting cell proliferation and limited hair cell regeneration in situ
in both cultured and live adult mice inner ear utricles. A preclinical
study of this drug candidate is currently under process.
64
Development Of A Novel Alginate based Material For Targeted
Intestinal Delivery Of Therapeutic Agents
K. Enck1, S. Banks2, V. Agwu3, A. Peeden4, H. Yadav5, M.Welker2,
E. C. Opara1;
1Biomedical Engineering, Wake Forest University, Winston-Salem,
NC, 2Chemistry, Wake Forest University, Winston-Salem, NC,
3Biomedical Sciences,Wake Forest University,Winston-Salem, NC,
4Biotechnology, Forsyth Tech, Winston-Salem, NC, 5Molecular
Medicine, Wake Forest University, Winston-Salem, NC.
Alginate is a complex polysaccharide routinely used for various
encapsulation purposes including oral drug delivery of therapeutic
agents since it can immobilize and protect compounds from the harsh
stomach acid. We have chemically modified alginate to enhance the
bioavailability of orally-administered therapeutic substances through
the generation of alginate microbeads resistant to low pH stomach
conditions, but readily disintegrate in the more neutral pH of the
small intestine. The alginate modification was achieved by oxidizing
the vicinal diol in the alginate chain to an aldehyde, then coupling
aminoethyl benzoic acid to the aldehyde. By uniquely combining
both oxidizing and condensation chemistries, we have been able to
more precisely control the degree of modification of alginate, which
results in controlled levels of degradation of alginate hydrogel mi-
crobeads under simulated gastrointestinal tract (GIT) regional pH
conditions. Under these simulated GIT conditions, our in vitro ex-
periments have shown that we can encapsulate specific compounds
for oral drug delivery, protect them from low pH conditions and
deliver them under neutral-basic pH conditions similar to those in the
small intestine where nutrients are absorbed most effectively. Thus,
the modification of alginate with aminoethyl benzoic acid would lead
to enhanced bioavailability of therapeutic agents after release and
absorption in the small intestine and as well as for targeted site
delivery of certain substances such as probiotics.
65
Tissue Engineering Bio-mimetic Ovarian Constructs
With Sustained Hormone-releasing Profile For Cell-based
Hormone Replacement Therapy For Ovarian Failure
S. Sivanandane1, J. M. Saul2, A. Atala1, J. D. Jackson1, J. J. Yoo1,
E. C. Opara1;
1Wake Forest Institute for Regenerative Medicine, Wake Forest
School for Medicine, Winston-Salem, NC, 2Department of
Chemical, Paper, and Biomedical Engineering, Miami University,
Oxford, OH.
We recently developed a cell-based hormone replacement therapy
(cHRT) as an alternative to pharmacological HRT (pHRT), which has
been associated with some adverse effects. Our previous constructs
used calcium as alginate cross-linker to encapsulate ovarian endocrine
cells. Although the constructs corrected many of the abnormalities
associates with ovarian failure they did not deliver sustained levels of
estrogens. Therefore, in order to develop a long-term sustained
hormone-secreting ovarian constructs, we have replaced calcium with
strontium in the fabrication process. In addition, we have incorporated
bone marrow stromal cells (BMSCs) into the constructs for cellular
aromatase enzyme supplementation in order to enhance the secretion
of estrogens. Rat ovarian cells (granulosa and theca cells) and BMSCs
were encapsulated in layer-by-layer constructs, thus compartmenta-
lizing the two ovarian cell types along with the BMSCs in each layer.
The in vivo functions of the constructs were tested in an ovariecto-
mized (ovx) ratmodel for a period of 90 days. The improved constructs
were able to deliver sustained levels of ovarian sex steroids (17b-
estradiol and progesterone) while suppressing the levels of follicle-
stimulating hormone and luteinizing hormone, thus restoring the
negative feedback loop, which in contrast to pHRT approaches. The
end-organ effects induced by ovariectomy such as body weight alter-
ations, body fat changes, uterine morphometry and bone density were
corrected by the ovarian constructs. The current study demonstrates
that our improved bio-mimetic ovarian constructs fabricated using
encapsulation techniques deliver long-term sustained levels of hor-
mones, and could be used as a cHRT for ovarian failure.
66
Combined Resveratrol and NicotinamideMediated Activation of
PARP-1 Restricts the Inflammatory Phenotype of Macrophage
M. Yanez1, M. Jhanji2, S. Mathew2, E. Jabbarzadeh1;
1Department of Chemical Engineering, University at South Carolina,
Columbia, SC, 2Department of Drug Discovery and Biomedical
Sciences, University at South Carolina, Columbia, SC.
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Inflammation is the response of body to injuries and foreign
materials, and plays an important role in the effective management
of diseases. The cascade of inflammatory response begins with the
recruitment of neutrophils that produces inflammatory cytokines to
stimulate the recruitment and differentiation of monocytes into
macrophages. The phenotypes of macrophages, generally classified
as pro-inflammatory (M1 macrophages) and wound healing (M2
macrophages), are the key targets in the anti-inflammatory drug
discovery approaches. In the present work, we studied the combi-
natorial role of nicotinamide and resveratrol in the phenotypic
regulation of inflammatory macrophages. Consistent with previous
works, we also observed that both nicotinamide and resveratrol
could suppress the expression of pro-inflammatory cytokines in-
cluding TNFa and IL-6 and could up regulate the expression levels
of the anti-inflammatory mediators (IL-10 and MRC1). Strikingly,
the effects of nicotinamide were more profound than resveratrol
while co-treatment with resveratrol further modulated the effects of
nicotinamide. The results suggest that a combination of resveratrol
with nicotinamide would trigger the conversion of nicotinamide
into NAD+ through the salvage pathway and would result in a
favorable immune response for a longer period of time. Further
investigations into the molecular mechanisms of action demon-
strated that Poly [ADP-ribose] polymerase 1 (PARP-1)-mediated
activation of Bcl-6 was primarily responsible for the observed anti-
inflammatory effects. Our work further delineates the potential of
pharmacologically active natural compounds to modulate inflam-
mation with broad applicability in regenerative medicine and drug
discovery.
Scientific Session 3: Regenerative Medicine
Transplantation
Monday, December 4, 2017, 4:15 PM - 5:45 PM
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Transplantation of a Human Tissue Engineered Bowel (hTEB)
in a Athymic Rat Model
R. Tamburrini1,2, E. Zakhem3,4, G. Orlando1, K. Bitar3,5,6;
1Wake Forest School of Medicine, Winston Salem, NC,
2Department of General Surgery, University of Pavia, Pavia,
ITALY, 3Wake Forest Institute for Regenerative Medicine,
Winston Salem, NC, 4Program in Neuro-Gastroenterology and
Motility, Wake Forest School of Medicine, Winston salem, NC,
5Program in Neuro-Gastroenterology and Motility, Wake Forest
School of Medicine, Winston Salem, NC, 6Section on
Gastroenterology, Wake Forest School of Medicine, Winston
salem, NC.
Background: Intestinal failure is a condition that results from the
loss of a large surface area of the small intestine. Patients lose the
ability to digest and absorb nutrients.
Objective: The objective of this study was to transplant human-
based engineered neo-intestines into athymic rats.
Methods: (1) TEB was developed by engineering innervated
human intestinal circular smooth muscle sheets around tubular
chitosan scaffolds. (2) TEBs were implanted in the omentum of
athymic rats. (3) After 4 weeks, TEBswere anastomosed to the native
small intestine of the same rats.
Results: (1) Following omentum implantation, TEB before
anastomosis revealed maintenance of cell morphology, phenotype
and function. (2) Following anastomosis, the rats initially lost weight
then started steadily regaining normal weight over the study period.
(3) At time of harvest (6 weeks), TEB was healthy with food digest
observed inside the lumen. (4) Organ bath studies revealed functional
innervated smooth muscle. (5) H&E demonstrated maintenance
of smooth muscle alignment. Neo-epithelialization was also ob-
served with well-defined crypts and villi structures. Alcian blue stain
demonstrated the presence of mucin, confirming the presence of
Goblet cells.
Conclusion: The results shown in this study demonstrated the
successful transplantation of engineered human intestines in rats.
Food particles were observed in the lumen of the implanted tissues
and rats gained weight over the study period. The bioengineered
tissues were viable and have acquired epithelial components with
villi structures necessary for digestion and absorption. TEB provides
a therapeutic approach to lengthen the gut to treat patients with in-
testinal failure.
69
Generating a New Pediatric Surgical Option to Treat
Esophageal Atresia
T. Jensen1, A. Mitchell1, H. Wanczyk1, I. Sharma2,
W. Sayej3, C. Finck4;
1Pediatrics, UConn Health, Farmington, CT, 2Surgery,
UConn Health, Farmington, CT, 3Gastrointestinal Diseases,
Connecticut Children’s Medical Center, Hartford, CT,
4Pediatric Surgery, Connecticut Children’s Medical Center,
Hartford, CT.
Esophageal atresia occurs in 1 in 3000 births. Typically, surgi-
cal repair includes reconnection of the esophagus or in cases
where the esophagus cannot be reconnected, interposition of a piece
of stomach or intestine. These surgical options cause significant
morbidity, therefore, a new therapeutic option is needed. Porcine
amniotic fluid stem cells were obtained via amniocentesis approxi-
mately 70-90 days prior to term. Cells were isolated, expanded and
characterized via flow cytometry and qRT-PCR. Cells were over
90% positive for mesenchymal stem cell markers CD73, CD90 and
CD105. Approximately 10 million cells were seeded onto the extra
luminal surface of a polyurethane scaffold (Biostage) and allowed
to incubate for 7 days in a rotating hollow organ bioreactor (Bio-
stage). Approximately 4cm of intra-thoracic esophagus was re-
moved in 2 piglets from the same litter as the isolated amniotic fluid
stem cells and replaced with the seeded scaffolding in accordance
with IACUC approval (HH#2014-0132). The lumen in both piglets
were stented open with a 10mm metal stent. The stents were then
removed and changed after 3 weeks. This revealed that the scaffold
had been extruded and the lumen regenerated. Piglets were fed via G-
tube for 5-6 weeks, and then successfully transitioned to oral feeding.
These piglets demonstrated the translational and preemptive appli-
cation of maternal amniotic fluid stem cells and a bioengineered
synthetic scaffold in replacing missing gaps of esophageal tissue in
offspring. Further studies are ongoing to delineate the mechanism of
esophageal regeneration.
70
3D Bioprinting of Human Kidney Construct: A Step Towards
Solid Organ Printing
P. R. Anil Kumar1, M. Ali2,1, S. J. Lee1, J. J. Yoo1, A. Atala1;
1Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC, 2Chemistry Department, Zagazig University, Zagazig, EGYPT.
Current treatments for end-stage renal disease include dialysis or
kidney transplants. However, problems such as limited donor organs,
graft failure, and other complications remain a concern. Bioengi-
neering of living organ-like structures offers an alternative to the
present treatments. Recently, three-dimensional (3D) bioprinting has
evolved as a revolutionary technology capable of bioengineering
living tissues or organs for transplantation. Here, we used 3D bio-
printing strategy to bioengineer a kidney construct containing human
primary renal cells. Primary renal cells were isolated from human
kidneys, and they were suspended in gelatin methacrylate (GelMa)-
based bioink for 3D bioprinting. For in vitro study, a solid block
design of kidney construct was fabricated using our Integrated Tissue
and Organ Printing (ITOP) system. The bioprinted renal constructs
were evaluated for cell viability, proliferation, and renal tissue
maturation/formation over a period of 14 days in culture. The bio-
printed renal tissue constructs showed high cell viability and pro-
liferation and exhibited the structural and functional characteristics
of kidney tissue. We demonstrated the potential of the use of 3D
bioprinting strategy to fabricate the functional renal constructs for
future application.
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71
Beginning a New Banff Classification of Tissue Engineering
Pathology
K. Solez1, A. Petrosyan2, J. F. Burdick3;
1Laboratory Medicine and Pathology, University of Alberta,
Edmonton, AB, CANADA, 2University of Southern California, Los
Angeles, CA, 3Surgery, Johns Hopkins Medical Institutions,
Baltimore, MD.
The science of regenerative medicine is arguably older than
transplantation - the first major textbook was published in 1901 - and
a major regenerative medicine meeting took place in 1988, three
years before the first Banff meeting. However, the subject of re-
generative medicine/tissue engineering pathology has never been
given focused attention. Depending on one’s vantage point and organ
orientation regenerative medicine is already here, is right around the
corner, or will occur within our lifetime. Defining and classifying
tissue engineering pathology is long overdue. In the next decades, the
field of transplantation will enlarge at least tenfold, through tissue
engineering approaches.We suggest that transplantation pathologists
will become tissue-(re-)engineering pathologists with enhanced skill
sets to address many concerns involving the use of bioengineered
organs. We outline ways of categorizing abnormalities in tissue-
engineered organs through either traditional light microscopy or
several other modalities of examination. Based on these analyses we
propose creating a new Banff Classification of tissue engineering
pathology to standardize and assess de novo bioengineered solid
organs transplantable success in vivo. We recommend constructing a
framework for the creation of a classification of tissue engineering
pathology now with interdisciplinary consensus discussions to fur-
ther develop and finalize the classification at future Banff Transplant
Pathology meetings, in collaboration with the human cell atlas pro-
ject. The future safety and efficacy of bioengineered tissues and
organs is crucial to long-term transplantation success. A possible
nosology of pathologic abnormalities in tissue-engineered organs is
suggested.
72
Engineering Chorionic Villus-derived Mesenchymal Stromal
Cells For In Utero Treatment Of Spina Bifida
D. Hao1, L. Lankford1, P. Kumar1, K. Gao1, C. Wang1,
J. Harvestine2, K. Leach2, D. Farmer1, A. Wang1;
1Surgery, University of California, Davis Medical Center,
Sacramento, CA, 2Biomedical Engineering, University of California,
Davis, Davis, CA.
Spina bifida (SB) is the most common cause of lifelong paralysis.
SB is more than just a neurological disorder; it is a complex disease
with significant malformation of bone, muscle and connective tissue
overlying the spinal cord that results in severe neural tissue damage
and neurological deficits. Repairing the damaged spinal cord is a
long-standing challenge for the entire field; however, the question of
how to protect the spinal cord once repaired has been largely ignored.
This study proposes a fetal tissue engineering approach to design a
bioengineered construct to generate de novo segments of the bony
spine in order to provide support and protect the cord from future
damage. In this study, three methods were evaluated for the feasi-
bility of obtaining a significant number of placental first trimester
chorionic villus-derived mesenchymal stromal cells (CV-MSCs)
within a time frame relevant for autologous in utero fetal trans-
plantation. 1.262 · 109 (–3.937 · 108 Standard Deviation, SD, n = 4)
CV-MSCs were obtained within 3 weeks using the optimal isolation
method. The cells exhibited high proangiogenic, while also posses-
sing robust osteogenic potential when seeded on composite hy-
droxyapatite/poly (lactide-co-glycolide (HA-PLG) scaffolds. In
conclusion, this approach develops a bioengineered scaffold that can
facilitate new bone regeneration, holds great potential for fetal bone
regeneration and provides a path toward a more comprehensive ap-
proach for the treatment of SB.
73
Protecting Transplanted Cell Therapies Using
Immunomodulatory Materials
D. Delcassian1,2,3, R. Elgueta4, C. Ortiz4, M. Bochenek1,
O. Qatachi2, C. Shuo Shan1, C. McGladrigan1, R. Hausser1,
R. Langer1, D. Anderson1, K. Shakesheff2;
1MIT, Cambridge, MA, 2University of Nottingham, Nottingham,
UNITED KINGDOM, 3Harvard Medical School, Boston, MA,
4Kings College London, London, UNITED KINGDOM.
Cell and organ transplantation offers the potential to restore organ
function, however, a major limitation to this therapy is the require-
ment for patients to take global immunosuppressive drugs, often
daily, for the remainder of their lives, perhaps putting them at risk of
serious side effects. This research describes efforts to design new
ways to deliver localised and targeted immunosuppression to protect
cell transplant therapies from host immune attack. We have devel-
oped a targeted microparticle system which can deliver localised
immunomodulatory cues to a host transplant niche. These materials
can control the behaviour of T cells, and we use them to modulate the
host immune system in transplantation by directing T cell phenotype
in vitro and in vivo. By increasing the percentage of Treg cells in the
local transplant niche, alongside the draining and non-draining
lymph nodes, we have been able to extend transplant graft lifetimes
in two in vivo models, namely partial organ (skin graft) transplants
and organoid transplants in islet therapy. In both systems, comparison
of engraftment in systems using repeat administration of immuno-
suppressive drugs, or a single dose of our targeted and biodegradable
microparticle delivery platform was performed. Our results show an
increase in functional transplant lifetime in systems using our ma-
terials; in some cases functional graft lifetime was increased from
3 weeks to up to 3 months.
Scientific Session 4: Biofabrication and Bioreactors 2
Tuesday, December 5, 2017, 8:00 AM - 9:30 AM
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3D Bioprinting of Cartilage Tissue Using Canine Mesenchymal
Stem Cell Spheroids under the Optimal Growth Factor
Condition
K. Endo1, N. Fujita1, Y. Kunitomi2, T. Takeda1, J. Chen1,
K. Nakayama3, R. Nishimura1;
1Department of Veterinary Medical Sciences, The University of
Tokyo, Tokyo, JAPAN, 2Cyfuse Biomedical KK, Tokyo, JAPAN,
3Department of Regenerative Medicine and Biomedical
Engineering, Saga University, Saga, JAPAN.
Introduction: 3D bioprinting technology using spheroids of
mesenchymal stem cells (MSCs) is expected to offer a new strategy
for regenerative therapy. In this study, we investigated the optimal
growth factor condition for hyaline cartilage differentiation of canine
bone marrow peri-adipocyte cells (BM-PACs) that we have previ-
ously reported as newly developed MSCs [1] and tried to fabricate
cartilage constructs with a 3D bioprinting device.
Materials and Methods: Spheroids of BM-PACs were cultured
in chondrogenic media supplemented with BMP-2, GDF-5 or IGF-1.
The optimal chondrogenic condition was determined by the amount
of cartilage matrix synthesized and chondrogenic gene expression.
Then, spheroids were assembled into a patch-like construct by a Bio-
3D printer (Regenova, Cyfuse Biomedical KK) and cultured under
the optimal chondrogenic condition.
Results: Spheroids treated with BMP-2 and GDF-5 showed
increased glycosaminoglycan production. The expression of type
II collagen tended to increase in GDF-5 treated spheroids. Al-
though there was no change in chondrogenic gene expression,
BMP-2 significantly increased the expression of type X collagen.
After chondrogenic induction, the assembled spheroids were in-
tegrated each other and a transparent construct was obtained.
Similar synthesis of cartilage matrix as spheroid was observed in
the construct.
Discussion: GDF-5 was effective growth factor for hyaline
cartilage differentiation of canine MSCs. 3D bioprinting of car-
tilage construct using canine MSC spheroids under the optimal
condition can offer new insights for cartilage regenerative therapy
for dogs.
References: 1. Lin HY et al., StemCells Dev. 26(6), 431-440, 2017.
Acknowledgments: This work was supported by JSPS KA-
KENHI Grant Number 16J08547.
77
Adapting Commercial Projection SLA system for Printing
Live Cell-Laden Hydrogels
D. Choudhury1, W. Wong2, A. Bin Abdul Rahim1, T. Wang1,
J. Ong1, M. Win Naing1;
1Bio-Manufacturing Programme, SIMTech A*STAR, Singapore,
SINGAPORE, 2School of Chemical and Biomedical Engineering,
NTU, Singapore, SINGAPORE.
3D Bioprinting applies layer-by-layer based 3D printing tech-
nologies to develop precisely designed scaffolds for tissue repair
and organ replacement [1]. Projection stereolithography presents
a promising method to enhance yield with faster turnaround time
due to its fine resolution and high fabrication speed [2]. We report
an optimized process for printing live cell-laden hydrogels using a
commercial SLA printer. This procedure employs visible light
photocuring of poly (ethylene glycol) diacrylate (PEGDA) hy-
drogels in presence of photoinitiators. Desktop PICO2 (Asiga)
SLA printer was modified: (a) Smaller build tray volume for lesser
usage of precious materials (b) PMMA build tray base coated with
hydrophobic fluorinated ethylene film (FEP) to prevent scaffolds
from adhering to the build tray. Cytotoxicity of the water soluble
photoinitiator lithium phenyl(2,4,6-trimethylbenzoyl) phosphi-
nate (LAP) on WS-1 fibroblasts was evaluated and 0.3% (w/v)
LAP concentration was chosen. Percoll 37.5% SIP solution was
found to ensure the highest even suspension of cells in the
monomer solution. Printing parameters for hydrogels were opti-
mized: Keeping the light wavelength, intensity and slice thickness
constant, burn-in exposure time and layers were varied. Both
bright field and fluorescence microscopy indicated live cells in-
side the scaffold after 72 hours of culture. These optimization
studies lay groundwork for higher-resolution, large scale and
faster printing of tissues using SLA system. In vitro printed tis-
sues could be used for drug testing, regenerative medicine and
disease modelling. 1. Murphy SV, Atala A. Nature Biotechnol-
ogy. 32, 773, 2014. 2. Pereira R, Ba´rtolo P. Computational
Methods in Applied Sciences. Springer 31, 149, 2014.
78
The Effect Of Varying Duration And Frequency On A Tendon
Tissue Engineered Construct
C. Coffey, V. Sikavitsas;
Stephenson School of Biomedical Engineering, University
of Oklahoma, Norman, OK.
The proper utilization of mechanical stimulation, as documented
in literature, is typically a positive influence on the differentiation of
in vitro cultured stem cells and on the quality of deposited extra-
cellular matrix. Cyclic mechanical stimulation is the primary mode
of inducing tenocytic differentiation, and this study aims to validate
and optimize cyclic strain regimes previously used in house studies
on mesenchymal stem cell (MSC) seeded human umbilical veins
(HUV). We hypothesize that the extended stretching regimens nor-
mally utilized cause cellular fatigue, eliciting less of a response than
repeated short stimulations. During culture, the HUVs are subjected
to cyclical 2% strain for differing durations and frequencies before
being removed and examined for cellularity, maximum tensile strength
and tendon gene expression. In this study we investigated the effects of
changing the duration (0.5, 1, and 2 hours/day) and frequency (0.5, 1, 2
cycles/minute) of stimulation of a human umbilical vein seeded with
mesenchymal stem cells cultured for up to 7 days and up to 14 days.
The tendon constructs are examined for cellularity, tensile strength,
collagen fibril alignment and tendon gene expression compared to static
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controls. At 7 days, slower frequencies and shorter durations were best
for construct quality. Preliminary results will be compared with day 14
results. Through this optimization, we hope to engineer a more tendon
like construct than has previously been obtained.
79
Innovative Cartilage Regeneration for in situ Co-axial
3D Bioprinting
S. Duchi1,2, C. Onofrillo3, C. D. O’Connell4, R. Blanchard5,
A. F. Quigley6, R. M. Kapsa6, G. G. Wallace7, C. Di Bella8,
P. F. Choong9;
1Department of Surgery, University of Melbourne @ St. Vincent
Hospital, 29 Regent Street-Clinical Sciences Building, Fitzroy
3065, VIC, Australia, Fitzroy, AUSTRALIA, 2ARC Centre of
Excellence for Electromaterials Science, Intelligent Polymer
Research Institute, Innovation Campus, 2500 Squires Way,
University of Wollongong, NSW, Australia, Wollongong,
AUSTRALIA, 3Intelligent Polymer Research Institute, University
of Wollongong, Wollongong, AUSTRALIA, 43D Biofab, 3D
Biofab, Melbourne, AUSTRALIA, 5Department of Surgery,
University of Melbourne, Melbourne, AUSTRALIA, 6Department
of Clinical Neuroscience, University of Melbourne, Melbourne,
AUSTRALIA, 7University of Wollongong, ARC Centre of
excellence for electtromaterial sceince, Wollongong,
AUSTRALIA, 8Department of Medicine, University of Melbourne,
Melbourne, AUSTRALIA, 9Department of Orthopaedics,
University of Melbourne, Melbourne, AUSTRALIA.
Cartilage injuries can cause pain and loss of function, and if
severe may result in osteoarthritis (OA). Surgical procedures have
been disappointing because they lead to poor quality regenerated
tissue. 3D bioprinting introduces a new strategy to cartilage tissue
engineering for the generation of organized 3D scaffolds com-
posed of biomaterials with cells. Our team has developed a
handheld 3D printer (Biopen) that extrudes Mesenchymal Stem/
Stromal Cells encapsulated within a hydrogel (GELatin-Metha-
crylamide/Hyaluronic Acid-Methacrylate), with the aim to induce
hyaline cartilage regeneration (1). The key feature of the Biopen is
a co-axial nozzle that prints an organized Core/Shell structure in
which the inner soft Core, containing stem cells, is protected by a
robust Shell which hardening is induced by UV photocuring of a
selected photoinitiator. The aim of this study is to prove the
chondrogenic differentiation of human adipose derived Stem Cells
harvested from the infra-patellar fat pad of patients undergoing
total knee joint replacements, after 3D bioprinting with the Biopen.
We demonstrated that our strategy drives chondrogenic differentia-
tion, as reflected by the production of hyaline-like extracellular
matrix and the increase in phenotypic cartilage gene expression
markers. The ability to deliver in real time and in situ a chondrogenic
bioscaffold is a world-first innovation and has important implications
for customizing cartilage repair in patients with cartilage injuries or
early OA.
References: 1. O’Connell, C. D. et al. Biofabrication 8, 15019
(2016).
Acknowledgments: Arthritis Australia. Victorian Orthopaedic
Research Trust. ARCCentre of Excellence Scheme (# CE140100012).
St. Vincent’s Hospital (Melbourne) REF grant.
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In Vitro Models of Liver Cancer PDXs
E. Fong1, T. Toh1, T. Huynh2, E. Chow1, H. Yu1;
1National University of Singapore, Singapore, SINGAPORE,
2National Cancer Center Singapore, Singapore, SINGAPORE.
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Perfusable Tissue-Engineered Model of Neuroblastoma
for Studying Drug Resistance
A. Villasante1, K. Sakaguchi2, J. Kim1, N. V. Cheung3,
M. Nakayama4, H. Parsa1, T. Okano4, T. Shimizu4,
G. Vunjak-Novakovic1;
1Biomedical Engineering, Columbia University, New York, NY,
2Faculty of Science and Engineering, Waseda University, TWIns,
Tokyo, JAPAN, 3Department of Pediatrics, Memorial Sloan
Kettering Cancer Center, New York, NY, 4Institute of Advanced
Biomedical Engineering and Science. Tokyo Women’s Medical
University, Tokyo, JAPAN.
Neuroblastoma is a vascularized pediatric tumor derived from neural
crest stem cells that express a number of stemness markers, including
SOX2, a factor associated with the undifferentiated stem cell phenotype.
For high-risk patients, long-term survival is barely 50% despite surgery
and induction chemotherapy consolidated by isotretinoin (INN). INNhas
shown effectiveness in inducing cell differentiation, cell growth arrest
and inhibition of angiogenesis in in vitro studies and in clinical trials.
However, while more than 40% children suffer relapse during or after
INN treatment, little is known about the mechanism of drug resistance.
Interestingly, expression of SOX2 was related to drug-resistance and
tumor relapse in many types of cancer. We engineered a perfusable,
vascularized in vitro model of three-dimensional human neuroblastoma
to study the effects of INNon tumor vasculature and drug-resistance. The
bioengineered model recapitulated the clinically observed vasculogen-
esis and vasculogenic mimicry, and contained subpopulations of stem-
like neuroblastoma cells expressing high levels of SOX2. Treatmentwith
INN augmented populations of cells expressing high levels of SOX2 and
did not target new blood vessels formed by SOX2+/CD31+ cells. Our
results reveal some roles of SOX2 in drug resistance, and suggest that
SOX2 could be a therapeutic target in neuroblastoma.
Acknowledgments: The work was funded by the JSPS Post-
doctoral Fellowship for Overseas Researchers (AV), JSPS Kakenhi
25282145 (MN) and NIH (EB002520 and EB17103 to GVN).
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The Effects of Normal, Metaplastic, and Neoplastic Esophageal
Extracellular Matrix upon Macrophage Activation
L. T. Saldin1, M. Klimak2, R. C. Hill3, M. C. Cramer1, L. Huleihel2,
M. Quidgley-Martin2, D. Cardenas2, T. Keane1, R. Londono4,
G. Hussey2, L. Kelly5, J. E. Kosovec5, E. Lloyd5, A. N. Omstead5,
D. Matsui5, B. Jobe5, K. C. Hansen3, A. Zaidi5, S. F. Badylak6;
1Bioengineering, University of Pittsburgh, Pittsburgh, PA,
2University of Pittsburgh, Pittsburgh, PA, 3Department of
Biochemistry and Molecular Genetics, University of Colorado
Denver, Aurora, CO, 4Cellular and Molecular Pathology, University
of Pittsburgh, Pittsburgh, PA, 5Esophageal and Lung Institute,
Allegheny Health Network, Pittsburgh, PA, 6Department of Surgery,
University of Pittsburgh, Pittsburgh, PA.
Laboratory tools to study the effect of the microenvironment upon
cancer cell phenotype have largely remained unchanged; specifi-
cally, collagen gels and Matrigel have represented the gold standard
for the past several decades. The stimulus for the present study was to
develop a new tool to investigate cancer cell biology with disease-
specific extracellular matrix (ECM) hydrogels.
ECM hydrogels were prepared from decellularized normal, meta-
plastic, and neoplastic (adenocarcinoma, EAC) esophageal tissue, and
the effect of these hydrogels upon macrophage activation was inves-
tigated. Matrix-bound nanovesicles (MBV) were isolated from the
ECMmaterials. MBV have been shown to rapidly andmarkedly affect
cell phenotype. Important unanswered questions are: 1) What is the
miRNA profile contained within the ECM-MBV to drive EAC pro-
gression? 2)How does diseased ECMactivate an important cell type in
an inflammatory-driven cancer, the macrophage?
The three ECM types showed distinctive fiber networks by SEM and
protein profiles by mass spectroscopy. Metaplastic and neoplastic ECM
activate human THP1 macrophages to a dual ‘‘pro-inflammatory’’
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(TNFalpha+) and ‘‘immunomodulatory’’ (IL1RN+) state, with greater
expression correlating with advanced disease. Neoplastic ECM mod-
ulates the macrophage secretome to increase normal esophageal epi-
thelial cell migration, characteristic of tumorigenesis. Top differentially
regulated MBV-miRNA were notably related to epithelial-
mesenchymal transition, gastrointestinal cancer, and macrophage acti-
vation by small RNA sequencing, suggesting the distinctive role of
ECM to influence cell behavior.
In conclusion, ECM hydrogels representative of the normal,
metaplastic, and neoplastic microenvironment were developed. A
better understanding of ECM-MBV miRNA and disease-specific
macrophage activation will help guide regenerative therapies for EAC.
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A Tumor-on-a-Chip Platform for Screening Precision Driven
Medicines
S. Forsythe, N. Mehta, M. Devarasetty, A. Mazzochi,
K. Votanopoulos, W. Gmeiner, A. Skardal;
Wake Forest University, Winston Salem, NC.
Cancers of the digestive system enclose the largest projected cancer
group in new cases reported and the second largest in deaths projected,
with one third of both coming from colorectal cancer. New methods of
detection and treatment are needed as these cancers can develop from a
plethora of mutations requiring different targeted treatments. In order to
improve on these limitations, we have developed a 3D colorectal cancer
model that can be used to test high throughput drug screening in com-
parison to 2D testing. The model was tested using several colorectal
cancer cells lines with detected metastatic mutations including K-RAS
andB-Raf and cellswere encased in hydrogel to be tested against known
targeted chemotherapy regimens utilized in the clinic today.A two-layer
gel structure was also developed to mimic the tumor microenvironment
to test how the chemotherapeuticswould affect themigration of the cells
in the metastatic core to the outer epithelial layer. Additionally, the
system was utilized to test novel 5FU analogue chemotherapeutics
developed to reduce general toxicity, while maintaining tumor speci-
ficity. Finally, patient derived primary colorectal tumors have been
procured and after processing, the system has tested both current and
novel chemotherapeutics to compare efficacy of the targeted regimens.
Scientific Session 5: Rapid Fire Session 2
Tuesday, December 5, 2017, 10:00 AM - 11:30 AM
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Highly Valuable Endogenous Molecules Incorporated Within
Physically Cross-linked Gellan gum Scaffolds for Bone Tissue
Regeneration
R. Lo´pez Cebral1,2, A. Civantos3, V. Ramos3, B. Seijo4,5,
J. L. Lo´pez-Lacomba3, J. V. Sanz-Casado3, T. H. Silva1,2,
J. M. Oliveira1,2, R. L. Reis1,2, A. Sanchez4,5;
1University of Minho (UMinho), Guimara˜es, PORTUGAL, 2ICVS/
3B’s - PT Government Associate Laboratory, Braga, Guimara˜es,
PORTUGAL, 3Complutense University of Madrid (UCM), Madrid,
SPAIN, 4University of Santiago de Compostela (USC), Santiago de
Compostela, SPAIN, 5Genetics and Biology of the Development of
Kidney Diseases Unit, Sanitary Research Institute (IDIS) of the
University Hospital Complex of Santiago de Compostela (CHUS),
Santiago de Compostela, SPAIN.
Traumatisms, infections and bone disorders are main causes that
affect bone homeostasis and produce damage in bone tissue. Their clin-
ical relevance and increase in the elderly population has promoted in-
tensive research in the area of bone regeneration during the last years.
Nevertheless, unsatisfactory results have extended the search for the
perfect bone regeneration-promoting platform to the present day. This
platform should be highly biocompatible and, ideally, benefit from the
intrinsic biopotential of endogenous molecules. Nevertheless, endoge-
nous molecules are prone to lose their activity when submitted to harsh
conditions. Therefore, their incorporation into a regenerative platform is
very challenging. The authors developed hydrogel scaffolds formed by
gellan gum and physically cross-linked by the endogenous polyamine
spermidine. The mild preparation conditions permitted the incorporation
of other interesting endogenous molecules, including Bone Morphoge-
netic Protein 2 (BMP-2). Indeed, the effective trans-differentiation of
C2C12 cells toward osteoblastic lineage confirmed the release of bioac-
tive BMP-2. After in vivo implantation in Wistar rats, abundant angio-
genesis, mature bone tissue and bone marrow tissue were observed.
BMP-2 was also loaded into a commercial scaffold formulation, thus
allowing for comparison. Micro-computed tomography and tissue
staining confirmed the ability of the studied hydrogel scaffolds to induce
the formation of more mature and dense ectopic bone tissue, which re-
mained during a longer periodwithout being reabsorbedwhen compared
with the commercial formulation. These results confirm the potential of
the developed hydrogel scaffolds as both innovative growth factor de-
livery platforms and scaffolds for regenerative medicine applications.
85
Response Surface Optimization of Alginate Biomaterial
Parameters for Maintenance of Preconditioned MSC Phenotype
B. Hung, J. Leach;
University of California at Davis, Davis, CA.
While cell-based tissue engineering remains an attractive alternative to
current strategies for repair of tissue defects, directing cell fate post-
implantation remains a challenge. Immediate implantation of naı¨ve stem
cells, while clinically relevant, cannot provide implanted cells with suf-
ficient bioactive signals to repair tissue. Prolonged in vitro cultivation
allows control over presentation of appropriate cues, but raises safety and
translatability concerns. In this study, we hypothesized thatmesenchymal
stem cells (MSCs) preconditioned for a brief 1-week period under dif-
ferentiation conditions can continue to differentiate after removal of dif-
ferentiation factors, provided they are aggregated and implanted in an
instructive biomaterial. Cell-cell cohesion and endogenous matrix pro-
duction within MSC aggregates enhance MSC viability and function,
while interaction with biomaterial substrates greatly influencesMSC dif-
ferentiation. To test this hypothesis, MSCs were cultivated in monolayer
under adipogenic, chondrogenic, and osteogenic conditions for 1 week
and then aggregated into spheroids of 5,000 to 20,000 MSCs. Spheroids
were encapsulated in alginate with storage modulus ranging from 200 to
15,000 Pa and arginine-glycine-aspartate (RGD) concentration ranging
from 0 to 4 mM. Constructs were then cultured under expansion condi-
tions for 2 weeks and assessed for differentiation. Outputs were fit to
response surface models with spheroid cell number, storage modulus,
and RGD concentration as input parameters. Differentiated phenotype
was maintained and response surface analysis showed cell number
alone did not affect differentiation, but modulus and RGD content
influenced chondrogenesis and osteogenesis. Moreover, the three pa-
rameters had significant interactions. This approach may inform future
cell-based approaches while minimizing in vitro cultivation.
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Development Of A Textured Patch for the Engineering
of Heart Tissues
F. Cleymand1, J. Robin2, T. Nguyen3, P. Menu4, J. F. Mano5;
1Institut Jean Lamour, NANCY, FRANCE, 2Institut Charles
Gerhardt de Montpellier, Montpellier, FRANCE, 3School of
Surgery, NANCY, FRANCE, 4Pathophysiology and Molecular
Engineering Articular (IMoPA), Vandoeuvre-le`s-Nancy, FRANCE,
5CICECO, Aveiro, PORTUGAL.
Ischemic heart failure continues to pose an unequivocal chal-
lenge to the health care systems around the world owing to the
structural complexity of cardiac tissue, as well as the polymorphism
of tissue degradation inherent to the chronic phase of myocardial
infarction that are still refractory to conventional treatments. The
cardiac tissue rehabilitation concept notably consists in stem cells
transplantation and/or tissue engineering (TE) to repair or reshape
the highly-damaged tissue However, outcomes extracted from
both experimental and early clinical settings have shown poor
ORAL ABSTRACTS S-23
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
therapeutically benefices. Therefore, the development of suitable
innovative biomaterials for Cardiac Tissue Engineering (CTE) to
enhance the regeneration effect represents an attractive and active
field of research. In CTE, different fabrication methods are pro-
posed to develop 3D-scaffolds, in this work an innovative thera-
peutic functional ‘‘natural’’ thin patch with flat geometry and
controlled hierarchical surface texture is proposed. Mechanical,
physico-chemical and biological characterizations assess the ther-
apeutic potential of these new substitutes
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Hybrid Degradable Scaffold supports Functional Skin Tissue
Generation upon Seeding Adipose Derived Mesenchymal Stem
Cells committed to Dermal Lineage
V. K. Krishnan1, R. Rashmi2, V. S. Harikrishnan2, L. K. Krishnan2;
1Department of Biomaterials Science and Technology, Sree
Chitra Tirunal Institute for Medical Sciences & Technology,
Trivandrum, INDIA, 2Department of Applied Biology,
Sree Chitra Tirunal Institute for Medical Sciences & Technology,
Trivandrum, INDIA.
Tissue-engineered skin equivalents are expected to have great
potential to treat chronic burn wounds. However, they have several
limitations such as immune reaction and entrapped non-degradable
epidermal components. A combination product of electrospun ter-
polymer poly(lactide-glycolide-caprolactone)(PLGC) and biomi-
metic fibrin composite (PLGC-F) has been found to promote dermal
fibroblast growth1. Similar grafts with enhanced surface area has
been studied in this work to explore their potential to guide skin
tissue regeneration. Human adipose derived mesenchymal stem
cells (ADMSCs)-induced fibroblasts (IEC & IC-SCRT approved)
were used to validate the graft for dermal tissue generation in vitro
and to study the scaffold degradation after long-term (90 days)
culture. Extra cellular matrix (ECM) deposition upon culture sug-
gested formation of skin like tissue with adequate mechanical
strength. Parameters studied include cell proliferation studies, ECM
quantification, polymer degradation and variation in mechanical
strength. Scaffold patches were implanted in subcutaneous tissue of
rabbit skin and explanted after 90 days. Both in vitro cell grown
scaffolds and explants were analyzed for mechanical strength and
their solvent extracts to estimate polymer degradation. The wound
healing efficiency was analyzed by treating 4cm2 size burn wounds
in rabbit model for 28 days which suggested that the combination
graft (PLGC-F) showed optimal properties for guided tissue re-
generation in terms of reduction in wound size, epithelialisation,
collagen organization and angiogenesis. Polymer degradation after
90 days implantation was remarkable and no adverse tissue reaction
was noted.
References: 1. Renjith PN et al., Biores Open Access. 3(5), 217-
225, 2014.
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Microribbon-based Hydrogels with Tunable Biochemical
Compositions Enhance MSC-based Cartilage Regeneration
C. Gegg1, X. Tong2, F. Yang1;
1Bioengineering, Stanford University, Stanford, CA, 2Orthopaedic
Surgery, Stanford University, Stanford, CA.
Introduction: Hydrogel scaffolds are often used to deliver cells
for cartilage repair but generally have weak mechanical properties
and lack the macroporosity to facilitate extracellular matrix depo-
sition. We recently reported a method to fabricate novel micro-
ribbon (mRB)-based hydrogels, which are injectable, macroporous,
and possess cartilage-mimicking shock-absorbing properties. The
objective of this study was to evaluate the effects of varying mRB
compositions on enhancing mesenchymal stem cell (MSC)-based
cartilage regeneration.
Methods: Microribbons were fabricated by wet-spinning poly-
ethylene glycol (PEG), gelatin, chondroitin sulfate (CS) and hya-
luronic acid (HA). All polymers were modified with methacrylate to
enable intercrosslinking. Passage 6 human MSCs (15M/mL) were
encapsulated in mRB-based hydrogels (7.5% w/v). Eight hydrogel
compositions were examined: each composition alone (PEG, GEL,
CS, HA) and mixed mRB compositions in a 1:1 ratio (PEG-CS, PEG-
HA, GEL-CS, GEL-HA). All samples were cultured in chondrogenic
medium for three weeks. Outcomes were evaluated by cell viability,
biochemical assays, mechanical testing, and histology.
Results: Gelatin uRBs led to robust neocartilage deposition
throughout the scaffold. In contrast, CS and HA uRBs led to min-
imal cartilage formation. Interestingly, when CS or HA uRBs were
mixed with PEG or gelatin uRBs, the resulting scaffolds supported
enhanced neocartilage formation, with up to a 45-fold increase in
compressive moduli compared to day 1 and extensive sGAG and
collagen deposition.
Significance: Our results validate mRBs as macroporous ma-
trices for supporting robust cartilage regeneration by stem cells in
3D. mRBs with tunable biochemical cues could serve as novel
injectable building blocks for further enhancing MSC-based car-
tilage regeneration.
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Alginate/gelatin Hydrogels as Bioprintable Inks Directing
Tumor Spheroid Formation
T. Jiang1, J. G. Munguia-Lopez2, K. Gu3, M. M. Bavoux4,
S. Flores Torres5, J. Kort Mascort5, J. Grant6, S. Vijayakumar6,
A. De Leon-Rodriguez1, J. M. Kinsella5;
1Mechanical Engineering, McGill University, Montreal, QC,
CANADA, 2Molecular Biology, Instituto Potosino de Investigacio´n
Cientı´fica y Tecnolo´gica, A.C. (IPICyT), San Luis Potosi, MEXICO,
3Chemical Engineering, McGill University, Montreal, QC,
CANADA, 4Bioengineering, Ecole Polytechnique Fe´de´rale de
Lausanne (EPFL), Lausanne, FRANCE, 5Bioengineering, McGill
University, Montreal, QC, CANADA, 6Materials Engineering,
McGill University, Montreal, QC, CANADA.
Physiological tumor microenvironments exhibit varied me-
chanical and biological properties that influence the formation rate,
size, and frequency of multicellular tumor spheroids (MCTS). Here
we developed a tunable composite hydrogel composed of alginate
and gelatin to create 3D bioprinted models of triple-negative breast
cancer cells that develop distinct MCTS differences dependent
upon the mechanical and biochemical properties of the gels for
greater than 30 days in culture. MDA-MB-231 cells were homo-
genously dispersed in Alginate (1%, 3%, 5%) and gelatin (5%, 7%,
9%) dissolved in phosphate buffered saline before crosslinked by
CaCl2. The crosslinked hydrogels have stiffness varying between
4.6*28.9 kPa primarily depending upon the concentration of al-
ginate. Confocal imaging shows cancer cells in the gelatin con-
taining hydrogel formulations start to form MCTS on day 15 while
those in alginate-only gels remain as single punctate cells with
decreasing number over time. The MCTS continue expanding in
hydrogels containing gelatin and 1% alginate until reaching a di-
ameter over 300 mm after 30 days. In gels containing 3% and 5%
alginate with stiffnesses of 16.6 and 28.9 kPa, cells remain as small
MCTS. Gelatin provides cell-matrix adhesion sites that promote
MCTS formation, while theMCTS growth can be suppressed due to
the increased stiffness of the matrix. These mechanically and bio-
chemically tunable bioinks are capable of recapitulating the native
tumor stroma and provide a novel tool to study how mechanics and
cell-matrix interactions result in tumor development.
90
Engineering Fibrin Nanoparticles for Enhanced Wound Healing
I. Muhamed, F. Ligler, A. Brown;
Joint dept of Biomedical Engineering, North Carolina State
University, Raleigh, NC.
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The inability of a wound to heal quickly is a key concern in
managing wounds in major injuries, especially in conditions, which
impair coagulation such as hemophilia, diabetes and VonWillebrand
disease. Commercially available fibrin sealants quickly seal tissues
and stop bleeding. However, these sealants require supraphysiolo-
gical concentrations of thrombin and fibrinogen to obtain sufficient
polymerization kinetics and mechanics required for clinical use.
These formulations can inhibit subsequent wound repair due to the
lack of porosity, which limits cell migration into the fibrin network.
Our objective is to synthesize pre-polymerized fibrin nanoparticles
that will quickly seal tissues while also promoting healing by i)
enhancing cell migration due to increased fibrin network porosity
while maintaining mechanical robustness and ii) improving clot
degradation kinetics through tunable fibrinolytic properties. To that
end, we have synthesized Fibrin Nanoparticles (FBN) using a 2-
phase microfluidic fibrin droplet generator. We hypothesize that
macroscopic gels created from FBN networks will be better suited for
wound healing therapies than commercially available bulk fibrin gels
and will enhance cell migration. Indeed, our results show that FBNs
promote human dermal fibroblast migration in a 3D wound assay
mimic compared to bulk fibrin. Additionally, traction force micros-
copy experiments demonstrate that fibroblasts generate contractile
forces on FBNs similar to collagen surfaces.
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Cell-Cell Interactions Enhance Cartilage Formation in 3D
Gradient Hydrogels that Mimics Tissue Zonal Organization
D. Zhu1, P. Trinh2, E. Liu1, F. Yang1,3;
1Bioengineering, Stanford University, Stanford, CA, 2Biology,
Stanford University, Stanford, CA, 3Orthopedic Surgery, Stanford
University, Stanford, CA.
Cartilage tissue is characterized by zonal organization with gradual
transitions of biochemical andmechanical cues from superficial to deep
zones. Previous tissue engineering strategies mostly employ scaffold
with homogeneous cues, which fail to mimic the zonal organization of
native cartilage.We have recently developed hydrogels as 3D cell niche
with continuous gradient of biochemical and mechanical cues, which
induce zonal-specific response of chondrocytes to form cartilage that
mimics articular cartilage organization. While the role of cell-ECM
interactions have been studied extensively, how cell-cell interactions
across different zones influence cartilage zonal development remains
unknown. The goal of this study is to examine the role of cell-cell
interactions in modulating cartilage formation in 3D using gradient
hydrogels. When encapsulated in PEG/CS gradient hydrogels,
chondrocyte exhibit zonal-specific responses in cell proliferation as
well as cartilage ECM deposition. In contrast, when each zone is
cultured separately, the extent of zonal-response of chondrocytes
were much lower than intact gradient hydrogel group. Co-culturing
of hydrogels cut into 5 zones in the same well led to comparable
cellular response across all zones. We further evaluated the mem-
ory of cell-cell interactions by first priming chondrocytes in intact
gradient hydrogels for one week, then divided into separate zones
and cultured separately. Priming enabled memory of cell-cell in-
teractions and restored the zonal response. Together, our results
highlight that cell-cell interactions play a critical role in resulting in
the cartilage zonal development. Such gradient hydrogels could fa-
cilitate employing heterotypic cell interactions to enhance regeneration
of cartilage with biomimetic zonal organizations.
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Graphene Oxide Influence the Release of Protein from Layer-by-
Layer Self Assembled Electrospun PCL Fiber
E. Kolanthai, L. H. Catalani;
Departamento de Quı´mica Fundamental, University of Sao Paulo,
Sao Paulo, BRAZIL.
The controlled delivery of growth factors (GFs) at harmed tissues
has shown promising results in tissue regeneration applications.
Since they can stimulate cell differentiation, growth of new blood
vessels and accelerate new tissue regeneration at damaged tissues in
human body. However, when large amounts of GFs are released at
affected area of the tissue it may trigger abnormal cell responses. To
overcome this problem, we propose the production of GFs reservoirs
as coating over polymeric membranes using self-assembled Layer-
by-Layer (LbL) technique as protein carriers, in order to obtain a
device of slow and controlled release of GFs. Electrospun poly-
caprolactone (PCL) mats were chosen as carrier membranes for this
study, while bovine serum albumin labelled with fluorescein iso-
thiocyanate (BSA-FITC) and lysozyme labelled with fluorescein
isothiocyanate (Lyso-FITC) were taken as model proteins. Graphene
oxide (GO) particles and amine terminated GO particles were coated
over the electrospun PCL fiber mat using LbL technique in order to
enhance protein load and stability. Using heparin/chitosan poly-
electrolyte solutions and the protein co-solutions, a series of LbL
reservoirs containing either BSA-FITC/GO-BSA-FITC or Lyso-
FITC/GONH2-Lyso-FITC were assembled in 10 layer pairs (10 LP)
with different architectures. To confirm the protein loading on LbL
grown fibers, they were subjected to different studies such as func-
tional, thermal, morphology and fluorescence analysis. Further, the
protein release from fiber was examined in PBS at 37C and the
release profile showed controlled and extended protein release in the
presence of GO when compared to amine terminated GO particles.
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Emulsion-free Chitosan Microgels for Growth Plate Cartilage
Tissue Engineering
C. B. Erickson1, M. S. Riederer2, N. A. Fletcher2,
M. J. Osmond2, K. A. Payne1, M. D. Krebs2;
1University of Colorado, Anschutz Medical Campus, Aurora,
CO, 2Colorado School of Mines, Golden, CO.
While chitosan has been used extensively for articular carti-
lage regeneration, few studies have investigated chitosan for growth
plate cartilage regeneration. Further, chitosan microspheres are
commonly fabricated using an emulsion method, which requires
cytotoxic solvent washes that can negatively affect tissue growth. In
this work, degradation, release, and growth plate regeneration
properties of emulsion-free chitosanmicrogels were investigated. All
animal procedures were approved by the University of Colorado
IACUC. 6% chitosan was crosslinked with 50mM genipin, and was
manually pressed through a 106 mm sieve producing irregularly-
shaped particles £500 mm in diameter. Microgels 125-250mm in di-
ameter were selected by filtering and used for subsequent experi-
ments. Microgels loaded with the chemokine CXCL12 displayed a
linear release up to 37 days as measured by ELISA. Incubation in
0.5mg/ml lysozyme showed degradation after one week in vitro.
Further, injection of these microgels in a rat growth plate injury
model showed full microgel degradation, and increased cartilaginous
repair tissue by 28 days. Thus, these microgels demonstrate both
in vitro and in vivo degradation, and can release chemokines in a
linear, time-dependent manner. This fabrication method provides a
novel, emulsion-free chitosan-genipin biomaterial system that may
be used in tissue engineering applications, and is particularly
promising for treating growth plate injuries.
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Hyaluronic Acid conduits filled with polylactic fibres
and Ependymal Progenitor Cells create a new biohybrid
concept for cell transplantation in Spinal Cord Injury
C. Martinez-Ramos1, A. Alastrue2, L. Rodriguez-Dolado1,
E. Lopez Mocholi2, M. Monleon-Pradas1, v. moreno2;
1Biomateriales, Universidad Politecnica De Valencia, valencia,
SPAIN, 2Advance Therapies, Centro De Investigacion Principe
Felipe, valencia, Spain.
SCI results in the loss of sensory and motor functions due to the
death of neurons and degeneration of axons. Transplant of ependymal
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progenitor/stem cells (epSPC) may improve functional recovery of the
injured spinal cord by delivering neurons and their support cells
through differentiation. We have employed a combinatory therapeutic
strategy (hybrid scaffold with stem cells) to induce differentiation to-
wards neurons rather than glial cells and to enhance axonal growth. In
this study, epSPC were seeded in a tubular conduit of hyaluronic acid
(HA) containing aligned poly(lactic acid) fibers (PLLA) and we
evaluated the efficacy of neuronal differentiation and axonal growth
along of the PLLA fibers. To evaluate the security of the biohybrid the
construct was implanted into a rat spinal cord injury model. The bio-
hybrid showed minimal inflammatory reaction and the epSPC were
distributed and spread in and around the lesioned area. This approach
of combining biomaterials with different structures and stem cells
offers a promising treatment for the injured spinal cord.
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Vessel Formation from Modular Vascularized Microbeads
A. Y. Rioja1, Y. P. Kong1, J. A. Beamish1, X. Hong1, J. Habif1,
J. Bezenah2, C. X. Deng1, J. P. Stegemann1, A. J. Putnam1;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Chemical Engineering, University of Michigan, Ann Arbor, MI.
Significant morbidity and mortality due to limb ischemia can be
attributed both to macrovascular and microvascular inadequacy. We
developed pre-vascularized fibrinmicrobeads that can be delivered in a
minimally invasive manner, jump-start inosculation with host vascu-
lature, and quickly enhance local microvascular networks with the
potential to improve blood flow to ischemic areas. Microbeads con-
taining endothelial cells and stromal fibroblasts pre-cultured for 3 days
formed more extensive microvascular networks when embedded and
cultured in model tissues, compared to microbeads pre-cultured for
other time periods. In vivo implants containing pre-cultured microbe-
ads, freshmicrobeadswith no pre-culture period, acellularmicrobeads,
or cells without microbeads were injected within a fibrin matrix into
subcutaneous pockets on the dorsal flanks of SCID mice. Implants
containing pre-cultured microbeads formed functional connections to
host microvasculature within 3 days, exhibiting more extensive vessel
coverage, higher vessel numbers, and less implant compaction after
injection compared to other groups. They also maintained a more
broadly distributed microvessel network at day 7, which we attributed
to a better preservation of the implant volume compared to other
groups and confirmed with ultrasound imaging of model implants.
Surprisingly, constructs containing pre-cultured microbeads had a
lower bulk elastic moduli compared to controls, but higher local
stiffness near the microbeads, suggesting the initial cell distribution
influences construct compaction and the subsequent distribution of
perfused microvasculature.
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Fabrication of hollow beads With Precision Pore Structures
For Cell Transplantation
G. Peng-Lai;
Peking University, Beijing, CHINA.
Scaffold materials find important applications in tissue engineering
and cell transplantation. Although various techniques have been used
to create porous scaffolds for construction of cell-material systems,
precisional control over the internal nano-/micro-pores in scaffolds are
still hard to achieve. Here, an immersion-precipitation phase trans-
formation (IPPT) process was established for fabricating the hollow
bead-based scaffolds using polyethersulfone (PES). Hollow beadswith
the outer diameter in 1.5-4mm and the wall thickness in about 450mm
were obrained. In particular, the wall contained parallel channels, with
the diameter decreasing outward from 50mm to reach a dense layer
on the surface. By controlling the designing time in dimethylaceta-
mide, two types of beads, with highly monodisperse pore sizes on
the surfaces, 0.401– 0.187mm (bead with nanopores, BNP) and
9.22– 3.83mm (Bead with micropores, BMP), were prepared. When
loaded with mesenchymal stem cells (MSCs), the cells were found to
distribute inside channels and form clusters. Through in vivo nonin-
vasive imaging studies in the murine host, it was found that both BNP
and BMP scaffolds significantly extended the residence time of MSCs
transplanted in the subcutaneous space, in comparison with the directly
injected MSCs. Specially, the BNP scaffold supported a higher per-
centage of cell survival at all time points compared to BMP, and the
cellular residence time reached approximately two weeks. Our study
shows the IPPT process can generate hollow spherical membranes
with oriented channels with precision pore sizes and structures. The
hollow beads may be further investigated as cell scaffolding/delivery
materials for cell-based therapy.
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Novel Supercritical Co2 Processed Composites For Bone
Applications
S. Pitka¨nen1, K. Paakinaho2, S. Miettinen1;
1The faculty of Medicine and Life Sciences, University of Tampere,
Tampere, FINLAND, 2Department of Electronics and
Communications Engineering, BioMediTech, Tampere University
of Technology, Tampere, FINLAND.
Tissue engineered grafts are still used significantly less in contrast to
autologous or allogenic bone grafts. However, with bone transplants
there are problems like the morbidity of the harvesting site and limited
availability. Therefore, new bone substitutes are needed in the treatment
of large bone defects. Composites comprising poly(L-lactide-co-e-
caprolactone)with 50wt-%ofb-tricalciumphosphatewere foamedwith
supercritical CO2 and cut into discs. Porosity and pore size of the
composites were analyzed by m-CT. In vitro testing was done by cul-
turing human adipose stem cells (hASCs) in the composites up to
21 days. Cell viability was assessed by Live/Dead staining and osteo-
genic differentiation was analyzed by alizarin red and immunocyto-
chemical staining of osteogenic marker proteins. In vitro analyses were
conducted at 7-, 14- and 21d. Thereafter, composites were implanted in
rabbit distal femur defects. Empty defects were used as control. His-
tological staining and m-CT analysis were conducted 4-, 12- and 24
weeks after implantation. 6 rabbits were sacrificed per time point.
Porosity of the composites was 63-65% with average pore size of 380-
440mm. The novel composites supported the viability of hASCs. Fur-
thermore, hASCs differentiated towards osteogenic lineage when cul-
tured in the composites. In the rabbit model, host tissue was able to
grow into the composites already in 4 weeks and histological staining
showed that at 24 weeks calcified bone had formed inside the porous
composites in defects. To conclude, these flexible and user-friendly
supercritical CO2 -processed composite scaffolds show great potential
as a new bone substitute material for treating bone defects.
98
Gellan Gum: a Multifunctional Tool to Modulate Cell
Microenvironment
S. Vieira, A. da Silva Morais, R. L. Reis, J. M. Oliveira;
Department of Polymer Engineering, 3B’s Research Group, Barco -
GMR, PORTUGAL.
Cell encapsulation is an alternative to the use of immunosuppres-
sant drugs after cell transplantation. It shields cells from the host im-
mune system, allowing the diffusion of nutrients and oxygen1. The
alginate - poly-L-lysine - alginate system is the most well-studied
method2, but biocompatibility issues were reported3. Thiswork aims to
use methacrylated gellan gum (GG-MA), an anionic hetero-
polysaccharide, to engineer the microenvironment provided in cell
encapsulation strategies. Capsules were formed by gravitational drip-
ping, extruding GG-MA into a poly-L-Lysine (PLL) bath4. Due to the
interaction between the carboxylic groups of the GG-MA and the
charged PLL amines, a capsule is formed. Morphology was assessed
using scanning electron microscopy and micrographs, revealing a di-
ameter of 2.3– 0.145mm. Drug release capacity was quantified using
albumin-fluorescein isothiocyanate conjugate (BSA-FITC, 66 kDa) as
a model of large glomerular molecules; methylene blue (MB, 319.85
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Da) as a small molecule model; and Dextran-FITC with 4, 20 and
70kDa. While small molecules (MB and 4kDa Dextran-FITC) were
rapidly released, the larger molecules had a hampered flow. In vitro
tests, using hASC, have shown that cells remain viable after 7 days of
culture. In vivo results, using CD1 mice, have shown that GG/PLL
complexes do not elicit fibroblast deposition and can tune the mi-
croenvironment, from bioactive to biotolerable. Briefly, the results
herein presented show the potential of GG-MA/PLL capsules for
cell encapsulation as they are: (i) easy to produce, using one-step
only; (ii) have selective permeability; (iii) hASC maintained their
viability after encapsulation; and (iv) biocompatible.
99
Development of Thermally-Responsive Fibrin Gels
for On-Demand Delivery
C. Linsley, B. Tawil, B. Wu;
Bioengineering, UCLA, Los Angeles, CA.
One of the goals of personalized medicine is to deliver the right
dosage at the right time, which requires innovative delivery systems
capable of customization. On-demand delivery systems are capa-
ble of exerting explicit control over where, when and how much of
a therapeutic is released by making release stimuli-dependent.
This lab has developed a strategy for light-actuated delivery that
uses the photothermal response of biocompatible chromophores to
trigger release from thermally-responsive delivery vehicles. However,
there is a lack of biocompatible thermally-responsive biomaterials.
Fibrin is a traditionally non-stimuli-responsive biomaterial with a
long history of use in FDA approved products, and has previously
been functionalized with exogenous peptides by enzymatic incor-
poration via Factor XIII for tissue engineering applications. This
same approach can be used to functionalize fibrin with thermally-
responsive oligonucleotide tethers for on-demand growth factor de-
livery. Specifically, a peptide sequence from a Factor XIIIa substrates,
a2-plasmin inhibitor, has been conjugated to fluorescently-tagged ol-
igonucleotides using the heterobifunctional crosslinker (succinimidyl
4-[N-maleimidomethyl]cyclohexane-1-carboxylate (SMCC) and en-
zymatically incorporated into fibrin hydrogels during polymerization.
Both the incorporation efficiency of double-stranded oligonucleotides
and the thermally-triggered release of single-stranded oligonucleo-
tides from the fibrin hydrogels was measured via fluorescence.
Triggered release data shows that heat labile oligonucleotide tethers
remain annealed at room temperature and thermal release of compli-
ment oligonucleotide strands from the parent strands is achievable with
5 minute heating intervals at 45C. These results suggest have the
potential to aid in future studies aiming to functionalize other tradi-
tionally non-stimuli-sensitive biomaterials with a long history of use in
FDA approved products.
Scientific Session 5: Tissue Chips and Tissue
Organoid Models 1
Tuesday, December 5, 2017, 10:00 AM - 11:30 AM
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Tumor-on-a-chip Microfluidic Devices for Personalized
Cancer Drug Testing
S. Rajan1,2, A. R. Mazzocchi1,2, A. Skardal1,2,3, A. R. Hall1,2,3;
1Biomedical Engineering, Virginia Tech - Wake Forest School of
Biomedical Engineering and Sciences, Winston-Salem, NC, 2Wake
Forest Institute for Regenerative Medicine, Winston-Salem, NC,
3Comprehensive Cancer Center of Wake, Winston-Salem, NC.
Traditional chemotherapeutic treatments show variability in patient
response even between similar cancer types. Recent advances have
helped address this variability by aiding chemotherapy design based on
genetic profile through precision medicine. However, despite this in-
dividualized data, clinicians are still left with multiple drug options to
which patient response can vary unpredictably. As a result, there is a
need for model systems to help predict the personalized response to
chemotherapeutics. Here, we address this need by engineering 3D tu-
mor organoids directly from patient tumor biopsies that provide a
patient-specific module in a microfluidic device for in vitro treatment
optimization. Initially, we implement this tumor-on-a-chip platform
using a patient-derived mesothelioma tumor biospecimen. We dem-
onstrate the ability to biofabricate andmaintain viable 3D patient tumor
constructs within a microfluidic device for 14 days. The tumor con-
structs were exposed to one of two different doses (0.1mM, 10mM) of
chemotherapeutic mixtures carboplatin/premetrexed or cisplatin/pre-
metrexed for 7 days and LIVE/DEAD assays were performed. Quan-
tification performed on segmented confocal images of constructs
showed that constructs treated with cisplatin/premetrexed resulted in
significantly increased tumor cell death, which was notable as retro-
spective comparisons to clinical outcomes revealed that the corre-
sponding patient responded exceptionally well to cisplatin-based
treatment. These data demonstrate the power of correlation and pre-
dictive potential for these patient-specific tumor models. This platform
is ideally positioned to test personalized response to drug combinations
in a parallel format to predict treatment effectiveness.
101
Primary Patient Mesothelioma Organoids for Genetic Mutation-
Driven Experimental 3-Deazaneplanocin a Treatment
A. Mazzocchi1, S. Rajan1, K. Votanopoulos2, A. Hall1,
A. Skardal1,2;
1Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC, 2Comprehensive Cancer Center at Wake Forest Baptist Medical
Center, Winston-Salem, NC.
Many cancers continue to go untreated as their mutations or
combination of mutations have no effective treatment. However,
many novel chemotherapy drugs are being tested both in vivo and
in vitro to show potential efficacy in cancers with actionable muta-
tions that have previously gone untreated. One such compound is 3-
deazaneplanocin A (DZNep), which is both an S-adenosylhomocysteine
synthesis inhibitor and a histone methyltransferase EZH2 inhibitor.
The recent advance of precision medicine has allowed for genetic
testing to determine actionable mutations in tumors and thus predict
potential best treatments.We have had the unique opportunity to treat
two separate sets of patient tumor-derived 3D organoids with various
concentrations of DZNep to determine efficacy. Omentum samples
of mesothelioma origin were obtained from two separate patients,
both of which received genetic testing and one of which had an EZH2
mutation (BAP1), which we hypothesized could be targeted with
DZNep. Organoids were treated with DZNep and it was found that
the tumor with themutation was responsive to the drug in comparison
to the control environment whereas the other was not. Additionally,
we used HCT116 cells as a negative control cell line that is unaffected
by the treatment of DZNep. Results included quantification of live/
dead staining, MTS proliferation assay quantification, and IHC anti-
body staining. This data is promising in that it showswe have been able
to advance organoid development to allow for precision medicine-
driven testing of experimental drugs not clinically approved andmatch
genetic testing to appropriate treatments for patients.
102
Three-dimensional (3D) High Throughput Organophosphate
Toxicity Screening and its Correlation with Pharmacokinetic/
pharmacodynamic Model
Y. Koo1, C. Akwitti1, B. T. Hawkins2, Y. Yun1;
1Bioengineering, NC A&T SU, Greensboro, NC, 2Engineering
and Applied Physics Division, RTI international, Durham, NC.
High-content, high-throughput platforms are constructed to
screen a test set of OP agents for concentration-dependent effects
on: 1) cell viability/toxicity, 2) penetration of OP across the
blood brain barrier (BBB), and 3) inhibition of acetylcholines-
terase (AChE) activity in target cells following OP exposure. We,
ORAL ABSTRACTS S-27
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
further explore a pharmacokinetic/pharmacodynamics (PKPD)-
based computational model, based on experimental data, to
identify the most critical pathways that mediate OP acute neu-
rotoxicity. We estimated parameters from the experimentation
and existing literature, which is used to develop 3D finite element
method (FEM)-based models incorporating 3D in vitro assay
geometry, diffusion kinetics, chemical reaction dynamics, and
ionic conductance. We correlate the results generated from
pharmacokinetic/ pharmacodynamics (PKPD) computational
simulation model with the data from in vitro brain on a chip
platform, allowing in silico modeling of various OP compounds
under various conditions (sensitivity analysis), which provide
key knowledge for OP screening to acute neurotoxicity.
103
Biofabrication of 3D Neural Microphysiological Systems
D. A. Bowser1, A. D. Sharma2, J. L. Curley2, M. J. Moore3,2;
1Bioinnovation Ph.D. Program, Tulane University, New Orleans,
LA, 2AxoSim Technologies, New Orleans, LA, 3Department of
Biomedical Engineering, Tulane University, New Orleans, LA.
Neural system-on-a-chip platforms have demonstrated great potential
as in vitro tools for modeling neuronal injury and disease and as high-
throughput preclinical drug screening devices. Current designs based
on microfabricated platforms and 3D neural organoids have limita-
tions in their abilities to recapitulate cell-cell interactions, morphology,
and functionality seen in vivo. Microfabricated platforms can pro-
vide specified tissue organization, but typically restrict cell biology to
2D configurations, which can alter cellular physiology. Conversely, self-
assembling 3D neural organoids provide a more physiologically-
relevant structure but fail to represent macroscale tissue organization.
There is a need for neural system-on-a-chip platforms that articulate the
complexity and robustness of in vivo tissue at all levels to accurately
inform scientific discovery. We describe the fabrication and character-
ization of rat spinal cord-derived and human iPSC-derived neuronal
organoids along with their incorporation into a micropatterned 3D dual
hydrogel culture system. The neural organoids can be fabricated with a
consistent size, are highly viable, and contain a variety of cells present in
the spinal cord. Sensory neural cell aggregates were found to extend
neurites towards spinal cord organoids when co-cultured. The micro-
patterned 3D dual hydrogel culture system, consisting of growth re-
strictive and growth permissive components, provides a 3D environment
for constraining neurite growth to form anatomically-relevant connec-
tions between cell populations. The combination of organoid and mi-
cropatterned hydrogel system results in the creation of an in vitro CNS
nerve-on-a-chip device that controls for the multiscale organization by
providing 3D cellular assembly along with directed guidance for neurite
outgrowth into physiologically relevant neural tracts.
104
Creating 3-Dimensional Human Testis Organoid System
from Immature Testicular Cells for in vitro Spermatogenesis
and Evaluation of Environmental Agents
N. Pourhabibi Zarandi1, G. Galdon1, H. Sadri-Ardekani1,2,
A. Atala1,2;
1Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston Salem, NC, 2Department of Urology,
Wake Forest School of Medicine, Winston Salem, NC.
Introduction: 3-dimensional (3D) organ-like structures mim-
icking the function of native organs is eagerly desired. Recently we
developed in vitro 3D organoids from mature human testicular cells
capable to differentiate spermatogonial stem cells (SSC) and produce
androgen. Our objective is to show the feasibility of the same 3D
system using immature cells.
Methods: Isolated cells from prepubertal testicular tissue were
cultured in 2-dimensional (2D) condition. Specific genes expression
assay and Flowcytometry were used to prove the presence and
quantify SSCs, Sertoli, Leydig and peritubular cells. 2D cultured
cells integrated into 3D culture using 10000 cells per organoid. The
system was evaluated with live/dead cell staining, ATP production
assay, genes expression and androgen production. Undifferentiated
organoids were exposed to environmental agents including Mercury,
Thallium and Lead in different concentrations for 48 hours.
Results: Specific markers for spermatogonia including ZBTB16,
PGP9.5, THY1, CD9, FGFR3 and SSEA4; GATA4, SOX9, Clusterin
and CD49f for Sertoli cells; STAR, TSPO and Cyp11A1 for Leydig
cells; and CD34 for peritubular cells; all proved the presences of dif-
ferent cell types. The organoids maintained their structure, viability,
metabolic activity, and produced androgen. Digital PCR for PRM1 and
Acrosin showed 0.4% early and 0.2% late post meiotic germ cells re-
spectively. All three environmental agents decreased Leydig cells pop-
ulation but only Mercury and Thallium affected spermatogonial cells.
Conclusion:Human 3D testicular organoid system was generated
successfully using isolated immature human testicular cells and
maintained long term in 3D culture, produced androgen, differenti-
ated SSCs and was used as a novel testicular toxicity model.
105
Controlling and Monitoring Oxygen Levels in 3D Gut-on-Chip
K. R. Rivera, S. T. Magness, M. A. Daniele;
Biomedical Engineering, University of North Carolina at Chapel Hill
and North Carolina State University, Chapel Hill, NC.
In the small intestine, a strict oxygen gradient is necessary to support
a diverse cell environment, including aerobic intestinal epithelial stem
cells and anaerobic bacteria. In vivo, oxygen supplied to intestinal cells
comes frommicrovasculature surrounding intestinal crypts. The intestinal
lumen remains anoxic, maintaining microbial homeostasis. Recapitulat-
ing this environment in vitro to simultaneously study anaerobic bacteria
and aerobic epithelial cells remains a technical challenge.Wehypothesize
that a 3Dorgan-on-chipmodel of the intestinal epitheliumcan recapitulate
the steep oxygen gradientwithin intestinal crypts.Using conventional soft
lithography techniques, a microdevice has been created with key com-
ponents that establish a steepoxygengradient. Themicrodevice includes a
biomimetic scaffold composed of gelatin and collagen with embedded
microvessels that provide oxygen to primary intestinal epithelial stem
cells and an anaerobic chamber to facilitate bacterial growth. Using finite
element analysis, a COMSOL model demonstrates oxygen diffusion
through the scaffold to an epithelial cell layer. The model informs pa-
rameters such as optimal microvessel diameter and scaffold thickness
necessary for epithelial cell growth, as well as influx of nitrogen and
outflow of oxygen required to create the targeted oxygen gradient. The
COMSOL model will be experimentally validated using a microdevice
with implanted photonic oxygen sensors tomonitor an oxygen gradient in
real-time. A phosphorescent lifetime detector will be used to monitor
oxygen tension during controlled perfusion experiments. Optimization of
a 3Dorgan-on-chipmodel that contains a physiologically relevant oxygen
gradient will inform studies concerning intestinal stem cell differentiation
and epithelial-endothelial cell dynamics.
Scientific Session 5: Matrix Biology
Tuesday, December 5, 2017, 10:00 AM - 11:30 AM
106
Antimicrobial Peptides with Biologic and Biosynthetic Scaffolds
for Regenerative Medicine
C. Pineda Molina1, G. S. Hussey2, J. L. Dziki2, J. Eriksson2,
S. F. Badylak1;
1Department of Bioengineering, University of Pittsburgh,
Pittsburgh, PA, 2Department of Surgery, University of
Pittsburgh, Pittsburgh, PA.
Naturally occurring antimicrobial peptides(AMP) are an important
endogenous component of the innate immune response, providing
protection against pathogens(1). The AMP cathelicidin-LL37 has a
broad-spectrum bactericidal activity, promotes cell infiltration and re-
epithelialization(2,3), and has been recognized as a pro-angiogenic
factor(4), all of which are important in tissue repair and potential re-
generative medicine applications. The degradation products (i.e.
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matricryptic peptides) of biologic (extracellular matrix(ECM)-derived)
and biosynthetic (byproducts of microorganisms) scaffolds modulate
macrophage response, promote constructive tissue remodeling(5,6) and
provide resistance to persistent bacterial contamination(7). The present
study evaluated the expression of AMP by macrophages exposed to
ECM-scaffolds or biosynthetic materials, and the molecular mecha-
nisms promoting the cathelicidin-LL37 expression. Murine bone
marrow-derived macrophages were exposed in-vitro to degradation
products of ECM-bioscaffolds from different tissue sources, or the
biosynthetic material poly-4-hydroxybutyrate. In a separate in-vivo
study, a rat bilateral partial thickness abdominal wall defect model was
used to evaluate the host response to the implanted scaffold materials at
3, 7, 14, and 35 days. The expression of AMP by macrophages was
determined by qPCR and immunolabeling. Without exception, biologic
and biosynthetic scaffolds significantly promoted the expression of
cathelicidin-LL37 in exposedmacrophages bymechanisms that involve
activation of the MAP-kinase pathway. The results expand the under-
standing of the role of cathelicidin-LL37 in regenerative medicine. The
already recognized ability of biologic and biosynthetic scaffolds can be
expanded to include the induction of AMP expression by infiltrating
cells. These findings provide a plausible explanation for the relative
infection resistance of biologic and biosynthetic scaffolds.
107
Il-33 As a Key Signaling Molecule for the Therapeutic
Effects of ECM Bioscaffolds for Cardiac Repair
G. S. Hussey1, J. L. Dziki1, H. R. Turnquist2, S. F. Badylak1;
1McGowan Institute for Regenerative Medicine, Pittsburgh, PA,
2Department of Immunology, University of Pittsburgh, Pittsburgh, PA.
ECM-scaffolds are FDA approved for numerous clinical applica-
tions including cardiac repair. Although a Phase I study investigating
the use of an intracardiac injection of ECM hydrogel following myo-
cardial infarction is currently in progress, the mechanisms by which
ECMdirects cardiac tissue remodeling are only partially understood. A
new perspective on the bioactivity of ECM-scaffolds is presented
herein; specifically, that matrix bound nanovesicles (MBV) embedded
within ECM-scaffolds are a rich source of extra-nuclear interleukin-33
(IL-33). IL-33 is typically found in the nucleus of stromal cells and
generally regarded as an alarmin to alert the immune system to cell
injury, resulting in production of pro-inflammatory mediators via
poorly defined mechanisms involving the IL-33 receptor, ST2. How-
ever, emerging evidence suggests that IL-33 may function as a pro-
moter of tissue repair especially in models of cardiovascular disease
where IL-33 induction following cardiac stress has been correlated
with improved outcomes. We show that IL-33 is stably stored within
ECM and protected from inactivation by incorporation into MBV.
Results of the present study show that MBV from IL33+/+, but not
IL33-/- mouse tissues, directs ST2-/- macrophage differentiation into the
reparative, pro-remodeling M2 phenotype, and further suggest that
MBV-associated IL-33 modulates macrophage activation through a
non-canonical ST2-independent pathway. The discovery of IL-33 as an
integral component of ECM-MBV provides mechanistic insights into
the regulation of immune-driven pathological fibrosis. Furthermore,
the use of ECM-scaffolds for cardiac repair can now be examined
with new insights that will help guide the design of next generation
products, diagnostics and therapeutic applications.
108
SMAD2/3 & MAN1 Interactions are Negatively Regulated
by Substrate Stiffness
L. Moretti1, D. M. Chambers2,3, T. H. Barker1;
1University of Virginia, Charlottesville, VA, 2Georgia Institute
of Technology, Atlanta, GA, 3Emory University, Atlanta, GA.
Activation of matrix-bound TGFb and its effects on fibroblasts are
mediated by extracellular matrix (ECM) stiffness. TGFb is of para-
mount importance in diseases of altered mechanics like cancer and
fibrosis, but the underlyingmechanisms of TGFb’smechano-sensitivity
are not completely understood.
MAN1, an integral, inner nuclear envelope protein sequesters
SMAD2/3, TGFb’s signaling partners, inhibiting cytokine signaling.
We hypothesized that the contractility stress of cells on stiffer, fi-
brotic substrates (*20 kPa for fibrotic lung tissue vs. *2kPa for
healthy lung tissue) is transmitted to the nucleus and ultimately to
MAN1 through the actin-nuclear LINC complex and MAN1’s LEM
domain. We hypothesize that MAN1’s conformation is disrupted
under strain, disrupting interaction with SMAD2/3.
We tested this premise by stably transfecting a luciferase reporter for
SMAD expression in human foreskin fibroblasts (HFF). Those were
plated on fibronectin coated polyacrylamide gels of different stiffness and
exposed to varying concentrations of TGFb. Luciferase signal increased
with substrate stiffness. Moreover, interaction frequency of MAN1 and
SMAD, measured by proximity ligation, increases with TGFb dosing
while decreasing with substrate stiffness. shRNA knock down of MAN1
recapitulates the fibrotic phenotype for HFF on soft substrates.
Current studies are investigating isolation of MAN1 from cyto-
skeleton forces by stably expressing a dominant negative version of
KASH and overexpressing the LEM domain.
Acknowledgments: Funding from the 2015 NIH Director’s
Transformative Research Award (1R01HL132585) to T.H.B. and
F30 Fellowship (F30HL122065) to D.M.C.
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Use of Osteogenically Enhanced Mesenchymal Stem Cells
and Their Cell-Derived Matrices for Bone Tissue Engineering
C. Sears1, E. McNeill2, B. Clough2, S. Jaligama3, J. Kameoka3,
C. A. Gregory2, R. Kaunas1;
1Biomedical Engineering, Texas A&M University, College Station,
TX, 2Department Molecular and Cellular Medicine, Texas A&M
Health Science Center, College Station, TX, 3Electrical Engineering,
Texas A&M University,
College Station, TX.
Of the 13 million bone fractures that occur annually in the United
States, about 10% fail to repair (Marsh et al. 1998). The canoni-
cal wingless (cWnt) signaling pathway is critical for healing of bone
fractures (Silkstone et al. 2008). We have demonstrated that inhibit-
ing peroxisome proliferator-activated receptor gamma activity with
GW9662 reduces negative cross-talk of the cWnt pathway, resulting in
an osteogenically enhanced human mesenchymal stem cell (OEhMSC)
phenotype (Zeitouni et al. 2012). OEhMSCs secrete an extracellular
matrix (OEhMatrix) that mimics the composition of anabolic bone tis-
sue and strongly enhances human mesenchymal stem cell retention and
subsequent bone repair in vivo (Zeitouni et al. 2012). Proteomic analysis
indicated high amounts of collagen types VI and XII in OEhMatrix
deposited byGW-treatedOEhMSCs in conventional monolayer culture.
Thus, we assessed OEhMatrix deposition onto gelatin methacrylate
(GelMA) spheres by immunostaining against collagens VI and XII.
Fresh OEhMSCs seeded onto decellularized OEhMatrix-coated spheres
showed enhanced osteoprotegerin secretion compared to OEhMSCs
seeded on uncoated spheres. Combining OEhMSCs with OEhMatrix-
coated GelMA spheres resulted in enhanced healing of murine critical-
sized calvarial defects, which was comparable to that achieved with a
recombinant human bone morphogenetic protein 2 (rhBMP2) gelatin
sponge clinical control. We submit that these injectable microspheres
accelerate bone repair, indicating their potential as a bone graft for use in
minimally invasive surgery for non-loading conditions such as cranial
repair and intervertebral cages for spinal fusion.
110
In Situ Imaging of Tissue Remodeling with Collagen Hybridizing
Peptides
Y. Li1, J. Hwang1, Y. Huang2, T. J. Burwell3, N. C. Peterson3,
J. Connor3, M. S. Yu1, S. J. Weiss4;
1University of Utah, Salt Lake City, UT, 2Department of Internal
Medicine, University of Utah, Salt Lake City, UT, 3MedImmune
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LLC, Gaithersburg, MD, 4Department of Internal Medicine and the
Life Sciences Institute, University of Michigan, Ann Arbor, MI.
Collagen, the major structural component of nearly all mamma-
lian tissues, undergoes extensive proteolytic remodeling during de-
velopmental states and a variety of life-threatening diseases such as
cancer, myocardial infarction, and fibrosis. While degraded collagen
could be an important marker of tissue damage, it is difficult to detect
and target using conventional tools. Here, we show that a designed
peptide (collagen hybridizing peptide: CHP) which specifically hy-
bridizes to the degraded, unfolded collagen chains, can be used to
image degraded collagen and inform tissue remodeling activity in
various tissues: labeled with 5-FAM and biotin, CHPs enabled direct
localization and quantification of collagen degradation in isolated
tissues within pathologic states ranging from osteoarthritis and myo-
cardial infarction to glomerulonephritis and pulmonary fibrosis, aswell
as in normal tissues during developmental programs associated with
embryonic bone formation and skin aging. The results indicate the
general correlation between the level of collagen remodeling and the
amount of denatured collagen in tissue, and show that the CHP probes
can be used across species and collagen types, providing a versatile
tool for not only pathology and developmental biology research but
also histology-based disease diagnosis, staging and therapeutic
screening. This study reveals the potential of CHP as a promising
targeting moiety for theranostic delivery in many diseases.
[The manuscript of this work is currently under review of ACS
Nano.]
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Soluble Extracellular Matrix Derived from Cartilage and Stem
Cells: Application for Inflammation Suppression and Cartilage
Regeneration
H. Shen1,2, H. Lin1, M. Fritch3, R. Tuan1,3,4;
1Department of Orthopaedic Surgery, University of Pittsburgh,
Pittsburgh, PA, 2Suzhou Institute of Nano-tech and Nano-bionics,
Chinese Academy of Sciences, Suzhou, CHINA, 3Department
of Bioengineering, University of Pittsburgh, Pittsburgh, PA,
4McGowan Institute for Regenerative Medicine, University
of Pittsburgh, Pittsburgh, PA.
Introduction: Osteoarthritis (OA) often begins with pathologic
activation of resident chondrocytes, followed by production of pro-
inflammatory factors and other degradative enzymes. Additionally,
macrophages migrate and undergo polarization to the proin-
flammatory state (M1) in OA joint, further aggravating cartilage
damage. We have previously shown that water-soluble extracellular
matrix from cartilage (cECM) upregulated chondrogenesis of human
mesenchymal stem cells (hMSCs), and that from hMSCs (sECM)
maintained chondrocyte phenotype during expansion. In this study,
we further explored the potential application of cECM and sECM for
OA treatment. We hypothesized that cECM and/or sECM would
promote cartilage regeneration and suppress inflammation, via
modulating M1 macrophage polarization, thus mitigating OA carti-
lage degeneration.
Methods: Soluble, urea-extracted ECMs from bovine cartilage
and hMSCs were prepared according to our published procedure.
Interferon-g and lipopolysaccharide were used to active macrophage
(RAW264.7) to M1 state. Cartilage explants were harvested from
adult bovine knee joint.
Results: Upon treatment with either cECM or sECM, nitric
oxide and pro-inflammatory cytokine production from M1 macro-
phage significantly decreased. Moreover, with cECM addition,
matrix was retained in cartilage explant, indicated by stronger
Safranin O staining, suggesting the positive effect of cECM on
cartilage regeneration. Co-cultures of M1 macrophages with car-
tilage explant are being examined for induction of cartilage de-
generation, to assess the efficacy of cECM and sECM in improving
cartilage health.
Significance: These findings demonstrate that the positive ef-
fect of cECM or sECM in suppressing inflammation and promoting
the regeneration of cartilage, which may be applicable for OA
treatment.
Scientific Session 6: Research Challenges in Stem Cell
Culture and Differentiation on Biomaterials targeting
for Stem Cell Therapy
Tuesday, December 5, 2017, 1:00 PM - 2:30 PM
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Tissue Development-Mimicking Extracellular Matrices
and Scaffolds for Stem Cells Culture
G. Chen, N. Kawazoe;
Research Center for Functional Materials, National Institute
for Materials Science, Tsukuba, Ibaraki, JAPAN.
Extracellular matrices (ECM) surround cells in vivo and play
important roles in controlling cell functions. Extracellular matrices
are tissue-specific and dynamically remodelled during the devel-
opment of each tissue and organ. To mimic the dynamic change
of ECM composition, we have developed a method to prepare
development-mimicking ECM by controlling stepwise differenti-
ation of human bone marrow-derived mesenchymal stem cells
(MSCs). Matrices derived from undifferentiated cells and cells at
early and late stages of osteogenesis and adipogenesis of MSCs
were termed as stem cell matrices, osteogenesis early stage ma-
trices, osteogenesis late stage matrices, adipogenesis early stage
matrices and adipogenesis late stage matrices, respectively. The
stepwise osteogenesis- and adipogenesis-mimicking matrices had
different compositions and showed different effects on osteogenic
and adipogenic differentiation of MSCs. Osteogenesis early stage
matrices were more favorable to osteogenic differentiation, while
adipogenesis early stage matrices were more favorable to adipo-
genic differentiation of MSCs than other matrices. Furthermore, 3D
stepwise chondrogenesis-mimicking ECM scaffolds were prepared
fromMSCs by controlling the stages of chondrogenic differentiation.
ECM scaffolds mimicking early stage chondrogenesis facilitated
chondrogenic differentiation, while ECM scaffolds mimicking late
stage chondrogenesis remarkably inhibited chondrogenic differen-
tiation of MSCs. The biomimetic matrices and scaffolds should be
useful for stem cell culture and tissue engineering.
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Proliferation and Differentiation of Human Pluripotent Stem
Cells Cultured on Biomaterials having Nanosegments
A. Higuchi1,2;
1Department of Chemical &Materials Engineering, National Central
University, Jhong-Li, TAIWAN, 2Riken, Saitama, JAPAN.
Human embryonic stem (ES) and induced stem (iPS) cells have
the potential to differentiate into any kind of cell and produce an
unlimited cell source for cell therapy. Establishing cultures of human
ES and iPS cells in xeno-free conditions is essential for producing
clinical-grade cells. We designed oligopeptide-grafted hydrogels
with several structures: single chains, single chains with joint seg-
ment, dual chains with joint segment, and branched-type chains.
Furthermore, oligopeptide sequences used for oligopeptide-grafted
hydrogels were selected from the integrin-binding domain of ECM
and the glycosaminoglycan-binding domain. The goal of this study
was to investigate which oligopeptide-grafted hydrogel molecular
design and elasticity favorably supports long-term culture of human
ES and iPS cells while maintaining their pluripotency in xeno-free
cell culture conditions. We found that the hydrogels grafted with
vitronectin-derived oligopeptides having a joint segment or a dual
chain, which has a storage modulus of 25 kPa, supported the long-
term culture of human ES and iPS cells for over 10 passages. The
dual chain and/or joint segment with cell adhesion molecules on
the hydrogels facilitated the proliferation and pluripotency of human
ES and iPS cells. Our results suggest that hydrogel design and sur-
face density of cell-binding domains are important for facilitating
the proliferation of human ES and iPS cells and for maintaining
the pluripotency of these cells in xeno-free culture conditions for a
long-term. We also discuss the efficiency of hESC differentiation
S-30 ORAL ABSTRACTS
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
into cardiomyocytes cultured on biomaterials grafted with several
nanosegments.
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Designing an Artificial Pancreas
C. Duffy, A. Cook;
Chemical Engineering, Brigham Young University, Provo, UT.
Objective: Type 1 Diabetes (T1D) is an autoimmune disease
characterized by the destruction of pancreatic b-cells. No protocol
has yet been established for a retrievable device that contains pan-
creatic b-cells differentiated from induced pluripotent stem cells
(iPSCs) to treat T1D. We are investigating methods to increase the
yield of pancreatic b-cells differentiated from iPSCs and researching
the use of hydrophilized, expanded polytetrafluoroethylene (ePTFE)
for use in an implantable, retrievable, and replaceable containment
device that mitigates the effects of T1D.
Methodology: Human iPSCs were generated from peripheral
blood monocytes. Differentiation to the pancreatic progenitor stage
was accomplished by using the STEMdiff Pancreatic Progenitor
kit. Correctly differentiated cells were then tested by performing
fluorescence-activated cell sorting (FACS), using a Becton, Dick-
inson FACSAria Fusion system. FACS analysis was performed
with FlowJo software. The ePTFE membranes were treated with
cross-linked polyvinyl alcohol to create a hydrophilic surface mod-
ification.
Results and Significance: We successfully completed the
STEMdiff Pancreatic Progenitor kit protocol and our analysis
suggests that approximately 23% of differentiated cells expressed
CXCR-4, a key definitive endoderm marker, compared to only 2% of
the undifferentiated iPSCs. This demonstrated that iPSCs can be
differentiated to an early pancreatic lineage with moderate yield.
Improved yields are the focus of future work. After testing three
different densities of ePTFE, we found that the highest porosity al-
lowed for the best diffusion of D-glucose, greater than 96%. This
demonstrated that glucose can diffuse through ePTFE. These results
increase the feasibility of encapsulating differentiated pancreatic
b-cells in an ePTFE containment device.
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iPSCDifferentiation to Various Lung Cells and their Progenitors
and Subsequent Seeding into Decellularized Scaffolds
A. Mitchell, T. Jensen, C. Finck;
University of Connecticut, Farmington, CT.
Induced pluripotent stem cells (iPSC) can be directed to become
any cell in the lungs. During embryogenesis interactions between the
endoderm and mesoderm are the precursor to lung bud formation.
Such cells and their progeny can be subsequently used to repopulate
decellularized lungs in order to generate disease models. iPSCs were
separately differentiated toward an alveolar-like phenotype through
endoderm and lung bud progenitor intermediaries or to a blood
vasculature lateral plate mesoderm (LPM) fate. Cell phenotype was
assessed throughout using flow cytometry, immunofluorescent
staining and qRT-PCR for characteristic markers. Decellularized rat
lung scaffolds were prepared by pressure controlled perfusion of the
vasculature with 0.1% SDS following which differentiated iPSCs
were implanted via the trachea and cultured in a pressure-controlled
physiologic bioreactor. At each stage of differentiation marker ex-
pression was >90% including CXCR4 at definitive endoderm,
FOXA2 at anterior foregut endoderm (AFE), TTF1 in lung bud
progenitors and SPC at the alveolar stage. Cells taken at the AFE
stage were able to repopulate the majority of a decellularized lung
scaffold, integrating with and attenuating the extracellular matrix
whilst also maintaining their marker expression. Cells differentiated
to LPM tested >80% for GATA4, PDGFRa and VEGFR2. Our
protocol can produce a high purity of cells at any stage of the em-
bryogenesis of alveolar-like cells. Additionally these cells can be
used to successfully repopulate the airways of decelluarized lung
scaffolds. Currently we are assessing the co-culture of AFE and LPM
into their respective compartments to reseed a decellularized lung.
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TGF-b1 Signaling Mediates Vascular Smooth Muscle
Differentiation from Human Cardiac Stem Cells
on Keratose Hydrogels
B. T. Ledford1, M. Van Dyke2, E. Tovillo1, M. Chen1, C. Barron1,
A. Cartaya1, J. He1;
1Department of Biomedical Sciences and Pathobiology, Virginia
Polytechnic Institute and State University, Blacksburg, VA,
2Department of Biomedical Engineering and Mechanics, Virginia
Polytechnic Institute and State University, Blacksburg, VA.
Our published work demonstrated that a majority (*72%) of
human cardiac stem cells (hCSCs) cultured on keratose (KOS) hy-
drogels expressed the marker of vascular smooth muscle cells
(VSMCs), a-smooth muscle actin (a-SMA), compared to*5% on
standard tissue culture polystyrene plates (TCPS)1. The aim of the
present study is to investigate the mechanisms underlying the pre-
ferred VSMC differentiation of c-kit+ hCSCs on KOS hydrogels. We
hypothesize that transforming growth factor-b1 (TGF-b1)2 plays a
critical role in VSMC differentiation on KOS hydrogels. Cells were
cultured and differentiated both on TCPS and KOS plates and various
biological assays were used to analyze gene and protein expressions.
We found that treatment of 5ng/mL recombinant human TGF-b1
(rhTGF-b1) resulted in 64.5 – 4.2% a-SMA+ cells on TCPS in
KnockOut serum replacement (KSR) medium. ELISA studies indi-
cated that hCSCs produced a significant amount of TGF-b1 on KOS
hydrogel (28.3– 0.4pg/mL) 28 days post-differentiation compared
to pre-differentiation (0.3 – 1.5pg/mL, n = 4, p < 0.001). In addition,
a-SMA+ cells on KOS hydrogel were significantly reduced from
71.7 – 3.7% to 26.8 – 5.2% (n = 5, p < 0.01) after treatment of A83-
01, a TGF-b1 antagonist. These findings suggest that TGF-b1
signaling pathway likely mediates VSMC differentiation on KOS
hydrogels.
References:
1. Ledford BT, Simmons J, Chen M, Fan H, Barron C, Liu Z, Van
Dyke M, and He JQ. Stem Cells and Development. April 2017.
2. Zhao L, Hantash BM. Vitam Horm. 87, 127, 2011.
Acknowledgments: This work is supported by the grant award
from the Virginia’s Commonwealth Health Research Board (CHRB)
(208-09-16JHE).
Disclosures: The authors declare no conflict of interest.
Scientific Session 6: Tissue Chips and Tissue
Organoid Models 2
Tuesday, December 5, 2017, 1:00 PM - 2:30 PM
117
Synthetic Development of Cerebrovascular Organoids
M. Skylar-Scott1, L. Nam1, A. Ng1, J. Huang1,
G. Church2, J. A. Lewis1;
1Harvard University, Cambridge, MA, 2Harvard Medical School,
Boston, MA.
When clusters of pluripotent stem cells (PSCs) are differentiated
into a neural lineage in 3D culture, they undergo a process of self-
assembly, developing into complex cerebral organoids. These orga-
noids can serve as powerful in vitro models of neurodevelopment and
disease. However, existing cerebral organoid models are avascular,
and, lacking adequate nutrient perfusion, develop necrotic cores once
their diameter exceeds approximately 1mm. The co-differentiation of
PSCs into tissues containing both vascular and cerebral cells poses a
challenge, as these tissues derive from the mesoderm and ectoderm,
respectively, and thus require distinct differentiation conditions. Here,
we present a synthetic approach by genomically modifying human
induced-PSCs to enable simultaneous, efficient, programmable, and
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rapid differentiation into vascular and cerebral lineages pro-
ducing neurovascular tissues with tailorable densities of vascu-
lature and neural cells. When these modified PSCs are cultured in
three-dimensional culture, they develop into three-dimensional
cerebrovascular organoids, exhibiting, ventricle-like structures,
neural differentiation, and lumenized endothelium. Next, we
implant these cerebrovascular tissues into 3D printed organoid
perfusion-chips, wherein the organoids are fully embedded in
collagen adjacent to perfusable, endothelial cell-lined channels.
Via directed perfusion of nutrients through the vascular network,
we aim to enhance the viability, size, and complexity of devel-
oping cerebral organoids with applications in developmental and
drug screening.
118
Engineering Hydrogels to Form Liver Organoids that Support
Hepatocyte Phenotype and Function
A. Z. Unal, S. E. Jeffs, J. L. West;
BME, Duke University, Durham, NC.
Liver function depends on healthy hepatocytes, their interactions
with non-parenchymal cells (ECs, pericytes etc), and signals from the
environment (ECM, vasculature, etc.) We have previously shown
that endothelial cells (ECs) and pericytes co-cultured in cell-adhesive
and proteolytically degradable poly(ethylene glycol) (PEG) hydro-
gels form stable microvascular networks.2 Here, we co-cultured
hepatocytes with ECs and pericytes in these modified PEG hydrogels
to form vascularized liver organoids. Hepatocyte presence did not
inhibit EC tubulogenesis and over 75% of hepatocytes localized to EC
tubules, as observed in vivo. Hepatocytes in vascularized gels exhibited
increased albumin secretion and maintained both urea synthesis and
cytochrome P450 activity for at least 28 days. At day 28, hepatocytes
in 3D co-cultures secreted significantlymore albumin than hepatocytes
seeded on collagen coated plates at day 1. The 3D co-cultures secreted
significantly higher amounts of albumin than hepatocyte monocultures
encapsulated in PEG hydrogels. The 3D co-cultures also secreted
significantly more albumin than hepatocytes co-cultured with ECs/
pericytes on 2D collagen coated plates and hepatocytes fed with
conditioned media from EC/pericyte co-cultures. These results indi-
cate that both the 3D hydrogel environment and cell-cell mediated
interactions are important in maintaining hepatocyte function. Co-
culture in 3D hydrogels enables robust hepatocyte-hepatocyte inter-
actions as well as hepatocyte to non-parenchymal cell interactions that
are not possible in 2D and seem to slow hepatocyte de-differentiation.
Our liver tissue-like organoids create a biomimetic environment that is
promising for maintaining prolonged hepatocyte function for use in
models and in therapeutic devices.
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Mimicry of Neuroinflammatory Environment in Alzheimer’s
Disease and Discovery of Microglial Modulation in Neutrophil
Recruitment to Central Nervous System
J. Park, I. Wetzel, H. Cho;
Mechanical Engineering and Engineering Science, UNC Charlotte,
Charlotte, NC.
The accumulation of immune cells in brain parenchyma is a
critical step in the progression of neuroinflammatory diseases, in-
cluding Alzheimer’s disease (AD). The accumulation mechanisms of
innate immune cells, microglia, are well studied in the context of AD
pathogenesis, however, the mechanisms of peripheral immune cells
are not clear, yet. Here, we reconstituted an AD microenvironment:
induction of neuroinflammation by stimulating human microglia
with amyloid-beta (A-beta), a signature molecule in AD, and em-
ployed this environment to investigate the recruitment mechanism of
human peripheral immune cells - neutrophil - in the context of the
innate-peripheral immunity crosstalk. We cultured human microglia
in a central microchamber with a treatment of soluble A-beta at the
concentration of 2mM for 4 days and plated freshly isolated human
neutrophils to an outer chamber connected with neutrophil-exclusive
migration channels. The neutrophil recruitment was assessed by
measuring the speed, persistence of recruitment, and counting the
number of accumulated neutrophils. We found that microglia-derived
IL6, IL8, CCL2, CCL3/4, and CCL5 are effective for recruiting neu-
trophils in the recapitulated AD environment and observed the sig-
nificantly reduced neutrophil recruitment by neutralizing antibodies
for IL6, IL8, and CCL2. The increased proinflammtory factors such as
IL6 are observed on recruited-neutrophil with microglia co-culture
condition in central chamber. We envision that our discovery provides
new insights to understand the innate-peripheral immune cell inter-
actions in human AD brains and strategies to modulate AD neuroin-
flammation for the therapeutic purpose.
120
Multi-tissue Interactions In An Integrated Three-tissue
Organ-on-a-chip Platform
M. Devarasetty, S. Forsythe, S. Murphy, T. Shupe, S. Lee, J. Jackson,
J. Yoo, S. Soker, C. Bishop, A. Atala, A. Skardal;
Institute for Regenerative Medicine, Wake Forest Baptist Medical
Center, Winston-Salem, NC.
Unfortunately, many drugs have progressed through preclinical
and clinical trials, after which they existed on the market for years in
some cases, before being recalled by the FDA for toxicity in humans.
We have developed a multi-tissue body-on-a-chip platform that op-
erates under a common media in a single microfluidic perfusion
system for drug and toxicology screening. To date, liver, cardiac,
lung, vascular, testes, gut, and brain organoids have been incorpo-
rated into the system. The organoids remain viable and functional for
at least one month, with most types remaining functional for much
longer. The platform has been validated in multi-organoid toxicology
experiments that model integrated metabolism and downstream
metabolite effects across several tissue types. As an example, re-
covery of cardiac sensitivity to epinephrine in the presence pro-
pranolol may be observed as the beta blocker is metabolized by the
liver organoids. Another example involves bleomycin induced lung
inflammation where the injured lung produces high levels of IL-1
beta that decreased cardiac organoid beat frequency. These types of
responses would be impossible to detect in a single tissue platform.
Themulti-organoid platform has been used to predict toxicity in FDA
withdrawn drugs, demonstrate toxicity of environmental pollutants
and model the effects of chemical warfare agents. The future vision
for the platform is a comprehensive representation of human physi-
ology on a single microfluidic chip, with the ultimate goal of out-
performing both 2D human cell culture and animal testing for
predicting compound toxicity and developing countermeasures for
toxic agents.
Scientific Session 6: Unlocking the Potential of Gelatin
and Collagen in TERM
Tuesday, December 5, 2017, 1:00 PM - 2:30 PM
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Potential Of Gelatin In Tissue Engineering To Realize
Regenerative Medicine
Y. Tabata;
Institute for Frontier Life and Medical Scienecs, Kyoto University,
Kyoto, JAPAN.
Regenerative medicine is a new therapeutic trial based on the
natural potential of body itself. The natural potential is physiologi-
cally regulated by the ability of cells for proliferation and differen-
tiation. The basic idea of tissue engineering is to artificially create a
local environment which enables cells to promote their ability, re-
sulting in cell-induced tissue repairing of regenerative medicine. If a
key growth factor is supplied to the right place at the right time period
and concentration, the body system will initiate the natural induction
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of cell-based tissue regeneration. One practically possible way to
enhance the in vivo therapeutic efficacy of growth factors and che-
mokines is to make use of drug delivery system (DDS) technology.
Biodegradable hydrogels of gelatin for the controlled release of bi-
ological factors have experimentally and clinically succeeded in the
regeneration therapy of various tissues. This release system can be
combined with cells or/and the cell scaffold to promote the thera-
peutic efficacy of tissue regeneration. In this paper, several concrete
experimental data on promoted tissue regeneration are presented to
emphasize scientific, clinical, and industrial potentials of gelatin in
tissue engineering to realize regenerative medicine.
122
Development of Highly Purified Medical Gelatin Called
Bematrix.
H. Ida1, D. Bailey2, H. Tsukamoto1, Y. Hiraoka1;
1R & D Center, Nitta Gelatin Inc., Yao-city, JAPAN, 2Nitta Gelatin
NA Inc., Morrisville, NC.
Due to its high biocompatibility and biodegradability, gelatin has
been widely used in medical field applications such as DDS, medical
device and regenerative medicine including cell transplantation (1,
2). When gelatin is applied in clinical applications, it is important to
remove, reduce or inactivate endotoxin, viruses, bacteria and fungi.
In general, those issues can be resolved by methods such as high
temperature processing and/or filtration. However, these techniques
cannot be effectively used for gelatin purification as heat treatment
can alter the physical properties of gelatin and filtration is often not
possible due to the high viscosity of gelatin solutions. A new ap-
proach using an Alkali solution treatment has allowed us to develop a
highly purified gelatin we call ‘‘beMatrix’’. This purified gelatin
resulted in an endotoxin level lower than 10 EU/g and viral inacti-
vation was confirmed. Using the alkali technique, the physical
properties of gelatin were also confirmed to be unchanged. In addi-
tion, safety tests including cytotoxicity, sensitization, intracutaneous
reactivity and pyrogenicity were carried out. The beMatrix gelatin
was found to be negative for each test suggesting it is safe for clinical
applications. Having many uses in medical applications, beMatrix
has the potential to rapidly expand gelatin-based regenerative ther-
apy. (1) Young S, Wong M, Tabata Y and Mikos AG. J Control
Release 109(1-3), 256, 2005(2) Kimoto M, Shima N, Yamaguchi M,
Hiraoka Y, Amano S and Yamagami S. Invest Ophthalmol Vis Sci.
55(4), 2337, 2014
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Tissue Engineering Technology of bFGF Release for Various
Plastic Surgical Reconstructions
N. Isogai, T. Fukuda, N. Hirano, T. Morotomi, H. Kusuhara;
Plastic and Reconstructive Surgery, Kindai University Faculty
of Medicine, Osakasayama, JAPAN.
Cartilage tissue is characterized by its poor regenerative prop-
erties, and the clinical performance of cartilage grafts to replace
cartilage defects has been unsatisfactory. Recently, cartilage regen-
eration with mature chondrocytes and stem cell have been developed
and applied in clinical settings. However, there are challenges with
the use of mature chondrocytes and stem cells for tissue regeneration,
including high cost associated with the standard stem cell isolation
methods and decreased cell viability due to cell manipulation. Pre-
vious studies demonstrated that cartilage can be regenerated from
chondrocyte clusters that contain stem cells. Based upon some of the
existing techniques, the goal of the present study was to develop a
novel and practical method to induce cartilage regeneration. A
micro-slicer device was developed to process cartilage tissues into
micron-size cartilage (micro-cartilage) in a minimally-invasive
manner. We evaluated the size of micro-cartilages and demonstrated
that 100-400mm micro-cartilage are optimal for generating high cell
yield with collagenase digestion. In addition, autologous intra-fascial
implantation of the composites of micro-cartilage and absorbable
scaffold with a slow release system of basic fibroblast growth factor
(bFGF) was carried out to induce cartilage regeneration. Our results
demonstrated that the extent of bFGF diffusion depends on the size of
micro-cartilage, and that cartilage regeneration was induced most
effectively with 100mm micro-cartilage via SOX5 up-regulation.
The technique was applicable in the field of Plastic and Re-
constructive Surgery and some of our clinical cases for ear and eye
socket reconstructions are to be demonstrated.
124
New Transportation System of 3D Tissue Constructs
with Newly Developed Gelatin
H. Ida1, Y. Ohyabu2, M. Ida1, K. Fujii2, S. Yunoki2, Y. Hiraoka1;
1R & D Center, Nitta Gelatin Inc., Yao, JAPAN, 2Biotechnology
Group, Tokyo Metropolitan Industrial Technology Research
Institute, Tokyo, JAPAN.
A new type of gelatin known as HTg has been recently devel-
oped. This specialized gelatin is characterized by having an in-
creased gelling temperature and the ability to form gels more
quickly than standard commercialized gelatin (1). HTg has the
potential to be used extensively in fields such as DDS, cell culture,
organ-on-a-chip and cell transplantation. Recently some remark-
able 3D tissue constructs including cell sheet, spheroid or organoid
have been developed and are expected to be widely used in regen-
erative medicine. Transportation of these cellular 3D constructs has
proven to be very challenging. During transportation, damage to
cellular 3D constructs from shear stress, vibration and environ-
mental change can affect cellular function or break apart the com-
plicated structures. To address this issue, we propose a new
transport system of 3D constructs using HTg. This process includes
the introduction of warmed HTg solution onto cells, setting of cells
under 30C to achieve HTg gel protection, transport of tissue con-
structs without temperature control, and finally the dissolution of
HTg gel allowing for collection of cells at 37C. In addition, HTg
gel is stable through transportation even around 30C allowing for
safe transport of cells without any damage. Here, Cell-sheet of
NIH3T3 cells could be collected by the cell viability greater than
90% seven days after gel protection. This result demonstrated that
our proposed method using HTg is very beneficial to the safe
transport of 3D tissue constructs.
(1) Ohyabu et al. JBB 118(1), 112. 2014.
125
Hand-spun Gelatin Micro and Nanofibers for Cartilage
Regeneration
M. Wang1, C. Cui1, J. T. Lawrence2, M. Pacifici2, L. Han1;
1Drexel University, PHILADELPHIA, PA, 2Children’s Hospital
of Philadelphia, PHILADELPHIA, PA.
Micro/nanofibers are promising for engineering tissues including
muscle, bones, and cartilages. Being an inexpensive biopolymer and
a collagen derivative, gelatin is a biomaterial of choice for tissue-
engineering fibers. However, existing methods to fabricate micro/
nanofibers, e.g. wet-spinning and electrospinning, are difficult to use
for gelatin, as these methods demand a narrow range of material
properties including conductivity, viscosity and surface-tension, and
often have an extremely low production rate for sub-micron size
fibers.
Method: We invented a ‘hand-spinning’ technique to produce
gelatin based micro- and nanofibers by a large, clinical-relevant
quantity. Gelatin fibers were produced through repeated stretching
and folding a polymer ring that encapsulated a core of gelatin. After
N cycles of stretching and folding, the core of micro/nano fibers were
retrieved from the polymer ring in organic solvents, methacrylated,
aldehyde fixed, and freeze-dried for storage. To form a fibrous
scaffold, the fibers were rehydrated, mixed with cells, and cross-
linked by light (365 nm).
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Chiondrogensis study: Human mesenchymal stem cells (hMSC)
were encapsulated among stretched-and-folded fibers with diameters
of 5 mm or 50 mm, and cultured in standard chondrogenic media four
weeks. Results showed the microfiber-based scaffolds led to uniform
cell distribution, cartilage-like extracellular matrix formation, and
dramatically increased mechanical property. The results also suggest
the existence of an optimal porosity for cartilage formation, as hMSC
in the 5 mm-fiber scaffolds performed significantly higher level of
chondrogenic gene expression and matrix production in comparison
with hMSC in the 50mm-fiber scaffolds.
Scientific Session 6: Bio-inspired Materials
for Tissue Regeneration
Tuesday, December 5, 2017, 1:00 PM - 2:30 PM
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Cicada Wings Bioinspired Membranes for Tissue Engineering
C. P. Roux-Pertus, S. Fleutot, F. Cleymand;
Institut Jean Lamour UMR7198 CNRS/Universite´ de Lorraine,
Nancy, FRANCE.
Biomimetic approaches are often used in tissue engineering in
order to design optimized new scaffolds. For instance cicada wings
have already inspired corneal transplants with antibacterial proper-
ties. The surface of wings of Mediterranean cicadas has been char-
acterized by a multiscale approach, as used on Dynastes hercules [1],
to elaborate biomimetic ECMs from chitosan based micro-/ nano-
particles produced with a homemade ElectroHydroDynamic Ato-
mization (EHDA) apparatus. Thanks to an optimization of the
elaboration parameters the morphology, the size and the 3D distri-
bution of the particles have been controlled. The physical and che-
mical properties of these new scaffolds have been characterized by an
optimized multiscale approach.
[1] Roux-Pertus C, Oliviero E, Richard V, Fernandez F, Maillot F,
Ferry O, Fleutot S, Mano J.F, Cleymand F, Multiscale character-
ization of the hierarchical structure of Dynastes hercules elytra,
Micron, 2017.
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Development and Characterization of Free Standing
Biomembranes for Tissue Engineering Applications
F. Cleymand1, S. Fleutot1, J. F. Mano2;
1Institut Jean Lamour, NANCY, FRANCE, 2CICECO, Aveiro,
PORTUGAL.
Tissue Engineering (TE) and cell therapy comprise a market for
regenerative products that is expected to grow worldwide from $6.9
billion in 2009 to almost $32 billion by 2018 [1]. Advances depend
on the availability of specific biomaterials that allow controlling
biological systems behaviour [2]. In this context, we developed bio-
inspired systems from renewable resources with controlled external
shape and internal architecture. Different home-made fabrication
apparatus have been developed to produce controlled systems
which could provide a better environment for the cells to stimulate
the regenerative process. Mechanical, physico-chemical and bio-
logical characterizations assess the therapeutic potential. This
presentation will report our recent advances on free-standing bio-
membranes such as: 1) Chitosan membranes functionalized in
volume by incorporating nanoliposomes based on marin origin
lecithin. [3]. 2) Electrospun micro and nanofibers of chitosan and
crosslinked chitosan fibers which has been inspired by the hierar-
chical structure of Dynastes hercules elytra [4], and can be seen as
new architecture to TE. [1] Tissue Engineering, Cell Therapy and
Transplantation: Products, Technologies & Market Opportunities,
Worldwide, 2009-2018.’’ Report #S520; Med Market Diligence,
LLC. [2] R. Langer, D.A. Tirrell, Nature (2004), 428, 487-492. [3]
F. Cleymand, H. Zhang, G. Dostert, P. Menu, E. Arab-Tehrany, E.
Velot, Joa˜o F. Mano, RCS Advances, 6, 83626-83637 (2016) [4] C.
Roux-Pertus, E. Oliviero, V. Richard, F. Fernandez, F. Maillot, O.
Ferry, S. Fleutot, Joao F Mano, and F. Cleymand, Micron http://dx.
doi.org/10.1016/j.micron.2017.05.001
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From The Hierarchical Structure Of Dynastes Hercules Elytra
To Bioinspired Nanofibers Membranes
S. Fleutot, C. Roux-Pertus, F. Cleymand;
Institut Jean Lamour, NANCY, FRANCE.
Thanks to millions of years of natural optimization, beetle elytra
(hard thickened forewings that protect the fragile hindwings) have
evolved to become the model of honeycomb structures and are op-
timal composite materials of proteins, lipids and chitin. Their
structure could provide inspiration for different applications: engi-
neering artificial extracellular matrix with interesting mechanical
properties, aeronautics, new sensors with hygrochromic properties/
In this context, the present study focuses on the elaboration of
bioinspired nanofibers membranes from the hierarchical structure of
beetle forewings. First, a combination of structure andmicrostructure
characterization techniques (SEM, TEM and for the first-time X-Ray
tomography) was performed on adult male Dynastes hercules for a
fine understanding of the 3D structure of elytra[1]. Secondly, based
on the determined periodic arrangement over a short distance for
trabeculae, nanofibers chitosan scaffolds were produced by electro-
spinning. Elaboration parameters have been optimized to produce
membranes with high spatial interconnectivity, high porosity, and
controlled alignment. Finally, physico-chemical properties, cell-
scaffold interactions and proliferation have been investigated to
demonstrate the potential of home-made structured membranes for
tissue engineering applications.
[1] Roux-Pertus, C., Oliviero, E., Richard, V., Fernandez, F.,
Maillot, F., Ferry, O., Fleutot, S., Mano, J.F., Cleymand, F., Micron,
2017, accepted
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Urinary Bladder Matrix Reapproximates Mechanical
Strength of Native Abdominal Wall in a Long-Term Porcine
Hernia Model
A. Young1, C. A. Ronaghan2, C. E. Brathwaite3, T. W. Gilbert1;
1ACell, Inc., Columbia, MD, 2Texas Tech University, Lubbock, TX,
3NYU Winthrop Hospital, Long Island, NY.
Scaffolds composed of urinary bladder matrix (UBM), an ECM-
based material derived from the basement membrane of the porcine
bladder, have been previously shown to support constructive re-
modeling and site appropriate tissue deposition in many clinical
applications. However in instances where continued mechanical
strength is desired, the use of a degradable biomaterial may seem
counterintuitive. In this study, an 8-month porcinemodel of a midline
abdominal wall defect was utilized to evaluate the remodeling and
mechanical strength of UBM scaffolds. These animals were com-
pared to a control group that received the defect but no scaffold
material, and an uninjured baseline group (n= 4/group). Histologic
evaluation demonstrated that the UBMmaterial was macroscopically
degraded within 3 months and was replaced with a loose, vascular-
ized connective tissue. There was no evidence of mineralization,
encapsulation, seroma, or herniation at any time point. In contrast,
the control group demonstrated a 50% herniation rate at the defect
site and an increase in diastasis recti at 8 months post-operatively.
Mechanical strength of the excised abdominal wall tissue increased
over time for all groups, and by 8 months, there was no statistical
difference in strength compared to uninjured control tissue. The loose
nature of the connective tissue at the remodeling site allowed for easy
dissection to re-access abdominal tissue planes. These long-term
results in a large animal model demonstrate that UBM scaffolds
facilitated constructive remodeling and resulted in host tissue capa-
ble of supporting the native mechanical loading of the anatomical
site, despite a relatively rapid remodeling profile.
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Esophageal Extracellular-matrix Hydrogel for Treatment
of Barrett’s Esophagus in a Canine Model
J. D. Naranjo1, L. T. Saldin1, C. Torres1, P. Chan1, R. Das2,
K. McGrath2, E. Sobieski1, J. Dziki1, M. Klimak1, S. Patel1,
M. Cramer1, Y. Lee1, S. F. Badylak1;
1McGowan Institute for Regenerative Medicine, Pittsburgh, PA,
2UPMC, Pittsburgh, PA.
Background: Barrett’s esophagus(BE) is the only identifiable pre-
malignant condition that leads to esophageal adenocarcinoma(EAC).
The high mortality of this cancer and the lack of preventative and
curative treatment options requires the development of new therapies
that target BE and prevent EAC. Extracellular matrix(ECM) derived
from normal tissues has been shown to mitigate or reverse neoplastic
cell phenotype. We evaluated a hydrogel derived from normal
esophageal-ECM(eECM) for treatment of BE in a canine model.
Methods: eECM-hydrogel was produced by pepsin-digestion of
decellularized porcine esophageal mucosa. Strength of adhesion of the
gel to esophageal mucosa and retention over time was evaluated at
different eECM concentrations(8,12,16-mg/mL). Acid reflux was in-
duced surgically in 8 dogs by Heller myotomy, creating a diaphrag-
matic hernia and daily administration of pentagastrin. After 3 months,
pentagastrin was replaced with omeprazole and dogs were treated with
25ml of per-os hydrogel twice daily during 1 month. Endoscopy was
performed before and after treatment to evaluate disease course.
Results:Mucoadhesion of eECM-hydrogel to porcine esophageal
mucosa increased with hydrogel concentration and showed contin-
ued presence after 24 hours of laminar flow in-vitro. Labelled hy-
drogel was detected by endoscopy and shown to coat the lower third
of the esophagus 40minutes after oral delivery at 12mg/mL. Biopsies
of dog with acid reflux showed intestinal metaplasia in the lower
esophagus at 3 months and mitigation of esophagitis from >4 folds to
2 folds after 1 month of treatment.
Conclusion: eECM-hydrogel represent a viable strategy to miti-
gate and/or reverse esophagitis and Barrett’s esophagus potentially
by delivering homeostatic and anti-inflammatory microenviron-
mental signals.
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Matrix-bound Nanovesicles Recapitulate the Effects of ECM
Bioscaffolds upon Macrophage Phenotype
J. Dziki1, L. Huleihel2, J. Bartolacci1, T. Vorobyov3, B. Arnold1,
M. Scarritt3, C. Pineda1, S. LoPresti1, B. Brown1, S. Badylak3;
1Bioengineering, University of Pittsburgh, Pittsburgh, PA, 2Surgery,
University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh,
Pittsburgh, PA.
Long-term functional tissue replacement using tissue engineered
technologies depends upon an appropriate host immune response.
In contrast, dysregulation of the immune response is implicated in many
disease processes and in poor tissue remodeling outcomes. Both the
native extracellular matrix (ECM) and biomaterials composed of ECM
possess the appropriate signaling milieu to facilitate immunomodulation
in normal development, homeostasis, wound healing, and in the latter
case, functional tissue remodeling. The specific component(s) within the
ECM that activate the immune response, however, are only partially
understood. Matrix-bound nanovesicles (MBV), a putative bioactive
componentwithin theECM, represent one possiblemechanismbywhich
ECM can promote macrophage activation. In the present study, mouse
bone marrow derived macrophages were exposed toMBV derived from
ECM bioscaffolds or to their parent ECM. Gene and protein expression
profiles and functional macrophage assays including phagocytosis and
nitric oxide production show that MBV alone recapitulate the effects of
ECMbioscaffolds uponmacrophage phenotype. Specifically, both ECM
and MBV promote a downregulation of pro-inflammatory macrophage
markers and an increased expression of pro-remodeling markers. MBV
derived from small-intestinal-submucosa (SIS) and urinary-bladder-
matrix (UBM) were found to be enriched in miRNA 125b-5p, 143-3p,
and 145-5p, inhibition of which within macrophages is associated with a
gene and protein expression profile consistent with a pro-inflammatory,
rather than pro-remodeling macrophages. Results implicate MBV and
their miRNA cargo as a driver of the macrophage response to ECM-
bioscaffolds andmayhave important implications in the regulation of the
immune response in tissue homeostasis and normal wound healing.
Scientific Session 7: Vascular Tissue Engineering
and Tissue Vascularization
Wednesday, December 6, 2017, 11:15 AM - 12:45 PM
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Application Of A Novel Small Peptide Targeting Endothelial
Progenitor Cells For Improved Endothelialization And Patency
In Vascular Grafts
D. Hao1, Y. Fan1, Y. Wu1, W. Xiao2, Y. Li2, R. Liu2, C. Pivetti1,
D. Farmer1, K. Lam2, A. Wang1;
1Surgery, University of California, Davis Medical Center,
Sacramento, CA, 2Biochemistry and Molecular Biology, University
of California, Davis, Sacramento, CA.
We screened high-throughput one-bead one-compound (OBOC)
combinatorial libraries and identified LXW7, a ligand that has high-
specific binding affinity for avb3 integrin on the surface of active en-
dothelial progenitor cells (EPCs) and endothelial cells (ECs). Culture
surface coated with LXW7 strongly supported the attachment and pro-
liferation of ECs and EPCs, and enhanced the phosphorylation of VEGF
receptor 2 and the activation ofmitogen-activated protein kinaseERK1/2
in ECs. LXW7 supported limited attachment of platelets and did not
support attachment of THP-1 monocytes. To test the in vivo function of
LXW7,we functionalized small-diameter vascular graftswithLXW7via
CLICK chemistry and investigated its functions on endothelialization
and graft patency in a rat carotid artery bypass model. Immunohis-
tological analyses showed that at 1 week after implantation, the LXW7
modified vascular grafts possess significantly more CD34+ EPCs in the
middle segment of the luminal surface than the control grafts. At 6weeks
after implantation, mature endothelialization was present throughout the
whole length of the LXW7modified grafts while only a limited number
of CD31+ ECs were seen in the middle of the control grafts. Patency
testing results confirmed that at 6 week after implantation, 5 out of 6
LXW7-modified vascular grafts remained patent versus in the control
group only 1 out of 6 grafts was patent. Collectively, our results have
demonstrated that LXW7 specifically supports EPC/EC attachment and
functions, and can achieved rapid endothelialization and long-term pa-
tency of vascular grafts. LXW7 and their derivatives hold great promise
for endothelialization related tissue regeneration applications.
133
Compliance-Induced Intimal Hyperplasia using an Ex Vivo
Arterial Culture System
P. Diaz-Rodriguez1, T. Graf1, J. Diaz Quiroz1, V. Guiza-Arguello2,
A. Kishan3, A. Post3, E. Cosgriff-Hernandez3, M. Hahn1;
1Rensselaer Polytechnic Institute, Troy, NY, 2Universidad Industrial
de Santander, Santander, COLOMBIA, 3Texas A&M University,
College Station, TX.
A major roadblock in ‘‘off-the-shelf’’ vascular graft development
is the potential for arterial re-occlusion due to intimal hyperplasia
(IH). A strong empirical correlation exists between graft compliance
and long term arterial patency. However, there has not been a de-
finitive study to demonstrate that a synthetic graft with increased
compliance would perform similarly to an autograft. Using an ex vivo
arterial culture assay, the present study examines the effects of in-
creasing graft-host compliance mismatch on the initiation of IH.
Multilayer Vascular Grafts (MLVG) of various compliances were
inserted into porcine carotid artery segments via end-to-end anasto-
mosis. The MLVGs were prepared from electrospun polyurethane
sleeves with poly(ethylene-glycol) hydrogel luminal linings, the sleeve
fabrication conditions varied to achieve grafts of distinct compliance
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levels. Autografts and ePTFE grafts were included as high compliance
and low compliance clinical controls, respectively. Grafted vessels
were cultured within an ex vivo bioreactor for 14 days, then collected
and prepared for immunostaining with IH markers.
Following 14 days of culture, even smooth muscle cell staining was
present at the anastomoses of the autografts and the high compliance
MLVG samples. However, as the compliance of theMLVGdecreased,
isolated patches of abnormally dense smoothmuscle cell staining were
increasingly observed in the arterial wall. The extent of these regions
was similar in low compliance MLVG and ePTFE controls. Cumula-
tive immunostaining data supports the empirical correlation between
the degree of graft-host compliancemismatch and the degree of IH and
serves as a foundational study for future graft development.
Funding: NIH R21
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Self-expandable In-vivo Tissue-engineered ‘‘biotube’’ Vascular
Grafts: Proof Of Concept In A Growing Beagle Model
M. Furukoshi, E. Tatsumi, Y. Nakayama;
Artificial organs, National Cerebral and Cardiovascular Center,
Osaka, JAPAN.
Purpose:Biotube is a cell-free collagenous tube formed in a mold
upon its subcutaneous embedding by in body tissue architecture
technology (IBTA). In our previous study, in situ vascular re-
constraction occurred in collagenous matrix of Biotube as a scaffold
within several months after implantation as an arterial graft. It was
our long-term dream to confirm growth potential of Biotube after its
vascular reconstruction. This study aimed to evaluate the growth
potential of Biotubes by angiographic examining their caliber ad-
aptation using a juvenile beagle model for 2 years.
Methods and Results: Biotubes (ID 2, 2.5, 3mm, length ca. 1 cm)
were prepared by embedding molds into subcutaneous pouches for 8
weeks in adult beagles (age 1 year). The obtained allogenicBiotubeswere
implanted into common carotid arteries (ID ca.2mm) of juvenile beagles
(n=13, age 11 weeks). In all cases, patency was maintained without
aneurysm or stenosis for all observation periods. Vascular reconstruction
occurred almost at 1-month and completely at 1-year of implantation.
Follow-up angiogram showed that caliber sizes of almost all Biotubes
were gradually expanded with growing native vessels without Biotubes
with initial ID of 2mm. In addition, elongation of Biotube length was
confirmed in macroscopic observation at 1-year after implantation.
Conclusion: In this beagle model, Biotubes could be expanded
and elongated according to the growing native vessels. Size mis-
match between artificial vascular grafts and growing patients vessels
remains a serious problem in pediatric surgery. The growth potential
of Biotubes may have high potential usefulness in pediatric surgery.
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Harnessing the Vasculogenic Properties of Mural Cells to Create
Perfuseable, Complex Vascular Networks In Vitro
J. Chery1, S. Wang1, C. Blankenship1, S. Huang1, B. Jordan1,
S. Johnson1, J. Lee1, J. Shaw2, A. Wineman3, S. Weiss4, M. Si1;
1Cardiac Surgery, University of Michigan Medical School, Ann
Arbor, MI, 2Aerospace Engineering, University of Michigan, Ann
Arbor, MI, 3Mechanical Engineering, University of Michigan, Ann
Arbor, MI, 4Internal Medicine, University of Michigan Medical
School, Ann Arbor, MI.
The absence of perfuseable vasculature remains a critical obstacle to
the generation of engineered tissues. Current approaches rely on the use
of endothelial cell (EC)-centric mediated angiogenesis. Alternatively,
we have discovered that high density, 3D cultures ofmesenchymal stem
cells (MSCs) and vascular smooth muscle cells (SMCs) can generate
complex vascular networks in fibrin hydrogels. The addition of arterial,
venous or microvascular ECs contributed to further branching com-
plexity, but was not necessary for mural cell-driven vascular network
formation. Interestingly, in the presence of endothelial cells, angiogenic
sprouting was led by mural cells. Whole genome profiling revealed that
mural cells upregulated transcripts associated with lumen formation,
pro-invasive processes, basement membrane formation and angiogenic
growth factor expression when cultured under vasculogenic conditions.
Utilizing this model, we have generated multi-scalar (mm-mm diame-
ter), multi-phenotype (arterial, venous, microvascular) and dense vas-
cular networks that can occupy 1 cm3 of fibrin gel. Furthermore, these
networks are perfuseable and can accommodate continuous and pul-
satile flow for up to 7 days. Lastly, we have demonstrated that flow into
the arterial channel of the engineered vascular networks passes through
the microvasculature into venous channels, completing a vascular
subunit necessary to support parenchymal cell viability and function. In
sum, mural cell-driven vascular network formation can be used as a
novel strategy to vascularize engineered tissues.
Scientific Session 7: Peripheral Nerve Regeneration-
Towards Clinical Translation
Wednesday, December 6, 2017, 11:15 AM - 12:45 PM
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ESWT Accelerates Peripheral Nerve Regeneration by Reducing
Schwann cell Phenotype Commitment
C. M. Schuh1,2, D. Hercher1,2, M. Stainer1,2, R. Hopf1,2,
J. Ferguson1,2, A. Nogradi1,2,3, H. Redl1,2, T. Hausner1,2;
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna, AUSTRIA, 2Austrian Cluster for Tissue
Regeneration, Vienna, AUSTRIA, 3Department of Anatomy, Histology
and Embryology, University of Szeged, Szeged, HUNGARY.
The gold standard in peripheral nerve regeneration is the autolo-
gous nerve graft, where a sensory nerve is transplanted to a motor
defect site. This treatment however shows inferior results for motor
nerves, as the transplanted sensory Schwann cells and nerve channels
differ in behaviour and structure. In this study we investigated how
Extracorporeal Shockwave treatment (ESWT) improves peripheral
nerve regeneration in the clinically relevant femoral nervemodel (qPCR,
electrophysiology,/) and how it affects on Schwann cell phenotype.
In vitro model: Schwann cells isolated from motor, sensory and mixed
nerves were treated with ESWT and evaluated concerning expression of
Schwann cell specific markers (S100b, P75, MAG, P0-FACS) and
proliferation in pro-proliferation (PPM)/pro-myelination (PMM) me-
dium. In vivo data indicate inferior regeneration of motor axons through
a sensory nerve graft. ESWT can ameliorate this effect and accelerate
nerve regeneration. Cultured for 10 weeks in PPM all ESWT SCs
showed no change in SC marker expression or proliferation, while
marker expression and proliferation of control groups steadily decreased.
Motor SC cultured in PMM were able to switch to myelination quicker
and to a higher extent than sensory SC (MAG, P0), with ESWT both
phenotypes showed even stronger myelin-associated protein expression.
Summarizing, significant differences in all parameters were observed
only between the motor/sensory control group, and ESW treated groups
showed improved results in vitro and in vivo. This study indicates that
ESWT is able to accelerate peripheral nerve regeneration by altering SC
phenotype in a model which reflects the clinical reality after autologous
nerve transplantation.
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Effects of Amniotic Fluid Derived Stem Cells (AFS)
on Regeneration of Large-gap Peripheral Nerve Injuries
in a rat model
X. MA, A. Marquez-Lara, E. Elsner, T. L. Smith, Z. Li;
Orthopedic Surgery, Wake Forest University, Winston Salem, NC.
Acellular nerve allografts (ANA) have been developed to replace
autografts for repairing large-gap peripheral nerve injuries. Tissue
engineering strategies have attempted to mimic regenerating axons’
environment by adding supportive cells other than Schwann cells. We
hypothesized that ANAs can be seeded with amniotic fluid-derived
stem cells (AFS) to promote and accelerate nerve regeneration. The
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presence of the AFS cells provides support for the regenerating axons
without the requirement of becoming Schwann cells.
Methods: ANA construct (Group 1), ANA construct with AFS
cells (Group 2), or autograft (Group 3) were used to repair a 1.5 cm
rat sciatic nerve injury (n= 12 per group). Walking track analysis,
electromyography, nerve histology were assessed at 4 months post-
injury. Fate of MPIO (micron sized iron oxide) labeled AFS cells
were tracked by MRI and Prussian blue staining.
Results: Gait analysis showed group 2 had significantly better
recoveries in overlap distance, paw angle degree, paw drag, stance
width, axis distance and SFI compared with group1. (P< 0.05) Group
2 also demonstrated greater gastrocnemius CAMP ratio, sciatic axon
diameter, fiber diameter, myelin thickness, G ratio and NMJ numbers
compared to group 1 (P< 0.01). Group 2 showed no significant dif-
ference of motor recovery from group 3. MRI demonstrated that AFS
cells appeared as hypointense region at 4 weeks post-surgery, which
was confirmed by iron staining.
Conclusions: AFS cells may be a suitable cell source to replace
Schwann cells to support and accelerate peripheral nerve regenera-
tion following large gap nerve injury.
138
Nerve Regeneration Using Lysophosphatidylcholine and
Multiple Treatments of Nerve Growth Factor
A. D. Cook, K. S. Karlinsey, A. D. Thompson, R. L. Wood,
M. N. Rigby, S. V. Coffin, S. C. Steffensen, B. L. Roeder;
Brigham Young University, Provo, UT.
Peripheral nerve damage affects hundreds of thousands of people
every year. This study tested the effectiveness of using lysopho-
sphatidylcholine (LPC) in combination with multiple injections of nerve
growth factor (NGF) to increase the healing rate of damaged left sciatic
nerves in female rats using a sciatic nerve crush model. A previous study
with thismodel found no significant difference between rats treatedwith a
combination of LPC andNGF and rats treated with only NGF. Due to the
short half-life of NGF, we concluded that a single treatment was likely
insufficient to have a significant effect. Therefore, we used three separate
treatments of NGF to stimulate nerve growth. The rats were randomly
divided intoeight groups (n>6pergroup):Crush,Crush+NGF(with1, 2,
or 3 injections), Crush + LPC, and Crush + LPC + NGF (with 1, 2, or 3
injections). The healing of the nerves was measured by monitoring
electrophysiological parameters (compound muscle action potential am-
plitudes and nerve conductance velocities) weekly, and morphological
parameters (total fascicular area, total myelinated fiber counts, fiber
densities, fiber diameters, and g-ratio) after sacrifice at 6 weeks. After six
weeks,we found that rats receiving2 treatments ofNGF(with andwithout
LPC) appeared to have better recovery than rats receiving 3 treatments of
NGF, but were not statistically significantly different from each other.
Further researchwill investigate this treatment combination in transection
injuries as well as other treatments for damaged peripheral nerves.
139
Improved Method for Streptozotocin-induced Diabetic
Peripheral Neuropathy in Murine Models
A. D. Cook, M. Bradshaw, J. Brown, M. Campbell, K. Cole, Y. Del
Resario, W. Harris, L. Kartchner, R. Lavering, S. Werner, B. Witt,
G. Boatright, II, R. Wood;
Brigham Young University, Provo, UT.
The high prevalence of diabetes mellitus with associated co-
morbidities mandates the development of appropriate models for
studying the etiology, symptoms, and potential treatments for dia-
betic peripheral neuropathy (DPN). Streptozotocin (STZ)-induced
rats may be used to successfully model the progression of nerve
degeneration from DPN, however high mortality can occur without
providing insulin. Administration of insulin after diabetic induction
more accurately models treatment of diabetes in humans and may
play a role in decreased mortality due to STZ side effects. In this
study, rat nerve function was assessed after providing insulin in STZ-
induced diabetic rats using three sensory tests: applied force reaction
time, infrared reaction time, and digit spread. The force results and
time results were analyzed separately. Analysis of male vs. female,
diabetic vs. non-diabetic rats was also performed. The male diabetic
rats showed test results that were significantly less than the non-
diabetic control rats in IR data (p= 0.0138), force data (p= 0.0079),
and reaction time data (p= 0.0115). The female diabetic rats also had
results that were significantly less than non-diabetic rats in IR data
(p< 0.001) and reaction time data (p= 0.0408), but not significantly
different with the force data (p= 0.0761). Digit spread produced in-
significant results throughout testing. Mortality was decreased by
27%. Considering all diabetic rats vs. all non-diabetic rats, both tests
showed a statistically significant decrease. By decreasing mortality
and successfully evaluating nerve function, this study supports its use
as an appropriate model for studying peripheral diabetic neuropathy.
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Biodegradable Conduits for Peripheral Nerve Injuries Modeled
in Primates
G. DiBernardo1, J. Bliley1, D. Kim1, M. Schusterman, III1,
M. Waldner1, R. Schroth1, C. Mahoney1, D. Grybowski1,
D. Bourne1, I. James1, N. Fadia1, V. McGovern1, A. Narayanan1,
K. Washington1, A. Spiess1, D. Crammond2, K. Marra1;
1Plastic Surgery, University of Pittsburgh, Pittsburgh, PA,
2Neurosurgery, University of Pittsburgh, Pittsburgh, PA.
The current standard of care for peripheral nerve injuries is auto-
grafting, which unfortunately results in donor site morbidity and loss of
function. In patients with multiple nerve injuries, obtaining adequate
nerve tissue canbe challenging.Apromising alternative to autografting is
an off-the-self biodegradable poly(caprolactone) nerve conduit embed-
ded with glial cell line-derived neurotrophic factor (GDNF).
A 5-cm defect was created on the median nerve of non-human pri-
mates (NHPs). The gap was repaired with an autograft, decellularized
human allograft, PCL conduit with GDNF, or an empty PCL conduit.
Precision pinch was assessed using a modified Klu¨ver board at baseline
through 1-year. Percent correct pinch retrieval was recorded. In-
traoperative electrophysiology was used to record compound nerve ac-
tion potentials, nerve conduction velocity, and motor evoked potentials.
Histological analysis was used to determine neurofilament and Schwann
cell density. A biopsy of the abductor pollicis brevis (APB) muscle,
which is innervated exclusively by themedian nerve, was taken at 1-year
post-procedure and stained to assess muscle atrophy.
The PCL/GDNF and autograft treatment groups trended towards
improved functional return (60%) compared to the PCL empty group
(34%) at 1 year compared to baseline. The decellularized group had
higher neurofilament density than PCL/GDNF group. Nerve con-
duction was present in the APB of the PCL/GDNF and decellularized
nerve groups suggesting the nerve was able to regenerate across the
5-cm gap and reinnervate the APB. Future work will focus on clinical
translation of this research.
Scientific Session 8: Stem Cell Models for Predicting
Developmental Toxicity
Wednesday, December 6, 2017, 1:30 PM - 3:00 PM
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Development of High Throughput Platforms for Generating
Cardiomyocytes from Mouse Embryonic Stem Cells
C. M. Barron1, M. Chen1, B. T. Ledford1, A. S. Goldstein2,
K. J. Edgar3, J. He1;
1Department of Biomedical Sciences and Pathobiology, Virginia
Polytechnic Institute and State University, Blacksburg, VA,
2Department of Chemical Engineering, Virginia Polytechnic
Institute and State University, Blacksburg, VA, 3Department of
Sustainable Biomaterials, Virginia Polytechnic Institute and State
University, Blacksburg, VA.
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Stem cells hold great potential as an unlimited source of cardiomyo-
cytes (CMs) for cell-based therapy of heart disease, drug screening, and
toxicity testing. However, generation of CMs in large quantities and high
purity remains both technologically challenging and labor-intensive. To
this end, we have developed a simple, robust 96-well Eppendorf Tube
Array (96w-ETA) protocol, and we compared it with an alginate-based
micro-encapsulation method under the same differentiation conditions
(i.e., containing BMP-4, Activin-A, bFGF, and Apelin1). Using the 96w-
ETAmethod, 3x104mouse embryonic stem cells (mESCs)were added to
each tube, incubated for 5 days to form *640mm embryonic bodies
(EBs), and subsequently transferred to regular culture dishes with dif-
ferentiationmedium.Within 7-14 days after plating, we observed*99%
beating EBs. Although this method is more efficient and cost-effective
than the conventional Hanging-Drop method2, it still requires manual
replating of EBs and the removal of non-CMs from the resultant EBs. At
present, we are examining the microencapsulation-based CM differenti-
ation from singlemESCs,whichwe expectwill result in a higher purity of
CMs and eliminate themanual step of replating.Ultimately,we anticipate
that both approaches can be streamlined into high throughput platforms
through the incorporation of automated robotic technologies.
References:
1. Wang IN, Wang X, Ge X, et al. PLoS One. 7, e38328, 2012.
2. McClelland KS, Bowles J. Differentiation. 91, 50, 2016.
Acknowledgments: This work is supported by the grant award
from the Virginia’s Commonwealth Health Research Board (CHRB)
(208-09-16JHE).
Disclosures: The authors declare no conflict of interest.
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Modular Crispr-Cas9 Ribonucleoprotein Complexes
For Precise Gene Editing Of Human Cells
K. Saha, J. Carlson-Stevermer, A. Abdeen, L. Kohlenberg,
M. Goedland, K. Molugu, M. Lou;
University of Wisconsin-Madison, Madison, WI.
Writing specific DNA sequences into the human genome is
challenging with nonviral gene-editing reagents, since most of
the edited sequences contain various imprecise insertions or deletions.
We developed a modular RNA aptamer-streptavidin strategy, termed
S1mplex, to complex CRISPR-Cas9 ribonucleoproteins with a nucleic
acid donor template, as well as other biotinylated molecules such as
quantum dots. In human pluripotent stem cells, tailored S1mplexes
increased the ratio of precisely-edited to imprecisely-edited alleles up
to 18-fold higher than standard gene-editing methods and enriched cell
populations containing multiplexed precise edits up to 42-fold. By
exploiting the versatility of the S1mplex, assembled fluorescent labels
can be used for the selection of defined sequence edits at two distinct
loci, resulting in up to 10 precise edits for every imprecise edit. This
work sharpens the CRISPR scalpels used in genome surgery. All
components of the strategy can be chemically synthesized or re-
combinantly produced: thus, this approach has strong potential to
generate off-the-shelf, preassembled reagents that can be customizable
for any patient. 44,750 disease-associated single nucleotide or indel
mutations (1-50 nucleotides in length) in the ClinVar database can be
corrected, in principle, by precise editing with our S1mplex approach.
These advances with versatile, preassembled reagents could greatly re-
duce the time and cost of in vitro/ex vivo gene editing applications with
human cells, including pluripotent stem cells, in precision medicine and
drug discovery.
Scientific Session 8: Therapeutic Applications
of Biomaterials for Guided Tissue Regeneration
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Deterministic Single-Cell Biomaterial Encapsulation
for Cell Therapy
A. Mao, J. Shin, N. Shah, D. Mooney;
Harvard University, Cambridge, MA.
Intravenous infusion of stem cells, through promising pre-
clinically in a variety of disease and injury contexts, is hampered by
the short residence times of injected cells. Here, a microfluidic sys-
temwas developed for encapsulation ofmesenchymal stem cells (MSC)
on a single-cell level in a non-Poisson determinedmanner. Encapsulated
MSCs exhibited high viability and the capacity for trilineage differen-
tiation. Moreover, the encapsulating alginate microgels were found to
form thin, 6-um average thick layers that exhibited tunable mechanical
and compositional properties. Encapsulation of MSCs into alginate
significantly increased their residence time upon intravenous infusion,
and manipulation of biomaterial properties was found to influence the
residence time, in part by changing cell morphology. Prolonged resi-
dence time was accompanied by increases in both engineered and native
secreted factors. Finally, the efficacy of encapsulated MSCs was tested
in the context of bone marrow transplantation in a syngeneic murine
transplant model. Infusion of encapsulated MSCs was found to ac-
company expedited hematopoietic reconstitution, compared to the in-
fusion of unencapsulated MSCs and bone marrow alone. These results
suggest that single-cell encapsulation of cells into biomaterial scaffolds
may be an effective strategy for improving outcomes of cell infusion.
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Biomaterial Scaffolds for Recapitulating Niche Interactions
for T-cell Development
N. Shah, A. Mao, T. Shih, D. Mooney;
Harvard University, Cambridge, MA.
Introduction: Immune deficiency after hematopoietic stem cell
transplantation (HSCT) limits its applicability as a treatment for life-
threatening blood disorders. We hypothesized that the development
of T-cells can be promoted by using a biomaterial-based scaffold that
which specifies the T-cell lineage program in progenitor heamto-
poeitic cells through the Notch-Delta pathway.
Methodology: A biomaterial comprised of alginate with tethered
notch ligand Delta like ligand-4 (DLL-4) and encapsulated bone mor-
phogenetic protein-2 (BMP-2) was polymerized into a porous hydrogel.
Wild-type C57BL/6 and NSG mice with implanted human tissue (BLT
mice) were transplanted with syngeneic whole bone marrow cells and
human CD34+ cells respectively, along with simultaneous subcutaneous
hydrogel injection in the dorsal flank. Histology, flow cytometry and
RNA sequencing were used to assess T-cell reconstitution.
Results: The hydrogel concentrated transplanted cells and in-
duced a bony nodule (*90mm3).Within the hydrogel, CLPs derived
from transplanted cells selectively expanded. In C57BL/6 mice, the
hydrogel accelerated reconstitution of T-cells, restored thymic out-
put, and diversified the T-cell receptor. The reconstituted T-cells
conferred protection against a pathogen challenge. In BLT mice, the
hydrogel accelerated human T-cell reconstitution by up to 33%,
slowed onset of graft-versus-host disease and prolonged survival.
Significance: The results indicate that a programmable biomate-
rial scaffold with biological cues can recapitulate some niche inter-
actions to drive immune reconstitution. By providing niche cues for
T-lymphopoiesis, the reconstitution of immune competent T-cells
can be accelerated after HSCT, to potentially reduce associated im-
munological complications.
Grant Acknowledgments: CRI Irvington Postdoctoral Fellow-
ship and NIH grant R01EB014703.
145
Fabrication of 3D-Printed, Bidirectional Growth Factor
Gradient Scaffolds for Osteochondral Tissue Repair
S. Bittner, B. Smith, A. Melchiorri, A. Mikos;
Bioengineering, Rice University, Houston, TX.
Cartilage damage, due to injury and osteoarthritis, is among the
most common causes of disability among adults in the United States.
Cartilage defects, which have limited endogenous capacity for self-repair,
remain a challenge for tissue engineering, as they are highly complex
despite being relatively avascular. Previous strategies have been limited
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by the inability to produce mechanically sufficient articular cartilage as
well as failure to mimic the complex interplay between cartilage and
subchondral bone found in native tissues. Past work in our laboratory has
shown that the development of heterogeneous scaffolds that address the
complexity of the osteochondral unit may offer some solutions to these
issues. In the present work, bilayered composite scaffolds using a porous
poly(e-caprolactone) (PCL) backbone were fabricated via a novel multi-
material three-dimensional printing (3DP) system and used to deliver
gelatin microparticle(GMP)-loaded growth factors (GFs) in a spatially
controlled manner. The release of TGF-b and IGF-1, which have been
shown to enhance osteochondral tissue formation in vitro, from GMPs is
well-characterized, and these GFs were selected for use in these 3DP
constructs. Uniform and bidirectional release of encapsulated growth
factors was characterized using scaffolds of varying pore architectures,
and the scaffold design andGF loadingwere optimized for use in planned
future ex vivo and in vivo experiments.
Acknowledgment: This work was supported by the NIH (P41
EB023833).
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Controlled Sequential Release of Growth Factors by Cell-Free
Multi-layered Scaffold for Functional Recoveries of Sciatic
Nerves
H. Hong, J. Min, B. Yun, Y. Jung, G. Kim, W. Koh;
Yonsei University, Seoul, KOREA, REPUBLIC OF.
Through controlled release of growth factors by multi-layered scaf-
folds, regeneration of sciatic nerves has been promoted. The scaffold
consists of three layers, where upper layer is fabricated by poly-
caprolactone (PCL) aligned electrospun nanofibers for attachment and
differentiation of cells towards the direction of sciatic nerve. The mid-
dle layer is fabricated by poly (lactide-co-glycolic acid) 6535 (PLGA
6535), which consists of 65% polylactic acid (PLA) and 35% poly-
glycolic acid (PGA), and the last layer is fabricated by PLGA 8515
consisting of 85% PLA and 15% PGA. PLGA is known for hav-
ing different degradation rates depending on the ratio of PLA and PGA.
The PLGA layers act as reservoirs for release of growth factors;
neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and
platelet-derived growth factor (PDGF). In rat model, the injured nerve,
which was rolled up by the growth factors laden and multi-layered
scaffold, was recovered after 5 weeks from the time of surgery. The
initially released NT-3 and BDNF from PLGA 6535 have especially
promoted regeneration of the neural tissue, and the sustainably released
PDGF from PLGA 8515 further enhanced the regeneration procedure to
replace the function of hind limb locomotor activity. In addition, an
implication of aligned PCL layer was crucial in functional recoveries of
sciatic nerves. This study demonstrated that the multi-layered scaffold
has performed a function that can be used to promote the locomotor
activity and to enhance nerve regeneration in combination with aligned
topography of fibrous scaffold and controlled release of growth factors.
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Graphene Oxide Incorporated Nanofibrous Scaffold for Solid
Phase-Mediated Gene Delivery into Mesenchymal Stem Cells
H. Shen1,2, Z. Zhang2, R. Tuan1;
1Department of Orthopaedic Surgery, University of Pittsburgh,
Pittsburgh, PA, 2Division of Nanobiomedicine, Suzhou Institute
of Nano-tech and Nano-bionics, Chinese Academy of Sciences,
Suzhou, CHINA.
Introduction: Delivery of functional genes into stem cells via
shows great application prospect in DNA-based tissue engineering.
Graphene oxide (GO) with ultrahigh surface area, ultra-strong ad-
sorption capability and good biocompatibility, has received in-
creasing interests as a non-viral gene nanovector. To enhance the
transfection efficiency of stem cells, polyethylenimine (PEI)/plasmid
DNA (pDNA)- GO/poly(D, L-lactic-co-glycolic acid) (PLGA) na-
nofibrous scaffold was developed as a substrate for solid phase-
mediated gene delivery and tissue engineering application.
Methods: Human mesenchymal stem cells (hMSCs) were ob-
tained with IRB approval. GO was synthesized by modified Hum-
mers method. PLGA nanofibers were prepared using a protocol
developed in our laboratory. pDNA was immobilized on the scaffold
via physical interactions.
Results: With the presence of GO, the nanofibers (GO/PLGA)
showed an enhancement of gene immobilization, and supported long-
term release of pDNA. hMSCs cultured on PEI/pDNA-GO/PLGA
scaffold showed significantly higher green fluorescent protein ex-
pression than the nanofibrous scaffoldwithout GO (PEI/pDNA-PLGA)
or the scaffolds without gene immobilization (GO/PLGA and PLGA
nanofibers with adding PEI/pDNA in the culture medium).
Conclusions: These findings demonstrate that solid phase-
mediated gene delivery using PEI/pDNA-GO/PLGA significantly
enhanced the gene transfection efficiency, and its potential utility in
tissue engineering.
Acknowledgments:We acknowledge the financial supports from
US Dept. of Defense, NSFJS (No. BK20150363, to He Shen) and
NSFC (No. 81501074, to He Shen).
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Fibrous Scaffolds Coated with Exosomes for Immune-mediated
Tissue Regeneration
N. Su, Y. Hao, Y. Luo;
Biomedical engineering, Peking University, Beijing, CHINA.
The immune system has been identified as a key mediator in tissue
regeneration. Both innate and adaptive immune responses participate in
tissue repair through tuning the angiogenesis, fibrosis and the local stem
cell behaviors.The immune response towards in vivo implantedmaterials
is inevitable and variable with the characteristics of materials, thus could
be utilized tomodulate the immune signaling to create a pro-regenerative
environment. Mesenchymal stem cells (MSCs) provide promising re-
pair/regenerative modalities in many diseases through their secretome.
Especially, MSCs secreted exosomes exhibited the functions of immune
modulation by targeting a broad spectrum of immune cells. Here, we
developed cell-free scaffolds coated with exosomes as a new regenera-
tive system with immune modulatory properties. The scaffolds with
varied physical properties were designed to attract immune cells. The
exosomes collected fromadipose tissue derivedMSCswere incorporated
in the scaffolds with the purpose to educate immune cells to facilitate
tissue regeneration. The result showed that electrospun fibrous scaffolds
covalently modified with cationic polyetherimide could efficiently be
loaded with exosomes through electrostatic interactions. The scaffolds-
exosome constructs promoted the polarization of macrophage cells to-
wards the pro-regenerative phenotype compared to the blank scaffolds
in vitro. The exosome-loaded scaffolds will be further tested in wound
healing models to provide insights into biomaterial design for immune-
mediated regeneration.
Scientific Session 8: Tissue Engineering Approaches
for Musculoskeletal Defects Session 2
Wednesday, December 6, 2017, 1:30 PM - 3:00 PM
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Combined Drug and Electrical Stimulation Synergistically
Increase Function of Engineered Human Skeletal Muscle
A. Khodabukus1, L. Madden1, C. Jackman1, N. Prabhu1,
T. Koves2, N. Bursac1;
1Biomedical Engineering, Duke University, Durham, NC,
2Molecular Physiology, Duke University, Durham, NC.
Exercise is critical tomaintenance ofmuscle function and mass and
is an effective intervention against multiple chronic diseases including
obesity, type II diabetes, and sarcopenia. In vitro models of exercised
human muscle have the potential for discovery and testing of new
therapeutic targets for metabolic and muscle wasting disorders. Here
we applied intermittent electrical stimulation (ES) for 7 days to 3D
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tissue engineered human skeletal muscle1 (myobundles). ES alone
significantly increased (3-5 fold) contractile force due in part to myo-
tube hypertrophy, hyperplasia, and improved sarcomeric organization.
ES also increased metabolic flux as evidenced by increased glucose
uptake, lactate buildup, andmedium-chain acylcarnitine accumulation.
To further increase force generation, we treated myobundles with
creatine (CR) or theb2-agonist salmeterol (SAL)which have both been
shown to improve exercise performance.ES anddrug treatment induced
significant and additive force increases compared to control (CTL:
1.1–0.18mN, CTL+ES:3.7–0.6mN, CR: 3.2–0.5mN, CR+ES:7.6–
0.9mN, SAL: 3.5–0.6mN, SAL+ES:7.9–0.8mN). Myotube diameter
significantly increased with both drug treatment and ES (CTL:
8.5–0.5mM, CTL+ES:12.1–0.7mM, CR: 11.3–0.8mM, CR+ES:16.4–
1.0mM, SAL: 9.5–0.84mM, SAL+ES: 17.3–1.1mM). This system can
be used to study exercise-related effects onmuscle structure and function
and identify new compounds able to enhance muscle performance.
Reference: 1. Madden L, et al. eLife 4:e04885 2015.
Acknowledgments: NIH grants UH3-TR000505 and AR065873.
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Regeneration and Osteointegration of the Anterior Cruciate
Ligament with a Silk Fiber based Scaffold
A. Teuschl1,2, H. Redl3,2, T. Nau3,2;
1Chemical Engineering, University of Applied Sciences Vienna,
Vienna, AUSTRIA, 2The Austrian Cluster for Tissue Regeneration,
Vienna, AUSTRIA, 3Ludwig Boltzmann Institute for Experimental
and Clinical Traumatology, Vienna, AUSTRIA.
Tissue Engineering in ACL injuries has gained increasing re-
search interest. To allow ACL regeneration, a scaffold which pro-
vides the mechanical basis, cells from different sources, and
mechanical as well as biological factors are needed. The optimal
scaffold for ACL regeneration is regarded to be biocompatible and
biodegradable to allow tissue ingrowth, but needs to have the right
mechanical properties to provide immediate mechanical stability.
Hypothesis: A degradable silk-fiber scaffold with mechanical
properties similar to the ACL is able to initiate ligament regeneration
and osteointegration after ACL resection under in-vivo conditions.
Methods: Thirty-three mountain sheep underwent ACL resection
and randomization to two groups: 1) ACL reconstruction with
scaffold alone (SA), 2) ACL reconstruction with cell-seeded scaffold
(CS). Histological evaluation of the regenerated ligament was per-
formed after six and twelve months. Bone histology was performed
to assess osteointegration.
Results: After six months, connective tissue surrounded the silk
scaffold with ingrowth in some areas. The cell seeded scaffolds had
significant lower silk content and higher content of newly formed tissue.
After twelve months, the density of the silk fibers decreased signifi-
cantly, and the ingrowth of formed tissue increased in both groups. No
differences between the two groups regarding the silk fiber degradation
as well as regenerated tissue were detected anymore. Bone histology
revealed good osteointegration after 12 months.
Conclusions: The silk-fiber based scaffold stimulated ACL re-
generation as well as osteointegration under in-vivo conditions.
Additional cell seeding lead to increased tissue regeneration after 6
months, whereas these differences diminished after twelve months.
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Tissue-Engineered Fascia Based on Mesh Implants for Pelvic
Prolapses
Y. Y. Sulina, A. I. Ishchenko, L. S. Alexandrov, A. A. Ishchenko,
I. D. Klabukov, M. E. Krasheninnikov, A. G. Demchenko,
Y. S. Lyashenko, A. V. Lyundup;
Institute for regenerative medicine, Sechenov First Moscow State
Medical University, Moscow, RUSSIAN FEDERATION.
Genital prolapse is an extremely common female health condition
which occurs in more than 300 million women worldwide. Severe de-
grees of prolapse require surgical treatment which can lead to compli-
cations. We designed tissue-engineered constructs (TECs) based on
mesh implants from polypropylene, vicryl and porcine dermal collagen
(Permacol) with seeded autologous rats dermal fibroblasts and bone
marrow mesenchymal stem cells. Constructs and control meshes were
implanted into rats and tissue reactions and collagen production were
assessed. In pilot study at 2.5 and 4 months after implantation there was
increasing connective tissue production forming tissue-engineered fascia
and therewasminimal inflammatory response in TECs groups. Themost
cytocompatible material was Permacol considering the number of cells
and the formation of a full cell monolayer covering the entire surface of
the implant. Bone marrow mesenchymal stem cells can be used to im-
prove the biocompatibility of implanted mesh for the surgical treatment
of pelvic organ prolapse.
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Osteogenic, Chondrogenic, and Angiogenic Gene Expression of
Tissue-Engineered Flaps Grown in an In Vivo Ovine Bioreactor
T. C. Piepergerdes1, A. M. Tatara1,2, S. R. Shah1,2, E. Watson1,2,
B. T. Smith1,2, G. L. Koons1,2, N. Demian3, J. Melville3, I. Hanna3,
T. Ho4, J. Shum3, J. J. van den Beucken5, J. A. Jansen5,
M. E. Wong3, A. G. Mikos1;
1Department of Bioengineering, Rice University, Houston, TX,
2Medical Scientist Training Program, Baylor College of Medicine,
Houston, TX, 3Department of Oral and Maxillofacial Surgery,
University of Texas at Houston Science Center, Houston, TX,
4Department of Otorhinolaryngology, University of Texas at
Houston Science Center, Houston, TX, 5Radboud University,
Nijmegen Medical Center, Nijmegen, NETHERLANDS.
In order to generate vascularized flaps appropriate for mandibular
reconstruction, we have devised a strategy inwhich in vivo bioreactors
can be 3D-printed to the shape of a specific defect, filled with acellular
autologous or synthetic scaffold material, and then implanted against
the periosteum of the rib in order to generate custom vascularized bony
tissues suitable for mandibular repair. While this strategy has previ-
ously been demonstrated to be effective in an ovine model of disease
(Tatara et al, Acta Biomaterialia 2016), the cell populations that mi-
grate within the bioreactors have not been extensively characterized. In
this study, tissues grown within bioreactors filled with morcellized
autologous bone or 85% beta-tricalcium phosphate/15% hydroxyap-
atite synthetic biphasic ceramic graft after nine weeks of implantation
against periosteum in sheep (n= 9 per scaffold) were harvested from
the side 1) nearest and 2) most distal to the periosteum (source of
migrating cells). Genetic expression of early and late markers of os-
teogenesis, angiogenesis, and chondrogenesis (Runx2, Osteocalcin,
BMP2, BMP7, bFGF, VEGF, Collagen II, and Sox9) were evaluated
and compared as a function of scaffold and location within the bio-
reactor by RT-qPCR using native ovine periosteum and skin as con-
trols. In addition, genetic expression was correlated with radiologic
and histologic data from the tissue specimens. Briefly, scaffold type
did not significantly change tissue gene expression (nor did it result in
final tissue radiographic or histologic differences). However, prelim-
inary data suggest that cells within the bioreactor display disparate
expression profiles dependent upon their proximity to the periosteum.
153
Electrospun Fibrin Nanofiber Construct for Regenerating
Vascularized Skeletal Muscle in Volumetric Muscle Loss
J. Gilbert-Honick1, K. Wagner2, H. Mao3, W. Grayson1;
1Department of Biomedical Engineering, Johns Hopkins University,
Baltimore, MD, 2Kennedy Krieger Institute, Johns Hopkins School
of Medicine, Baltimore, MD, 3Department of Materials Science and
Engineering, Johns Hopkins University, Baltimore, MD.
Tissue engineering has unprecedented potential to create a clinical
treatment for volumetric muscle loss (VML) since the standard of
care, an autologous muscle flap, is limited by tissue availability and
donor site morbidity. Previous approaches to VML have achieved some
regeneration but lack themyofiber and vascular density of nativemuscle.
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Here we present a novel technique to substantially regenerate a murine
VML defect with electrospun fibrin scaffolds that mimic the alignment
and 10-15 kPa stiffness of nativemuscle, are suturable, and offer scale-up
capabilities. C2C12 myoblasts seeded at 7.7·106 cells/ml and cultured
for 7 days on the scaffolds formed aligned, multinucleated, and striated
myotubes and demonstrate electromechanical coupling with measurable
force of contraction. To test the regenerative capacity of engineered
grafts murine VML defects were created by resecting *30% of the
tibialis anterior (TA) and 4 grafts were bundled and sutured into each
defect site. C2C12-seeded scaffolds enabled remarkable regeneration
with negligible fibrosis after 2 and 4weeks. The defect siteswere densely
populated with myofibers positive for myosin heavy chain, embryonic
myosin, and laminin as well as dense, highly organized vascular net-
works as in native muscle. Acellular scaffolds did not result in similar
regeneration. Preliminary data also demonstrates that engineered grafts
provide functional improvements over untreated VML defects and ap-
proach the performance of native TA muscle. In summary, the electro-
spun fibrin microfibers support the formation of functional muscle grafts
and robust regeneration of VML defects, and have the potential to ad-
vance the development of improved treatments for VML.
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Repair Large Articular Cartilage Defect Using 3D Bioprinted
Micro-Cartilages through a Minimally Invasive Approach
B. Grottkau1,2, Z. Hui1, Y. Pang1,2;
1Orthopaedic Surgery, Massachusetts General Hospital, Boston,
MA, 2Harvard Medical School, Boston, MA.
Articular cartilage has very limited capability of self-healing and
osteoarthritis is the leading cause of disability. 3D live cell bioprinting is
an emerging technology which has strong potential to regenerate dam-
aged tissues. Previously, we have successfully bioprinted micro carti-
lages using our novel 3D bioprinting system and accomplished the
implantation to the cartilage defect through a minimally invasive ap-
proach. In the current study, we further validated the clinical feasibility
of the bioprinted micro-cartilage using a large articular cartilage defect
model, which approximates the defect size that is normally observed
clinically. The bioprinted micro cartilages show standard morphology
and biochemical and molecular profiles comparable to the native carti-
lage. The micro-cartilages were successfully implanted arthroscopically
and completely covered the cartilage defect. An orthopaedic surgeon can
accomplish the implantation of the bioprinted micro-cartilages using the
standard arthroscopic surgical techniques. Only a few days post im-
plantation, the implantedmicro-cartilages show effective adhesion to the
surrounding cartilage and subchondral bone remaining in place even in
the present of shear force. The self-assembly of the micro cartilages
started hours after implantation and assembled cartilage shows contin-
uous growth and mature. Histology and immunohistology results show
good integration of the bioprinted cartilages to the surrounding cartilage
and subchondral bone. The results from this study demonstrate that our
bioprinted micro-cartilage is promising for the clinical application.
Scientific Session 8: Skin Regeneration
and Immunomodulation
Wednesday, December 6, 2017, 1:30 PM - 3:00 PM
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Glycosaminoglycan-based Hydrogels To Control
Pro-inflammatory Chemokines And Rescue Wound
Healing Deficiency
L. Schirmer1, P. Atallah1, N. Lohmann2, C. Werner1, F. Sandra2,
U. Freudenberg1, J. C. Simon2;
1Leibniz-Institut fu¨r Polymerforschung Dresden, Dresden,
GERMANY, 2Universita¨t Leipzig, Leipzig, GERMANY.
Excessive production of inflammatory chemokines can cause chronic
inflammation and thus impair the cutaneous wound healing process.
Accordingly, capturing such chemokine signals may stop chronic in-
flammatory processes and thus become a powerful treatment option for
chronic wounds. Here, a modular hydrogel based on derivatives of the
glycosaminoglycan (GAG) heparin and star-shaped poly(ethylene gly-
col) (starPEG) was customized for maximal chemokine sequestration
based on the GAG’s natural ability to bind and sequester a wide range of
cytokines. The resulting scavenging characteristics of thematerials were
compared in binding assays using recombinant chemokines MCP-1 and
IL-8, inflammatory conditioned media and wound exudates of human
patients suffering from chronic venous leg ulcers, respectively. The
effects of hydrogel-based chemokine sequestration were investigate in a
murine model of delayed cutaneous wound healing (db/db mice) to
evaluate the overall pro-regenerative effect of the starPEG-GAGwound
dressings. The developed material effectively scavenged the inflam-
matory chemokines MCP-1, IL-8, MIP-1a and MIP-1ß from condi-
tioned medium and wound fluids from patients with chronic venous leg
ulcers and to reduce the migratory activity of human monocytes and
neutrophils. In an in vivo model of delayed wound healing (db/db mice)
starPEG-GAG hydrogels were able to reduce inflammation, as well as
promote the formation of granulation tissue, angiogenesis and wound
closure. Wound dressings formed from GAG-based gels were demon-
strated to act as an efficient ‘molecular sink’, neutralizing high amounts
of chemokines thereby preventing further recruitment of immune cells
to ultimately resolve the inflammatory process.
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Macrophage Infiltration into Macro-porous Electrospun
Scaffolds Initiates a Reparative Inflammatory Response
A. Timnak1,2, Y. Har-el1,2, P. I. Lelkes1,2;
1Bioengineering, Temple University, Philadelphia, PA, 2Temple
Institute for Regenerative Medicine and Engineering (TIME),
Philadelphia, PA.
A recurring problem encountered with electrospun matrices is the
restricted penetration of cells into the interior of such fibrous scaffolds.
This limitation has been attributed to the density of the ensuing elec-
trospun mesh and lack of pores large enough to allow cell infiltration.
Upon in vivo implantation, scaffolds with large pores will be populated
by infiltrating cells, including macrophages, whereas they accumulate
adjacent to the surface facing scaffolds with small pores. The inability
of macrophages to infiltrate the scaffold leads to their fusion and
eventually fibrotic encapsulation of implanted scaffolds. In this study,
we developed a unique macro-porous, cell permeable, soy-protein-
based electrospun scaffold as an immunomodulative structure and
compared cell penetration in vitro into the macro-porous scaffolds to
that into conventional (microporous) scaffold electrospun from the
same material. We then implanted both types of scaffolds subcutane-
ously in a rat model and evaluated differential influx and perseverance
of macrophages as indicators of the severity of in vivo inflammation.
Our in vitro results demonstrated enhanced penetration of macro-
phages into the macro-porous scaffold compared to zero penetration
into control traditionally spun scaffolds. Our in vivo results suggest that
infiltration of macrophages into macro-porous implants plays a pivotal
role in modulating the inflammatory response of the host. In extending
our prior work on the use on electrospun soy scaffolds as bioactive
wound dressings, we are currently carrying out experiments in a rat
model of delayed wound healing comparing re-epithelialization and
dermal tissue regeneration in full thickness excisional wounds treated
with macro-porous and control scaffolds.
157
Allogeneic Graft Tolerance without Immunosuppression
via Engineered Immunomodulatory Signal Presentation
D. Headen1, K. Woodward2, J. Weaver1, M. M. Coronel1,
p. shrestha2, W. Bowen2, C. Johnson1, L. Shea3, E. Yolcu4,
A. Garcia1, H. Shirwan2;
1Georgia Institute of Technology, Atlanta, GA, 2University of
Louiville, Louisville, KY, 3University of Michigan, Ann Arbor, MI,
4Department of Microbiology and Immunology, University of
Louiville, Louisville, KY.
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Type 1 Diabetes (T1D) is an autoimmune disease in which auto-
reactive T cells target and destroy the insulin-producing beta cells in
the pancreas. Clinical islet transplantation (CIT), a cell-based therapy
has been an attractive approach to establish physiological insulin
production in T1D patients. Whereas initial success in restoring met-
abolic control has been attained, long-term insulin independence (>3
years) has only been achieved in a small subset of patients in part due to
the progressive graft loss associated with the allo and auto immune
responses to the transplanted graft. We have developed synthetic
surface functionalized microparticles for the localized presentation of
SA-FasL, an immunomodulatory signal, to abrogate T-cell responses.
Herein, we sought to evaluate the effect of these microparticles on islet
function in vitro as well as graft acceptance and tolerance in an animal
model of diabetes. For this purpose, SA-FasL functionalized micro-
particles (SA-FasL-PEG) were co-culture with pancreatic islets for
24 hrs. Metabolic activity, live/dead and functional assessments
demonstrated no difference between islets co-culture with or without
SA-FasL-PEG particles, validating the cytocompatibility of our plat-
form. Significantly, allo-transplantation of SA-FasL-PEG particles
with islets in the kidney capsule lead to sustained diabetes reversal (> 6
weeks) without the need for long-term immunosuppression. Contra-
riwise, control islets were promptly rejected within two weeks post-
transplantation. In conclusion, we have engineered a platform for the
controlled loading, presentation, and retention of SA-FasL protein
within the graft microenvironment for immunomodulation. Thus, this
technology has the potential to heighten the performance of allografts
without the need of systemic immunosuppression.
158
In Vitro Platform for Characterizing Immunological
Responses to Encapsulated Cells
Y. Li1, A. Frei1, A. Bayer2, E. Yang3, C. L. Stabler1;
1Biomedical Engineering, University of Florida, Gainesville, FL,
2Immunology, University of Miami, Miami, FL, 3Microbiology,
University of Miami, Miami, FL.
Alginate encapsulation has been extensively studied as an ap-
proach to protect transplanted cells from host immune recognition
and destruction. Despite widespread use, the mechanisms by which
alginate encapsulation affects host immune responses to transplanted
cells remain unknown. While it is suspected that alginate encapsu-
lation blocks contact-dependent direct antigen recognition, it re-
mains unclear if indirect recognition occurs, whereby shed donor
antigen is presented and recognized by the host. To explore these
mechanisms, we generated an in vitro platform capable of delineat-
ing direct and indirect recognition processes using ovalbumin (OVA)
as a model antigen. Cells (splenocytes) isolated from membrane-
bound OVA (mOVA) mice were used as stimulators and co-cultured
with antigen-specific responders (OTI). Proliferation and activation
of the clonally-specific OTI CD8+ T cells were quantified via flow
cytometry. Co-culture of OTI splenocytes with encapsulated mOVA
cells resulted in robust CD8+ T cell proliferation and activation,
indicating the presence of strong indirect recognition. To parse out
the roles of responder cell populations, OTI CD8+ T cells were pu-
rified and co-cultured with unencapsulated or encapsulated mOVA
cells either alone or with supplemental antigen presenting cells
(APCs). Purified CD8+ T cells responded to unencapsulated mOVA
cells but were not activated in the presence of encapsulated mOVA
cells, unless supplemented with APCs, lending further credence to
the indirect recognition hypothesis. This work demonstrates the
impacts of alginate encapsulation on host immune responses, and the
ability for adapting this model to an efficient immunological
screening platform for additional encapsulation approaches.
159
Functionalization of Immunomodulatory IL-10 to PDMS Porous
Surfaces Attenuates Inflammatory Macrophage Responses
K. Jiang, S. Wiggins, J. Liang, C. L. Stabler;
Biomedical Engineering, University of Florida, Gainesville, FL.
Inflammatory responses can impart detrimental effects to tissue
engineered grafts. In the context of islet transplantation, significant
islet loss is attributed to early inflammatory events and islet apoptotic
stress. Macrophage infiltration and their subsequent phenotype plays
a dominant role in early inflammatory progression. The biomaterial
properties of the implant, such as surface chemistry, porosity, and
topography, can influence macrophage polarization towards an M1
(inflammatory) or M2 (anti-inflammatory) phenotype at the trans-
plant site. Herein, we sought to 1) understand the impact of surface
topography and porosity of a PDMS (polydimethylsiloxane) scaffold
on macrophage phenotype; and 2) examine the capacity to direct the
resulting macrophage phenotypic response towards M2 via the sur-
face functionalization of IL-10, a potent anti-inflammatory cytokine.
Bone marrow-derived macrophages were seeded and cultured on the
2-D PDMS porous surfaces and characterized in vitro. Cytokine and
gene analysis of macrophages after culture exhibited a unique pro-
inflammatory M1-inclined phenotype, with elevated production of
pro-inflammatory cytokines (IL-6, TNFa, MCP-1, and MIP-1a) and
M1-associated genes (Il-1b, Il-6, Cox2 and Nos2). PDMS porous
surfaces where then functionalized with IL-10 via thiol-maleimide
chemistry, as verified via XPS. IL-10-functionalized PDMS porous
surfaces significantly reduced macrophage production of pro-
inflammatory cytokines, such as IL-6 and TNFa, despite no changes
in overall macrophage presence or viability. This study demonstrates
that the surface functionalization of porous surfaces with IL-10
provides a promising approach to modulate macrophage responses
in situ.
160
Fabrication of Vascularized Skin Tissue Grafts using 3D
Bioprinting Technology
T. Baltazar1,2, J. Merola3, C. M. Catarino1, M. Saltzman3, J. Pober3,
P. Karande1;
1Rensselaer Polytechnic Institute, Troy, NY, 2Instituto Superior
Te´cnico, Lisbon, PORTUGAL, 3Yale University School of
Medicine, New Haven, CT.
Skin microvasculature not only promotes graft survival by sup-
plying skin cells with oxygen and nutrients but is also known to
modulate inflammation and immune cell migration to the wound site.
Vascularization of skin grafts is crucial for successful skin engraft-
ment. Here, using a 3D bioprinting platform, we show successful
integration of a vascularized bed in a 3D printed human skin model.
In addition, we show the influence of different cell sources (fibro-
blasts, endothelial cells and pericytes) in controlling the formation of
vasculature. We have further investigated the inclusion of CRISPR/
Cas9-edited endothelial progenitor cells in 3D bioprinted vascular-
ized skin grafts to evade immune response. We anticipate that this
approach will reduce the capacity of human endothelial cells to
initiate rejection events in human organ transplants. Moreover, we
hypothesize that the pre-vascularized skin construct will enable
faster integration with the host skin, and accelerated recovery of
blood perfusion to the wound site to promote healing. These ad-
vances will allow the fabrication of human skin tissues suitable for
clinical translation.
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Mechanisms of Xenon Effect on Skin and Red Blood Cells
A. Ponomarev1, V. Rodin2, L. Gurevich3, O. Makeev1;
1Department of Medical Cell Technologies, Ural State Medical
University, Ekaterinburg, RUSSIAN FEDERATION, 2Institute of
Organic Chemistry, Johannes Kepler University Linz, Linz,
AUSTRIA, 3Department of Physics and Nanotechnology, Aalborg
University, Aalborg, DENMARK.
The usage of Xenon (Xe) is known in anesthesia and biobanking
areas. It is considered preservation effect of Xe is associated either with
clathrate formation - solid gaseous structures or dissolution of Xe
molecules in liquid phase without physical state modification (so-called
hyperbarium) [1]. This study is addressed to establish differences be-
tween hyberbarium or clathrate Xe actions as well as its applications on
various bioobjects with anaerobic - red blood cells (RBCs) and aerobic
(skin fragments) metabolism. Xe clathrates and hyperbarium storage
were simulated under 277 K and 620-725kPa and 300-350kPa, re-
spectively. RBCs were divided at three groups: clathrates, hyperbarium
and CPDA-1 as control and stored for 30 days. It was demonstrated that
the hemolysis index in clathrate group (29.65–3.71, CI95%) was sig-
nificantly higher than in hyberbarium (17.81– 2.75, CI95%) as com-
pared to control (15.68– 1.11, CI95%). Skin fragments were harvested
from rat tails and divided on hyberbarium, clathrate and dimetylsulf-
oxide cryopreserved as control group and stored for 7 days. Assessment
was performed by point-score method including epidermal-dermal in-
tegrity various assays and engraftment index. It was shown that scores
in clathrate group (7.7– 0.7, CI95%) was significantly higher than in
hyperbarium (5.3– 2.2, CI95%) and control (6.0–1.7, CI95%). The
results highlighted the differences between anaerobic and aerobic me-
tabolism. The advantages of either gaseous (hyperbarium) or solid Xe
state (clathrates) for tissue and RBCs have been clarified.
Reference: 1. Rodin V, Ponomarev A, et al. Xenon-water inter-
action in bacterial suspensions as studied by NMR. International
journal of biochemistry and biophysics 5(1), 26-36, 2017.
162
Deciduous Dental Pulp Stem Cells Cryopreservation
D. F. Bueno1, J. M. Ferreira2;
1Stem cell and tissue engineering, R-CRIO, Sao Paulo, BRAZIL,
2Stem cell and tissue engineering, R-CRIO, Campinas, BRAZIL.
Current strategies for tissue engineering depend on autologous
cells and in this context Deciduous Dental Pulp Stem Cells (DDPSC)
are great promise as an alternative source of cells for treating dam-
aged tissue. All children will lose their deciduous teeth and this make
them a non-invasive source of stem cells. The multipotent capacity of
DDPSC open new avenues for researchers to start a cryopreservation
of DDPSC start-up company named R-Crio and located in Campinas,
Sa˜o Paulo, Brazil. Our Aim is to describe how DDPSC can be collect
and cryopreserved by a start-up company respecting the International
Society for Cell Therapy recommendations.
Methods: The R-Crio company has registered dentists and pedi-
atric dentists who receive their specific training to perform the tooth
extraction. When the tooth arrives at the company after checking the
patient ‘s registry data record and their pre-collection blood tests the
tooth will be send to the Good Practice of Manufacturing (GMP)
laboratory which has the required operating Brazilian licenses at
ANVISA, as well as, it has the Federal Council of Dentistry registry.
Using specific process developed by R-Crio Company to isolate and
to characterize DDPSC this cells are cryopreserved (4 cryotubes with
106 DDPSC) in liquid nitrogen.
Conclusion: to deliver for society DDPSC cryopreserved, in GMP
conditions, open new avenues for the use of these cells in tissue
engineering and cell therapies.
163
Cryopreserving Tissue Engineered Constructs With Dmso-free
Cryoprotectants: Toward Clinical Solutions For Regenerative
Medicine
S. Matosevic, C. Zylberberg, S. Pasley;
Akron Biotechnology, Boca Raton, FL.
Cryopreservation of composite tissues and organs is a critical need
in regenerative medicine. While bioengineered tissues and organs may
help alleviate issues arising due to organ and tissue shortage, they
cannot support more than minimal cell losses due to cryopreservation
in order to maintain full function. As the search for clinically safer
cryoprotectants (CPAs) that are devoid of DMSO progresses, so does
our understanding of the biophysical cues that direct the cells to re-
spond differently to the presence of different stabilizers and cryopro-
tectants. This makes developing cryopreservation media reliant on
understanding the cryoprotectant candidates’ effects on cells’ and
tissues’ biophysical and mechanical properties. Work in our labora-
tories has focused on developing novel DMSO-free formulations based
on combinations of natural biomolecules, amino acids, carbohydrates
and antioxidants, tailored for a range of cell types in order to cryo-
preserve regenerative medicine products: from fragile immune cells to
more complex tissue constructs and composites. Here we present re-
cent work from our lab on developing solutions that specifically focus
on structures that are used in regenerative medicine from cell therapy
to tissue transplantation. These solutions address the shortcomings
associated with traditional, largely DMSO-based cryoprotectants, and
highlight factors such as freezing procedure, cryoprotectant loading
and type on optimal recovery of cells post-thaw. Viability is measured
alongside functionality to determine cryoprotectant performance and
eliminate temporary, acute effects that mask longer term CPA per-
formance. The impetus behind this line of work is to generate
clinically-relevant tissue preservation solutions to advance the safety
and efficacy of tissue engineered therapy.
164
Generation Of Fertility In Klinefelter Patients: Describing
Model Of A Multidisciplinary Program
S. Kogan1, G. Galdon2, N. Pourhabibi Zarandi12, D. F. Crudo3,
M. J. Pettenati4, S. A. Qasem5, D. D. Childs6, D. B. Rukstalis7,
S. S. Howards7, H. Sadri-Ardekani1, A. Atala1;
1Wake Forest Institute for Regenerative Medicine (WFIRM) and
Department of Urology, Wake Forest School of Medicine, Winston
Salem, NC, 2Wake Forest Institute for Regenerative Medicine
(WFIRM), Wake Forest School of Medicine, Winston Salem, NC,
3Section of Pediatric Endocrinology, Department of Pediatric, Wake
Forest School of Medicine, Winston Salem, NC, 4Section of Medical
Genetics, Wake Forest School of Medicine, Winston Salem, NC,
5Department of Pathology, Wake Forest School of Medicine,
Winston Salem, NC, 6Department of Radiology,Wake Forest School
of Medicine, Winston Salem, NC, 7Department of Urology, Wake
Forest School of Medicine, Winston Salem, NC.
Introduction: Klinefelter Syndrome (KS) is the most common
genetic disorder affecting 1/660 newborn males with dramatic loss of
spermatogonial stem cells (SSC) following the onset of puberty.
Material and Methods: To establish a multidisciplinary referral
program to offer clinical-experimental fertility preservation options
TISSUE ENGINEERING: Part A
Volume 23, Supplement 1, 2017
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to KS patients. Newly diagnosed KS patients at any age are referred
by either pediatrician or medical geneticist to urology clinic. Each
patient is enrolled in a long term follow-up to monitor his endocrine
profile, pubertal development and testicular structure to detect early
fibrosis with Elastography-Ultrasound. At Tanner stage III or higher,
one step fertility preservation is offered, including semen collection,
microsurgical testicular sperm extraction (micro-TESE) and SSC
cryopreservation. The extracted sperm is stored in a clinical setting
for future IVF/ICSI and testicular tissue containing SSCs is stored in
experimental testicular tissue bank for future use for in vitro or
in vivo spermatogenesis (auto-transplantation).
Result: December-2014 to May-2017, 17 patients have been en-
rolled. Three patients (11, 13 and 17 years-old; none-mosaic XXYY,
XXY and XXY respectively) went through electroejaculation or self-
collection with successful semen collection. No sperm found. Micro-
TESE was performed in both testes and no testicular sperm were
found by an embryologist presented in the operating room. A biopsy
from each testis was stored to preserve SSCs. Diagnostic pathology
confirmed the absence of testicular sperms and presence of sper-
matogonia in <10% of tubules in all patients.
Conclusion: We have established an effective, comprehensive
and safe multidisciplinary team approach for potential early fertility
preservation in Klinefelter patients.
Biofabrication and Bioreactors
165
Fabrication Of Tissue-Engineered Constructs For Bile
Duct Reconstruction
T. G. Dyuzheva1, A. V. Lyundup1, I. D. Klabukov1,
A. D. Shepelev2, T. K. Tenchurin2, M. E. Krasheninnikov1,
V. G. Mamagulashvili2, S. V. Krasheninnikov2, M. V. Balyasin1,
A. G. Demchenko1, Y. S. Lyashenko1, R. V. Oganesyan1,
A. S. Titov1, T. E. Grigoryev2, S. N. Chvalun2;
1Institute for regenerative medicine, Sechenov First Moscow State
Medical University, Moscow, RUSSIAN FEDERATION,
2Kurchatov institute, Moscow, RUSSIAN FEDERATION.
Iatrogenic bile duct injury is still a challenge for surgeons. Up to 2.7-
0.05% of patients are require to reconstructive bile duct surgery after
cholecystectomy.The standard surgery includes suturing of the ductwith
small intestine, but this reconstruction can lead to various complications.
No one method was proposed as the best option for the repair and native
reconstruction of common bile duct, though the use of bioengineered
materials and methods is keeping an experimental surgical research. We
have constructed a multilayered tube consisting of three synthetic poly-
mers layers and two types of cells: bonemarrowmesenchymal stemcells
(MSCs) and bile duct epitheliocytes. All polymers were tested for bio-
compatibility with the use of two cell lines: fibroblasts 3T3 and epithe-
liocytes MCF7 cells. The inner layer was formed with bile duct
epitheliocytes and PCL modified by EGF during a electrospinning fab-
rication, which allows to stimulate a proliferations of epitheliocytes. The
medium layer was formed by PCL thin film. The outer layer of the tube
included a copolymer PCL/PLGA (70:30) with seeded MSCs. The co-
polymer was modified with VEGF165 plasmid (NeovasculgenTM),
which increase of angiogenesis on 70% after subcutaneous implantation
in rats. The construct is biodegradable in various model mediums:
deionized water, phosphate buffer, bile, full culture medium. The next
step is pre-clinical trials on rabbits and minipigs for assessment of im-
plantation safety and efficacy. We suppose that this tubular multilayered
tissue-engineered construct will be capable of integration after implan-
tation and may be used to reconstruct damaged bile ducts.
166
Drug Release Evaluation from Dexamethasone-Loaded PCLA
Scaffold fabricated by 3D Printer
J. Park1, J. Park1, J. Yoo2, S. Lee2, H. Lee3, M. Kim1;
1Ajou University, Suwon, KOREA, REPUBLIC OF, 2Wake Forest
School of Medicine, Winston-Salem, NC, 3Ajou University, Ajou,
KOREA, DEMOCRATIC PEOPLE’S REPUBLIC OF.
For effective drug delivery, well-controlled and desired release
period are very important in medicine treatment to cure disease be-
cause it could induce appropriate duration of remedial effect and re-
duction of side effects. In this study, we examined effect for melting
points on drug release of drug-loaded scaffold. We synthesized poly(e-
caprolactone-ran-lactide) (PCLA) copolymers with varying composi-
tions of various monomer rations. The melting points were measure by
differential scanning calorimetry (DSC) and PCLA copolymers
melting points decreased as the LA content increased. Dexamethasone
(Dex)-loaded PCLA scaffold were prepared by solid freeform fabri-
cation and the drug loading efficiency of scaffolds were above 90%.
The in vitro and in vivo drug release behavior of Dexa-loaded PCLA
scaffold showed similar sustained release profile to 30 days after initial
burst of Dexa. The in vitro and in vivo order of the Dex release was
good agreement with the melting point order of the drug carrier.
Scanning electron microscopy (SEM) and optical image were used to
examine the morphology of the in vivo Dexa-loaded PCLA scaffolds.
We confirmed that the possibility of the control of Dexa release using
Dexa-loaded PCLA scaffold with different melting points.
167
The Effects of Cell Density on the Printability of Collagen
Bioinks for Cartilage Bioprinting
N. Diamantides, L. Bonassar;
Meinig School of Biomedical Engineering, Cornell University,
Ithaca, NY.
A major advantage of bioprinting is the ability to incorporate cells
into the hydrogel bioink being printed allowing for precise control
over cell placement within a printed construct. We have previously
found that the shape fidelity of constructs printed with collagen
bioinks can be predicted by the storage modulus of the collagen
before gelation. The effect of cell density on collagen rheological
properties and shape fidelity has not been assessed. Therefore, the
objective of this study was to determine the effects of incorporating
cells on the rheology and printability of collagen bioinks. We in-
corporated primary chondrocytes (0-100x106 cells/mL correspond-
ing to 0-20% volume fraction) into 8mg/mL collagen bioinks and
measured the storage modulus before, during, and after gelation and
measured the footprint area of dots printed using a commercial 3D
printer, a surrogate measure of bioink shape fidelity.We found that the
addition of cells had no effect on the storage modulus of the collagen
before gelation. However, the storage modulus after gelation and the
rate of gelation decreased with increasing cell density. The addition of
cells was found to have no effect on the shape fidelity of collagen
bioinks with no differences found in the footprint areas of printed dots.
These findings show that the addition of cells decreases gel mechanics
and gelation kinetics but does not impair the printability of collagen
bioinks suggesting that cartilage constructs can be printed using
chondrocyte-laden collagen bioinks with the same degree of geometric
accuracy as those printed using acellular collagen bioinks.
168
Large-scale Preparation Of Hair Follicle Germs Through
Self-organization Of Epidermal And Mesenchymal Cells
T. Kageyama, C. Yoshimura, 240-8501, J. Fukuda;
Faculty of engineering, YOKOHAMA National University,
Yokohama, JAPAN.
Regenerative medicine has been increasingly expected as a new
approach for the treatment of hair loss. Recent studies have shown
that transplantation of a compartmentalized hair follicle germ (HFG),
which was fabricated by integrating two respective aggregates of
mesenchymal and epithelial cells, led regeneration of hair follicles.
This approach is excellent, but one drawback is to require labor steps
for the preparation of the germs particularly considering that hun-
dreds of thousands of hair follicles are necessary for a single patient.
In this study, we propose a robust approach for a large-scale prepa-
ration of HFGs through self-organization of cells. We revealed that
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when the two types of hair cells, mouse epidermal and mouse/human
mesenchymal cells, were mixed in suspension and seeded in a mi-
crowell they initially formed a randomly-distributed single cell ag-
gregate but then spatially separated each other and exhibited typical
morphological features of HFG in three days of culture. The HFGs
efficiently generated hair follicles and hair shafts after intracutane-
ously transplanted in the back of nude mice. This finding facilitated a
large-scale preparation of compartmentalized HFGs (*5,000
HFGs). We fabricated a microwell array culture device with oxygen-
permeable silicone and demonstrated that oxygen supply through the
bottom of the silicone device was crucial for the spontaneous for-
mation of HFGs and subsequent hair shaft generation. This simple
HFG preparation may provide a practical and robust approach for
hair regenerative medicine.
169
Evaluation of Bi-layer 3D Printed-Scaffold in Osteochondral
Regeneration
S. Yen1, M. Shie2, Y. Shen3, Y. Chen4;
13D Printing Medical Research Center, China Medical University
Hospital, Taichung, TAIWAN, 2School of Dentistry, China Medical
University, Taichung, TAIWAN, 3Department of Bioinformatics and
Medical Engineering, Asia University, Taichung, TAIWAN,
4Graduate Institute of Biomedical Sciences, China Medical
University, Taichung, TAIWAN.
Osteochondral defects usually caused by trauma or disease, with
damage of both articular cartilage and underlying subchondral bone. In
order to repair osteochondral defects, the needs of the bone and cartilage
must be approached together. The combination of biodegradable ma-
terials and ceramic in a bi-layered composite scaffold is promising in
this area. Three-dimensional (3D) bioprinting technology is considered
have great potential and broad applications in tissue engineering, it is
enabled printing of a multitude of biocompatible materials and geo-
metric structures. In this study, we used water-based light-cured poly-
urethane (PU) and calcium silicate (CS) to fabricate a bi-layered 3D
printed-scaffold and evaluated the ability of osteochondral repair. To
investigate the potential of the PU or PU/CS scaffold for regeneration of
osteochondral tissue, the 3D printing cartilage (PU) and bone (PU/CS)
mono-scaffolds were analysis with cell viability, degradation rate,
mechanical properties, Alcian blue staining, Alizarin red staining, and
ALP analysis. The 3D printing PU or PU/CS scaffold seeded with
humanWharton’s jelly mesenchymal stem cells (hWJMSCs), the SEM
and fluorescent images results showed an excellent cytocompatibility.
Regarding in vitro bioactivity, the different content PU/CS scaffolds
were soaked in simulated body fluid, the scaffold surface was cover
abundant apatite spherulites after immersion for 28 days. In summary,
the PU/CS integrated bi-layered 3D printed-scaffolds might have po-
tential in osteochondral tissue engineering.
170
A 3D-Printed Multi-Channel Conduit for Peripheral
Nerve Repair
M. Shie1, Y. Shen2, C. Chen3, Y. Chen4;
1School of Dentistry, China Medical University, Taichung,
TAIWAN, 2Department of Bioinformatics andMedical Engineering,
Asia University, Taichung, TAIWAN, 3Master Program for
Biomedical Engineering, China Medical University, Taichung,
TAIWAN, 4School of Chinese Medicine, China Medical University,
Taichung, TAIWAN.
Although the gold standard for the surgical treatment of peripheral
nerve injury, the autograft is associatedwithmany drawbacks, including
a second surgical procedure, donor site morbidity, mismatch of donor
nerve size, and limited donor nerve length. In this study, we developed a
liquid resin preparation process of water-based polyurethane (PU) based
photosensitive materials applied with polydopamine (PDA) combined
extracellular matrix (ECM) with application of the materials for 3D
printed nerve conduits as an alternative to the autograft. Nerve guidance
conduits may be used to promote neuronal growth and guide axonal
extension after nerve injury. The 3D printing conduit cultured with
humanWharton’s jelly mesenchymal stem cells (hWJMSCs), the SEM
and fluorescent images results indicated an excellent cytocompatibility.
The 3d-printed conduits not only supported the attachment, proliferation
and survival of the seeded hWJMSCs but also up-regulated the ex-
pression of neurogenesis-related proteins in vitro. In addition, 10mm
sciatic nerve transection rat model was used to evaluate the efficacy of
the conduit up to 8 weeks after nerve transection and conduit implan-
tation. Finally, the regeneration assessment was examined electro-
physiological activity, functional and histological assessments to
compared with commercialize silicon conduit in this study. Conse-
quently, the resulting PDA/ECM promotes macrophage migration at
injury sites to re-construct microenvironments and thus facilitates nerve
regeneration. This study proves the 3D-printed PU nerve conduit that
has potentially clinical application in promoting the neurorrhaphy.
171
Voxelated Tissue Engineering with 3D Bioprinted Auxetic
Metamaterial for Controlled Patterning of Multiple Cell Types
K. Wang1, C. Ho1,2, M. Shie2, Y. Chen2, B. Wang3,1;
1Georgia Tech Manufacturing Institute, Georgia Institute of
Technology, Atlanta, GA, 23D Printing Medical Research Center,
China Medical University Hospital, Taichuang, TAIWAN,
3Industrial and Systems Engineering, Material Science and
Engineering, Georgia Institute of Technology, Atlanta, GA.
Bioprinting is one of the most promising solutions to global
shortages of tissues and organs for transplant. The integration of ad-
ditive manufacturing technologies remarkably expanded the design
space for the scaffold. However, not many application cases have
exploited and demonstrated the full potential of additive manufactur-
ing. In this study, we demonstrate a novel scaffold design which em-
ploys the latest advances in 3D printed auxetic metamaterials. The
concept of this innovation is that it places the target tissue into inter-
connected, submillimeter-scale voxels that consists of cell-laden
thermosensitive hydrogel with any desired cell types. Pluronic F-127 is
used as the support material during printing and is removed by soaking
the final build in serum-free medium at 4 C after the build is made.
The cleaned 3D printed object has carefully designed voids inside it,
which serve as channels for circulation of cell cultural medium. The
dimensions of the channels are controllable by adjusting the overall
volume of the auxetic construct, which can be utilized to facilitate a
microfluidic circulation throughout the construct during cell growth.
The auxetic metamaterial design provides a new way to pattern dif-
ferent cell types and regulate nutrient/waste exchange while the cells
populate, both of which are critical challenges in engineering large
solid tissues. Furthermore, this voxelated concept for tissue engi-
neering and its associated setup can also be a platform for sophisticated
control strategies that aim to 1) accelerate tissue regeneration, 2)
minimize variation in cells in different locations, 3) achieve cell self-
alignment, and 4) enhance tissue’s mechanical properties.
172
Manufacturing of Artificial Tissues using Hybrid Biomaterials
and a Low-Cost Three Dimensional Printer
J. Gagan1, M. Barnhart2, J. Pena1, T. Schurr1, D. Stout3;
1Electrical Engineering, California State University, Long Beach,
Long Beach, CA, 2Mechanical Engineering, California State
University, Long Beach, Long Beach, CA, 3Mechanical and
Aerospace Engineering, California State University, Long Beach,
Long Beach, CA.
Every 10mins, someone is waiting for a tissue or organ transplant as
there is no abundance of tissues Bioprinters are a great solution, but on
average cost $95,000 with some successful prints as most use one
biomaterial. Herewith, we present a novel bioprinter system by taking
a $600 industrial printer (RepRap Prusa i3) andmodifying it to include
microvalves, a pressure-regulated system for dispensing, and a water-
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jacket bound incubation chamber. All of these components maintain
the integrity and homeostasis of the cells and their environment and are
controlled by the printer’s central processing unit via Arduino. Though
the printer sets a high advantage, the biomatrix developed, the cell-cell
interactions, and the composition of the material are of equal impor-
tance. Therefore, a method to develop a hybrid biomatrix that serves to
cultivate an interior tissue complex that builds structures and an ex-
terior tissue that maintains its integrity. What makes up this matrix are
two biomaterials (Type I Collagen and Alginate), which are cross-
linked with Ethlyenediaminetetraacetic acid (EDTA) to keep cells
stable during the printing process. Experimentation proved successful,
where all cells encapsulated remained unchanged and had a viability of
90%. With an inexpensive printer and the proper biomatrix, it is pos-
sible to print artificial tissue structures that are capable of holding any
cell line and be able to structure several tissue types.
173
Characterization Of Decellularized Extracellular Matrix
On 3d-printed Ceramic Scaffolds For Promoted Osteogenesis
Differentiation
Y. Chen1, Y. A. Wu2, M. Shie3;
1Graduate Institute of Biomedical Sciences, China Medical
University, Taichung, TAIWAN, 2School of Medicine, China
Medical University, Taichung, TAIWAN, 3School of Dentistry,
China Medical University, Taichung, TAIWAN.
Currently available orthopedic implants are extremely biocompatible
but lack certain extents of biological characteristics that allow further
interaction between the biomaterial and the surrounding tissues. Nature
extracellular matrix (ECM)-coated 3D bioscaffolds was received con-
siderable interest for hard tissue regeneration due to their ability to
promote cell behaviors and decreased inflammatory responses. This
research was focused on the design and manufacturing of 3D-printed
ceramic that is made out of calcium silicate (CS), and extracellular
matrix (ECM) from MG63 cell, generating a enhancing bone tissue
engineering strategy that revolves around the concept of promoting
osteogenesis by creating an osteoinductive microenvironment through
the incorporation of bone-growth-promoting MG63’s ECM. Therefore,
we performed decellularization on MG63 cell cultured on ceramic
scaffolds to obtain the ECM-coated 3D scaffold and further analyzed the
biological behaviors of the ECM-coated scaffolds. The data indicated
that the ECM-coated ceramic scaffolds showed excellent bioactivity and
effectively promoted cellular adhesion, proliferation, and differentiation
of human Wharton’s Jelly mesenchymal stem cells by increasing the
expression of osteogenic-related genes, such as ALP, BSP and OC, and
presented anti-inflammatory characteristics by showing a decrease in
expression of TNF-a and IL-1. Overall, our study presented a valuable
technique of producing promising 3D ceramic bioscaffold that augment
bone tissue regeneration effects in numerous aspects.
174
Autologous Blood Vessel from Human ADMSCs
R. Ramesh, S. S, L. K. Krishnan;
Thrombosis Research Unit, Sree Chitra Tirunal Institute for Medical
Sciences and Technology, Trivandrum, INDIA.
Differentiation potential of adipose derived mesenchymal stem
cells (ADMSCs) has been widely studied. Ability to become endo-
thelial cells (EC) and smooth muscle cells (SMCs) is an important
advantage for constructing non-immunogenic tissue engineered small
diameter vascular grafts (TEVG). This study intends to demonstrate
construction of functional TEVG by seeding pre differentiated SMC
and EC. Major EC function demonstrated is nitric oxide (NO) release
into culture medium. Ability of ADMSC-derived SMC to deposit
collagen and elastin tomaintain compliance of the constructed vessel is
another aspect. The pre-differentiation protocol for obtaining EC
comprised exposure to hypoxia and shear stress. To obtain SMC,
platelet growth factor and BMP4 were the induction factors used.
Human adipose tissue obtained (IEC and IC-SCR approved) from
same donor was employed for obtaining well-characterized ADMSC
and after expansion separate induction protocol was used to generate
both ECs & SMCs. Replicate donor tissue was used to demonstrate
repeatability. Lineage commitment of hADMSCs to ECs was evi-
denced by gene expression of endothelial markers (eNOS and CD31)
and differentiation was confirmed by Ac-LDL uptake assay, CD31
immunofluorescence and NO production. Similarly, lineage commit-
ment of hADMSCs to SMCs upon induction was detected by gene
expression of specific markers calponin and smooth muscle actin
(SMA) and differentiation was confirmed by a-SMA and calponin
immunofluorescence. Passaging of differentiated SMC and long-term
culture resulted in ECM deposition. Decellularized culture substrates
were employed to demonstrate collagen and elastin deposition by
qualitative and quantitative methods. The study established that
functional TEVG may be constructed using autologous hADMSC.
175
Growth Factor Loaded Bioinks for Enhanced Extracellular
Matrix Deposition
B. Kessel, M. Zenobi-Wong;
Swiss Federal Institute of Technology Zurich, Zurich,
SWITZERLAND.
Introduction: Cartilage is a tissue with complex geometry and
unique shape for every individual, therefore, replacement of this tissue
can be elegantly addressed with 3D bioprinting. Recent studies have
shown strongly increased deposition of extracellular matrix (ECM) in
scaffolds of sulfated polymers, which have high affinity to certain
growth factors (1). In this study, we created a bioink based on alginate-
sulfate (AlgS) and gellan gum and investigated the chondrogenic po-
tential of bioprinted scaffolds with Transforming Growth Factor beta
(TGFb) either supplemented in the media or preloaded in the ink.
Methodology: Bovine chondrocytes were isolated, expanded to pas-
sage 3,mixedwith bioink and printed into cylindrical scaffolds. Scaffolds
were cultured either in TGFb1 containing media or loaded with TGFb1
and subsequently cultured in TGFb1-free medium for 21 days.
Results: Scaffolds were successfully bioprinted with post-
printing viability of over 90%. Cells proliferated and exhibited
spread morphology. Although atypical for chondrocytes, spread
morphology was also observed in casted AlgS scaffolds that in-
duced strong chondrogenic phenotype (1). Deposition of collagen
II and collagen I was observed in TGFb1 supplemented scaffolds.
Scaffolds loaded with TGFb1 showed increased ECM deposition
compared to unloaded, however, less then constant supplemen-
tation of TGFb1.
Conclusions: In this study we could demonstrate the feasibility of
loading bioinks with growth factors for enhanced deposition of ECM.
Patient-specific grafts without the need for in vitro pre-culture can be
created and could be used for clinical applications in the maxillo-
facial and orthopedic fields.
1. O¨ztu¨rk E. et al. Adv. Funct. Mater. 2016, 26(21): 3649-3662.
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3D Printed Biphasic Elastomeric Scaffolds with Cell-Laden
Hydrogels for Blood Vessel Tissue Engineering
Y. Shen1,2, Y. Wu3, M. Shie4,5, Y. Chen6,5;
1Department of Bioinformatics and Medical Engineering, Asia
University, Taichung, TAIWAN, 23D Printing Medical Research
Institute, Asia University, Taichung, TAIWAN, 3Department of
Industrial Engineering and Enterprise Information, Tunghai
University, Taichung, TAIWAN, 4School of Dentistry, China
Medical University, Taichung, TAIWAN, 53D Printing Medical
Research Center, China Medical University Hospital, Taichung,
TAIWAN, 6Graduate Institute of Biomedical Sciences, China
Medical University, Taichung, TAIWAN.
The total mortality rate of all cardiovascular disease-related dis-
eases is higher than other diseases, causing about 17.1 million deaths
worldwide each year. TheWorld Health Organization (WHO) predicts
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that about 23.3 million people will die from cardiovascular diseases by
2030. Although artificial blood vessels have been widely used for
many years, current grafts applied in clinical suffer from the problems
of infection, progressive obstruction, calcification, poor long-term
durability, and a lack of growth potential. In 70-100% of cases, graft
failure occurred about 10 to 15 years after surgery. With the devel-
opment of 3D printing technology, 3D printed and biomimetic blood
vessels may provide a great potential in blood vessel tissue engineer-
ing. Here, biphasic elastomeric scaffolds for blood vessel tissue en-
gineering were manufactured by digital light processing (DLP) 3D
printing technology. The design of the scaffold structure uses con-
nected porous and nonporous phases as the basis for mimicking the
media and intima layers of the blood vessel, respectively. The biode-
gradable and photosensitive polyester elastomers were applied to
provide similar mechanical properties of blood vessels. The scaffolds
can recover from deformation, and have good cytocompatibility and
flexibility. To establish the media layer of the blood vessel, the
porous structure was filled with cell-laden hydrogels. Furthermore,
the customized and Y-shaped biphasic elastomeric blood vessel
scaffolds can be fabricated by DLP 3D printing technology. The
biphasic elastomeric scaffolds with cell-laden hydrogels may im-
prove the development of blood vessel tissue engineering.
177
Tissue-engineered Bioequivalent Based on Hybrid Matrix
and Spheroids from Buccal Epithelium for Urethral
Reconstructive Surgery
A. Shpichka1, A. Gorkun2, I. Zurina2, A. Koroleva3, E. Istranova1,
L. Istranov1, P. Timashev4, I. Saburina2, Y. Rochev5, D. Butnaru1;
1Institute for Regenerative Medicine, Sechenov First Moscow State
Medical University, Moscow, RUSSIAN FEDERATION, 2FSBSI
Institute of General Pathology and Pathophysiology, Moscow,
RUSSIAN FEDERATION, 3Laser Zentrum Hannover e.V.,
Hannover, GERMANY, 4Institute of Photonic Technologies,
Crystallography and Photonics Federal Research Center, Moscow,
RUSSIAN FEDERATION, 5National University of Ireland Galway,
Galway, IRELAND.
To date, the common way to treat urethral stricture is substitute
urethral reconstruction using a buccal mucosa graft or an acellular
matrix. However, many studies showed that the use of these materials
can lead to the development of fibrosis, recurrent stricture, necrosis,
and graft rejection (Atala et al., 2017). This occurs because of insuf-
ficient cell number, possible changes in cell phenotype (epithelial-
mesenchymal transition), and absence of blood supply in a graft. We
therefore sought to develop a tissue-engineered urethral wall bioe-
quivalent, which can be used to treat urethral strictures longer than
2 cm. We developed a three-component system: hybrid matrix, mod-
ified fibrin, and cell spheroids. Matrices consisted of reconstituted type
I and III collagen reinforced with glycolide and L-lactide fibers and
provided mechanical support. Spheroids were obtained from human
buccal mucosa epithelial cells and ensured epithelial phenotype pres-
ervation. Fibrin hydrogel, which immobilized cells on amatrix surface,
was prepared in accordance with our previous data (Koroleva et al.,
2016; Shpichka et al., 2017) and induced vasulogenesis. Thus, the
developed bioequivalent is promising; and after required trials its use
can be easily translated into clinical practice.
References:AtalaA et al. J Tissue Eng Regen Med (2017), 11: 3-19.
Koroleva A et al. BioNanoMat (2016), 17(1-2):19-32.
Shpichka AI et al. Cell and Tissue Biology (2017), 11(1):81-87.
Acknowledgments: This work was supported by the Russian
Science Foundation, grant 15-15-00132.
178
A Conditioning Platform for Kidney Tissue Engineering using
a 3D Printed Bioreactor
T. P. Burton, A. Callanan;
Institute for Bioengineering, University of Edinburgh, Edinburgh,
UNITED KINGDOM.
T P Burton and A Callanan Institute for Bioengineering, University
of Edinburgh. Kidney tissue engineering is an accelerating field, with
recent advances using induced human pluripotent stem cells to create
kidney organoids1. For advancement in kidney tissue engineering a
greater control of the growth environment is required, in terms of both
3D structure where cells grow and the bioreactor stimulus they receive.
Decellularized tissue is the main focus of this research at present1;
however, the decellularized tissue is often poorly characterised with
recellularization proving an daunting challenge.
We showed how a 3D printed bioreactor can be used alongside
polymer scaffolds as a conditioning tool for tissue engineered kidney
constructs, providing a highly controlled and customizable envi-
ronment within which to influence cell differentiation, survival and
function. The device is capable of delivering a range of shear stresses
representative of in vivo conditions, and houses any electrospun
polymer scaffold. The dual purpose device can be used as a pre-
conditioning tool for kidney cells, or as a testing bed; providing a
controlled environment in which to investigate disease states or
treatments. This system provides a much needed tool within the field
of kidney tissue engineering and bioengineering at large.
References: 1. Morizane, R. & Bonventre, J. V. Kidney Orga-
noids: A Translational Journey. Trends Mol. Med. 23, 246-263, 2017.
Acknowledgments: This work is funded by an Engineering &
Physical Sciences Research Council [EPSRC] doctoral training
partnership studentship and MRC computational and chemical bi-
ology of the stem cell niche grant (CCBN) MR/L012766/1.
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Development of Protein-based Hydrogels for 3D Printing
of Tissue Constructs
J. A. Tumbic1, D. L. Heichel1, A. W. Ma1,2, K. A. Burke1,2,3;
1Polymer Program, Institute of Materials Science, University of
Connecticut, Storrs, CT, 2Chemical and Biomolecular Engineering,
University of Connecticut, Storrs, CT, 3Biomedical Engineering,
University of Connecticut, Storrs, CT.
Substrate topography, along with mechanical properties and pres-
ence of cell-relevant ligands and cues, has been established as a crucial
design parameter that affects cellular behavior in in vitro tissue models.
Understanding cellular behavior in engineered human tissue is expected
to lead to greater physiological relevance of these models, which may
ultimately facilitate application of the model for in vitro drug screening
or disease modeling. In the small and large intestine, villi and crypts,
respectively, are the major morphological features that contribute to
tissue function. Recent examples of in vitro tissue models have sought
to incorporate crypt topographies more representative of large intestine
morphology into culture substrates through different means, including
the use of decellularized extracellular matrix, formation of hydrogels
around sacrificial components, or casting scaffolds against patterned
substrates. While previous work with these models have shown that
topography affects cellular response, there are two main limitations
with thesemodels: 1) the constructs degrade quickly inmany cases, and
2) the topography cannot be easily varied. This research focuses on
preparing intestine-like structures by 3D printing silk protein hydrogels.
Silk proteins can be enzymatically crosslinked into biocompati-
ble hydrogels with long-term stability and tunable mechanical proper-
ties. This work develops a new synthetic approach that enables 3D
printing of the enzymatically-crosslinked hydrogels. Rheological ex-
periments were used to determine flow behavior and gelation kinetics,
and constructs were then 3D printed using robotic dispensing. Intestinal
cell lines were cultured on and within the gels to quantify cell attach-
ment, proliferation, and morphology on the printed constructs.
180
Electrospinning for Resorbable Vasrcular Scaffolds
with Complex Shape and Bifurcation
C. Rodriguez1, R. Tejeda-Alejandre1, H. Lara-Padilla1,
C. Mendoza-Buenrostro1, D. Dean2;
1Tecnologico de Monterrey, Monterrey, MEXICO, 2Plastic Surgery,
The Ohio State University, Columbus, OH.
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While autologous tissue is the graft of choice in most surgical bypass
procedures, the next ideal option is the use of synthetic vascular grafts,
particularly in the case of pediatric applications. While significant
advances have been reported in the use of electrospinning for vascular
grafts both at in vitro and in vivo level, most of the work is limited to
straight, tubular shapes with uniform diameters. In order to generate
complexly-shaped resorbable scaffolds with curving and bifurcated
tubular shapes with non-uniform diameters, this study proposes com-
bination of directed electrical field and dynamic positioning of elec-
trospun fibers aimed at a custom, 3D printed mandrel. The proposed
approach produced a woven membrane of electrospun fibers. In this
study, the fibers used were polycaprolactone (PCL). They were spun
onto a 3D printed (in ABS plastic) bifurcated tubular mandrel. Con-
ventional tubular scaffolds base on PCL have tensile strength in the
range of 3 and 4MPa in order to be considered adequate for in vivo
testing as vascular grafts inside models. In tension tests, the scaffolds
produced with the proposed novel method can reach up to 1.90MPa.
The results show a promising new process in order to achieve re-
sorbable vascular scaffolds with complex shape and bifurcation.
181
Three-dimensional Tissues Using Human Pluripotent Stem
Cell Spheroids as Biofabrication Building Blocks
Q. Li, H. Lin, 68588, Y. Lei, 68588;
Department of Chemical & Biomolecular Engineering, University
of Nebraska-Lincoln, Lincoln, NE.
A recently emerged approach for tissue engineering is to biofab-
ricate tissues using cellular spheroids as building blocks. Human
pluripotent stem cells (hPSCs), including human embryonic stem
cells (hESCs) and induced pluripotent stem cells (iPSCs), can be
cultured in vitro over a long term to generate large numbers of cells.
And they can presumably be differentiated into all the cell types of
human body. Additionally, patient-specific iPSCs and their deriva-
tives induce minimal or no immune rejection in the patient. These
characteristics make hPSCs ideal cell source for biofabrication. We
previously developed a thermoreversible hydrogel-based cell culture
system that can economically produce large numbers of hPSC
spheroids. With hPSCs and this culture system, there are two po-
tential methods to biofabricate the desired tissue. In Method 1, hPSC
spheroids are first utilized to biofabricate a hPSC tissue that is sub-
sequently differentiated into the desired tissue. The key for Method 1
to succeed includes: (1) hPSC spheroids can quickly fuse to form the
hPSC tissue and (2) hPSCs in the hPSC tissue can be differentiated
into the desired tissue cells. In Method 2, hPSC spheroids are first
converted into tissue spheroids in the thermoreversible hydrogel-
based cell culture system and the tissue spheroids are utilized to
biofabricate the desired tissue. The key for the success of this method
is tissue spheroids can quickly fuse to form a cohesive tissue. In this
paper, we explore these questions and study which method is more
appropriate for tissue biofabrication with hPSCs.
182
A Novel Integrated Bioprinter, Biopaper, Bioreactor System
for the Fabrication and Culture of iPSC Derived Brain
Tissue Constructs
J. D. Gaston1, R. K. Pirlo2;
1American Society for Engineering Education, Washington, DC,
2Chemistry, U.S. Naval Research Laboratory, Washington, DC.
With the growth of the biofabrication and bioengineering fields,
the ‘‘tools of the trade’’ have improved in number and ease of use,
with better output quality and reduced cost. Contemporary tissue
engineering must employ more than a single, novel technology by
integrating multiple tools/processes and transfering tissue con-
structs between biofabrication/analysis platforms. This non-trivial
challenge must be addressed in multi-tool, multi-process labora-
tories. We have developed a tissue engineering system combining
a laser-induced forward transfer based cell printer, a framed bio-
paper substrate/scaffold, and a perfusion bioreactor system that
supports bilayer and stacked tissue constructs that integrates with
the bioprinter. The bioprinter was built as previously reported with
modifications to ensure pattern registration to the dimensions of the
bioreactor aseptic environment maintenance. Human iPSCs were
differentiated microvascular endothelial cells and astrocytes. The
framed biopaper, an electrospun nanofiber mat attached to a laser-
cut cyclic olefin copolymer (COC) frame, was loaded into the
bioreactor. The bioreactor was 3D printed. The astrocytes were
seeded on the biopaper and microvascular endothelial cells were
printed onto this biopaper. The heterotypic tissue construct was
cultured under perfusion and remained viable in the bioreactor for
14 days. This work was supported by the Chemical Biological
Technologies Directorate under project number from the Depart-
ment of Defense Chemical and Biological Defense program
through the Defense Threat Reduction Agency and the Defense
Health Agency. This information is to be released under Dis-
tribution A.
Biomaterial Scaffolds
183
WITHDRAWN
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The Influence of Strontium Doped Biphasic Ceramic
on the Osteoporotic Rabbit Bone
M. Pilmane1, I. Salma1, G. Salms1, K. Make1, J. Locs2, D. Loca2;
1Institute of Anatomy and Anthropology, Riga Stradins University,
Riga, LATVIA, 2Centre for Biomaterial Innovation and
Development, Riga Technical University, Riga, LATVIA.
Introduction: The still unclear Strontium (Sr) influence on the
different bone molecular events in case of combination of bio-
material and Sr ions requests the evaluation of effect of Sr doped
biphasic material on the distribution of osteocalcin (OC), osteo-
protegerin (OPG), nuclear factor kappa beta 105 (NFkB105), bone
morphogenic protein 2/4 (BMP2/4) in 12 weeks long implantation
in osteoporotic rabbit bone.
Methods:Osteoporosiswas induced in 37matured female rabbits. A
4mm bone defect of right trochanter was filled with granules composed
of 70% hydroxyapatite (HA), 30% tricalcium phosphate (TCP) and 5%
of Sr in 7 rabbits; HA(70)/TCP(30) in 7 rabbits. Following groups (7
rabbits each) contained the above mentioned material without Sr. Sham
surgery was done in 8 rabbits. Left legs was set as a relative control, but
the last group consisted of intact bone (5 animals). Bone samples were
analysed by immunohistochemistry and morphometrically by Image
Pro Plus 7 program. Semi-quantitative method was used for interpre-
tation of results.
Results: Only the volume of intact bone statistically significantly
differed from indicators of all other groups. The relative number of
OC, OPG, NFkB105 and BMP2/4-containing cells was higher in the
femur with biomaterial. Only OPG elevated significantly, but num-
ber of BMP2/4 positive cells was slightly increased after biomaterial
and Sr implantation.
Conclusions: Different biomaterial and Sr implantation of 12
weeks doesn’t change the osteoporotic bone volume in rabbits. The
Sr doped biphasic ceramic seems to increase the suppression of
osteoclastogenesis and shows a slight tendency for stimulation of
bone regeneration.
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185
Early Response in Peripheral Nerve Injury Repaired
With Decellularized Nerve Allograft
D. Pan, E. Larson, M. Wood;
Washington University in St Louis, Saint Louis, MO.
Peripheral nerve injuries can result in a defect, which requires the
use of autologous nerves or acellular nerve allografts (ANAs) to bridge
the defect to facilitate regeneration. While alternatives to autologous
nerve grafts, such as ANAs, are desired, axonal regeneration is signifi-
cantly limited across long ANAs (>3cm). To determine how longer
ANAs limit regeneration, we examined the cellular repopulation of short
(2 cm) compared to long (4 cm)ANAs for up to 4weeks post-grafting in a
rat sciatic nerve defect. In thismodel, axons regenerate across 2 cmANAs
robustly, while axon regeneration across 4 cm ANAs is severely limited.
We observed that both long and short ANAs were repopulated with cells
at similar rates and densities for the first 2 weeks, where macrophages
(CD68+) were prominent in either ANA (42% vs 38%). Interestingly
though, by 2 weeks differences in angiogenetic processes were emerged.
The total length of blood vessels (RECA-1+) in the proximal and distal
regions of long and short ANAs were similar, but in the mid-region, total
blood vessel length was significantly higher in the short ANAs than the
long ANAs (10280 units vs 3020 units). Concomitant to these differences
in the mid-region of long compared to short ANAs, regions of hypoxia in
the mid-graft of long ANAs were present, as visualized via hypoxyprobe
and nuclear localization of HIF-1a staining. Taken together, these data
suggest that longer ANAs are deficient or delayed in angiogenesis, which
may play a role in limiting axonal regeneration across long ANAs.
186
A Nano-scaled And Multi-layered Recombinant Fibronectin/
cadherin Chimera Composite Selectively Concentrates
Osteogenesis-related Cells And Factors To Aid Bone Repair
J. Xing;
Department of Orthopedics, Southwest Hospital, the Third Military
Medical University, Chongqing, CHINA.
Easily accessible and effective bone grafts are in urgent need in clinic.
The selective cell retention (SCR) strategy, by which osteogenesis-
related cells and factors are enriched from bone marrow into bio-
scaffolds, holds great promise. However, the retention efficacy is limited
by the relatively low densities of osteogenesis-related cells and factors in
marrow; in addition, a lack of satisfactory surface modifiers for scaffolds
further exacerbates the dilemma. To address this issue, a multi-layered
construct consisting of a recombinant fibronectin/cadherin chimera was
established via a layer-by-layer self-assembly technique (LBL-rFN/
CDH) and used to modify demineralised bone matrix (DBM) scaffolds.
Themodification was proven stable and effective. By themechanisms of
physical interception and more importantly, chemical recognition (fi-
bronectin/integrins), the LBL-rFN/CDH modification significantly im-
proved the retention efficacy and selectivity for osteogenesis-related
cells, e.g., monocytes, mesenchymal stem cells (MSCs) and hemato-
poietic stem cells (HSCs), and bioactive factors, e.g., bFGF, BMP-2 and
SDF-1a. Moreover, the resulting composite (designated as DBM-LBL-
rFN/CDH) not only exhibited a strong MSCs-recruiting capacity after
SCR, but also provided favourable microenvironments for the prolifer-
ation and osteogenic differentiation of MSCs. Eventually, bone repair
was evidently improved. Collectively, DBM-LBL-rFN/CDHpresented a
suitable biomaterial for SCR and a promising solution for tremendous
need for bone grafts.
187
Thiolated Poly(Lactic-co-Glycolic Acid) Macromers for
Biomolecule Conjugation by Alkyne-Azide Click Chemistry
J. L. Guo1, Y. Kim1, P. S. Engel2, A. G. Mikos1;
1Bioengineering, Rice University, Houston, TX, 2Chemistry,
Rice University, Houston, TX.
Synthetic hydrogels offer high tunability of their structural charac-
teristics and physico-chemical properties for tissue engineering appli-
cations. However, hydrogels usually require the conjugation of
biomolecules to confer biological activity and induce tissue formation
and regeneration in vivo. To meet this need, our objective is thus to
develop thiol-terminated poly(lactic-co-glycolic acid) (PLGA) macro-
mers with alkyne moieties for the conjugation of biomolecules via
alkyne-azide ‘‘click’’ chemistry. By exploiting the high selectivity and
yield of the alkyne-azide cycloaddition reaction,1 we aim to achieve
‘‘click’’ binding of tissue-relevant biomolecules to this polymer. Our
methodology to generate this polymer involves the functionalization of
PLGA termini with 1,4-butynedithiol, producing alkyne and thiol groups
at the chain termini. Following this, biomolecule conjugation can be
achieved by reaction of alkyne groups with azide-linked biomolecules.
Preliminary results have demonstrated the successful synthesis of this
macromer with expected structure and controlled molecular weight.
Ultimately, this novel, tunable polymer demonstrates significance in its
presentation of nucleophilic thiol termini for crosslinking with other
polymer systems, in addition to highly orthogonal alkyne-azide ‘‘click’’
chemistry for biomolecule binding.
References: 1. Majireck, M. M. &Weinreb, S. M. A Study of the
Scope and Regioselectivity of the Ruthenium-Catalyzed [3+ 2]-
Cycloaddition of Azides with Internal Alkynes. J. Org. Chem. 71,
8680-8683 (2006).
Acknowledgments: The authors would like to acknowledge
support by the National Institutes of Health (R01 AR068073).
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The Enhancement Of Bone Formation With The Micro
And Nano-scaled Surface Coatings On Biodegradable
Mg-based Bone Scaffolds
S. Wang1, C. Yang2, C. Lo1;
1Department of Biomedical Engineering, National Yang-Ming
University, TAIPEI, TAIWAN, 2Department of Materials Science
and Engineering, National Formosa University, Yunlin, TAIWAN.
Magnesium (Mg) alloys are biodegradable and can enhance bone
formation while maintaining desired mechanical strength in the wound
healing process.However,Mg-based implantswith desired degradation
rate remain a challenge. Previously, we conducted a pilot study by
comparing electrochemical and long-term biocompatible properties of
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hydroxyapatite (HA) and fluorohydroxyapatite (FHA) coated Mg
within similar body fluid.We observed that the FHA coating displayed
preferable corrosion resistance and had a suitable topography for cul-
turing cells. In this study, human mesenchymal stem cells (hMSCs)
were used to examine cell viability, cell proliferation, and osteogenic
differentiation on the uncoated biodegradable Mg, Mg(OH)2-Mg, HA-
Mg, and FHA-Mg scaffolds. Our results confirmed that the degradation
rates were regulated by different kinds of surface modification. MTT
assays demonstrated that the initial high concentration (1300 ppm) of
Mg2+ released from uncoated Mg scaffold resulted in low hMSC via-
bility, whereas the lower concentration (400*500 ppm) of Mg2+ re-
leased from Mg(OH)2-Mg and HA-Mg caused no harm to cells. Both
SEMimages andAlamarblue assays showed that theFHA-Mg scaffold,
which had the least released Mg2+ concentration (150 ppm), sig-
nificantly enhanced the proliferation of hMSCs. Compared withmicro-
scaled surface of Mg(OH)2-Mg and HA-Mg scaffolds, the nano-scaled
needle-like structures on FHA-Mg scaffolds were observed. Further-
more, osteogenic differentiation of hMSCs on FHA-Mg scaffold was
noticeably observed two weeks after cell seeding in the presence of
osteogenic inducing medium. The results indicate that the nano-scaled
needle-like FHA-Mg scaffold may provide an efficient approach to
improve early biocompatibility of the Mg-based implantation for bone
tissue engineering.
190
In Vivo Vascularization of a Modular Bone Regeneration
Platform
K. B. Miles1, C. S. Chung2, H. W. Matthew1;
1Chemical Engineering and Materials Science, Wayne State
University, Detroit, MI, 2Physiology,Wayne State University School
of Medicine, Detroit, MI.
Introduction: Inadequate vascularization limits attempts to regen-
erate functional bone. Modular tissue engineering promises the ability
to generate well vascularized tissue constructs from endothelialized,
cell-laden modules. We examined the in vivo vascularization of im-
plants composed of fused glycosaminoglycan (GAG)/chitosan/hy-
droxyapatite (HAP) microcapsules containing osteoprogenitors (OP),
and evaluated how accessory cells could enhance vascularization.
Methodology: OPs and HAP microgranules were co-
encapsulated in GAG/chitosan microcapsules and the capsules were
coated with endothelial progenitors (EP) or undifferentiated mes-
enchymal stem cells (MSC). Cell-coated capsules were fused into
disc constructs (6 · 5mm) and implanted subcutaneously in rats.
Doppler Ultrasound imaging of constructs was conducted at 1, 2 and
4 weeks post-implantation to characterize blood flow within the
constructs. The vascular area fraction (VAF) was calculated from the
US images. Results were compared to acellular fused constructs, and
OP constructs without accessory cells. Implants were harvested for
histology at 1, 2 and 4 weeks.
Results: At 1 week post-surgery, all implant conditions had
similar average VAF, between 3.4% and 4.4% of total implant area.
After 4 weeks, implants with accessory cells (OP+EP and OP+MSC)
had higher average VAFs (8.7–5.1% and 6.3–2.6% respectively)
than either acellular (2.0–1.9%) or OP-only (1.9–1.4%) implants.
Given the Doppler resolution limit, microvessel (D < 30 mm) density
comparisons requires analysis by quantitative histology (ongoing).
Microvessel densities will be reported: preliminary observations
suggest that microvessel densities were higher in conditions con-
taining EP and MSC. Results suggest that the microcapsules with
external accessory cells are an effective new design for achieving
well-vascularized bone grafts.
191
Living Nanofiber Yarn-Based Woven Biotextiles for Tendon
Engineering Using Cell Tri-Culture and Mechanical Stimulation
S. Wu, P. N. Streubel, B. Duan;
University of Nebraska Medical Center, Omaha, NE.
Tendon grafts are essential for the treatment of various tendon-
related conditions due to the inherently poor healing capacity of native
tendons. In this work, we combined electrospun nanofiber yarns with
textile manufacturing strategies to fabricate nanofibrous woven bio-
textiles with hierarchical features, aligned fibrous topography, and
sufficient mechanical properties as tendon tissue engineered scaffolds.
Comparing to traditional electrospun random or aligned meshes, our
novel nanofibrous woven fabrics possess strong tensile and suture-
retention strengths and larger pore size. Cell proliferation and infil-
tration, and the expression of tendon-specific genes by human adipose
derived mesenchymal stem cells (HADMSC) and human tenocytes
(HT), were significantly enhanced on the woven fabrics compared to
those on their electrospun nonwoven counterparts. Co-cultures of
HADMSC with HT or human umbilical vein endothelial cells (HU-
VEC) on woven fabrics significantly upregulated the functional ex-
pression of most tenogenic markers. HADMSC/HT/HUVEC tri-
culture on woven fabrics showed the highest upregulation of most
tendon-associated markers. Furthermore, we conditioned the tri-
cultured constructs in the dynamic conditioning and demonstrated that
dynamic stretch promoted total collagen secretion and tenogenic dif-
ferentiation. Our nanofiber yarn-based biotextiles have significant
potential as engineered scaffolds to synergize the multiple cell inter-
action and mechanical stimulation for promoting tendon regeneration.
192
Characteristics of Nanofibrous Scaffolds Made By Animal Fiber
Protein
K. SAWADA;
Integrated Life, Osaka Seikei College, Osaka, JAPAN.
Keratin is a fibrous protein that constitutes the intermediate fila-
ments in epithelial cells of vertebrate animals and is a chief constituent
of hair, nail, horn, and beak. A key characteristic of keratin is its amino
acid composition and high cysteine content that permits the formation
of many disulfide bonds. These bonds maintain a firm steric structure
andmake the proteinwater-insoluble. Keratin also contains amino acid
sequences such as RGD and LDV that are involved in cell adhesion
and have similarities to fibronectin, which is a known cell-adhesive
protein. Thus, much like fibronectin, high cell affinity is expected for
keratin if it is used as a biomaterial. In this study, keratin protein
extracted from wool fibers and human hair was processed into nano-
fiber sheets which have different diameters. In order to improve the
mechanical property and functionality of the scaffold, multilayer na-
nofiber sheets were also prepared by using several kinds of bio-
absorbable synthetic polymers as auxiliaries. The physical properties
of each of the nanofiber sheets were evaluated for hydrophilicity,
mechanical strength, and surface structure. Biocompatibility of keratin
nanofiber sheets were also evaluated by culturing fibroblast on them.
From an evaluation performed for mechanical properties of keratin
nanofiber sheets, it had been proved to hold strength durable enough to
ordinary use. Fibroblast culture on the keratin nanofiber sheets resulted
in proliferation in cells with the lapse of days.Moreover, recipient cells
were well attached on the keratin nanofiber sheets without remarkable
inflammation when they were implanted in rats.
193
Surface Modification Of Poly(lactic Acid) Nerve Regeneration
Tube Using Oligo(d-lactic Acid) Bioactive Peptide Conjugates
Y. Hsu, T. Yamaoka;
National Cerebral and Cardiovascular Center, Osaka, JAPAN.
Nerve injuries, typically result in significant nerve gaps leading to
the loss of motor and sensory functions. When the gap is too large, an
autologous nerve graft from the patient’s own body is used to bridge
the injury site. However, autologous nerve grafts have several dis-
advantages including permanent loss of donor function and size
mismatch between the injured nerve and the graft nerves. Therefore,
artificial nerve conduit is of great interest for bridging the gap be-
tween severed nerve stumps. Poly(lactic acid) (PLA) and its
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copolymers are preferred because they are not enzymatically hy-
drolyzed to low toxic lactic acid and are metabolized via the tricar-
boxylic acid cycle in vivo. In addition, its mechanical properties,
shaping and molding properties are excellent, and it is easy to be
molded. However, since PLA lacks congenital biological activity, it
is usually modified with biologically active molecules. We then fo-
cused on the bioactive peptide sequence, isoleucine-lysine-valine-
alanine-valine (IKVAV), which was discovered from laminin by
Tashiro et al. in 1989, to modified PLA. IKVAV known to promote
neural cell adhesion, proliferation and neurite outgrowth. In this study,
we developed a PLLA nanofibrous nerve conduit, modified with a
conjugate of oligo(D-lactic acid) (ODLA) and the neurite outgrowth,
thereby promoting peptide IKVAV to improve the nerve regeneration.
PLLA/ODLA-IKVAV nanofiber was fabricated by electrospinning,
then, the neurite outgrowth of PC-12 on PLLA/ODLA-IKVAV na-
nofiber and on control PLLA nanofiber. We also modified the ODLA-
IKVAV chemical structure improve the hydrophilicity and exposing
efficiency of IKVAV sequence to the outmost surface of nanofibers.
194
Gellan Gum Spongy-like Hydrogels Reinforced
with Hydroxyapatite for Bone Tissue Engineering
F. Maia1, D. S. Musson2;
13B’s Research Group - Biomaterials, Biodegradables and
Biomimetics, Guimara˜es, PORTUGAL, 2Department of Medicine,
University of Auckland, Auckland, NEW ZEALAND.
Bone tissue engineeringwith cell laden hydrogels has been attracting
a lot of attention. In fact, they can resemble in some aspects the ex-
tracellular matrix, as the high water content. In a forward thinking
manner, da Silva engineered hydrogels where cells adhered and pro-
liferated without the need of any backbone modification, which they
called gellan gum (GG) spongy-like hydrogels [1]. In this work, we
took advantage of these characteristics and combined it with hy-
droxyapatite to reinforce the gellan gum (GG-HAp) spongy-like hy-
drogels. Since, there is limited knowledge about the interaction between
osteoclasts and biomaterials, we assessed the ability of developed hy-
drogels to support osteoclastogenesis. First, mechanical properties were
evaluated. Then, isolated bone marrow cells were cultured in the
spongy-like hydrogels and treated with 1,25-dihydroxyvitamin D3
(Vitamin D3) to promote osteoclastogenesis. Cultures without Vitamin
D3 and standard 2D cultures were used as control. After 7 days, cell
viability and differentiationwas assessed. It was shown that the addition
of HAp to GG spongy-like hydrogels enable the formation of lager
pores and thicker walls, allowing to withstand higher loads and resist
fracture to a higher extent. Additionally, cells were viable and meta-
bolically active. Finally, it was observed that the GG-HAp spongy-like
hydrogels supported cell differentiation into pre-osteoclasts, as sug-
gested by the presence of aggregates of TRAP-stained cells, and the
expression of DC-Stamp and Cathepsin K, necessary for cell fusion and
resorption capacity, respectively. Overall, GG-HAp spongy-like hy-
drogels showed to support osteoclastogenesis, an important feature
when establishing new biomaterials for bone tissue applications.
195
Rapid Photocrosslinking of Core/shell Bioink for in situ
Intra-surgical application
C. Onofrillo1, S. Duchi2, C. O’Connell3, R. Blanchard4, A. Quigley5,
R. M. Kapsa5, G. G. Wallace6, C. Di Bella7, P. F. Choong8;
1Intelligent Polymer Research Institute, University of Wollongong,
Wollongong, AUSTRALIA, 2Department of Surgery, University of
Melbourne, Melbourne, AUSTRALIA, 33D Biofab, Melbourne,
AUSTRALIA, 4Surgery, University of Melbourne, Melbourne,
AUSTRALIA, 5Clinical Neurosciences, University of Melbourne,
Melbourne, AUSTRALIA, 6University of Wollongong, ARC Centre
of excellence for electtromaterial sceince, Wollongong,
AUSTRALIA, 7Medicine, University of Melbourne, Melbourne,
AUSTRALIA, 8Orthopaedics, St Vincent’s Hospital, 41 Victoria
Parade, University of Melbourne, Melbourne, AUSTRALIA.
Abstract: Three-dimensional (3D) bioprinting is driving major
innovations in cartilage tissue engineering. Extrusion-based 3D
bioprinting requires a phase change from a liquid hydrogel to a semi-
solid crosslinked network. The hardening of the hydrogel can be
achieved by a photoinitiated free radical polymerization that is
highly efficient but generates cytotoxicity. Thus, we aimed to define
the conditions to match cell viability with stiffness and rapid pho-
tocrosslinking that can be exploited for intra-surgical application.
We have previously developed a handheld bioprinter for in situ an-
atomic application, ‘‘Biopen’’ (1, 2), that is customized in the present
work for the co-axial extrusion of a stem cell niche in a non- cross-
linked Core, while the photocrosslinking procedure is segregated in
the stiff outer Shell. Confocal imaging was used to characterize the
Core/Shell organization of a gelatin-methacrylamide/hyaluronic
acid-methacrylate (GelMA/HAMa) bioscaffold and a stiffness of
200KPa was reached in only 10 seconds of UV photocuring with a
selected photoinitiator. The bioprinted Adipose Derived Stem Cells
maintained 90% viability after bioprinting exerting a 30% increase in
cell number in only 10 days. Our Core/Shell 3D bioprinting couples
the rapid generation of high modulus bioscaffold with cell survival,
resulting ideal for cartilage engineering surgical techniques.
References:
1. O’Connell, C. D. et al. Biofabrication 8, 15019 (2016).
2. Di Bella, C. et al. JTERM, 10.1002/term. 2476 (2017).
Acknowledgments:Arthritis Australia - Zimmer Australia Grant.
Victorian Orthopaedic Research Trust. The ARC Centre of Ex-
cellence Scheme (Project Number CE 140100012). St. Vincent’s
Hospital (Melbourne) Research Endowment Fund.
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Novel Biomanufactured Seamless Collagen Scaffolds
As A Substitute For Biologically-Sourced Materials
In Reconstructive Urological Applications
N. Sopko1, D. Lee2, T. Yoshida1, X. Liu1, A. Singh1, T. Bivalacqua1;
1Urology, Johns Hopkins School of Medicine, Baltimore, MD,
2Johns Hopkins School of Medicine, Baltimore, MD.
Objectives: Biological-sourced materials such as decellularized hu-
man epicardium (DHE) and decellularized porcine small intestinal sub-
mucosa (SIS) are used for complex reconstructive urological operations
such as tunica reconstruction for severe Peyronie’s disease. Although
effective, they are expensive and have theoretical risks of infection and
inconsistency given their allogenic and xenogenic sources. We have
engineered a novel molded collagen type I scaffold that can be used as a
reconstructive material in complex urological repairs. We sought to
compare the mechanical and biological properties of our molded colla-
gen scaffolds with conventional biological-sourced materials.
Materials andMethods: Stress and strain weremeasured forDHE,
SIS, porous molded collagen (PMC) and cross-linked molded collagen
(CMC). All four materials were evaluated by scanning electron mi-
croscopy (SEM) and implanted subcutaneously in rats and harvested
3d, 7d, 14d, and 28d and evaluated for persistence, gross appearance
in situ, and cellular infiltration assessed by immunohistochemistry
(IHC) and quantitative polymerase chain reaction (qPCR).
Results: PMC and DHE had SEM architecture and stress and
strain properties similar to SIS and DHE, respectively. All materials
persisted to 28 days. None of the materials appeared grossly infected
or inflamed. All materials had evidence of cellular infiltration by IHC
by 28d. qPCR demonstrated expression of genes associated with
neovascularization and inflammation in all materials.
Conclusions: Engineered molded collagen scaffoldmay provide an
inexpensive, consistent, and safe source of materials that can be cus-
tomized and used for complex reconstructive urological applications.
197
Biogelx: Designer Gels for Cell Culture
E. Lopez-Bernardo1, E. Irvine2, D. Lightbody1, R. Ulijn3;
1Biogelx, New York, NY, 2Biogelx, Newhouse, Lanarkshire,
UNITED KINGDOM, 3CUNY Advanced Science Research Center,
New York, NY.
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Biogelx is a biomaterials company that designs tuneable peptide
hydrogels, offering artificial tissue environments to cell biologists for
a range of cell culture applications.
The hydrogels are highly tunable, cell-matched biomaterials, ca-
pable of revolutionizing the way cell biologists control and manip-
ulate cell behavior in the laboratory. This is of direct relevance to
fundamental cell research, including the study of stem cell biology
and disease models within academic and medical labs. Biogelx’s
hydrogels also have a potentially dramatic impact on harnessing the
capabilities of 3D bio-printing; where they are being used as the ‘bio-
ink’ in the printer.
Biogelx offers a range of hydrogel platforms that are three dimen-
sional (3D), 99% water and have the same nanoscale matrix structure
as human tissue. This gives control back to the cell biologist, as the gels
can be tuned to meet the needs of any given cell type.
This presentation showcases the underlying chemistry of Bio-
gelx’s peptide hydrogels, highlighting the range of chemical and
mechanical modifications that can be implemented within the gels, in
order to address a wide range of cell based applications. Some ex-
amples of academic and industrial collaborative work shall also be
presented, including how the gel tunable properties, can be used to
influence the differentiation pathway of stem cells.
198
Biodegradability And Thrombosis Assessment Of Magnesium-
based Alloys Using A Microfluidic System
L. Liu1,2, Y. Koo1,2, B. Collins1, Z. Xu1, J. Sankar1, Y. Yun1,2;
1Nation Science Foundation-Engineering Research Center for
Revolutionizing Metallic Biomaterials, North Carolina Agricultural
and Technical State University, Greensboro, NC, 2Department of
Chemical, Biological, and Bioengineering, FIT BEST Laboratory,
North Carolina Agricultural and Technical State University,
Greensboro, NC.
Magnesium (Mg)-based stents are extensively explored to alleviate
atherosclerosis due to their biodegradability and hemocompatibility. To
ensure the quality, safety and cost-efficacy of bioresorbable scaffolds and
full utilization of the material tunability afforded by alloying, it is critical
to access degradability and thrombosis potential of Mg-based alloys us-
ing improved in vitromodels that mimic as closely as possible the in vivo
microenvironment. In this study, we investigated biodegradation and
initial thrombogenic behavior of Mg-based alloys at the interface be-
tweenMg alloys’ surface and simulated physiological environment using
a microfluidic system. The degradation properties of Mg-based alloys
WE43, AZ31, ZWEK-L, and ZWEK-C were evaluated in complete
culture medium and their thrombosis potentials in platelet rich plasma,
respectively. The results show that 1) physiological shear stress increased
the corrosion rate and decreased platelets adhesion rate as compared
to static immersion; 2) secondary phases and impurities in material
composition induced galvanic corrosion, resulting in higher corrosion
resistance and platelet adhesion rate; 3) Mg-based alloys with higher
corrosion rate showed higher platelets adhesion rate. We conclude that a
microfluidic-based in vitro system allows evaluation of biodegradation
behaviors and platelets responses ofMg-based alloys under specific shear
stress, and degradability is related to platelet adhesion positively.
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Digital Additive Biomanufacturing of 3D Cell-Synell
Co-Cultures
F. Tourlomousis1, T. Karydis1, S. Johnson1, K. Adamala2,
R. C. Chang3, A. Mershin1;
1Massachusets Institute of Technology, Cambridge, MA, 2University
of Minnesota, Minneapolis, MN, 3Stevens Institute of Technology,
Hoboken, NJ.
Synells are cell-sized bioreactors containing one or more genes
and the enzymes, cofactors, and substrates required for their tran-
scription (TX) and translation (TL) into proteins [1].
In this work, lipid vesicle synells are fabricated by flow-focusing
microfluidic devices that allow control over the relative concentrations
of TX-TL components necessary for the expression of functional
proteins. Multiphase flow simulations of synell generation allow the
optimization of synell size and polydispersity. Various configurations
of three-dimensional (3D) synell - human mesenchymal stem cell
(hMSC) co-cultures are demonstrated using a repertoire of direct
writing additive biomanufacturing (ABM) processes [2].
In one example, 3D microscale fibrous poly-e(caprolactone) (PCL)
structures are fabricated using a melt electrospinning writing (MEW)
process. The produced structured material substrates entrap synells
within their lattice pore microarchitecture with subsequent hMSC
seeding. In another exemplar case, synell- and hMSC-laden 3D fibrous
self-assembled peptide hydrogel structures are fabricated using a
direct-write ABM process. Confocal microscopy reveals divergent
synell-hMSCs spatial configurations in 3D between the two cases.
This work can inform the reliable fabrication of complex 3D
biologically-relevant systems with superior spatial patterning and
functional control over different scales.
References
1. Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R.,
and Boyden, E. S. Engineering genetic circuit interactions within and
between synthetic minimal cells, Nat. Chem. 9, 5, 2016.
2. Tourlomousis, F., Ding, H., Kalyon, D. M., and Chang, R. C.
Melt electrospinning writing process guided by a printability num-
ber. ASME J. Manuf. Sci. Eng.,139, 2017.
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Chitosan-halloysite Nanotubes Scaffolds Containing
In Situ-Reduced Silver Nanoparticles As Antimicrobial
Dressings For Tissue Engineering Applications
A. Hernandez Rangel, 761381, P. S. Silva Bermu´dez2, A. Almaguer
Flores3, V. Garcı´a3, C. Ibarra2, C. Velasquillo2, G. Luna Ba´rcenas4;
1Biomateriales, CINVESTAV, Quere´taro, MEXICO, 2Instituto
Nacional de Rehabilitacio´n, Mexico, MEXICO, 3UNAM, Mexico,
MEXICO, 4CINVESTAV, Quere´taro, MEXICO.
Incorporation of nano-structures into chitosan (CTS) usually im-
proves its properties andmicrostructure. Naturally occurring halloysite
nanotubes (HNT) can be used as reinforcement nano-fillers while
silver nanoparticles (AgNP) can be used to increase the antibacterial
action of CTS. Therefore, in this work we developed novel CTS-HNT-
AgNP nanocomposite scaffolds by combining a solution-mixing, an in
situ reduction process and a freeze-gelation technique, aiming to obtain
antimicrobial and mammalian cells cytocompatible scaffolds for their
potential application in tissue engineering. The microstructure of the
scaffolds was improved with the incorporation of HNT, the com-
pression stress of the CTS-HNT scaffolds was 5 times higher com-
pared with bare CTS scaffolds due to the strong interactions between
HNT and CTS functional groups, which was confirmed by infrared
spectroscopy. AgNP were successfully obtained in situ by using only
CTS as reducing and stabilizing agent. Transmission electron mi-
croscopy revealed that AgNP were spherical in shape with an average
size of 17 nm. The obtained CTS-HNT-AgNP scaffolds inhibited the
proliferation of Gram-negative and positive bacteria depending on
AgNP concentration. In vitro human fibroblasts viability assays
showed that HNT addition improved the cytocompatibility of the
scaffolds even withAgNP incorporation. Our results demonstrated that
the CTS-HNT-AgNP scaffolds with improved mechanical, antibac-
terial and cytocompatibility properties could be a promising material
as cellular dressings for wound healing.
202
Osteogenic Differentiation of Mesenchymal Stem Cells
Encapsulated in Feather Keratin Hydrogel
E. Jabbari;
University of South Carolina, Columbia, SC.
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Keratin is a family of fibrous proteins found in nature as the
major component of wool, hair, and horn of mammals and birds
feather. Keratin has a relatively high fraction of cysteine residues
compared to other proteins for the formation of inter- and intra-
molecular crosslinks. The disulfide crosslinks in combination with
other structural features impart high strength to keratinized tissues.
The objective of this work was to synthesize a photo-polymerizable
hydrogel based on keratin extracted from poultry feather and
evaluate the hydrogel as a matrix for encapsulation and delivery of
mesenchymal stem cells (MSCs) in regenerative medicine. Keratin
was extracted from feather barbs by reducing the disulfide bonds in
cysteine residues to sulfhydryl groups (-SH). Next, the free thiol
groups were converted to dehydroalanine (Dha) by oxidative
elimination using O-(2,4,6-Trimethylbenzenesulfonyl) hydroxyl-
amine. Then, the Dha moieties were converted to S-allyl cysteine
by reaction with allyl mercaptanol to produce keratin allyl thioether
(KeratATE). KeratATE hydrogel was dissolved in aqueous solu-
tion, MSCs were added, the cell-suspended hydrogel precursor
solution was crosslinked by ultraviolet radiation, and cultured in
osteogenic medium. The KeratATE hydrogels had a porous, in-
terconnected, honeycomb microstructure and the gels degraded in
trypsin solution. MSCs seeded in KeratATE hydrogel had elon-
gated spindle-shape morphology and the cells produced a miner-
alized matrix upon incubation in osteogenic medium. KeratATE
Hydrogel derived from poultry feather is a viable alternative to
collagen as an in injectable, photo-polymerizable hydrogel with
tunable degradation for encapsulation and delivery of stem cells in
tissue regeneration.
203
WITHDRAWN
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Fabrication of Biodegradable, 3D-Printed, Oxygen Releasing
Scaffolds
A. L. Farris, W. L. Grayson;
Biomedical Engineering, Johns Hopkins University, Baltimore, MD.
Oxygen is a crucial metabolic substrate and regulator of the
survival and regenerative capacity of cells transplanted to regen-
erate bone defects.1 To improve cell viability under hypoxia, we
reported the use of polyacrylonitrile microspheres, or microtanks,
that provided controlled oxygen release to their microenviron-
ments.2 However, polyacrylonitrile is non-biodegradable and its
high oxygen permeability led to a relatively short oxygen release
half-life. To address these limitations, we have fabricated mi-
crotanks composed of an inner polyvinyl alcohol (PVA) layer
surrounded by an outer poly(lactic-co-glycolic acid) (PLGA) shell
using a water/oil/water double emulsion. Both PVA and PLGA are
biodegradable and PVA has lower oxygen permeability than
polyacrylonitrile, allowing for longer oxygen release. Following
fabrication, microtanks were centrifuged to remove compromised
tanks and filtered to obtain an average diameter of 42 mm. We
incorporated microtanks into scaffold struts using a 3D printing
process. By changing the weight/weight ratios, we could vary the
microtank concentration in porous polycaprolactone scaffolds.
We loaded scaffolds with oxygen using a hyperbaric oxygen
chamber and utilized resazurin dye to visualize controlled release
of oxygen into the pore spaces. We are currently investigating the
potential of these oxygen-releasing scaffolds to extend the via-
bility and osteogenic differentiation of cells maintained in hyp-
oxic microenvironments.
1. Farris AL, Rindone AN, and Grayson WL. Oxygen delivering
biomaterials for tissue engineering. Journal of Materials Chemistry
B 4, 3422-3432 (2016).
2. Cook CA., Hahn KC, Morrissette-McAlmon JBF, and Grayson
WL. Oxygen delivery from hyperbarically loaded microtanks ex-
tends cell viability in anoxic environments.Biomaterials 52, 376-384
(2015).
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Marrow-Isolated Adult Multilineage Inducible (MIAMI)
andAnnulus Fibrosus Cell Co-Cultures on Electrospun Scaffolds
for Intervertebral Disc Tissue Engineering
F. Zisi Tegou1, F. M. Andreopoulos1,2, G. J. Delcroix3,4,
G. D’Ippolito1,4;
1Department of Biomedical Engineering, University of Miami
College of Engineering, Miami, FL, 2Department of Surgery, Miller
School of Medicine, University of Miami, Miami, FL, 3College of
Allopathic Medicine, Nova Southeastern University, Ft. Lauderdale,
FL, 4GRECC & Research Service, Bruce W. Carter Miami VA
Healthcare Center, Miami, FL.
Intervertebral disc (IVD) degeneration accounts for most cases
of low back pain, affecting 80% of the adult population1. Although
tissue-engineering shows potential for treatment, IVD cells are
sparse and not readily available, rendering their use for implanta-
tion difficult. In this study, we propose co-cultures of marrow-
isolated adult multilineage inducible (MIAMI) with native annulus
fibrosus (AF) cells as an alternative source of cells. MIAMI cells
are an immature sub-population of bone marrow MSCs2. We hy-
pothesize that such co-cultures will more efficiently guide MIAMI
differentiation towards IVD lineages, thereby enhancing func-
tional outcomes, compared to AF/MSC co-cultures previously
proposed3. In our study, we fabricated nano-fibrous, randomly-
oriented, polycaprolactone scaffolds using a custom electrospin-
ning apparatus. AF/MIAMI co-cultures are seeded on the scaffolds
and the optimal cell ratio is determined based on the strongest
expression of markers characteristic for the AF portion of the disc
(collagen I and V, Sox9 and HtrA1 genes). Under SEM, scaffolds
appeared to possess uniform diameter fibers smaller than a micron.
GFP-MIAMI cells adhered to the scaffold upon culturing for 72hr,
and GFP expression demonstrated that MIAMI cells were present
both on surface and within the scaffold. Our polycaprolactone
scaffolds are therefore suitable biocompatible cell carriers. Further
studies will involve RT-PCR, SEM imaging, DNA and sGAG
content on AF/MIAMI, to prove the benefits of MIAMI cells over
MSCs in AF co-cultures.
References:
1. Whatley B, et al. Material Science and Engineering C 32:61-
77, 2012.
2. D’Ippolito G, et al. Journal of Cell Science 117.14:2971-2981,
2004.
3. Tsai TL, et al. Spine 14.9:2127-2140, 2014.
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Role of Nanofibrillar Scaffolds on Endothelial Function
and Survival
G. Yang1, M. Wanjare1, K. Nakayama2, N. Huang1;
1Cardiothoracic Surgery, Stanford University, Palo Alto, CA,
2Stanford University, Palo Alto, CA.
Research Background&Objectives:Endothelial cells (ECs) are
a promising cell type for the treatment of peripheral arterial disease
(PAD). We previously showed that anisotropic nanofibrillar scaf-
folds augment the angiogenic function of human ECs. In order to
optimize the biomechanical properties of nanofibrillar scaffolds, we
examined the effect of nanofibril size and crosslinking on endothelial
survival and function.
Methodology: Aligned nanofibrillar collagen scaffolds were
fabricated using a shear-based method. Scaffolds formulations
of varying fibril diameters were prepared by altering the ionic
strength of monomeric collagen. Scaffolds were further cross-
linked at varying levels. Scaffolds were characterized for surface
topography and degradation rate. Human ECs were seeded onto
the scaffolds for assessment of migration and survival under
hypoxia (1% O2).
Results: Scaffold formulation with low ionic strength had low
diameter (LD) fibrils (*270 nm), compared to the high ionic
strength formulation group (*630 nm). HD scaffold showed higher
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elastic modulus than LD group (20.74 – 11.73 mPa vs. 13.23 – 6.17
mPa). The mean direction of migration with respect to the fibril axis
was 37.06, compared to 48.45 in the LD group within 24 hours,
regardless of the degree of crosslinking. Cell survival was 9%
higher on HD scaffolds than that on LD group under hypoxia after
3 days. These data demonstrate that aligned scaffolds of HD scaf-
folds promoted greater cell survival and alignment along the fibril
direction.
Significance: Aligned nanofibrillar scaffolds that improve sur-
vival, migration and angiogenesis of ECs provides a viable clinical
strategy for the therapeutic neovascularization of PAD patients.
207
Surface Modification of TiO2 Nanotubes with Bioactive
Molecules to Improve the Osteocompatibility of Ti6Al4V
based Bone Implants
S. SAHA;
Biotechnology & Medical Engineering, National Institute of
Technology, Rourkela, Rourkela, INDIA.
Titanium alloys are among the most used metallic biomaterials,
particularly for orthopedic applications, as they have low specific
weight, excellent mechanical properties, immense resistance to
corrosion in biological fluids, good wear resistance and very low
toxicity towards the host. Further, to improve bone fixation and
enhance the biocompatibility of the Titanium based implants, bone
cements are used in conjugation with the implant materials during
the joint replacement surgeries. However, such implants fail due to
de-bonding of cementing material followed by accumulation of the
particulate causing toxicity and cell death. Also, bone loosening
might occur at the cement-prosthesis interface and/or cement -
bone interface, thereby increasing the chances of implant failure
by two-folds. Therefore, in the present study the surface of
Ti6Al4V was modified through the synthesis of TiO2 nanotubes
using anodic oxidation. Furthermore, the modified surface was
coated with a naturally derived, biodegradable, non-toxic polymer
(silk fibroin protein). The as-modified surface was characterized
for its morphology, surface roughness, wettability and osteo-
compatibility using MG-63 cell line. It was observed from the
study that the suggested modification significantly enhanced the
biocompatibility and osteo-integrative property of the Ti6Al4V
implant surface.
208
In vitro and In vivo Study of Controllable Biodegradability
of Magnesium Implant for the Repair of Bone Defects
J. Wang;
Department of Orthopaedics, Xijing Hospital, Fourth Military
Medical University, Xi’an, CHINA.
Magnesium is a lightweight metal with many advantages such as
accelerating bone formation and being biodegradable. These make
magnesium be proposed as a revolutionary biodegradable mate-
rial for orthopedic applications. However, magnesium corrodes too
quickly in electrolytic aqueous environments. These drawbacks
make magnesium be abandoned as a kind of orthopedic application.
In this study, we applied a new approach in the design of an Mg-
based implant material to control the biodegradation rate. By
mixing magnesium particles into PLGA matrix to fabricate an Mg/
PLGA composite, like a drug release system, the corrosion resis-
tance decreased and the biodegradation rate became controllable.
This study was designed to test the biological performance of Mg/
PLGA composite both in vitro and in vivo. In vitro results showed
that the extract fromMg/PLGA composites exerted favorable effect
on osteoblast behavior including cell proliferation and osteogenic
differentiation. In vivo study revealed that a significantly large
amount of new bone formation was observed on the Mg/PLGA
composites compared to the pure PLGA evidenced by Micro-CT
and histology analysis. These results demonstrate that Mg/PLGA
composite has excellent osteogenesis properties and suggest the
potential clinical applications of the Mg/PLGA composites as a
kind of sustained-release material in bone defect treatment. Fur-
thermore, the mechanism underlying this process was explored. We
found that Mg2+ could promote the biological behaviour of rat
calvarial osteoblasts by activating the PI3K/Akt signalling path-
way. These findings advance the understanding of cellular re-
sponses to biodegradable metallic materials and may attract greater
clinical interest in magnesium.
209
Biological Scaffold of Gelatin-Endogenous Cells Composite
Prepared by Bio-3D Printing
C. Ma, T. Xu;
Department of Mechanical Engineering, Tsinghua University,
Beijing, CHINA.
Tissue and organ weakness that can be used for organ transplan-
tation is one of the major challenges facing the medical profession
today. Due to traditional manufacturing technology is difficult to
complete the precise construction of complex organizations, and also
can’t avoid the rejection of the material in the human body, so many
patients suffering from pain, and no satisfactory treatment results are
available. Emerging bio-3D printing technology has become a key
research method in the field of material preparation with its unique
ability to form complex structure and precise similarity. On this
basis, the addition of endogenous cell complexes makes the original
chemical material become a bioactive tissue functional material. This
provides the possibility of implantable human endogenous functional
materials.
In this paper, we will add endogenous cells in the biological 3D
printing process added to the cross-linked structure of the gelatin
stent gap, and then have excellent biocompatibility of tissue cells
containing gelatin tissue-like scaffold, The tissue-like scaffold
obtained by printing is immersed in a fluid capable of providing cell
growth. When the cells have a high survival rate, the cells are more
likely to be self-propagating through cell differentiation and che-
motaxis Organization, so that can quickly repair the organization
and organs at the same time reduce the occurrence of rejection
response.
210
A New Technology For Making Multi-branched Vascular
Scaffold With Controlled Release Of Growth Factors
L. Liu;
Department of Mechanical Engineering, Tsinghua University,
Beijing, CHINA.
The small diameter vascular system that with well functioning is
the essential condition for the metabolism of cells in the tissues, a
creative way that combines 3D printing and electrostatic self-
assembly technology is proposed to create a small diameter vas-
cular scaffold with multiple layers and multi-branched structures.
Using a 3D printed mould, the mould has a primary vessel with
diameter of 2mm, and several secondary vessels with diameter of
1mm. To create the hollow vessels, hydrogel solution mixed with
growth factors was covered onto the mould. After cross-linked, the
mould was removed. Using self-assembly technique, a dense layer
that is 10mm thick composed of chitosan and heparin was added to
the outer surface of the hollow structure. This multi-layer surface
with heparin contributes to anticoagulation, and also used as outer
shell for achieving the controlled release of the internal growth
factors. This multi-layer, multi-branched structure has been tested,
and results demonstrated that the small diameter blood vascular
structure had good anticoagulation properties and greatly reduced
the probability of thrombus generation. Furthermore, because of the
controlled release of the growth factors, there is a wide application
of this structure, such as stem cell induction, targeted drug delivery
and so on.
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Amnion MSCs Remodel Biomimetic Nucleus Pulposus
Replacement for Intervertebral Disc Regeneration
C. M. Fernandez, J. J. Mercuri;
Bioengineering, Clemson University, Clemson, SC.
Intervertebral disc (IVD) degeneration (IDD) is an aberrant cell-
mediated process in which proteases degrade the nucleus pulposus
(NP) disrupting the mechanical function of the IVD eventuating in
low back pain. Biomaterials used for NP regeneration must have
similar mechanical characteristics to the native NP and support cell-
mediated remodeling. We recently demonstrated the formation of a
mimetic, extracellular matrix-based biomaterial hydrogel from de-
cellularized bovine tail IVD NP tissue which support human amni-
otic mesenchymal stromal cell (hAMSC) viability. To further
investigate the ability of the biomaterial to support regeneration,
hAMSC seeded hydrogels were cultured for 14 days prior to evalu-
ation for matrix remodeling using unconfined compressive dynamic
mechanical analysis at physiologically relevant testing frequen-
cies. We hypothesized that hAMSCs would remodel the biomate-
rial yielding increased viscoelastic properties over time in culture.
Results demonstrated that the complex, storage, and loss moduli of
the hAMSC seeded hydrogels at day 14 were significantly (p < 0.05)
greater than their respective values at day 3 and to non-seeded hy-
drogel controls. Furthermore, these properties were shown to be
test frequency-dependent. In general, the viscoelastic properties of
the hAMSC seeded hydrogels were found to be within the range of
values reported for human NP tissue. Together, the observed increase
in mechanical properties of the hAMSC-seeded biomaterial with
time in culture demonstrate that hAMSCs remodeled the biomate-
rial and create a tissue that resembles human NP. Funding:
NIH(NIGMS:5P20GM103444-07)
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Freestanding Multilayered Membranes patterned
with Micro-Reservoirs as potential Regenerative Paths
M. P. Sousa1, N. I. Martins2, C. A. Custo´dio1, V. C. Pinto3,
P. J. Sousa3, G. Minas3, F. Cleymand4, J. F. Mano1;
1CICECO – Aveiro Institute of Materials, University of Aveiro,
Aveiro, PORTUGAL, 23B’s Research Group – Biomaterials,
Biodegradables and Biomimetics, University of Minho, Guimara˜es,
PORTUGAL, 3Microelectromechanical Systems Research Unit
(CMEMS-UMinho), University ofMinho, Guimara˜es, PORTUGAL,
4Ecole des Mines de Nancy, Campus Artem, CS 14234, Nancy,
FRANCE.
Polymeric membranes have been investigated as biomaterials for
tissue regeneration, most of them presenting a flat geometry or a
patterned texture at the nano/micrometer scale. Bottom-up strategies
have been selected to produce such systems and layer-by-layer
technique has been one of the most interesting. Taking advantage of
this technology, we propose a new concept of a flexible freestanding
membrane featuring well arrays forming pore-like environments to
accommodate cells. Briefly, chitosan and alginate are alternately
deposited over a patterned PDMS substrate, repeating this procedure
100 times using a robotic system. After drying, the multilayer system
can be easily detached from the PDMS substrate. The photolithog-
raphy technology used to produce the molds allows obtaining
an array of wells on the final membranes with a tuned shape and
micro-scale precision 1. The influence of crosslinking, fibronectin
immobilization and patterning on the behavior of SaOs-2 cells is
investigated. The results suggest that the presence of patterned wells
influences positively cell adhesion, morphology and proliferation
and that cells colonize preferentially the well regions. Such positive
outcomes should result of the more 3D environment felt by the cells
on the surface of the membrane. These patterned membranes with
arrays of one-side closed pores may adequate groups of cells that
could be faced to the tissue to regenerate while blocked to migrate
from the location.
1. Martins NI, Sousa MP, Custo´dio CA, Pinto VC, Sousa PJ,
Minas G, Cleymand F, Mano JF. Multilayered membranes with
tuned well arrays to be used as regenerative patches. Acta Bioma-
terialia, 2017.
213
Heart dECM Hydrogel by Supercritical Carbon Dioxide
for Enhancing the Effect of Angiogenesis
Y. Seo1,2, Y. Jung2,3, S. Kim2,1;
1KU-KIST Graduate School of Converging Science and Technology,
Korea University, Seoul, KOREA, REPUBLIC OF, 2Center for
Biomaterials, Korea Institute of Science and Technology, Seoul,
KOREA, REPUBLIC OF, 3Korea University of Science and
Technology, Daejeon, KOREA, REPUBLIC OF.
Decellualrization by various detergents such as sodium dodecyl
sulfate (SDS) and triton X-100 can remove the cell nuclei in tissue
organs. However, this leads to ECM structure denaturation, less
presence of various ECM proteins and cytokines and loss of me-
chanical properties. To overcome these limitations, in this study, we
developed a super critical carbon dioxide (scCO2) decellularization
method with rat heart tissues, which is a detergent-free system that
prevents ECM structure disruption and retains various angiogenic
proteins in the heart dECM. The heart was placed into the scCO2
reactor and decellularized at 37C and 350 bar. After scCO2 decel-
lularization, the native scCO2-treated group and detergent-treated
group were evaluated by DNA, collagen, glycosaminoglycans
(GAGs) quantification and H&E and immunofluorescence staining.
As a result, similar to the native group, the scCO2-treated group
contained more ECM components such as collagen, GAGs, laminin,
fibronectin and myosin heavy chain (MHC) as well as angiogenic
factors including vascular endothelial growth factor (VEGF), fibro-
blast growth factor (FGF), and platelet-derived growth factor
(PDGF) and others when compared to the detergent-treated group. In
addition, to estimate the effect of angiogenesis, collagen and the
dECM gel solution were injected in a rat subcutaneous layer (n= 6 in
each group: collagen, scCO2-treated and detergent-treated group).
After 3 days, the gels were harvested and estimated by immuno-
fluorescence staining and the ImageJ program for angiogenesis
analysis. Here, we suggest that heart-derived decellularized extra-
cellular matrix (HdECM) with scCO2 decellularization is a promis-
ing highly angiogenic material for ischemic tissue regeneration and
wound repair.
214
An Efficient Protocol For Porcine Liver Decellularization
In Three Days Supports Subsequent Recellularization
L. A. Faccioli1, G. D. Suhett2, V. Hoff1, C. Hochman-Mendez1,
M. F. Santiago1, T. P. Aloila3, P. R. Salvalaggio3, A. C. Goldberg3,
D. B. Parente1, F. Moll4, A. C. Carvalho1, R. C. Goldenberg1;
1Federal University of Rio de Janeiro, Rio de Janeiro, BRAZIL,
2Albert Einstein Hospital, Sa˜o Paulo, BRAZIL, 3Albert Eisntein
Hospital, Sa˜o Paulo, BRAZIL, 4D’Or Institute for Research and
Education, Rio de Janeiro, BRAZIL.
Decellularized porcine livers have a wide range of applications in
regenerative medicine, however previously existing protocols for
organ decellularization still need to be adjusted to a full size porcine
liver.
Objective: to establish a protocol that enables effective decel-
lularization of the entire porcine liver in a short period.
Method: Livers (n= 3) were perfused with decellularizing solu-
tions through the portal vein during 3 days at room temperature. To
analyze the extracellular matrix (ECM), after decellularization, his-
tology and electron microscopy were performed. The vascular tree
integrity was evaluated, by magnetic resonance and computed to-
mography, injecting gadolinium and iodine, respectively. Toluidine
blue dye was also used. The presence of residual cells was analyzed
by DAPI and quantification of DNA by spectrophotometry. Collagen
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IV presence was detected by immunohistochemistry. To recelularize
106/ml of HEPG2 cells were cultured over the matrix. Cell presence
in the recellularized matrix was visualized by DAPI and secretion of
albumin was detected by ELISA.
Results: After 3 days, this new protocol, based on the use of
sodium-deoxycholate as detergent, was effective in preserving all
ECM structures and the vascular system. DNA quantification indi-
cated that >97% of cells were removed. Electron microscopy showed
the presence of collagen in ECM and cells could not be detected. Cell
seeding showed that ECM could be recellularized after 15 days.
Conclusion: By enabling the achievement of liver scaffolds
with preserved tissue integrity in 3 days at room temperature, this
novel protocol brings new perspectives to the development of
bioartificial livers.
215
In Vitro and In Vivo Vascular Cell Response and Release
Profile for Carbon Monoxide Releasing Molecules
Incorporated within Electrospun Scaffolds
K. S. Washington1, A. Patel1, N. Abeyrathna2, Y. Liao2,
C. A. Bashur1;
1Biomedical Engineering, Florida Institute of Technology,
Melbourne, FL, 2Chemistry, Florida Institute of Technology,
Melbourne, FL.
Carbon monoxide (CO) has the potential to improve endothelial
function in small-diameter vascular grafts. CO is a cell-signaling
molecule produced naturally in the body with anti-inflammatory
properties at appropriate concentrations. We previously reported
controlled CO release from scaffolds with visible-light activated
carbon monoxide releasing molecules (CORMs). However, incuba-
tion time limitations for the anthracene-based diketone CORM
(DK1) were found. In this study, we aim to extend the culture time
that allows CO release by using a more hydrophobic CORM and
determining the endothelial cell (EC) response to this material. In
vivo response was investigated in a pilot study. Both DK1 and the
aliphatic chain modified diketone (DK3) were synthesized. Poly(e-
caparolactone) with 0-2% w/w CORMs were electrospun. Scaffolds
were activated with 470nm light and CO release was tracked through
fluorescence signal. We determined activation profile comparison of
wet versus dry for all scaffold conditions. Maximum relative fluo-
rescence was at 180s for DK3 (n = 7). The ability to extended incu-
bation time prior to activation and CO release was demonstrated
(71.4 and 79.1% for 1 and 24 hours of incubation versus the 3min
reading, respectively; n = 3). Further, cell studies with DK3 are on-
going. Preliminary DNA analysis shows a significant increase in EC
density from day 3-14 when seeded on DK3. In addition, in vivo pilot
study results demonstrate patency, viability and cell infiltration
through the graft wall when conduits are implanted into the aorta of
rats. Von Willebrand Factor of non-activated samples illustrates
endothelial cell layer was formed in the lumen.
216
Mg-based Helical Stent Scaffold Biodegradation Analysis :
Static, Dynamic, and Porcine Ex Vivo Models
Y. Koo1, T. Tiasha, 452212, V. N. Shanov2, J. Sankar3, Y. Yun1;
1Bioengineering, NC A&T SU, Greensboro, NC, 2Chemical and
Materials Engineering, University of Cincinnati, Cincinnati, OH,
3Mechanical engineering, NC A&T SU, Greensboro, NC.
A bioresorbable metallic helical stent was explored as a new de-
vice opportunity (magnesium scaffold), which can be absorbed by
the body without leaving a trace and simultaneously allowing res-
toration of vasoreactivity with the potential for vessel remodeling. In
this study, we evaluated Mg-based helical stent scaffold deployment,
expandability and subsequent degradation using static, dynamic, and
porcine ex vivo models. Our presentation showed that a Mg-based
helical stent was uniformly expanded up to 100% compared to its
predeployment diameter. By assessing stent degradation in three
different environments, we observed: 1) stress- and flow-induced
degradation; 2) a high degradation rate in the dynamic reactor; 3)
production of intermediate products (MgO/Mg(OH)2 and Ca/P)
during degradation; and 4) intermediate micro-gas pocket formation
in the neighboring tissue ex vivo model. Overall, the expandable Mg-
based helical stent employed as a scaffold performed well, with high
expansion rate (>100%) in porcine ex vivo model.
217
Bioprinting Of Prevascularized b-cell Sheet To Improve Islet
Transplantation
S. Jeon;
UNIST, Ulsan, KOREA, REPUBLIC OF.
Bioprinting of Prevascularized b-cell Sheet to Improve Islet
Transplantation Seunggyu Jeon, Hyun-Wook Kang
School of life sciences, Ulsan National Institute of Science and
Technology, Ulsan, South Korea. hkang@unist.ac.kr
Type I diabetes is an incurable autoimmune disease, which is failure
in producing sufficient insulin because of loss of b cells in pancreas.
Islet transplantation has been considered as a viable option for healing
the disease. However, absence of vascular network and low mechan-
ical stability of islet construct are still big obstacles in its clinic ap-
plications. Therefore, the way to fabricate prevascularized b-cell
construct having reliable stability was studied to overcome the diffi-
culties in this research. Mouse insulinoma cell line 6 (Min6), human
umbilical vein endothelial cells (HUVEC) and polycaprolactone
(PCL) were applied to fabricate a prevascularized b-cell laden sheet by
co-bioprinting of the multiple materials. Min6 and HUVEC laden
hydrogel were printed individually within PCL lattice structure having
300mm channel. Time-series micrographs of vessel formation within
the sheet was observed. And viability, proliferation and functionality
test of b cells were also conducted to show its usefulness. These results
successfully demonstrated that the bioprinted b cell sheet having pre-
vascular structures has great potential to treat type I diabetes in clinics.
References:
1. Smink AM, Faas MM, de Vos P. Toward Engineering a Novel
Transplantation Site for Human Pancreatic Islets. Diabetes. 62, 1357,
2013.
2. Eberhard D, Kragl M, Lammert E. ’Giving and taking’: endo-
thelial and beta-cells in the islets of Langerhans. Trends in endo-
crinology and metabolism.TEM.;21,457, 2010.
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Sterilization of Chemically Cross-linked Polyvinyl Alcohol
Hydrogel
G. Pohan, S. Mattiassi, E. K. Yim;
Chemical Engineering, University of Waterloo, Waterloo, ON,
CANADA.
Polyvinyl alcohol (PVA) tubular scaffold, crosslinked with tri-
sodium trimetaphosphate, was used as a vascular graft and being
tested in a rabbit in vivo model. Sterilization of the PVA graft prior to
implantation is necessary to eliminate disease-transmitting agents
such as bacteria, viruses, spores and fungi. There are a few estab-
lished terminal sterilization method of a medical device that are
approved by regulatory agencies such as FDA, among which g-
radiation (25kGy) and ethylene oxide (EtO) were chosen as potential
sterilization methods. Studies have shown the effects of these ster-
ilization techniques to the physical properties of PLA and PLGA1,2.
We hypothesize that g-radiation and EtO also affect physical prop-
erties of PVA. Grafts with 2mm ID were fabricated with dip casting
method3. We fabricated grafts with 2 different radial compliance
ranges (0.1-0.4% and 1.0-1.4%). The g-radiation softened PVA, in-
creased the compliance by 0.6-1.3% and reduced Young’s modulus
by 0.2-0.4MPa, while EtO decreased PVA compliance by 0.5-0.8%
and increased Young’s modulus by 0.1-0.2MPa. In addition, steril-
izations of micro-patterned PVA film with gratings, convex and
concave lenses topography further show the effect of both
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sterilization techniques on PVA at micron level. Understanding
sterilization effect on the mechanical property of a vascular graft
helps to improve long-term patency. 1. Valente TAM, et al., Appl.
Mater. Interfaces. 2016, 8. 2. Holy CE, et al., Biomat 2001, 22. 3.
Cutiongco MFA, et al., Biomat 2016, 84.
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Collagen Bioinks for 3D Bioprinting
B. Bagley;
Advanced Biomatrix, Carlsbad, CA.
This poster discusses native extracellular matrix bioinks. Pre-
sented are a number of unique collagen-based bioinks that have been
shown to support the growth and proliferation of various cell types
and can be printed into a variety of structures. A detailed comparison
of completely native collagen bioinks with other bioink formulations
that consist of partially native and synthetic materials. Bioinks being
compared include: methacrylated collagen, high concentration col-
lagen, mixture of methacrylated/high concentration collagen, me-
thacrylated gelatin, mixture of gelatin/alginate and collagen/
hyaluronic acid. Presented will be bioprintability, mechanical and
structural properties, printing resolutions, shear thinning, gel stiff-
ness, extrudability and cell viabilities.
220
Biomimetic Self-Mineralizing Polysaccharide Material
for Bone and Cartilage Tissue Engineering
P. S. Ruparelia1, R. Warren1, D. LaJeunesse1, S. Lee2;
1Nanoscience, University of North Carolina Greensboro,
Greensboro, NC, 2Wake Forest School of Medicine,
Winston-Salem, NC.
Creation of engineered tissue constructs requires a biomaterial
scaffold that not only provides structural support but also mimics the
extracellular matrix (ECM) for cellular processes until native tissue
forms in vivo. Specifically, cell-instructive scaffolds for tissue en-
gineering applications mimic important characteristics of ECM-
based microenvironment. In this study, bacterial cellulose (BC), a
biomimetic self-mineralizing polysaccharide material, was used to
evaluate its biocompatibility for application in bone and cartilage
tissue engineering. The fabricated BC and BC-modified hydroxy-
apatite (BC-HA) scaffolds were characterized for its morphology,
topography, elemental information and thermal properties using
Scanning Electron Microscope (SEM), Attenuated Total Reflectance
Fourier Transform Infrared (ATR-FTIR) spectroscopy, X-Ray dif-
fraction, Thermogravimetric Analysis (TGA), and Differential
Scanning Calorimetry (DSC). This study also examined the biolog-
ical properties and osteoconductivity of native BC and BC-HA
scaffolds using human-derived placental stem cells (PSCs). BC is
highly crystalline material having a cellulose-I structure with en-
tangled fibrils of 40-60 nm in diameter. The crystallinity is severely
damaged between 250C-350C and decreases for modified BC. The
results showed that BC scaffold supports cell adhesion and prolif-
eration of PSCs while supporting osteogenic differentiation of PSCs
on BC-HA as compared to native BC for bone tissue engineering.
References:
1. Wen-Hua Gao. BioResources 6(1), 144-153, 2011.
2. Y.Z.Wan. Composites Science and Technology 66, 1825-1832,
2006.
221
Surface Topography of Silk Films Influences the Functional
Behavior of Vascular Cells
P. Gupta, B. B. Mandal;
Department of Biosciences and Bioengineering, Indian Institute of
Technology Guwahati, Guwahati, INDIA.
Fabrication of vascular grafts by considering the native like micro
architectural features may ultimately determine the graft success.
Herein, we investigated the role of surface topography on functional
behavior of endothelial (ECs) and smooth muscle cells (SMCs). Both
patterned and flat silk films from mulberry (Bombyx mori - BM) and
Indian endemic non-mulberry silk (Antheraea assama - AA) were
implemented. Patterned silk films were able to guide unidirectional
cellular alignment whereas cells cultured on flat films exhibited
random distribution. Post 7 days culture, SMCs cultured on flat BM
films initiated self-assembly and resulted in formation of cell ag-
gregates whereas flat AA films supported uniformmonolayer culture.
Patterning of SMCs on BM and AA films induced their functional
contractile phenotype as evinced by upregulation of SM-MHC,
Calponin and a-SMA genes. AA films also favored higher expression
of extracellular matrix (ECM) proteins - Elastin and Collagen, a pre-
requisite of mechanical resilience. On the other hand, ECs cultured
on patterned silk films showed upregulation of eNOS and secreted
higher amount of Nitric Oxide (NO) that helps maintaining the blood
vessel tone. This study delineates the impact of alignment on func-
tionality of vascular cells.
References:
1. P. Gupta, M. Kumar, N. Bhardwaj, J. P. Kumar, C. S. Krish-
namurthy, S. K. Nandi and B. B. Mandal, ACS Applied Materials &
Interfaces, 2016, 8, 15874-15888.
2. K. H. Nakayama, V. Surya, M. Gole, T. W. Walker, W. Yang,
E. Lai, M. A. Ostrowski, G. G. Fuller, A. Dunn and N. Huang, Nano
letters, 2015, 16, 410-419.
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Comprehensive Examination Of Mechanical And Diffusional
Effects OnCell Behavior Using ADecoupled 3dHydrogel System
S. KIM;
Material Science Engineering, UNIST, Ulsan, Korea, KOREA,
REPUBLIC OF.
Hydrogels possess several physical and chemical properties suit-
able for engineering cellular environments for tissue engineering
applications. However, it is still a significant challenge to indepen-
dently control the mechanical and diffusional properties of hy-
drogels, both of which are well known to influence various cell
behaviors in 3D cell culture systems. Here, we have employed a
polymeric crosslinker that allows for the adjustment of the
number of crosslinkable functional groups to control the me-
chanical properties of the hydrogel. By using the polymeric
crosslinker with varying degrees of substitution (DS), the moduli of
the resulting hydrogels could be controlled in a wide range
without changing their concentration. Furthermore, their diffu-
sional properties were not significantly affected by the changes in
DS as characterized by their swelling ratios, pore diameters and drug
release rates. The viability of cells encapsulated in this hydrogel
system successfully demonstrated the varying effects of mechanical
properties on different cell types, whereas the cells in a conventional
hydrogel system were not significantly influenced by changes in
diffusion.
223
Spontaneous Differentiation of mESC Cultivated on 3D
Poly(Lactide-Co-Glycolide) Scaffolds Coated with Fibronectin
P. Pranke1, A. G. Galuppo1, P. C. Chagastelles1, A. Ferreira1,
J. Wendorff2;
1Analysis, Federal University of Rio Grande do Sul, Porto Alegre,
BRAZIL, 2Department of Chemistry, Philipps University Marburg,
Marburg, GERMANY.
The use of adhesion molecules play an important role in mouse
embryonic stem cells (mESCs) balance between pluripotency and
differentiation. The aim was to evaluate the spontaneous differen-
tiation of mESCs cultivated on 3D PLGA scaffolds coated with
fibronectin. For the electrospinning the polymer poly(D,L-lactide-
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co-glycolide) was dissolved in dichloromethane:ethanol (8:2). The
scaffolds were hydrolyzed by NaOH and arranged in control, gelatin
or fibronectin groups. Gelatin-coated plates were used as control. The
scaffolds were characterized by SEM for fiber diameter and contact
angle. A total of 1.5x104 cells/cm2 was seeded and analyzed after
5 days without LIF. The morphology (Confocal microscopy), via-
bility (MTT test) and differentiation (Nestin, alpha-SMA and Sox-17
immunofluorescence) of the mESCs/scaffolds were evaluated. The
fibers were well-shaped, with a diameter around 4.1 mm; the contact
angle of the gelatin was the lowest (P < 0.05). All the groups pre-
sented cells with morphological changes and viability tests with
similar results, but the cells on the plate presented a significantly
higher viability (P < 0.05). The results show few Nestin+ and Alpha-
SMA+ cells on the scaffolds and no positivity for Sox-17 in all the
groups. Therefore, the scaffold structure allows for the mESCs to
maintain pluripotency for longer than the plate. The study shows that
the 3D scaffold structure allows the mESCs to change the balance
between maintaining pluripotency and differentiation, favouring
maintenance of pluripotency and assisting in inhibiting differentia-
tion. Therefore, the 3D system for a mESC culture can be considered
an important tool for the study of cell fate determination. Financial
support: CNPq/CAPES/FAPERGS/IPCT.
Cancer
224
Electrospun Three Dimensional Models of Osteosarcoma Tumor
Microenvironments
E. R. Molina1, T. Satish1, B. A. Menegaz2, S. Lamhamedi-
Cherradi2, J. A. Ludwig, IV2, A. G. Mikos1;
1Bioengineering, Rice University, Houston, TX, 2Sarcoma Medical
Oncology, MD Anderson Cancer Center, Houston, TX.
Osteosarcoma (OS) is the most common primary tumor of the
bone, comprising 56% of all bone cancers, and is the third most
common tumor of adolescence. Though modern treatments have
increased the 5-year survival to*70% when disease is localized, the
survival for patients who present with metastatic disease—roughly
30%—hasn’t changed in more than four decades. The inability to
cure metastatic OS patients is due in large part to phenotypic het-
erogeneity that exist both within the same tumor and among different
tumors in the same patient. This problem is compounded by the lack
of accurate pre-clinical models of OS that rely heavily on standard
2D monolayer culture on hard plastic surfaces which has been shown
to alter differentiation and phenotype. Recent attempts at the identi-
fication of aggressive tumor cell phenotypes in cancer have involved
hydrogels, organoids, microfluidic devices, and suspension culture.
Three-dimensional environments have been shown to generate more
aggressive cells characterized by increases in drug resistance and tu-
morigenic potential. This works aim to develop three-dimensional
microenvironments in electrospun poly-caprolactone (PCL) suitable
for assessing cancer biology, including critical pathological pathways
and drug resistance mechanisms. Osteosarcoma cells in our systems
have been shown to have differential activation of the IGF-1 and Wnt
pathways which are critical to OS progression, differential growth
patterns and phenotypes, and reduced responsiveness to chemotherapy
that may more accurately represent the behavior of tumors in vivo. Our
model system provides a new platform for the study of divergent
cancer phenotypes, cancer biology, and mechanisms of resistance.
225
Involvement of Extracellular Matrix in the Metastasis
of Breast Cancer Cells
D. Parikh, H. Wang;
BCB, Stevens Institute of Technology, Hoboken, NJ.
Breast cancer, as the most common cancer among women, affects
approximately one out of every eight women over their lifetime. The
malignancy of breast cancer is mainly attributed to its invasiveness
and its metastasis to remote sites (e.g., lung, bone) for secondary
tumor. Despite the tremendous progress in therapeutics and diag-
nosis, it remains a big challenge to treat those metastatic ones. Thus,
mechanistic understanding of the regulation of metastasis would
be of great benefits. While identifying the essence of extracellular
matrix (ECM) in mediating chemotaxis to breast cancer cells,
development of an in vitro system that can recapitulate the key
physicochemical attributes of ECM becomes highly desirable. In
this regard, efforts were specifically made to create tissue-specific
ECM-like matrices by electrospinning the solutions containing
tissue-ECM-specific macromolecules into fibers (average fiber
diameter = 500-600nm). These fibrous matrices were morphologi-
cally, compositionally and dimensionally similar to the tissue ECM.
Breast cancer cells (MDA-MB-231 and MCF-7) cultured on these
matrices were analyzed for various metastatic markers like vimentin,
vinculin, focal adhesion kinase, and e-cadherin. Interestingly, cancer
cells exhibited varying morphology, protein expression and migra-
tion profiles on different tissue-mimetic matrices. which might
undergo non-canonical pathways. Taken together, the prepared
biomimetic matrices are effective to unveil the effect of tissue-
specific composition on phenotypic expression of breast cancer cells.
226
Enhanced Cytotoxic Effect of Two Novel Curcumin
Derivatives on Chemoresistant Cell Lines
W. F. Taylor, E. Jabbarzadeh;
Chemical Engineering, University of South Carolina, Columbia, SC.
Cancer remains the second leading cause of death in the United
States despite the numerous drugs and therapies developed for its
treatment, largely due to the occurrence of multiple drug resistance,
distant metastases, and tumor recurrence. As a result, there remains a
demand for new anti-neoplastic compounds. Natural products, such
as those isolated from medicinal plants, have been a historically rich
source pharmaceutically active compounds, especially in the con-
text of cancer. One such natural product which has garnered much
attention and study as an antioxidant, anti-inflammatory, and anti-
cancer agent among other properties is curcumin, an active constit-
uent of turmeric. However, the clinical effect of curcumin in humans
has been hindered by its poor bioavailability, likely a result of its
rapid metabolism or excretion and its poor absorption. Two novel,
semi-synthetic derivatives of curcumin were synthesized with the
aim of increasing the bioavailability and efficacy of the compounds
against cancer. These derivatives were exposed in vitro to a doxo-
rubicin resistant ovarian carcinoma cell line and a 5-fluoro-2’-
deoxyuridine (FdUrd) resistant colorectal carcinoma cell line. The
curcumin derivatives were able to induce cell death in both cell lines
and exhibited higher toxicity than curcumin in the resistant colorectal
carcinoma model. Further, the derivatives showed an enhanced
ability over curcumin to act synergistically with FdUrd to inhibit cell
proliferation. The strong cytotoxic effect demonstrated by these
derivatives may indicate a better potential clinical efficacy for their
use in the treatment of cancer.
227
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3D bioprinted Environments For Toxicological Studies
On Multi-cellular Tumor Spheroids
S. Flores Torres1, A. M. Sakho2, T. Jiang3, J. Kort Mascort1,
J. Jang4, J. M. Kinsella1;
1Bioengineering, McGill University, Montreal, QC, CANADA,
2Pharmacology and Therapeutics, McGill University, Montreal, QC,
CANADA, 3Mechanical Engineering, McGill University, Montreal,
QC, CANADA, 4Experimental Medicine, McGill University,
Montreal, QC, CANADA.
Using 3D-bioprinting, we’ve developed a method to create 3D
constructs capable of maintaining cell culture for extended periods of
time (> 30 days) by embedding cancer cells into a hydrogel composed
of alginate/gelatin. Within that time the embedded cancer cells reor-
ganize into multi-cellular tumor spheroids (MCTS). Breast cancer
cells (MDA-MB-231 and MCF-7) were independently loaded (1x106
cells/ml) into the hydrogels, sequentially printed and the cell-laden
construct was crosslinked with CaCl2 (10mM) before culturing. Cell
reorganization into MTCS was monitored using fluorescence micro-
scope. Drug-response tests were performed at different periods of time
considering different conditions (single cell and different MCTS sizes
between 100-500mm). Cell live/dead counts after exposure to either
doxorubicin or 5-fluorouracil were studied using Live/Dead assays
(Thermofisher) and the viability was evaluated by MTS assays after
digesting the gels and by the signal ratios from controls and treated
samples. Drug uptake is confirmed by fluorescent microscopy after
24 h of exposure. The signal ratio after 250 h of exposure of green
(live) to red (dead) and fluorescent images indicate that the MTCS
maintain their shape and viability. Overall, toxicological responses
against anti-cancer drugs suggest that cancer cells in 3D bioprinted
environments respond significantly different compared to conven-
tional cell culture toxicology screens.
229
An In Vitro Model of Glioblastoma
H. Sivakumar, A. Skardal;
Wake Forest Institute of Regenerative Medicine, Winston salem,
NC.
The aim of this project was to create a bioengineered 3D in vitro
model of glioblastoma (a brain cancer arising from astrocytes) which
faithfully recapitulates the tumor architecture along with its in-
tratumor heterogeneity and microenvironment seen in vivo in hu-
mans. The cell lines U138, U373, U87, U87EGFRviii, A172, and
human astrocytes were labeled with individual fluorescent dyes and
employed to create multicellular spheroids, thus encompassing all
the major mutations observed in glioblastoma. Spheroids were en-
capsulated in a hyaluronic acid/gelatin hydrogel that mimics the
brain extracellular matrix. We studied tumor growth, migration
distances, proliferation and viability of the different cell lines at
different time points and in different stiffness environments. Metrics
were analyzed using microscopy and macro-confocal imaging. We
observed that cell lines with EGFR mutation or upregulation like
U87EGFRviii, A172 and U373 proliferated at a higher rate than other
cell lines in the spheroid in a stiffer environment. We believe that the
observed phenomena - different cell lines dominating the spheroids
at different time points - replicated tumor evolution of changing
heterogeneity which is observed in glioblastoma clinically. Our re-
sults demonstrate that this platform is a good model to study disease
progression kinetics and cancer evolutionary dynamics under dif-
ferent conditions and it is amenable to drug testing as well. We are
currently adapting this system for use in personalized precision
medicine by employing patient tumor biospecimen-derived cells
within the platform to track clonal evolution and assess individual
patient response to therapies.
230
Rheology vs Alignment: Two Operators of the Mechanical
Tumor Microenvironment
M. Devarasetty, A. Skardal, S. Soker;
Biomedical Engineering, Wake Forest Institute for Regenerative
Medicine, Winston Salem, NC.
The tumor microenvironment is a complex space consisting of a
number of stimuli such as: stromal cells, signaling and paracrine
factors, as well as extracellular matrix (ECM) components. Each of
these factors push and pull cancer cells in different directions and the
sum of the interactions defines a cancer cell’s final disposition. Much
has been made of the microenvironment in recent years; one hotly
researched aspect is ECM mechanics. In terms of the mechanical
interaction of the ECM and the cancer cell, a number of observations
have been made, such as: stiffer environments produce more ag-
gressive cancer cells and facilitate migration and invasion, and
aligned matrices are associated with healthy tissues while unaligned
matrices are associated with poor prognosis. Although there is a
wealth of literature describing the interaction of both stiffness and
alignment, there are few studies that determine the relative input of
either stimuli. In this study, we produce submucosal constructs with
varying ECM alignments and stiffnesses to generate a toolbox of
ECM compositions. Using HCT-116 cell spheroids, we then inte-
grate a tumor compartment into the submucosal construct. Finally,
we use WNT activity and epithelial-to-mesenchymal transition
(EMT) markers to assess the relative effects of stiffness and align-
ment on cancer cell progression. In all, we observe matrix alignment
produces a dominating effect on cancer cell phenotype across the
stiffnesses assayed. Higher stiffness is associated with increased
WNT activity, but this activity is significantly decreased when
spheroids are cultured in highly aligned matrices.
231
High-throughput Screening of Brain Cancer-ECM Interactions
in 3D using Gradient Hydrogels
D. Zhu1, P. Trinh2, F. Yang1,3;
1Bioengineering, Stanford University, Stanford, CA, 2Biology,
Stanford University, Stanford, CA, 3Orthopedic Surgery, Stanford
University, Stanford, CA.
Brain cancer is a devastating disease given its extreme invasive-
ness and delicate location, yet effective therapies remain elusive.
Glioblastoma multiforme (GBM) is one of the most fatal forms of
brain cancer. One key hallmark of brain tumors is the significantly
increased tissue stiffness as the cancer progresses, however, how
varying matrix cues modulate GBM progression in 3D remains lar-
gely unknown. The objectives of this study is to develop a facile
method that allows fabrication of 3D gradient hydrogels with brain-
mimicking biochemical cues and tunable stiffness as in vitro brain
tumor models, and apply such biomaterials platform for evaluating
GBM-niche interactions in a high-throughput manner. Gradient hy-
drogels were fabricated using our recently published method (2017).
The resulting gradient hydrogels exhibit brain-mimicking stiffness
ranging from*40 Pa to 1000 Pa. While all zones support high GBM
viability and proliferation, increasing hydrogel stiffness led
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significant decreases in GBM spreading in 3D, as shown by actin
staining. This is coupled by stiffness-dependent up-regulation of
genes responsible for the ECM degradation, which is essential for
cancer metastasis. When encapsulated in gradient hydrogels, GBM
270 exhibited differential resistance to Temozolomide (TMZ), a drug
clinically used for treating GBM, highlighting the important role of
matrix cues on drug responses of GBM. Together, our results validate
such 3D gradient hydrogels as a biomimetic cancer cell niche, which
enables high-throughput screening studies to accelerate the discov-
ery of the role of niche cues in cancer progression using reduced
materials, cells and time.
232
MicroscaleMethods For Investigating Car T-cell Killing Efficacy
N. Piscopo1, A. Das1, K. Mueller1, K. Walker2, C. Capitini2,
K. Saha1;
1Department of Biomedical Engineering, University of Wisconsin -
Madison, Madison, WI, 2Hematology/Oncology, University of
Wisconsin - Madison, Madison, WI.
Chimeric Antigen Receptor (CAR) T-cell therapy utilizes T-cells
engineered with a CAR to target cancer cells. While CAR T-cell
therapy using an anti-CD19 CAR has shown promise in addressing
B-cell lymphomas and leukemia, it has not shown equivalent promise
in treating solid tumors. We demonstrate a novel microwell based
imaging platform for assaying the effectiveness of anti-GD2 CAR T-
cell therapy (GD2 is a biomarker for certain neuroblastomas and
melanomas) in vitro. We developed a mathematical model to fit
imaging data to analyze the growth of engineered CAR T-cells and
their cytotoxicity. We integrate these platforms to further our in-
vestigations. We demonstrate that microwell based imaging can be
used to estimate time course of cell death. Parameter estimation can
be used to compare CAR T-cells performance within the assay.
Refinement and further data collection is required to advance both
platforms.
233
Modular Tissue Engineering of Bone Microenvironment
for Propagating Circulating Tumor Cells
A. Agarwal;
Biomedical Engineering/Pathology & Laboratory Medicine,
University of Miami, Miami, FL.
Circulating tumor cells (CTC) are precursors of all distant metas-
tases, and an important clinical biomarker for cancer diagnosis. Fur-
ther, understanding their progression to metastasis, particularly in key
sites such as bone, is crucial for developing new therapeutic strategies.
However, widespread utility of CTC as a clinical and research tool
remains exceptionally limited by the inability to reliably propagate and
expand their population.We seek to reengineer the close interaction of
invading CTC with stromal cells of mesenchymal identity and peri-
vascular location (mesenchymal stem cells - MSC as pericytes), as
well as secretory osteoblasts. An in vitro recapitulation of the meta-
static dissemination to bone could provide ‘natural’ habitats in which
CTC thrive. A two-compartment fluidic device was fabricated in-
house using rapid prototyping techniques such as laser engraving, 3D
printing, and micromilling. The top compartment, containing osteo-
blasts derived from human MSC (hMSC) seeded on a semi-permeable
membrane, was connected to osteoblast media flow. The bottom
compartment, containing hMSC embedded in MatrigelTM, was con-
nected to independent connectors that flowed endothelial growth me-
dium, to maintain/drive them towards a pericyte phenotype. Each
compartment was reversibly, and individually sealed. By modifying
the fluid pressures, each compartment was perfused with their own
media. Ongoing studies include phenotypic analysis on the cancer cells
to determine their response to the bone microenvironment, as well as
seeding CTC cells, isolated from breast cancer patients, in the bottom
compartment for analysis of their proliferation profile.
234
Biomimetic Surface Modification for the Development
of in vitro Tumor Models
C. Williams, P. McKernan, R. Harrison, V. Sikavitsas;
Stephenson School of Biomedical Engineering, University of
Oklahoma, Norman, OK.
Traditional chemotherapy regimens put a high degree of emphasis
on the use of historical data to predict a cancer patient’s response to a
proposed therapy. Unfortunately for the patients, this often leads to
continuous rounds of trial-and-error in the search for a compatible
treatment, decreasing their chances for survival. Tumor engineering
seeks to alleviate this issue by growing patient tumors outside of the
body, providing a high throughput avenue for treatment discovery.
Utilizing a variety of techniques for 3D culture, researchers have cre-
ated models that more closely resemble and predict in vivo tumor drug
responses; however, there is still more room for improvement. In par-
ticular, these in vitro models consistently exhibit poor cell proliferation
and distribution, which severely limits their predictive capabilities. To
combat this major issue, we have leveraged our patented biomimetic
surface modification platform for tumor engineering applications. In
particular, we have identified variousmoieties specific to certain tumors
that are integral to cellular adhesion, and have used these to modify our
scaffolds and trick the cancer cells into exhibiting higher rates of ad-
hesion. For instance, in terms of prostate cancer, poly(L-lactic acid)
(PLLA) scaffolds were modified to express n-cadherin, which is a
highly upregulated protein used for cellular adhesion. After cell seed-
ing, we were able to significantly increase PC3 seeding efficiency and
potentially improve cell physiology without compromising the me-
chanical and degradation properties of the underlying PLLA.
Cardiovascular
235
Piezoelectric Vascular Prostheses
L. Ricotti;
The BioRobotics Institute, Scuola Superiore Sant’Anna, Pontedera,
ITALY.
This work focuses on a novel vascular prosthesis, based on an
electrosprayed elastomeric porous materials doped with piezoelec-
tric nanoparticles. The nanocomposite prosthesis was seeded with
human endothelial precursor cells (EPCs) and stimulated with ul-
trasonic waves, thus to exploit the indirect piezoelectric effect and to
generate electrical charges on the prosthesis surface. Results high-
lighted an improved differentiation of EPCs on the piezoelectric
prosthesis when stimulated by ultrasound, in comparison with non-
stimulated counterparts.
236
inCITE Optical Clearing affords Unprecedented Interrogation
of Macroscale Architecture and Cell/Matrix Content within
Bioengineered Heart Valves
F. K. Marini, 27101, K. Stumpf, L. Mutkus, J. K. Williams;
Regenerative Medicine, Wake Forest University,
Winston-Salem, NC.
Objective: Long-term function of bioengineered heart valves
relies on in vivo restoration of native tissue-like cell/matrix content
and 3-D architecture. This study explores the utility of novel quan-
tifiable multiplexed multispectral immunohistochemistry (MMI) (up
to 8 markers on one slide) and 3-D analysis of cleared tissues using
inCITE - (index-matched Clear Imaging for Tissue Evaluation) to
evaluate these parameters in self-seeding bioengineered heart valves.
Methods:Decellularized pig valves were conjugated with CD133
(a marker for endothelial progenitor cells) (n= 6) and implanted in
the pulmonary position of sheep for 3 months. MMI and inCITE
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analysis were used to evaluate the expression and spatial relation-
ships of smooth muscle actin, vimentin, collagen, elastin as com-
pared to age-matched native control heart valves.
Results: Cell (endothelial and interstitial) and matrix content
(elastin, collagen), as well as biomechanical properties, in en-
gineered valves leaflets were restored to near native values by 3
months. However, both MMI and inCITE analysis revealed that
many of the interstitial cells were still myocyte positive, and myo-
fibroblast negative, suggestive of continued maturation. Archi-
tectural analysis revealed numerous regions of disorganized cell/
matrix and anisotropic matrix/matrix distribution. Specifically cells
and matrix had not aligned with flow, as seen in the native leaflets.
Conclusion: While CD133 conjugated implants had native-
leaflet like cell and matrix content, they had not established native
leaflet-like cell/matrix architecture 3 month post implantation. We
propose that inCITE and MMI technology may be more useful than
standard histological techniques in predicting successful regenera-
tion of tissues.
238
Antithrombogenecity of a PMPC-grafted PEEK Mechanical
Heart Valve in Porcine Model
Y. Kambe1, A. Mahara1, H. Tanaka1, K. Fukazawa2, Y. Liu1,
T. Mukaeda1, K. Kojima1, K. Ishihara2, T. Yamaoka1;
1National Cerebral and Cardiovascular Center, Osaka, JAPAN,
2The University of Tokyo, Tokyo, JAPAN.
Lifelong dosing of anticoagulants such as warfarin is inevitable
after the implantation of mechanical heart valves. This fact accom-
panies decreased quality of life. Here, we have been developing and
evaluating a polymer-based blood compatible mechanical valve,
which requires less dose of anticoagulants. A bileaflet mechanical
valve was made of poly(ether-ether-ketone) (PEEK) because it
shows good workability and endurance. PEEK has a benzophenone-
like structure in its unit, where radicals are generated by photo-
irradiations1). Thus, antithrombogenic poly(2-methacryloyloxyethyl
phosphorylcholine) (PMPC) was directly graft-polymerized on the
surface of the PEEKvalve by a 27-mW/cm2UV irradiation at 60C for
30min. The existence of PMPC on the valve surface was confirmed by
strong nitrogen and phosphorus XPS peaks. Short-term (<26h) eval-
uation of the PMPC-grafted PEEK (PEEK-g-PMPC) valve was con-
ducted by an aortic valve replacement in porcine model, where no
anticoagulants were used after the operation. Six miniature pigs were
divided into two groups: PEEK-g-PMPC valve transplantation (n= 4)
and PEEK valve transplantation (n= 2; as the control). SEM obser-
vation showed that blood clots formed by hematocytes and fibrous
materials attached to the PEEK valve surface within 2 h post-
implantation. These clots were likely to grow to cover a part of the
surface by 10 h. In contrast, such growing clots were not observed on
the PEEK-g-PMPC valve even at 26 h post-implantation. Long-term
antithrombogenicity of the PEEK-g-PMPC valve is now being in-
vestigated. The authors thank Profs. Hirano and Nagasaki for their
support of the operation. 1) ACS Appl Mater Interfaces 1, 537, 2009.
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Neointima Formation Process On Peptide-modified
Acellular Graft
A. Mahara1, K. Kojima2,1, Y. Hirano2, T. Yamaoka1;
1Department of Biomedical Engineering, National Cerebral and
Cardiovascular Center Research Institute, Osaka, JAPAN, 2Faculty
of Chemistry, Materials and Bioengineering, Kansai University,
Osaka, JAPAN.
Introduction: Our previous report demonstrates an excellent pa-
tency of the peptide-modified acellular grafts measuring 20-30 cm in
length and having 2mm inner diameter as femora-femoral crossover
bypass in minipig transplantation model1. Neointima was observed on
the graft surface after transplantation for one week. However, it was
not able to identify how rapid endothelialization was occurred with
long-bypass graft. In this presentation, we discuss the rapid en-
dothelialization process on the graft in minipig transplantation model.
Materials andMethods: After transplantation into minipig for 1,
3, and 7 days, the luminal surface of the peptide-modified grafts was
stained with antiCD31, CD105, CD34, and Flk-1 antibody to identify
the cell type on luminal layers.
Results: After one day transplantation, the cell indicating CD34
and Flk-1 positive were observed on center part of the graft where
was 10 cm far from anastomotic site. The cells formed layer on the
surface, and expressed CD31, 34, 105, and Flk-1 after 3 day.
Conclusion: The neointima was formed by the capturing of blood
circulating endothelial progenitor cells during 1 to 3 day after
transplantation.
Acknowledgments: This research was supported by the In-
tramural Research Fund of National Cerebral and Cardiovascular
Center (22-2-4) and the S-Innovation Project of AMED.
References: 1. Mahara A, Somekawa S, Kobayashi N, Hirano Y,
Kimura Y, Fujisato T, and Yamaoka T. Biomaterials 58, 54, 2015.
Conflict of interest: The authors declare that they have no conflict
of interest.
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Beating Clusters Created with Cardiac Extracellular Matrix
from Decellularized Porcine Hearts and Repopulated with
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
S. Moncada, D. Despain, K. McEntire, T. Knutson, H. Behrmann,
M. Hodgson, J. Rich, B. Roeder, N. Momtahan, A. D. Cook;
Brigham Young University, Provo, UT.
Beating human heart tissue was created in vitro using non-
immunogenic scaffolds generated from decellularized porcine hearts
combined with cardiomyocytes (CMs) derived from human induced
pluripotent stem cells (hiPSCs). Whole porcine hearts were decel-
lularized to create 3D scaffolds capable of supporting the human cells
mechanically and biochemically. From the left ventricle of the de-
cellularized hearts, 300mm thick, 10mm round slices were prepared
and mounted on glass coverslips. Human iPSCs were differentiated
into cardiac progenitors and 4 days after differentiation, these cells
were seeded onto the decellularized tissue samples. Ten days after
recellularization, clusters of differentiated CMs started to beat
spontaneously. Immunofluorescence images showed confluent cov-
erage of CMs on the decellularized slices and the effect of the
scaffold was evident in the alignment of the CMs in the direction of
the collagen fibers. A resazurin-based viability assay showed at-
tachment and survival of 75% of the seeded cells up to 14 days after
recellularization. The clusters continued to beat for 60 days. To
improve the beating function of the CMs implanted in the tissue
scaffold, we are using mechanical, electrical and pharmacologi-
cal stimulation. By combining mechanical stimulation through a
mechanical stretching device, electrical stimulation through trans-
mitting electrical frequencies ranging from 1 to 1.6Hz, and phar-
macological stimulation through drugs, such as epinephrine, we
hypothesize that we will increase the beating function of the cardiac
tissue from 10 beats per minute (current rate) to 60 beats per minute.
241
In Vitro Fabrication of Functional Anisotropic 3D Constructs
using Silk-Cardiomyocyte Monolayers
S. Mehrotra, B. B. Mandal;
Department of Bioscience and Bioengineering, Indian Institute of
Technology Guwahati, Guwahati, INDIA.
Cardiac tissue engineering seeks to develop a construct with ability to
restore the structural and functional aspects of infarctedmyocardium1. In
this context, our study uses mulberry (Bombyx mori) and non-mulberry
(Antheraea assama) silk fibroin to fabricate 3-D construct of cardio-
myocyte monolayers using patterned silk films. These fabricated films
exhibited effective swelling, biodegradability and enhanced mechanical
properties. They provided contact guidance to the growing cardiomyo-
cytes allowing them to form unidirectionally aligned cell monolayers
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and exhibited low immunogenicity both in vitro and in vivo. Enhanced
proliferation and maturation of primary rat cardiomyocytes (PCMs) and
H9c2 cells was observed on non-mulberry films, owing to the presence
of intrinsic cell binding motifs (RGD)2. This was further attested by the
upregulation of cardiac specific genes on non-mulberry silk films. The
patterned silk-cardiomyocyte monolayers were then stacked onto each
other to form 3-D construct. Histological assessment exhibited uniform
cardiomyocyte distribution and maintenance of an intact 3-D structure.
Moreover, increasedDNAcontent of the construct indicated the absence
of cell necrosis. Collectively, this study highlights the suitability of non-
mulberry A. assama silk fibroin as a potential biomaterial and the
prospects of using silk-cardiomyocytes monolayers for cardiac tissue
engineering applications.
References:
1. Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Mar-
sano A, Martens TP and Radisic M, Tissue Engineering. Part B,
Reviews, 16,169-187,2010.
2. Gupta A, Mita K, Arunkumar K P and Nagaraju J, Scientific
reports, 5, 12706, 2015.
Acknowledgment: The authors would like to acknowledge Dr.
Samit Kumar Nandi for helping with in vivo immunocompatibility
assessment.
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Pulmonary Artery Reconstruction using In Body Tissue
Engineered Bovine Biosheet: Xenotransplantation in a
Beagle Model
M. Furukoshi, E. Tatsumi, Y. Nakayama;
Artificial organs, National Cerebral and Cardiovascular Center,
Osaka, JAPAN.
Purpose: Upon implantation as a scaffold of autologous or allo-
genic collagenous tissues prepared subcutaneously in molds using
our developed in-body tissue architecture technology (IBTA), which
can form membranous (Biosheet) or tubular (Biotube) tissues, in situ
reconstruction to target cardiovascular tissues, such as arteries or
heart valves, could be successfully occurred within several months
after implantation. However, this approach was encumbered by long
production times (1-2 months). The solution would be transition to a
xeno graft that is available off-the-shelf. This study presents the first
use of bovine Biosheet to demonstrate the feasibility and safety for
transitioning to a xenoimplantation in a beagle model.
Methods and Results: Collagenous tubular tissues were formed in
stainless steel molds by their embedding into bovine subcutaneous
pouches for 2 months, harvesting, and removing. Upon cutting open the
prepared tubes, Biosheets (thickness 0.5mm) were obtained as mem-
branous tissues and stored in alcohol solution before use in implanta-
tion. Under anesthesia, pulmonary arterial defects (size; 10·10mm) in
beagles were made, and patched repair was performed with the bovine
Biosheets. Follow-up ultrasound examination indicated no thrombosis
or stenosis. After 1-month implantation, histological observation
showed vascular remodeling on the implanted Biosheets with no signs
of degradation or dilation. There was no evidence of immune response.
Conclusion: In this study, xenogenic bovine Biosheet could be
successfully engrafted in short-term implantation into beagles. It may
have potential to use of bovine Biosheets for implantation during any
time of need as ready-made xenogenic tissues.
243
Multi-factor Analysis of Synthetic and Natural/Protein Content
in Engineered Vascular Tissues using Raman Spectroscopy
A. S. Theus, K. R. Kerney, J. L. Spano, M. Fenn, C. A. Bashur;
Biomedical Engineering, Florida Institute of Technology,
Melbourne, FL.
Tissue-engineered vascular grafts (TEVGs) are a promising al-
ternative for small-diameter arteries. It is important that TEVG
composition prevents compliance mismatch and improves viabil-
ity. Raman spectroscopy has been used to assess components of
tissue-engineered scaffolds. However, Raman has not been applied
to semi-quantitatively assess 3D engineered-tissues and cellular
remodeling of natural/synthetic-blend materials. Electrospun me-
shes were prepared with 100% poly(e-caprolactone)(PCL), 90%
PCL/collagen, and 90% PCL/fibrinogen. Meshes were character-
ized using SEM, XPS, and Raman. Meshes had similar fiber di-
ameters (0.63– 0.20—0.92– 0.39mm), andwere characterizedwithout
incubation, with incubation in media, and with culture of smooth
muscle cells for 7-21 days. Differences in cell proliferation and con-
tractile markers (RT-PCR) were observed, especially with collagen
incorporation. Raman peak integration showed increases in 740cm-1
(p < 0.0001) and 1050cm-1 (p < 0.0001) peaks for protein-blended
samples. However, the strong PCL signal prevented resolution of
the 1550cm-1 peak found in pure fibrinogen but not collagen.
Subtracting the PCL spectra showed characteristic fibrinogen peaks
in blended materials, but these results were not quantitative. Thus,
multivariate-factor analysis (MFA) was used to evaluate changes in
mesh composition after culturing, with factor scores plotted against
wavenumbers. Factor 1 spectrum is from PCL, whereas Factors 2-3
are from a linear combination of incorporated proteins and other
components post-culture. Overall, this work demonstrates that MFA
analysis of Rama spectra can assess natural material incorporation
into TEVGs. We are currently performing non-negative least squares
(NNLS) analysis to determine if additional resolution can be ob-
tained to detect small changes with remodeling that cannot be reli-
ably assessed with traditional techniques.
244
Designing A Novel Pouch To Minimize Peritoneal Adhesions
With In Vivo Bioreactor- Based Vascular Graft Strategies
K. vuppuluri1, M. Shojaee1, A. Carriero2, C. A. Bashur1;
1Biomedical Engineering, Florida Institute of Technology,
Melbourne, FL, 2The City College of New York, New York, NY.
Tissue engineered vascular grafts require strategies to allow graft
remodeling but avoid stenosis and loss of graft mechanics. In our
approach, we use the peritoneal cavity as an ‘‘in vivo bioreactor’’ to
recruit autologous cells and improve graft patency. In a previous study,
we generated vascular grafts by implanting poly(e–caprolactone)-
based electrospun conduits enclosed within an ePTFE pouch into the
rat peritoneal cavity for 4 weeks. The results demonstrated that the
constructs remained patent after being grafted autologously for 6
weeks into the abdominal aorta, and peritoneal pre-implantation re-
duced overall lipid oxidation, intimal layer thickness, and expression
of macrophage markers. In this study we plan to overcome the po-
tential side effect of peritoneal adhesion formation by designing a new
pouch composed of poly(ethylene glycol) diacrylate (PEGDA) to re-
place ePTFE pouches. While PEG is used to provide resistance to
protein adhesion and cell attachment, our strategy is unique in si-
multaneously creating pores to enable tissue generation in the enclosed
conduits. A pilot study was performed to determine the response in a
rat model, and the results demonstrated a notable decrease in formation
of peritoneal adhesions. Immunofluorescence images showed similar
cell infiltration and expression of endothelial cell and contractile
markers as the samples from an ePTFE pouch. Compressive properties
of these pouches are being studied at different PEGDA concentrations
and pore diameters to find the pouch parameters that give desired
mechanical properties. Overall, the results showed apparent benefits of
peritoneal pre-implantation and effective reduction in peritoneal ad-
hesions when a PEG pouch was utilized.
245
Evaluation of Novel Therapeutics To Treat Neonatal
Coagulopathy
K. A. Nellenbach1, N. Guzzetta2, A. C. Brown1;
1Biomedical Engineering, Joint Department of Biomedical
Engineering, North Carolina State University and University of North
Carolina at Chapel-Hill; ComparativeMedicine Institute, Raleigh, NC,
2Department of Anesthesiology, Emory University School of
Medicine and Children’s Healthcare of Atlanta, Atlanta, GA.
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Post-operative bleeding is a serious complication for neonates
undergoing corrective cardiac surgery requiring cardiopulmonary
bypass (CPB). Mitigating post-CPB bleeding is currently addressed
through transfusion of adult blood products, including platelets and
cryoprecipitate (fibrinogen component). However, the effectiveness
of such transfusions is inconsistent in neonates; additionally, multi-
ple infectious and noninfectious risks are associated with blood
product transfusion. Moreover, neonatal clotting components display
qualitative and quantitative deficiencies, including in the primary
coagulation protein fibrinogen1. The goal of this study is to 1) evaluate
new hemostatic therapies and 2) establish in vivo models of neonatal
coagulopathy. We aim to determine how different pro-coagulant
agents alter neonatal fibrin matrix properties. Plasma was obtained
from neonates scheduled for cardiac surgery and CPB. Samples were
collected before and after CPB and following the transfusion of
cryoprecipitate. Pro-coagulant therapeutics were added to post-CPB
samples. Confocal microscopy and Atomic Force Microscopy (AFM)
were utilized to examine clot structure and mechanics. Our long-term
goal is to decrease transfusion requirements by determining more ef-
ficacious and safe methods of enhancing clot formation in neonates
following complex cardiac surgery. In order to facilitate future pre-
clinical studies for neonatal specific therapies, we additionally aim to
validate a porcine model of neonatal coagulopathy.
246
Cellular Cross talk And Paracrine Interactions Between
Epicardial Adipose Tissue And Myocardium
S. H. Hagvall, D. Nguyen, R. Nilsson, A. Carlsson, M. Althage,
M. Magnine;
Translational Science, AstraZeneca R&D, Mo¨lndal, SWEDEN.
Epicardial adipose tissue (EAT) plays an important role in normal
and pathological cardiac function. There is interest in investigating the
cross-talk between EAT and the myocardium. What is needed is a
preclinical translatable model system in which these interactions can be
studied and physiologically relevant treatments performed. We aim to
understand the molecular regulatory mechanisms of EAT in order to
provide insights into the treatment of cardiovascular diseases and re-
generative medicine. We set up a co-culture system of human cardiac
and EAT tissues (from the same patient) using two-organ-chips. The
circulating conditionedmedium and the tissue pieces were collected for
proteome profiler, metabolomics and histological analysis. Our pre-
liminary proteome analysis indicates a higher expression of proteases
involved in extracellular matrix degradation and remodeling under
dynamic co-culture, which may in turn result in vascular formation in
both cardiac tissues and EAT. It has been reported that cardioprotective
factors reverse some harmful effects of EAT-derived factors in heart
failure patient. In our experiment, the expression of a cardioprotective
factor was higher in the co-culture under dynamic condition. A higher
level of matrix proteases as well as a higher expression of these pro-
tective factors stimulate endothelial cells and vascular formation under
dynamic condition as compared to static culture. Our ongoing meta-
bolomics analysis indicates the difference between the dynamic and
static condition. We believe that our final results will identify clinically
relevant processes/pathways or secreted factors, as potential new tar-
gets, which might allow pharmacological interventions in the field of
cardiovascular and metabolic diseases.
247
248
Optimization of MSC/iPSC-EC Vascular Network Formation in
Fibrin Scaffolds Using Statistical Design of Experiments
B. M. Roux1,2, A. Cinar3, E. M. Brey1,2;
1Biomedical Engineering, Illinois Institute of Technology, Chicago,
IL, 2Research Service, Edward Hines, Jr. VA Hospital, Hines, IL,
3Chemical and Biological Engineering, Illinois Institute of
Technology, Chicago, IL.
Engineered tissues with pre-formed vascularization may enhance
regeneration. Induced pluripotent stem cell-derived endothelial cells
(iPSC-EC) are a promising EC source for clinical application, but
their investigation for tissue engineering applications has been lim-
ited. Design of experiments (DOE) methodology can help optimize
multivariable systems and determine effects and interactions that
may not be elucidated in traditional experimental design. This study
aims to utilize DOE to optimize the in vitro formation of vascular
networks of iPSC-EC and mesenchymal stem cell (MSC) co-culture
spheroids in fibrin scaffolds. 5000-cell spheroids of iPSC-ECs and
MSCs (0, 25, 50, 75, or 100% MSC) were encapsulated in fibrin
hydrogels (1, 3, or 5mg/ml) and cultured for 1, 2, or 3 weeks. Im-
munostaining for CD31 was used to assess EC outgrowth and quantify
EC network area, mean vessel length, andmean vessel diameter. iPSC-
EC/MSC spheroids formed extensive networks throughout the scaffold
that varied with ratio, fibrin concentration, and culture time. The
highest EC network area (2.53– 0.48mm2) and mean vessel length
(969.6– 79.3mm) was observed with 75% MSC spheroids in 3mg/ml
fibrin after 3 weeks. The in vitro results were used to create a DOE
predictive response model (MODDE Pro Software) and generate
contour plots for each response. Based on the model, a spheroid
composition of approximately 60% MSC will result in the highest EC
area, and approximately 67% MSC will result in the highest vessel
length. iPSC-ECs show promise as a potential autologous EC source
for vascularization of tissue engineering strategies.
249
Fabrication of Modular Tissue Engineered Blood Vessels
H. A. Strobel1, M. Piola2, G. B. Fiore2, M. Soncini2, E. Alsberg3,
M. Rolle1;
1Worcester Polytechnic Institute, Worcester, MA, 2Politecnico di
Milano, Milano, ITALY, 3Case Western Reserve University,
Cleveland, OH.
Tissue engineered blood vessels (TEBVs) enable in vitro disease
modeling and drug testing. However, existing TEBV fabrication ap-
proaches create homogenous tubes, which lack the capacity to model
focal diseases such as intimal hyperplasia or aneurysm. Alternatively,W
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we developed a modular system to fabricate TEBVs from tissue ring
building units. By combining individual ring units, spatially distinct
tissue regions can be created along the tube length. To create rings,
human smooth muscle cells are seeded into custom agarose molds,
where they self-assemble into 3D tissue rings. In previous work, we
showed that gelatin microspheres can be incorporated within rings
during self-assembly to allow local growth factor delivery and creation
of tissue ring unitswith distinct structure and function. Here,we use ring
building units to create and dynamically culture tissue tubes on a custom
designed bioreactor. Custom electrospun polymer cuffs were fused onto
tube ends to create reinforced material for improved handling and
cannulation. After 3 days of ring culture and 7 days of ring fusion, tubes
were cannulated. Cuffs fit snugly over cannulas, without the need for
sutures, enabling dynamic culture (2 dyne/cm2 flow) for 7 days before
fixation. To create tubes with focal heterogeneities, rings with incor-
porated microspheres were fused in a region between rings without
microspheres. Smooth muscle cells within rings with microspheres
maintained their spatial position, indicating the potential of this system
for creating distinct tissue regions characteristic of focal vascular dis-
eases. In ongoing work, we are evaluating localized microsphere-
mediated growth factor release to simulate intimal hyperplasia.
250
TG2 Expression in Arterial TEVGs
T. Fukunishi1, H. Zhang1, C. Ong1, L. Santhanam1, J. Johnson2,
N. Hibino1;
1Johns Hopkins Hospital, Baltimore, MD, 2Nanofiber Solution. Inc,
Columbus, OH.
Objectives: Tissue-engineered vascular grafts (TEVGs) require
adequate extracellular matrix (ECM) to withstand arterial pressure.
Tissue transglutaminase (TG2) is an enzyme that cross-links ECM
proteins and plays central role in the development of vascular stiff-
ness associated with aging. The purpose of this study is to investigate
ECM-TG2 expression and vascular stiffness in TEVG remodeling.
Methods: Fast- and slow-degrading electrospun scaffolds
were fabricated from polydioxone (PDO) and poly(L-lactide-co-
caprolactone) (PLCL) copolymer, with a PDO/PLCL ratio of 9:1
being fast-degrading and 1:1 being slow-degrading. The two types of
small-diameter arterial TEVGs were implanted in rats (n= 5/group)
as abdominal aorta interposition conduits. The grafts were harvested
at 1 month for evaluation of patency, vascular neotissue formation,
TG2 expression, and mechanical properties.
Results:All TEVGs were patent and did not display any dilation at
1 month. ECM area in fast-degrading TEVGs was significantly larger
than that in slow-degrading TEVGs (42.91– 4.21% vs. 14.5– 2.33%,
p< 0.001), with significantly larger TG2 area as well (26.26– 8.55%
vs. 7.55– 1.83%, p= 0.0014). The mechanical properties of fast-
degrading TEVGswere akin to that of native aorta, as demonstrated by
strain-stress curve. The area of remaining scaffold was significantly
reduced at 1 month in fast-degrading TEVGs compared to the slow-
degrading TEVGs (2.84– 0.86% vs. 18.53– 6.65%, p< 0.001).
Conclusions: At one month, rapid and well-organized ECM in
fast-degrading TEVGs led to increased TG2 expression and native-
like mechanical properties, compared to slow-degrading TEVGs.
251
3D Tissue-engineered Model of Pressure-overload Induced
Cardiac Fibrosis
Y. Li, H. Asfour, L. Mao, H. A. Rockman, N. Bursac;
Duke University, Durham, NC.
Heart failure is characterized by extensive fibrosis contributed by
activated and proliferative cardiac fibroblasts (CFs). CFs interact with
cardiac myocytes and dynamically modulate heart function, represent-
ing a potential target for therapeutic interventions [1]. Here, we devel-
oped an in vitro model of cardiac fibrosis by 3D co-culture of CFs from
failing adult mouse hearts and healthy neonatal rat cardiomyocytes.
Transverse aortic constriction was applied for 12 weeks to induce
pressure overload and heart failure in adult mice. Distinct fractions of
CFs from failed and age-matched sham-operated (control) hearts were
isolated using FACS based on the expression of surface markers and
were immediately encapsulated within fibrin-based 3D engineered
cardiac tissues without 2D subculture known to profoundly alter cell
phenotype [2]. Compared to use of control CFs, engineered cardiac
tissues with CFs from failing hearts exhibited significantly elevated
Collagen I and III, prolonged action potential duration, and decreased
contractile force, closely resembling the phenotypeof pressure-overload
fibrosis and heart failure in vivo. Interestingly, these structural and
functional effects were CF-fraction dependent. This 3D model of car-
diac fibrosis represents a well-controlled platform for systematic studies
of the fibroblast-induced changes in cardiomyocyte phenotype aimed at
discovery of novel fibroblast-targeted therapies for heart failure.
References:
1. Gourdie RG, Dimmeler S, Kohl P. Novel therapeutic strategies
targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug
Discov 2016.
2. Rohr S. Cardiac fibroblasts in cell culture systems: myofibro-
blasts all along? J Cardiovasc Pharmacol 2011;57:389-99.
Acknowledgments: NIH grants HL126524, HL132389, and
HL134764, and AHA grant 14PRE20490190.
Commercialization of Regenerative Medicine Products
252
Automated Closed-System Bone Marrow-derived hMSC
Isolation for Regenerative Medicine Biomanufacturing
D. Wang, E. Gill, J. Takacs, L. T. Lock;
RoosterBio Inc., Frederick, MD.
With over 500 clinical trials investigating the use of mesenchymal
stem/stromal cells (hMSCs) for RegenerativeMedicine, there is a critical
need for economical biomanufacturing processes capable of generating
billions to trillions of cells for commercial applications. An efficient
hMSC isolation process is the foundation for realizing economically vi-
able hMSC-based therapeutics. The traditional method for hMSC isola-
tion from buffy coat, usingmanual density gradient separation, is an open
process susceptible to contamination and substantial operator dependent
variability.We hypothesize that an automated closed-system process will
reduce variability and maintain cell quality while also streamlining the
regulatory process. The Sepax processing system (GE/BioSafe) was
evaluated for isolating hMSCs from bone marrow (BM). Fresh BM as-
pirates (AllCells), from multiple distinct donors, were processed in par-
allel using a manual or Sepax method. The resulting mononuclear cell
fractions were cultured in RoosterNourishTM-XF media (RoosterBio) for
9-10 days, and cell expansion, morphology, identity (surface marker ex-
pression, tri-lineage differentiation) and potency (cytokine secretion,
immunomodulatory potential) quality parameters were assessed. The use
of the Sepax system yielded a 3x fold increase in hMSCs over themanual
method while maintaining cell quality parameters and reducing the time
and labor needed for cell processing by ‡50%. Thus, closed automated
processing via Sepax is a robust, consistent and reproducible alternative
for hMSC isolation. The improved yield along with reduced time, labor,
and risk of this method will contribute to the decrease in cost of goods
(COGs) of hBM-MSCs for regenerative medicine applications.
253
A Post-manufacturing, Therapy Distribution Model
C. C. White1, B. Wang1, K. Wang1, C. Ho2, R. R. Bishop1;
1Industrial and Systems Engineering, Georgia Institute of
Technology, Atlanta, GA, 2Georgia Tech Manufacturing Institute,
Georgia Institute of Technology, Atlanta, GA.
We present a graph-based supply chain model of (autologous)
CAR-T cell therapy that serves as the basis for the development of
strategies to: 1) deliver cell therapy products that are safe and have a
high level of efficacy, 2) minimize fulfillment time and variability,
and 3) reduce total manufacturing and logistics costs while reducing
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the risk of patient morbidity and mortality. We then provide a more
detailed optimization model of a daily post-manufacturing, therapy
distribution problem considering two objectives: minimize total
distribution cost and maximize total service level, where service
level is directly related to the health of the patient and the health of
the therapy and is enhanced with fast fulfillment. A solution to this
model would address such questions as: given a set of therapies for
distribution and the time when they would be released for distribu-
tion, how many delivery vehicles to use, what therapies should be
assigned to which vehicles for delivery, what should be the sequence
of deliveries for each vehicle, and what should be the departure time
for each vehicle from the production facility? The problem objective
is to generate a set of non-dominated solutions from which the de-
cision maker (DM) would choose a most preferred non-dominated
solution, based on the DM’s preferred trade-off between cost and
service level. This model could be used to address questions such as:
what is the value of real-time decision making based on real-time
patient and therapy health information? What is the value of trans-
porting live cells versus cryopreservation?
254
A Novel System For The Rapid Isolation Of Human
Adipose-derived Stem Cells Using A Gmp Collagenase
J. Murray1, E. Scott2, B. K. Mynampati1, S. Fernandez1;
1University of Florida Jacksonville, Jacksonville, FL, 2University
of Florida Gainesville, Gainesville, FL.
Introduction: Translating basic science discoveries to approved
products in the marketplace remains one of the greatest challenges in
healthcare. Autologous adipose-derived stem cells (ASCs), when
used in clinical practice, will need to meet critical quality attributes
(CQAs) to include identity, potency, purity, and safety.
Purpose: This project tests the feasibility of a kit (‘‘Stem cell
Isolation Kit’’ designed by Reviticell Holdings, Inc., Jacksonville,
FL) to isolate ASCs from lipoaspirate to meet the CQA of identity
within regulatory, practitioner, and engineering criteria.
Methods: Fresh human lipoaspirate was processed with a GMP
collagenase (Corase, Reviticell Holdings, Inc., Jacksonville, FL),
in a closed system. Both short term incubation and centrifugation
were included in the processing. ASCs were then cultured. The CQA
of identity of the ASCs was matched against ISCT/IFATS criteria.
Results: Each isolation from lipoaspirate took 30 minutes. Cel-
lular viability of the initial stromal vascular fraction (SVF) was >90%
with a minimum viable cell count of 160,000 nucleated cells per
gram of tissue processed. Cellular phenotypic ontology revealed
plastic adherent cells with confirmatory corresponding flow cytom-
etry markers (+CD105, CD73, and CD90, - CD34, CD45, CD11b,
CD19, and HLA-DR). Differentiation to adipocytes, osteoblasts, and
chondroblasts was confirmed.
Conclusions: The kit-based system, from Reviticell Holdings,
Inc., isolates ASCs as identified by the ISCT/IFATS criteria. The kit,
with its modular system, can be easily configured to accommodate to
new isolation protocols for ASCs of different CQAs when needed.
Assays respective to ASC potency, purity, and safety will need to be
completed.
255
Automated Quantitative Image Analysis and Precision Selection
of Desired Sub-Population of iPS Cells Using Cell XTM
and ColonyzeTM Platform
V. Mantripragada, V. Luangphakdy, B. Handerhan, K. Powell,
G. Muschler;
Biomedical Engineering, Cleveland Clinic, Cleveland, OH.
Induced pluripotent stem (iPS) cells are being developed for a
broad range of research and therapeutic applications. However, re-
programmed iPS clones are inevitably heterogeneous. Value judge-
ments must be made regarding which clones to use or exclude. iPS
labs currently make decisions by visual inspection and manual se-
lection, which are prone to large variation and lack the standardi-
zation needed for clinical translation. Automated methods are needed
that enable rapid, quantitative, repeatable and reproducible: i) im-
aging and quantitative analysis of iPS clones, ii) objective determi-
nation of critical quality attributes (CQAs) (e.g. morphology or
markers) that predict long term biological performance and iii)
precise automated selection of desired cells or removal non-desired
cells. This paper describes the development and validation of Cell
XTM, a robust robotic system that enables each of these critical
aspects of iPS cell processing and analysis. Large field of view im-
ages are acquired from standard tissue culture plates (6 to 96 wells)
with 1m/pixel resolution in 1-8 minutes, using phase-contrast or
fluorescence. Integration with ColonyzeTM software enables Auto-
mated Multimodal Large field of view Image Analysis (AM-LIA)
based on metrics of proliferation, migration, surface markers, or cell
and colonymorphology, using principles outlined in ASTMStandard
F2944-12. This integration enables automated image capture, anal-
ysis and ‘‘picking’’ or ‘‘removal’’ of desired or undesired colonies
based on defined and reproducible criteria. Cell XTM and Colony-
zeTM together eliminated labor-intensive manual processing steps,
and provide unprecedented rigor in the analysis and management of
heterogeneous iPS cell populations.
256
Application Case Study All-in-one Bio 3D Printer, IN VIVO
from ROKIT Inc
H. Lee, J. Park, J. Huh, B. Nam, M. Lee, H. Ban;
ROKIT Inc, Seoul, KOREA, REPUBLIC OF.
For about recent a year, approximately 60 customers purchased our
all-in-one 3D printers for mostly their research purposes. For the last a
year, we can feel sudden increasing movement of tissue engineering
and biofabrication research using bio 3D printers and we are intro-
ducing its applications case studies through the consulting with our
customers. First, cell bio printings with bio-inks is a one big category.
Vascularized kidney, cardiac myocyte regeneration, Neuron regener-
ation for dementia patients, liver function regeneration, Oncology
using target therapy, and pancreatic cell regeneration are proposed for
tissue engineering researches using our product of 3D bio printers. All
the cases include live cell as a printing bio-materials and consist with
scaffold design. Second application category is human skin equivalent.
Skin is relatively easier than other organs for fabrication sue to is
structure. Dermis and epi-dermis are not containing large vascular, so
many researchers are working on this topic. One third of our customers
were also purchased our 3D bio printers for human skin equivalent.
The final applications for HSE are cosmetics test for substitution of
animal tests and artificial skin for wound healing for burnt patients.
Third application cases are bone and teeth, hard tissue application.
Not just simple or uniform shape of bone-replace scaffold, non-
uniform, which is gradually increasing pore size toward outside. This
structuremay prevent clogging or fouling on the surface and cannot fill
the designed structures. In fact, more than half of the studies related to
bio-implant is recently focused on scaffolds’ internal structure design.
Imaging
257
Nano Onion Carbon Dots - a tool for in vitro imagining
and accelerated wound healing
K. Bankoti, S. Dhara;
Indian Institute of Technology, Kharagpur, India, Kharagpur,
west bengal, INDIA.
Nitrogen, Sulphur and Phosphorous co-doped water-soluble carbon
nanodots are synthesized from culinary waste onion peel powder (OPP)
by short microwave treatment. Onion Derived Carbon Nano Dots
(OCND) comprises of hydrophilic groups decorated amorphous nano-
dots and exhibited bright stable fluorescence at excitation energy of
450nm and emission wavelength at 520nm along with free radical
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scavenging property. TheOCNDexhibited excellent stability at different
pH and UV exposure. Although extracted polyphenols degraded in the
extract, but interestingly itwas evidenced to be cytocompatible andblood
compatible as observed during cytotoxicity, fluorescence imagining of
cell and haemolysis study. The present work not only focuses on syn-
thesis of OCND from OPP extract, but also provides an interesting fact
that even after degradation of polyphenols in the extract; they are non-
toxic to human cells (HFF &MG63) and RBCs. Moreover, OCND had
no adverse effect on migration rate of Human Foreskin derived Fibro-
blasts (HFFs) as observed from scratch assay. In addition to accelerating
migration rate of fibroblast, the OCND altered intra- and extracellular
reactive oxygen species (ROS) by enhancing antioxidant mechanism of
fibroblast under oxidative stress. Further, OCND was observed to ac-
celerate wound healing in full thickness (FT) wound in rat model on
topical application, which can be attributed to its radical scavenging
potential. In summary, study leads to a new source of OCND synthesis
route, which is inherently co-doped with phosphorous, sulfur and nitro-
gen and holding a great promise for myriad biological applications in-
cluding bio-imagining, free radical scavenging and wound healing.
Matrix & Extracellular Matrix Biology in Regenerative
Medicine
258
Regenerative Nanotherapeutics to Modulate the Tumor
Microenvironment in Non-Small-Cell Lung Cancers
D. Seshadri, A. Ramamurthi;
Biomedical Engineering, Cleveland Clinic, Cleveland, OH.
Response rates to emerging immunotherapies for Non-Small Cell
Lung Cancers (NSCLCs) are <20%, largely owing to the tumor micro-
environment (TME) that favors immune-evasion and pro-tumorigenic
pathways such as macrophage polarization from a pro-inflammatory
(M1) to an immunosuppressive and pro-tumorigenic/angiogenic (M2)
phenotype. The TME is also compromised by chronic enzymatic break-
down and lack of natural regenerative repair of the alveolar elastic matrix
with generated elastin peptides also stimulating M1 to M2 phenotypic
switch. In prior work, we developed doxycycline (DOX)-releasing
polymer nanoparticles that both augment elastogenesis and inhibit elas-
tolysis, effects attributed to both the DOX and cationic amphiphiles
functionalized on the NP surface. Since DOX is known to inhibitM1-M2
phenotypic switch[1] in this work we explored the utility of our NPs to
accomplish this. We formulated cationic DOX-loaded poly(ethylene
glycol)-poly(lactic glycolic-acid; PEG-PLGA) NPs covalently conju-
gated with an antibody against interleukin 4 receptor (IL4R) on the M1
macrophages, since IL4 activation of IL4R triggers macrophage polari-
zation. The structure-property relationship of the synthesized diblock
copolymer and fabricatedNPswere characterized as also targeted binding
of the NPs to M1 macrophages. We showed that steady and sustained
(>30 days) release of DOX from these NPs is possible in the 1-10mg/ml
dose range and at these doses, the released DOX inhibited M1 macro-
phage polarization as assessed via immunofluorescence, cytokine arrays,
and functional assays for pro-angiogenic effects.
References: 1. He L, Marneros AG. Journal of Biological
Chemistry 289, 12, 2014.
Acknowledgment: This work is sponsored by NSF grant
#1508642 awarded to A.R.
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JNK-inhibitory Nanotherapeutics to Augment Vascular
Elastic Matrix Regenerative Repair
A. Camardo1, D. Seshadri1, T. P. Broekelmann2, R. P. Mecham3,
A. Ramamurthi1;
1Biomedical Engineering, Cleveland Clinic, Cleveland, OH, 2Dept of
Cell Biology, Washington University at St. Louis, St. Louis, MO, 3Dept
of Cell Biology, Washington University at St. Louis, St. Louis, MO.
Abdominal aortic aneurysms (AAAs) are localized aortal wall ex-
pansions resulting from matrix-metalloproteinase (MMP)-mediated
disruption and loss of elastic fibers in the AAA wall. Elastic fibers do
not naturally regenerate/repair which prevents AAA arrest/regression.
We have shown that low mg/ml doses of doxycycline (DOX) stimulate
elastic matrix neoassembly and crosslinking by cultured aneurysmal
smooth muscle cells (SMCs) by upregulating TGF-b1 upon inhibition
of the regulatory protein c-Jun-N-terminal kinase 2 (JNK 2). Using
JNK 2 inhibition as a metric for pro-regenerative matrix effects of
DOX, we presently demonstrate that sustained, steady-state release of
DOX at the useful dose, from poly(ethylene glycol)-poly(lactic gly-
colic acid) nanoparticles (NPs), provides pro-elastogenic and anti-
proteolytic effects more efficacious than exogenous DOX alone, an
outcome attributed to previously determined functional properties of
cationic amphiphile-functionalized polymer nanocarriers. Released
DOX inhibited expression and phosphorylation of JNK which in-
creased expression of TGF-b1 and increased elastogenesis and lysyl
oxidase-mediated crosslinking of the elastic matrix. Independent of
DOX-release, the surface-functionalized cationic amphiphile reduced
expression and activity of MMP-2. Our results suggest that JNK in-
hibition is a useful metric to assess pro-elastic matrix regenerative
effects and point to the combinatorial regenerative benefits provided
by our multi-functional DOX-encapsulated NPs.
Acknowledgment: This work was supported by funding from the
NIH (HL132856), AHA (16IRG27250113), and NSF (1508642)
awarded to A.R
260
C-Jun N-terminal Kinase Gene Silencing as an Effective
Modality to Augment Elastic Matrix Regenerative Repair
in a Proteolytic Milieu
D. Ortiz-Seranno, A. Camardo, A. Ramamurthi;
Biomedical Engineering, Cleveland Clinic, Cleveland, OH.
Inherently poor regenerative repair of elastic matrix disrupted by
chronically overexpressed matrix metalloproteases (MMPs) prevents
restoration of tissue homeostasis, as in abdominal aortic aneurysms
(AAAs). We previously showed that at doses <10mg/ml, doxycycline
has both anti-MMP and pro-elastogenic effects on aneurysmal smooth
muscle cells (SMCs), and that these occur downstream of JNK2 inhi-
bition and then upregulation ofTGF-b1. These pro-regenerative effects
positively correlated to severity of JNK inhibition. Accordingly, we
investigated JNK2 gene silencing as a modality to more efficiently
inhibit JNK2 to augment elastic fiber neoassembly and anti-MMP ef-
fects. Cultured AAA SMCs from a rat model were stimulated with
cytokines (30min) and then transfected with a pool of 3 anti-JNK2
siRNA probes, with scrambled siRNA (negative control) or cultured
with no siRNA (treatment control). Healthy rat aortic SMCs served as
cell controls. We showed efficient transfection of siRNA probes, their
inhibition of JNK2 with no non-specific effects, and subsequent de-
crease in JNK2 protein synthesis. JNK2 inhibition positively correlated
to TGF-b1 increases, elastic matrix amounts, lysyl oxidase production
and enzyme activity and desmosine crosslinking of elastin and elastic
fiber formation and negatively to synthesis and activity of elastolytic
MMPs2 and 9. Importantly, our results showed these effects to bemore
pronounced than that previously achieved by DOX treatment. Our
study indicates siRNA-mediated JNK2 knockdown as an efficient
mechanism to augment elastogenesis in a proteolytic tissuemilieu.This
work was supported by funding from the NIH (HL132856), AHA
(16IRG27250113), and NSF (1508642) awarded to A.R
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Characterization Of Tissue- And Age- Specific ECM-based
Gels For 3D Cell Microenvironment
L.Zakharova, S.D’Imperio, 85260,C.A.Bradley,G.S.Cook, 85260;
Research and Development, Lattice Biologics, Scottsdale, AZ.
The extracellular matrix (ECM) consists of structural and func-
tional molecules secreted by the resident cells. The 3-dimensional
organization and composition of an ECM is distinctive for each tissue
type. Solubilized gel-forming ECM could potentially be used to
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develop products such as 3D culture substrates, growth factor de-
livery vehicles, or scaffolds that promote tissue regeneration. One
goal of ours is to design a 100% allograft custom-fabricated human
ECM-derived 3D microenvironment that mimics the biological
properties of native ECM. Toward this goal, we evaluated the bio-
chemical and functional characteristics of ECM isolated from human
placenta, adipose, and cadaveric muscle tissues. In addition, we
compared the properties of muscle-derived ECM isolated from
young versus old donors. Proteomic analysis showed the presence of
proteins involved in matrix remodeling, angiogenesis, cell growth
and differentiation. ECM protein variability largely depended on
tissue type and donor age. Regardless of tissue origin, ECM-based
3D gels affected cell morphology by reducing cell spreading. Dif-
ferentiation of adipose-derived stem cells (ADSCs) subjected to
ECM sourced from various tissues showed no effect on adipogenic
ADSC differentiation. Contrastingly, we found that the presence of
young muscle ECM augmented chondrogenic ADSC differentiation,
while old muscle ECM favored osteogenic ADSC differentiation. In
summary, tissue- and age-related properties of ECM should be
considered in developing 3D culture models for basic and transla-
tional research.
262
WITHDRAWN
263
Testicular ECM Enhances Human Spermatogonial Stem Cell
Survival in Culture
M. H. Murdock1, S. David2, I. Swinehart1, J. Reing1,
K. Gassei2, K. E. Orwig2, S. F. Badylak1;
1Surgery, University of Pittsburgh, Pittsburgh, PA, 2Obstetrics,
Gynecology, and Reproductive Science, University of Pittsburgh,
Pittsburgh, PA.
Successful human spermatogonial stem cell (hSSC) culture could
enable stem cell therapies for male infertility. Conditions for expanding
rodent SSCs in culture are established and robust, but hSSC cultures are
less successful and no published hSSC culture system has yet been in-
dependently replicated. Our long-term goal is to establish a feeder cell-
free, serum-free culture system for hSSC. Mammalian extracellular
matrix (ECM) contains signaling molecules that promote mitogenesis,
migration, and/or differentiation of various stem/progenitor cells.Human
testicular ECM (htECM), porcine testicular ECM (ptECM), porcine
small intestinal submucosa ECM (SIS-ECM), and porcine urinary
bladder ECM (UBM-ECM) were prepared, and used to coat tissue cul-
tureplates for hSSCculture. In addition to culture of hSSCupon theECM
materials described above, hSSCwere cultured on STOmouse fibroblast
feeder cells (control), murine laminin or human laminin. UTF1 positive
undifferentiated human spermatogonia were quantified by immunocy-
tochemistry at days 0, 7 and 14 in culture. By 7 days thewellswith feeder
cells showed*31% the number of starting UTF1+ cells, whereas wells
with htECM or SIS showed 60% and 68%, respectively. After passage
and continued culture to day 14, recovery of UTF1+ cells from htECM-
coatedplateswas significantly higher than fromcultureswithSTOfeeder
cells. Homologous species (human), homologous tissue (testis) ECM
improves SSC survival in culture and establishes a foundation for
development of robust human SSC culture methods.
264
Characterization of Mesenchymal Stem Cell-Derived Bone
Extracellular Matrix on 3D-Printed Poly(propylene fumarate)
Scaffolds for Critical Size Bone Defect Repair
C. D. Zhang1, K. Richardson2, M. Wade2, D. Dean2;
1The Ohio State University College of Medicine, Columbus, OH,
2Department of Plastic Surgery, The Ohio State University,
Columbus, OH.
Current approaches to critical size bone defect repair are depen-
dent on tissue transplantation, which is associated with donor site
morbidity and pain. In many cases there is insufficient donor tissue.[1]
The development of bone tissue engineered grafts promises to alle-
viate these limitations.
Previous work in our lab has produced bone-like extracellular ma-
trix (ECM) from bonemarrow derived humanmesenchymal stem cells
(BM-hMSCs) on poly(propylene fumarate) (PPF) thin films.[2] The
goal of this project is to characterize bone ECM produced by the same
methods on3DprintedPPF scaffolds. 3Dmicro-CT (mCT) scan images
of the scaffold surface have now characterized coverage and thickness
of that ECM coating. Additionally, we are collecting histological, na-
noindentation, and compression testing data to further characterize the
properties of the ECM that coats these 3D printed, porous scaffolds.
Recent micro-CT imaging of a pilot specimen presented an ap-
proximately 5 micron thick ECM that completely covered the scaf-
fold. Our goal is to tune our in vitro BM-hMSC culturing methods to
produce a 30-70 micron uniformly thick ECM coating on these
scaffolds. Those methods will also be tuned to insure that this
artificially-created bone ECM has mechanical properties that are
similar to native bone ECM.
1. Armini AR, et al. Crit Rev Biomed Eng. 40, 363, 2012.
2. Mishra R, et al. Tissue Engineering. 22, 2016.
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From Cover to Core: Acellular Human Dermis
for the Regeneration of Human Heart
C. Castaldo, D. Nurzynska, V. Romano, A. Sacco, I. Belviso, M. Di
Gennaro, A. Carfora, A. Avagliano, F. Schonauer, S. Montagnani,
F. Di Meglio;
Public Health, University of Naples Federico II, Naples, ITALY.
Elasticity of myocardium is mostly due to elasticity of cardio-
myocytes and is essential for cardiomyocyte alignment and differ-
entiation. Cardiac decellularized ECM (d-ECM) is emerging as
natural scaffold to promote and support myocardial regeneration. It is
noteworthy that cardiac d-ECM is obtained through complete re-
moval of cardiomyocytes with loss of elasticity. We hypothesize that
decellularized skin might be an easily accessible, viable alternative
for myocardium regeneration, as decellularization is unlikely to
cause loss of skin elasticity, provided by elastic fibers rather than by
resident cells. Skin fragments from patients undergoing plastic sur-
gery were decellularized through novel simple and fast protocol.
Decellularized Human Skin (d-HuSk) obtained was assayed in
quantitative dye-binding method to measure content of elastin, while
elastin distribution was evaluated on histological sections by Para-
ldehyde Fuchsin Gomori and Weigert Van Gieson stainings. d-Husk
was then sectioned and used as scaffold to prepare three-dimensional
culture of cardiac primitive cells (CPCs). Then, survival and ability
of CPC cultured on d-HuSk to differentiate towards cardiomyocytes
was evaluated at gene and protein level. Histological and quantitative
analysis provided evidence of effective decellularization, preserved
tissue architecture and retention of elastin. CPCs engrafted onto d-
Husk, survived, and retained expression of markers specific for
cardiomyocytes at gene and protein level. Our study provides com-
pelling evidence that common signals act in cardiac and skin mi-
croenvironment to maintain CPC ability to differentiate towards
cardiac muscle and that skin holds promise as an alternate biological
scaffold for cardiovascular regenerative medicine.
266
Low Adhesive Scaffold Collagen Promotes Cell Motility
by Regulating Gene Expression in Fibroblasts
S. Kunii1, Y. Horiuchi2, N. Kato3, E. Yamamoto3, Y. Akahoshi2,
H. Ida4, Y. Hiraoka4, K. Morimoto1;
1Genetic Engineering, Kindai University, Kinokawa, JAPAN, 2Life
Science Laboratory, Kindai University, Osaka-Sayama, JAPAN,
3Biomedical Engineering, Kindai University, Kinokawa, JAPAN,
4Biomaterial Group, Nitta Gelatin Inc., Yao, JAPAN.
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Background: Fibroblasts exist in the connective tissues and are
generally separated by extracellular matrices (ECMs). One of func-
tions in fibroblast is synthesis, secretion, and deposition of the ECM
proteins such as collagen molecules. In addition, fibroblasts can
migrate in connective tissues for remodeling and renewal. We suc-
ceeded in developing low adhesive scaffold type I collagen (LAS-
Col) (patent pending), and we found that fibroblasts cultured on
LASCol spontaneously form an aggregated sphere body (spheroid),
and the resulting spheroid weakly adhered to LASCol. In this study,
we report the changes in gene expression of fibroblasts induced by
LASCol and the increase in cell motility.
Materials & Methods: The culture dish was coated with LASCol
solution or atelocollagen solution. Subsequently, mouseNIH/3T3 cells
were cultured on each dish. After 1 h, to confirm spheroid formation,
cell crawling was monitored and analyzed by a time-lapse observation.
To investigate the cell motility, we measured mRNA expression level
of myosin IB (Myo1b), vimentin (Vim), phosphatidylinositol-4,5-
bisphosphate 3-kinase catalytic subunit alpha (Pik3ca), and platelet
derived growth factor subunit A (PDGFA) by RT-qPCR.
Results: By time-lapse observation, we showed that NIH/3T3
spheroid formed on LASCol acquired the great ability of rapid mi-
gration. The quantity mRNAmeasured in spheroid clearly increased,
as compared with single cell. We demonstrated that LASCol induced
the increase of gene expression related in cell motility.
Funding: This work was supported by Adaptable and Seamless
Technology Transfer Program through target-driven R&D, JST, Ja-
pan (AS2414037P to K.M.).
267
Processing Tissue-Specific Extracellular Matrix for Use as
Electrospun Meshes
M. Smoak1, A. Kishan2, E. Cosgriff-Hernandez2, A. Mikos1;
1Bioengineering, Rice University, Houston, TX, 2Bioengineering,
Texas A&M, Houston, TX.
Decellularized extracellular matrix (dECM) has become an at-
tractive platform for complex organ engineering because it provides
signaling molecules and native membrane proteins that more closely
mimic the cellular microenvironment than commercially available
natural polymers. However, there remain many obstacles in modu-
lating the physiochemical and mechanical properties of such mate-
rials to achieve the requisite design criteria for tissue scaffolds. The
objective of our work is to develop a protocol to decellularize and
process ovine donor tissue into bioactive electrospun meshes. Elec-
trospinning allows for manipulation of porosity, pore size, fiber
morphology, and mechanical properties with corollary effects on cell
adhesion, proliferation, and differentiation. This versatile technology
combined with dECM enables the development of tunable natural
and hybrid biomaterials for tissue engineering applications.
Previous decellularization protocols were modified for enhanced
compatibility with electrospinning conditions. Harvested ovine tis-
sues were thinly sliced and washed overnight in high purity water to
remove blood, connective tissue, and microvasculature. After ho-
mogenization, samples were treated with Trypsin, Triton X-100, and
sodium dodecyl sulfate to remove cellular material and neutralize
charges. Finally, samples were dried and milled into a fine powder.
This decellularization method effectively removes over 95% of DNA
as confirmed by Picogreen assay and allows for appropriate conditions
to produce electrospun fibers. DNA, collagen, and GAGs assays have
shown promising results in ovine muscle harvested from quadriceps of
White Dorper sheep. However, we believe that this method is versatile
enough to be implemented in several tissues to produce tissue-specific
dECM-laden scaffolds for tissue engineering applications.
268
Optimization of Human Heart Decellularization Method
V. Romano, F. Di Meglio, D. Nurzynska, I. Belviso, A. Sacco, M. Di
Gennaro, A. Carfora, A. Avagliano, L. Greco, S. Montagnani,
C. Castaldo;
Public Health, University of Naples, Naples, ITALY.
Extracellular matrix (ECM) is an intricate mesh of collagenous
and non-collagenous proteins, whose presence and amount vary ac-
cording to type of tissue. ECM drew the attention of regenerative
medicine scientists as natural scaffold suitable for stem cell delivery
into damaged tissues. Although a multitude of protocols and com-
binations of chemical agents and physical methods have been tested
and proved effective in the decellularization of human heart, none of
the ones tried in our setting fulfilled the goal of obtaining a struc-
turally preserved cardiac decellularized ECM (d-ECM). While test-
ing already described procedures, we made several adjustments that
led to the development of a novel, simpler and robust protocol to
decellularize adult human heart. Specifically, we decellularized
cardiac samples of the free wall of both ventricles of adult human
hearts scaled down to 40x28x6mm, to fit into embedding cassettes
used to avoid stirring stress and preserve structure. To shorten the
procedure, a combination of SDS, Triton X-100 and antibiotics was
used in simple and fast two-step protocol. After decellularization, d-
ECM was fixed and processed for histological study or snap-frozen
for molecular biology analysis or cytocompatibility test in vitro.
Histochemistry and immunoistochemistry confirmed the absence of
nuclei and the preservation of architecture and composition of d-
ECM. Further, while DNA content in d-ECM was well below ac-
cepted standards, sGAG, elastin and growth factors were retained and
d-ECM scaffolds supported cardiac primitive cell engraftment and
survival. Hence, according to our evidence, our protocol is simple,
fast, effective and is worth improving for clinical translation.
269
Matrix-bound Nanovesicles Within Tissue ECM Rapidly Alter
Their Cargo In Response To Tissue Injury In A Rat Muscle
Crush Model.
J. Bartolacci, S. Badylak;
University of Pittsburgh, Pittsburgh, PA.
Volumetric muscle loss (VML), 25% loss ofmusclemass or function,
represents a significant unmet medical need. Current treatment options
include autologous and free grafts which are less than satisfactory and
result in donor site morbidity, and experimental stem cell therapy has
failed to change the clinical course. Acellular extracellular matrix (ECM)
bioscaffolds have been shown to induce functional skeletal muscle re-
generation in 13 VML patients who had failed standard of care. Skeletal
muscle has greater regenerative capabilities than most other tissues, and
the spatiotemporal cellular events following muscle injury are well
characterized. However, the signaling molecules that regulate these pro-
cesses are largelyunknown.The importanceof the innate immune system,
specifically the macrophage component, for skeletal muscle regeneration
has recently been recognized. The ability of ECMdegradation products to
induce a regulatory macrophage phenotype has been well documented.
Recently discovered matrix-bound nanovesicles (MBV) within ECM
have been shown to strongly influence cell behavior and represent a
possible signaling mechanism for supporting skeletal muscle regenera-
tion. In the present study, rat tibialis anterior muscles were subjected to a
crush injury and allowed to heal for 14 days.MBVwere isolated from the
ECM of both crushed and mock-injured counterpart muscles. Results
show that, within the first 14 days following injury,MBV cargo is altered
when compared to MBV derived from mock-injured muscle. These
findings suggest that MBV are rapidly responding entities capable of
adapting to injury. MBV represent a bioactive component of ECM that
regulate tissue restoration and remodeling after injury.
270
Rapid Condensation And Robust Chondrogenesis Of Human
Mesenchymal Stem Cells Within Their Own Extracellular
Matrix: The Application For Cartilage Regeneration
Y. Yang, H. Shen, C. Lucas, H. Lin, R. Tuan;
Department of Orthopeadics, University of Pittsburgh, pittsburgh, PA.
Objectives: Mesenchymal stem cell (MSC) derived extracellular
matrix (mECM) represents a very bioactive substrate. In this study,
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long-term confluent MSC cultures producing mECMwere briefly pre-
treated the culture with trypsin, which allowed MSCs to only partially
detach from its mECM and adopt a round morphology in situ. We
hypothesized that the rounded MSCs would undergo a rapid cellular
condensation process upon chondroinduction, which would result in
robust cartilage formation with a compact and uniform structure.
Methodology:Human bonemarrow derivedMSCs (hBMSCs)were
isolated and expanded (IRB approved). After a 30s trypsin treatment, 3D
bead-like constructs were formed and maintained in chondrogenic me-
dium supplemented with transforming growth factor-b (TGF-b3). Cel-
lular condensation was detected with peanut agglutinin binding. Bovine
cartilage explant cultures were utilized to test cartilage repair potential
in vitro. In vivo cartilage formation was tested by subcutaneous im-
plantation of MSC beads into SCID mice (IACUC approved).
Results:MSCs withinmECMunderwent rapid cellular condensation
as early as 1 day after chondroinduction, which was not seen in standard
high-densityMSC pellet culture until day 4. After 28 days, MSC-mECM
displayed a chondrogenesis level similar to MSC pellet, but with signif-
icantly reduced hypertrophy. MSC-mECM also exhibited higher me-
chanical strength (compressive modulus=620kPa), and showed good
integration with cartilage tissues without calcification, which was seen in
standard MSC pellet. In vivo implantation further showed that MSC-
mECM formed a compact, uniform and cartilage-like construct.
Significance: MSC-mECM thus represents an efficacious stem
cell-based protocol for cartilage repair without the use of exogenous
scaffolds.
Musculoskeletal
271
Bone Regeneration At Rat Calvarial Defects Induced By Plasmid
MicroRNA-200c
L. Hong, A. Akkouch, S. Eliason, B. Amendt;
Iowa Institute for Oral Health Research, University of Iowa, Iowa
City, IA.
MicroRNA (miR)-200c actively regulates osteogenic differenti-
ation, bone development, and inflammation. It has a potential use as a
therapeutic reagent for bone regeneration.
Objectives: This project is to test the effectiveness of plasmidmiR-
200c on enhancing osteogenic differentiation and bone regeneration.
Methods: Plasmid DNA encoding miR-200c was transfected into
human bone marrowMSCs. The cells with miR-200c overexpression
were subsequently exposed to osteogenic differentiation media for
up to 4 weeks. The biomarkers of osteogenic differentiation were
quantitatively measured at different time points. Additionally, plas-
mid miR-200c at different doses were loaded into collagen sponge
and implanted into calvarial defects at a rat model. The rats were
euthanized after 4 weeks. The bone regeneration with different
treatments were analyzed using mCT and histology.
Results: The expression of miR-200c in human bone marrow
MSCs was confirmed using real-time PCR after the plasmid miR-
200c was treated. The biomarkers of osteogenic differentiation, in-
cluding ALP, Runx2 and OCN, were up-regulated in the cells treated
with miR-200c. The bone regeneration measured using mCT in the
defects treated with miR-200c are significantly higher than that re-
ceiving sponge alone or sponge loaded empty vectors.
Significance: These data demonstrated that miR-200c potently
improves osteogenic differentiation of human MSCs and promotes
bone formation, which indicating its potential to be used for oral and
craniofacial bone regeneration.
272
The Effect of SDF1a on Skeletal Muscle Regeneration After
Compartment Syndrome Injury
K. E. Moschouris, N. Sharma, Y. Zhou, D. Dukes, J. M. Poteracki,
S. Soker, T. Criswell;
Wake Forest University, Winston-Salem, NC.
Skeletal muscle dysfunction can be debilitating to normal life
despite its remarkable ability to regenerate after minor injuries. There
are a few effective treatments for severe skeletal muscle injuries.
SDF1a is a chemokine which promotes migration of stem cells
through binding to the CXCR4 receptor and has been suggested to
enhance tissue vascularization. In this preliminary study, we tested
the effects of SDF1a treatment on the recovery of skeletal muscle
regeneration in a rat compartment syndrome(CS) injury model. We
have previously demonstrated that this model causes damage to
muscular, vascular, and neural compartments as seen in patients (1).
Male Lewis rats (*12 months of age) were injured as previously
described and divided into either SDF1a or saline treated groups.
Immediately after injury, SDF1a at 50 mL (100 ng/mL) or saline were
injected into the injured muscle. In vivo muscle function (isometric
torque) was determined prior to injury and 7 and 14 days after injury
via stimulation of the peroneal nerve. Histological assessments and
qPCR were used to determine the tissue and molecular effects of
SDF1a treatment. Our data showed that SDF1a treatment resulted in
a decrease in degenerating fibers at 14 days post-injury and increased
pax7 expression and decreased fibrosis at days 7 and 14 post-injury as
compared to the saline treated group. Despite not finding any dif-
ference in functional recovery with SDF1a treatment, these results
are promising. More experiments will be done to confirm these
findings.
1. Criswell et al. 2012.
273
The Effect of Exercise on Skeletal Muscle Regeneration
after Compartment Syndrome Injury
Y. Zhou, N. Sharma, D. Dukes, J. Poteracki, K. Moschouris,
N. El-Akabawy, T. Fair, S. Soker, T. Criswell;
Wake Forest Institute for Regenerative Medicine, Winston
Salem, NC.
Skeletal muscle injury is a major cause of disability. It is well
known that physical therapy can facilitate the recovery of muscle
function after injury. However, there is little data on the effect of
exercise on the specific physiological and molecular aspects of
muscle regeneration. The goal of this experiment to develop and
optimize an exercise protocol that can be used in future experiments.
Adult male Lewis rats were acclimated to walking on the treadmill
using a mild exercise protocol prior to injury. Injury was induced as
previously described1. Rats were divided into (1) sedentary, (2) flat
and (3) decline walking groups. After injury, rats in exercised groups
were walked on the treadmill until fatigued, for a total of 27 days.
Isometric torque was used as the measure of muscle function at day 7,
14 and day 28 after injury. Tibialis anterior (TA) muscles were
collected for histology and molecular analyses. There was no dif-
ference in relative muscle weight although body weight decreased in
the exercised groups compared with sedentary group. A small in-
crease in function was detected in the decline group at day 28.
Marginal differences were found in myogenic and vascular markers
by qPCR. These modest differences between the groups are possibly
due to the small number of animals used in this pilot experiment. The
dose of exercise and training time after injury need to be optimized
and sample size will be increased in future studies. 1. Criswell T
et al., Am J Pathol. 180: 787, 2012.
274
Development of Fasciotomy Procedure in a Rat Model
of Compartment Syndrome
J. M. Poteracki, K. Moschouris, D. Dukes, Y. Zhou, S. Soker,
T. L. Criswell;
Regenerative Medicine, Wake Forest University,
Winston-Salem, NC.
Skeletal muscle injuries are a serious cause of disability in the
military and civilian populations. Compartment syndrome (CS) is a
secondary injury, proceeding any primary injury that results in
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swelling and edema within the fascicle compartment of a muscle.
This swelling leads to occlusion of the tissue vasculature and, if left
untreated, tissue necrosis and loss of limb. The current standard of
care for CS is surgical fasciotomy: an incision through the muscle
compartments to relieve pressure. This fasciotomy procedure may
save the limb, but often leaves a number of patients with scarring and
reduced muscle function. Therefore, additional treatments to in-
crease tissue regeneration after fasciotomy need to be explored. Our
group previously developed a rodent model of CS for exploring the
pathophysiology of the condition and testing potential treatment
methods1. For this pilot study, we developed and characterized a
rodent model of CS followed by fasciotomy and treatment. CS was
induced on the hindlimb of adult male Lewis rats as previously de-
scribed1. Fasciotomy was performed on the anterior muscle com-
partment of adult male Lewis rats with or without CS injury.
Functional and histological data from these groups were analyzed.
Similar to clinical outcomes, a slight functional improvement was
found in animals that had received a fasciotomy after CS. Future
experiments will be performed to better optimize this procedure.
1. Criswell et al. ‘‘Compression-Induced Muscle Injury in Rats
That Mimics Compartment Syndrome in Humans.’’ The American
Journal of Pathology180.2 (2012): 787-97. Print.
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Delivery of Stem Cell Treatment in a Percutaneous Needle
Puncture Model of Degenerative Disc Disease in Rabbits
T. D. Luo, Z. K. Zabarsky, A. Marquez-Lara, T. J. O’Gara,
J. S. Willey, A. H. Jinnah, X. Ma, T. L. Smith;
Wake Forest School of Medicine, Winston-Salem, NC.
Various models have been proposed to study pathophysiology of
intervertebral disc degeneration, a leading cause of back pain. The
purpose of this study was to introduce a minimally-invasive tech-
nique via percutaneous needle puncture of annulus fibrosus with
subsequent needle injection of treatment in New Zealand white
rabbits. Under fluoroscopic guidance, an 18-gauge 9-cm spinal
needle was inserted percutaneously into the nucleus pulposus of L5-
L6 disc in 12 rabbits. At 4 weeks, a 23-gauge needle was directed
through an 18-gauge needle percutaneously into the nucleus, and a
microsyringe was used to inject 10-mL amniotic stem cell suspension
in 4 rabbits or 10-ml saline in 4 rabbits. No complications were as-
sociated with surgery. Weekly x-ray measurements of disc height
index (DHI), calculated as the ratio of disc height to sum of height of
two adjacent vertebral bodies, demonstrated baseline mean of 0.076,
which decreased to 0.038 at 4 weeks (p< 0.001). Final DHI at 12
weeks were 0.048, 0.034, 0.037 in the treated, untreated control, and
saline control groups, respectively (p= 0.001). MRI assessment at 4
weeks demonstrated that needle injury reduced T2 relaxation time by
79% compared to uninjured L4/L5 disc treated, untreated control,
and saline control groups, respectively (p< 0.001). At 12 weeks, T2
relaxation times were 235%, 110%, and 131% of the 4-week MRI
assessment for (p= 0.009). The percutaneous needle technique ef-
fectively produced disc injury, which improved after stem cell de-
livery to the injured disc. The injury and treatment procedures are
minimally invasive, with minimal risk to the wellbeing of the animal.
276
Effect of Matrix Source and Cell Density on Engineering
the Superficial Zone of Articular Cartilage
S. Moeinzadeh, E. Jabbari;
University of South Carolina, Columbia, SC.
Articular cartilage is composed of structurally and functionally
distinct zones including superficial, middle and calcified zones. The
superficial zone is most vulnerable to cell death after injury. Current
cartilage tissue engineering strategies are focused on regeneration of
the middle zone ignoring the thin yet vital superficial zone. In an
attempt to engineer the superficial zone of articular cartilage, hydrogel
matrices based on native bovine fetal or adult cartilage (CarMa hy-
drogel) were synthesized and loaded with human mesenchymal stem
cells (hMSCs). CarMa-laden hMSCs were incubated in chondrogenic
medium supplemented with BMP-7 and TGF-b1 for 21 days. The
effects of matrix source (fetal vs adult cartilage) and cell density on
differentiation of hMSCs to the superficial zone chondrogenic lineage
were investigated using RT-PCR, Western Blot and histochemical
analysis. Results showed that superficial zone protein (SZP) and
Collagen type II (Col II) RNA and protein expressions of hMSCs
increased over 21 days in both fetal and adult based gel matrices.
However, the RNA and protein expressions of SZP and Col II after
21 days were significantly higher in fetal based gels than those in adult
based gels. In addition, the SZP and Col II RNA expression of hMSCs
in fetal based CarMa hydrogel after 21 days increased by 6.5 and 4.6
folds, respectively, when the cell density increased from 25 to 200
million cells/mL. According to the results, the fetal cartilage based
matrix and a high cell seeding density are more suitable for differen-
tiation of hMSCs to the superficial zone chondrogenic lineage.
277
Synchronized Vascularization and Osteogenesis using
Enzymatically Responsive Nanoparticles
S. Kader, E. Jabbari;
University of South Carolina, Columbia, SC.
The on-demand release of morphogens using enzymatically re-
sponsive nanoparticles (NPs) is a promising approach for stimulating
vascularized osteogenesis. The objective of this work is to engineer
biomimetic, enzyme-responsive nanoparticles with tunable degrad-
ability in response to cell-secreted enzymes. The secreted enzymes
control the release rate of the grafted rhBMP2 within a 3D matrix.
First, the level and temporal secretion of plasmin from human
mesenchymal stem cells (hMSCs) and endothelial colony forming
cells (ECFCs) were determined. Next, plasmin’s cleavable peptide
and self-assembled peptide (AcGF3) were synthesized as a one se-
quence using solid phase peptide synthesis. Then, the peptide was
conjugated to different molecular weight of maleimide PEG via
Michael-like reaction and the ends of the peptide-PEG were functio-
nalized with NHS group. The functionalized peptide-PEG conjugates
were dissolved in dimethyl sulphoxide (DMSO) and self-assembled
into NPs against aqueous solution. Then, rhBMP2 or VEGF were
grafted to NPs through NHS- lysine’s e-amine of rhBMP2. The
rhBMP2 release from the NPs was measured by ELISA assay. Nearly
20, 55 and 56% of the rhBMP2 released from the NPs with PEG
molecular weights of 2, 5 and 7.5 kDa, respectively, and the released
rhBMP2was enzymatically active by exogenous plasmin. Further, The
NPs had the highest Runx2, ALP, andCol I fold expression at day 14 of
MSC cultures compared to direct addition of BMP2 and highest extent
of mineralization at day 21. These results demonstrate that the release
of rhBMP2 in response to enzymes secreted by MSCs can enhance
osteogenesis and mineralization.
278
Effects of Post-Delivery Placenta Disc (HPH) on Porcine
Hyaline Cartilage Matrix Breakdown
X. MA1, S. Tomblyn2, J. Willey3, S. Washburn4, T. L. Smith1,
R. Yammani5;
1Orthopedic Surgery, Wake Forest University, Winston Salem, NC,
2Plakous Therapeutics, Winston Salem, NC, 3Radiation and
Oncology, Wake Forest University, Winston Salem, NC, 4Lyndhurst
Gynecologic Associates, Winston Salem, NC, 5Molecular Medicine,
Wake Forest University, Winston Salem, NC.
Current therapies for osteoarthritis (OA) do not affect progression
from trauma to arthritis. The placental disc synthesizes and regulates
chemokines in amniotic fluid. HPH is an acellular preparation of the
term placental disc yielding consistent concentrations of its chemo-
kines. We hypothesized that beneficial chemokines in HPHwould slow
and/or reverse catabolic degradation of cartilage in OA. This study
assessed effects of HPH on acute catabolic processes of the osteoar-
thritic microenvironment in pig chondrocytes and cartilage explants.
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Methods: Full cartilage explant discs were collected from the
knees of 3 month old pigs. Primary chondrocytes were grown as
monolayers. Explants and cells were co-cultured with IL-1a (20ng/
ml) and concentrations of HPH of 3.75 or 5.625mg/ml, respectively,
for 48 hours. Explant-conditioned media was collected for glycos-
aminoglycan (GAG) measurement. Media and cell lysates were
immunoblotted for MMP1, MMP3 and MMP13.
Results: Explant media GAG was significantly elevated with IL-1a
stimulation. HPH alone did not increase media GAG compared to
control. Low dose HPH reduced GAG release by 30% and high dose
further decreasedGAGconcentration by 64%when compared to IL-1 a
treatment. (P<0.01) All MMPs were up-regulated with IL-1a stimu-
lation. This upregulation was significantly reduced by treatment of high
concentration of HPH. High concentration HPH alone decreased ex-
pression of MMP-1and MMP13 compared to controls (p< 0.01).
Conclusion: Active degradation of cartilage induced by IL-1a
stimulation was ameliorated by HPH application in cultured cartilage
explants, and chondrocytes. HPH may have potential as a novel
therapeutic application for arthropathy.
279
Robust Chondrogenesis of Human Mesenchymal Stem Cells
within TGF-b3 Loaded Hydrogels: Significant Contribution
of Newly Produced Cartilage Matrix to Mechanical Properties
H. Lin, A. Sun, G. Yu, M. Fritch, H. Shen, P. Alexander, R. Tuan;
University of Pittsburgh School of Medicine, Pittsburgh, PA.
Introduction: We previously developed a photocrosslinked
(poly-D,L-lactic acid/polyethylene glycol, PDLLA-PEG) scaffold,
which is biodegradable, biocompatible, with a Young’s modulus
within the physiological range of cartilage. In this study, we intro-
duced hyaluronic acid (HA) into PDLLA-PEG scaffolds to supply
bioactive motifs and provide a carrier for transforming growth factor-
b3 (TGFb3). We hypothesized that this chondrosupportive scaffold
would support robust chondrogenesis of human bone marrow mes-
enchymal stem cells (hBMSCs) without exogenous TGF b3 sup-
plementation, and that the newly produced cartilage matrix would
adequately reinforce the degrading PDLLA-PEG/HA.
Method: hBMSCs were obtained from surgical waste with IRB
approval. TGFb3 release from PDLLA-PEG/HA was performed up to
28 days with PDLLA-PEG as the control. Chondrogenesis was assessed
by real time PCR, histology, GAG quantitation and mechanical testing.
Results: TGFb3 release from PDLLA-PEG/HA was detected for
up to 3 weeks, and only for 1 week from PDLLA-PEG. After 4 weeks
of culture in TGFb3-free medium, the Young’s modulus of 10mg/ml
TGFb3-loaded PDLLA-PEG/HA scaffolds, containing 20· 106
hBMSCs, decreased from 600kPa to 380kPa as compared to a decrease
from 650kPa to 150kPa in 10mg/ml TGFb3-loaded PDLLA-PEG
control group, suggesting that newly produced cartilage matrix sig-
nificantly contributed to the mechanical strength of the construct only
in PDLLA-PEG/HA group. Interestingly, GAG deposition in TGFb3-
loaded PDLLA-PEG/HA was similar to those not loaded with TGFb3
but cultured in full chondrogenic medium containing 10ng/ml TGFb3.
Significance: TGFb3 encapsulated PDLLA-PEG/HA represents a
robust and potentially point-of-care MSC delivery method for car-
tilage repair, with the capacity of maintaining mechanical property
over time.
280
Biofabrication of Tissue-Specific Extracellular Matrix Proteins
to Enhance Skeletal Myocyte Expansion and Differentiation
of Muscle Progenitor Cells
I. Vasiutin1, D. Zhang2, Y. Zhang2, H. Yi1, Z. Wang1, Y. Zhou1,
J. Yoo1, A. Atala1, Y. Zhang1;
1Wake Forest Insitute for Regenerative Medicine, Winston Salem,
NC, 2Department of Urology, Children’s Hospital of Chongqing
Medical University, Chongqing, CHINA.
Skeletal muscle progenitor cells (MPCs) are considered a key
candidate for cell therapy in the treatment of skeletal muscle injuries or
stress urinary incontinence due to urethral sphincter dysfunction.
However, it is challenging to expand functional skeletal muscle cells
in vitro from a small tissue biopsy because skeletal myocytes often
decrease their phenotypic expression in culture conditions. Thus, we
sought to develop a better culture system for expansion and differen-
tiation of MPCs to be used for myogenesis in vivo. Porcine-derived
muscle extracellular matrix (ECM)was generated via decellularization
with distilled water, 0.2mg/mLDNAse or 5% fetal bovine serum, with
liver and kidney ECM as controls, respectively. Acellular matrices
were homogenized and dissolved. Each ECM solution was combined
with a hyaluronic acid-based hydrogel decorated with heparin (ECM-
HA-HP). Cell proliferation and myogenic differentiation capacity of
human MPCs were assessed when cells grew on each ECM-HA-HP
substrate. The skeletal muscle ECM-HA-HP substrate significantly
enhanced human MPC proliferation compared to liver or kidney-
ECM-HA-HP substrates. Numbers of myofibers and myotubules sig-
nificantly increased on muscle ECM-HA-HP substrate compared to
other gel substrates. Numbers of MPCs expressing specific muscle cell
markers (i.e. myosin, desmin,myoD, andmyf5) significantly increased
when these cells were cultured on muscle ECM-HA-HP substrate. In
conclusion, skeletal muscle ECM-HA-HP as a culture substrate is an
optimal culture microenvironment similar to the in vivo environment.
This makes possible the potential use of skeletal muscle-derived ECM
gel in 3D bio-printing to enhance the skeletal muscle repair or cell-
based therapy for urethral sphincter tissue regeneration.
281
In Vitro Bioengineered Model for Studies of Human Muscle
Regeneration
J. Wang, A. Khodabukus, M. Juhas, N. Abutaleb, N. Bursac;
Duke University, durham, NC.
Skeletal muscle injury drives the typically quiescent muscle stem
cells (satellite cells) to activate, proliferate, and differentiate [1]. Through
this regenerative process, satellite cells (SCs) contribute to new muscle
formation. Current engineered human muscle tissues made of expanded
progenitors lack regenerative ability and a functional SC pool [2]. In our
studies, primary SCs isolated from surgical muscle biopsies were ex-
panded without losing Pax7 expression and incorporated into fibrin-
based hydrogels. The gels were cultured in high-serum growth media to
encourage cell proliferation followed by low-serum differentiation to
stimulate myoblast commitment, fusion, and myotube formation and
maturation [2]. Differentiated tissues contained functionalmyofibers that
harbored a pool of SCs in a homeostatic, quiescent state. Regenerative
capacity of the engineered muscle was improved by augmenting SC
density by lengthening the high-serum culture time and adding freshly
sorted primary human SCs into the hydrogel. To model muscle injury
in vitro, several approaches used in animal models were compared based
on their ability to induce loss of contractile function, SC activation, and
muscle fiber fragmentation. Cardiotoxin, eccentric contraction (EC), and
calcium ionophore treatments, each resulted in significant contractile
function decrease. However, only EC and ionophore treatment activated
SCs, while only the ionophore significantly fragmented myofibers. This
injury model is now applied for studies of muscle regeneration in vitro.
Herein, we have described the first in vitro model of human skeletal
muscle tissue with an injury-responsive, functional SC pool.
References:
1. Lepper C, et al. Development 2011.
2. Madden L, et al. eLife 2015
Acknowledgments: NSF-GRFP, NIH/NIAMS gran-
ts:AR065873, AR055226, NIH-UH3TR000505
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Tenogenic Differentiation Of Umbilical Cord-derived
and Adipose-derived Mesenchymal Stem Cells
M. Baek1, J. Kim1, M. Ahn1, S. Lee2, K. Min3;
1CHA University, Seongnam-si, KOREA, REPUBLIC OF,
2Department of Orthopaedic Surgery, CHA University,
Seongnam-si, KOREA, REPUBLIC OF, 3Rehabilitation Medicine,
CHA University, Seongnam-si, KOREA, REPUBLIC OF.
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Objectives: to investigate the tenogenic differentiation of um-
bilical cord-derived (UC) and adipose-derived (AD) mesenchymal
stem cells (MSCs).
Methodology: UC- and AD MSCs were treated with trans-
forming growth factor (TGF)-b1 (10 ng/ml) for the first 3 days and
connective tissue growth factor (CTGF) (100 ng/ml) plus ascorbic
acid (50 mg/ml) for the next 7 days. The conditioned media were
changed every 3 days. The expression levels of tendon-specific
genes such as scleraxis, tenascin-C, collagen type I and teno-
modulin were measured by quantitative polymerase chain reac-
tion. Protein levels were assayed by Western blotting and
immunofluorescence staining of tenomodulin and vimentin were
used.
Results: Gene expression levels of scleraxis and tenascin-C were
increased in both of UC- and AD MSCs in the presence of TGF-b1
and CTGF. In immunofluorescence staining, tenomodulin and vi-
mentin were expressed in both cells.
Their significance: UC-MSCs can be obtained without ethical
issues and efficiently expanded for therapeutic purposes. In addition,
they might be a source of allogeneic cell therapy with less immu-
nogenicity. The present study demonstrated that UC MSCs can dif-
ferentiate into tenogenic lineage, which was induced by growth
factors. While AD-MSC has been investigated as a source of stem
cell therapy in tendinopathy, UC-MSC could be an alternative can-
didate for the purpose
Regenerative Medicine Transplantation
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In Body Tissue Architecture (IBTA) Technology For Autologous
3D Tissue Fabrication
Y. Nakayama, T. Terazawa, E. Tatsumi;
Artificial Organs, National Cerebral and Cardiovascular Center
Research Institute, Osaka, JAPAN.
Ideal incubation environment, including germ-free and nour-
ishment or oxygen supply, is regulated in each animal body.
Therefore, animal bodies is appropriate for tissue fabrication. Since
over ten years ago we attempted in-body tissue architecture (IBTA)
technology as a novel concept in regenerative medicine. The
technology can produce autologous implantable collagenous tis-
sues, consisting of only recipient’s own cells or matrices without
any artificial materials, with desired shape, thickness, and robust-
ness by simply embedding molds into subcutaneous pouches of
animals within 2 months. Through a series of the tissue fabrication
process no cell management protocol is needed. Tubular tissues,
named biotubes, obtained from rod-shaped molds, are applied as
aortic grafts for almost ten years in a canine model. Small caliber
biotubes (0.6mm) could be function as femoral arteries over 1 year.
Growth potential of biotubes was demonstrated when implanted
using a beagle juvenile model. The first-in-human study of biotubes
was successfully performed for hemodialysis access. Sheet-like
tissues, named biosheets, from rod- or plate-shaped molds are ap-
plied for reconstruction materials for valvular leaflet, dura, cornea,
trachea, esophagus, myocardium, abdominal wall, small intestine,
uterus et al. All implanted tissues were reconstructed as target
native tissues within several months. Four types of heart valve-
shaped tissues with complex 3D forms could be obtained as bio-
valves. Mechanical strength of the leaflet part was equivalent to that
of the human pericardium. In a goat model, postoperative echo-
cardiography after surgical replacement of the biovalves showed
smooth movement of the leaflets with little regurgitation even un-
der systemic circulation.
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Regenerative Effects of Hyaluronic Acid with Functional
Endometrial Stromal Cells on the Regeneration of Damaged
Uterine Endometrium
Y. Kim1, Y. Kim2, J. Joo3, S. Lee4, H. Liu5, S. Ku1;
1Seoul National University Hospital, Seoul, KOREA, REPUBLIC
OF, 2Dept of OBGYN, Korea University Medical College, Seoul,
KOREA, REPUBLIC OF, 3Dept of OBGYN, Pusan National
University School of Medicine, Pusan, KOREA, REPUBLIC OF,
4Korea University Medical College, Seoul, KOREA, REPUBLIC
OF, 5Center for ReproductiveMedicine and Infertility, Weill Cornell
Medical College, New York, NY.
The inner layer of uterus called endometrium is critical for
embryonic implantation and its damage can lead to female infer-
tility. Endometrial stromal cells (EMSCs) are from functional basal
layer of uterine endometrium, and hyaluronic acid (HA) is well
known for its role during implantation. In this study, we investi-
gated the regenerative effects of murine EMSCs that are pre-mixed
with HA hydrogel in an experimentally induced endometrial
damage model. EMSCs were harvested from 6-week-old C57BL/6
female mice and in vitro decidualized using treatment of 1 nM of
estrogen and progesterone and loaded onto HA hydrogel. Recipient
animal previously injured by chemical method using ethanol, and
the extent of damage was assessed by histopathological staining.
Decidualized EMSCs at were injected and the regeneration was
confirmed by tissue analyses and development of implanted em-
bryos. At 14 days after injection, cell-treated animals demonstrated
significantly regenerated endometrial structure. HA hydrogel pro-
vided 3-dimmensional architecture for the attachment and growth
of decidualized EMSCs with higher expression of prolactin and
CD44 compared to damaged control. This study provides an effi-
cacy of in vitro decidualized EMSCs combined with HA hydrogel
on the regeneration of damaged endometrium. This strategy for
regeneration of endometrium could be used as therapeutic model
for uterine factor-derived infertile women (2016R1E1A1A01943455
and 2016R1D1A1A02937287).
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Tagging and Tracking of Neural Progenitor Cells as part
of implanted Biosphincters for Treatment of Fecal Incontinence
P. Dadhich1, E. Zakhem1,2, K. N. Bitar1,2,3;
1Wake Forest Institute for Regenerative Medicine, Wake Forest
Institute for Regenerative Medicine, Winston salem, NC, 2Program
in Neuro-Gastroenterology and Motility, Wake Forest School of
Medicine, Winston salem, NC, 3Section on Gastroenterology,
Wake Forest School of Medicine, Winston salem, NC.
Background: Implantation of bioengineered BioSphincters offers
a potential treatment for fecal incontinence (FI). It is important to
track the implanted BioSphincters following implantation to inves-
tigate their integration with the native environment.
Objective: (1) Develop a method for stable lentiviral-
transduction of enteric neural-progenitor cells (NPCs) and ana-
lyzing their in-vitro biological and functional activity as part of the
engineered BioSphincters. (2) Assess the fate of NPCs upon in-vivo
transplantation.
Methods: Lentiviral-transduction for NPCs was optimized.
Biosphincters were engineered using IAS smooth muscle cells
(SMCs) and tagged NPCs. Biosphincters were characterized
in vitro and following their transplantation into FI model estab-
lished in rabbits.
Results: FACS confirmed *98% GFP-positive NPCs. NPCs vi-
ability and proliferation rate remained unaffected after lentiviral
transfection. qPCR revealed similar bIII-tubulin expression between
tagged (2.94– 0.16) and untagged (3.03– 0.16) BioSphincters, in-
dicating similar NPC differentiation capacity between tagged and
untagged NPCs. Organ-bath studies showed similar functionality of
BioSphincters engineered with either tagged or untagged NPCs.
Following implantation of tagged BioSphincters, histological anal-
ysis revealed tagged neurons in the native circular muscle of the IAS,
indicating the survival of the transplanted tagged NPCs.
Conclusion: The NPCs transfection method was successfully
optimized. Tagged NPCs were phenotypically and functionally in-
tegrated into the bioengineered BioSphincters. The biological and
functional activities of the tagged NPCs in the BioSphincters were
unaffected after transfection. The transplanted tagged cells displayed
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native muscle innervation demonstrated by histological and func-
tional assays. This study provides a method to track cell survival,
migration and differentiation following their transplantation.
286
Synthetic Peptide Effects on Chondrogenic Differentiation
of Stem Cells
S. Mahzoon1, V. Sjoelund2, M. Detamore3;
1Mechanical Engineering, University of Oklahoma, Norman, OK,
2Laboratory for Molecular Biology and Cytometry Research,
University of Oklahoma Health Sciences Center, oklahoma City,
OK, 3Stephenson School of Biomedical Engineering, University
of Oklahoma, Norman, OK.
One of the great challenges of using stem cells in cartilage repair is
promoting their chondrogenic differentiation in a materials-only
approach. Our approach focuses on developing high throughput
methods of finding cell-binding peptides with the ability of stimu-
lating chondrogenic differentiation in stem cells. Reducing the
binding sequences to a small peptide is attractive because of the
advantages peptides have compared to large molecules; peptides are
easy to synthesize in large quantities, and their small size reduces the
chance of any non-specific binding. Incorporating these peptides in a
biocompatible and biodegradable construct that provides the requi-
site structural integrity for cartilage applications can lead to im-
proving chondrogenic differentiation of scaffolds and promoting
clinical translation of arthritis treatments. In our approach, by iden-
tifying overlapping sequences in target molecules of interest, as well
as exploring the literature for a sequence known to bind to a target
receptor, we have identified two proprietary peptide sequences. The
chondrogenic potential of these peptides was explored by culturing
rat bone marrow-derived mesenchymal stem cells either on surfaces
coated with the peptides or on uncoated surfaces with soluble peptide
in the medium. Different concentrations of the peptides were ex-
plored to elucidate dose effect versus negative (no peptides) and
positive (RGD sequence or TGF-b3) controls. The preliminary gene
expression results have indicated that the proprietary peptides have
the potential to enhance chondrogenic differentiation of rBMSCs and
are promising candidates for designing bioactive scaffolds with the
capability of improving stem cells chondrogenic differentiation.
287
Cell Therapeutics For Hypoparathyroidism: Differentiated
Parathyroid Like Cells From Tonsil Derived Stem Cells
H. Kim1, S. Jung1, H. Park2, H. Kim1;
1Otorhinolaryngology Head & Neck Surgery, Ewha Womans
University, Seoul, KOREA, REPUBLIC OF, 2Otorhinolaryngology
Head & Neck Surgery, Hallym University, Chooncheon, KOREA,
REPUBLIC OF.
The incidence of thyroid cancer has become epidemic in developed
countries. Thyroid cancer has been most common cancer in Korea.
Thyroidectomy is well-established and safe procedures, though, collat-
eralmorbidities, such as injury of parathyroid glands, are not uncommon.
Several different methods have been used clinically in the managing of
hypoparathyroidism.; autografting of parathyroid tissues discarded from
patients during surgery, daily intake of multiple mega-doses of calcium
and vitamin D for a remarkably long time, and daily injection of the
synthetic PTH. These managements have several drawbacks. To restore
damaged parathyroid function, parathyroid tissue engineering has been
rising as new treatment approach. It was previously reported that human
embryonic stem cells (hESC) and trans-differentiated thymic stromal
cells could be used for the in vitro regeneration of parathyroid-like cells.
However, these cells have critical limitations for clinical use, including
ethical issues associated with the use of hESC and the considerably long
time (‡10 weeks) required for trans-differentiation of thymic stromal
cells into PTH-secreting parathyroid-like cells. To overcome these
limitations, we recently introduced human tonsil-derived mesenchymal
stem cells (TMSC) for in vivo parathyroid tissue regeneration. TMSC
differentiated into parathyroid like cells in 7 to 10 days, shorter than that
of thymic cells. Differentiated TMSC(dTMSC) release parathyroid
hormone (PTH) which is responsive to extracellular calcium levels. We
also developed ‘hypoparathyoidism animal models’ with rat. dTMSC
showed almost complete recovery of survival rates and restored serum
levels of PTH and iCa2+ in our animalmodel (parathyroidectomized rats
fed calcium-free diet).
288
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Repopulation of Primary Renal Cells for Whole Organ
Engineering: Functional Evaluations
M. Abolbashari1, M. Lee1,2, S. Agcaoili1, J. Huling1, C. Smith1,
T. Kim1,3, T. Aboushwareb1, I. Ko1, A. Atala1, J. Yoo1;
1Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC, 2Department of Laboratory Medicine, Chung-Ang University
College of Medicine, Seoul, KOREA, REPUBLIC OF, 3Department
of Urology, Chung-Ang University College of Medicine, Seoul,
KOREA, REPUBLIC OF.
Renal transplantation is the only definitive treatment for end stage
renal disease (ESRD), however it is severely limited by the avail-
ability of donor organs. Whole organ engineering based on decel-
lularization/recellularization techniques using patient’s own cells has
been proposed as an alternative approach to renal transplantation.We
previously demonstrated that repopulation of primary renal cells
within acellular porcine kidney scaffolds leads to cell attachment and
organization with maintenance of cellular phenotypes. In this study,
we examined whether the recellularized porcine kidney scaffolds
possess functional capabilities. Primary cultures of porcine renal
cells were expanded, characterized, and seeded into upper pole of
decellularized renal scaffolds, followed by bioreactor perfusion
culture for 14 days. To evaluate the renal function of the repopulated
renal structures formed within the scaffold, the level of the produced
erythropoietin (EPO) in culture media as well as EPO mRNA ex-
pression, hydrolases activity, and sodium reabsorption were mea-
sured. Histological and immunohistochemical analysis demonstrate
that the seeded renal scaffolds showed good cell attachment and cell
organization. The results of EPO quantification showed that the
seeded cells produced the EPO and its level increased over time in the
media, confirmed by sufficient amounts of EPOmRNA by the seeded
cells. Also, the repopulated renal scaffolds showed hydrolase activity
by transporting glutamic acid and leucine from the recellularized
cells. In the determination of electrolyte re-adsorption, the re-
populated cells were found to uptake sodium. These results provide
preliminary data for the generation of a transplantable renal graft as a
potential treatment for ESRD.
Skin & Wound Healing
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Proliferative Capacity of Human Chondrocytes in 3D Bioprinted
Cartilage in vivo - a Quantitative Analysis
P. Apelgren1, M. Amoroso1, A. Lindahl2, C. Brantsing2, N. Rotter3,
P. Gatenholm4, L. Ko¨lby1;
1Department of Plastic Surgery, Institution of Clinical Science,
Gothenburg, SWEDEN, 2Department of Clinical Chemistry and
Transfusion Medicine, Institution of Biomedicine, Gothenburg,
SWEDEN, 3Department of Otorhinolaryngology, University
Medical Centre Ulm, Ulm, GERMANY, 4Department of Chemistry
and Chemical Engineering, 3D Bioprinting Centre, Gothenburg,
SWEDEN.
Cartilage repair and replacement is a major challenge in plastic
reconstructive surgery. The development of a process, able to create
patient specific cartilage framework, would be a major breakthrough.
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Objective: To quantitatively evaluate, in vivo, the proliferation
capacity and cartilage formation ability in mono- and cocultures of
human chondrocytes and human mesenchymal stem cells in a 3D
bioprinted hydrogel scaffold.
Methods: 3D bioprinted constructs (5· 5 · 1.2mm) were pro-
duced using nanofibrillated cellulose and alginate in combination
with human chondrocytes and human mesenchymal stem cells with a
3D extrusion bioprinter. Immediately following bioprinting, the
constructs were implanted subcutaneously on the back of 48 nude
mice and explanted after 30 and 60 days, respectively and examined
morphologically and immunohistochemically.
Results and conclusion: After implantation the constructs re-
tained their mechanical properties and were easy to handle. Con-
structs with human nasal chondrocytes only showed good
proliferation abilities and after 60 days 17.2% of the surface area was
covered with proliferating chondrocytes. In constructs with a mix of
chondrocytes and stem cells an additional proliferative effect was
observed. The chondrocytes produced glucosaminoglycans and
collagen type 2. This study shows a technique to create 3D bioprinted
cartilage in a clinically relevant setting with human cells in vivo.
291
Functionalised Collagen Systems With Bespoke Molecular
And Macroscopic Characteristics For Chronic
Wound Management
G. Tronci1, H. Liang1, D. J. Wood2, S. J. Russell1;
1School of Design, University of Leeds, Leeds, UNITED
KINGDOM, 2School of Dentistry, University of Leeds, Leeds,
UNITED KINGDOM.
Chronic wounds are unable to heal via a timely and orderly self-
healing process, resulting in an economic burden to healthcare providers
worldwide. Despite several chronic wound dressings are commercially
available, bespoke clinical solutions enabling wound regulation at both
macro- and microscopic scales are only partially realised. To explore this
challenge, we have designed a functionalised collagen material that can
be injected in situ as hydrogel-forming liquid to e.g. spatially-challenging
cavity wounds or delivered as textile fabric to e.g. topical ulcers. In both
formats, thematerial building block consists of a type I collagen precursor
functionalised with photo-active compounds, e.g. 4-vinylbenzyl chloride.
The presence of photo-active adducts is key to achieve a covalent photo-
network of collagen triple helices, leading to either direct gelation in situ
or geometrically-stable fibrous assembly following contact with wound
exudate. Other than the material format and macroscopic properties,
bespoke synthetic routes have been developed to conveniently manipu-
late the molecular architecture aiming to achieve drug-free covalent
networks capable to manage the activity of upregulated, neotissue-
degrading matrix metalloproteinases (MMPs) at the chronic wound mi-
croenvironment. This can be realised either in one step, by selecting
photo-active crosslink-forming adducts inherently mediating secondary
interaction with active sites of MMPs; or sequentially via functionalisa-
tion of the collagen precursor with chelating functional groups prior to
photo-network formation. Pre-clinical evaluation in diabetic mice has
demonstrated the potential of photo-network collagen films in inducing
complete healing in a full-thickness wound model and accelerating
healing kinetics compared to a polyurethane commercial dressing.
292
Efficacy of Keratinocyte Sheet Cultured in Temperature
Responsive Dish in Ovine Burn Wound Healing
S. Alharbi1, Y. Niimi2,3, H. Hawkins4, R. Cox4, A. Osada3,
K. Ihara3, H. Sakurai3, P. Enkhbaatar2;
1Department of Neuroscience and Cell Biology, University of Texas
Medical Branch, Galveston, TX, 2Department of Anesthesiology,
University of Texas Medical Branch, Galveston, TX, 3Department
of Plastic and Reconstructive Surgery, Tokyo Women’s Medical
University, Tokyo, JAPAN, 4Department of Pathology, University
of Texas Medical Branch, Galveston, TX.
Using cultured autologous keratinocyte sheets as a therapy for burn
wounds has been investigated for over 30 years. However, certain
disadvantages inhibit the use of this technology in the clinical practice.
We hypothesized that the enzymatic method (dispase) used for de-
tachment of cultured keratinocyte sheets may have negatively im-
pacted the quality of the sheets, resulting in poor acceptance. A novel
technology has been introduced that allows non-enzymatic detachment
of the sheets using temperature responsive dishes. In the present study,
we compare the quality and efficacy of ovine keratinocyte sheets de-
tached by temperature reduction (T sheet), against enzymatic detach-
ment with dispase (D sheet). For comparison, six full thickness dorsal
burn wounds (5X5cm) were induced in sheep. Following debridement,
wounds were grafted with ovine cadaver skin. After 3 weeks, rejected
cadaver epidermis was replaced with keratinocyte sheets, and then
wound healing was monitored for two weeks. Cultured T sheets were
stronger and their detachment was easier compared to D sheets. T
sheets had better graft acceptance and significantly higher wound re-
epithelialization percentage at days 7 and 14 after sheet grafting
(95.5– 1.3 T vs. 59.1– 5.7 D on day 7 and 98.6– 1.4 T vs. 81.1– 6.0 D
on day 14). No significant difference in the epidermal thickness be-
tween the groups. T sheets are better accepted than D sheets in burn
wounds. The keratinocyte sheet harvesting method using temperature-
responsive culture dishes provides better sheet quality and can over-
come some of the obstacles of using keratinocyte sheets in therapy.
293
Effect of Platelet Derived Growth Factor (PDGF) on Human
Foreskin Fibroblast (HFF) Proliferation and Migration
in a Novel 3D Wound Assay
V. S. Hughey1, C. S. Linsley1, B. M. Wu1,2, B. Tawil1;
1Bioengineering, University of California, Los Angeles, Los
Angeles, CA, 22. Division of Advanced Prosthodontics and the
Weintraub Center for Reconstructive Biotechnology, University
of California, Los Angeles, Los Angeles, CA.
Effect of Platelet Derived Growth Factor (PDGF) on Human
Foreskin Fibroblast (HFF) Proliferation and Migration In A
novel 3D Wound Assay
Objectives: Chronic wounds are a major problem in the healthcare
industry and their prevalence continues to increase with the rise of
conditions such as diabetes, heart disease, and obesity (1). Although
numerous factors affect mending of the skin, platelet derived growth
factor (PDGF) has been identified as having the potential to increase cell
migration and proliferation. In this study, the effects of PDGF peptides
on human foreskin fibroblasts (HFFs) were investigated in vitro.
Methodology: The effects of various concentrations of the PDGF
peptide on the growth of HFF cells were studied through proliferation
using alamarBlue assays and migration using scratch assays. Various
concentrations of the PDGF peptide were tested along with a control
conditions with no peptide at or a random peptide sequence.
Results: The PDGF peptide affected cell migration to a greater
extent than it did their proliferation. Although lower concentrations
of PDGF were somewhat effective in increasing cell growth, at
concentrations above some ideal value, PDGF peptide negatively
affects cell proliferation.
Acknowledgments: This project is supported by the National
Institutes of Health (R21 AR064437) and UCLA Eli and Edythe
Broad Center of Regenerative Medicine and Stem Cell Research
Innovation Award.
References: 1. Nunan, Robert, Keith G. Harding, and Paul Martin.
‘‘Clinical Challenges of Chronic Wounds: Searching for an Optimal
Animal Model to Recapitulate Their Complexity.’’ Disease Models &
Mechanisms 7.11 (2014): 1205-1213. PMC. Web. 23 May 2017.
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3D Bioprinted Skin Tissue Models Using RGD Peptide
Conjugated Nanocellulose Bioinks
P. Gatenholm, E. Karabulut, L. Strid Orrhult;
Chemical and Biological Engineering, Chalmers University
of Technology, Goteborg, SWEDEN.
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3D Bioprinting is a revolutionary technology for converting bio-
materials and living cells to tissue models with advanced functionality
and versatile design. [1] The use of biocompatible inks in 3D Bio-
printers allow for the rapid manufacturing of 3D tissues and organs
in vitro and the precise control over microarchitecture and function-
ality of cell-laden constructs. The printing versatility of bioinks to-
gether with living cells diminishes the risk for poor cell viability and
cell accessibility throughout the 3D network. A typical bioink consist
of cells mixed with hydrogels to generate a good distribution of cells
inside the 3D scaffold. In the present study, cell adhesive peptide-
modified cellulose nanofibril (CNF) bioinks were prepared for 3D
bioprinting of human skin tissue models. The CNFs were bioconju-
gated covalently with a cell adhesive peptide, GRGDSP, in order to
promote human dermal fibroblast adhesion and viability in the scaf-
folds. The degree of peptide conjugation, colloidal stability and che-
mical composition of the functionalized CNFs were analyzed by
chemical characterizationmethods. The printability of the bioinks with
various CNF and alginate ratio was evaluated using a 3D printer under
different printing conditions. The influence of peptide modification
and bioink composition on fibroblast adhesion, viability and prolifer-
ation was studied in vitro. The results showed that the adhesion, via-
bility and proliferation of fibroblasts were promoted significantly in the
3D constructs bioprinted with GRGDSP modified bio-inks.
1) Murphy SV, Atala A, Nature Biotechnology, 32 (8), 773-785,
2014.
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The Effects of Red Bull on HFF-1 Cells
A. Beck, A. Sharma, A. Batish, D. Foshee;
MS Biotechnology, California State University, Channel Islands,
Camarillo, CA.
Objective: Energy drinks have been popularized due to their
proposed stimulatory effects. Studies have shown that increased
consumption may have a negative impact on important cellular
functions. In this study, the effect of Red Bull Energy Drink on
proliferation, morphology and integrin expression of Human Fore-
skin Fibroblast (HFF-1) cells was investigated.
Methodology: HFF-1 cell proliferation and morphology was
examined on ECM (collagen and fibronectin) coated plates and
in media containing Red Bull (1% diet Red Bull and 10% Red Bull)
at different time intervals. HFF-1 cell migration was investigated on
ECM coated Boyden chambers. Integrin expression of HFF-1 cells
was studied in 10% Red Bull media over the course of 7 days.
Results: On day 7, proliferation was highest (10.1 fold) on plates
coated with 10mg/ml fibronectin. HFF-1 cells were then cultured in
media with different concentrations of Red Bull Energy Drink on
10mg/ml fibronectin coated plates. Results showed that cells cultured
in media containing 1% diet Red Bull had significantly higher pro-
liferation compared to cells 10% Red Bull media. Next, HFF-1 cell
migration was examined on collagen and fibronectin plates. A
Boyden Chamber Assay revealed that cell migration appeared to be
highest in chambers coated with 10ug/ml collagen indicating an in-
verse relationship between cell proliferation and migration. Finally,
integrin expression was analyzed using FACS analysis of HFF-1
cells in media containing Red Bull on plates coated with 10mg/ml
fibronectin. Results showed that b1 integrin expression was in-
creased when cells were exposed to 10% Red Bull over 7 days.
296
Wound Healing Potential of Chlorogenic acid and Myricetin-
3-O-glucoside Isolated from the Leaves of Parrotia persica
S. Eslambolchi Moghadam1, E. Jabbarzadeh2;
1Chemical engineering, University of South Carolina, Columbia, SC,
2Chemical engineering, University of south carolina, Columbia, SC.
Medicinal plants have a significant potential to treat wounds caused
by trauma, diabetes, ischemic syndromes and other pathological dis-
eases. This is due to their antioxidant, anti-inflammatory and anti-
bacterial characteristics. In this context, polyphenols and flavonoids
have received increasing attention due to their low toxicity and po-
tential to alleviate symptoms and inhibit the development of various
skin disorders, skin aging, and skin damage, including wounds and
burns. In this work, we explored the potential of a flavonoid,myricetin-
3-O-glucoside, and a phenolic compound, chlorogenic acid, both iso-
lated from Parrotia persica leaves, to promote wound healing and
angiogenesis. This was accomplished using in vitro scratch and tube
formation assays utilizing human epidermal keratinocytes (HKCs),
human dermal fibroblasts (HDFs) and human umbilical vein endo-
thelial cells (HUVECs). The assessment of dose response of the
compounds demonstrated no cell toxicity between the dosages of 1mg/
ml to 20mg/ml.We observed chlorogenic acid at 10mg/ml to be able to
accelerate wound closure of HKCsmigration by 6-fold as compared to
growth media (negative control). On the contrary, myricetin was most
effective in promotion of wound closure in assays using HDFs (3-fold
increase) and HUVECs (2-fold increase), respectively. Both com-
pounds were able to induce tube formation at an approximately 50%
higher rate as compared to growth media control groups. Altogether,
our results demonstrate the potential of myricetin and chlorogenic acid
to be used in combination in treatment of lesion, bedsores, skin
wounds, diabetes ulcers, skin aging and skin diseases.
297
Eggshell Membrane Reinforced with Chitosan/poly (vinyl
alcohol) electrospun Nanofibers to fabricate a Bi-layered scaffold
for Wound Healing Applications
P. Guha Ray1, P. Pal2, S. Dhara3, P. Basak4;
1School of Bio-Science and Engineering, Jadavpur University,
Kolkata, INDIA, 2School of Medical Science and Technology,
Indian Institute of Technology, Kharagpur, INDIA, 3School of
Medical Science & Technology, Indian Institute of Technology,
Kharagpur, INDIA, 4School of Bio-science and Technology,
Jadavpur University, Kolkata, INDIA.
The objective of the present study is to modify the surface of col-
lagenous microfibrous eggshell membrane (ESM) with electrospun
chitosan/ poly (vinyl alcohol) (PVA) smooth nanofibers to fabricate a bi-
layered scaffold which is mechanically stable, biocompatible, non-
immunogenic and cost effective for wound healing applications.
A homogeneous blend of chitosan and PVA was electrospun onto the
ESM to decorate it with randomly arranged nanofibers, followed
by cross-linking of these nanofibers (256–62nm u) to the microfibers
(1–0.5mm u) using NHS/EDC coupling (ECPN). The surface topog-
raphy of the 280mm thick bi-layered scaffold was explored using
FE-SEM and AFM. FT-IR and XPS analysis revealed successful
crosslinking between the nanofibers of chitosan/PVA andmicrofibers of
ESM which corroborates to the FESEM and AFM results. The matrix
exhibits moderate enzymatic degradation after 30 days, 80%wettability,
tensile strength of 7.2MPa and substantial anti-microbial activity. Ad-
ditionally, MTT assay demonstrates excellent cell viability whereas
Rhodamine-DAPI studies confirm superior cell adhesion and prolifer-
ation of human dermal fibroblast (hDF) cells. Furthermore, the in vivo
analysis of the samples presented enhanced wound healing character-
istics when deployed over a full thickness wound on a rat model.
Moreover, histopathological examination of the treated wounds at pe-
riodic intervals revealed fast epithelization and collagen deposition in
the extracellular matrix. Owing to its excellent bi-layered microstruc-
ture, physicochemical and biocompatible properties, along with its su-
perior wound healing efficacy, the nano/micro architectured ECPNmats
could be a potential wound healing matrix for clinical skin regeneration.
298
The Effect of Manuka Honey on Neutrophil Cytokine Release
B. A. Minden-Birkenmaier1, M. Z. Radic2, R. A. Smith3,
G. L. Bowlin1;
1Biomedical Engineering, University of Memphis, Memphis, TN,
2Microbiology, Immunology, and Biochemistry, University of
Tennessee Health Science Center, Memphis, TN, 3Orthopaedic
Surgery & Biomedical Engineering and Imaging, University of
Tennessee Health Science Center, Memphis, TN.
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While the role of neutrophils has been classically considered
phagocytic, recent studies show an ability to regulate healing
through cytokine release. Neutrophil behavior can be separated into
two microenvironment-induced phenotypes: pro-inflammatory
‘‘N1s’’, which fight infection but delay wound healing, and anti-
inflammatory ‘‘N2s’’, which promote tissue repair. Due to the im-
portance of the N1/N2 balance in directing wound resolution, there is
growing interest in regulating neutrophil phenotype. Clinical evi-
dence has demonstrated the ability of Manuka honey to reduce
wound inflammation and improve healing. Given this evidence, it is
hypothesized that Manuka honey will modulate neutrophil pheno-
type to aid in wound resolution. In this study, Manuka honey’s effect
on neutrophil phenotype was measured using a differentiated human
promyelocytic leukemia cell (dHL-60) model. After differentiation
to a neutrophil-like phenotype, non-polarized N0s, inflammatory-
polarized N1s, and anti-inflammatory-polarized N2s were exposed to
Manuka honey-supplemented (0-20%) media for 3 and 24 hours.
Trypan blue was used to assess the honey’s in vitro cytotoxicity, and
levels of 17 released cytokines were measured using a magnetic
bead-based immunoassay. A significant (p < 0.05) cytotoxic effect
was seen at honey concentrations of 5% and higher. Low and inter-
mediate concentrations of honey (0.5% and 3%) lowered the pro-
duction of inflammatory molecules for the N1 phenotype while
raising their production by the N0s and N2s, and the highest con-
centration of honey (20%) suppressed cytokine release via cytotox-
icity. These results indicate that Manuka honey modulates neutrophil
cytokine release, which may facilitate enhanced wound healing.
299
3D Bioprinting of a Human Skin Tissue Model
L. Strid Orrhult1, J. Sunde´n1, P. Gatenholm1,2;
13D bioprinting center, Chalmers, Go¨teborg, SWEDEN,
2Wallenberg Wood Science Center, Go¨teborg, SWEDEN.
Skin is the largest organ of the human body and the first barrier to
outer environment. In case of injury, for example burn wounds, the
barrier is compromised and the body is more exposed to the dam-
aging environment. For larger injuries, skin transplants might be
needed. However, this cause additional pain and suffering for the
patient. 3D bioprinting can be used for biofabrication of human skin
grafts with autologous cells. The printed skin can be transplanted
with perfect fit to the patients wound, and thereby solve the problem
with lack of skin for transplantation.
In this study, we focus on a bioink based on fibrin, a native human
protein active in the wound healing process, mixed with nanocellu-
lose and alginate modified with RGD. Human dermal fibroblasts
(HDF) were mixed with fibrin bioink or nanocellulose bioink (con-
trol) and 3D bioprinted. The printed constructs were cultured in vitro.
Human epidermal keratinocytes (HEK) were seeded in pure fibrin on
top of the constructs and then cultured in an air-lift system.
Data shows that cell viability was high in both groups. At 14 days
post-printing, most of the HDFs in fibrin bioink displayed a stretched
morphology while HDFs in control showed mostly a rounded mor-
phology. Collagen production and the experiments with HEKs are
still under evaluation. Since HDFs are stretching out when attaching
to the environment, the fibrin bioink seems to mimic the dermis better
than control bioink. Therefore, fibrin-based bioinks may be a good
scaffold when creating biofabricated skin.
300
Development and Characterization of Protein-Based Degradable
Membranes for Stratification of Cellular Co-Cultures
J. Navarro Rueda, J. P. Swayambunathan, J. P. Fisher;
Department of Bioengineering, University of Maryland, College
Park, MD.
We developed a dual-chambered bioreactor (DCB) to stratify cell
populations and mimic the multilayered structure of skin. Further-
more, by employing membranes with varying permeability to regu-
late transport between the chambers, we aim to control molecular
cross-talk between engineered dermal layers. We produced keratin
membranes via ultra-violet crosslinking, hypothesizing that the
amount of energy projected during curing (4 to 200mJ/mm3) defines
the network’s crosslinking degree, and thus membrane permeability.
Crosslinking was assessed by sol fraction, swelling with phosphate-
buffered saline (PBS) and minimum essential medium (MEM),
mechanical properties, and changes in differential scanning calo-
rimetry (DSC) and thermogravimetric analysis (TGA) profiles.
Our approach produced membranes with various degrees of cross-
linking and permeability, where increasing the amount of cross-
linking energy results in (1) decreased sol fraction (75.2– 0.1% to
56.4 – 0.1%), (2) slower PBS and MEM uptake with higher swelling
(1274 – 208% to 1729– 229%) and longer stability periods before
degradation (3 to 28d), (3) higher compressive modulus (2.4 – 0.6kPa
to 18.8 – 3.1kPa), and (4) significant alteration of TGA and DCS
profiles with an additional energy peak (36.1– 4.3% to 65.9 – 18.8%
change). In the DCB, one chamber contained human mesenchymal
stem cells (hMSCs) with adipogenic media; the other, normal human
dermal fibroblasts (NHDFs) with NDHF media. After 7d, the adja-
cent co-culture allowed NHDF proliferation and hMSC adipogenic
differentiation and proliferation. The membrane allows co-culture
separation and its crosslinking degree regulates transport before
starting to degrade. Overall, modular DCBs using degradable
membranes can regulate gradients and stratification, and can be used
to fine-tune interactions between cell populations in tissue en-
gineered constructs.
301
Enhancement of Wound Matrix Stability through
Microdeformation Inducing Microgels
M. Castaneda, Jr., S. Nandi, S. Menegatti, A. Brown;
North Carolina State University, Raleigh, NC.
Fibrous proteins like fibrin, fibronectin, and collagen play im-
portant roles in wound repair by providing 1) physical and bio-
chemical cues to direct cell migration into the wound bed and 2)
mechanical strength to the surrounding tissue. The mechanical in-
tegrity of the fibrous networks is compromised in chronic wounds
due to excess protease activity and fibroblast senescence. The
premise of this study is to develop wound targeting ultra-low
crosslinked (ULC) pNIPAm microgels that interact specifically with
these fibrous networks and improve the mechanics of wound-
associated matrices by inducing micro-deformations within the fi-
brillar networks. ULC microgels are highly deformable and previous
studies have shown that, when coupled to fibrin-binding antibodies,
ULCmicrogels induce deformation within the fibrin network through
a Brownian Wrench Mechanism. Here, we coupled fibrin-binding
peptides to ULC microgels and incorporated them into a fibrin net-
work. Cryo-SEM demonstrated that fibrin-targeting particles pro-
mote more network collapse than the non-targeting particles.
Network collapse was found to correlate with an increase in network
density, ECM stiffness, and enhanced network mechanics and sta-
bility. Current work is also investigating the utility of this approach
with fibronectin and collagen-specific peptides. These particles may
prove useful in the treatment of chronic wounds.
Acknowledgments: Research and Innovation Seed Funding
North Carolina State University Analytical Instrumentation Facility.
301A
Evaluation Of The Effects Of Air Pollutants
On Diabetic Wounds
Y. Choi1, J. Lim2, D. Ham2, E. Yeo3, Y. Lee, Sr.2;
1orthopedic, Soonchunhyang university Bucheon Hospital, Republic
of Korea, KOREA, REPUBLIC OF, 2orthopedic, Soonchunhyang
university Bucheon Hospital, Seoul, KOREA, REPUBLIC OF,
3orthopedic, Departments of Orthopedic Surgery, Veterans Health
Service Medical Center, Seoul, KOREA, REPUBLIC OF.
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Abstract: Although air pollution containing fine dust particles is
gaining attention worldwide, little is known about the effects of such
pollutants on diabetic wounds. Air pollutants from diesel exhaust
particles (DEPs) cause inflammation, resulting in the increased ex-
pression of pro-inflammatory cytokines and chemokines, which at-
tract monocytes and T cells to the sites of inflammation. We
evaluated the effects of air pollutants on diabetic wounds.
Materials and Methods: Fibroblast cells were derived from
streptozotocin-induced diabetic rats. Cell CountingKit-8 (CCK-8) assays
were used to determine cell viability. The expression of pro-inflammatory
cytokines, including tumor necrosis factor-a (TNF-a), cyclooxygenase-2
(COX-2), and interleukin-6 (IL-6), was evaluated by reverse transcription
polymerase chain reaction and Western blot analysis.
Results: The proliferation of DEP-treated fibroblasts decreased
with time. The mRNA expression of TNF-a and COX-2 in DEP-
treated fibroblasts increased in both normal and diabetic fibroblasts,
where IL-6 expression remained unchanged. The protein expression
of TNF-a, COX-2, and IL-6 in DEP-treated fibroblasts increased
compared to samples not exposed to DEP.
Conclusions: DEPs regulate the expression of pro-inflammatory
cytokines such as Il-6, TNF-a, and COX-2, which may impede di-
abetic healing in vitro.
References: Wu, W., Fruin, S. & Diaz-Sanchez, D. Particle and
fibre toxicology 9, 1 (2012).
Acknowledgments: This research was supported by National
Research Foundation.
Disclosures: The Author Disclosure Form states that the use of
data, tables, figures published in the Journal of Wounds without
written permission of the copyright holder is plagiarism, even if the
authors use them from their own papers.
Soft Tissue
302
Dual Method Verification of Adipogenesis in Cultures
Containing an Adipose Derived Delivery System
for Adipose Restoration
C. Mahoney1, C. Imbarlina2, J. P. Rubin3, K. Marra3;
1Bioengineering, University of Pittsburgh, Pittsburgh, PA, 2Biology,
Carlow University, Pittsburgh, PA, 3Plastic Surgery, University of
Pittsburgh, Pittsburgh, PA.
Hydrogels derived from adipose derived extracellular matrix
(AdECM) have shown potential in its ability to generate new adipose
tissue in vivo. The goal of this study was to evaluate quality and
efficacy of a composite adipose derived delivery system (CADDS)
containing adipogenic factors encapsulated in polymeric microspheres
to increase adipogenesis in human adipose-derived stem cells (ASC)
culture before examining volume retention in an immunocompetent rat
model. Two separate methods of adipogenesis quantification were
used to determine if the CADDS scaffold increased adipogenesis in
adipose-derived stem cell culture. These two methods compared Oil
Red O staining with UV spectrophotometric measurements. Oil Red O
stained lipids from the 7 and 14-day in vitro study of ASC differen-
tiation demonstrated increased adipogenesis of the adipogenic factor-
loaded CADDS when compared to the empty CADDS. Quantification
using Image J of Brightfield images demonstrated significantly in-
creased adipogenesis at day 7 in conditions containing CADDS with
adipogenic factor-loaded microspheres. A similar trend with the
CADDS experimental groups using spectrophotometry was observed,
at both 7 and 14 day time points. Next steps involve the analysis of the
composite adipose-derived scaffold in vivo using a rat model to study
volume retention, immune response, and neotissue formation.
303
Co-culture of Adipose-derived Stem Cells and Human
Umbilical Vein Endothelial Cells for Vascularized Adipose
Tissue Engineering
F. Yang1, B. M. Roux1,2, E. M. Brey1,2;
1Biomedical Engineering, Illinois Institute of Technology, Chicago,
IL, 2Edward Hines Jr. V.A. Hospital, Hines, IL.
Adipose tissue is highly dependent on vascular networks for sur-
vival post transplantation. Therefore, engineered adipose tissue re-
quires an extensive vascular network for survival and function.
Adipose-derived stem cells (ADSCs) are a promising cell source for
the engineering of adipose tissue because of their relatively high
availability and efficient differentiation into mature adipocytes. In
addition, ADSCs can exhibit pericyte characteristics when co-cultured
with endothelial cells to promote vascular formation. This study aims
to develop a 3D vascularized construct of mature adipocytes that can
mimic in vivo adipose tissue by co-culturing ADSCs and human um-
bilical vein endothelial cells (HUVECs). Spheroids containing ADSCs
and HUVECs were encapsulated in fibrin hydrogels and cultured for 2
or 3 weeks. The culture conditions were optimized in terms of cell
ratio, fibrinogen concentration, medium content, adipogenic factors, as
well as the timing of differentiation. Adipogenic differentiation was
assessed by Bodipy staining. Vascularization was assessed by CD31
immunostaining. The results show that mature adipocytes congregate
around the spheroids in the engineered adipose tissue. Vessel-like
structures sprout from the surface of the spheroids and branch through
the adipocytes forming a vascularized adipose unit.
Stem Cells
304
305
Regulation of Senescence of Mesenchymal Stem Cells
by the Hippo Pathway Effectors TAZ/YAP
j. wang, G. Yin;
Hangzhou Medical College, Hangzhou, CHINA.
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Stem cells such as mesenchymal stem cells (MSCs) harbor a
promising role in regenerative medicine. However, the longer ex
vivo passage of MSCs is usually accompanied with senescence, and
it is still remained to be determined the mechanism underlying the
senescence. MSCs senescence is accompanied by some striking
morphological changes. Transcription co-activator YAP plays an
important role in the regulation of organ size. A growing body of
evidence has shown that YAP could be regulated by mechanical
signals through F-actin. Here, we found that with the increasing
passages of MSCs, the cells showed with decreased F-actin poly-
merization and inactivated of downstream protein YAP, observed by
YAP and F-actin staining, as well as a positive relationship between
the inactivity of YAP and b-gal staining. Taken together, our date
indicated that important role of YAP and F-actin in the regulation of
cellular senescence. It may provide significant insight to the under-
standing of stem cells aging and pave the way for the clinical ap-
plication of MSCs.
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Adult Stem and Progenitor Cell Heterogeneity in Human
Bone and Adipose Tissues
M. A. Qadan1,2,3, N. S. Piuzzi1,4, C. Boehm1, W. Bova1,
R. J. Midura1, V. C. Hascall1, C. M. Malcuit2, G. F. Muschler1,4;
1Department of Biomedical Engineering, Cleveland Clinic
Foundation, Cleveland, OH, 2School of Biomedical Sciences, Kent
State University, Kent, OH, 3Department of Biotechnology and
Genetic Engineering, Philadelphia University, Amman, JORDAN,
4Department of Orthopaedic Surgery, Cleveland Clinic Foundation,
Cleveland, OH.
Advancing the understanding of the heterogeneous population of
native stem/progenitor cells (Connective Tissue Progenitors/CTPs)
in different tissues is key to define the ideal cell source to use in cell
therapy.
The aim of this study was to compare sources and characterize the
biological features of human CTPs derived from bone and adipose
tissues in primary culture and after expansion to passage-2 (P2).
Cancellous bone and subcutaneous adipose tissues were collected
from 8 patients in IRB-approved protocols. Three cell-fractions were
isolated per patient: MS, bone-derived marrow-space; TS, bone-
derived trabecular-surface; and AT, adipose tissue-derived cells. We
assessed CTP prevalence (PCTP), colony metrics, cell counts using
ColonyzeTM software; and phenotypic characteristics using flow
cytometry to determine percentage of cells expressing classical-MSC
surface-markers: CD73, CD90, CD105, as well as CD146, E-
cadherin, Ep-CAM, hyaluronan, Oct3/4, Sox-2, Nanog, SSEA-4,
SSEA-3, Cripto-1.
Mean PCTP and cell density in TS-fraction were significantly
higher (P = 0.0003 and P = 0.0002, respectively) than in MS. Mean
total cells/106 cells plated was significantly different between tissue
sources, with AT>MS (P = 0.01) and TS>MS (P < 0.0008). All P2
cell sources expressed classical-MSC markers >95%. However,
large variations were observed between patients and tissue sources
in all other markers. The prevalence and biological potential of
CTPs are different from one patient and one tissue to another. The
heterogeneity in stem/progenitor populations is an untapped op-
portunity for improving the performance of culture-expanded cells.
Lack of variation in classical-MSC markers limits their value.
Greater emphasis needs to be placed on establishing critical
quality-attributes based on other markers that will be predictive of
future biological behavior and therapeutic potency of stem/pro-
genitor cells.
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Effect of Low Level Laser Therapy on the Proliferation
of Adipose Tissue Mesenchymal Stem Cells
A. M. Andrade1, G. F. Luna2, P. Brassolatti3, A. M. Leal2,
M. C. Frade4, N. A. Parizotto5;
1Departament Physioterapy, Federal University Sa˜o Carlos, Sa˜o
Carlos, BRAZIL, 2Department Biotechnology, Federal University
Sa˜o Carlos, Sa˜o Carlos, BRAZIL, 3Department Morphology and
Patology, Federal University Sa˜o Carlos, Sa˜o Carlos, BRAZIL,
4Faculty of Medicine of Ribera˜o Preto., University of Sa˜o Paulo,
Ribera˜o Preto, BRAZIL, 5Department Physioterapy, Federal
University Sa˜o Carlos, Sa˜o Carlos, BRAZIL.
The use of mesenchymal stem cells (MSCs) has been widely
investigated in the different areas of tissue engineering and re-
generative medicine. The literature shows that the higher the pro-
liferation of MSCs, the greater the regenerative and cicatricial
capacity of the tissues. In this context, we can highlight the low
level laser therapy (LLLT), which presents itself as as an effective
therapy in the proliferation of several cell types, however the ap-
plication is dependent on several parameters, such as wavelength,
energy, power and time1. Objective of this study was to evaluate the
action of LLLT in MSCs with different energies. Was used adipose
tissue mesenchymal stem cells (ADSC) were divided into three
groups, one control group (GC) and two groups irradiated by
LLLT, GL1 with 0.56J and GL2 with 1.86J, at 24, 48 and 72 hours.
An InGaAIP laser was used, with 660nm, power of 40mW. The
ADSC were seeded in 24-well plates, intercalated to avoid dis-
persion of laser light. For the evaluation of cell proliferation and
viability the MTT and trypan blue tests were used. The results
showed that both energies accelerated cell proliferation, 41% and
56%, when compared to GC, and that the GL2 group presented a
higher proliferation (15%) when compared to GL1. Thus we can
conclude that LLLT has the capacity to accelerate the proliferation
process of ADSC.
Acknowledgments: FAPESP- 1 Mvula B, Moore TJ, Abrahamse
H. Effect of low-level laser irradiation and epidermal growth factor on
adult human adipose-derived stem cells. Lasers Med Sci 33-9, 2010.
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Generation Of Chondrocytes With Reduced Hypertrophy
From Human Mesenchymal Stem Cells By Modulating
The Erk1/2 Signaling Pathway
Y. Deng, Y. Yang, H. Lin, R. Tuan;
University of Pittsburgh, Pittsburgh, PA.
Objective: The initiation of hypertrophy concomitant with
chondrogenic differentiation of adult mesenchymal stem cells
(MSCs), characterized by high level expression of genes such as
collagen type X (COL10) and matrix metalloproteinases-13 (MMP-
13), represents a major barrier for clinical application of MSCs for
cartilage repair. During endochondral ossification, chondrocyte hy-
pertrophy is a highly regulated process, involving signaling by the
extracellular signal-regulated kinases(Erk)-1/2 pathway. We hy-
pothesized that MSC hypertrophy is similarly regulated, and that
optimal Erk1/2 inhibition in human MSCs would generate chon-
drocytic cells with low hypertrophy potential, without significantly
compromising chondrogenic differentiation.
Methodology: Human bone marrow derived MSCs (hBMSCs)
were obtained with IRB approval. hBMSCs were seeded in hya-
luronic acid(HA), previously shown to partially inhibit hypertrophy,
and cultured in full chondrogenic medium for 21 days. Erk1/2 in-
hibitor (PD98059) was added at day 3, 7, 10, or 14, and lasted for the
rest of culture.
Results: Early introduction of Erk1/2 inhibitors significantly
compromised both chondrogenic (collagen type II, COL2, and ag-
grecan, AGG) and hypertrophy gene expression. However, after
7 days of chondrogenesis, the addition of PD98059 resulted in sig-
nificantly increased COL2 (2.5-fold) and AGG (5-fold) expression,
and decreased COL10 (2-fold) expression. Safranin O staining and
immunohistochemistry (COL2 and COL10) further showed that
PD98059 treatment (starting from day 7) resulted in higher GAG and
COL2, but significantly less COL10 production, compared to un-
treated group.
Significance: Our findings represent a novel method to generate
chondrocytes with reduced hypertrophy potential from human
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MSCs, which may be applicable for the clinical repair of joint car-
tilage defect.
309
Differential Response of Amnion and Adipose MSCs
to Low Grade Inflammation - Implications for Mitigating
Osteoarthritis
K. E. Routhier, J. Mercuri;
Bioengineering, Clemson University, Clemson, SC.
Osteoarthritis (OA) is a disease of the synovial joint marked by
chronic, low-grade inflammation leading to cartilage destruction.
Strategies to combat OA progression include intra-articular injec-
tion of mesenchymal stromal cells (MSCs), however identification
of an optimal MSC source has yet to be identified. We recently
demonstrated that human amniotic MSCs (hAMSCs) mitigate OA
progression more effectively compared to adipose MSCs
(hADSCs) in human OA cartilage/synovium explant co-cultures.
However, the mechanisms responsible need to be elucidated. We
hypothesized that hAMSCs produce more anti- and less pro-
inflammatory cytokines compared to hADSCs when cultured in
low-grade inflammation. To test this, we used a simplified model of
hAMSCs and hADSCs cultured independently for 48 hours in
media containing an OA-mimetic pro-inflammatory cocktail (IL-
1b: 10 pg/ml + TNF-a: 500 pg/ml) or control media. Media was
analyzed for pro-/anti-inflammatory mediators and prostaglandin
E2 (PGE2) using a cytokine array and ELISA, respectively. Results
demonstrated hADSCs produced significantly (p < 0.05) more in-
terleukin (IL) -6, IL-8 and PGE2 compared to hAMSCs in control
media. Under inflammatory conditions, hADSCs produced signif-
icantly (p < 0.05) more PGE2 (a catabolic mediator of cartilage
homeostasis) than hAMSCs, and demonstrated increasing produc-
tion of MCP-1 and IL-8 (macrophage chemoattractants) with time;
the opposite trend was found in hAMSC cultures. This demon-
strates that hAMSCs produce lower concentrations of soluble me-
diators that can contribute to OA joint damage compared to
hADSCs. Funding: NIH(NIGMS:5P20GM103444-07)
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CD264: A Predictor of MSC Regenerative Potential
K. OConnor1, S. Madsen1, K. Russell1, A. Tucker1, J. Glowacki2,
B. Bunnell1;
1Tulane University, New Orleans, LA, 2Brigham and Women’s
Hospital, Boston, MA.
The regenerative potential of marrow-derived mesenchymal stem
cells (MSCs) exhibits significant variation in their regenerative po-
tential, particularly among older patients. The objective of this study
is to identify a cell-surface marker whose expression is predictive of
the in vitro proliferation and differentiation potential of MSCs. This
study evaluates surface expression of decoy TRAIL receptor CD264,
in vitro regenerative potential and metrics of cellular aging for
marrow MSCs from 12 donors, 20-60 years old. Male and female
donors were age-matched. When CD264(+) cell content was 20% to
35%, MSC cultures from young (20-40 yr) and older (45-60 yr) do-
nors proliferated rapidly and differentiated extensively. Older donor
MSCs containing less than 35% CD264(+) cells had a small size and
negligible senescence despite the donor’s advanced chronological
age. Above the 35% threshold, CD264 expression inversely corre-
lated with proliferation and differentiation potential. When
CD264(+) cell content was 75%, MSCs were enlarged and mostly
senescent with severely compromised regenerative potential. There
was no correlation of the older donors’ chronological age to either
CD264(+) cell content or the regenerative potential of the donor
MSCs. CD264 was upregulated after p53 and had a similar expres-
sion profile to that of p21 during serial passage of MSCs. No sex-
linked differences were detected in this study. The strong inverse
correlation of CD264(+) cell content to the in vitro regenerative
potential of MSCs has possible application to predict the therapeutic
potential of patient MSCs, and to standardize the composition and
efficacy of MSC therapies.
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Nerve Fibers Restoration In A Pudendal Nerve-transected Rat
Model Of Stress Urinary Incontinence After Sphincteric Adipose
Stem Cells Injection In Combination With Platelet-rich Plasma
G. M. Villoldo, Sr.1, R. Albite2, J. Jaunarena1, F. Pereyra-Bonnet2,
A. Sordelli2, M. Loresi2, M. Dadamo2, W. Gonzalez3, M. Ielpi2,
C. Giudice1, J. Moldes4, F. Debadiola4, G. Gu¨eglio1;
1Urology, Hospital Italiano, CABA, ARGENTINA, 2ICBME-IU,
Hospital Italiano, CABA, ARGENTINA, 3Transfusion Medicine,
Hospital Italiano, CABA, ARGENTINA, 4Pediatric Urology,
Hospital Italiano, CABA, ARGENTINA.
Objective: To assess whether adipose stem cell (ADSC) plus
platelet rich plasma (PRP) could promote nerve fibers formation in a
stress urinary incontinence (SUI) rat model.
Methodology: Thirty five female inbred Wistar rats were used in
our study. Animals were divided into seven groups (five animals per
group): continent (C), sham (S), PNT (D), PNT+PBS injection (P),
PNT+PBS+ADSC injection (PA), PNT+PRP injection (R) and
PNT+PRP+ADSC injection (RA). Twenty five females rats under-
went bilateral pudendal nerve section (PNT) to induce SUI. ADSCs
were purified from fat tissue of a 4-week-old inbred male Wistar rat,
labeled CM-Dil and injected into the urinary sphincter in twelve o´
clock position with 70 microliltres of PBS or PRP. Four weeks after
injection, cystometry was undertaken in all animals and leak point
pressure (LPP) measured to assess urethral resistance function. All
groups were sacrificed after cystometry, urethra sections were sub-
mitted for histology, immunohistochemistry assessment.
Results:LPPwas increased significantly in R, RA and PA animals
after implantation (P< 0.01), but was not different from group C and
S. Histological and immunohistochemical examination demon-
strated increased numbers of surviving ADSCs increased muscle/
collagen ratio as well as increased nerve fibers density arround stem
cells location in RA compared to PA animals (CM-Dil +).
Significance: PRP may potentially improve the action of trans-
planted ADSC to restore the histology and function of the urethral
sphincter by increasing the amount of nerve fibers arroundADSC in a
SUI rat model.
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Development Of An Antibody Immobilizing Device
For Label-Free Selective Capture And Collection Of Stem Cells
T. Kimura1, N. Nakamura2, Y. Hashimoto1, A. Kishida1;
1Institute of Biomaterials and Bioengineering, Tokyo Medical and
Dental University, Tokyo, JAPAN, 2College of Systems Engineering
and Science, Shibaura Institute of Technology, Saitama, JAPAN.
For tissue engineering and cell therapy, purification of stem cells
is one of important technologies. Generally, stem cells were labeled
by fluorescent andmagnetic modified antibody and purified by FACS
and MACS system, respectively. In the present study, for label-free
capture and collection of target stem cells, we developed an antibody
immobilizing device and investigated the capture and release of target
stem cells. Polyethylene meshes were modified by grafting of poly
(acrylic acid) (PAAc) and biotin was introduced into the PAAc graft.
The desthiobiotin-antibody (anti-mouse CD45 antibody) was im-
mobilized on the film through desthiobiotin-avidin interaction. The
immobilization of CD45 antibody was confirmed by immunostaining.
Mouse bone marrow cells (CD45 positive) were seeded on the meshes
with and without immobilizing CD45 antibody, the cellular adhesion
of cells was observed.When biotin conjugated water-soluble polymers
were used as dissociation agents, the captured cells were completely
released, indicating that the exchange reaction occurred due to the
different binding constant of desthiobiotin and biotin to avidin. From
these results, it was suggested that target cells could be selectively
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captured and collected by using the antibody immobilizing device via
desthiobiotin-avidin interaction.
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Human Urine-Derived Stem Cells Lessen Inflammation
and Fibrosis within Kidney Tissue In a Rodent Model
Of Aging-Related Renal Insufficiency
x. gu, Y. Jiang, H. Shi, L. Zhong, D. Zhang, W. Li, Y. Zhang,
D. Chen, Y. Jiao, A. Atala, D. Diz, Y. Zhang;
WakeForest BaptistHealthRegenerativeMedicine,Winston Salem,NC.
Introduction: Kidney function declines with age. Most older
patients with cardiovascular diseases have some degree of impaired
renal function. Cell-based therapy is a promising alternative method
of the treatment of chronic renal insufficiency. Our goal of is to
determine whether human urine-derived stem cells (USCs) can
prompt renal tissue remolding in a rodent model of age-related kid-
ney insufficiency.
Methods: Urine samples were obtained from healthy men (n= 6,
28-35y). Human USCs were isolated and expanded at passage 5.
Eighteen male SD rats (50-62w) with renal insufficiency were divided
into 3 groups (G). G1, animals received 5 intravenous cell implantations
of 2 x106 cells/0.2ml serum-free medium /rat/time period weekly; G2,
as in G1 but intraperitoneally delivered; G3, as in G1 but serum-free
medium alone. Healthy male SD rats at the same age were controls.
Results: ELISA assay showed that cultured USCs secreted >20
kinds of trophic factors. Immunocytochemical staining showed that
ED1 (inflammatory marker), alpha-smooth muscle actin (myofibro-
blast marker), and collagen deposition were significantly less within
the medulla or cortex in G1 and G2 rats, compared to G3. Cell
therapy with human USCs significantly inhibited inflammation and
fibrosis in renal interstitial tissue, and reduced collagen deposits
around renal vessels and the basement membrane of renal tubule and
glomerular tissue in vivo.
Conclusions: Renal fibrosis is potentially reversible and thera-
peutic use of USCs can reverse specifically targeted decrease of
influx of inflammatory macrophages, interstitial fibrosis formation
and collagen deposition through their paracrine effects
314
Whole Transcriptome Comparison between Multipotent
Adult Stem Cells (MASCs) and Two Families of Mesenchymal
Stem Cells (MSCs)
P. A. Lucas1, J. Black2, D. Cumming1, A. Sullivan1, W. Huang2;
1Orthopaedic Surgery, New York Medical College, Valhalla, NY,
2Pathology, New York Medical College, Valhalla, NY.
There are several different varieties of adult stem cells, which
include mesenchymal stem cells (MSCs), and multipotent adult stem
cells (MASCs). MASCs are found in several tissues in post-natal
animals and able to differentiate into phenotypes of all three dermal
lineages, with an apparent unlimited proliferation potential. We
hypothesize that MASCs have a unique gene expression profile in
comparison to MSCs. MASCs were isolated from human neonatal
foreskin and RNA-seq was performed on cells that were passage 20.
We then compared the gene expression of the MASCs to published
databases of genes expressed by bone marrow-derived mesenchymal
stem cells (BM-MSCs) and placenta-derived mesenchymal stem
cells (PL-MSCs). The NIH Database for Annotation, Visualization
and Integrated Discovery (DAVID) was used to perform gene
functional annotation clustering and pathway enrichment All three
stem cells do not express Oct-4, Sox-2, and Nanog We have identi-
fied 507 genes that are expressed inMASCs but not inMSCs, and 520
genes that were expressed in the MSC lineages but not the MASCs.
MASCs expressed epiregulin, a gene required for sustained cell
growth by telomerase; genes for early neural development (ROBO2,
FRMPD4, PCDH9); development of germline cells (LHX9 and
IGF2BP3); early neuroectodermal development (RSPO2 and ZIC1);
development of endodermal phenotypes (NKX6-1 and ONECUT1);
and genes associated with cardiac development (TBX5). The first 3
developmental pathways, as well as genes involved in germline de-
velopment, may help explain the wide differentiation potential of
MASCs. Expression of epiregulin may help explain the apparent
unlimited proliferation potential of MASCs.
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Effect of Anisotropy on Fate Specification of Human
Mesenchymal Stem Cells
M. E. Piroli, E. Jabbarzadeh;
Biomedical Engineering, University of South Carolina, Columbia,
SC.
Human stem cells hold the potential of almost unimaginable
medical breakthroughs for the treatment of a variety of diseases.
However, their use as a therapy is hampered due to the limited un-
derstanding of the mechanisms by which cells integrate environ-
mental stimuli. Efforts to understand extracellular biophysical cues
have demonstrated the critical role of cell geometrical parameters
and mechanical signals in determining the ultimate fate of stem cells.
The goal of this contribution was to dissect the interplay between cell
shape anisotropy and matrix stiffness in stem cell lineage specifica-
tion. To accomplish this goal, microcontact printing was employed to
create isotropic and anisotropic hydrogels of varying stiffness
moduli. Human mesenchymal stem cells (hMSCs) were confined to
the hydrogels at a single cell level and were given the choice to
differentiate along adipogenic and osteogenic routes. Our results
demonstrated that on soft matrices, anisotropy exerted a negligible
effect and the cells primarily differentiated to adipocytes. On the
contrary, cell shape anisotropy enhanced the effect of increased
stiffness guiding stem cells to differentiate along osteogenic lineage.
The insight gained from this project provide a rational basis for
designing stem cell culture systems that will facilitate their use in
research and clinical settings.
316
Transplantation of Human Urine-Derived Stem Cells
Transfected with Pigment Epithelium-Derived Factor to Protect
Erectile Function in a Rat Model of Cavernous Nerve Injury
T. Long1, Q. Yang2, X. Chen2, T. Zheng2, D. Han2, H. Zhang2,
Y. Shi3, J. Bian4, X. Sun2, K. Xia2, X. Liang3, G. Liu3, Y. Zhang1,
C. Deng2;
1Wake Forest Institute for RegenerativeMedicine,Winston Salem, NC,
2Department of Urology, the First Affiliated Hospital of Sun Yat-sen
University, Guangzhou, CHINA, 3Reproductive Medicine Research
Center, the Sixth Affiliated Hospital of Sun Yat-sen University,
Guangzhou, CHINA, 4Department of Urology, the Third Affiliated
Hospital of Southern Medical University, Guangzhou, CHINA.
Introduction: The aim of this study was to investigate whether
intracavernous injection of urine-derived stem cells (USCs) or USCs
genetically modified with pigment epithelium-derived factor (PEDF)
could protect the erectile function and cavernous structure in a bilateral
cavernous nerve injury-induced erectile dysfunction (CNIED) ratmodel.
Methods: USCs were cultured from the urine of six healthy male
donors. Seventy-five rats were randomly divided into five groups
(n = 15 per group): sham, bilateral cavernous nerve (CN) crush injury
(BCNI), USC, USCGFP+, and USCGFP/PEDF+ groups. The sham
group received only laparotomy without CN crush injury and in-
tracavernous injection with PBS. All of the other groups were sub-
jected to BCNI and intracavernous injection with PBS, USCs,
USCsGFP+, or USCsGFP/PEDF+, respectively.
Results: The USC and USCGFP/PEDF+ groups displayed more
significantly enhanced ICP and ICP/MAP ratio (p< 0.05) 28 days after
cell transplantation. Immunohistochemistry and Western blot analysis
demonstrated that the protection of erectile function and the cavernous
structure by USCsGFP/PEDF+ was associated with an increased
number of nNOS-positive fibers within the penile dorsal nerves, im-
proved expression of endothelial markers (CD31 and eNOS) and a
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smooth muscle marker (smoothelin), an enhanced smooth muscle to
collagen ratio, decreased expression of transforming growth factor-1
and decreased cell apoptosis in the cavernous tissue.
Conclusion: The paracrine effect of USCs and USCsGFP/
PEDF+ prevented the destruction of erectile function and the
cavernous structure in the CNIED rat model by nerve protection,
thereby improving endothelial cell function, increasing the smooth
muscle content, and decreasing fibrosis and cell apoptosis in the
cavernous tissue.
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Urine-Derived Stem Cells: A Potential Bio-marker for Renal
Insufficiency
L. dou, G. xiong, D. Zhang, W. Tang, H. Yi, G. Li, M. Bleyer,
A. Bleyer, A. Atala, Y. Takahashi, J. Ma, Y. Zhang;
WakeForest Baptist HealthRegenerativeMedicine,Winston Salem,NC.
Introduction: Kidney tissue biopsy is most commonly used to
diagnose renal insufficiency after renal transplantation and other
kidney diseases. However, this invasive approach causes severe
complications such as arteriovenous fistula and hematuria. The need
for accurate and noninvasive biomarkers for early prediction of acute
kidney injury and chronic kidney disease is clear. Our goal is to
investigate whether patient-sourced urine-derived stem cells (USCs)
as a potential biomarker to address this need.
Methods: We collected 72 urine samples from 24 male patients
(average age 60-75y) with renal insufficiency and 30 urine samples
from 10 heathy men (60-75y) as controls. We used these samples to
quantify the numbers of cells shed off into urine, numbers of cell
clone s, and cell phenotypes.
Results: USCs (70%) from patient had weaker regenerative
capacity in cell proliferation, less secretion of paracrine factors and
telomerase activity, and lower renal tube epithelial differentiation
potential compared to healthy controls. Patient samples also had
high levels of inflammation factors and oxidative stress. Protein
levels of LC3, ATG3, 5 and 7 for autophagy markers and pmTOR/
mTOR, pRaptor/Raptor, p-ULK-1 for mTOR signaling molecules
were lower in patients’ USCs. In addition, miRNA-next-generation
sequencing showed that the top 10 up-regulated (including miR-
146a) and down-regulated miRNAs (including miR-193b) among
changed miRNAs with higher than 1000 reads in the patients’
USCs.
Conclusions: Regenerative performance of USCs in paracrine
effect and repair capacity declines with age. Specific miRNA chan-
ges identified in this study might lead to novel tools for diagnosis and
prognosis of renal insufficiency.
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Assessing the Osteogenic Potential of Adipose-derived Stromal
Vascular Fraction Cells
E. L. Nyberg, A. Farris, W. Grayson, 21231;
Biomedical Engineering, Johns Hopkins University, Baltimore, MD.
Critical-sized craniofacial bone defects are challenging to treat
due to their geometric complexity. Scaffold-based technologies that
deliver osteogenic stem cells have shown remarkable regeneration
but are hampered by the need for extensive in vitro manipulation prior
to implantation. To address this, we explore the bone forming potential
of the stromal vascular fraction (SVF) obtained from lipoaspirate. SVF
contains a sub-population of adipose-derived stem cells (ASCs), which
can be effectively induced to deposit mineralized tissues. In this study,
we determined whether the heterogeneity of SVF inhibited or enhanced
bone formation in 3D-printed scaffolds relative to passaged ASCs from
the same donor. SVF and ASCs were suspended in a fibrin hydrogel at
20,000 cells/mL and cast in a porous 3D-printed osteoinductive scaffold
a 30:70 mixture of decellularize bone matrix:polycaprolactone. Cell
seeded scaffolds were cultured for three weeks in control media (low
glucose DMEM +10% serum) or osteoinduction media (control media
+ osteoinductive supplements), harvested and analyzed biochemically
for calcium and DNA content. We observed that both populations
successfully mineralized the scaffold demonstrating robust bone for-
mation properties of SVF. However, SVF deposited significantly less
calcium than ASCs in both control media (443.5– 6.9mg vs. ASC:
525.2–12.1mg, p<0.05) and osteoinductionmedia (489.6–13.9mg vs.
ASC: 603.3– 8.0mg, p< 0.005). Ongoing studies will assess whether
this reduction in mineralization is due to the smaller fraction of os-
teoprogenitors in SVF or the inhibition of osteogenesis by other sub-
populations in SVF as well as examining the bone forming potency in
critical sized cranial defect models.
Tissue Chips & Tissue Organoid Models
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Primary Patient Tumor Organoids for Personalized Drug
Treatment
A. Mazzocchi1, K. Votanopoulos2, S. Soker1,2, A. Skardal1,2;
1Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC, 2Comprehensive Cancer Center at Wake Forest Baptist Medical
Center, Winston-Salem, NC.
Recently, there has been an increased focus on personalized drug
treatments for cancer as the influence of genetic mutations on che-
motherapy efficacy has become better understood. However, success
rates in the clinic are still low. Precision medicine could benefit from
personalized models in which therapies identified through genetic
screening can be tested prior to administration to the patient.We have
hypothesized that 3D organoid biofabrication technologies allow for
patient tumor cells to remain viable for personalized drug screening,
which can compliment precision medicine genetic screening. To test
this, we have biofabricated primary patient tumor organoids using
extracellular matrix hydrogels for maintenance of tumor biopsy-
derived cell population viability in vitro to carry out chemotherapy
drug screens. We have been able to carry out this work with six
successful patient samples, including high grade appendiceal, low
grade appendiceal, and peritoneal mesothelioma tumors, yielding
quantitative treatment results. This has included the survival and
drug testing of cancer cell types previously undocumented in relation
to successful cell culture. The development of this application has
allowed for drug screens with multiple treatments yielding statisti-
cally significant conclusions to which chemotherapies are most ef-
fective. These results have been gathered using quantification of live/
dead cell staining and MTS proliferation assays. Maintenance of
cancer type phenotypes were additionally confirmed using IHC an-
tibody staining. With further development we hope to be able to use
patient specific organoids for prediction of the most effective treat-
ments for individual patients in the clinic.
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Three-dimensional (3D) Quadruple Cultured Brain on Chip
for Organophosphate Toxicity Screening
Y. Yun1, Y. Koo1, B. T. Hawkins2;
1Bioengineering, NC A&T State University, Greensboro, NC,
2Engineering and Applied Physics Division, RTI international,
Durham, NC.
Organophosphate-based compounds (OPs) represent a significant
threat to warfighters and civilian populations. There is a pressing need to
develop in vitro testbed to rapidly screen large numbers of organophos-
phate compounds (over fifty thousand potential combinations existed).
Herewe report on high content brain-on-a-chip, a three dimensional, two-
compartment, organotypic microphysiological system which can mimic
in vivo environment of neurovascular (blood compartment with endo-
thelial cell) and nerve system (brain compartment with neuroblastoma,
astrocyte, and microglia) with high throughput capability and further
screen neurotoxicity of a set of organophosphate compounds. We dem-
onstrate its utility and reproducibility in measuring OP effects on endo-
thelial barrier integrity, brain AChE activity and cell viability. We found
that theOPs cross the blood brain barrier (BBB) and rapidly inhibit AChE
activity, which results were correlated with in vivo data.
322
Tissue-Engineered Human Skeletal Muscle Model
of Rheumatoid Arthritis
C. E. Oliver, B. N. Davis, J. Hong, K. M. Huffman, G. A. Truskey;
Biomedical Engineering, Duke University, Durham, NC.
Rheumatoid arthritis (RA) is a chronic inflammatory disease that
primarily targets the joints, but also affects other tissues including skel-
etal muscle. Disability rates from RA reach 40% from 5-10 years after
diagnosis. Skeletal muscle contributes to RA disability, but the under-
lyingmechanisms are not well understood. Since animalmodels and cell
culture systems are imperfect replicates of human disease and do not
recapitulate biologic and physiologic features of human skeletal muscle,
we use engineered, electrically-responsive, contractile human skeletal
muscle constructs (myobundles) to model RA in vitro and identify fea-
tures of the disease phenotype. To establish the in vitro systemas amodel
to test therapies for RA in skeletal muscle, we are testing the hypothesis
that (1) myobundles derived from cells of RA patients show reduced
capacity for repair and differentiation and reduced force production and
(2) the decrement in differentiation and function is due to select myokine
and cytokine production.Weexpect that pro-inflammatory cytokines and
myostatin will be elevated in RA. Myostatin is particularly important
since it not only is a negative regulator ofmuscle differentiation, butmay
promote tissue fibrosis during chronic inflammation. To study the role of
myostatin, we are using the small molecule LDN-193189, which, at a
dose of 0.05mM,blocksmyostatin and subsequent downstream signaling
events and promotes myogenesis in 2D and 3D culture.
323
In Vitro Three-dimensional Vascularized Tissue Platform
Y. Jung, T. Kim, S. Kim;
Korea Institute of Science and Technology, Seoul, KOREA,
REPUBLIC OF.
The vascular network structures are general and essential circu-
latory system that functions to transport blood or lymph throughout
the body. These structurers have a major role in the regulation of
metabolic activity, development, healing, immune response and the
progression of many diseases. Therefore, the mimicking of the vas-
cular network structures has potential uses in applications of various
parts such as tissue regeneration and drug screening. In this talk,
in vitro 3D vascularized tissue platform will be introduced, which
based on compressed collagen tube and lung tissue derived decel-
lularized extracellular matrix made of human hMSCs, human lung
fibroblasts and HUVECs in microfluidic chambers. To establish the
3D vascularized tissue system, at first, we fulfilled formation and
characterization of the compressed collagen tube and ldECM hy-
drogel, respectively. In the 3D vascularized bed system which was
combined the compressed collagen tube and ldECM hydrogel, we
could find that microvascular network was formed in ldECM hy-
drogel and anastomosis from the compressed collagen tube to mi-
crovascular network in the ldECM hydrogel. Therefore, this unique
experimental platform can be used to investigate angiogenesis and
anastomosis and applied to drug screening.
324
Tissue-engineered Skeletal Muscle Actuator Having Long-term
Drivability
H. Terazawa, S. Takagi, T. Nakamura, H. Tsutsui, T. Fujisato;
Biomedical Engineering, Osaka Institute of Technology, Osaka,
JAPAN.
The living muscles have excellent characteristics of lightweight,
high flexibility, and remarkable efficiency for driving energy. We
have made a three-dimensionally cultured tissue-engineered skeletal
muscle actuator having native-like contractive property driven by
electric stimulation. In this work, effective electric stimulation for
long-term drive of the actuator has been studied. Two artificial ten-
dons made up of acellular porcine blood vessel were incorporated at
the both ends of the actuator to handle firmly. After insertion of two
artificial tendons into pins on the culture substrate, C2C12 cells
embedded within collagen gel solution were placed between two
tendons. The construct was then cultured in differentiation media to
enhance differentiation of the C2C12 cells to myotubes. Three weeks
after incubation, continuous electric stimulation was applied for
1 hour to the tissue-engineered muscle actuator to induce twitch or
tetanus. The isometric twitch force of the tissue-engineered muscle
actuator was not affected by continuous twitch induced by single
electric stimulation. However, it gradually decreased by continuous
tetanus induced by electric stimulation of more than 15Hz frequency.
The isometric twitch force recovered soon after the end of continuous
tetanus when the frequency of electric stimulation was low, however
not recovered enough when the frequency was high. These results
suggest that the frequency of electric stimulation to the tissue-
engineered muscle actuator is important for its long-term drive.
325
3-deimensional Choroidal Neovascularization Model Using
Endothelial Cell invasion
H. Kim, M. Huh, K. Lee, B. Park, S. Yi, J. Kim;
Kyungpook National University School of Medicine, Daegu,
KOREA, REPUBLIC OF.
Purpose: Accumulation of A2E and Exposure of blue light are a
factor of marcular degeneration. These are related with angiogenesis
between retinal pigment epithelial (RPE) cells, endothelial cells and
choroid. We developed 3D retinal-vascular mimetic system reflect-
ing angiogenesis induced by A2E-blue light damage.
Methods: Human RPE cells and peripheral micro-vascular en-
dothelial (PMVE) cells were co-cultured in a microfluidic channel.
hRPEs were pretreated with 10 mM A2E, and then the cells were
exposed with/without blue light (the channel of RPE cells were ex-
posed to 400– 10 nm for 30 seconds). We examined the chemical and
optical stimulus on 3D retinal-vascular mimetics system, and then
evaluated cell invasion, Vascular endothelial growth factor (VEGF)
secretion and activation of the signal mediators.
Results: In the 3D retinal-vascular mimetic system between RPE
and PMVE cells, PMVE cell were invaded into RPE cells in hypoxia
(21.0 – 3.93 cell/unit area), A2E (22.3– 4.26 cell/unit area), and A2E
with blue light (36.3– 5.02 cell/unit area) conditions for 24hrs. The
secretion of VEGF by RPE increased A2E with/without blue light
and hypoxia conditions by ELISA assay.
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Conclusions: In this study, data indicated A2E-blue light induced
the secretion of VEGF and the invasion of PMVE cells in 3D co-
culture model. We established new 3D retinal-vascular mimetic
model, an angiogenesis model related with CNV, would be able to
detect invasion of endothelial cells under a disease condition. This
model would be to employ for a candidate selection before a pre-
clinical trial.
326
Drug and Environmental Toxin Screening in Bioengineered
Liver and Cardiac Tissue Analogs
S. Forsythe, M. Devarasetty, T. Shupe, C. Bishop, S. Soker,
A. Atala, A. Skardal;
Wake Forest University, Winston Salem, NC.
Modern drug testing often progresses from 2D cell culture to
animal models without an intermediate 3D in vitro human-derived
testing platform. This can often lead to proposed pharmaceuticals
progressing either too fast through animal model testing, only to
notice serious toxic side effects human trials or worse, the general
population. Countless drugs have reached the public only to be re-
called later after causing toxicity and death in humans, resulting in
massive associated costs. To address this shortcoming, we employed
bioengineered 3D cardiac and liver organoids to screen a panel of
FDA recalled drugs that caused adverse effects to these respective
organs, and charted the response of the organoids to these com-
pounds. These drugs, from multiple drug companies and designed to
treat a wide range of ailments, all reached the general public andwere
found to cause serious adverse effects in the general population.
Tests were performed that ATP activity, LIVE/DEAD viability and
cytoxicity staining, and cardiac organoid beating activity. Results
showed that the 3D organoids had responses that matched the listed
reasons that each drug was recalled. Additionally, in further analysis,
known environmental toxins were also obtained and tested in these
organoids, further demonstrating the capability of these organoids to
be deployed in toxicity testing. Taken together, these results show the
potential application of human-based 3D organoids to be applied in a
variety of toxicity screening applications, such as drug development
and environmental toxin detection.
Unlocking the Potential of Gelatin and Collagen
in Regenerative Medicine
327
Effect of ECM protein coating and multi-layering on Smooth
Muscle Cell Differentiation from Adipose Stem Cells
K. S. Tobik, J. Nagatomi;
Bioeningeering, Clemson University, Clemson, SC.
For bladder tissue engineering, human adipose-derived stem cells
(hADSCs) are an attractive cell source that can be differentiated into
smooth muscle cells (SMCs). The objective of this study was to
investigate the effect of ECM proteins on differentiation of hADSCs
into SMCs in a 3D multilayer. hADSCs were coated with fibronectin
and gelatin (FN-G) in a layer-by-layer fashion and seeded onto cell
culture inserts with FN-G coated membranes under growth media.
After two days, the media were changed to smooth muscle inductive
media medium (SMIM: DMEM, 2.5 ng/mL TGF-b1, 5 ng/mL
PDGF-BB) and the cells were cultured for 10 days under standard
culture conditions (37C, humidified, 95% air, 5% CO2). Changes in
cell morphology and SMC phenotypic marker expression were
examined via histology and immunofluorescence. SMCs pre-
differentiated in a flask then cultured on a membrane formed a
monolayer. However, membrane differentiated SMCs resulted in a
multilayer construct. As hADSCs differentiate into SMCs, they be-
came less elongated and more fusiform in shape, attributing to the
larger cell layers. Both groups displayed SMC phenotypic markers,
suggesting differentiation from hADSCs into SMCs. The results of
this study concluded that differentiation of SMCs from hADSCs on
the membrane resulted in a multilayer construct that expressed SMC
phenotypic markers that can further be developed to form a bladder
tissue biomimetic patch.
Acknowledgments: NIH P20GM103444
Poster Session 2
Monday, December 4, 2017, 6:30 PM - 8:30 PM
Biofabrication and Bioreactors
328
A Controlled Atmosphere Reduces Biofabrication
Contamination Risk
A. Henn, A. Chapman, S. Darou, R. Yerden;
BioSpherix, Parish, NY.
Microbial contamination can bring biofabrication production
processes to a halt, costing valuable time and samples. The largest
source of bioburden in a biomanufacturing environment is personnel,
even when they are dressed in cleanroom garb. The next largest
sources are air and surface contamination. Using bioprinters in BSC
can reduce contamination risks during the bioprinting step, however
there is still risky room air present in a BSC, and the rest of the
production process is prone to contamination as well. The Xvivo
barrier isolator can separate the entire process from the risks of
personnel and room air with a soft, flexible glovefront. Filtered,
tanked, medical grade gases provide a completely controlled and
aseptic environment. We decided to study the reduction in risk for
bioprinted constructs associated with the separation of the room air
from the bioprinting environment. With the null hypothesis that the
environment would make no difference, we printed test samples ei-
ther inside or outside of the Xvivo System using the INKREDIBLE
3D Bioprinter by CELLINK. We also performed environmental
monitoring of the chamber and bioprinter using touchplates and an
air sampler. We incubated the constructs in a highly permissive
color-changing TSB broth. We found that enclosure with the Xvivo
System effectively prevented contamination of the constructs and the
equipment. Rejecting our hypothesis, we concluded that separation
of the process from room air reduces contamination risks for both
biomanufacturing equipment and the cell and tissue products.
329
Crosslinkable Amine Coating of Poly(L-Lactic Acid) for Bone
Tissue Engineering Scaffolds
N. R. Richbourg1, V. Sikavitsas2;
1School of Chemical. Biological, and Materials Engineering,
University of Oklahoma, Norman, OK, 2Stephenson School of
Biomedical Engineering, University of Oklahoma, Norman, OK.
Introduction:Materials for tissue engineering have seen increasing
attention since the properties of the scaffolding structure affect cell
adhesion and proliferation, host immunogenic response, and stem cell
differentiation. Poly (L-lactic acid) (PLLA) is especially popular in
bone tissue engineering for its mechanical strength and biodegrad-
ability, but its chemical structure limits its usefulness in establishing
cell extracellular matrix (ECM) and addressing other biochemical
needs. Efforts to activate PLLA scaffolds by incorporating amine
groups through various processes have indicated positive effects
on cell adhesion and proliferation at the cost of sub-surface material
integrity or nonhomogeneous modification of scaffolds. Other tech-
niques have depended on non-FDA-approved chemicals for tissue
engineering applications or costly equipment. In this study, we propose
a simple wet chemistry modification approach that only uses approved
materials for PLLA amine-coating and seek to demonstrate its ho-
mogeneity, surface-specificity, and potential for specialized subse-
quent crosslinking modification to bioactive molecules with known
effects on surface-adherent cells.
Conclusions: This study produced a simple wet chemistry tech-
nique for biologically activating PLLA scaffolds that acts
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homogenously on 2D films by introducing primary amine groups
which can be crosslinked for further directed modification. Further
experiments will demonstrate the surface specificity of the modifi-
cation, potential for 3D scaffold applications, negligible effects on
topography, and direct effect on adherent stem cells.
References:Alvarez-Barreto, J.F., Shreve, M.C., Deangelis, P.L.,
and Sikavitsas, V.I. Tissue Engineering 13, 6, 2007.
330
Engineering Personalized Constructs for Intervertebral
Disc Regeneration
J. B. Costa, J. Silva-Correia, V. P. Ribeiro, A. da Silva Morais,
J. M. Oliveira, R. L. Reis;
3B’s Research Group, University of Minho, Guimara˜es,
PORTUGAL.
Lower Back Pain associated to intervertebral disc (IVD) degen-
eration is estimated to affect up to 80% of the population at some time
in their lives, presenting a huge socio-economic impact in industri-
alized countries, since it is one of the main causes of medical visits,
work absenteeism and hospitalization (1). One possible strategy
addresses total IVD substitution/regeneration which should comprise
personalized approaches by means of using reverse engineering, i.e.
combining imaging techniques (e.g. MRI and micro-CT) and 3D-
bioprinting technology. The implantation of custom-made implants
closely mimicking native IVD and possessing an appropriate size,
shape, mechanical performance, and biodegradability can improve
recovery time after surgery and help to restore spine biofunctionality.
Hydrogels have become especially attractive as matrices for devel-
oping a wide variety of tissue engineered tissues and organs (2).
Nevertheless, one of the main disadvantages of processing hydrogels
is the difficulty to shape them in predesigned geometries even when
Rapid Prototyping technologies are used. The difficulties are mostly
related with the difficulty in controlling the gelation event. In this
work, a two-stage strategy is proposed. In the first stage, human IVD
datasets (MRI or CT) are adequately analyzed for developing ac-
curate 3D models that mimic the native IVD sub-compartments. In
the second stage, 3D anatomical scaffolds are printed and charac-
terized thoroughly in vitro, in terms of physico-chemical, mechanical
and biological performances.
References:
1. Silva-Correia J, et al. Biotechnol Adv, 31, 1514, 2013.
2. Pereira DR, et al. J Tissue Eng Regen Med, 7, 85, 2013.
331
Computational Model of Perfusion for 3D Printed Bone
Tissue Engineering Scaffold In Vitro Culturing
H. Lara-Padilla1,2,3, M. B. Wade1, C. Rodriguez1,2,
D. Konstantinou1, D. Dean1;
1The Ohio State University, Columbus, OH, 2Tecnolo´gico de
Monterrey, Monterrey, MEXICO, 3Universidad de las Fuerzas
Armadas ESPE, Sangolquı´, ECUADOR.
Our work with bone marrow-derived human Mesenchymal Stem
Cells (hMSCs)-seeded, 3D printed porous poly(propylene fumarate)
(PPF) resorbable scaffolds has led us to ask: As these scaffolds grow
in size, will there be a limit beyond which static culture will prove
insufficient? The goal of this study is to insure that our in vitro, pre-
implantation, scaffold culturing always results in a scaffold that is
fully coated with bone ECM (extracellular matrix). We expect that
that the size limit will be determined by scaffold permeability,
nutrient infusion and turnover levels, waste product removal, and
cytokine delivery. To model and test our model we have chosen
hMSC-seeded, cylindrical porous PPF scaffolds with a Schoen’s gy-
roid pore geometry. Our models of these cylindrical scaffolds compute
time-dependent velocity and pressure profiles using COMSOL (Los
Angeles, CA). The model assumes homogeneous distribution of cells
on the scaffold surface. Results indicate that we now have an ade-
quate description of the interaction between porous scaffolds and the
flow of cell culture media. We have found that perfusion rates are
highly dependent on pore distribution within the scaffold. Our next
experiments will answer the simple question: With fixed pore ge-
ometry, and cylindrical scaffolds and bioreactors where the diameter
does not change, at what length is flow required to allow full hMSC
coating of the scaffold to mature and produce the desired bone ex-
tracellular matrix prior to implantation.
332
3D Bioprinting of Biomimetic Skeletal Muscle Tissue Constructs
J. Kim, Y. Seol, I. Ko, J. Yoo, A. Atala, S. Lee;
Wake Forest Institute for Regenerative Medicine,
Winston Salem, NC.
Bioengineered skeletal muscle tissue can be a promising solution
to achieve functional recovery of volumetric muscle injuries. How-
ever, the conventional methods have been limited to fabricate a
volumetric muscle tissue with the functional cellular organization
and accelerated vascularization and nerve integration. In this study,
we utilized 3D bioprinting strategy to create volumetric skeletal
muscle constructs that mimic the native skeletal muscle organization
and function. To facilitate long-term tissue survival and accelerate
innervation in vivo, human neural stem cells (hNSCs) were combined
with human muscle progenitor cells (hMPCs) in the 3D bioprinted
muscle constructs. The introduction of hNSCs enhanced the cell
viability and tissue maturation, which includes highly aligned
myotube formation in vitro. The implanted bioprinted muscle con-
structs developed highly oriented myofibers with the integration of
host vasculature and nerve, and muscle mass and function were
improved in a rat tibialis anterior (TA) excisional model. Our results
demonstrate that creation of biomimetic engineered muscle tissue
constructs using the 3D bioprinting system is feasible and that this
muscle construct can contribute to the restoration of muscle function.
333
Optimizing The Tissue Engineering Of Tubular Organ
Structures By Bioprinting
A. Shafiee;
Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC.
Normal 0 false false false EN-US JA X-NONE /* Style Defini-
tions */ table.MsoNormalTable {mso-style-name:’’Table Normal’’;
mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-
style-noshow:yes; mso-style-priority:99; mso-style-parent:’’‘‘;
mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-
para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-
size:12.0pt; font-family:Cambria; mso-ascii-font-family:Cambria;
mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Cambria;
mso-hansi-theme-font:minor-latin;} Optimizing the conditions for
cells to self-assemble into functional structures in vitro may help to
engineer tissues and organoid. To facilitate self-assembly one can
employ the technology of bioprinting; a robust and accurate way to
arrange cells and supporting biological materials. Bioprinting is
distinct from 3D printing in that post-printing maturation comprises a
critical part of the tissue or organoid formation. After printing, it
takes time for the structure to mature via self-organization processes,
in particular tissue fusion, and become fully functional. Quantitative
information about the maturation process is critical to assure that the
final product has the appropriate properties for use. In particular, the
possibility to accelerate this process may allow for earlier implan-
tation. Tubular organ structures form a large portion of the human
body and play vital role in it. Here we report on the optimization of
the tissue engineering process of fabricating tubular bio-printed bi-
ological structures, which, among others, allows for predictive
quantification of the maturation process. We prepared convenient
bioink particles, spherical and cylindrical aggregates and assessed
their biomechanical properties such as apparent tissue surface ten-
sion (ATST) and characteristic fusion time. The fastest fusion of
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bioink particles and, consequently construct maturation, was
achieved using cylindrical bioink. This finding has important im-
plications for the time needed to fabricate vascular conduits for re-
generative purposes.
334
Digitizing a Sea Sponge to Print a Living Filter
J. E. Snyder1, T. J. Kalkus1, L. J. Rothschild2;
1NASA Academic Mission Service, Universities Space Research
Association, Moffett Field, CA, 2Space Science and Astrobiology
Division, NASA Ames Research Center, Moffett Field, CA.
For safe human travel to deep space, NASA’s Technology
Roadmap calls for ‘‘innovative physical manufacturing processes
which combine the ‘digital thread’ that integrates modern design and
manufacturing.’’ Our objective is to 3D print a living filter by rep-
licating the anatomical architecture of a sea sponge (Cinachyra spp.)
using a combination of noninvasive medical imaging and biofabri-
cation. The methodology defines four tasks: (1) Characterize the
essential attributes that make the sea sponge of interest to NASA,
those being filtration and self-regeneration. Filtration absorbs or-
ganic waste, and self-regeneration replenishes ‘‘stock material’’ in
resource-scarce outer space. (2) Digitization via microCT scanning
and analysis of a sponge specimen reveals the sponge’s anatomy is a
heterogeneous composite of open pore space, low- and high-density
cell-laden matrix. (3) Fabricate a living sponge replicate by 3D
printing a sponge cell suspension loaded into a multi-material bio-
printer. (4) Compare the 3D printed sponge to that of the original,
natural sponge. Our results demonstrate our objective is feasible.
Surface-area-to-volume topologies and minimum feature size de-
rived from microCT data facilitated pervasive nutrient diffusion,
thereby maintaining cell viability. Post-printing, cells proliferate and
begin to function as designed, absorbing organic debris from effluent.
Inclusion of the symbiotic bacteria living on the sponge’s surface will
be critical to increasing the printed sponge’s metabolism. The find-
ing’s major significance is the demonstration of a successful, first
iteration proof-of-concept living filter. Future work to genetically
engineer the sponge cells, as well as it’s bacteria, may enhance the
filter’s selectivity for toxins.
335
Cell-laden Bioprinting Hydrogel Depending on Diffent
Compositons For Soft Tissue Engineering
S. Park, J. Lee, W. Kim;
Korea Institute of Machinery & Materials, Daejeon, KOREA,
REPUBLIC OF.
Bioprinting techniques, which can construct three dimensional
structures with biocompatible materials and cells, have gained great
attractions for various biomedical applications, such as tissue engi-
neering and drug screening studies. For a successful bioprinting,
bioinks are critical to ensure the processibility of printing and the
viability of the encapsulated cells. Alginate is the most popular
bioink for such purposes owing to its biocompatibility and me-
chanical properties. However, the influence of its composition on
bioprinting with cells has not been well explored. In this study, we
prepared the different compositions of alginate bio-inks by varying
concentrations of high molecular weight alginate and low molecular
weight alginate (by varying the ratios of high and low molecular
weight alginate and their total concentrations). We found that bioinks
containing 3wt% alginate permitted good shapes and controls of
bioprinting. Our bioprinting with fibroblasts and in vitro culture
studies revealed that the printed scaffolds supported cell viability and
growth up to 7 days. Interestingly, the bioinks prepared with high and
low Mw alginate at 2:1 ratio resulted in the better cell growth com-
pared to those with other compositions. Our study will benefit the
design and applications of alginate-based bioinks for bioprinting
platforms in tissue engineering.
336
Formulation of Photoinitiator Free Gelatin Based Bioink
and its Application to Tissue Printing
J. Lim1, S. An2, T. Lee2, J. Huh1;
1Kyungpook National University, Daegu, KOREA, REPUBLIC OF,
2Daegu-Gyeongbuk Medical Innovation Foundation, Daegu,
KOREA, REPUBLIC OF.
Current major challenge in 3D printing of biological tissues is
lacking of proper printable biomaterials, so called bioinks. Devel-
opment of 3D printable bioinks for safely and efficiently printing
tissue substitute is on high demand. Most of hydrogel based bioinks
include photoinitiator to be crosslinked by either UV or visible light
to obtain mechanically stable gel. However, use of crosslinking
chemical has concerns for its potential harm to biological substances.
Our study aimed to formulate and optimize a gelatin-protein complex
bioink without any crosslinking chemical still having proper rheo-
logical, chemical and biological properties. We investigated its ap-
plicability and efficiency to print soft tissue especially skin. This new
hydrogel is designed to enhance angiogenesis and effective wound
healing. The formulation was investigated in vitro and in vivo for its
printability, stability, cell viability, migration, invasion and angio-
genic property. The study results indicated a potential of this bioink
as a 3D printing material since they are easy to print, gelling, not
toxic, stable, and cost effective.
337
An Ex Vivo Bone Bio Reactor System
R. Dua1, H. Jones2, P. C. Noble2;
1Chemistry Department, Hampden Sydney Collge, Hampden
Sydney, VA, 2Institute of Orthopedic Research & Education,
Houston, TX.
Recent approaches in materials and manufacturing processes have
allowed the development of intricate implant surfaces to facilitate
bony attachment. However, refinement and evaluation of these new
design procedures is hindered by the cost and complications of ani-
mal studies, particularly during early iterations in development
process. To address this issue, we have designed and validated an ex-
vivo bone bioreactor culture system to facilitate empirical testing of
candidate structures and materials. In this study, we investigated
mineralization of a titanium wire mesh scaffold under both static and
dynamic culturing using our ex vivo bioreactor system. Cancellous
cylindrical bone cores were harvested from bovine metatarsals and
divided into five groups under different conditions. After incubation
for 4 & 7 weeks, the viability of each bone sample was evaluated
using Live-Dead assay and microscopic anatomy of cells were de-
termined using histology stain H&E.Matrix deposits on the scaffolds
were examined with scanning electron microscopy (SEM) while its
chemical composition was measured using energy-dispersive x-ray
spectroscopy (EDX). The viability of bone cores was maintained
after seven weeks using our protocol and ex vivo system. From SEM
images, we found more organic matrix deposition along with crys-
tallite like structures on the metal samples pulled from the bioreactor
indicating the initial stages of mineralization. EDX results further
confirmed the presence of carbon and calcium phosphates in the
matrix. In conclusion, we can say that the bone bioreactor can be used
as an alternate tool to in-vivo for bone ingrowth studies on new
implant surfaces or coatings.
338
In Silico Approach For Bioprinting
M. B. Kersanach, J. Dernowsek, R. A. Rezende, J. V. Silva;
Division of 3D Technologies, Renato Archer Information
Technology Center, Campinas, BRAZIL.
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A very complex design (blueprint) will be fundamental to reach a
3D bioprinted organ in the future. Since many biological and me-
chanical aspects are involved the project of an organ encompasses an
over wide range of variables. In vitro and in vivo experiments require
the investment of large sums of money and time, besides being
specific and complex. A viable alternative is to create the blueprint by
means of in silico (computational) simulations, which is not only
faster, but allows a broader flexibility in the choice and tailoring of
parameters to be studied. This paper proposes using predictive
probabilistic methods and energy calculations - applied to two
frameworks: mechanical and biological. The mechanical would use
finite element analysis to observe mechanical behavior such as hy-
drostatic pressure, elasticity, and fluid flow. While the biological
would use complex systems of cellular interaction to analyze be-
haviors such as cell division, diffusion and chemotaxis of the basic
units that make up the organ. A possible application, which is pre-
sented here, is a simulation of the process of osteogenesis - the for-
mation of bones. Osteogenesis occurs with the differentiation of
mesenchymal cells into osteoblasts that produce the bone matrix
which can simulate for instance the expected exponential growth of
the number of cells of the spheroid due to mitotic behavior or the total
volume of the spheroid. The integration of mechanical and biological
bias software brings to the in silico approach a variety of parameters
that aid the decision to best apply biofabrication methods.
339
Microtissue Sliding Technique for Biofabrication
K. L. Manning1, J. R. Morgan2;
1Center for Biomedical Engineering, Brown University, Providence,
RI, 2Department of Molecular Pharmacology, Physiology and
Biotechnology, Brown University, Providence, RI.
One approach to overcoming a grand challenge of tissue engi-
neering, the fabrication of thick tissues with high cell densities, is
modular tissue engineering. Modular tissue engineering involves
building macrotissues using microtissue building parts in a layer-by-
layer approach. Part movement and placement is a critical compo-
nent of constructing macrotissues. As such we wanted to determine if
we could slide microtissues as a placement mechanism. Microtissues
were formed by seeding cells into nonadhesive micro-molds, where
cells self-assembled scaffold-free parts in the shape of toroids and
honeycombs. To determine if toroids and honeycombs could slide on
a non-adherent surface in liquid media, we constructed a sliding set-
up using a goniometer. Microtissues were placed at 15, 20 and 30
and the time recorded to travel 10mm. Both toroids and honeycombs
slid in the non-adherent liquid environment at all three angles tested,
with the velocity increasing as the angle increased. In addition,
honeycombs slid at a faster velocity than the toroids. We aim to
harness the ability of microtissues to slide as a technique to biofab-
ricate thick macrotissues of a high cell density.
340
Rapid Generation of Three-dimensional Large Tissues
using Standing Wave
M. Nakao, C. Imashiro, Y. Kurashina, K. Takemura;
Keio University, Yokohama, JAPAN.
Background and Objective: Scaffold-free tissues are essential
for advancing regenerative medicine and drug discovery. As one of
the promising methods for generating scaffold-free tissues, an
acoustic standing wave has been employed in previous studies.
However, they use special and complex devices to generate tissues,
which are generally in micrometer size [1]. We propose a novel
method to rapidly generate millimeter-sized tissues in a clinically
ubiquitous cell culture dish using an acoustic standing wave.
Method:We fabricated a cell trapping device in which a ø60 dish
was set above a Langevin transducer via degassed water in an acrylic
pool. Note that the distance between the dish and the transducer was
adjusted to generate a 110.7 kHz acoustic standing wave. By in-
jecting C2C12 myoblast into the dish, the cells were trapped at the
nodal position of the acoustic standing wave and were cultured for
3 hr to generate a tissue. The size and the cell proliferation of the
generated tissue was evaluated. For evaluating the cell proliferation,
the tissue was dispersed into single cells by trypsinization and cul-
tured for 7 days.
Results and Conclusion: The maximum diameter and thickness
of the generated tissue after 3-hr trapping were 6.5mm and 2mm,
respectively. Moreover, the cell proliferation for 7 days was com-
parable to that of cells with general culture in a dish. In short, the
proposed method rapidly generates a large scaffold-free tissue in a
clinically ubiquitous cell culture dish. [1] Evander M, Nilsson J. Lab
on a Chip. 12, 22, 2012.
341
3D Biofabrication with Advanced Solutions Life Science
L. Sanders;
Advanced Solutions Life Sciences, Louisville, KY.
The 3D biofabricating technology of the BioAssemblyBot,
which is the world’s first 6-axis robotic 3D bio-printer, precisely
creates cell systems and microenvironments at high resolutions en-
abling in vivo-like cell behavior in a prescribed manner. Further,
users can implement both additive and contour 3D printing ap-
proaches as well as take advantage of interchangeable end-effectors
or tools that allow for the incorporation of an array of different tasks
and materials in a single fabrication project. The design, visualiza-
tion, and analysis of precise and reproducible 3D computer models
are done through our software program, Tissue Structure Information
Modeling (TSIM). An example case of our entire fabrication
workflow from our Lab Innovations team is to generate liver tissue
mimics containing a pre-determined self-organization based upon
design parameters. In creating dense 3-dimensional tissue systems,
we leverage both TSIM and the BioAssemblyBot to generate
multiple columns within multi-well plate formats that serve as re-
gions of nutrient and gas exchange, thereby eliminating the concern
for hypoxia that is commonly seen in larger tissue aggregates. When
hepatocytes and other non-parenchymal cells are placed surrounding
these cavities, they self-organize per the overall pattern provided.
This system can then be used to conduct drug-screen assays that
provide results more meaningful than 2-dimensional assays. There-
fore, Advanced Solutions Life Sciences provides an enabling plat-
form in which tissue microenvironments can be designed while also
providing the permissive environment in which natural biological
processes can occur. Altogether resulting in more in-vivo like tissue
mimics.
Biomaterial Scaffolds
342
Dehydration Methods Affect Properties of Urinary Bladder
Matrix Derived Particulate
B. D. Young, L. Huleihel, N. T. Remlinger, A. Young, T. W. Gilbert;
ACell, Inc., Columbia, MD.
Extracellular matrix (ECM) biomaterials can be dehydrated and
milled to make a dispensable particulate for medical applications.
For example, ACell’s MicroMatrix is made of lyophilized, milled
Urinary Bladder Matrix (UBM) and is used clinically in various
wound management applications, particularly for wounds with tun-
neling/undermining or irregular contours. Altering the ECM dehy-
dration process is a non-chemical means of impacting the properties
and behavior of the resulting UBM particulates. In this study, UBM
sheets were dehydrated using different drying methods (lyophiliza-
tion and vacuum pressing) to produce distinct UBM particulate
for comparison. Assessment of the particulates included the determi-
nation of bulk particulate densities, particle size distributions, scanning
electron microscope imaging, and relative enzymatic (proteinase K)
degradation profiles. The particulate produced from vacuum pressed
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sheets were much denser and less fibrous, with marked morphological
differences, compared to the particulate produced from lyophilized
sheets, and the vacuum pressed sheets also showed a slower enzymatic
degradation rate in vitro. These results reveal that altering dehydration
and processing methods of ECM materials, prior to milling, can result
in particulates with distinct characteristics which could have clinical
benefits. Specifically, a more persistent and denser ECM particulate in
wound applications could reduce the frequency of necessary inter-
ventions such as dressing changes.
343
Functionalized Gold Nanorods Affect the in Vitro Neurogenic
Potential of Human Mesenchymal Stem Cells
S. D. Newby1, K. M. Alghazali2, Z. A. Nima2, R. N. Hamzah2,
F. Watanabe2, S. E. Bourdo2, T. J. Masi3, S. S. Stephenson3,
D. E. Anderson1, A. S. Biris2, M. S. Dhar1;
1Large Animal Science, College of Veterinary Medicine, University
of Tennessee, Knoxville, TN, 2Center for Integrative
Nanotechnology Sciences, University of Arkansas at Little Rock,
Little Rock, AR, 3Department of Surgery, University of Tennessee
Graduate School of Medicine, Knoxville, TN.
AbstractA novel layered structure was developed using amine
functionalized gold nanorods (AuNRs-SH-PEG-NH2). The designed
structure was used successfully to investigate the ability of AuNRs to
act as a bioactive scaffold. The adherence of cellular proteins was
enhanced by functionalizing gold nanorods via thiol linkage to an
amine-terminated polyethylene glycol from which the amino groups
are intended to interact with the cellular proteins. The gold nanorod
scaffold was characterized using transmission and scanning electron
microscopy, ultra violet-visible spectroscopy, Zeta-potential, and X-
ray photoelectron spectroscopy. Neurogenic potential of adipose
tissue - derived human mesenchymal stem cells (hMSCs) was
evaluated using the in vitro expression patterns of Vimentin, S100b,
and glial fibrillary acidic protein (GFAP). The expression pattern and
localization of Vimentin confirmed the mesenchymal origin of stem
cells and tracked morphological changes in hMSCs during differ-
entiation. Since, S100b and GFAP co-localize in astrocytes, their
expression patterns were used as indicators for neural differentiation
and results suggested that this process was enhanced when the cells
were seeded on the AuNRs in the absence of neural supplements in
the media. The study indicates that the scaffold design and the sur-
face properties of AuNRs could affect the neural differentiation of
hMSCs and hence, might prove beneficial for neural tissue engi-
neering scaffolds.
344
Investigation on the Effects of Acid and Alkali Treatment
on Decellularized Tilapia Fish Skin
L. Suryani;
School of Chemical and Biomedical Engineering, Nanyang
Technological University, Singapore, SINGAPORE.
In the pressing need of an effective wound dressing whose raw
material is easy to get, available in abundance, low-cost, safe from
transmissible diseases, environmental-friendly, and high cultural
acceptance, decellularized nile tilapia fish skin is one of the best
choice that fulfills the mentioned benefits. Not to mention the novelty
of the material itself when currently there is only one commercial
product in the market that produces decellularized fish skin. How-
ever, the currently available methodology of decellularization has a
limited biocompatibility with L929 fibroblast cells. Therefore, pre-
treatment using ascorbic acid and sodium hydroxide was added in the
hope to improve the biocompatibility of the scaffolds. However,
instead of improving the biocompatibility between the scaffold and
the L929 cells, these treatments result in an improved mechanical
property (softer scaffold) that plays an important role in a real clinical
study by preventing abrasion due to friction between an overly stiff
wound dressing with the wounds.
345
A Novel Nanocomposite Containing Graphene as a Platform for
Stem cell delivery and Bone Regeneration
M. Dhar1, H. Elkhenany1, S. Bourdo2, K. Alghazali2, A. Biris2,
D. Anderson1;
1University of Tennessee, Knoxville, TN, 2University of Arkansas,
Little Rock, AR.
The potential of graphene-based nanoparticles (GNPs) has recently
gained significant attention in biomedicine, especially in tissue engi-
neering. In this study, we investigated the osteoinductive and osteo-
conductive effects of a composite consisting of agarose and low oxygen
content graphene (LOG) nanoparticles on adult mesenchymal stem
cells (MSCs) in vitro and in vivo. We showed that adult goat MSCs
were viable in the presence of 0.1mg/mL LOG and retained their stem
cell properties. A 3D scaffold made from agarose was used to encap-
sulate MSCs and GNPs. Scanning electron microscopy demonstrated
the cell morphology and adherence of MSCs to GNPs in the 3D form.
The GNPs and MSCs in the 3D scaffold were xenogenically implanted
into a rat unicortical tibial bone defect. The combination of MSCs and
GNPs resulted in improved active bone formation and increased min-
eralization. These results strengthen the applicability of GNPs as an
adjunct treatment for bone tissue engineering.
346
Molecular Assessment of Collagen Denaturation in
Decellularized Tissues Using a Collagen Hybridizing Peptide
Y. Li1, J. Hwang1, B. San1, N. J. Turner2, L. J. White3, D. M. Faulk2,
M. S. Yu1, S. F. Badylak2;
1University of Utah, Salt Lake City, UT, 2University of Pittsburgh,
Pittsburgh, PA, 3University of Nottingham, Nottingham, UNITED
KINGDOM.
Decellularized extracellular matrix (ECM) derived from tissues
and organs are emerging as important scaffold materials for regen-
erative medicine. Many believe that preservation of the native ECM
structure during decellularization is highly desirable. However, be-
cause effective techniques to assess the structural damage in ECM
are lacking, the disruptive effects of a decellularization method and
the impact of the associated structural damage upon the scaffold’s
regenerative capacity are often debated. Using a novel collagen hybrid-
izing peptide (CHP) that specifically binds to unfolded collagen chains,
we investigated the molecular denaturation of collagen in the ECM de-
cellularized by four commonly used cell-removing detergents: sodium
dodecyl sulfate (SDS), 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS), sodium deoxycholate (SD), and Triton
X-100. Staining of the detergent-treated porcine ligament and urinary
bladder matrix with carboxyfluorescein-labeled CHP demonstrated that
SDS andTritonX-100 denature the triple helical collagenmoleculewhile
CHAPS and SD do not, although second harmonic generation imaging
and transmission electron microscopy (TEM) revealed that all four de-
tergents disrupt collagen fibrils. Our findings from the CHP staining were
further confirmed by the circular dichroism spectra of intact triple helical
collagen molecules in CHAPS and SD solutions, and the TEM images of
CHP-conjugated gold nanoparticles binding only to the SDS and Triton
X-100 treated collagen fibrils. CHP is a powerful new tool for direct and
reliable measurement of denatured collagen molecules in decellularized
tissues. It is expected to have wide applications in the development and
standardization of the tissue/organ decellularization technology.
347
Evaluation Of A Novel Nanocomposite For Osteogenesis
A. J. Bow1, S. D. Newby1, B. K. Barnes2, S. E. Bourdo2,
D. E. Anderson1, A. S. Biris2, M. S. Dhar1;
1Large Animal Science, College of Veterinary Medicine, University
of Tennessee, Knoxville, TN, 2Center for Integrative
Nanotechnology Sciences, University of Arkansas at Little Rock,
Little Rock, AR.
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The use of biomaterials for regenerative purposes has been a
widely pursued area of research. Among these pursuits is the de-
velopment of a biomaterial capable of stimulating growth and pro-
liferation of osteocytes for bone repair. Design of an effective
material for replacing and restoring function of damaged bone has
been an evasive and complex challenge, largely attributed to the
highly dynamic nature of the organ. Implementation of components
that mimic those found in natural bone allow for construction of a
biomimetic scaffold with a favorable environment for osteogenesis.
The investigated material embodies this concept and is a multi-
composite of a polymer, nanohydroxyapatite and cancellous granules
of bone mineral substitute. The multicomposite scaffold was tested
in vitro and subsequently in vivo using MC3T3E1 cells for cell ad-
hesion, proliferation and osteogenic differentiation. In vitro analyses
demonstrated modulation of gene expression in exposed cells with
characteristics similar to those exhibited during bone remodeling.
The in vivo analyses using a rat unicortical tibial bone defect model,
displayed endogenous cell migration and new bone formation with
no signs of inflammatory reaction. Results suggest the potential to
translate this strategy into a large animal model.
348
Cytotoxicity After Hydrogen Peroxide Gas Sterilization
Of Graphene-based Biomaterials
R. Steiner1, D. Anderson1, M. Dhar1, A. Biris2, S. Bourdo2;
1University of Tennessee Knoxville, Knoxville, TN, 2University
of Arkansas Little Rock, Little Rock, AR.
Graphene is increasingly the focus of studies aimed at determining
the use of this material for biomedical applications. Complex bio-
materials including graphene may offer scientific advancement
of tissue regeneration strategies with a wide range of applications
including peripheral nerve regeneration. We conducted studies de-
signed to assess the suitability of novel graphene-polymer biomate-
rial designs as candidates for regeneration of damaged peripheral
nerves. Specifically, graphene based materials crosslinked with
polyethylene glycol (PEG) is being studied for suitability in biomi-
metic peripheral nerve scaffolds. These in vitro studies utilized PC12
immortalized cell lines co-cultured with various iterations of
graphene-PEG. Initial studies revealed failure of cellular adhesion
and rapid cytotoxicity with cell death. This complication lead to a
systems analysis of the components, steps, and protocols associated
with the in vitro system. System analysis revealed that the use of
hydrogen peroxide gas to sterilize the biomaterials within X hours
prior to cell culture experiments resulted in generation of cytotoxic
radicals. Additional studies are required to more fully assess the
factors associated with cytotoxicity and determine protocols for safe
and effective sterilization of carbon based biomaterials. This may
have a profound effect on future manufacturing processes and hos-
pital protocols for preparation of graphitic scaffolds for implantation
in the body.
349
Nanofibrous Scaffolds Produced by Electrospinning, Rotary-Jet
Spinning and Airbrush for Orthopedic Tissue Regeneration
P. Ghannadian;
Chemical Engineering, Northeastern University, Boston, MA.
Nanofibrous Scaffolds Produced by Electrospinning, Rotary-
Jet Spinning and Airbrush for Orthopedic Tissue Regeneration
Paria Ghannadian1, Mirian De Paula2, Siddhi Kankaya3, Anderson
Lobo4, and Thomas J. Webster1
1Department of Chemical Engineering, Northeastern University,
Boston, MA, 2Biomedical Engineering, Universidade do Vale do
Paraiba, Brazil, 3Department of Pharmaceutical Sciences,
Northeastern University, Boston, MA, 4Department of Biomedical
Engineering, Universidade Brasil, Sao Paulo, Brazil.
Abstract: Biomaterials-based three-dimensional scaffolds are
being extensively investigated in orthopedic tissue engineering.
Polycaprolactone (PCL) is a bioresorbable polymer with potential
applications for bone and cartilage repair. In this study, poly-
caprolactone fibers (with and without hydroxyapatite nano particles
(nHAp) and carbon nanotubes (CNT)) were produced using three
different methods: electrospinning, rotary-jet spinning and airbrush.
The scaffolds were characterized using contact angles, atomic force
microscopy, differential scanning calorimetry, scanning electron
microscopy, and transmission electron microscopy and were sub-
jected to cell culture, bacterial assays and mechanical (tensile)
testing. The biological and material properties were studied to un-
derstand how the various fabrication techniques and nanoparticles
affect fibroblasts, gram positive and gram negative bacteria growth
on samples. Experiments showed no toxic effect on cells and a sig-
nificant decrease in bacterial density (in range of 4% for electro-
spinning to 80% for rotary-jet spinning) by adding nHAp and CNT to
the PCL scaffolds without using growth factors or antibiotics.
350
Preclinical Evaluation of Bioengineered Collagen
Composite Constructs
P. Ayala1,2, E. Dai2, M. Hawes3, L. Li2, O. Chaudhuri4,
C. A. Haller2, D. J. Mooney5,6, E. L. Chaikof2,6;
1Long Beach State University, Long Beach, CA, 2Beth Israel
Deaconess Medical Center, Boston, MA, 3Charter Preclinical
Services, Hudson, MA, 4Harvard University, Cambridge, CA,
5Harvard University, Cambridge, MA, 6Wyss Institute for
Biologically Inspired Engineering, Boston, MA.
Biomaterial options for tissue repair and regeneration are limited;
integration and vascularization remains a critical challenge in tissue
repair. Current biologic meshes used in soft tissue repair are derived
from different tissue sources and are generally sold as decellularized
tissues. We report the pre-clinical evaluation of collagen based
bioengineered constructs through comparison with a commercial
product in a rat model of abdominal full thickness defect. The
commercial product is a biologic mesh derived from bovine peri-
cardium (Veritas). Bioengineered constructs, were prepared from
porcine skin extracted collagen type 1. After purification, the colla-
gen was formed into sheets that were physically bonded to form a
mechanically robust construct that was subsequently laser micro-
patterned with pores. The collagen construct was then embedded in
an RGD-functionalized alginate gel that serves as a bioactive inter-
face (collagen-alginate construct). Overall, the performance of the
bioengineered constructs was similar to that of the commercial
product with comparable integration strength at 8 weeks. These de-
signed collagen bioengineered constructs demonstrate promise for a
variety of load bearing applications in tissue engineering.
351
Fabrication of Alginate/hydroxyapatite Microsphere
as Substitute Material for Bone Tissue Regeneration
H. Park, K. Byun, H. Yun;
Korea Institute of Materials Science, Changwon, KOREA,
REPUBLIC OF.
We fabricated alginate/hydroxyapatite hybrid microsphere for
bone tissue regeneration which has a potential to utilize as bone
substitute materials. Themicrospheres were prepared withmixture of
alginate solution and hydroxyapatite via ionic cross-linking. We
investigated Bone Morphogenetic Protein 2 (BMP-2) loading capa-
bility and release behavior of the microsphere as a carrier for in-
duction of osteogenic differentiation. We also investigated bone
tissue regeneration efficacy of encapsulated cells which were stim-
ulated by released proteins from hydroxyapatite. The osteogenic
potential was estimated by histological and immunohistochemical
analysis, quantification of ALP, Calcium and osteogenic marker gene
expression (e.g., type I collagen and osteopontin). We could
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effectively tailor BMP-2 loading capability and release behavior by
regulation of alginate/hydroxyapatite weight ratio in microsphere. In
addition, we could successfully induce osteogenic differentiation of
encapsulated cells by released BMP-2. These alginate/hydroxyapa-
tite hybrid microspheres might be approached for cell and protein
delivery carrier for various tissue engineering applications.
352
Fabrication of Plasma Treated Chitosan Nanofiber Scaffolds
for use as Tissue Engineering Applications
B. Gu, S. Park, C. Kim;
Korea Institute of Radiological and Medical Sciences, Seoul,
KOREA, REPUBLIC OF.
Chitosan has been demonstrated to be an invaluable material in
the fields of tissue engineering because of its good biocompatibil-
ity, biodegradability, and non-toxic properties. To improve the
initial cell adhesion and infiltration of chitosan nanofiber scaffolds,
we studied the synergetic effects of the plasma treatment and ultra-
sonication, respectively, in chitosan nanofiber scaffolds for tissue
engineering applications. The basic characterizations of modified
chitosan nanofiber scaffolds such as surface properties, mechanical
properties, and wettability were performed. The contact angles also
decreased as the duration of the plasma treatment on chitosan na-
nofiber scaffolds was prolonged. In addition, the cell study in vitro
confirmed that the plasma treatment improves the initial cell ad-
hesion, proliferation and infiltration of human dermal fibroblast
cells. After 6 hours of cell culture, the cell on plasma treated na-
nofiber scaffolds showed enhanced cell adhesion and spreading
than untreated nanofibers. To investigate the effect of modified
nanofiber scaffolds on cell viability, we seeded HDFs on chitosan,
sonicated chitosan, and plasma and sonicated chitosan nanofiber
scaffolds after 1, 4 and 7 days of culture. Collectively, the results
showed that such plasma treatment could greatly improve the
biocompatibility, wettability and infiltration of chitosan nanofiber
scaffolds, and thus increase the potential for tissue engineering
applications.
353
Osteoinductive and Proangiogenic Bioactive Glass Silk
Composite Scaffolds towards Resorbable and Vascularized
Bone Grafts
J. C. M., P. Gupta, B. B. Mandal;
Department of Biosciences and Bioengineering, Indian Institute
of Technology Guwahati, Guwahati, INDIA.
Successful reconstruction of large volume segmental bone defects
necessitates the use of resorbable and proangiogenic scaffolding
matrix. Vascularization forms the main essence of bone formation
and bone remodelling during healing process. Herein, we investi-
gated the use of copper doped bioactive glass silk composite matrices
for mediating osteogenesis, angiogenesis and bone resorption. Two
silk varieties namely, mulberry (Bombyx mori) and non-mulberry
(Antheraea assama) were studied as scaffolding matrix. Degummed
silk microfibers functionalized with copper doped bioactive glass
were used as reinforcements in the silk matrices to augment the
mechanical properties in the composite matrices. The composite
matrices enhanced the osteogenic potential of human mesenchymal
stem cells (hMSCs) in comparison to pure silk matrices. The func-
tionalized silk microfibers also improved cell attachment and
migration of hMSCs and endothelial cells, in co-culture. The incor-
poration of Cu2+ in sol derived bioactive glass helped in stabilization
of nuclear HIF-1a resulting in upregulation of angiogenic specific
markers (VEGF, angiopoietin-1 and CD-31) through CXCL12/
CXCR4 signalling. The hypoxic scenario that is prevalent in the
micro-millieu upregulated MMP-9, cathepsin and tartarate resis-
tant acid phosphatase in human osteoclasts, thereby substantiating
the effectiveness of these composite scaffolds in mediating bone
remodelling.
References:
1.Mandal, BimanB., et al. ‘‘High-strength silk protein scaffolds for
bone repair.’’ Proceedings of the National Academy of Sciences
109.20 (2012): 7699-7704.
2. M, Joseph Christakiran, et al. ‘‘Mimicking Hierarchical Com-
plexity of the Osteochondral Interface Using Electrospun Silk-
Bioactive Glass Composites.’’ ACS Applied Materials & Interfaces
9.9 (2017): 8000-8013.
354
Bioprinting Three-Dimensional Scaffolds with Modified
Gelatin in Dynamic Culture Condition for Bone Tissue
Engineering Application
S. Devi Eswaramoorthy, A. Joshi, A. Joshi, G. Prabu Sankar,
S. Rath;
Indian Institute of Technology Hyderabad, Sangareddy, INDIA.
3D bioprinting is the combined printing of cells along with bio-
materials to get a cell loaded construct as a whole. Gelatin is tem-
perature sensitive, self-supporting for layer-by-layer deposition and
has the ability to gel rapidly on the printing surface which makes it a
suitable biomaterial for extrusion bioprinting1. Modified form of
gelatin is used to achieve better polymerisation. Dynamic culture
techniques are known to enhance osteogenic differentiation2. The
aim of this study is to achieve enhanced osteogenesis on a 3D bio-
printed scaffold having mesenchymal stem cells (MSCs) and mod-
ified gelatin in pure form or with the addition of hyaluronic acid,
which would be cultured in dynamic conditions. MSCs were ob-
tained from lipoaspirate by enzymatic digestion. Modified gelatin at
a concentration of 10% or with the addition of 0.5% hyaluronic acid
was mixed with 0.5% photoinitiator. The 3D construct was printed
using a 3D-printer (Biobot, USA) at a speed of 4mm/s and pressure of
20psi. The 3D bioprinted scaffold was checked for cell viability
using FDA/PI staining. Cell proliferation study, osteogenic differ-
entiation potential, degradation studies and mechanical tests are also
evaluated. Our preliminary results show good cell viability on 3D
printed scaffolds. Dynamic culture condition result in better osteo-
genic differentiation.We anticipate that the findings of this study will
be used to achieve enhanced osteogenesis using our combination of
modified gelatin hydrogel and dynamic condition.
References:
1. Rutz LA et al. Advanced Materials 27, 1607, 2015.
2. Stiehler M et al. Journal of Biomedical Materials Research Part
A 1, 96, 2009.
355
Comparison Of Three Types Electrospun ECM/PEUU Scaffold
For Abdominal Muscle Regeneration
T. Uchibori1, K. Takanari1, W. R. Wagner2;
1Plastic and Reconstructive Surgery, Nagoya Univesity, Nagoya,
JAPAN, 2Surgery, Bioengineering, and Chemical Engineering,
McGowan Institute for Regenerative Medicine, Pittsburgh, PA.
Tissue-derived extracellular matrix (ECM) materials have been
used as surgical mesh devices in numerous preclinical and clinical
area. Our group have been using electrospun biodegradable poly
(ester urethane) urea (PEUU) as a regeneration material and syn-
thesized ECM/PEUU scaffold for soft tissue regeneration in various
areas, including cardiac area and abdomen. In this study we prepared
a model rat with bilateral partial-thickness abdominal wall muscle
defects (1 · 1 cm) and examined the difference in terms of muscle
regeneration by comparing a group in which the ECM was derived
from dermal tissue, small intestine and urinary bladder. Each groups
were sacrificed 2, 8 and 16 wk after the implantation and im-
munohistological and rtPCR assessments were performed. The data
showed dermal ECM group could retain the space to be filled with
regenerated muscle tissue in 8 and 16 wk time point. The other
groups were also seen regenerated muscle tissue infiltration but they
couldn’t retain the space to be replaced completely. And dermal
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ECM group also increased mRNA for muscle regeneration factors.
To supply grows factors and to retain space are the main tasks for
tissue regenerative scaffold. The dermal ECM/PEUU scaffold could
match to play these rolls.
356
Incorporation of Growth Factor Peptide Mimics into GelMA
Bioinks
J. Su1, P. Thayer2, H. Martinez3;
1Northwestern University, Evanston, IL, 2CELLINK, Blacksburg,
VA, 3CELLINK, Gothenburg, SWEDEN.
Despite the growth of the 3D bioprinting field in recent years, the
diversity of currently available biomaterials that can be bioprinted
remains limited compared to traditional construct fabrication
techniques. Therefore, the goal of this project is to expand the
diversity of this palette though the incorporation of growth factor-
mimicking peptides into established bioink systems for enhancing
bioink bioactivity and recapitulating complex extracellular matrix
microenvironments such as tissue-specific niches. We hypothesize
that the incorporation of VEGF and FGF mimetic peptides into 3D-
printable bioinks via covalent cross-linking mechanisms will en-
hance the bioactivity of these bioinks. Therefore, two bioinks based
on GelMA were developed through the incorporation of acrylated
growth factor mimetic peptides. Either a VEGF mimicking AcQK
peptide or a FGF mimetic F2A4-K-NS peptide was incorporated
via blending into GelMA at several different concentrations.
Bioink printability and bioactivity was analyzed through a tubu-
logenesis assay (VEGF-mimetic bioink) or the activation of FGF
receptors and downstream signaling cascades such as ERK1/2
(FGF-mimetic bioink) The printed constructs were also stained
with LIVE/DEADCell Viability Assay and histology performed on
days 1 and 7 to visualize cell distribution and ECM deposition.
Analysis of both vessel formation and activation of FGF receptors
were positive and dependent on the concentration of the incorpo-
rated peptide. These results demonstrate that VEGF or FGF-2
mimetic acrylated peptides can be incorporated within bioinks,
printed, and exhibit a positive biological response form the in-
corporated cells.
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Decelluarlized Corneal Lenticule Embedded Compressed
Collagen: A Biocomposite For Limbal Epithelial Stem Cell
Carrier
H. Kim1, M. Huh1, H. Hong2, S. Park2, D. Kim2;
1Kyungpook National University School of Medicine, Daegu,
KOREA, REPUBLIC OF, 2Department of Mechanical Engineering,
Pohang University of Science and Technology (POSTECH), Pohang,
KOREA, REPUBLIC OF.
Collagen-based limbal epithelial stem cell (LESC) carrier is one
of the promising ways to treat clinically the limbal stem cell defi-
ciency (LSCD). The carrier possesses adequate biological properties
for LESC expansion and delivery to the diseased area. While pre-
vious studies have tried to utilize compressed collagen as LESC
carrier in the meaning of chemical-free approach, only the physical
entanglements of collagen fibrils in the compressed collagen cannot
provide suitable mechanical strength and long-term stability required
in a surgical application. To overcome the limitation, this study
fabricated the LESC carrier in the form of biocomposite by inte-
grating decellularized corneal lenticule (dCL) inside the compressed
collagen. The corneal lenticule mechanically support the compressed
collagen inside the biocomposite. The bicomposite was obtained by
compression/dehydration of collagen gel embedded with dCL.
In vitro and In vivo tests verified that the biocomposite can effec-
tively promote the corneal epithelium reconstruction with successful
LESC expansion on the biocomposite, comparable to the compressed
collagen.
360
Development of 3D Bioactive Composite Scaffold for Bone
Regeneration
J. Li, P. Habibovic, L. Moroni;
MERLN Institute for Technology-Inspired Regenerative Medicine,
Maastricht University, Maastricht, NETHERLANDS.
Currently, metallic implants have been used in fixation devices
and supporting structures for orthopaedic applications. Due to high
stiffness difference between bone and metallic implant, stress
shielding may occur. This results in bone resorption, leading to
poor integration of implant into the surrounding bone and implant
loosening, hence reducing the implant life time. To avoid this
issue, there is an increasing need for materials that are bioactive,
mimicking the structural anisotropy of autologous bone. Calcium
phosphate is similar as bone material, but too brittle to use. In this
study, a bioactive composite with a high content of ceramic (up to
60% in weight) was developed by using biodegradable poly(eth-
ylene oxide terephthalate)/poly(butelene terephthalate and b-
tricalcium phosphate (TCP). TCP is already applied in the clinic,
for being osteoinductive and degradable in vivo. 3D composite
scaffolds with controllable TCP content were fabricated by addi-
tive manufacturing (AM). The scaffolds exhibited a fully inter-
connected porous network with controllable porosity and pore
size. The TCP content directed the hydrophilicity of composite.
Degradation experiments showed a release of calcium and phos-
phate ions, which may be an important factor for composite bio-
activity. Further experiments will be performed to examine the
role of the released ions for (stem) cell proliferation and differ-
entiation. With AM, the resulting scaffolds could mimic the
structures and properties of both cancellous and cortical bone. The
creation of additive manufactured patient-specific implants using
this bioactive composite with designed properties will provide the
basis for improved bioactivity that is required for a successful bone
regeneration.
361
Placenta Derived Extracellular Matrix for Osteochondral
Tissue Engineering
A. Rameshbabu, S. Dhara;
School of Medical Science and Technology, Indian Institute
of Technology Kharagpur, Kharagpur, INDIA.
Introduction: Repair of osteochondral defects requires simulta-
neous restoration of both cartilage and bone. In this context, ECM
derived from placental tissues (PEMS) is an attractive option as it
contains abundant extracellular matrix components coupled with
well-preserved endogenous bioactive molecules.
Materials and Methods: The decellularized placental extracts
mixed homogeneously, poured into moulds of required dimensions,
freeze-dried for 72 h to obtain PEMS. Three osteochondral cylin-
drical defects (4mm in diameter and 5mm deep) with a sterilized
stainless-steel drill bit was made. Out of 3 cylindrical defects in an
animal, one was left untreated (Empty Defect), one was implanted
with cell-free PEMS (CFP) and one with cell-seeded PEMS (CSP)
(n = 5). For CSP, Human Amniotic Membrane-derived Stem
Cells were cultivated in PEMS for 7 days before implantation in the
defect site. Rabbits were sacrificed 60 days post-implantation and
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specimens were retrieved for semi-quantitative histomorphological
analysis.
Results: From the histomorphometric analysis, it is evident that
the defects filled with CSP supported superior osteochondral re-
generation compared to CFP and ED after 60 days of implantation.
Moreover, from the histological grading scores, the CSP scored
higher than the CFP (p< 0.05) and the control group (p< 0.05).
Discussion & Conclusions: We developed biomimetic human
placenta-derived extracellular matrix sponges for osteochondral tis-
sue engineering. The ability of CFP and CSP to mediate early os-
teochondral repair in rabbit models is demonstrated.
References: Rameshbabu A.P. et al. Journal of Materials
Chemistry B. 4, 613, 2016.
362
Injectable Collagen-Chitosan Microspheres for Cutaneous
wound healing
S. Datta, S. Dhara;
SCHOOL OF MEDICAL SCIENCE AND TECHNOLOGY,
INDIAN INSTITUTE OF TECHNOLOGY KHARAGPUR,
KHARAGPUR, INDIA.
Introduction: Wound injuries occurred from skin carcinoma,
diabetic ulcer and burn can be categorized as non-healing wounds.
Cell-microsphere constructs not only provide amiable microniches
but also serve as a vehicle to deliver cells or growth factors directly at
the dermal wound area where it may accelerate the granulation tissue
formation by facilitating cellular migration, efficient transport pro-
cess. In present study, collagen-chitosan microspheres (ColCMs)
were synthesized and its application was observed.
Methods: ColCMs were synthesized in water-in-oil emulsion and
following characteristics were performed. SEM, degradation, cyto-
toxicity, cell proliferation and growth factor release study was in-
vestigated. Further, in vivo wound healing study by injecting the
microspheres at intra-dermal region (wound size 10mm) in a rat
model.
Results & Discussion: The resulting ColCMs were spherical and
*150mM in size. The constructs were significantly prominent with
excellent cytocompatibility compared to tissue culture plate. At day
5, proliferating as well as migrating primary rat fibroblasts were
visible under SEM by forming bridge between adjacent micro-
spheres. Significant cell proliferation rate was also confirmed by
higher DNA content and fluorescence microscopy (Rhodamine-
DAPI). Injected cell seeded ColCMs showed faster wound closure
rate than control (PBS) group. Histological findings revealed im-
proved neo-vascularization, re-epithelialization and dermal tissue
regeneration compared to control.
Conclusion: Therefore, 3D constructs is very efficient thus can be
used as injectable scaffold for dermal wound healing. In vitro stem
cell culture onto those microspheres in bioreactor will be explored
further for advance.
Reference: Kodali A., Lim T., Leong D., Tong Y. Macromol.
Biosci., 14(10):1458-68. 2014.
363
Chitosan Hollow Fibers For Tissue Engineering
T. Roy1, P. Dadhich2, B. Das1, S. Dhara1;
1IIT, Kharagpur, Kharagpur, INDIA, 2Wake Forest School of
Medicine, NORTH CAROLINA, NC.
The search for an ideal vascular graft with ideal material has been
an extensive research interest from the last century. With the recent
development in the field of tissue engineering, bioresorbable vas-
cular scaffolds comprising of Poly lactic acid (PLA) and Poly-
glycolic acid (PGA) are being explored extensively but polymers of
natural origin have not been utilized yet to full potential. In our study,
we have chosen to develop hollow fibers or tubes of chitosan by
spinning process. Chitosan is a natural amino polysaccharide poly-
mer, composed of glucosamine and N-acetyl glucosamine obtained
by N-deacetylation of chitin polymers, naturally derived from shells
of crustaceans, shrimps. Chitosan have functional groups of free
amine and hydroxyl which can be further modified to have desired
tailor-made properties.
364
Printability Metrics for Bioink Standardization
P. Thayer1, H. Martinez2;
1CELLINK, Blacksburg, VA, 2CELLINK AB, Gothenburg,
SWEDEN.
In recent years, bioinks with diverse compositions and applica-
tions have been developed. However, the development of novel
bioinks and blends has greatly outpaced the standardization of
printability analysis. The standardization of what constitutes good
printability is critical for consistency in the fabrication of existing
and new bioink blends. It is necessary to determine how printability
metrics can be rapidly quantified and utilized for comparison be-
tween different bioink compositions. Additionally, for better pre-
dictively of printability, determination of how varying bioprinting
parameters such as pressure, speed, viscosity, temperature, and
nozzle size and shape relate to the resulting filament size, unifor-
mity, and properties. To this end, we have developed standardized
protocols for the analysis and comparison of distinct bioink com-
positions. These protocols seek to collect reliable data from which
printability of bioinks can be predicted based on printing pressure,
nozzle shape and size, temperature, viscosity, and translation rate.
Additionally, developed image analysis algorithms that seek to
remove the ‘‘human element’’ from the analysis of printability and
better quantify filament shape or construct structural fidelity than
the common used ‘eye-test’. At the moment, the algorithms can
rapidly determine how filament diameter changes over the filament
length, permitting the quantification of irregularities in filament
shape at the beginning and end of the lines where the printing
nozzle is rapidly translating. Additionally, grid structures and an-
gles between the filaments can be quantified to determine regions of
imperfections in a printed pattern and where parameters must be
adjusted to result in a better print.
365
Evaluation of 3D Bioprinted Human Skin Analogs Comprised
of Distinct Bioinks
E. Ning1, E. Gatenholm2, L. Orrhult3, P. Thayer4,
H. Martinez2, P. Gatenholm3;
1University of Strathclyde, Glasgow, UNITED KINGDOM,
2CELLINK AB, Gothenburg, SWEDEN, 3Chalmers University,
Gothenburg, SWEDEN, 4CELLINK, Blacksburg, VA.
Recently, three-dimensional (3D) bioprinting has drawn at-
tention as an attractive technique for the rapid and reproducible
fabrication of constructs that recapitulate striated tissue structures
such as skin. The objective of this study was to utilize bioprint-
ing to fabricate multilayered constructs for ultimate application as
an engineered skin construct. Several bioinks/growth factor com-
binations were evaluated, including GelMA, GelMA-Heparin:
TGF-b3, CELLINK-RGD-TGF-b3, and CELLINK-RGD-fibrin.
The resulting constructs possessed dimensions of 10 by 10 by
1.6 mm and consisted of 4 layers each with a height of 0.4 mm and
spacing between each filament of 2 mm to allow nutrient diffu-
sion. After the bioprinting process, the cell-laden skin constructs
were crosslinked and incubated in 3D cell culture medium under
standard culture conditions (37C, 5% CO2 and 95% relative
humidity). The constructs were maintained in culture for 4 weeks
with a media change every 2-3 days. Human epithelial keratino-
cytes (HEKa) were seeded on top of the skin constructs on the
following day and the 3D skin constructs cultured at the air-liquid
interface (ALI) for 4 weeks. At day 14 and 28, samples were
collected for histological, immunohistochemical and gene ex-
pression analysis collagen I production, and cell morphology.
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Differences in dermal tissue maturation were evaluated between
the different bioinks. Future studies will focus on the generation
of more complicated dermal constructs with additional layers that
contain additional cell types and growth factors to better mimic
native dermal tissue.
366
Osseointegration Of Chitosan Coated Porous Titanium Alloy
Implant By Reactive Oxygen Species-mediated Activation
Of The Pi3k/akt Pathway Under Diabetic Conditions
l. wang1, X. LI2;
1Department of Orthopaedics, Xijing Hospital, Fourth Military
Medical University, Xi’an, CHINA, 2State Key Laboratory of
Mechanical System and Vibration, School of Mechanical
Engineering, Shanghai Jiao Tong University, Shanghai, CHINA.
Chitosan coated porous titanium alloy implant (CTI) is demon-
strated a promising approach to improve osseointegration capacity of
pure porous titanium alloy implant (TI). Since chitosan has been
demonstrated to exhibit antioxidant activity, we propose CTI may
ameliorate the ROS overproduction, thus reverse the poor osseoin-
tegration under diabetic conditions, and investigate the underlying
mechanisms. Primary rat osteoblasts incubated on the TI and the CTI
were subjected to normal serum (NS), diabetic serum (DS), DS+
NAC (a potent ROS inhibitor) and DS + LY294002 (a PI3K/AKT-
specific inhibitor). In vivo study was performed on diabetic sheep
implanted with TI or CTI into the bone defects on crista iliaca. Re-
sults showed that diabetes-induced ROS overproduction led to os-
teoblast dysfunction and apoptosis, concomitant with the inhibition
of AKT in osteoblasts on the TI substrate. While CTI stimulated
AKT phosphorylation through ROS attenuation, thus reversed oste-
oblast dysfunction evidenced by improved osteoblast adhesion, in-
creased proliferation and ALP activity, and decreased cytotoxicity
and apoptotic rate, which exerted same effect to NAC treatment on
the TI. These effects were further confirmed by the improved os-
seointegration within the CTI in vivo evidenced by Micro-CT and
histological examinations. In addition, the aforementioned promo-
tive effects afforded by CTI were abolished by blocking PI3K/AKT
pathway with addition of LY294002. These results demonstrate that
the chitosan coating markedly ameliorates diabetes-induced im-
paired bio-performance of TI via ROS-mediated reactivation of
PI3K/AKT pathway, which elicits a new surface functionalization
strategy for better clinical performance of titanium implant in dia-
betic patients.
367
Novel Heterogeneous Polycaprolactone/human Serum
Albumin Electrospun Membrane For Tissue Engineering
With Improved Properties
A. P. Tiwari, M. K. Joshi, C. H. Park, C. S. Kim;
Bionanosystem Engineering, Chonbuk National University, Jeonju,
KOREA, REPUBLIC OF.
Development of electrospun membrane with improved me-
chanical properties, proper biodegradation, and excellent bio-
compatibility simultaneously is the great challenging task. In
this background, we have prepared the heterogeneous poly-
caprolactone/human serum albumin (PCL/HSA) membrane by
blending the solution of the different mass weight ratio of PCL to
HSA using electrospinning technique. Physio-chemical and bio-
logical properties of the as-fabricated membranes were evaluated.
FE-SEM images revealed that all PCL/HSA mats were composed
of interlinked nano-nets along with conventional electrospun fibers
while nano-nets were not found for pristine PCL mat. PCL-HSA
membranes showed excellent mechanical properties (3 fold tensile
stress compared to pristine PCL), improved biodegradation, en-
hanced mineralization and extraordinarily supported the cells early
adhesion and proliferation compared to pure PCLmembrane. These
results indicate that the nano-nets supported PCL/HSA membranes
with the ability to induce progressive cell growth could be prom-
ising in tissue engineering applications.
368
Development of Biological and Mechanical Evaluation of Porous
poly(para-phenylene) for orthopedic implants
H. Ahn1, R. Patel2, A. J. Hoyt3, A. S. Lin4, B. Torstrick4,
R. E. Guldberg4, C. P. Frick3, R. D. Carpenter2, C. M. Yakacki2,
N. J. Willett1;
1Department of Orthopaedics, Emory University, Decatur, GA,
2Mechanical Engineering, University of Colorado, Denver, CO,
3Mechanical Engineering, University of Wyoming, Laramie, WY,
4Georgia Institute of Technology, Atlanta, GA.
Poly(para-phenylene) (PPP) is a novel high strength polymer that
has shown promise as an orthopaedic biomaterial. However, its
biocompatibility has not been previously reported. The objective of
this study is to evaluate the biological and mechanical behavior of
solid and porous PPP compared to polyether-ether-ketone (PEEK,
current orthopaedic material). Experiments were performed in four
groups for comparison: 1) Solid PPP, 2) Solid PEEK, 3) Porous PPP
and 4) Porous PEEK. Material cellular compatibilities were assessed
by measuring mouse pre-osteoblast (MC3T3 cells) proliferation and
osteogenic differentiation. To measure osseointegration, bilateral
drill holes were made in the tibial metaphysis of rats, and a 2mm ·
6mm cylindrical scaffold was placed in the defect. Bone ingrowth
was quantitatively assessed by microcomputed tomography. Finite
element simulated pushout tests were performed to predict interfacial
strength of the implants after bone ingrowth. MC3T3 cells were able
to grow on each scaffolds and the proliferation rate was not signifi-
cantly different in solid materials. Cells grown on porous scaffolds
showed a significant increase in ALP activity and calcium deposition
compared to cells on solid scaffolds. Porous PPP showed 9.4 folds
and 1.4 folds increase in bone volume to solid implants and porous
PEEK respectively. The finite element model showed approximately
50% higher interfacial strength for porous PPP implants than porous
PEEK. Histological assessment suggested porous PPP explants
showed cellularized and matured bone formation throughout the
entire porous structure. These results indicate that porous PPP has the
potential to accelerate bone fusion in the clinical setting.
369
3D Printing and Characterization of Bioceramic Tissue
Scaffolds using Mask-Projection Micro-stereolithography
D. C. Aduba, Jr.1,2, M. Bakum3,2, C. B. Williams1,2;
1Mechanical Engineering, Virginia Tech, Blacksburg, VA,
2Macromolecules and Innovation Institute, Virginia Tech,
Blacksburg, VA, 3Materials Science & Engineering, Virginia
Tech, Blacksburg, VA.
Introduction: The need for orthopedic bone tissue engineering
scaffolds is a significant issue that persists in the biomedical com-
munity. In 2014, the number of orthopedic surgical operations ex-
ceeded 600,000 in the United States [1]. Current commercial
treatments often use bone cement paste implants to fill defects.
However, there is a need to design and create customized porous
scaffolds to exactly fit the geometric dimensions of the bone defect
while governing bone tissue regeneration. Additive Manufacturing
(AM) is a tool that offers design freedom to fabricate complex
structures from computer aided design (CAD) models or CT-scans
specifically tailored for the patient.
Methodology: In this study, a vat photopolymerization (VP) ad-
ditive manufacturing process is employed to fabricate bioceramic
scaffolds from a suspension comprised of commercial photocurable
resins and dispersant containing Calcium Phosphate (60wt%). Green
parts underwent thermal treatment up to 1150 C to remove the
photocurable binder, enabling calcium phosphate particles to fill
vacated voids and densify into a final structure. Dimensional
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shrinkage, surface morphology, pore size, and part density after
sintering were evaluated.
Results: Porous cylindrical calcium phosphate scaffolds were
successfully 3D printed and sintered. Thermal treatment induced
shrinkage values of 12.6%, 8.7%, and 7.2% for the length, outer
diameter and inner diameter, respectively. Scaffold pore size was
281– 28 mm and relative density was 97.1%. Future work will focus
on osteoblast biocompatibility and cell response of these 3D printed
constructs.
Reference: 1. Parikh, S. N. (2002). Bone graft substitutes in
modern orthopedics. Orthopedics, 25(11), 1301-1309.
370
Blended Electrospinning: New Environments for Liver
Bioengineering
R. Grant1, D. C. Hay2, A. Callanan1;
1University of Edinburgh, Edinburgh, UNITED KINGDOM,
2Scottish Centre for Regenerative Medicine, University of
Edinburgh, Edinburgh, UNITED KINGDOM.
A combination of increasing liver disease incidence and a short-
age of organs available for patient treatment and research1 has led to
a need for liver ‘organoids’. Biofunctionalization of electrospun
polymer scaffolds with cell-derived extracellular matrix [ECM] has
been shown to influence hepatocyte function2, and with this in mind
we created blended protein/polymer scaffolds - directly incorporat-
ing bioactive proteins into electrospun polylactic acid [PLA] fibrous
scaffolds.
Scaffolds were fabricated containing each of the following; Col-
lagen I, Fibronectin, Laminin-521 and decellularized whole human
liver ECM. THLE-3 cells were seeded onto the scaffolds and as-
sessed for survival and function at 1/3/7 and 14 days using scanning
electron microscopy [SEM], mechanical and biochemical quantifi-
cation, histology, and gene expression analysis.
Initial results indicate that the incorporation of proteins into the
scaffold influences cell survival and function, with alterations in
albumin production and gene expression found between conditions.
Directly incorporating bioactive molecules such as proteins into
scaffolds provides a method of creating tailored, consistent envi-
ronments for liver bioengineering and the investigation of cell matrix
interactions. Blended protein/polymer scaffolds represent a viable
method of providing a bioactive environment for hepatocytes.
References:
1. Williams, R. et al. Lancet 384, 1953-1997, 2014.
2. Grant, R. et al. Tissue Eng. Part A [2017].
Acknowledgments: This work is funded by an EPSRC doctoral
training partnership studentship, UK Regenerative Medicine Plat-
form II [RMPII] grant MR/L022974/1 and MRC grant CCBN MR/
L012766/1.
371
A Tunable Poly(Diol Diacid) System for Drug Delivery
and Tissue Engineering Applications
E. Watson, C. Kim, A. M. Tatara, A. G. Mikos;
Bioengineering, Rice University, Houston, TX.
Introduction: A scaffold material with easily tunable mechanical
properties is of great utility as scaffold mechanical properties have
been shown to affect cell differentiation. Additionally, biomaterials
can be utilized to release antibiotics to combat infection. Terminal
diols can be reacted with diacids to form a polyester. By altering the
length of the diol and the saturation of the diacid, matrices with tunable
mechanical properties and drug release kinetics can be synthesized.
Methods: Polymers were synthesized using decanediol in a 1:1
molar ratio with a diacid. The diacids fumaric acid (FA) or succinic
acid (SA) were added in molar ratios of 1:0, 1:1, 1:9, 1:19, and 1:29.
After purification, the resulting polymers were evaluated via NMR
and GPC. After photocrosslinking with n-vinylpyrrolidone, the
swelling and sol fraction in an aqueous and organic solvent, com-
pressive moduli, and clindamycin release from these matrices were
measured.
Results: Polyester chains were capable of being formed with all 5
FA:SA ratios as evidenced by NMR and GPC. However, the ratio of
FA:SA incorporated into the polymer was lower than the initial
monomer feed. All 5 polymers formed solid constructs after cross-
linking; however, the group with the lowest FA:SA ratio was soluble
in chloroform, indicating a lack of crosslinking. Alternating ratio of
FA:SA significantly altered mechanical properties, swelling and sol
fraction, and drug release from matrices (p < 0.05).
Conclusions: By altering the FA:SA ratio in the initial monomer
feed, the crosslinking density of the polymer can be controlled, im-
pacting mechanical properties and drug release.
372
Synthetic Production of Cell Derived Extracellular Matrix for
Liver Bioengineering
R. Grant, A. Callanan, EH9 3JL;
University of Edinburgh, Edinburgh, UNITED KINGDOM.
An increasing incidence of liver disease and a shortage of organs
available for clinical transplant1 has led to a push for lab grown liver
‘organoids’2. Part of the challenge of developing such an organoid
lies in the creation of 3D scaffolds. Biofunctionalization of electro-
spun polymer scaffolds with cell-derived extracellular matrix [ECM]
has been shown to influence hepatocyte function3. We selected a
single ECM protein; Fibronectin, and selectively biofunctionalized
an electrospun polylactic acid [PLA] scaffold.
A fibronectin vector [Protein Structure Initiative:Biology Material
Repository] was transfected into confluent 5637 bladder epithelials,
seeded on electrospun PLA scaffolds and cultured for 7 days before
decellularization. The resulting synthetically derived ECM-PLA scaf-
folds were re-seeded with HepG2s, and cultured for 3/5 days before
scanning electron microscopy [SEM], mechanical and biochemical
quantification, histology, and gene expression analysis were performed.
SEM demonstrated retention of both native and synthetically
derived ECM proteins. Gene expression and albumin production was
significantly altered between conditions. Differences in mechanical
properties confirmed the presence of an altered ECM on the vector
treated constructs.
Transfected cells can be harnessed to produce customized ECMs
for liver bioengineering. These results demonstrate that synthetically
derived ECMs represent a viable method of biofunctionalizing
electrospun polymer scaffolds.
References:
1. Williams, R. et al. Lancet 384, 1953-1997, 2014.
2. Takebe, T. et al. Cell Stem Cell 16, 556-565, 2015.
3. Grant, R et al. Tissue Eng. Part A, 2017.
Acknowledgments: Engineering & Physical Sciences Research
Council [EPSRC] doctoral training partnership studentship andMRC
(CCBN) grant MR/L012766/1
373
Display of BMP-2 from PCL Micro-Fibers within Fiber-
Reinforced Collagen Composites
D. Gadalla, A. S. Goldstein;
Chemical Engineering, Virginia Tech, Blacksburg, VA.
Bone is the second most transplanted tissue after blood, and while
the iliac crest is the primary source of autologous tissue, continuing
concerns of tissue availability, donor site morbidity, and cost have
motivated the development of alternative tissue sources. Traditional
biomaterials for orthopaedic reconstruction continue to be me-
chanically robust and bio-inert polymers, ceramics, and alloys. They
can integrate with tissues but do not degrade; hence, they are ef-
fective at replacing bone function but suffer from mechanical fatigue
and implant loosening. The past decade, though, has seen the
emergence of degradable, drug-eluting, bioactive and biomimetic
‘‘smart’’ scaffolds that have potential for guiding bone regeneration.
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The purpose this this project is to establish a novel framework for
bone regeneration built around BMP-2-tethered fiber-reinforced
hydrogels. Here, sparse fiber layers are prepared by electrospinning
blends of polycaprolactone and heparin, to which the osteogenic
morphogen BMP-2 are adsorbed or covalently tethered. This thin
osteogenic layer - which does not impede cell migration or prolif-
eration - is then combined into a larger collagen gel to produce a
model 3D composite for bone regeneration. In this presentation we
examine how the mechanical and biochemical properties of the
composite affect viability, proliferation, and osteoblastic differenti-
ation of mesenchymal stem cells. We believe this model system has
promise for the fundamental studies (e.g., mechanotransduction,
cell-cell interactions, foreign body responses) as well as development
of a pedicle for bone transplantation.
374
EGF-Enriched Collagen Coated PDLLA Electrospun Scaffold
for Use as a Skin Substitute
P. Pranke;
Analysis, Federal University of Rio Grande do Sul, Porto Alegre,
BRAZIL.
Bioengineered skin substitutes are an alternative life-saving ap-
proach for treating several clinical situations, such as major traumas
and burns. In the search for a model that could be used not only as a
protection but also stimulate tissue healing, the current study has
aimed to produce and characterize an EGF enriched biomaterial
using PDLLA polymer and Type 1 Collagen. Scaffolds were con-
structed by the coaxial electrospinning technique and divided into the
following groups: 1) PDLLA, 2) PDLLA/EGF (coaxial fiber with
EGF core) and 3) PDLLA/EGF/Collagen (a PDLLA/EGF scaffold
with collagen coating). The sScaffolds were evaluated by scanning
electron microscopy (SEM) with fiber diameters for group 1 of
1.293mm –0.320, 1.235mm –0.48 for group 2 2 and 1,219.–0.42 for
group 3. All the groups showed similar pore sizes being 7,75mm,
7,410mm and 7,314mm for groups 1, 2 and 3, respectively and core-
shell relation was confirmed by confocal microscopy. Fourier
transform infrared spectroscopy (FTIR) analysis suggested the
presence of collagen in the fibers from group 3 with a strong peak in
1540-1660 cm-1 region. Coating of the scaffolds with collagen de-
creases contact angle measurements (WCA), which what suggests
increased hydrophilicity for group 3. In conclusion, a stable core-
shell fiber EGF-enriched scaffold was developed for application in
skin tissue engineering, which demonstrated better hydrophilicity
with collagen coating. Financial support: FINEP, CNPq, FAPERGS
and Stem Cell Research Institute.
Cardovascular
375
Automated Micro-Fabrication of a Small Diameter Vascular
Graft Mimicking the Structure and Mechanical Properties
of Human Vessels
C. A. Wilkens1,2, T. L. Akentjew3,1, C. F. Terraza1,2, J. J. Blaker4,
C. M. Garcı´a-Herrera5, J. I. Enrione6, L. M. Valenzuela3,
M. Khoury1,2, J. P. Acevedo1,2;
1Laboratory of Nano-Regenerative Medicine, Faculty of Medicine,
Universidad de los Andes, Santiago, CHILE, 2Cells for Cells,
Santiago, CHILE, 3Department of Chemical and Bioprocess
Engineering, School of Engineering, Pontificia Universidad de Chile,
Santiago, CHILE, 4School of Materials, The University of
Manchester, Manchester, UNITED KINGDOM, 5Departamento de
Ingenierı´a Meca´nica, Universidad de Santiago de Chile, Santiago,
CHILE, 6Laboratorio de Investigacio´n e Ingenierı´a de Biopolı´meros,
Faculty of Medicine, Universidad de los Andes, Santiago, CHILE.
Design strategies and fabrication of small diameter vascular grafts
has been converging towards tissue engineered grafts in order to
produce a biologically compatible graft that can overcome post-
surgical complications due to mechanical mismatch between the
graft and native tissue. We have developed an automated micro-
fabrication technology for the standardized fabrication of cellular-
ized multilayer cylindrical constructs with native-liked mechanical
behavior. The biofabrication technique combines the deposition of
cell-laden layers by a technology developed in house, and the in-
tercalated deposition of reinforcing nanofibers by an adapted solution
blow spinning device. The versatility of this automated technique
allowed us to resemble the pattern of different concentric cell types,
and the structural configuration of collagen and elastin fibers in na-
tive vessels. Encapsulated cells showed a homogenous distribution
and well-defined concentric patterns across the constructed graft.
Immunogenicity studies indicated that the combination of materials
chosen did not cause rejection in the studied animals. Finally, me-
chanical analysis shows that the engineered graft’s stress-strain curve
and compliance resembles that of a human coronary artery. In con-
clusion, this study demonstrated the feasibility of an automated
system for easy and rapid fabrication of suitable vascular grafts.
Acknowledgments: This work was funded by Fondef IDeA
ID15I10545, Fondecyt Postdoctoral 3160680 and Fondo Newton-
Picarte REDES No 140144 grants
376
Generation of Microchannels Using a Rapid Subtractive 3D
Printing System as a Template For Tissue Vascularization
M. Sameti1, S. R. Burtch1, R. D. Allado1, R. T. Olmstead2,
C. A. Bashur1;
1Biomedical Engineering, Florida Institute of Technology,
Melbourne, FL, 2MEDOPHO, Oviedo, FL.
One of the most challenging limitations with engineered tissues is
the lack of a microvascular system that can provide adequate oxygen
and nutrients to cells. One promising solution for this limitation is
generating a template microchannels within the scaffold to enable
transport of nutrients. In this study, we used a femtosecond laser-
based method for rapid 3D subtractive printing at a high rate of
2,500mm/s to generate microchannel within cell containing scaf-
folds composed of 0%, 1%, 2%, and 3% poly(ethylene glycol) dia-
crylate/collagen composite hydrogels. Compressive properties,
optical clarity, swelling, degradation and cell viability via live/dead
assay were measured to characterize the scaffolds. All blend condi-
tions tested were transparent enough to allow microchannel gener-
ation. Mechanical tests confirmed that these hydrogels are a good
model capable of generating channels. Different laser power was
used to show control over channel diameter. The average channel
width for all hydrogel was increased from 27.8– 5.1 to 45.6 – 7.7mm
when the laser energy increased from 1.7 to 3.5 mJ. Importantly, these
channels can be generated at a high rate with our technique, which is
2500 and 50 times faster than current inkjet and subtractive printing
methods, respectively. Cells seeded within hydrogels were viable
except for the ones that were very close to the channels (<10 mm).
Viability can be improved by optimizing the optical system and using
controlled photoablation. Overall, with the data that was collected,
we validated this laser technique as a viable rapid technique for
generating channels down to micrometer size.
377
Engineering Vascularized Grafts for Myocardial Regeneration
J. Morrissette McAlmon, B. Ginn, S. Somers, T. Fukunishi,
C. Thanitcul, G. Kostecki, N. Hibino, L. Tung, H. Mao, W. Grayson;
Johns Hopkins University, BALTIMORE, MD.
Tissue engineered cardiac ‘patches’ have the potential to restore
functionality to the infarcted myocardium. With the high metabolic
demands of cardiomyocytes, there is a need to engineer grafts with
embedded capillary-like vascular networks that will anastomose with
host and improve blood flow to the graft. In this study, we sought to
engineer aligned, electrophysiologically connected, vascularized
cardiac grafts by culturing cardiomyocytes, adipose-derived stem
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cells (ASCs), and endothelial cells on 1 cm· 1 cm electrospun fi-
brin microfiber sheets. We tested two fibrin concentrations, 0.75%
and 2.0%, that correlated with stiffnesses of 50.0– 11.2 and
90.0 – 16.4 kPa, respectively. When only cardiomyocytes were cul-
tured, we observed slightly better functional properties on the softer
vs. stiffer substrates: peak conduction velocities (CVs) were
19.8 – 3.5 vs. 14.8 – 2.8 cm/s, maximum captured rates (MCRs) were
4.15 – 0.67 vs. 3.56 – 0.53Hz, and the spontaneous contraction for-
ces measured 16.52 – 42.28 vs. 10.68 – 3.37 mN. However, there
were minimal functional differences in response to substrate stiffness
with tri-cultures: CVs were 15.7 – 2.7 vs. 16.7 – 3.2 cm/s and MCRs
were 4.00– 0.93 and 4.35– 0.86Hz, while vessel networks measured
100– 20 vs. 108– 18mm per field of view in the 50 kPa vs. 90 kPa
substrates, respectively. We sutured both groups of sheets epicar-
dially onto the left ventricular of live rats. Upon harvesting at Day 7,
we found significant cell survival and graft integration. Ultimately
we have shown that fibrin microfibers support the development of
densely vascularized cardiac tissue patches and have significant
potential as therapeutic grafts.
378
379
In vitro assessment of a PLGA/Gelatin Tubular scaffold toward
a Vascular Substitute.
R. Ontiveros, N. Va´zquez, K. Jarquı´n, C. Chaires, M. Herrera,
A. Castell;
Departamento de Biologı´a Celular y Tisular, Universidad Nacional
Auto´noma de Me´xico, Ciudad de Me´xico, MEXICO.
In this preliminary report, a fully constructed PLGA-gelatin tu-
bular scaffold was evaluated toward its in vitro cellular functionality
Materials and Methods: PLGA-Gelatin dissolved in Hexa-
fluoroisopropanol was electrospinned in a dynamic cylinder collec-
tor. SEM, FTIR, AFM were performed to evaluate morphology.
Beside, cell Viability, Cytotoxicity, Cell Adhesion and Extracellular
Matrix (ECM) Synthesis were analyzed.
Results: 2 mm PLGA-Gelatin fibers circularly oriented, generated
a 6mm lumen tubular scaffold with 0.45mm thick and Vascular
Smooth Muscle Cells was seeded on it. Cell Viability was de-
termined above of 98% and no cytotoxic effects was observed.
Collagen I, Collagen III, Fibrilin 1 and Elastin fibers replaced PLGA/
Gelatin ones.
Discussion and Conclusions: Scaffold were analyzed by their
morphological and cell-functionality properties, correlating topog-
raphy, composition, degradability, concluding that is creditable its
future employing in vascular grafts.
380
ABiofunctional Vascular Scaffold for Replacing Small-Diameter
Blood Vessels
Y. Ju, D. Green, I. Kim, A. Atala, J. Yoo, S. Lee;
Wake Forest Institute for Regenerative Medicine,
Winston-Salem, NC.
Diseases of the vascular system affect a large number of patients
and have resulted in a clear clinical need for the development of
functional vascular substitutes. We have previously fabricated a
vascular scaffold by electrospinning of poly(e-caprolactone) (PCL)
combined with collagen [1]. In this study, we hypothesized that
multiple bioconjugation of endothelial progenitor cells (EPC)/en-
dothelial cell (EC) specific antibodies and anti-thrombogenic agents
onto the vascular scaffold could facilitate in situ endothelialization
while preventing blood clotting. The biofunctionalized scaffolds
conjugated with EPC/EC-specific antibodies and heparin were able
to achieve effective EPC/EC capturing and anti-thrombogenesis.
In vivo experiment showed that these vascular scaffolds maintained a
high degree of patency and structural integrity without eliciting a
histologic inflammatory response over the course of 6-month period
in sheep. Moreover, the matured EC coverage on the lumen and
smooth muscle layer were observed at 6 months after implantation.
We demonstrated that the generation of the biofunctional vascular
scaffold, along with existing tools for selection and directed immo-
bilization of EPC/EC-specific antibodies and anti-thrombogenic
agent, could provide the necessary components for successful tissue
engineering of small diameter blood vessels.
Acknowledgments: This study was supported by the Armed
Forces Institute of Regenerative Medicine (X81XWH-08-2-0032).
Reference: 1. Ju YM, Choi JS, Atala A, Yoo JJ, and Lee SJ,
Bilayered scaffold for engineering cellularized blood vessels, Bio-
materials, 2010;31(15):4313-4321.
381
Glycocalyx Regeneration to Inhibit Endothelial Dysfunction
and Atherosclerosis
R. Mitra, G. O’Neil, S. Mensah, M. Cheng, P. Kulkarni, C. Ferris,
E. E. Ebong;
Northeastern University, Boston, MA.
Overview: We tested the idea that repairing damaged extracel-
lular glycocalyx (GCX) can reverse dysfunctional permeability
across the endothelial cell (EC) layer, impaired EC-to-EC transport
relevant to the loss of vascular tone control, and atherosclerosis
progression.
Methods: In cell culture and atherosclerotic animal experiments
[1] we studied EC with intact GCX, heparinase III enzyme degraded
GCX (to disrupt GCX heparan sulfate the most abundant GCX
component), mechanically degraded GCX, or regenerated GCX (by
replacing and stabilizing GCX heparan sulfate). We assessed cell
culture permeability of fluorescent polymer-coated gold nano-
particles [2]. EC-to-EC transport was evaluated by quantification of
Lucifer yellow dye spread via gap junctions in cultured EC mono-
layers [3]. Magnetic resonance imaging and histological analysis
were performed to visualize EC- and GCX-dependent atherosclerotic
plaque progression in the mice.
Results: The results demonstrated that GCX repair with exoge-
nous HS, sometimes requiring a co-factor, leads to nanoparticle
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permeability that is similar to healthy conditions, while degraded
GCX is six times more permeable. GCX repair also restores EC-to-
EC transport that was lost by GCX degradation. The effect of GCX
repair on atherosclerosis progression in animals is still under inves-
tigation.
Conclusion: This work will lead to new therapies targeted at the
GCX to address glycocalyx- and endothelial-dependent aspects of
vascular disease.
References:
1. Nam D et al. Am J Physiol Heart Circ Physiol, 2009.
2. Cheng, M et al. Int J Nanomedicine, 2016.
3. Ebong et al. Pflugers Arch, 2013.
Acknowledgments: NIH, NSF; and the contributions of Ju Qiao
and Dr. Anne van de Ven.
382
3D Bioprinted Functional and Contractile Cardiac
Tissue Constructs
S. Lee, Z. Wang, H. Cheng, J. J. Yoo, A. Atala;
Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston-Salem, NC.
Bioengineering of a functional cardiac tissue construct com-
posed of primary cardiomyocytes has great potential for myocardial
regeneration and in vitro tissue modeling. However, its applications
remain limited because the cardiac tissue is a complex and highly
organized structure with unique physiologic, biomechanical, and
electrical properties. In this study, we aimed to develop a con-
tractile cardiac tissue construct with cellular organization, unifor-
mity, and scalability by using a three-dimensional (3D) bioprinting
strategy. Primary cardiomyocytes were isolated from infant rat
hearts and suspended in a fibrin-based composite hydrogel bioink.
This cell-laden hydrogel was sequentially printed with a sacrificial
hydrogel and a supporting polymeric frame through a 300-mm
nozzle by pressured air. Bioprinted cardiac tissue constructs had a
spontaneous synchronous contraction in culture, implying in vitro
cardiac tissue development and maturation. Progressive cardiac
tissue development was confirmed by immunostaining for a-actinin
and connexin 43, indicating that cardiac tissues were formed with
uniformly aligned, dense, and electromechanically coupled cardiac
cells. Bioprinted cardiac tissue constructs exhibited physiologic
responses to known cardiac drugs (epinephrine and carbachol) re-
garding beating frequency and contraction forces. In addition,
Notch signaling blockade significantly accelerated development
and maturation of the bioprinted cardiac tissues. Our results dem-
onstrated the feasibility of bioprinting functional cardiac tissue
constructs that could be used for tissue engineering applications
and pharmaceutical purposes.
383
Manipulating Fibroblast Mechanical Memory
with Phototunable PEG Hydrogels
C. J. Walker1,2, L. A. Leinwand3,2, K. S. Anseth4,2,5;
1Materials Science and Engineering, University of Colorado
Boulder, Boulder, CO, 2BioFrontiers Institute, Boulder, CO,
3Molecular, Cellular, and Developmental Biology, University
of Colorado Boulder, Boulder, CO, 4Chemical and Biological
Engineering, University of Colorado Boulder, Boulder, CO,
5Howard Hughes Medical Institute, Boulder, CO.
Activation of valvular interstitial cells (VICs) to myofibroblasts
and their persistence play a key role in the progression of aortic
valve stenosis (AVS). In healthy valve tissue, VICs transiently
activate to myofibroblasts following injury. However, chronic ex-
posure to stiffened mechanical environments prevents reversal of
myofibroblasts to a quiescent state, resulting in persistently acti-
vated myofibroblasts. This in vivo time-dependent response to
stiffness implies VICs possess a mechanical memory of their past
environments. To study how VICs acquire their persistent pheno-
type, phototunable polyethylene glycol (PEG) hydrogel platforms
were used that mimic physiological stiffnesses. With light, the
hydrogel modulus may be reduced in situ from a pathological
stiffness that activated myofibroblasts, to a soft condition where the
quiescent VIC phenotype can be maintained. With this system, we
identified a time-dependent mechanical dose on stiff hydrogels that
triggers VICs to transform from transiently activated myofibro-
blasts to persistently activated myofibroblasts. After a short time
period (<5 days), activated VICs can return to a quiescent state
when switched from stiff to soft elastic moduli. However, after
VICs are exposed to stiff environments for a long period of time
(>7 days), the cells no longer can return to quiescence. The sig-
naling pathways associated with mechanical memory will be
identified with transcriptome analysis and potential mechanisms
will be validated using siRNAs and/or pharmacological inhibitors.
Understanding how VICs maintain mechanical memory will po-
tentially lead to a much-needed non-surgical treatment for indi-
viduals suffering from AVS.
384
Viability Assessment Of Engineered Heart Constructs:
Effects Of 3d Printing And Use Of Bioluminescence For
Longitudinal Monitoring
N. Muselimyan1, P. Koti1, B. Holmes2, H. Simonyan1,
H. Asfour1, C. Young1, N. Sarvazyan1;
1Pharmacology and Physiology, GWU, Washington, DC,
2Nanochon, Burke, VA.
In the fields of cell biology and tissue engineering, 3D printing
has quickly become a popular and effective method for creating
macroscopic tissue constructs. Yet, there are still significant con-
cerns that bioprinters decrease cell viability due to heat and me-
chanical stresses on cells during printing process. To address these
issues, we compared the viability of primary neonatal rat cardiac
fibroblasts and myocytes before and after an extrusion-based 3D
printing. Analysis of cell viability was conducted with microscopy,
immunocytochemistry, and bioluminescence imaging (IVIS Lu-
mina K machine Perkin Elmer, Waltham, MA). To evaluate the
effect of the 3D printing process on cell proliferation and viability,
3D printed cardiac fibroblast constructs were compared to cardiac
fibroblasts cultured in monolayers. Likewise, 3D printed cardiac
myocyte constructs were compared to cardiac myocytes cultured in
monolayers. We have also evaluated, side-by-side, two viability
assays for non-invasive longitudinal monitoring of engineered
heart tissue. The first one is a standard spectrophotometric assay
based on LDH release. The second relies on luciferin biolumines-
cence and involves infection of tissue construct with recombinant
adenoviral vector encoding firefly luciferase (AdCMVLuc). The
bioluminescence-based approach was found to be a simple-to-use
and highly effective way to monitor construct viability. It also
provided quantitative information about the distribution and pro-
liferation of viable cells within the construct.
385
Metabolic Assessment of Therapies for the Development
of Drug-Eluting Stents
A. De1, M. Pflaum1, D. Wirth2, D. Sedding3, B. Wiegmann4,
A. Haverich4, S. Korossis1;
1NIFE - Lower Saxony Center for Biomedical Engineering,
Hannover Medical School, Hannover, GERMANY, 2Department of
Gene Regulation and Differentiation, Helmholtz Centre for Infection
Research, Braunschweig, GERMANY, 3Department of Cardiology
and Angiology, Hannover Medical School, Hannover, GERMANY,
4Department of Cardiac, Thoracic, Transplant and Vascular Surgery,
Hannover Medical School, Hannover, GERMANY.
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Dental & Craniofacial
387
388
Craniomaxillofacial Tissue Regeneration using 3D-printed
Poly(propylene fumarate) Tissue Engineered Bone Grafts
Luo1, M. E. Wade2, J. Walker3, M. Larsen2, S. Montelone2,
B. Swan2, K. Martin2, R. Skoracki2, P. Larsen2, H. Emam2,
A. Kleinfehn4, Y. Luo4, Y. Xu4, M. Miller2, I. Valerio2, M. Becker4,
D. Dean2;
1,2Plastic Surgery, The Ohio State University, Columbus, OH,
3Youngstown State University, Youngstown, OH, 4Polymer Science,
The University of Akron, Akron, OH.
Craniomaxillofacial injuries represent 25% of U.S. military in-
juries in Afghanistan and Iraq. Additive manufacturing (3D Printing)
allows fabrication of patient-specific tissue engineered grafts. The
resorbable polymer, Poly(propylene fumarate) (PPF), can be 3D-
printed and degrades into non-toxic byproducts. Ring-opening po-
lymerization (ROP)-synthesized PPF was used for its controlled
molecular mass and molecular mass distribution which enables
tuning of degradation and mechanical strength. ROP PPF also im-
proves the UV-based 3D-printing of these implants which was done
on an EnvisionTEC (Dearborn, MI) Perfactory P3 3D-printer. The
implant shape was derived from a Computer Aided Design file that
fills a mandibular segmental defect seen in a 3D Computed Tomo-
graphy scan. The 3D printed porous implant was seeded with bone
marrow-derived human mesenchymal stem cells (hMSCs) and cul-
tured for three weeks to facilitate bone extracellular matrix (ECM)
deposition. hMSC to osteoblast differentiation was confirmed by
increased alkaline phosphatase expression after 18 days of in vitro
differentiation. ECM mineralization and coverage throughout the
implant was shown by scanning electron microscopy and an Alizarin
Red S Assay. A segmental mandibular defect was then created in a
canine model where the implant was affixed with a titanium bar and
screws. CT scans taken every four weeks show substantial neo-bone
formation.
389
Controlling Tissue Patterning in Scaffold-free, Engineered
Dentin-Pulp Complexes
F. Syed-Picard, L. Davidson;
University of Pittsburgh, Pittsburgh, PA.
A major challenge in organ engineering is generating multiple
tissues with proper spatial organization. Recently, we have shown
that scaffold-free constructs (SFCs) formed from human dental pulp
stem cells (hDPSCs) self-assemble into organized dentin-pulp
complexes. Understanding the mechanisms facilitating this pattern-
ing will enhance engineered organ design. We hypothesize that
transforming growth factor beta 1 (TGFb1) induces the formation of
a dentin-like structure on the periphery of the constructs, similar to
processes seen naturally during reparative dentinogenesis, and that
altering TGFb1 concentration gradients across SFCs will modulate
tissue patterning. Scaffold-free engineered dentin-pulp complexes
were formed by culturing hDPSCs in 24-well dishes in osteogenic
differentiation medium. The hDPSCs formed a tissue sheet that
contracted into a spherical tissue composed entirely of the cells
and their endogenous matrix. SFCs were assessed after static culture
+/- TGFb1 or after exposure of a linear gradient of TGFb1 using a
microfluidic device. In the presence of TGFb1, SFCs formed a
dentin-pulp complex with a distinct peripheral dentin-like tissue
characterized by localized mineral deposition and the expression of
dentin proteins. Whereas, SFCs formed without TGFb1 lacked this
dentin structure. Gradients of TGFb1 across the SFCs altered pat-
terning such that a dentin-like tissue formed in the direction of higher
TGFb1 concentration. In this study, we developed methods to gen-
erate engineered, multi-tissue structures with controllable spatial
organization. The ability to control patterning in engineered con-
structs will lead to improved methods for full organ regeneration.
Acknowledgments: This research is funded by NIDCR: K99
DE025088
390
Which Non-invasive Source Of Mesenchymal Stem Cells Have
The Best Osteogenic Potential To Be Used In Bone Tissue
Engineering For Cleft Lip And Palate Patients?
C. Pinheiro1, D. Tanikawa2,3, D. F. Bueno1,4,4;
1Hospital Sirio Libanes, Sa˜o Paulo, BRAZIL, 2Hospital Municipal
Infantil Menino Jesus, Sao Paulo, BRAZIL, 3Faculdade de Medicina
da USP, Sa˜o Paulo, Brazil, Sa˜o Paulo, BRAZIL, 4Hospital Municipal
Infantil Menino Jesus, Sa˜o Paulo, BRAZIL.
The closure of alveolar clefts is a major challenge in rehabilitation
of patients with complete CLP and it is being currently investigated
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the effectiveness of mesenchymal stem cells (MSC) to be used in
alveolar bone reconstruction. Studying new non-invasive sources of
the MSC can open fronts in regenerative medicine.
Purpose: In attempt to provide the best non-invasive source of
mesenchymal stem cells to be used in alveolar bone tissue engi-
neering for CLP patients.
Methods: The strains were obtained from deciduous teeth, or-
bicular oris muscle fragments and fragments of umbilical cord. They
were characterized by flow cytometry and induced to osteogenic
differentiation. The quantification of the calcium deposition mea-
sured by colorimetric assay.
Results: All cell strains reacted positively to mesenchymal
markers (CD29, CD90, CD105, CD166, CD73) and they were gen-
erally negative for CD45, CD34 and CD31. After the in vitro dif-
ferentiation under appropriate conditions, these cell populations can
undergo osteogenic cell differentiation. The best osteogenic potential
were observed at dental pulp stem cells and orbicular oris muscle.
Using real time PCR, we test the expression profile of some neural
crest genes in these cells, we observed the high expression level of
PAX3 gene in dental pulp stem cells, and orbicular oris muscle de-
rived MSC.
Conclusion: the non-invasive sources of MSC with the best oste-
ogenic potential are dental pulp stem cells and orbicular oris muscle,
we suspected that they have the best osteogenic potential, because
these cells can retain part of these neural crest genetic markers.
391
Clinically Relevant Bioprinting Workflow for Bone Tissue
Construct Design And Validation
S. Lee1, C. Kengla1, I. Kim1, C. Wivell2, E. Renteria2, J. J. Yoo1,
A. Atala1;
1Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston-Salem, NC, 2Materialise USA,
Plymouth, MI.
Three-dimensional (3D) bioprinting is emerging as a promising
enabling technology for tissue engineering applications. In this
study, we developed a workflow to take 3D medical images and
utilized them for bone construct design, bioprinting, and in vivo
validation. Medical imaging and 3D bioprinting strategy converged
to allow the fabrication of a structure with complex shape and inner
architecture based on patient anatomy and biomimicry. Bone con-
structs were made of a composition of poly(e-caprolactone) and b-
tricalcium phosphate (PCL/TCP) and fabricated on the Integrated
Tissue-Organ Printing (ITOP) system [1]. We examined bone re-
generation in a critically sized defect at 4 and 8 weeks with the
printed bone constructs. The results showed the increased bone
density and volume and new bone formation and maturation with
time. We demonstrated that the printed bone construts were able to
organize into mature tissues of their specific characteristics in vitro
and in vivo. We validated the concept that patient-specific anatomy
could be translated to 3D bioprinting strategy through medical im-
aging and image processing software with strong clinical relevance.
Acknowledgments: This study was supported by the Armed
Forces Institute of Regenerative Medicine (X81XWH-08-2-0032).
Reference: 1. Kang, H.-W. et al. A 3D bioprinting system to
produce human-scale tissue constructs with structural integrity. Nat.
Biotechnol. 34, 312-319 (2016).
392
Effect of hPDLSCs Transplantation on Periodontal
Regeneration in Rats with Ligature-induced Periodontitis
J. Yun1,2, M. Kim3,2, J. Kim3;
1Department of Periodontology, School of Dentistry and Institute of
Oral Bioscience, Chonbuk National University, Jeonju, KOREA,
REPUBLIC OF, 2Biomedical Research Institute of Chonbuk
National University Hospital, Jeonju, KOREA, REPUBLIC OF,
3Department of Periodontology, School of Dentistry, Chonbuk
National University, Jeonju, KOREA, REPUBLIC OF.
Cell therapy using human periodontal ligament stem cells
(hPDLSCs) has been indicated to be clinically useful in chronic
periodontitis. This study investigated immunomodulation and tissue
regeneration of hPDLSCs in periodontitis model. Rats received silk
ligature around the maxillary 2nd molars on both sides for 5 weeks.
hPDLSCs were injected into each palatal side of maxillary 2nd
molars. The immunological effect of hPDLSCs on gingiva and
spleen was determined by flow cytometry for isolated T lympho-
cytes. The frequency of regulatory T cell (Treg) increased approxi-
mately 1.5-fold (P< 0.01) in the spleen and 1.9-fold (P< 0.001) in the
gingiva at 7 days post-injection of hPDLSCs compared to ligature
only group. Regenerative efficacy of hPDLSCs was estimated
by mCT and histological analysis. The periodontal tissue regenera-
tion was shown significantly at 8 weeks after the treatment of
hPDLSCs. These results suggest that hPDLSC could upregulate Treg
and increase periodontal regeneration. *Acknowledgement: This
work was supported by the National Research Foundation of Korea
(NRF) grant funded by the Korea Government (MSIP) (NRF-
2015R1A2A2A01004589)
393
Effect of Estrogen Deficiency on Loaded and Non-loaded
Area of Temporomandibular or Knee Joint
H. Yang1, Y. Seong2, S. Hwang1;
1Department of Oral and Maxillofacial Surgery, Seoul National
University Dental Hospital, Seoul, KOREA, REPUBLIC OF,
2Dental Research Institute, Seoul National University, Seoul,
KOREA, REPUBLIC OF.
Low level of estrogen has regarded as a main contributing factor
of temporomandibular joint (TMJ) arthritis in youngwomen patients.
However, there is lack of evidence about the occurrence of arthritis in
knee joint (KJ) related with estrogen deficiency. This study aimed to
investigate the effect of estrogen deficiency on the loaded and non-
loaded bone area of TMJ or KJ. Total of 21 SD rats were allocated
into three groups, the sham-surgery group, the ovariectomy (OVX)
group and the estrogen replacement group following OVX. At 12
weeks after OVX, all groups were scarified. Changes in the bone area
of KJ and TMJwere analyzed usingmicro-CT.We analyzed the bone
areas in TMJ and KJ each, which were compartmentalized into three
areas on loaded, middle and non-loaded area. BMD and three-
dimensional micro-CT parameters were compared between TMJ and
KJ. Non-loaded area of TMJ showed significant decreases of BV/TV
and BMD in OVX rats, which was recovered with the estrogen re-
placement. However, there was no difference in BV and BMD either
in loaded area of TMJ or in all areas of KJ in both loaded and non-
loaded OVX rats. Middle area of TMJ in OVX rats with or without
loading showed a significant decrease in BV/TV, but no difference in
BMD. These results revealed that OVX-mediated estrogen defi-
ciency led to a significant decrease of bone formation and quality in
non-loaded bone area of TMJ and no influence on bone area of KJ,
suggesting that TMJ is more sensitive to estrogen deficiency.
394
Efficacy of the Collagen Sponge Combined with rhBMP-2
and Alendronate on Bone Regeneration
H. Yang1, T. Cho2, I. Kim2, B. Lee2, S. Hwang1,2;
1Department of Oral and Maxillofacial Surgery, Seoul National
University Dental Hospital, Seoul, KOREA, REPUBLIC OF,
2Dental Research Institute, Seoul National University, Seoul,
KOREA, REPUBLIC OF.
Inspired by the osteogenic cell differentiating and osteoclast
suppressing capabilities of alendronate (ALN), we manufactured a
composite type of ALN-loaded collagen sponge (ALN-CS) which
controls the early detrimental effect of high-dose recombinant human
bone morphogenetic protein (rhBMP)-2. This study aimed to eval-
uate ALN-CS as a high-dose rhBMP-2 carrier by investigating its
initial biomolecular effect and efficacy on intramembranous
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ossification at 1, 4, 8, and 24 weeks using a rat calvarial defect model
compared with nonloaded CS. The in vitro rhBMP-2 release in the
ALN-CS exhibited a lower burst followed by a sustained release
despite lack of calcium, compared to that in CS alone. In vitro
Characterization showed that osteoblast differentiation and miner-
alization of mesenchymal stromal cells were more enhanced with
ALN-CS. The ALN-CS-BMP group showed higher expression of
bone-forming/resorbing markers in vivo than the CS-BMP group at 1
week. However, osteoclasts activation in the ALN-CS-BMP group
was significantly reduced over CS-BMP group. ALN-CS-BMP
promoted early and dense ossification at the initial defect, with 100%
greater bone mass, 20% greater bone density, and less fatty marrow
tissue than CS-BMP, which continued during the whole healing
period. However, CS or ALN-CS alone failed to show complete
defect closure even at the 24-week healing interval. Our results
demonstrate that ALN-CS has remarkable advantages over CS alone
in high-dose rhBMP-2 delivery, with potent suppression of resorp-
tion, early and dense ossification with less fatty marrow formation,
which highlights its great clinical potential as a rhBMP carrier for
bone regeneration at intramembranous ossification site.
395
Application of Novel Osteogenic Agent, Oxy133 for Alveolar
Cleft Osteoplasty in a Rodent Model
A. Hokugo, R. Bakshi, S. Zhou, R. Jarrahy;
UCLA, Los Angeles, CA.
Objectives: Bone morphogenetic proteins (BMPs) have played a
central role in the development of regenerative therapies for bone re-
construction, including applications in cleft and craniofacial surgery.
However, the high cost and significant side effect profile of BMPs limits
their broad application. Osteogenic oxysterols, naturally occurring
products of cholesterol oxidation, are a promising alternative to BMPs.
The osteogenic capacity of these inert and relatively inexpensive
molecules has been documented in rodent and rabbit models of local-
ized bone formation. We studied the impact of Oxy133, a novel oxy-
sterol analogue, on in vivo bone regeneration in a rodent cleft model.
Methodology: A critical-sized alveolar cleft (7x4x3mm) was
generated according to the previously published method and one of
the following treatment options randomly assigned to each defect:
collagen sponge incorporated with 1, 10, or 20mg of Oxy133, BMP-
2, or no treatment. The maxilla was harvested for histologic and
radiographic analyses.
Results: The defect treated with collagen sponge incorporated
with 20mg Oxy133 and BMP-2 demonstrated robust bone regener-
ation. Additionally, a lower dose of Oxy133 (1mg) showed sub-
stantially increased bone formation as compared to no treatment.
Histological studies of 20mg Oxy133 group revealed almost com-
plete bridging of the alveolar defect with architecturally mature new
bone without any inflammation.
Significance: Collectively, these radiographic and histologic data
demonstrate that Oxy133 supports new bone formation in a cleft
palate model in the absence of any additional osteogenic growth
factors. Oxy133may therefore represent a viable alternative to BMP-
2 in bone tissue engineering paradigms.
Matrix & Extracellular Matrix Biology
in Regenerative Medicine
396
Evaluation of Native and Non-native Bio-inks For 3D Printing
of Human Tissues
C. Motter Catarino1, T. Baltazar2, S. Stuchi Maria-Engler3,
P. Karande1;
1The Howard P. Isermann Department of Chemical and Biological
Engineering, Rensselaer Polytechnic Institute, Troy, NY,
2Department of Bioengineering and, Universidade de Lisboa,
Lisboa, PORTUGAL, 3Department of Clinical Chemistry and
Toxicology, University of Sa˜o Paulo, Sa˜o Paulo, BRAZIL.
A variety of human skinmodels have been developed for applications
in regenerative medicine and efficacy studies. Typically, they employ
material of animal origin, which besides poorly representing physiology
of the human tissue microenvironment, can also potentially lead to ad-
verse immune responses. The use of recombinant extracellular matrix
proteins can overcome these limitations. In parallel, there is a growing
interest in employing 3D bioprinting platforms for tissue engineering
given the possibility for precise cell positioning, flexibility, reproduc-
ibility and high throughput. Here we present our work on combinatorial
screening of skin matrix components for the development of bio-inks to
be used with primary human skin cells for 3D bioprinting of skin. The
screening of the basal membrane proteins (collagen IV, laminin and
fibronectin) demonstrated that certain protein combinations increase
proliferation of keratinocytes compared to the control (no protein coat-
ing) while others mitigated cell proliferation. In the investigation of the
dermal components (collagen I and III, elastin and hyaluronic acid), the
primary influence on the rate of fibroblast proliferation was attributed to
the source of the collagen type I (rat tail, human and bovine). We will
present our results on the influence of the specific bioinks on skin cells
from different donors (adult and neonatal skin origins) as well as the
influence on biological and mechanical properties of the skin constructs
generated with these bioinks. Our approach highlights the relevance of
the bioinks to the development of 3D bioprinted Reconstructed Skin
Models that are suitable for clinical translation.
397
Influence of the Cell Microenvironmental Dimensionality
on The Signaling Pathways in Chondrogenic Differentiation
of Human Adipose Derived Stem Cells
B. Choi, J. Ahn, S. Lee;
Department of Biomedical Science, CHA University, Seongnam-si,
Gyeonggi-do, KOREA, REPUBLIC OF.
To design a novel stem cell niche for cartilage tissue engineering,
many researchers have tried to investigate how cells interpret microen-
vironmental signals. Yet most of these signaling studies have been per-
formed in two-dimensional (2D) environments. Although 2D in vitro
studies are useful to explain general principles about the regulation of
cellular signalingpathways bybiochemical and biophysical cues, they do
not recapitulate phenomena in 3D microenvironments. It is not clear
whether regulation of TGF-b3/Smad and MAPK signaling pathways
during chondrogenesis in 3D microenvironments are comparable with
those in 2D environments. In this study, we compared 2D and 3D TGF-
b3/Smad andMAPK signaling pathways in human adipose derived stem
cells (hADSCs) using tissue culture polystyrene plates for 2D and pho-
tocrosslinkable hyaluronic acid (HA) hydrogels for 3D. We found that
chondrogenesis in 3D was enhanced compared to 2D and phosphoryla-
tion of Smad2 increased with TGF-b3 treatment and phosphorylation of
p38 and JNK increased when hADSCs were encapsulated in HA hy-
drogels. In addition, effect of TGF-b3 conjugation in HA hydrogels on
these signaling pathways and cartilage regenerationwere further studied.
Taken together, these results showed that TGF-b3/Smad signaling was
dependent on the addition of the biochemical cue, TGF-b3,whileMAPK
signaling of p38 and JNK was dependent on the biophysical cue, di-
mensionality. Additionally, our results suggest that the interplay of bio-
chemical and biophysical factors on cellular signaling pathways should
be considered when designing novel biomaterials for tissue engineering.
398
Role of Extracellular Matrix in organ specificity
and differentiation
I. Ullah1, I. Fischer1, A. Rabien2, J. F. Busch2, B. Ergu¨n2, P. Reinke1,
A. Kurtz1;
1Berlin-Brandenburg Center for Regenerative Therapies, Berlin,
GERMANY, 2Department of Urology, Charite´ –
Universita¨tsmedizin Berlin, Berlin, GERMANY.
The instructive properties of the extracellular matrix (ECM) depend
onmatrix architecture (spatial cues), structuralmatrix proteins (chemical
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cues) and on functional matrix components such as growth factors
(functional cues). To investigate the tissue specificity of these cues, we
used ECM from different organs and determined their effect on human
induced pluripotent stem cell (iPSC) - derived mesodermal cells. Using
sections of ECM (600mM thick) derived from human kidney, heart and
liver we showed organ specific ECM instruction of iPSC - derived pre-
cursor mesoderm: heart ECM triggers differentiation into cardiomyo-
cytes, kidneyECM triggers differentiation into renal cells and liver ECM
does not trigger differentiation of mesodermal cells under identical cul-
tivation conditions. Cell identity of ECM - instructed cells was deter-
mined by PCR and immunocytochemistry and showed expression of
nephron cells on renal matrix and beating cardiomyocytes on heart ECM
expressing relevant markers. The iPSC-derived mesoderm cells on kid-
ney ECMdid not show any cardiacmarkers, and on heart ECM, no renal
markers were detected. The endodermal derived liver ECM did not in-
duce any renal, cardiac or liver markers in mesodermal cells. The slice
ECM allows to easily observing cell phenotypes on different ECMs
under the microscope or using high content screening devices.
Conclusion: Our results shows that our decellulrized matrix has
the ability to instruct IPS derived- mesodermal cells to differentiate
into their respective tissue cells and that specific matrix (organ spe-
cific) cues exist.
399
Improved Decellularized Lung Scaffold Recellularization with
ECM Hydrogel Coating
B. M. Young, R. A. Pouliot, P. A. Link, R. L. Heise;
Biomedical Engineering, Virginia Commonwealth University,
Richmond, VA.
Decellularized tissue has shown great promise as a whole lung
replacement but current approaches have incomplete cell coverage.
Insufficient attachment is partly due to direct exposure of the lung
basement membrane to harsh decellularization chemicals causing
functional ECM to be removed. The goal of this research is to add a
tissue specific ECM hydrogel to the airway surfaces to increase cell
attachment. Pig/mouse lung decellularization and hydrogel formation
were done according to established protocol [1]. SDS-PAGE,western
blotting, and rheometry were used to optimize and characterize hy-
drogel parameters. The hydrogel was applied as a thin ECM coating
to decellularized mouse lungs before seeding with human epithelial
cells using a programmed rotating device. Control decellularized
lung scaffolds were reseeded with cells alone. Seeding efficiency was
then assessed by histology and DNA quantification. ECM hydrogel
characterization shows that lung specific ECM profile is preserved
through processing with some protein fragmentation and mechanical
properties similar to native lung tissue. Recellularization using a slow
rotation set up and ECM hydrogel coating significantly increased cell
attachment and distal lung coverage compared with cells alone. Im-
provement of recellularization of decellularized scaffolds is an im-
portant first step towards whole lung regeneration.
Reference: 1. Pouliot R, Link P, Mikhaiel N, Schneck M, Va-
lentine M, Kamga F, Herbert J, Sakagami M, Heise R. Development
and characterization of a naturally derived lung extracellular matrix
hydrogel. Biomed Mater Res Part A. 104A. 1922, 2016.
Acknowledgments: NSF CAREER CMMI 135162, CHRB 236-
05-13, NIH R01AG041823.
400
Protein Nanoparticles from Porcine Lung Shift Macrophages
to Pro-Regenerative Phenotype
P. A. Link, A. M. Ritchie, G. M. Cotman, M. S. Valentine,
R. L. Heise;
Biomedical Engineering, Virginia Commonwealth University,
Richmond, VA.
Severe lung diseases can only be cured through lung transplanta-
tion; however, lung transplants are limited by availability and donor
compatibility. Engineering a transplantable lung has several hurdles to
overcome still such as ensuring cells are located in the appropriate
niches. Scaffolds based on extracellular matrix (ECM) proteins are
regularly used in clinical applications for other tissues. Initiating self-
repair of diseased lungs may be possible if clinicians can distribute
healthy ECM scaffolding to the diseased regions of the lung. We
hypothesize that nanoparticles formed from ECM proteins will induce
pro-regenerative effects in macrophages. We decellularized pig lungs,
leaving only a protein scaffold. The remaining proteins were digested
in acid and electrosprayed to form nanoparticles. The formed particles
were sterilized and added to bone-marrow derived monocytes from
C57BL6 mice. The formed nanoparticles had an average size of
222 nm. The macrophages exposed to nanoparticles increased CD206
25% over unactivated macrophages. Additionally, CD11b was de-
creased in the macrophages exposed to nanoparticles by 11% com-
pared to unactivated macrophages. These results may provide a novel
method to distribute healthy ECM to diseased regions of lung tissue
which may begin repair in certain lung diseases. This work was sup-
ported by NSF GRFP, and NSF CAREER CMMI-13516.
401
Combination of Amnion and Fibrin as a Potential HybridMatrix
for Guided Wound Regeneration Applications
R. Rashmi1, V. S. Harikrishnan1, V. Prashanth2, L. K. Krishnan1;
1Department of Applied Biology, Sree Chitra Tirunal Institute for
Medical Sciences and Technology, Trivandrum, Kerala, INDIA,
2ZumHeilen, Ti-Med, Sree Chitra Tirunal Institute for Medical
Sciences and Technology, Trivandrum, Kerala, INDIA.
Amniotic membrane (amnion/AM) has inherent anti-inflammatory,
anti-fibrotic, angiogenic and strong analgesic nature, whereas fibrin is a
natural wound healing scaffold. Effect of both fibrin and amnion on
chronic wound healing has been studied independently. This study
analysed the efficiency of the hybridmatrix of amnion and fibrin (AM-F)
by long term culture of dermal-like fibroblasts for accelerated and
guided wound regeneration. Adipose-derived mesenchymal stem cells
(ADMSCs) (IEC & IC-SCRT approved) pre-differentiated to fibro-
blasts were used for in vitro experiment, after confirming specific
marker expressions for fibroblast-specific protein-1 (FSP-1) and ex-
tracellullar matrix (ECM) molecules like fibrillin-1, collagen I, colla-
gen IV and elastin after 7d and 14d of induction. Lineage commitment
was evident by 7d and these cells were transferred to hybrid matrix for
long term culture of 20d and 40d. ECM quantification of the decel-
lularized matrix after induction showed higher ECM proteins as
compared to control (ADMSC-grown matrix). Hence the highly reg-
ulated fibroblast properties of induced ADMSC makes it an good
candidate for skin tissue engineering. To estimate the benefits of AM-F
matrix, proliferation assay by 3H-thymidine uptake, ECM expression
studies, collagen & elastin quantification after 20d and 40d of culture
were performed. Results confirmedmatrix effect on ECM synthesis by
ADMSC-derived fibroblasts. Wound healing efficiency was analyzed
by treating 4 cm2 size burnwounds in rabbitmodel. Healing in terms of
reduction in wound size, epithelialisation, collagen organization and
angiogenesis in 28 days was remarkably high in wounds treated with
AM-F matrix as compared to fibrin alone or sham wounds.
402
A Partial Least-Squares Model of Cardiac Reprogramming
Predicts Reprogramming Outcomes for Different
Microenvironments
Y. P. Kong1, A. Y. Rioja1, X. Xue2, Y. Sun2, J. Fu2, A. J. Putnam1;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Mechanical Engineering, University of Michigan, Ann Arbor, MI.
In recent years, in vivo cardiac reprogramming has emerged as a
promising paradigm-shifting strategy for heart regeneration. The
reprogramming efficiencies reported, although low (*1%), were
sufficient to achieve small improvements in ischemic heart function.
We hypothesize that further functional improvement may be attained
by engineering the cellular microenvironment. We investigated key
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microenvironmental influences on reprogramming using a tractable
polyacrylamide cell culture platform to independently vary the
modulus, ligand density, and ligand identity. The dedifferentiation
and cardiogenic efficiencies observed were modulated by the three
parameters, each in a unique fashion, thus generating a multi-
dimensional response landscape. This complex biological response
necessitated the use of a systems biology analysis, which connected
the extracellular input signals to the reprogramming outcomes
through cell-integrated signals. Observations of the YAP signaling
axis and cell generated traction forces, two established mechan-
otransduction signals, in fibroblasts reprogrammed on the poly-
acrylamide platform were consequently used in the derivation of a
partial least-squares (PLS) regression model. The resulting two
principle component PLS model predicted the outputs of the training
data with low residuals, and was then successfully able to predict
reprogramming outcomes for cells cultured on a different substrate
system. The inclusion of additional signals in this data-driven model
may further improve its predictive power, and thereby help in the
selection of biomaterial platforms that can improve cardiac repro-
gramming efficiencies in situ.
403
The Role of Complex Mechanical Stimuli on Differentiation of
3T3/L1 Fibroblastic Preadipocytes and the Lipid Accumulation
H. Ghazizadeh1, J. Plotkin2, Y. Patel3, S. Aravamudhan1;
1Nanoengineering, North Carolina Agricultural and Technical State
University, Greensboro, NC, 2Nanoscience, University of North
Carolina at Greensboro, Greensboro, NC, 3Biology, University
of North Carolina at Greensboro, Greensboro, NC.
Cells, especially those of fat and muscle, are constantly subjected to
mechanical stress during various physical activities. Understanding the
role of the physical activity and the resultant mechanical stresses are
critical for various cellular activities in the body, such as controlling cell
growth, migration, differentiation, apoptosis, and wound repair. Adi-
pogenesis process, which controls the overall metabolism through se-
cretion of adipokine hormones, is known to be effected by the
mechanical environment in the form of both static and dynamic stim-
ulation. In this study, we report on our understanding of the role of
regular (up to 10%) and cycle-by-cycle variable (0-75%variability with
mean stress amplitude maintained at 10%) stretch on the differentiation
of 3T3/L1 fibroblastic preadipocytes cultured on flexiblemembranes, in
a custom-built biaxial cell stretching system [1]. Prior to stretch, cells
were plated on the flexible membrane, and were allowed to proliferate
to reach the appropriate confluency. They were then treated with both
MDI and mechanical stretch for 45 hours and were allowed to differ-
entiate for 5 more days prior to any evaluation. Oil Red-O was used to
evaluate the cell differentiation through comparing the number of dif-
ferentiating cells, the number of lipid droplets per cell, and the size
range of the lipid droplets. The results showed excessive inhibition of
differentiation for applied variable mechanical stretch.
Reference: 1. Karumbaiah, L., S. E. Norman, N. B. Rajan, S.
Anand, T. Saxena, M. Betancur, R. Patkar and R. V. Bellamkonda
(2012). Biomaterials.
Acknowledgments: The Joint School of Nanoscience and Na-
noengineering at Greensboro.
404
Development and Characterization of 3D Printed
Pericardium Scaffolds to Promote Remodeling
in Vascular Wound Applications
L. Bracaglia1, M. J. Messina1, S. Winston1, V. Kuo1,2,
M. Lerman1,3, J. P. Fisher1;
1Fischell Department of Bioengineering, University of Maryland,
College Park, MD, 2Sheikh Zayed Institute for Pediatric Surgical
Innovation, Children’s National Health System, Washington, DC,
3Surface and Trace Chemical Analysis Group, Material
Measurement Laboratory, National Institutes of Standards and
Technology, Gaithersburg, MD.
A permanent, living replacement for vascular wall injury would
improve outcomes of major surgical reconstructions. An implantable
material that achieves this endpoint can be engineered by incorporating
extracellular matrix (ECM) molecules into structurally-supportive
synthetic hydrogels. These components together can promote endo-
thelial cell growth as well as modulate the inflammatory action from
macrophages, key indicators of long term incorporation of the de-
gradable scaffold. We have developed a 3D-printable and degradable
scaffold by combining polyethylene glycol (PEG) acrylate and ho-
mogenized pericardium matrix (HPM). HPM provides tissue specific
variety of structural proteins including collagen, fibronectin, and gly-
cosaminoglycans. HPM and PEGacrylate formed a hybrid hydrogel
with significantly distinct modulus between 0.5 and 20 kPa. Tissue
specific cell growth on hybrid hydrogels culminated with a co-culture
of rat aortic endothelial cells (RAECs) and rat macrophages (RMCs).
ECs cultured on HPM hydrogels laid more matrix with more VWF
staining compared to cells on PEG scaffolds. RMCs developed an M2
phenotype in response to low amounts (0.03%,w/v) of HPM in culture,
but responded with inflammatory phenotypes to high concentrations
(0.3%, w/v). In co-culture, both M1 and M2 macrophages were de-
tected, along with a combination of both inflammatory and healing
cytokines. This result may not be pathogenic, as some inflammation is
important to early wound repair, with a dynamic shift to an M2
dominated environment at later time points. Finally, models of neo-
natal vasculature were manufactured using DLP 3D printing, which
demonstrated the utility of this approach to building specific structures
for use in congenital heart defect reconstruction.
405
Derivation and Cellular Response Towards a Porcine-Derived
Vocal Fold Lamina Propria Extracellular Matrix Hydrogel
E. A. Wrona1,2, R. C. Branski3, D. O. Freytes1,2;
1UNC/NCSU Joint Department of Biomedical Engineering, Raleigh,
NC, 2Comparative Medicine Institute, Raleigh, NC, 3New York
University School of Medicine, New York, NY.
Due to their anatomical location, vocal folds are highly susceptible to
injury from external and internal stressors that can lead to irreversible
damage and changes in function. As the structure and composition of
the vocal folds are heavily linked to their unique function, we hy-
pothesize that a vocal fold-derived extracellular matrix (ECM) would
be the ideal scaffold in a regenerative approach to vocal fold repair. Our
group has previously described a porcine-derived vocal fold lamina
propria ECM (VFLP-ECM)1. In order to optimize the deliverymodality
of the VFLP-ECM, we have developed an injectable hydrogel form of
the ECMscaffold and have studied the effects of tissue specificity using
human vocal fold fibroblasts (hVFF) and human peripheral blood-
derived macrophages (hPB-Macrophages). Both cell types play unique
roles during the inflammatory and wound healing response at the site of
vocal fold injury. In the present study, we compare VFLP-ECM with
other ECMhydrogels (such as collagen, heart, bladder) in their ability to
activate and modify gene expression of hVFFs and hPB-macrophages.
This information will help us tailor the VFLP-ECM hydrogel to mod-
ulate the environment present during vocal fold injury.
Acknowledgments: We thank our funding sources: The UNC-
Chapel Hill/NCSU Joint Department of Biomedical Engineering,
The North Carolina Translational and Clinical Sciences (NC TraCS)
Institute and The Comparative Medicine Institute (CMI) at NC State
University.
Reference: 1. Wrona et al. Derivation and Characterization of
Porcine Vocal Fold Extracellular Matrix Scaffold. Laryngoscope
126, 4, 2016.
406
Elucidating Interactive Signaling of Biochemical andMechanical
Cues on MSC Chondrogenesis in 3D Using Gradient Hydrogels
D. Zhu1, E. Liu1, P. Trinh2, F. Yang1,3;
1Bioengineering, Stanford University, Stanford, CA, 2Biology,
Stanford University, Stanford, CA, 3Orthopedic Surgery, Stanford
University, Stanford, CA.
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Stem cell niche is a multi-factorial environment including bio-
chemical and mechanical cues. While extensive studies have high-
lighted the important role of biochemical or mechanical cue alone on
stem cell fate regulation, little is known about how interactive niche
signaling modulate stem cell fate in 3D. The goal of this study is to
employ a 3D gradient hydrogel platform we recently developed for
high-throughput screening of interactive niche signaling on MSC
fate. PEG-norbornene (PEGNB) and linear dithiol (SH) were used to
control stiffness, and methacrylated chondroitin sulfate (CS-MA)
and hyaluronic acid (HA-MA) were chemically incorporated as
biochemical cues. Hydrogel with stiffness gradient higher than
*20 kPa generally inhibited neocartilage deposition, and varying
biochemical cues did not lead to noticeable differences. When en-
capsulated in hydrogels with lower stiffness gradient (0.5 - 10 kPa),
chondroitin sulfate led to most robust cartilage matrix formation by
mesenchymal stem cells (MSCs) compared to that of hyaluronic
acid. Finally, we have utilized such platform for optimizing scaffold
design with stiffness ranging from 0.5 kPa to 15 kPa and chondroitin
sulfate concentration ranging from 3% to 8%. Such design supported
robust MSCs proliferation and matrix deposition while induced
distinct zonal-dependent tissue formation that mimics native carti-
lage zonal properties. Such 3D gradient hydrogels could provide a
powerful tool for elucidating the complex interactions between
multifactorial niche cues in a high-throughput manner, and facilitate
rapid identification of optimal niche cues that led to desirable stem
cell fate and tissue formation.
Musculoskeletal
407
Creation of a Novel Ubiquitous tdTomato Rat and Tracking
of Cells in an Implanted Engineered Skeletal Muscle Tissue
B. C. Syverud1, J. P. Gumucio2, B. L. Rodriguez1,
O. M. Wroblewski1, C. L. Mendias3, L. M. Larkin2;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Molecular and Integrative Physiology, University of Michigan, Ann
Arbor, MI, 3Orthopaedic Surgery, University of Michigan, Ann
Arbor, MI.
The growing deficit in suitable tissues for patients awaiting organ
transplants demonstrates the clinical need for engineered tissues as
alternative graft sources. Demonstrating safety and efficacy by
tracking the migration and fate of implanted cells is a key consid-
eration required for approval of promising engineered tissues. In this
study, we hypothesized that fabrication of engineered skeletal muscle
using cells isolated from a ubiquitously fluorescent animal would
allow tracking of cell migration following implantation. To test this
hypothesis, we generated a rat ubiquitously expressing tdTomato
(tdT) expression. Following validation of tdT fluorescence expres-
sion on the cell and tissue level, we fabricated engineered skeletal
muscle units (SMUs) from isolated tdT satellite cells and implanted
these SMUs into a volumetric muscle loss defect of the tibialis an-
terior (TA) muscle in a rat ubiquitously expressing green fluorescent
protein (GFP). Following a recovery period of 28 days, the repaired
TA muscles were explanted for histological analysis. Explanted
tissues demonstrated both tdT and GFP expression in the repair site,
indicating involvement of both implanted and host cells in the re-
generation process. It is worth noting that tdT fluorescence intensity
was consistently greater than GFP intensity. These results demon-
strate our successful generation of a novel tdTomato rat while also
showing one potential application taking advantage of this tdTomato
fluorescence. This unique animal could assist researchers in similar
cell tracking experiments and ultimately serve as a valuable pre-
clinical model system for promising tissue engineering therapies.
408
Evaluating Cyclic vs. Static Uniaxial Strains for Engineering
Functional Skeletal Muscle Grafts
S. M. Somers, J. Gilbert-Honick, R. Kabir, W. L. Grayson;
Biomedical Engineering, Johns Hopkins University, Baltimore, MD.
Tissue engineering of skeletal muscle grafts is a promising
strategy for the treatment of volumetric muscle loss. Yet, it re-
mains challenging to engineer grafts with functional properties
comparable to those of native tissues. Prior studies have reported
enhanced functional outcomes in response to static and cyclic
uniaxial tensile strains. However, differences in their experi-
mental designs make it impossible to compare the relative efficacy
of applied strain protocols. To address this, we have developed a
novel bioreactor platform for the application of various strain
regimens to C2C12s grown on aligned, electrospun fibrin scaf-
folds. We will investigate whether the application of static or
cyclic uniaxial strain more effectively increases the structural,
morphological, and functional outcomes of tissue engineered skel-
etal muscle constructs. We seeded 300,000 C2C12s onto each scaffold
and cultured under free-swelling conditions for 3 days before begin-
ning the strain application process. The experimental groups in-
cluded 0% strain (control) or 10% strain amplitude for 6 hours a day
using a static or cyclic (triangular waveform; 0.5Hz) profile. In all
groups the C2C12s exhibited multi-nucleation and alignment parallel
to the fibrin microfibers. Engineered muscle grafts spontaneously
contracted with forces ranging from 5 - 15 mN. Preliminary results
have shown that both static and cyclic strain increase the myotube
diameter and the number of nuclei/myotube as compared to controls,
as well as the appearance of spherical ‘myoballs’. Ongoing studies will
further investigate the interplay between biophysical cues and cell
morphology and explore the molecular mechanisms governing these
changes.
409
Bioinspired Three Dimensional Construct with Silk
Fiber Reinforcement for Regeneration of Load Bearing
Soft Tissues
Y. P. Singh1, M. Adhikary1, N. Bhardwaj2, B. K. Bhunia1,
S. Mehrotra1, B. B. Mandal1;
1Department of Bioscience and Bioengineering, Indian Institute
of Technology Guwahati, Guwahati, INDIA, 2Biological and
Chemical Sciences Section, Life Sciences Division, Institute
of Advanced Study in Science and Technology, Guwahati,
Guwahati, INDIA.
Fiber-reinforced composite scaffolds have gained ground in
tissue engineering applications by integrating mechanical strength
with ability to mimic native tissue structures1. Advancing this
strategy, our work focuses on blending silk fibers (mulberry Bom-
byx mori and non-mulberry Antheraea assamensis) with the bio-
compatible silk matrix material to improve its application for
cartilage tissue engineering. The physical characterization studies
of the fabricated scaffolds revealed that the scaffolds were porous
with interconnected pores, had swelling property for nutrient up-
take and biodegradable. The scaffolds supported proliferation of
primary chondrocytes and maintained chondrogenic nature of the
cells which was evident from alcian blue staining of GAG (sGAG)
secreted by the cells. Biochemical analysis showed collagen, sGAG
and DNA increased with time on culturing chondrocytes on the
scaffold after 28 days. The non-mulberry silk composites showed
enhanced growth and proliferation as compared to the mulberry
silk. This was further attested by upregulation (*2 fold) of
cartilage-specific ECM gene markers- Collagen-II, SOX9 and ag-
grecan, post 28 days of culture. The presence of intrinsic integrin
binding RGD sequence2 in Antheraea assamensis silk validated its
preferable choice over its mulberry counterpart. Easy aqueous
based fabrication technique, suitability of fibers as a substratum for
greater cell attachment and mechanical robusticity of fabricated
silk fiber-reinforced scaffolds establishes them as a sustainable
alternative. Such composite scaffolds have tantalizing potential to
refill the damaged tissue void by in vivo neo-tissue formation post
implantation.
References:
1. Li, Gang, et al. Macromolecular bioscience 15.8 (2015): 1125-
1133.
2. Gupta Adarsh, et al. Scientific reports 5 (2015): 12706.
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410
Tissue Engineered Muscle Repair (TERM) for treatment
Of A Critically Sized VML Injury in the Rat Latissimus Dorsi
J. A. Passipieri1, E. L. Mintz2, H. B. Baker3, J. Dienes1, K. Smith1,
D. Remer, 229081, G. J. Christ1,4;
1Biomedical Engineering Department, University of Virginia,
Charlottesville, VA, 2Pathology Department, University of
Virginia, Charlottesville, VA, 3The Fisher Department of
Bioengineering, University of Maryland, College Park, MD,
4Department of Orthopaedic Surgery, University of Virginia,
Charlottesville, VA.
Volumetric muscle loss (VML) injuries are extremely complex
and lead to permanent functional and cosmetic deficits. Improved
therapeutics for VML injury largely depend on the development of
more germane preclinical animal models. Herein, we tested the
effectiveness of the TEMR technology platform (i.e., muscle
progenitor cells seeded on an acellular porcine-derived bladder
acellular matrix/scaffold) to restore function in a biologically
relevant VML injury in the rat latissimus dorsi muscle (LD). The
VML injury model entailed resection of 1.8 cm2 of the LD. TEMR
constructs were implanted at the time of injury (n = 6). Control
groups included a no repair group (n = 6), and implantation of an
acellular scaffold (n = 8). Ex vivo muscle contraction force was
evaluated 8 weeks post-surgery via electrical field stimulation in
an organ bath. Contralateral LD muscles served as positive con-
trols. Samples were submitted to histological analysis. TEMR
implantation resulted in generation of 84% of isometric force
(TEMR: 2.7 – 0.2 N vs native LD: 3.2 – 0.07 N), which was sta-
tistically significantly greater than the 56% and 65% observed in
the untreated NR, and BAM group, respectively (NR: 1.8 – 0.1 N;
BAM: 2.2 – 0.2N; p < 0.05). TEMR constructs integrated with native
tissue, and were well vascularized 8 weeks post-implantation, with
new muscle tissue formation evident only in the TEMR-treated
group. In summary, TEMR constructs promoted substantial func-
tional recovery in a critically-sized, biologically relevant VML
injury in rats. These findings bode well for potential clinical ap-
plications to craniofacial repair (e.g., cleft lip) of the TEMR tech-
nology platform.
Acknowledgments: W81XWH-14-2-0004
411
Carbon Dot Doped SPION Gelatin Freeze Dried Composites
for Osteochondral Regeneration
B. Das, P. Dadhich, P. Pal, S. Dhara;
School of Medical Science & Technology, Indian Institute of
Technology, Kharagpur, Kharagpur, INDIA.
Mechanotransduction allows MSCs to differentiate into dif-
ferent phenotype. Exploration of magnetic field is one of the major
method by which this can be achieved. In current study, carbon
dots (CD) doped super paramagnetic nanoparticles (SPIONS) are
synthesized and explored for combined effect of chemical induc-
tion of CDs and magnetic mechanotransduction of SPIONs. The
doped nanoparticles were prepared by hydrothermal method and
characterized by TEM, XRD, XPS, FTIR, Raman spectroscopy,
SQUID and AES. Further, the nanoparticles were mixed with
gelatin to prepare freeze dried scaffold. The scaffold structure and
porosity was checked using SEM and in vitro cyto-compatibility
was performed using fluorescence microscopy, MTT assay and
ROS scavenging assay. Osteochondral differentiation was checked
by culturing MSCs in to scaffold and actuating them using 0.05 T
rare earth bar magnets. Via PCR and ALP assay osteochondral
regeneration was observed. The cell cultured scaffolds were im-
planted on rodent model for ectopic osteochondral differentiation
study. On histology, features of both chondrogenesis and osteo-
genesis were observed. No specific feature related to iron toxicity
was observed.
412
BMP-2 Indirectly Induces Angiogenesis During Large Bone
Defect Regeneration
H. B. Pearson1, L. Zhao2, D. E. Mason1, M. A. Kacena2,
J. D. Boerckel1,3;
1University of Notre Dame, Notre Dame, IN, 2Indiana University,
Indianapolis, IN, 3University of Pennsylvania, Philadelphia, PA.
Critical-sized bone defects do not heal without intervention and their
repair is often limited by insufficient neovascularization. Bone mor-
phogenetic protein-2 (BMP-2) stimulates osteogenesis and has been
proposed to induce angiogenesis by directly stimulating endothelial
cells. Thrombopoietin (TPO) has been shown to stimulate bone healing
through osteoblast activation by megakaryocytes, and may also pro-
mote angiogenesis. We hypothesized that BMP-2 or TPO delivery
would enhance vascularized regeneration of critical-sized bone defects
compared to treatment with scaffold alone. 8mm defects were created
in rat femora and stabilized with fixation plates without medullary
reaming. Defects were treated with a collagen sponge hydrated with
PBS, 5mg BMP-2, 5mg TPO, or 25mg TPO. Neovascularization was
evaluated by microCT angiography at weeks 3 and 8. Bone formation
was measured post-mortem at 3 weeks or in vivo at 4 and 8 weeks.
In vitro, endothelial colony forming cells (ECFC)were treatedwith 100
or 200ng/mL of BMP-2 and/or TPO and evaluated for migration, tu-
bulogenesis, and SMAD 1/5/9 nuclear localization. In vivo, BMP-2
significantly induced bone formation and neovascularization, but TPO
treatment did not significantly affect either. Studies have observed
significant effects of TPO delivery on bone regeneration, suggesting
limitations of the collagen sponge delivery method or need for med-
ullary reaming to promote megakaryocyte mobilization. BMP-2 and
TPO had no significant effect on in vitro ECFC migration or tubulo-
genesis, but BMP-2 supplementation increased SMAD nuclear locali-
zation. These data suggest that the effect of BMP-2 on angiogenesis is
secondary to bone formation-induced vascular recruitment rather than
direct endothelial cell activation.
413
A Whole Joint-in-Motion Culture System Reveals a Critical
Role of Glucose in Regulating Articular Cartilage and Growth
Plate Matrix Production
C. Hui Mingalone1, C. R. Nehme2, K. Garvey1, R. E. Banks1,
T. P. James3, W. C. Messner4, L. Zeng1;
1Tufts University, Boston, MA, 2Mechanical Engineering, Tufts
University, Medford, MA, 3Rose-Hulman Institute of Technology,
Terre Haute, IN, 4Tufts University, Medford, MA.
Introduction: Currently, there are no suitable in vitro systems to
evaluate mechanically and biochemically induced osteoarthritis
(OA), hampering therapeutic development. We designed a system
(JM1) to study cartilage destruction by facilitating joint culture
movement, and used this system to evaluate the effects of glucose
and mechanical stimuli on cartilage.
Materials and methods: 8-week-old Balb/c mouse knee joints
were isolated and mounted into JM1 devices. Joints were actuated
through a 0.5Hz extension-flexion cycle for 8hrs/day (‘‘dynamic
stress’’). Controls included joints cultured in petri dishes with no
movement (‘‘static’’) and on rotating platform (‘‘on rotator’’). Joints
were cultured in varying glucose or mannitol mediums. After 7 days,
joints were harvested and histology was assessed via OARSI scoring.
Results: 1. Glucose and mechanical loading synergistically affect
joint health. A) Increasing levels of glucose caused a reduction of
matrix in the articular cartilage. B) ‘‘Dynamic stress’’ group showed
highest cartilage matrix loss at any glucose level. 2. High glucose-
induced joint cartilage matrix loss is not due to osmolarity. Glucose
was substituted by mannitol to control for osmolarity effects. Our
results showed that high glucose metabolism, rather than osmolarity,
induced cartilage matrix loss.
Conclusions: This study demonstrates a uniquely designed
dynamic system for culturing whole mouse that recapitulates
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mechanically-induced human OA development. It allows for the
dissection of biochemical and biomechanical inputs, and serves as a
platform for mechanistic and therapeutic testing. Using this device,
we found that mechanical stress potentiates cartilage matrix loss
under high glucose levels. This study has implications for diabetes-
related OA.
414
Immune-Dysregulation in a Rat Model of Infected Femoral
Segmental Bone Defect
H. Ahn1, M. L. Schenker1, R. J. Kadakia12, P. Pradhan3,
L. D. Weinstock4, L. B. Wood4, K. Roy3, R. E. Guldberg3,
N. J. Willett1;
1Department of Orthopaedics, Emory University, Decatur, GA,
2School of Medicine, Emory University, Atlanta, GA, 3Georgia
Institute of Technology, Atlanta, GA, 4Mechanical Engineering,
Georgia Institute of Technology, Atlanta, GA.
Open contaminated fractures, particularly in the setting of seg-
mental bone loss, are a clinical challenge. In the setting of trauma and
infection, it has been proposed that immune-dysregulation and as-
sociated hardware failure. The purpose of this study was to investi-
gate the long-term immune response in a clinically-relevant model of
infected segmental bone defect. Thirteen-weeks-old female SD rats
underwent unilateral 3mm mid-diaphyseal femur bone defects sur-
gery, with plate stabilization. Infection group received biomaterial
soaked with luciferase expressing Staphylococcus aureus. Bacterial
growth and bone bridging was monitored using a Bruker Imaging
system. Systemic immune response was measured by peripheral
serum cytokine array and flow cytometry analysis of splenocytes,
bone marrow cells and adjacent soft tissue from defect site. Micro CT
scans were performed to quantify bone bridging and periosteal
growth. Bioluminescent signal appeared in infection animals at d3
post-surgery and was present up to d7. Serial radiographs showed no
bridging from infected animals at any time point. Three of four in-
fected rats had hardware failure and observed gray necrotic soft
tissue around the hardware. Luminex cytokine analysis demonstrated
infected animal had increased expression of immune suppressive
cytokines (IL-10) and reduced concentration of inflammatory cyto-
kines (TNF-a, IL-1) compared to controls. Moreover, infected rats
showed increased immune suppressive cell (MDSCs, Tregs) popu-
lation in spleen, bone marrows and infected tissues. This study would
be able to establish a clinically-relevant animal model of infected
non-union with hardware failure, and present supportive preliminary
evidence of chronic systemic immune dysregulation due to infection.
415
3D Printed Biphasic Osteon-like Scaffolds for Bone
Tissue Engineering
C. Piard, J. P. Fisher;
Fischell Departement of Bioengineering, University of Maryland,
College Park, MD.
Attempting to mimic the physical and chemical architecture of
biological tissues is particularly challenging, and often requires ad-
vanced fabrication techniques. We are interested in engineering
cortical bone tissue, and specifically its component osteons, which
consist of organized concentric calcified regions with interpenetrated
vasculature. Extrusion-based 3D printing (3DP) offers an efficient
tool for accurate fabrication of biomaterial scaffolds with tunable
properties. In the present study, we have developed a 3DP biphasic
bone-like scaffold, containing two separate osteogenic and vascu-
logenic cell populations encapsulated in fibrin bioink and co-printed
along a supporting polycaprolactone (PCL) carrier scaffold. To this
end, fibrin bioink was first optimized to improve the resolution of
printed fibers and ensure a reproducible printing process. The influ-
ence of printing parameters on cell survival was then investigated.
Human umbilical-vein endothelial cells (HUVEC) and human mes-
enchymal stem cells (hMSC) laden fibrin were printed in concentric
rings and cultured in vitro. After two weeks, cell viability (Live/
Dead) and cell proliferation (Picogreen) were assessed. Im-
munohistochemistry and quantitative polymerase chain reaction
showed an upregulation of osteogenic (alkaline phosphatase, bone
morphogenetic protein 2) and vasculogenic (vascular endothelial
growth factor) markers. Dynamic mechanical analysis showed an
elastic modulus of 0.7MPa– 0.3MPa under compression. Biphasic
scaffolds (fibrin and PCL) showed improved mechanical properties
with an average compressive modulus of 103MPa – 26.8MPa. Fi-
nally, biphasic biomimetic scaffolds seeded with rat aortic endo-
thelial cells and MSCs were implanted subcutaneously in rats.
Results showcase the capacity of our 3DP biphasic construct to
provide accurate physical cues for large-scale vascularized bone.
416
Using Ultrasound for Non-Destructive Evaluation of Engineered
Cartilage Damage by Sliding Shear
M. Motavalli1, J. Berilla2, J. Dennis3, A. Caplan1, J. Mansour4,
J. Welter1;
1Biology, Case Western Reserve University, Cleveland, OH, 2Civil
Engineering, Case Western Reserve University, Cleveland, OH,
3Orthopedics, Baylor College of Medicine, Houston, TX,
4Mechanical and Aerospace Engineering, Case Western Reserve
University, Cleveland, OH.
Overview:Cartilagemust function under transient compression and
shear. Under these conditions, catastrophic damage to tissue engineered
(TE) cartilage occurs, which limits its in-vivo utility. Currently, damage
is only observed after a test, providing no information as to when the
failure occurred. Here, we prototype an ultrasonic (US) system for
identifying tissue damage under compression and sliding shear.
Methods: 31 samples of scaffold free MSC-based TE cartilage
were glued to stainless steel reflectors, placed in the US testing de-
vice, and US signals between the cartilage surface and the reflector
were recorded. Samples were then subjected to between 0 and 1000
shear loading cycles, after which US data was recorded again. In
some cases, the transducer was scanned across the sample to evaluate
roughness. Samples were then processed for histology.
Results and Discussion: US scanning correctly identified several
failure modes of TE cartilage under sliding shear. In most samples,
damage was observed after tests, despite no visual cues of failure
during the tests. Ultrasound easily demonstrated thickness changes in
the samples pre- and post-sliding. Samples with eroded or roughened
surfaces demonstrated reduced or absent surface reflections. Surface
erosion was clearly illustrated by scanning across the sample.
Conclusions: Non-destructive monitoring of sliding shear experi-
ments using an ultrasound transducer built into the test rig identifies
early failure, greatly enhancing the evaluation of TE cartilage.
Acknowledgments: This work was funded in part by a grant from
the NIH/NIBIB P41EB021911.
417
Modeling and Analysis of Gait Biomechanics after Volumetric
Muscle Loss Injury
J. Dienes1, X. Hu1, K. D. Janson1, C. Slater1, R. Courter1,
K. McCormack1, G. J. Christ1, S. D. Russell2;
1Biomedical Engineering, University of Virginia, Charlottesville,
VA, 2Orthopaedic Surgery, University of Virginia,
Charlottesville, VA.
Many studies are underway to research methods of regenerating
muscle as a treatment for volumetric muscle loss (VML) injury, but
few have evaluated VML injury in relation to the biomechanics re-
quired for normal function. The ability to quantify changes in rat gait
will facilitate identification of relevant functional deficits resulting
from injury, as well as the functional effectiveness of regenerated
muscle. Four 12-week female Lewis rats were tested on a Panlab Rat
Treadmill at 40 cm/s with video recorded at 2, 4, and 8 weeks post-
surgery. Baseline testing occurred the week prior to surgery. Surgery
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consisted of removal of 20-30% of the right tibialis anterior (TA)
muscle and the extensor digitorum longus (EDL) and extensor hal-
licus longus (EHL) synergists. Prior to all runs, 3mm/5mm reflective
markers were placed on the joint centers of the pelvis, spine, tail, hip,
knee, ankle, and toe. Rats were recorded using Vicon Nexus motion
capture software with a 7-camera setup collecting at 120Hz. Marker
data was exported to a custom OpenSim rat hindlimb model for
simulation of gait kinematics. All data was filtered at 30Hz and post-
simulation analyses were performed in Matlab. We saw more hip
abduction, hip external rotation, and ankle plantarflexion post-injury
of the TA muscle which is indicative of circumduction, a classic
compensation for drop foot. These changes were durable over the 8-
week time course of study. The addition of force plates to capture
ground reaction forces in the future will further inform development
of more effective regenerative technologies for VML injuries.
418
The Osteogenesis and Degradation of 3D Printed Calcium
Silicate/Polydopamine/Polycaprolactone Scaffolds for Bone
Regeneration
C. Ho1,2, K. Wang2, M. Shie1, Y. Chen1, B. Wang2,3,4;
13D Printing Medical Research Center, China Medical University
Hospital, Taichung, TAIWAN, 2Georgia Tech Manufacturing
Institute, Georgia Institute of Technology, Atlanta, GA, 3H. Milton
Stewart School of Industrial and Systems Engineering, Georgia
Institute of Technology, Atlanta, GA, 4School of Materials Science
and Engineering, Georgia Institute of Technology, Atlanta, GA.
The emergence of three-dimensional printing techniques has been a
breakthrough in bone tissue engineering. Although there is still a
shortage of available biomaterials which exhibit both osteogenic ac-
tivity and printability could be readily used, incorporation of bio-
ceramics into printable composites which possess good osteogenic
activity. Calcium silicate-based materials (CS) have attracted much
attention due to their advantages in promoting the proliferation and
differentiation of osteogenic cells. Exciting results of the printed CS/
polymer scaffolds on the osteogenesis have been reported. Un-
fortunately, the presence of Ca(OH)2 in CS could accelerate the deg-
radation rate of the thermoplastic polymer, resulting in the premature
failure of the implanted scaffolds. Thus, we proposed a facile route to
fabricate the CS/polycaprolactone (CS/PCL) composites without af-
fecting the degradation rate through coating polydopamine (PDA) on
the surface of CS. The results indicated that the presence of PDA
between CS and PCL could be served as an anchor layer to reinforce the
compressive strength of the scaffolds. The in vitro degradation exper-
iments conducted by monitoring the pH change and weight loss of the
scaffolds after soaking in simulated body fluid confirmed that the in-
troducing of PDA into the composite indeed minimized the level of the
pH raise and decreased the degradation rate of the composite scaffolds.
More importantly, the CS/PDA/PCL scaffolds supported higher levels
of proliferation, alkaline phosphatase activity, and mineralization of
human mesenchymal stem cells than CS/PCL. Taking together, these
results suggest its potential application in bone regeneration.
Neuronal Tissue
419
The Effect of Keratin on Spinal Cord Injury Recovery
Z. Zabarsky1, A. Marquez-Lara1, T. Luo1, A. Jinnah1, M. Van
Dyke2, T. L. Smith1;
1Orthopaedic Surgery,Wake Forest University,Winston-Salem, NC,
2Biomedical Engineering and Mechanics, Virginia Polytechnic
Institute and State University, Blacksburg, VA.
Spinal cord injury (SCI) is a devastating neurologic event with
complex pathophysiological mechanisms that is difficult to treat:
currently no effective therapies are available. Keratin nanomaterials
(KN) can induce macrophage polarization and promote the M2 anti-
inflammatory phenotype to attenuate inflammatory responses. The
purpose of this study was to evaluate the ability of KN to reduce
secondary damage after SCI and improve the environment for nerve
regeneration and restoration of function. Female Lewis rats were
trained on a DigiGait Imaging System treadmill and baseline gait
recordings were obtained for two weeks before SCI. SCI was induced
at T9 with a blunt force of 150Kdyn, producing moderate injury with
partial recovery. Treatment groups were: intrathecal KN, topical KN,
and saline dural application controls. Functional recovery was ob-
served at 3 and 6 weeks post-SCI and compared to pre-SCI record-
ings, followed by tissue harvest for histology. Gait metrics of Stance
phase, %Swing/Stride, %Brake/Stride, Stride frequency, Stride
length, Paw area variability, and Paw angle were compared by two-
way repeated measures ANOVA followed by Bonferroni post-hoc
comparisons. Topical KN rats demonstrated increased fine motor
control, normal stride length and frequency, and normal paw angles
compared to controls or intrathecal KN and demonstrated values
similar to baseline. Quantification of lesion area and glial scar protein
yielded no significant differences between groups. KN-treatment
may limit secondary damage to improve motor function but future
experiments are required for understanding tissue healing and
mechanism of action.
420
Soluble Fractions Of ECM Decrease Viability Of Primary
Glioma Cells
M. H. Murdock1, J. Chang1, G. Hussey1, N. Amankulor2, J. Engh2,
S. Badylak1;
1Surgery, University of Pittsburgh, Pittsburgh, PA, 2Neurological
Surgery, University of Pittsburgh, Pittsburgh, PA.
Gliomas are the most lethal and common primary tumor type in
the central nervous system (CNS) across all age groups; affected
adults have a life expectancy of just 14 months. As glioma cells
invade the surrounding normal parenchyma they remodel the sur-
rounding extracellular matrix (ECM), suggesting that the native
normal microenvironment is not ideal for their progression. Recent
reports describe suppressive and/or lethal effects of mammalian
ECM hydrogels derived from normal (non-neoplastic) sources upon
various cancer types, though the ECM components responsible for
these effects are unknown.
We have shown that soluble fractions of ECM derived from
porcine dermis, small intestinal submucosa (SIS), and urinary blad-
der (UBM) all decrease the viability of human primary glioma cells,
and that UBM-ECM soluble fraction showed the most potency. In a
cell viability assay (MTT) normalized to the media treatment, non-
neoplastic CHME5 and N1E-115 cells scored between 103% and
114% when treated with a 3X concentrated soluble fraction solution
of dermis-ECM, SIS-ECM, or UBM-ECM. Two primary high grade
glioma cell types scored 78.5% and 90.5% with dermis-ECM,
48.5% and 64% with SIS-ECM, and 17% and 30.5% with UBM-
ECM (average of N = 2).We further observed that glioma cells have
decreased migration, and markedly decreased proliferation in the
presence of these matrix-embedded cues, indicating that non-
neoplastic ECM contains potent homeostatic regulators that are
capable of abrogating malignancy. Delivering soluble fractions of
ECM to a tumor site may represent a novel approach to cancer
therapy, sidestepping traditional cytotoxic therapies in favor of
utilizing putative endogenous anti-tumor pathways.
421
Peptide Amphiphile Scaffolds For Spinal Cord Regeneration
Z. Alvarez Pinto, A. N. Edelbrock, K. Sato, S. I. Stupp;
Northwestern University, Chicago, IL.
Spinal cord injury (SCI) is a debilitating condition affecting an
estimated 1,275,000 Americans at a cost of over 40 billion dollars
each year. SCI causes immediate damage of nervous tissue accom-
panied by loss of local blood vessels, release of inflammatory me-
diators and the cellular immune response at the site of injury. These
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processes lead to further axonal injury and cell death, which impede
endogenous tissue repair and limit prospective repair approaches. To
date, there is no single biological intervention that can address all of
the events that damage the spinal cord. Previously, our group dem-
onstrated that peptide amphiphile (PA) molecules self-assemble into
nanofibers that can be used as bioactive scaffolds, which were ben-
eficial upon injection in an experimental mouse model of SCI. Here, I
integrated orthogonal bioactive moieties that addressed different
aspects of the injury response in order to increase the potency of the
bioactive biomaterials that have already been shown to bridge the
lesion site effectively. This was accomplished by designing and
testing new fibroblast growth factor 2 (FGF-2) mimetic PA mole-
cules that self-assembled into nanostructures as an angiogenic and
neurogenic biomaterial platform for treating SCI. The FGF-2 mi-
metic sequence incorporated in a PAwas co-assembled with a known
PA that presents the neuroactive pentapeptide epitope from laminin,
IKVAV-PA, to promote vascularization, nerve regeneration, func-
tional recovery, and to limit the damage. This project evaluated the
synergies between the different PA sequences and defines the most
effective combinations, and determine the best stoichiometry
in vitro.
422
The Development of a Human Cortex Model for High
Throughput Neurotoxicity and Drug Screening
G. Nzou, S. S. Seale, E. E. Wicks, R. R. Wicks, J. D. Jackson,
A. J. Atala;
Wake Forest Institute of Regenerative Medicine, Wake Forest
University School of Medicine, Winston Salem, NC.
Increased cerebrovascular permeability due to blood brain barrier
(BBB) disruption is known for destabilizing brain homeostasis,
neuronal function and nutritional distribution in brain tissue. The
BBB controls these functions through a dynamic structure of tight
junctions and adherent junctions formed mainly between endothelial
cells. The integral selectivity characteristic of the BBB limits ther-
apeutic options for many neurologic diseases and disorders. Cur-
rently, very little is known about the mechanisms that govern the
dynamic nature of BBB. To date, most in vitro models only utilize
endothelial cells, pericytes and astrocytes. These models neglect the
role of other cell types in the brain cortex such as the neurons, mi-
croglia and oligodendrocytes. Thus, we seek to create a 3D spheroid
model of the blood brain barrier consisting of all major cell types that
closely recapitulate normal human brain tissue. Spheroids containing
6 cell types were maintained in static culture with growth media
exchange every other day and were fixed in 4% formaldehyde and
Immunohistochemistry was performed for TJ, AJ and cell specific
markers. Our data demonstrates expression of TJs and AJs. Fur-
thermore, our data on BBB functionality assessment using MPTP,
MPP+ and Mercury chloride in our spheroids indicate charge se-
lectivity through the barrier. Our spheroid model would have ap-
plications in drug discovery and neurotoxicity and cytotoxicity
testing. This model can serve as a tool for individualized, patient-
specific blood brain barrier disease models through the use of rep-
resentative cell types derived from induced pluripotent stem cells
(iPSCs).
423
3D Bioengineered Model of Human Enteric Nervous System
E. Manousiouthakis, Y. Chen, D. Cairns, Y. Razavi, D. L. Kaplan;
Biomedical Engineering, Tufts University, Medford, MA.
Bidirectional interactions between the central nervous system and
the gastrointestinal tract (GI) via the enteric nervous system sur-
rounding the GI tract are unmapped. Assortments of neurodevelop-
mental disorders are associated with disturbances in the
gastrointestinal system. There is a need for 3D intestinal systems
in vitro that permit the study of complex human cell interactions,
including the enteric nervous system. Tissue engineered systems
offer the potential to encompass the properties of endogenous human
systems in a modular, tunable format as in vitro models. Therefore,
we focus on the development of in vitro 3D human innervated in-
testinal tissues that encompasses both human induced neural stem
cells (hiNSCs) differentiated into pertinent enteric nervous system
neural cell types, as well as enterocyte-like (Caco-2) and goblet-like
(HT29-MTX) cells that create the intestinal epithelial layer, building
off of our earlier systems. Cultures of in vitro ENS (ivENS) scaffolds
indicate the capability to function for at least 27 days, indicating the
long term viability of experiments. Seeded hiNSCs migrate from
seeding locations toward the lumen of the scaffold to the epithelial
cells. Additionally, nNOS-expressing neurons were found within the
ivENS system. These tissue models elevate experimental options in
technology to understand neural circuits controlling the intestine and
communicating with the microbiome.
424
Fabrication of Anisotropically Organized 3d Neuronal
Bundles Using 3d Bioprinting
S. Noh;
UNIST, south korea, Ulsan, KOREA, REPUBLIC OF.
Nerve tissues have several structural features such as bundle
of axons and linearly ordered cellular components. Despite many
efforts for engineering of artificial nerve tissue, the introduced
methods still have limitations in producing 3D biomimetic archi-
tectures. Herein, a method to construct linearly organized, cable-
like bundles of 3D neuronal tissues has been proposed by using
contractile force of cells. A cellular bundle structure was fabricated
by applying neural cells, gelatin based bio-ink and synthetic
polymer into 3D bioprinting. Boundary conditions to induce con-
tractile force were obtained by printing fixed pillars on both side.
The printing results were evaluated by imaging and cytocompat-
ibility tests. Staining results successfully showed that bioprinted
artificial tissues were anisotropically organized. Overall structures
were well maintained for than week. Moreover, cellular activities
such as cell proliferation and differentiation to neuronal tissue were
well maintained after printing. These results indicated that the
proposed method is quite suitable to produce 3D biomimetic circuit
for nerve tissue engineering.
References:
1. Bang S, Na S, Jang JM, Kim J, Jeon NL. Engineering-Aligned
3D Neural Circuit in Microfluidic Device. Advanced Healthcare
Materials. 5, 159, 2016.
2. Kim SH, Im S-K, Oh S-J, Jeong S, Yoon E-S, Lee CJ, et al.
Anisotropically organized three-dimensional culture platform for
reconstruction of a hippocampal neural network. Nature Commu-
nications. 8, 14346, 2017.
425
Nerve Growth Factor incorporated Coaxial Electrospun
Cellulose Acetate/Polyvinylpyrollidone(CA-PVP-CA)
Nanofibers for Neural Cell Differentiation
R. Sharma, L. Zhang, S. Aravamudhan;
Joint School of Nanoscience and Nanoengineering, North Carolina
A&T State University, Greensboro, NC.
Efficient repair and regeneration of nerve gaps requires scaffold
to biomimic topographical structure of the native tissue along with
sustained supply of neurotrophic factors1. Electrospun nanofibers
mimicking extracellular matrix (ECM) have been extensively used
as nerve grafts because they could modulate diverse cellular
functions like differentiation2. Here, we present the synthesis of
core-shell nanofibers with Cellulose acetate (CA) shell and Poly-
vinylpyrrolidone (PVP) core material with nerve growth factor
(NGF) encapsulated in the core using coaxial electrospinning
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technique. After extensive optimization, (CA-PVP-CA) nanofibers
with average diameter of 493 nm were successfully obtained and
characterized by SEM, TEM, XPS and FTIR techniques. Next,
enzyme-linked immunosorbent assay (ELISA) was used to evaluate
the release of NGF from the coaxial nanofibers over period of
10 days. The effect of this coaxial scaffolds on the differentiation of
PC12 cells were evaluated over a period of 14 days and results show
that coaxial nanofibers could effectively promote differentiation of
PC12 cells.
References:
1. Kuihua Z, Chunyang W, Cunyi F, Xiumei M, Journal of Bio-
medical Materials Research Part A 102,2680,2014.
2. Kim TG, Lee DS, Park TG, International Journal of Pharma-
ceutics, 338,276,2007.
Acknowledgments: This work was performed in part at the Joint
School of Nanoscience and Nanoengineering, a member of the Na-
tional Nanotechnology Coordinated Infrastructure supported by the
National Science Foundation (Grant ECCS-1542174).
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Polymeric Microparticles and Extracellular Matrix Hydrogels
Facilitate Stem Cell Delivery for Spinal Cord Repair
A. Viswanath1, N. Tatic1, K. M. Shakesheff1, A. des Rieux2,
L. J. White1;
1University of Nottingham, Nottingham, UNITED KINGDOM,
2Universite Catholique de Louvain, Brussels, BELGIUM.
Traumatic spinal cord injuries (SCI) cause devastating neurological
deficits and disabilities. Initial trauma leads to immediate disruption of
neural tissue by axon shearing, blood vessel rupture and cell death.
Subsequently a cascade of secondary events occurs composed of is-
chemic injury, inflammation, cell death, demyelination of axonal tracts
and the creation of a glial scar. Cell transplantation to replace damaged
cells, provide trophic support and promote functional recovery is a
favourable strategy for SCI. Stem cells derived from dental tissues are
an attractive source due to accessible supply, high proliferation rates
and the potential for autologous transplantation. The objective of the
present study was to evaluate the suitability of different biomaterials,
including surface modified PLGA microparticles and extracellular
matrix hydrogels, to act as cell delivery vehicles for spinal cord repair.
Polymeric microparticles coated with spinal cord ECM hydrogels
promoted dental stem cell viability. Furthermore, release of glial de-
rived neurotrophic factor (GDNF) from microparticles stimulated
neural differentiation of the dental stem cells. Viability of dental stem
cells was similar in hydrogels derived from bone and spinal cord ex-
tracellular matrix (ECM). Spinal cord ECM hydrogels did not gel
in vivo whereas bone ECM hydrogels had higher storage moduli,
providing a stiff and fast gellingmaterial to overcome the flow of blood
and cerebrospinal fluid in vivo. The combination of bone and spinal
cord ECM hydrogels facilitated gelation, enhanced gel properties and
provided a homologous ECM hydrogel. These results will inform
further studies utilizing combinations of ECM hydrogels and micro-
particles for spinal cord repair.
427
3D Printing for Spinal Cord Injury
J. Koffler1, W. Zhu2, S. Chen2, M. Tuszynski1;
1Neuroscinces, UCSD, La Jolla, CA, 2Nanoengineering, UCSD,
La Jolla, CA.
There exists a great unmet medical need to develop novel therapies
that promote axonal regeneration after spinal cord injury. While
bioengineered scaffolds have been reported to support axon regener-
ation into spinal cord lesion sites, these technologies have been limited
by foreign body responses at implantation sites, cumbersome pro-
duction requirements, limitations in scaling to human size injuries and
lack of biomimicry of the natural spinal cord. We now report the first
use of advanced microscale 3D bioprinting to fabricate a scaffold
mimicking the complex fascicular architecture of the spinal cord. The
printed scaffold is simply and rapidly produced, reduces foreign body
responses, and supports linear, aligned host axonal regeneration in the
most challenging model of spinal cord inure - complete transection.
Moreover, loading neural stem cells into the scaffold supports host
axon regeneration and functional recovery in long-term in vivo studies.
This technology advances efforts to promote neural repair.
Production Assistance for Cellular Therapies
428
Role of Myelin Topography And Alignment on the
Activation of Astrocytes
F. Gurer1, V. Bulmus1, K. Baskerville2, T. Ozdemir3;
1Bioengineering, Izmir Institute of Technology, Izmir, TURKEY,
2Biology, Lincoln University, Lincoln, PA, 3Bioengineering,
Gaziosmanpasa University, Tokat, TURKEY.
Introduction: Myelin sheath is thick layers of neuronal plasma
membrane that serves as a capacitor during neuronal signal trans-
mission. Decay in myelin sheath is associated with several neuro-
degenerative diseases such as multiple sclerosis and Alzheimer
disease. Although its primary purpose is to insulate and accelerate the
neuronal impulse, very few studies focused on the geometrical aspect
of myelination in neuronal function. Here, we developed a versatile
platform to study the effect of myelin topography and alignment on
the neuronal signal transmission.
Materials and Methods: Electrospinning of Poly-epsilon-
caprolactone (PCL) was performed to achieve fibers with 0.5 mm
diameter. After electrospinning, the fiber surface was treated with
oxygen plasma and activated surfaces finally exposed to myelin so-
lution in 100% EtOH for surface coating. For astrocyte activation
10,000 astrocytes/10mm disc shaped scaffolds were seeded onto
sterilized scaffolds and cultured for 5 days and tested for astrocyte
activation markers. For neuronal signal transmission, myelinated
scaffolds were conjugated with motor proteins and further microtu-
bule movements were recorded using fluorescent microscope.
Results: Astrocyte spreading and in vivo like morphology was
observed on biomimetic fibrous scaffolds. Astrocyte activation
markers (GFAP and nestin) were checked using immunostaining.
The topographies and alignment on neuronal signal transmission
results show a direct correlation between myelin topography and
microtubule gliding speed.
Discussion and Conclusions: This study demonstrates of an ex-
perimental platform to investigate the effect of myelin topography
and astrocyte function as well as neuronal signal transmission using a
novel microtubule gliding assay.
429
Therapeutic Outcomes of Insulin-like growth factor-1 Released
from Alginate-gelatin Microbeads on Stress Urinary
Incontinence in Rats with Simulated Childbirth Injury
x. gu, H. Yan, L. Zhong, Y. Jiang, J. Yang, D. Lin, X. Yuan,
M. Kuang, A. Rietsch, A. Atala, E. Opara, M. Damaser, Y. Zhang;
WakeForest BaptistHealthRegenerativeMedicine,Winston Salem,NC.
Introduction and Objectives: Insulin-like growth factor-1 (IGF-
1) treatment can accelerate recovery from stress urinary incontinence
(SUI) induced by simulated childbirth injury in rats. A local sus-
tained delivery method is ideal for further clinical applications to
avoid side effects of IGF-1. Our goal was to determine the effects of
controlled release of IGF1 from alginate-gelatin microbeads (IGF1-
A-G-beads) on sphincter tissue repair in a rat SUI.
Methods: Female SD rats (n= 44) were divided into 4 equal
groups: A) sham vaginal distension (VD) + saline; B) VD + saline; C)
VD + empty A-G-beads; D) VD + IGF1-A-G-beads. All rats received
periurethral injections of A-G-beads immediately after VD. Leak
point pressure (LPP) testing and external urethral sphincter (EUS)
electromyography (EMG) were performed 1 week after VD. Urethral
tissue and anterior vagina were dissected for further analysis.
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Results: LPP was decreased in B or C group compared to A group.
In contrast, LPP of D group was greater than C group. The increase in
EUS EMG amplitude was reduced in B or C group compared to A. Rats
in D group had EUS EMG amplitude response to LPP testing part-
way between and not significantly different from either the A or B
group. Histological analysis demonstrated well-developed and orga-
nized skeletal muscle fibers in D group. In contrast, substantial muscle
fiber attenuation and disorganization was observed in B or C group.
Conclusions: IGF1-A-G-beads improved recovery in rat model of
SUI, suggesting that these microspheres could provide a local sus-
tained delivery method for IGF-1
Regenerative Pharmacology
430
Micropatterned Substrates To Promote and Dissect
Reprogramming of Human Somatic Cells
K. Saha, J. Carlson-Stevermer, T. Harkness, R. Prestil, S. Seymour,
G. Knight, R. Ashton;
University of Wisconsin-Madison, Madison, WI.
Reprogramming of human somatic cells to generate induced pluri-
potent stem cells (iPSCs) produces valuable precursors to disease
modeling and regenerative medicine. However, the reprogramming
process can be inefficient and noisy, creating many partially repro-
grammed cells in addition to fully reprogrammed cells. Understanding
and managing this population heterogeneity arising from reprogram-
ming could result in significant gains in creating robust cell therapies
and diseasemodels. To address these shortcomings, we have developed
a novel platform that enables dynamic live-cell microscopy of thou-
sands of cell subpopulations undergoing reprogramming. This platform
also allows multiplexed and independent control of the biophysical
environment. Micropatterning at island diameters below 450 microns
facilitated a change in shape, size and clustering of nuclei to promote
somatic identity erasure. Increased proliferation, cell density and de-
creased intercellular YAP signaling accompanied these nuclear chan-
ges. A combination of eight nuclear characteristics could be used to
track reprogramming progression and distinguish partially repro-
grammed cells from those that were fully reprogrammed. We could
use these characteristics to develop a regression model to aid in the
purification of high-quality iPSCs. Thus, micropatterned substrates
constitute a new tool for facile iPSC production and can be used in
high-throughput to probe and understand the subcellular changes
that accompany human cell fate transitions. Enhanced capabilities
to produce iPSCs on these micropatterned substrates can move both
allogeneic and autologous PSC-based regenerative medicine closer
to the clinic and use in precision medicine.
431
Regenerative Pharmacology for Post-Prostatectomy Sexual
and Urinary Dysfunction in a Nonhuman Primate Model
J. K. Williams1, J. P. Zambon1, A. Hemal2, M. Patel2,
S. K. Lankford, 271011, K. Andersson1, G. Badlani2;
1Regenerative Medicine, Wake Forest University, Winston-Salem,
NC, 2Department of Urology, Wake Forest University, Winston-
Salem, NC.
The objective of this study is to characterize a nonhuman primate
model of post-prostatectomy erectile and urinary dysfunction and test
local chemokine (CXCL12) therapy for these chronic conditions.
Eleven adult male cynomolgus monkeys were used; 2 for the study of
normal pelvic anatomy. Nine animals were evaluated for sexual be-
haviour and abdominal leak point pressures (ALPP) pre- and 6 months
post-prostatectomy. Five animals were necropsied for tissue evaluation
6 months post-surgery. The other four animals received urethral in-
jections of the chemokine CXCL12 (125 ng) 6 weeks following the
prostatectomy and were evaluated for up to 4 months thereafter.
Erectile function was assessed by measuring sexual behaviour in
mating situations. The anatomy, innervation and vascular supply to the
prostate and surrounding tissues of these monkeys are substantially
similar to those of human beings. After prostatectomy, there was
sustained and marked decrease in mating success (mounting attempts,
lack of intromission, ability to achieve and tomaintain an erection) and
in ALPP. Histologically there was marked reduction in nerve supply to
the urethra and penis. In the 4 animals receiving CXCL12, mating
success and ALPP improved within one month post injection and
urethral and penile innervation were restored by 4 months post injec-
tion. We conclude that radical prostatectomy in this model produces
persistent erectile and urinary dysfunction. Local injection of the cell
mobilizing chemokine CXCL12 restored urinary and erectile structure
and function and may represent a treatment for these conditions.
432
Adiponectin Improves The Osteointegration of Titanium
Implant Under Diabetic Conditions by Reversing Mitochondrial
Dysfunction and Oxidative Stress via the AMPK Pathway
X. Hu, Y. Feng, L. Wang, G. Xiang, W. Lei;
Department of Orthopedics, Xijing Hospital, The Fourth Military
Medical University, Xi’an, People’s Republic of China, Xi’an,
CHINA.
Diabetes-induced reactive oxygen species (ROS) overproduction
would result in compromised osteointegration of titanium implant (TI)
and high rate of implant failure, yet the underlyingmechanisms remain
elusive. Adiponectin (APN) is a fat-derived adipocytokine with strong
antioxidant, mitochondrial-protective and anti-diabetic efficacies. We
hypothesized that mitochondrial dysfunction under diabetes may ac-
count for the oxidative stress in osteoblasts and titanium-bone interface
instability, which could be ameliorated by APN. To test this hypoth-
esis, we incubated primary rat osteoblasts on TI and tested the cellular
behaviors when subjected to normal milieu, diabetic milieu (DM), DM
+ APN, DM + AICAR (AMPK activator) and DM + APN + Com-
pound C (AMPK inhibitor). In vivo, APN orAPN +Compound Cwere
administered to diabetic db/db mice with TI implanted in their femurs.
Results showed that diabetes induced structural damage, dysfunction
and content decrease of mitochondria in osteoblasts, which led to ROS
overproduction, dysfunction and apoptosis of osteoblasts accompanied
by the inhibition of AMPK signaling. APN alleviated the mito-
chondrial damage by activating AMPK, thus reversing osteoblast
impairment and improving the osteointegration of TI evidenced by
Micro-CT and histological analysis. Furthermore, AICAR showed
beneficial effects similar to APN treatment, while the protective
effects of APN were abolished when AMPK activation was
blocked by Compound C. This study clarifies mitochondrial dys-
function as a crucial mechanism in the impaired bone healing and
implant loosening in diabetes, and provides APN as a novel
promising active component for biomaterial-engineering to im-
prove clinical performance of TI in diabetic patients.
433
Novel Target in Medical Devices
n. motayagheni;
WFIRM, Winston Salem, NC.
Introduction: Calcium channel blockers are widely used in the
treatment of cardiovascular diseases. Calcium homeostasis is critical
for multiple functions including motility and biofilm formation in
bacteria. Biofilm formation are leading causes of infectious com-
plications in patients with indwelling catheters, artificial cardiac
valves. We report here that swimming motility and biofilm formation
in pathogenic Escherichia coli and Proteus mirabilis is inhibited by
verapamil, a calcium channel blocker. The central hypothesis for this
study is that Calcium channel blockers will prevent bacterial motility
and aggregation and biofilm formation.
Methods: First, we tested the effect of various concentrations
of verapamil on growth of common bacterial pathogens including
E. coli, P. mirabilis and Klebsiella pneumoniae. At high doses
(‡12mM) verapamil was able to inhibit growth of these pathogens.
Next, we tested the effect of verapamil, at levels that does not affect
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bacterial growth (3 and 6mM), on swimming motility in vitro. Lastly
using crystal violet staining and optical density meter we evaluated
biofilm formation in plastic catheter.
Results: Our results revealed that verapamil inhibits flagella-
mediatedmotility inE. coli also in P. mirabilis. Importantly it was able
to decrease biofilm formation on plastic catheter dose dependently.
Conclusion: We identified for the first time that verapamil de-
creases bacterial aggregation and biofilm formation of tested bacte-
rial pathogens in a dose-dependently in a plastic catheter. Further
ex vivo and in vivo experiments are necessary to determine if Calcium
channel blockers could be repurposed as novel therapeutics or pro-
phylactic targets in medical devices.
434
Inhibition of Nf-kb and Inos Inflammation Signaling Pathway
Through Nipep-1 Peptide on Raw 264.7 Cells
D. Choi;
Biological Sciences, Chungbuk National University, Cheongju,
KOREA, REPUBLIC OF.
Development of anti-inflammatory peptide NIPEP-1 that sup-
presses NF-kB and iNOS expressions in lipopolysaccharide-
stimulated RAW 264.7 cells Da hyeon Choi1), Gookjin Yoon2),
Yeonsu kim3), DongWooLee3), BuemSoo Jo3), Hyun Jung Lee3), Jue-
Yeon Lee3), Chong-Pyoung Chung3), Sangmee Ahn Jo4), Inho Jo5),
Yoon Jeong Park2), Yoon Shin Park1),* 1) School of Biological Sci-
ences, College of Natural Sciences, Chungbuk National University,
Cheongju, Korea 2) Dental Regenerative Biotechnology Major, Seoul
National University, Seoul, Korea 3) Central Research Institute, Nano
Intelligent Biomedical Engineering Corporation (NIBEC), Seoul,
Korea 4) Department of Pharmacology, College of Pharmacy, Dan-
kook University, Cheonan, Korea 5) Department of Molecular Medi-
cine, School of Medicine, Ewha Womans University, Seoul, Korea
Current inflammation therapeutic agents have several limitations such
as non-specific bio-distribution and induction of cytotoxicity. Peptide
drugs have been proposed as promising agents that can overcome these
drawbacks, we designed NIPEP-1 peptide that has strong anti-
inflammatory functions.We treated lipopolysaccharide (LPS: 1mg/ml)
to RAW 264.7 cells to induce the inflammatory response for 0.5 hr.
Thereafter, RAW 264.7 cells were co-treated with NIPEP-1 with dif-
ferent concentrations (10, 50, and 100mg/ml) and time points (0.5, 1, 4,
and 24hr). Western Blot analysis was adopted to check the protein
expression related to inflammation such as p-IKK-a/b, iNOS and p-
NF-kB-p65. Here, we confirmed successful induction of inflammation
stimulated by LPS treatment to RAW 264.7 cells and checked inhi-
bition of NF-kB and iNOS expression. Therefore, we suggest that
NIPEP-1 can be a promising agent for a variety of inflammatory dis-
eases treatments including rheumatoid arthritis and dermatitis.
435
Manipulation of Regeneration-Related Genes in the Adult
Zebrafish Heart: Gene Silencing Effect and Cell-Level
Biodistribution of siRNA Nanoparticles
F. Wang1, L. Gao2, J. Xiong2, Y. Luo1;
1Biomedical Engineering, Peking University, Beijing, CHINA,
2Peking University, Beijing, CHINA.
With the damaged cardiomyocytes losing their contractile and
regeneration capacity, the heart would be dysfunctional, resulting in
the cardiovascular diseases which are the leading cause of mortality
and morbidity worldwide. SiRNA technology opened a new avenue
for effective manipulation of regenerative pathways in cardiac tis-
sues. To facilitate the siRNA delivery into the cells, numerous
nonviral nanomaterials were developed while the delivery mecha-
nisms have not been elucidated due to the difficulty in tracking and
imaging the nanoparticles in vivo. Herein, taking advantage of zeb-
rafish, the delivery efficiency of a polyamidoamine (PAMAM)-
based siRNA delivery system was demonstrated. Moreover, the
delivery mechanisms, especially the cell-level biodistribution of
siRNA nanoparticles in the heart were investigated. The nano-
particles were detectable in different specific GFP-expressing cells in
the transgenic zebrafish heart and allowed the precise quantification
of the biodistribution at the cellular level. It was shown that in the
injured heart, the 40 % uptake of siRNA was mediated by the leu-
kocytes, accompanied by 19% by cardiac and 19% by endothelial
cells. The profiling of the distribution of nanoparticles in the heart
with the cell-level precision provide important insights into how the
nanomaterial-based delivery systems can be designed as regenera-
tive nanomedicine for the treatment of cardiovascular diseases.
Skin & Wound Healing
436
Poloxamer-Based Hydrogel for Vaginal Tissue Healing
O. Wyman1, J. Hakim2, C. Hsu3, M. Dickinson3;
1Baylor College of Medicine, Houston, TX, 2Obstetrics and
Gynecology, Baylor College of Medicine, Houston, TX,
3Molecular Physiology and Biophysics, Baylor College of Medicine,
Houston, TX.
Vaginal reconstructive surgery (VRS) requires extensive postopera-
tive care.A common complication afterVRS is vaginal scar tissue (VST)
occurring in 73%of patients. There is no standard of care to reduceVST,
and reduction requires improving vaginal angiogenesis while preventing
vaginal wall fusion. One approach involves vaginal placement of es-
trogen cream (EC) daily to promote tissue healing and reduce VST. This
does not allow for assessments of delivered estrogen due to cream egress
from the vagina. Hydrogels are prominent platforms for wound healing
applications, but are not used extensively in the vagina.
We have targeted a unique hydrogel-based hyaluronic acid (HA)
mechanism to promote angiogenesis and wound healing in the vagina.
The combination of HA/Interleukin 10 (IL10) delivery reduces kidney
fibrosis following injury in a murine model. We have quantified dif-
ferences between hydrogel-based EC and HA/IL10 induced wound
healing in a murine vaginal injury model. Furthermore, we explored
synergies between hydrogel-based CEE and HA/IL10 in a temporally
staggered release system. An effective vaginal wound-healing system
will reduce health care costs and improve clinical outcomes.
437
Low-Level Laser Therapy (LLLT) 670 nm and Carboxyethyl
Gamma Aminobutyric Acid (CEGABA) Topical Treatment
in the Time Course on Wound Healing in Rats
A. N. Otterc¸o1,2, P. Brassolatti1, A. L. Andrade1, P. S. Bossini3,
N. A. Parizotto1;
1Physiotherapy, Federal University of Sa˜o Carlos (UFSCar), Sa˜o
Carlos, BRAZIL, 2Physiotherapy, University Center of Votuporanga
(UNIFEV), Votuporanga, BRAZIL, 3Physiotherapy, Sagrado
Corac¸a˜o University (USC), Bauru, BRAZIL.
Introduction: The laser therapy is indicated in wound healing by
stimulating fibroblasts proliferation and angiogenesis1. The CEGA-
BA has a positive growth effect and induces cell proliferation2. The
purpose was evaluate the effect topical CEGABA and laser GaAlAs
in the repair of cutaneous tissue.
Methodology: Forty Wistar male rats separated in 4 groups:
Control(CG); Laser Group(LG) GaAlAs, 670 nm, 39mW of power
output, energy per point of 1,17 J, radiating 1 point in 30 s; CEGABA
Group(CEGG) with 1% cegaba/volume-based and Laser with CE-
GABA Group(L+CEGG). Was used punch with 10mm of diameter
in the back of the animals. The treatment took 16 consecutive days.
Biopsy time points were made on the days 4, 11, 16. H&E analysis
were performed in addition to immunohistocchemistry (IHC) for
VEGF-a, and analyzed of variance the test two-away ANOVA with
post hoc Tukey (p&lt 0,05).
Results: Inflammatory infiltrate decreased significantly to LG on
11Th day (p&lt 0,001), on the 16Th day LG, CEGG and L+CEGG
(p&lt 0,01; p&lt 0,01 and p&lt 0,05 respectively) compared to CG. In
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the analysis of VEGF-A expression factor had increased from the
11Th to CEGG and L+CEGG (p&lt 0,01; p&lt 0,05 respectively) and
16Th day to LG (p&lt 0,05).
Discussion: The proposed treatments were effective in the healing
process and the granulation tissue was improved, shown that Laser
associated to CEGABA potentiates enhanced healing and may have
potencial aplication for cutaneous wounds.
References:
1. GUIRRO, E.C.O et al. Photomedicine and Laser Surgery, 28, 5,
2010).
2. CERINO, A. et al. Biochemical and Biophysical Research
Communications, 150, 3, 1998.
439
Amnion Membrane Biomaterials for Wound Healing
S. V. Murphy;
Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC.
Problem: There is a dire need for more effective products to
accelerate wound closure and healing. Here we describe the devel-
opment of several amnion-derived biomaterials for wound healing
applications, including a lyophilized wound covering, and a cross-
linkable hydrogel composed of hyaluronic acid (HA) and solubilized
amniotic membrane (SAM).
Objective: Evaluate whether the application of amnion-derived
biomaterials will promote faster wound healing and reduced scarring
compared to her commercially available wound healing products in a
porcine model of wound healing.
Methodology: Porcine skin woundmodel: A total of 72, 4.0·4.0 cm
full thickness wounds were created on the dorsal skin (n=9). Amnion
membrane-derived biomaterials were evaluated for their potential to
accelerate wound healing, and compared to several other commercially
available and amnion membrane-derived wound healing products.
Results: Analysis of wound closure, contraction and epithelial-
ization demonstrated that amnion-derived biomaterials were superior
in wound closure and epithelialization and in preventing contraction.
They achieved this through the significant acceleration of wound re-
epithelialization. The epidermis from Amnion hydrogel and Amnion
powder-treated wounds looked similar to healthy skin in regards to
the coverage, thickness and presence of rete peg protrusions into the
dermal area. Histochemical stains demonstrated that amnion-derived
biomaterials had a much more similar ECM composition to healthy
skin, with a dermis that consisted of thick, organized mature collagen
fibers and mucins/GAGs. Treatment of wound with amnion-derived
biomaterials did not result in any signs of immune cell infiltration.
Significance: This study demonstrates that amnion-derived bio-
materials accelerate the re-epithelialization of full thickness wounds.
440
Antibacterial Selenium Nanoparticle Coatings for Field
Hospitals
J. W. Moxley, Jr., T. J. Webster;
Chemical Engineering, Northeastern University, Boston, MA.
While advancing antibacterial resistance has recently come to
demonstrate a looming threat to the health-care infrastructure of de-
veloped nations, many areas throughout the developing world still
suffer persistently high mortality rates from commonly treatable bac-
terial strains. Humanitarian efforts in these regions, primarily seen
today in the form of non-governmental organizational (NGO) outreach
as well as peace-keeping military operations, are significantly strained
by an incapability to reproducibly produce and maintain sterile con-
ditions in the field. Injured personnel are often required to be rapidly
transported out of the region in order to receive safe medical treatment,
incurring large financial costs while demonstrating severe risks to the
individuals in the process. In order to address this issue, antibacterial
selenium nanoparticulate coatings were prepared for application in
rapidly constructed field hospitals operating in diverse environments.
These coatings have demonstrated antibacterial properties when ap-
plied towall paneling suspended in various bacterial cultures. Ongoing
work includes determining the effects of local weather (principally,
heat and humidity) and transportation (principally, vibrational and
shock disturbances) conditions on the persistence of applied coatings.
New means of rapid, on-site administration of antibacterial nano-
particulate coatings, onto both medical instrumentation and house-
keeping materials, are also currently under development.
441
Small Intestinal Submucosa-Chitosan Hydrogel as a Deep
Wound Healing Material
M. Pineda1, J. Jaramillo1, V. Talero1, R. Lo´pez2,3, C. Mun˜oz1,
J. C. Bricen˜o1,4;
1Biomedical Engineering, Universidad de los Andes, Bogota´ D.C.,
COLOMBIA, 2Faculty of Medicine, Universidad de los Andes,
Bogota´ D.C., COLOMBIA, 3Department of Pathology, Hospital
Universitario Fundacio´n Santa Fe de Bogota´, Bogota´, COLOMBIA,
4Research Department, Fundacio´n Cardioinfantil Instituto de
Cardiologia, Bogota´, COLOMBIA.
Skin wounds are a major public health problem, representing an
annual approximate cost of 25 billion dollars in the USA. This is
rapidly growing problem due to risk factors such as diabetes, obesity
and aging population. Current solutions cannot satisfactorily solve
this problem so we propose a Small Intestinal Submucosa-Chitosan
(SIS/Ch) hydrogel as a deep wound healing cost/effective material
with hemostatic, angiogenic and reepithelization capacities. The
objective of this study was to biologically evaluate the effect of SIS/
Ch hydrogels in deep wound re-epithelialization.
SIS and SIS/Ch hydrogels in-vitro tests included a MTT assay (Vero
cells) to test cytotoxicity, and an erythrocyte lysis test to assess hemolytic
effects. The SIS/Ch hydrogels were also evaluated in-vivo in a murine
model with excisional full thickness wound, including the panniculus
carnosus (n=6). Carboxymethylcellulose hydrofiber and open wound
were used as positive and negative controls, respectively. Wound con-
traction, histology and inmunohistochemical analysis were performed.
SIS/Ch hydrogels showed a cell viability percentage greater than
80%. Hemolysis index less than 5% confirmed absence of hemolytic
effects. SIS and SIS/Ch hydrogels showed a significantly higher re-
duction in wound area after 21 days compared to both controls.
Histological and inmunohistochemical results demonstrated a major
epithelial regeneration with myofibroblast presence, angiogenesis
and adequate collagen arrangement. Controls showed greater gran-
ulation tissue area with a non-full epithelial regeneration at 21 days.
These results demonstrate that the SIS/Ch hydrogels possess en-
ough biocompatibility and viability to reepithelialize deep wounds
and are a new promising material for clinical use.
442
In vivoDeepWound re-epithelialization through Small Intestinal
Submucosa/Chitosan Tridimensional Scaffolds
J. Jaramillo1, M. Pineda1, V. A. Talero1, R. Lo´pez2,3, C. Mun˜oz1,
J. C. Bricen˜o1,4;
1Biomedical Engineering, Universidad de los Andes, Bogota´ D.C,
COLOMBIA, 2Pathology Department, Fundacio´n Santa Fe de
Bogota´, Bogota´ D.C, COLOMBIA, 3School of Medicine,
Universidad de los Andes, Bogota´ D.C, COLOMBIA, 4Research
Department, Fundacio´n Cardioinfantil - Instituto de Cardiologı´a,
Bogota´ D.C, COLOMBIA.
Chronic wounds usually do not enter a normal reparative phase
and need external signals to promote extracellular matrix restoration
and adequate healing. We have previously demonstrated that new
Small Intestinal Submucosa-Chitosan (SIS-Ch) tridimensional
scaffolds have appropriate physicochemical properties as wound
dressings. We aimed to evaluate SIS-Ch scaffolds’ biological capa-
bility to induce skin wound re-epithelialization.
In-vitro biological evaluation (n= 3) included: a MTT assay (Vero
cells) to test cytotoxicity; an erythrocyte lysis test to assess hemolytic
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effects; and exposure to P. aeruginosa and S. aureus, to evaluate
scaffolds’ antibacterial effects by inhibition zone and turbidity
measurements. Also, scaffolds’ regeneration ability was studied
through a full thickness skin wound in a murine model (n = 6). A
commercial hydrofiber and absence of dressing were used as positive
and negative controls, respectively. Wound area reduction was cal-
culated; Hematoxylin-Eosin, Masson’s trichrome staining and in-
munohistochemical analysis were performed.
Vero cells viability greater than 90% was obtained, indicating
cytotoxicity absence. Hemolysis results confirmed a biologically
accepted hemolytic index (less than 2 %). SIS-Ch scaffolds’ anti-
bacterial properties were demonstrated through the presence of an
inhibition growth zone around the scaffolds and a lower bacterial
optical density. Wound area was significantly lower in SIS-Ch
groups after 14 days, compared to both controls. Reduced inflam-
mation, complete epithelium regeneration, collagen deposition, hair
follicle presence and angiogenesis with the SIS-Ch scaffolds dem-
onstrated their ability to induce deep wound healing in rats.
In conclusion, SIS-Ch scaffolds could be used as wound dressings
that induce a greater healing and regeneration effect compared to
commercial hydrofibers.
443
Bioactivation of Nanofibrous Scaffold through Collagen
Protrusion for Partial Thickness Wound Healing
P. Pal, P. K. Srivas;
School of Medical Science & Technology, Indian Institute of
Technology, Kharagpur, INDIA.
Dermal ECM has collagen I as the major structural and functional
protein, which possesses cell binding sequences such as Gly-Phe-Hyp-
Gly-Glu-Arg (GFOGER) and Arg-Gly-Asp (RGD), making it the
preferred choice of support matrix for skin tissue engineering. Collagen
type I built scaffold overwhelmingly controls and mediates fibroblast
and keratinocyte functions and its breakdown products are chemotactic
for different players of wound healing cascade. Nanofibrous scaffold
promotes better cell attachment due to its high surface area to volume
ratio. Integra made of collagen-GAG freeze-dried structure is con-
sidered as ‘‘gold standard’’ skin substitute. However, owing to presence
of silicon layer, Integra needs a double surgical innervation to replace
synthetic silicon layerwith thin autograft. To address this issue, we have
developed a hierarchical porous bioactive scaffold with overlying po-
rous 3D nanofibrous layer and an underlying thin freeze-dried collagen
fibrillary layer. Collagen would provide faster cellular adhesion, en-
hancing cellular infiltration within scaffold, while nanofibrous scaffold
would further boost cellular migration, proliferation, and differentiation
leading to faster re-epithelialization and wound closure. The collagen
layer upon fibrillogenesis resulted in fibers of diameter 12.23–4.49mm.
The water contact angle was 60 , while its water uptake capacity was
132%, degrading 38% in twomonths. The architecture and composition
of the scaffold promoted efficient cell attachment, migration and pro-
liferation from initial days of cell seeding, eventually covering the entire
fiber structure. Scaffold implantation on full thickness wound in rat
model proved beneficial with faster healing and re-epithelialization in
comparison to TegadermTM standard dressing material.
444
Vascular Network Formation is Regulated by Tensile Forces
in 3D Bioprinted Tissue
M. Varkey, G. Zhang, A. Atala;
Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC.
Vascular Network Formation is Regulated by Tensile Forces in
3D Bioprinted Tissue Guangliang Zhang1,2#, Mathew Varkey1#, Zhan
Wang1, Anthony Atala1 1. Wake Forest Institute for Regenerative
Medicine, Winston-Salem, 2. Ruihua affiliated hospital of Soochow
University, Suzhou, China, 25104; mvarkey@wakehealth.edu, #Equal
contribution The purpose of this study is to further understand the role
of tensile forces in vascular network formation using 3D bioprinted
tissue. Briefly, print code was generated; polycaprolactone (PCL)
support scaffold frames with gelatin spacer layer were printed, on top of
this a layer of PCL into which fibrin-gelatin hydrogel containing HU-
VECs and fibroblasts was printed as vessel lines. Post-printing the
constructs were cultured and assessed. Angle, length and branches of
the vessel-like structures were measured. Formation of vessel-like
structures was assessed 7 days post-printing. In the test group the ves-
sels mostly grew in one direction, while in the control group they grew
in chaos. Fibrinogen concentration affected vascular network forma-
tion; 5mg/ml fibrinogen scaffolds showed better vessel formation, with
vessels growth parallel to the direction of force. Y27632 reduced cell-
generated forces resulting in damaged networks and less-elongated
vessels, while blebbistatin reduced network quality. This suggests that
tensile forces due to the interaction between PCL scaffolds and printed
cell-laden hydrogels regulate vascular network formation. Further un-
derstanding of underlying mechanisms will enable better control of
vascular network formation in bioprinted tissue. 1. Kang HW, Lee SJ,
Ko IK, et al. Nat Biotechnol. 34, 312, 2016. 2. Rosenfeld D, Landau S,
Shandalov Y, et al. Proc Natl Acad Sci. 113, 3215, 2016.
445
Single Stage Procedure to Repair Full Thickness Wounds
in Porcine Model
J. A. Molnar1, S. Damaraju2, B. R. Mintz, 085362, A. Gandhi2,
S. Saini2, R. Ingram2;
1Wake Forest Baptist Health, Winston-Salem, NC, 2Integra
LifeSciences, Plainsboro, NJ.
Introduction: Clinical application of skin substitutes is often a two-
step procedure: application of the scaffold to the wound followed by
engraftment of split thickness autograft. This two-step procedure requires
multiple interventions due to wound contracture and autograft morbidity.
In this study, we hypothesized that a single stage procedure can be
achieved by combining autologous cells in acellular fetal bovine dermal
matrix (ADM) for the treatment of full thickness wounds (FTWs).
Methods: A split-thickness biopsy was harvested from pig and
processed using a cell harvesting device for preparing cell suspen-
sion. Cells at density of 80,000 cells/cm2 were seeded onto ADM. A
total of 12, 4 · 4 cm FTWs were created on the dorsum of Yorkshire
pigs (n= 12) and treated with: cells; cells+ADM; ADM or empty.
Wound measurements and biopsies were taken on days 9, 14, 28 and
42. Excised tissue was processed for histopathology. Mechanical
testing was performed on excised tissue via indentation mapping, a
novel application in skin, and tensile extension to failure.
Results:Empty and cells wounds contracted themost between days
0 and 14 compared to cells+ADM and ADM groups. By day 14, re-
epithelialization (%) was significantly greater in cells+ADM (77%)
compared to ADM (28%), cells (30%) and empty (29%) groups. From
indentation mapping, differences in healing wound and contractile
tissue was noted. Groups containing cells exhibited lower mean load at
rupture (1.61 kg) in tensile testing than those without (2.39 kg).
Conclusions: The combination of autologous cells with ADM can
be promising single stage procedure for dermal reconstruction.
446
The Effect of Amniotic Membrane on Adipose Derived Stem
Cells for Chronic Wound Repair
G. Portocarrero Huang1, S. M. Damaraju2, A. Gandhi2, S. Saini2,
R. Ingram2, T. L. Arinzeh1;
1New Jersey Institute of Technology, Newark, NJ, 2Integra
LifeSciences, Plainsboro, NJ.
Introduction: Chronic wounds have impaired healing due to
growth factor deficiency and inadequate vascularization. Amniotic
membranes are rich in growth factors, which have the potential to
improve tissue regeneration by recruiting stem cells at wound site
and enhance neovascularization in chronic wounds. In this study,
effect of amniotic membrane (AM) on human adipose derived stem
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cells (ADSCs) pre-seeded on collagen-GAG matrix (CG) was eval-
uated for its ability to alter stem cell activity in vitro.
Methods: ADSCs were seeded at 200,000 cells/cm2 on CG,
CG+AM (HydraTekTM Amniotic membrane), and tissue culture
polystyrene (TCP) in serum or serum-free growth media. Samples
were measured for DNA, release of VEGF and KGF and production
of collagen type I. Confocal imaging was performed to visualize cell
morphology and skin extracellular matrix proteins.
Results: Cells on CG+AM had significantly greater release of
VEGF over CG and TCP as early as day 4. Cell-free controls con-
firmed that the factors released were from the cells. By day 14, cells
on CG+AM produced over ten times more collagen type I than cells
on CG and TCP, which was supported by immunostaining results.
Conclusions: These findings suggest that the Amniotic membrane
can stimulate ADSCs to secrete endogenous growth factors and pro-
duce more extracellular matrix. This combination of CG with an am-
niotic membrane would be an attractive treatment for chronic wounds.
Stem Cells
447
Fibroblast Looks Like a Mesenchymal Stem Cell and Talks Like
a Mesenchymal Stem Cell: is It a Mesenchymal Stem Cell
in Disguise?
A. Sacco, F. Di Meglio, D. Nurzynska, V. Romano, I. Belviso, M. Di
Gennaro, A. Carfora, A. Avagliano, L. Greco, F. Schonauer,
S. Montagnani, C. Castaldo;
Public Health, University of Naples, Naples, ITALY.
Induced Pluripotent Stem Cells (iPSCs) are adult somatic cells ge-
netically reprogrammed to an embryonic stem cell-like state. Fibroblast
(FB) is the adult somatic cell most commonly used for reprogramming
and is defined by spindle-shape morphology, plastic-adherence and
expression of several markers. Nonetheless, such properties also define
Mesenchymal Stem Cells (MSCs), that also share with dermal FB the
ability to differentiate into osteoblasts, adipocytes and chondroblasts.
Moving from the hypothesis that the most striking difference
between FBs and MSCs is in the name, we isolated and cultured
human dermal and visceral FBs from tissue waste fragments of pa-
tients undergoing surgical procedures, and evaluated their mor-
phology and expression of markers typical of MSCs, at gene and
protein level. Additionally, we analyzed synthesis and release of
specific growth factors in culture medium and, finally, we tested FB
ability to differentiate into osteoblasts, adipocytes and chondroblasts.
Interestingly, all FBs in culture adhered to plastic culture dishes,
expressed markers typical of MSCs, like CD90, CD105, CD146,
SSEA-4, ECM2, ID-1, and were morphologically undistinguishable.
As reported for MSCs, FBs released EGF, FGF-4, GDNF, HGF, IGF,
TGF-b and VEGF, and were capable of differentiating into cells of
mesodermal origin.
Our findings raise the question of whether FBs and MSCs are not
admittedly the same population.Wemight infer that previously described
differences are due to different stages of differentiation, which also ac-
count for reports on high variability in both expression of mesenchymal
markers by MSCs and efficiency of FB reprogramming to iPSCs.
448
In Vivo Chondrogenesis In 3D Bioprinted Human Cell-laden
Hydrogel Constructs
L. Strid Orrhult1, P. Apelgren2,3, S. Schwarz4, L. Ko¨lby2,3,
G. Schulze-Tanzil4, P. Gatenholm1,5;
13D bioprinting center, Chalmers, Go¨teborg, SWEDEN,
2Department of Plastic Surgery, Sahlgrenska University Hospital,
Go¨teborg, SWEDEN, 3Institute of Clinical Sciences, Sahlgrenska
Academy, Go¨teborg, SWEDEN, 4Department of Anatomy,
Paracelsus Medical University, Nuremberg, GERMANY,
5Wallenberg Wood Science Center, Go¨teborg, SWEDEN.
Cartilage is an avascular tissue that once degenerated or wounded has
limited ability to heal. Untreated cartilage injuries can lead to osteoar-
thritis(OA) which is a leading cause of disability among older adults,
and affects upwards of one in eight adults [1]. This highly widespread
disease and associated disability have a huge effect on individuals and
on society. The demand for cartilage tissue restoration is therefore high.
3D bioprinting technology allows creation of 3D constructs using
biologically relevant materials such as biopolymers and cells. The
aim of this study is to investigate the use of 3D bioprinting in a
clinically relevant setting to evaluate the potential of this technique
for in vivo chondrogenesis and thus repair of human cartilage.
Bioprinted cell-laden constructs were implanted subcutaneously in
mice. Human nasal chondrocytes (hNCs) were cultured alone or co-
cultured together with human bone marrow derived mesenchymal stem
cells (hBMSCs), human adipose derived stem cells (hASC) or human
stromal vascular fraction (SVF). After 30 and 60 days, the scaffolds
were harvested for histological and immunohistochemical analysis.
Preliminary data show an increase in both proliferation of chon-
drocytes and glycosaminoglycan production and co-culture with
stem cells are enhancing these effects. We also show that nano-
cellulose/alginate bioinks demonstrate good long-term mechanical
and structural stability in vivo.
1. Hunter, D.J., D. Schofield, and E. Callander, Nat Rev Rheu-
matol, 2014. 10(7): p. 437-441.
449
Effect Of Ecm Proteins And Their Elasticity On iPS Cell
Differentiation To Self-beating Cardiomyocytes
T. Yamaoka, M. Hirata;
Department of Biomedical Engineering, National Cerebral and
Cardiovascular Center Research Institute, Suita, JAPAN.
The purpose of this study is to clarify the effect of culture sub-
strates with different ECM proteins and different elasticities on the
cardiac differentiation of induced pluripotent stem cells (iPSs). We
investigated the differentiation in three steps: (1) cardiac marker gene
expression, (2) contraction-relating gene expression, and (3) beating
and its duration. To this end, in addition to iPS cells, neonatal car-
diomyocytes (NCMs) were selected and used. These cells were
cultured on hydrogel (HG) substrates with the young modulus of 9,
20, and 180 kPa and on hard tissue culture polystyrene dishes
(TCPS). These substrates were immobilized with collagen (Col),
gelatin (Gel), or fibronectin (FN). The most effective niches for the
above three stages differed very much. The cardiac marker gene
expression of iPSs was improved on TCPS/FN and TCPS/Gel. In
contrast, on HG/FN the cardiac differentiation was greatly sup-
pressed and the undifferentiated marker gene was still highly main-
tained. The contractile gene expression and self-beating high on
TCPS/FN and HG/Col, which suggests that the combination of ECM
and matrix elasticity is more important for inducing the cardiac
differentiation. In addition, the beating behavior lasted longer period
of time onHGs irrespective of the ECM type. These results suggested
that the culture substrates might be changed and controlled stepwise
along with the cell differentiated stages in order to prepare the
beating cardiomyocytes from stem cells at a high efficiency.
450
Dexamethasone Released from PEUUR Promoted Cell Viability
of Cardiac Stem Cells
E. M. Claros1, V. H. Lalwani1, D. Gadalla2, B. T. Ledford1,
A. S. Goldstein2, J. He1;
1Department of Biomedical Sciences and Pathobiology, Virginia
Polytechnic Institute and State University, Blacksburg, VA,
2Department of Chemical Engineering, Virginia Polytechnic
Institute and State University, Blacksburg, VA.
Stem cell-based therapy holds great potential to treat myocardial
infarction (MI). Unfortunately, theMI-induced inflammation results in
a poor engraftment and survival rate of the transplanted cells. To
address this, we propose co-delivering stem cells with an anti-
inflammatory dexamethasone (Dex)1-releasing elastomeric scaffold.
S-112 POSTER ABSTRACTS
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Our previous work has shown that electrospun poly(ester-urethane
urea) (PEUUR) scaffolds support c-kit+ human cardiac stem cells
(hCSCs) viability and differentiation into cardiomyocytes2. The
present study examines the impact of Dex released from PEUUR
scaffolds on hCSCs under normal and induced-cell death. Dex-
PEUUR scaffolds were fabricated by electrospinning blends of
PEUUR and Dex in hexafluoroisopropanol, and hCSCs were cultured
on Dex-PEUUR scaffolds, ordinary PEUUR scaffolds, and tissue-
culture polystyrene (TCPS) substrates. Cell viability, proliferation,
cellular morphology, and cardiac differentiation were analyzed before
and 7, 14, 21, 28 days after 5-azacytidine-differentiation using Live/
Dead assay, PCR, and immune antibody analysis. The present data
indicated that there were similar cell viabilities between Dex-PEUUR
and TCPS, while the cell morphology and proliferation seemed sig-
nificant different between PEUUR and TCPS. Ongoing studies are
expected to demonstrate increased hCSCs viability on Dex-PEUUR
scaffolds under induced-cell death using interleukin or Doxorubicin.
References:
1. Song IH, Caplan AI, Dennis JE. J Orthop Res. 27, 216, 2009.
2. Kan, L, Thayer P, Fan H, Ledford B, ChenM, Goldstein A, Cao
G, and He JQ. Exp Cell Res. 347, 143, 2016.
Acknowledgments:This work is supported by the grant award
from the Virginia’s Commonwealth Health Research Board (CHRB)
(208-09-16JHE).
Disclosures: The authors declare no conflict of interest.
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In Vitro Biomimetic Mineralization of GAG/Chitosan Modules
by Osteoinduced MSCs
K. B. Miles, H. W. Matthew;
Chemical Engineering and Materials Science, Wayne State
University, Detroit, MI.
Introduction: Biomaterials that facilitate mineralization may
improve strategies for generation of tissue engineered bone. We
examined the in vitro mineralization of glycosaminoglycan (GAG)/
chitosan microcapsules containing osteoinduced mesenchymal stem
cells (MSCs), to evaluate these microcapsules as a platform for
modular bone tissue engineering.
Methodology: MSCs were encapsulated in GAG/chitosan mi-
crocapsules with or without hydroxyapatite (HAP) microgranules,
and cultured in expansion (Exp) or osteogenic (Osteo) induction
media. After 4 weeks of culture, capsules were sectioned, and imaged
via SEM to characterize the cell-deposited matrix.
Results: Osteoinduced MSCs deposited significant bone-like min-
eral in microcapsule interiors, while no significant mineral was de-
posited under Exp media conditions. New mineral was mainly
deposited on the pre-existing HAP in the Osteo+HAP condition, while
the interior surface of the microcapsule membrane was well mineral-
ized in the absence of HAP microgranules. Furthermore, mineral
morphology differed depending on HAP presence. New mineral pre-
sented as 1-5mm plate-like crystals in the absence of HAP, while
mineral deposited on pre-existing HAP formed 1-5mm diameter
spherulites. Spherulites were composed of smaller 30 nm diameter
spherulite. Compressive stress/strain analysis of fused capsule con-
structs showed that mineralization increased construct mechanical
properties by*3 orders of magnitude; however, the HAP and HAP-
free capsules possessed similar yield strengths (10.4– 4.4 MPA).
These results demonstrate the ability to alter deposited mineral ar-
chitecture based on presence or absence of templating mineral. Ad-
ditionally, incorporation of HAP mineral was not necessary to achieve
high increases in compressive yield strengths in vitro.
452
Culturing and Expanding Human Mesenchymal Stem Cells
in Three-dimensions
N. Celik1, C. Cui2, M. Wang2, L. Han2;
1Drexel University, Philadelphia, PA, 2Mechanical Engineering &
Mechanics, Drexel University, Philadelphia, PA.
Introduction: Tissue-engineering strategies often demand a large
number of stem cells and cell-passaging, which is normally achieved
by two-dimensional (2D) cell expansion on Petri dishes or culturing
flasks. Stem cells on these 2D systems become confluence in about
two weeks, reaching 3 to 10 folds maximum proliferation, and must
be trypsinized, detached and re-plated to continue expansion. Trypsi-
nization, however, exposes stem cells to biochemical and biophysical
stresses known to accelerate senescence, phenotype changes, or lost
of stemness. A cell-expanding strategy that maximize proliferation
per passage, whileminimizing the need for trypsinization, can promote
the quality of stem cells post expansion and benefit the research and
applications of cells based therapy.
Method: In contrast to traditional cell expansion, we created a
three-dimensional (3D) cell-expansion system using Micro-Ribbons
made of polystyrene, which is the same material for culture flasks.
These microribbons (500 micron wide and 50 micron tick) produced
a large surface area per weight to support high cell proliferation,
leading to a maximum cell number per passage that is dramatically
higher than the traditional system (by more than 10 folds). Cells
reaching confluence in 3D were re-suspended by trypsin following
the similar protocol for 2D cell expansion. In this presentation, we
will demonstrate the results of our study on the expansion of human
mesenchymal stem cells (MSC). Results on MSC proliferation rate
per passage, change of gene expression post passaging, and the dif-
ferences between the results from our 3D platform and traditional 2D
system will be explained in detail.
453
Vimentin Intermediate Filaments May Influence Chondrogenic
Extracellular Matrices Over Time
P. Sharma1, D. Wagner2, A. H. Hsieh1,3;
1University of Maryland, College Park, MD, 2Indiana University-
Purdue University Indianapolis, Indianapolis, IN, 3University of
Maryland, Baltimore, MD.
Vimentin intermediate filaments have been shown to be involved in
short term chondrogenesis. However, vimentin’s role in human mes-
enchymal stem cell (hMSC) long term chondrogenic extracellular
matrix (ECM) deposition remains to be clarified. Better understanding
of vimentin’s role in chondrogenesis may help in understanding ther-
apeutic outcomes ofMSC therapies. Here, hMSCs expressing lentiviral
shRNA targeting vimentin or LacZ (Control) for 14 days were formed
into pellets. Chondrogenesis was induced via chondrogenic media
supplemented with 10 ng/ml TGFb3. ECM deposition and gene ex-
pression were analyzed on days 14 and 21 using immunohistochemis-
try/histology for Type II collagen and sulfated glycosaminoglycans
(sGAGs) and RT-PCR for 18s, sox9, mmp13, adamts4, and adamts5,
respectively. Statistical differences were determined using Student’s
T-test. A potential, but not definitive, disruption of Type II collagen and
sGAG deposition was observed. Gene expression revealed few signif-
icant differences between shVim- and shLacZ-hMSCs. However,
shVim-hMSCs demonstrated gene expression changes from Day 14 to
Day 21 (Day21 relative to Day14 - [sox9: p= 0.025, [mmp13:
p=0.042, [adamts4: 0.267, Yadamts5: 0.012) while shLacZ-hMSCs
did not (Day21 relative to Day14 sox9: p=0.103, mmp13: p=0.101,
adamts4: 0.982, adamts5: 0.221). While prior evidence suggests vi-
mentin influences chondrogenesis in the short term, it may have a lesser
influence in long term cultures. However, a decrease in vimentin does
appear to increase the dynamism of gene expression over time, which
could tune changes to the ECM. Ongoing studies will delve more
deeply into the relationship between vimentin and chondrogenic, deg-
radative, and ECM adhesive protein gene expression.
454
Influence of Vimentin Intermediate Filaments on Mesenchymal
Stem Cell Spreading in Response to Environmental Cues
P. Sharma1, D. Wagner2, A. Hsieh1,3;
1University of Maryland, College Park, MD, 2Indiana University-
Purdue University Indianapolis, Indianapolis, IN, 3University of
Maryland, Baltimore, MD.
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Vimentin intermediate filaments have been shown to be involved in
cellular mechanotransduction and adhesion. However, the role of vi-
mentin in mesenchymal stem cell (MSC) response to environmental
cues such as adhesion to different extracellular matrix (ECM) proteins
is still uncertain. Investigating how vimentin is involved with MSCs’
response to such changing environmental cues will improve under-
standing of how MSCs interact with differing environments such as
microcarriers for manufacturing or tissue engineered scaffolds. Here,
hMSCs expressing lentiviral shRNA vectors targeting vimentin or
LacZ(Control) for 14 days were seeded onto glass coverslips coated
with 10 or 50mg/ml of either fibronectin(Fn) or type I collagen(ColI).
Cell areas were measured after 2 hrs using ImageJ to determine initial
response to different ECM proteins. Statistical differences were de-
termined using Mann-Whitney U tests (alpha= 0.01). Cellular area
measurements revealed that shVim-hMSCs had smaller cell areas than
shLacZ-hMSCs on fibronectin (10mg/ml Fn: p< 0.0005, 50mg/ml Fn:
p< 0.0005), but not on collagen regardless of concentration (10mg/ml
ColI: p= 0.051, 50mg/ml ColI: p= 0.186). Further, shLacZ-hMSCs
appeared to be responsive to changes in collagen concentration (ColI
10mg/ml vs. 50mg/ml - shLacZ: p= 0.005, shVim: p= 0.015), while
shVim-hMSCs appeared to be responsive to changes in fibronectin
concentration (Fn 10mg/ml vs. 50mg/ml - shLacZ: p= 0.02, shVim:
p= 0.006). These results demonstrate that vimentin may be involved in
MSC early sensing of fibronectin. Cues like ECM proteins can impact
downstream MSC activity and investigating these can lead to im-
proved understanding of mechanisms that drive MSC behavior. In-
vestigation of the expression of cell-surface adhesion proteins will
elucidate this response further.
455
Mesenchymal Stem Cell Immunomodulatory Effects depend on
the Degree of Existing Inflammation
P. Diaz-Rodriguez, S. Samavedi, H. Chen, M. Hahn;
Rensselaer Polytechnic Institute, Troy, NY.
Humanmesenchymal stems cells (hMSCs) have been investigated
for the treatment of numerous diseases due to their immunomodu-
latory capacity. Recently, their ability to not only decrease inflam-
mation but also be polarized to a pro-inflammatory phenotype has
been hypothesized, a factor which may underlie the high variability
in hMSC clinical outcomes. The present study evaluates the impact
of existing macrophage-mediated inflammation on the immuno-
modulatory capacity of hMSCs.
Bone marrow-derived hMSCs and pro-inflammatory, LPS-activated
macrophages (AMs) were used to establish different inflammatory
environments by modulating AM:hMSC ratios. Poly(ethylene glycol)
hydrogels containing various levels of AMs or hMSCs were combined
using a Transwell system to producemono-culture or co-culture groups.
After 72 hours of culture, cell protein expression was assessed by
western blot and multiplex protein analysis.
As expected, hMSC expression of COX-2, a key anti-
inflammatory factor in hMSCs, increased in a dose-dependent
manner following exposure to AMs. However, the increase in hMSC
COX-2 did not always correlate with reduced pro-inflammatory
factor secretion by co-cultured AMs. Specifically, at low AM:hMSC
ratios, AM secretion of TNF-a and IL-6 decreased substantially.
However, high AM:hMSC ratios were associated with no change in
AM pro-inflammatory cytokine production. The AM results may be
due to the associated increase in hMSC pro-inflammatory/pleiotropic
cytokine production seen with increased AM levels concomitantly
with increased COX-2. These results increase the knowledge of the
paracrine effects of hMSCs and indicate that their successful use
must account for the existing inflammatory environment.
456
Alginate Encapsulated Multipotent Adult Progenitor Cells
Enhance Bone Defect Repair
J. Bossert, A. LoGuidice;
RTI Surgical, Alachua, FL.
A current challenge for many cell-based therapies is the long-term
retention or initial homing to the target region in order for the stem
cells to elicit their therapeutic effects [1]. The use of alginate for the
encapsulation of cells or delivery of drugs has been extensively in-
vestigated, but to date the encapsulation of multipotent adult pro-
genitor cells (MAPC) in alginate remains uninvestigated. This study
examined the use of alginate encapsulated MAPC to enhance the
repair of bone defects. We have shown that MAPC in alginate can
remain viable for at least 28 days in vitro, and significantly upre-
gulate their expression of key angiogenic cytokines GRO-a and
VEGF during encapsulation, when compared to MAPC cultured on
normal tissue culture plates. Given that revascularization is a key step
in the healing of bone defects, an in vivo pilot study was performed to
determine if the angiogenic cytokine upregulation observed in vitro
would translate into improved healing in a rat fibular defect model.
The preliminary histopathological evaluation has shown that en-
capsulated MAPC have increasing bone healing and neovascular-
ization over a 4 week time course. The results of these studies have
shown that alginate encapsulated MAPC have promise to improve
current treatment options for poorly vascularized bone defects.
Reference:
1. Hocking AM. The Role of Chemokines in Mesenchymal Stem
Cell Homing to Wounds. Adv. Wound Care 4, 623, 2015.
457
Role of Nanoelectrodes and Electrical Stimulation to Modulate
Cellular Functions
K. S. Garde, S. Aravamudhan;
Nanoengineering, NC A&T SU, Greensboro, NC.
The application of external stimuli to influence cell proliferation
and differentiation is an important aspect of tissue engineering.
Physical (2D/3D structures, material properties, topography) and
chemical (growth factors, hormones, drugs) stimulus have improved
structure and functionality of tissue engineered products. Another
type of external stimuli is electrical potential and current, which
remains fairly unexplored despite its huge value1. In this project, we
explore 3D penetrating nanoelectrodes (of various aspect ratios) to
deliver electrical stimuli and its potential to differentiate human
Adipose Derived Stem Cells (hADSCs) to neuronal lineage. The
degree of differentiation of hADSC to neural lineage varied based on
the strength of the electric field and the aspect ratio of the nanoe-
lectrodes. The extent of differentiation was evaluated by im-
munostaining for markers of PAX6, NESTIN and MAP2. The
functional ion channels in hADSCs and neural lineage were further
analyzed using whole-cell patch-clamp recording. This study dem-
onstrates that electrical stimulation can play a vital role in modu-
lating cellular functions, particularly in the differentiation of
hADSCs and thereby aid in the development of a growth factor-free
differentiation protocol.
Reference: 1. Balint, R.; Cassidy, N. J.; Cartmell, S. H., Electrical
stimulation: a novel tool for tissue engineering. Tissue engineering.
Part B, Reviews 2013, 19(1), 48-57.
Acknowledgments: This work was performed at Joint School of
Nanoscience and Nanoengineering, a member of the National Na-
notechnology Coordinated Infrastructure supported by the National
Science Foundation (Grant ECCS-1542174).
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Adipose-Derived Stem Cells Delay Muscle Atrophy after
Peripheral Nerve Injury in Rats
B. K. Schilling1, M. Schusterman2, D. Kim2, D. Grybowski2,
A. Repko3, K. Klett4, K. Marra2;
1Bioengineering, University of Pittsburgh, Pittsburgh, PA, 2Plastic
Surgery, University of Pittsburgh, Pittsburgh, PA, 3Biological
Sciences, University of Pittsburgh, Pittsburgh, PA, 4Chemical
Engineering, University of Pittsburgh, Pittsburgh, PA.
S-114 POSTER ABSTRACTS
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Peripheral nerve damage contributes to atrophy of its innervated
muscles; even if immediate primary nerve intervention is performed,
the successful reinnervation of the nerve does not ensure the return of
muscle function, which then requires additional therapies [1]. This
study investigates the ability of adipose-derived stem cells (ASCs) to
delay muscle atrophy after peripheral nerve injury in a rat model.
Twenty Lewis rats underwent excision of the right sciatic nerve; left
hindlimbs were used as controls throughout. Investigation conditions
included: empty defect, autograft, autograft with injection of ASCs
into the gastrocnemius, or autograft with injections of ASCs on Days
0 and again on 21. All rats were sacrificed on Day 42 and bilateral
gastrocnemius muscles were harvested and weighed. Weights were
reported as a percentage of the contralateral, unaffected muscle.
Specimens were evaluated histologically to evaluate muscle fibers,
fatty infiltration, and fibrosis. DiR imaging confirmed presence of
ASCs at sacrifice. Statistical analysis of the muscle weights by
ANOVA revealed significantly larger masses in muscle with the
single ASC injection compared to controls, suggesting that injection
of ASCs delayed progression of muscle atrophy.
Reference: 1. Grinsell D, Keating CP. BioMed Research Inter-
national. 2014.
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Tissue Chips & Tissue Organoid Models
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461
Development of a Human Tissue-EngineeredModel of Duchenne
Muscular Dystrophy
A. Khodabukus, N. Prabhu, N. Bursac;
Biomedical Engineering, Duke University, Durham, NC.
Current animal models of Duchenne muscular dystrophy (DMD)
fail to fully recapitulate the severity of the disease seen in humans.
Given the wide range of mutations underlying DMD, the ability to
study DMD from patient biopsies would allow patient-specific drug
screening. Here we sought to determine if a 3D tissue-engineered
skeletal muscle system1 (myobundle) can replicate the contractile
and morphological phenotype of DMD muscle. Myobundles were
generated from primarymyoblasts derived from 2DMD andmultiple
healthy (H) patients. Functionally, DMD myobundles generated
significantly lower tetanic force (H: 1.64 – 0.21mN, DMD:
0.24– 0.05mN) and exhibited greater force loss (H: 30.1 – 2.3%,
DMD: 50.4 – 2.91%) following repeated eccentric contractions than
healthy bundles. The decrease in force may be partially due to a
decrease in differentiation as shown by a decrease in muscle cross-
sectional area and mean myotube diameter. Additionally, by quan-
tifying fiber size distribution, we found an increased abundance of
fibers over 20 mm in DMD bundles due to the presence of hy-
percontracted fibers that could be directly visualized in longitudinal
myobundle sections. The human myobundle system recapitulated
contractile (i.e. muscle weakness and increased susceptibility to ec-
centric contraction) and morphological (i.e. hypercontracted fibers
and increased variation in myofiber size) seen in DMD patients. This
system provides a novel platform for the study of DMD pathogenesis
and drug development in a patient-specific manner.
Reference: 1. Madden L et al. eLife 4: 2015.
Acknowledgments: NIH grant UH3-TR000505
462
Adhesive Film-based Microfluidic Device For Motility
Assessment Of Cancer Cells
S. Rajan1,2, P. Hambright3, A. Skardal1,2,4, A. R. Hall1,2,4;
1Biomedical Engineering, Virginia Tech - Wake Forest School of
Biomedical Engineering and Sciences, winston salem, NC, 2Wake
Forest Institute for Regenerative Medicine, Winston salem, NC,
3Wake Forest University, winston salem, NC, 4Comprehensive
Cancer Center of Wake, Winston salem, NC.
Recent studies have shown that cell motility plays a central role in
metastasis and tumor invasion [1]. Studying motility in cancer
models that mimic the in vivo tumor microenvironment and testing
drugs on this model can aid in developing treatments for aggressive
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cancers. 3D cell culture recapitulates the tumor microenvironment
more accurately than in 2D models and translates to humans better
than animal models [2]. We have developed a photopatterning
technique through which 3D cell cultures of arbitrary size and shape
can be formed in situ in the chambers of an active adhesive film-
based microfluidic device, enabling complex structures to be pro-
duced and allowing independent chemical delivery to parallel models
[3]. Here, we expand this system through a novel architecture that
enables direct, quantitative imaging of cell motility throughout an
experiment. In this study, multiple replicates of 3D cell culture
motility structures containing human colon carcinoma cells
(HCT116) are produced in situ in a microfluidic device and chal-
lenged in parallel with various concentrations of the chemothera-
peutic drug 5-Fluorouracil. Cancer cell motility and viability are
probed as a function of drug exposure over 7 days. We envision this
system as a valuable tool for assessing the inhibition of motility, and
therefore as an aid in the development of drugs for the prevention of
metastasis.
References:
1. Wells A. Adv. Cancer Res. 2000, 78: 31-101.
2. Imamura, et al. Oncol Rep 2015 33(4):1837-43.
3. Skardal, et al Biofabrication 2015, 7(3):031001.
463
Adhesive Film Based Multi-organoid Body-on-a-chip Platform
For Assessing Drug Efficiency And Toxicity
S. Rajan1,2, J. Aleman1, M. Wan1, N. P. Zarandi1, U. Gandhi1,
G. Nzou1, C. E. Bishop1, H. Sadri-Ardekani1, S. Murphy1, A. Atala1,
A. Skardal1,2,3, A. R. Hall1,2,3;
1Wake Forest Institute for Regenerative Medicine, Winston-Salem,
NC, 2Biomedical Engineering, Virginia Tech –Wake Forest School
of Biomedical Engineering and Sciences, Winston-Salem, NC,
3Comprehensive Cancer Center of Wake, Winston-Salem, NC.
Current drug development techniques are expensive and inefficient,
partially due to the use of preclinical models such as 2D cell cultures
and animal models that often do not accurately recapitulate in vivo
drug efficacy and cytotoxicity. For example, understanding the
cytotoxic side effects in non-target organs in animal models may
not accurately translate to humans. To address this challenge, we
demonstrate a double-sided adhesive film-based body-on-a-chip
microfluidic device that enables the assessment of drug efficiency
and toxicity on multiple 3D tissue organoids in parallel. These
miniaturized structures require less than 200 mL fluid volume and
are amenable to both 3D cell culture and spheroid integration.
Here, we describe a demonstration of this technology by presenting
a multi-chamber device consisting of (1) liver organoids, (2) cardiac
organoids, (3) lung cell constructs, (4) brain organoids, and (5) testes
organoids in tissue volumes roughly proportional to in vivo organ sizes.
We first show that these multiple tissue types can be kept in common
circulation with high viability for 14 days. We then validate the plat-
form for accurate drug response by introducing the prodrug capecita-
bine, and demonstrating that its metabolism by liver into 5-fluorouracil
(5-FU) induces downstream toxicity in lung and cardiac organoid.
Importantly, removal of the liver from a subset of devices prior to drug
administration resulted in no downstream toxicity, illustrating the
importance of the metabolically active liver organoids. In summation,
we present a multi-organoid body-on-a-chip system that can be used
for the accurate characterization of drug interactions in vitro.
464
An in vitroModel of Fibrosis-Induced Abnormal Development of
the Biliary Tract
M. Brovold, S. Soker;
Wake Forest Insitute for Regenerative Medicine, winston-salem,
NC.
Purpose: Congenital liver disorders (CLD) can culminate in the
need for pediatric liver transplant. CLD’s often result in a profibrotic
environment generated largely by activated hepatic stellate cells
(aHSC), which produce chemokines, ECM proteins and restructuring
of the ECM. Our lab has developed a unique in vitro model that
simulates a fibrotic environment. We propose to use to model the
effects of the fibrotic environment during development and if aHSC
cause abnormal development.
Methods: Fibrosis models were produced by culturing the He-
paRG cell line with aHSC or LX-2 (immortalized HSC cell line) in a
collagen gel. Several experiments were conducted: HSC’s or LX-2
only and (HSC’s or LX-2+HepaRG within collagen gel. Cells were
culture for 1 and 3 weeks. Cells were analyzed for changes in de-
velopmental pathways using qPCR and changes in the ECM were
quantified by image analysis.
Results: Co-cultures of liver progenitors and HSC resulted in a
variation of gene expression in progenitor cells compared to pro-
genitors alone. aHSC’s modification of the collagen gel resulted in
larger collagen I fibrils as compared to LX-2 quantified by picrosirius
red. HepaRG’s formed primitive biliary structures, which were larger
within the aHSC co-culture as compared to LX-2 or HepaRG alone.
Discussion and Conclusions: aHSC’s interrupt normal develop-
mental gene expression and growth of liver progenitor cells in this
model system. A larger analysis of additional developmental path-
ways such as OPN, TBX3, Notch etc. will be conducted and com-
pared to tissue samples from patients who suffer from these liver
disorders.
465
Enhancing the Stability of Self-Assembled Toroid-Shaped Tissue
Constructs via Media Composition
B. T. Wilks, M. N. Nakhla, J. R. Morgan;
Molecular Pharmacology, Physiology and Biotechnology, Brown
University, Providence, RI.
During cellular self-assembly, monodispersed cells are seeded
into a non-adhesive mold, adhere and exert forces on one another
resulting in compaction into a highly dense tissue construct. By
modifying the geometry of the non-adhesive agarose gel in which
cells are seeded, it is possible to control the alignment of the cells as
they assemble around precisely placed peg features.1 However, as
highly contractile cell types such as fibroblasts coalesce into a self-
assembled tissue and continue to exert forces on one another, tension
in the tissue builds and ultimately results in necking and failure.2 In
order to maximize the long-term stability of these tissues, media
composition was optimized with matrix promoting supplements
ascorbic acid and l-proline. Similarly, fetal-bovine serum (FBS) was
removed due to its implication in cellular contractility. Toroids from
the FBS medium group rapidly self-assembled, thinned and
71% – 8% (n= 12) broke by day 4. Conversely, only 8%– 17%
(n = 12) of serum-free medium (SFM) with supplementation tissues
broke within the same time span. This has the potential to become a
platform for the production of precisely aligned ECM of tunable
composition, for harvest or designer biomaterial.
References:
1. Schell, J. Y. et al. Harnessing cellular-derived forces in self-
assembled microtissues to control the synthesis and alignment of
ECM. Biomaterials 77, 120-129 (2016).
2. Wang, H. et al. Necking and failure of constrained 3D micro-
tissues induced by cellular tension. Proc. Natl. Acad. Sci. U. S. A.
110, 20923-8 (2013).
Acknowledgments:
NSF grant CBET-1428092
Sidney Frank Fellowship
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Embryoid Body Culture of Mouse iPS Cells using an Oxygen-
permeable Microwell Chip
D. Miyamoto, K. Nakazawa;
The University of Kitakyushu, Kitakyushu, JAPAN.
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Embryoid body (EB; iPS cell aggregate) can promote the initial dif-
ferentiation of iPS cells. As a new platform of EB culture, we have
developed a microwell chip, in which microwells of several hundred
micrometers were regularly fabricated on a culture substratum. In this
study, we investigated the effects of oxygen environment in microwell
chip culture on the EB properties. We fabricated the chips which con-
tained 139microwells (500mm in diameter) on poly-methylmethacrylate
plate (PMMA chip; oxygen non-permeable material) or poly-
dimethylsiloxane plate (PDMS chip; oxygen permeable material),
and evaluated the EB growth and cell differentiation properties.
Mouse iPS cells formed a single EB in each microwell within 1 d of
culture. Although the EB size in both chips increased with the in-
crease of culture period, the EB growth in PDMS chip was higher
than that in PMMA chip. The expression of hepatic markers (TTR
and AFP) in the PDMS chip was lower than that in the PMMA chip,
while the expression of vascular markers (Flk1 and PDGFRb) in the
PDMS chip was higher than that in the PMMA chip. These results
indicate that the oxygen environment is important factor to control
cell proliferation and differentiation fate of the EBs, and the micro-
well chip culture is a promising platform to control the EB properties.
467
In Situ Monitoring of Engineering Muscle to Assess Myopathy
X. Zhang, G. A. Truskey;
Duke University, Durham, NC.
Tissue engineered human skeletal muscle provides a new platform
tomodel muscle diseases and to study themuscle function in response
to drugs and toxins in vitro [Stem Cell Research & Therapy, 4(1): S10
(2013)]. In this work, we developed a novel in situ system to monitor
the muscle force with higher throughput and low cost. Myobundles
were fabricated from human myoblasts using a hydrogel molding
technique. PDMS molds with four seeding chamber were designed to
fabricate multi-myobundles array. Each myobundle was indepen-
dently bonded in series with an ecoflex (platinum-catalyzed silicone)
film containing beads (53-63mm). Then force generation of myo-
bundles in the frame was obtained from mapping the displacement of
the beads and the measured elastic modulus of ecoflex membrane.
Myobundle contractile forces measured with the microbeads em-
bedded in ecoflex agreed well with simultaneous measurements with
a force transducer. This novel system was tested through monitoring
the force change of myobundles treated with doxorubicin and cer-
ivastatin. For doxorubicin (1mg/ml), the contractile force generation
ofmyobundles in all groupsweremaintained or increased in first three
days after shifting to differentiation media (then doxorubicin was
added) and this trend was maintained for another 5 days in control
groups. In contrast, the tetanus force for myobundles treated with
doxorubicin continuously dropped from 5 day onward. The force
declines after day4 of continuous exposure to 100 nM cerivastatin and
the inhibitory effect of cerivastatin could be eliminated by incubation
with 0.3mM mevalonate. This method opens new possibilities for
investigating the mechanical stresses of muscle.
Poster Session 3
Tuesday, December 5, 2017, 4:30 PM - 6:30 PM
Biomaterial Scaffolds
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Synthesis and Evaluation of Dual Crosslinked Alginate
Microbeads
S. Somo1, K. Langert2, C. Yang3, V. Ibarra1, A. Appel1, B. Akar1,
M. Cheng3, E. Brey1,2;
1Illinois Institute of Technology, Chicago, IL, 2Edward Hines Jr. VA
Hospital, Chicago, IL, 3Chang Gung Memorial Hospital, Taoyuan,
TAIWAN.
Alginate hydrogels have been investigated for a broad variety of
medical applications. The ability to assemble hydrogels at neutral pH
and mild temperatures makes alginate a popular choice for the en-
capsulation and delivery of cells and proteins. Alginate has been
studied extensively for the delivery of islets as a treatment for type 1
diabetes. However, poor stability of the encapsulation systems after
implantation remains a challenge. In this paper, alginate was modi-
fied with 2-aminoethyl methacrylate hydrochloride (AEMA) to in-
troduce groups that can be photoactivated to generate covalent
bonds. This enabled formation of dual crosslinked structure upon
exposure to ultraviolet light following initial ionic crosslinking into
bead structures. The degree of methacrylation was varied and in vitro
stability, long term swelling, and cell viability examined. At low
levels of the methacrylation, the beads could be formed by first ionic
crosslinks followed by exposure to ultraviolet light to generate co-
valent bonds. The methacrylated alginate resulted in more stable
beads and cells were viable following encapsulation. Alginate mi-
crobeads, ionic (unmodified) and dual crosslinked, were implanted
into a rat omentum pouch model. Implantation was performed with a
local injection of 100ml of 50 mg/ml of LPS to stimulate a robust
inflammatory challenge in vivo. Implants were retrieved at 1 and 3
weeks for analysis. The unmodified alginate microbeads had all
failed by week 1, whereas the dual-crosslinked alginate microbeads
remained stable up through 3 weeks. The modified alginate mi-
crobeads may provide a more stable alternative to current alginate-
based systems for cell encapsulation.
470
Self-foldable 2-D Micro-patterns for Creating 3-D Cell Niches
with Tunable Micro-topography
C. Cui, M. Wang, L. Han;
Mechanical Engineering and Mechanics, Drexel university,
Philadelphia, PA.
2-D cell-culture platforms are well established and easy for cell
seeding and culturing, whereas 3-D scaffolds are promising for tissue
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regeneration study, as they better resemble the dimensionality of
extracellular matrix (ECM) in vivo. Despite the progress in 3D
technology, bio-fabrication of 3-D scaffolds often demands com-
plicated and time-consuming procedures. 3-D scaffolds are often
difficult to cellularize due to inefficient cell penetration or diffusion.
Here we present an easy-to-use platform that consists of 2-D, self-
foldable, hydrogel-based micropatterns, which can turn into biomi-
metic 3-D structures. In brief, biomaterials with distinct swelling
ratios were inkjet-printed by layers into cell-sized patterns on glass
substrates pre-coated with a releasing layer. The patterns were seeded
with human mesenchymal stem cells (MSC), incubated for 1 day for
cell attachment, and released to activate self-folding. Due to het-
erogeneous swelling, rectangular micropatterns folded into micro-
tubes, which are promising for engineering linear tissues including
muscles, blood vessels and nerves. Fluorescent imaging on day 1
showed extensive cell spreading and uniform cell distribution inside
the self-folded scaffolds. On day 12, the cytoskeleton of MSC spread
in parallel to each other along the tubular scaffold, due to the uni-
directional ECM shape. Our platform enables the formation of
uniformly-cellularized 3-D micro-scaffolds with customized ECM
topography, while supporting conventional 2-D cell-seeding proce-
dure. The inkjet-printing approach is efficient and enables the rapid
production of 3-D scaffolds at large quantity, which benefits high
throughput studies and is promising for clinical applications.
471
PC-12 Cell Proliferation On Coaxial Electrospun Microfibers
Containing FGF-2
K. Reis1, L. Sperling2, P. Pranke2;
1Post Graduate Program in Physiology, Federal University of Rio
Grande do Sul, Porto Alegre, BRAZIL, 2Analysis, Federal
University of Rio Grande do Sul, Porto Alegre, BRAZIL.
Fibroblast growth factor (FGF-2) is an important bioactive agent
involved in tissue repair that can be encapsulated through coaxial
electrospinning for controlled release. The aim of this study has been
to analyze the biological potential of these electrospun fibers on rat
pheochromocytoma PC-12 cell line. The core of the fibers consisted
of 100mg/ml FGF-2, 10% polyethylene glycol and 2% bovine serum
albumin in water; the shell solution consisted of 18% poly(lactic-co-
glycolic acid) (PLGA 75:25) in 1-1-1-3-3-3-hexafluoro-2-propanol.
The morphology of the PLGA/FGF-2 microfibers was analyzed by
scanning electron microscopy (SEM) and their diameter was calcu-
lated using ImageJ software. Verification of the core-shell structure
was performed by transmission electron microscopy (TEM). The
scaffolds were seeded with PC-12 cells. Cell viability was evaluated
byMTT assay; cell proliferation andmorphology was analyzed using
images from SEM and CLSM. Coaxial electrospinning resulted in
fibers with a uniform morphology and without any beads. Through
TEM analysis, it was possible to visualize the core-shell structure of
the microfibers. Additionally, by using fluorescein in the core, it was
possible to confirm the presence of fluorescence inside the fibers by
CLSM. The average diameter of the fibers was 2.18 – 0.74mm.
In vitro, the coaxial fiber scaffold supported the attachment of PC-12
cells, as shown by the SEM images. The MTT assay demonstrated
that the cells proliferated and maintained viability. These results
indicate the cytocompatibility of the FGF-2 loaded core-shell mi-
crofibers and their great potential in tissue engineering.
FINEP, CNPq, FAPERGS and Stem Cell Research Institute.
472
3D Macro-porosity Regulates Stem Cell Fate in Hand-spun
Micro and Nanofibers
M. Wang, C. Cui, L. Han;
Drexel University, Philadelphia, PA.
Introduction: 3D topographic cues, including shape and macro-
porosity of extracellular matrix, regulate mechanosensing and
subsequent cell bioactivities including survival, proliferation, and
differentiation. Research on how 3D topographic cues influence
cell behaviors is limited by a lack of proper ECM model of cus-
tomizable, cell-size features. Here we present Fiber-Gel, a new
biomaterial platform to help study the biological effects of ma-
trix porosity. Fiber-Gel is made of photocrosslinkable gelatin mi-
crofibers of a widely customizable diameter, ranged from 200
nanometers to 100 microns. The microfibers form highly tunable
macro-pores, ranging from 500 nm to 500 mm in pore size, pro-
viding an easy-to-used platform for studying how cells or stem cells
respond to the porous topographic cues. The elasticity of individual
fibers is customizable. We invented a ‘hand-spinning’ technique,
which repeatedly stretches and folds a ring of gelatin core into
micro/nano fibers with diameter ranged from 200 nm to 100 mm.
This hand-spinning method will be introduced in detail.
Cell study andResults:Cultured in mixed adipogenic/osteogenic
media and encapsulated in Fiber-Gel of varied pore size and fiber
elasticity, human mesenchymal stem cells (MSC) in Fiber-Gel of
macropores (>> cell size) and high elasticity (*50 kPa) presented
elevated osteogenic gene expression. MSC in macropores and low
elasticity (*1 kPa) presented elevated adipogenic gene expression.
In contrast, regardless of the elasticity of fiber, MSC in Fiber-Gel
of subcellular pores (<cell size) resented elevated adipogenic gene
expression. Above results demonstrated the great potential of our
Fiber-Gel as a novel platform for the fundamental study on stem cell
mechanosensing.
473
The Impact of Sterilization Upon the Biologic and Viscoelastic
Properties of Extracellular Matrix Hydrogels
L. J. White1, T. J. Keane2, A. Smoulder2, L. Zhang2, J. Reing2,
N. J. Turner2, S. F. Badylak2;
1University of Nottingham, Nottingham, UNITED KINGDOM,
2McGowan Institute for Regenerative Medicine, Pittsburgh, PA.
Prior to clinical use, ECM hydrogels undergo processing, sterili-
zation and storage. Each of these treatments has the potential to alter
the structure of the hydrogel and compromise in vivo performance.
Evaluation of stability and function of ECM hydrogels after sterili-
zation and storage is critical in creating an off-the shelf biomaterial
with retained desired properties. Yet, no studies to date have ad-
dressed how sterilization and storage effect ECM hydrogel me-
chanical properties and bioactivity. In the present study, a new form
of material, lyophilized digest, was introduced to mitigate potential
storage issues with ECM hydrogels. Well-accepted terminal sterili-
zation methods currently used for ECM sheets and powders (i.e.,
gamma irradiation, electron beam irradiation, ethylene oxide (EO)
exposure) and supercritical CO2 (scCO2) sterilization, a relatively
new method, were used to investigate sterilization effects upon
the biologic and viscoelastic properties of ECM hydrogels. 30 kGy
irradiation and scCO2 treatment were the only methods to com-
pletely inhibit bacterial growth in ECM hydrogels. However, expo-
sure to 30-kGy E-beam or gamma irradiation prevented hydrogel
formation. Rheological properties of the hydrogels were not affected
by scCO2 sterilization with stiffness equivalent to non-sterilized
control samples. Macrophages exposed to LPS prior to treatment
with terminally sterilized ECM hydrogels did not show any statisti-
cally significant change in TNFa secretion compared to the non-
sterilized control. These results will inform future clinical translation
of ECM hydrogels.
474
Controlled Release of IGF-1 from IGFBP-3 Conjugated
Scaffolds for Volumetric Muscle Injury
Y. Ju, E. Elsangeedy, J. Lee, I. Kim, A. Atala, J. Yoo, S. Lee;
Wake Forest Institute for Regenerative Medicine,
Winston-Salem, NC.
Current treatment options to repair volumetric muscle loss injury
involve the use of existing host tissue like muscular flaps or grafts.
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In many instances, this approach is challenged by the host muscle
tissue availability and donor site morbidity such as functional loss
and volume deficiency. In this study, we aimed to develop a bio-
functionalized scaffolding system to utilize endogenous stem/
progenitor cells for in situ tissue regeneration [1]. To this end, we
fabricated an insulin-like growth factor-binding protein 3 (IGFBP-
3)-conjugated scaffold for the controlled delivery of IGF-1. In vitro
evaluations, including release kinetics and cellular infiltration, pro-
liferation, and migration, were performed. The results revealed that
the IGFBP-3 conjugated scaffolds provided the sustained release and
increased biological activity of IGF-1 via the IGF-1 binding domain.
Also, higher cell infiltration, proliferation, and migration were de-
termined in the IGFBP-3 conjugated scaffolds when compared with
control scaffold (no conjugation). Our current data strongly suggest
that IGF-1 delivery from IGFBP-3 conjugated scaffolds may accel-
erate host stem cell recruitment that can improve the muscle regen-
eration in situ.
Acknowledgments: This study was supported by the Muscu-
loskeletal Transplant Foundation.
Reference: 1. Ju YM, Yoo JJ, Atala A, and Lee SJ, Biomaterial
induced host stem cell recruitment for in situ muscle regeneration,
Acta Biomater., 2014;10(10):4332-9.
475
The Biomimetic Meniscus Scaffold Can Enhance Meniscus
Regeneration in Rabbit Model
W. Guo1, M. Chen2, S. Liu3, J. Mao4, S. Lu3, Q. Guo3;
1Orthopaedics Institute, Chinese PLA General Hospital;Center
for Craniofacial Regeneration, Columbia, New Yorker, NY,
2Orthopaedics Institute, Chinese PLA General Hospital, New York,
NY, 3Orthopaedics Institute, Chinese PLA General Hospital,
New Yorker, NY, 4Center for Craniofacial Regeneration, Columbia
University Medical Center, New York, New York, USA.,
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The inner region of meniscus cannot be self-healing due to the
lack of blood supply. The aligned structure of the native meniscus
can make it easy to resist body load-bearing. Meniscus native mi-
croenvironment can be beneficial to the tissue regeneration. Thus,
one of the major solution that may regenerate the meniscus injuries is
designing a biomimetic scaffold that not only can own a good bio-
mechanical capacity but also mimic the native microenvironment.
A biomimetic meniscus scaffold that consisted of the poly(e-
caprolactone) (PCL) and the decellularized meniscal extracellular
matrix (MECM), was constructed via combination of 3D printing and
decellularization approach. The biomimetic scaffolds exhibited an
excellent biomechanical characteristics and biocompatibility. We
constructed the passagedmeniscal fibrochondrocytes (MFC)-scaffolds
composites and culture in vitro for 7 and 14 days, the results showed
that those constructs not only can enhance cell proliferation but also
can improve the glycosaminoglycan and collagen secretion. We also
implanted the GFP rat MFC-scaffolds composites into the nude rat
subcutaneous. The results show that those composites can form a
meniscus-like tissue by GFP rat MFC compared with the native me-
niscus after 4 weeks implantation. The repair effect was evaluated by
implanting the biomimetic scaffolds into meniscus defects of a rabbit
model. Our findings demonstrated that the biomimetic scaffolds were
able to induce meniscus regeneration, and the newly formed tissues
were similar to the native tissues. Consequently, the current study not
only achieves meniscus repair, but also suggests a promising strategy
for the fabrication of the biomimetic scaffolds.
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Mimicking Cartilage Zonal Organization by Spatial Patterning
of Microribbon-Based Stem Cell Niches
C. Gegg, F. Yang;
Bioengineering, Stanford University, Stanford, CA.
Introduction: Articular cartilage is characterized by zonal orga-
nization, with gradient transitions of biochemical and mechanical
properties. Regenerating cartilage with biomimetic zonal organiza-
tion remains a great challenge. Our research group recently devel-
oped a method to fabricate hydrogels from microribbon (mRB)-like
building blocks, which can be mixed with cells and intercrosslinked
to form cell-laden macroporous scaffolds. The objective of this study
was to create a spatially-patterned, multi-compositional extracellular
matrix (ECM)-based mRB scaffold and evaluate its potential for
mimicking cartilage zonal organization.
Methods: Microribbons were fabricated by wet-spinning as we
previously reported. To mimic zonal transitions, five layers of MSC-
loaded mRBs were patterned in a laminar manner. The layers con-
sisted of mixed compositions of chondroitin sulfate and gelatin, with
decreasing percentages of CS from 100% to 50% to mimic the su-
perficial to deep zones of articular cartilage, respectively. All polymers
were methacrylated to enable intercrosslinking of mRBs between ad-
jacent layers. Scaffolds were cultured in chondrogenic media for three
weeks. Outcome analyses include viability, biochemical assays (DNA,
sGAG, collagen), mechanical testing, and histology.
Results: mRBs enabled one-step crosslinking to form an integrated
macroporous scaffold with a gradient cue of ECM composition. Tuning
mRBcompositions led toMSCzonal-specific responses. Fromsuperficial
to deep, the resulting cartilage demonstrated an increase in compressive
moduli (9 to 456kPa), as well as a 3-fold increase in sGAG content.
Significance: Spatial patterning of mRBs with tunable composi-
tions facilitated MSC-based cartilage regeneration with zonal orga-
nization. This method may be broadly applied for recreating tissue
organization of various tissue interfaces.
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In Vitro Raw 264.7 Monocyte Biocompitibility Of Casting
Chitosan Film And Electrospun Chitosan Membranes Treated
By Two Methods
H. Su, J. D. Bumgardner;
The University of Memphis, Memphis, TN.
Guided Bone regeneration (GBR) membranes are widely used in
clinical surgery as a barrier to direct the formation of bone in the graft
space by protecting it from soft tissue intruding during healing. Chit-
osan is explored for making GBR membrane because of its biocom-
patibility and degradability. In the previous study, trimethylamine
(TEA)/acetone and di-tert-butyl dicarbonate (tBOC) treatment was
investigated for acidic salt removal from chitosan electrospun instead
of the commonNa2CO3 treatment to keep the nano-fibrous structure.1
In this study, electrospun chitosan membranes treated by TEA/tBOC
method and Na2CO3 method, and casting film were evaluated in cy-
tocompatibility with TIB 71TM RAW 264.7 monocyte cells. All the
TEA/tBOC treated and Na2CO3 treated membranes and casting film
were cytocompatible and supported cell proliferation for 3 days. TEA/
tBOC treated membrane did not active monocytes to produce nitric
oxide (NO) in vitro in the absence of lipopolysaccharide (LPS). In the
presence of 2mg/ml LPS, TEA/tBOC treated membrane and casting
film inhibited LPS-induced NO production of RAW 264.7 cells by
50% - 75% as compared to tissue culture plastic and Na2CO3 treated
membrane. Further evaluation are needed in the fibroblasts and oste-
oblasts compatibility and in vivo study.
Reference: 1. Su H, Liu KY, Karydis A, Abebe DG, Wu C,... &
Bumgardner JD. Biomedical Materials. 12, 015003, 2016.
Acknowledgments: Work supported by the Biomaterials Appli-
cations of Memphis (BAM) labs, UM-UTHSC, Memphis, TN.
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Conductive Scaffold Made From Micro-scale Wet-spun
PCL Fibres
S. Shafei, C. Wong, M. Naebe;
IFM, Geelong, AUSTRALIA.
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excellent for tissue engineering due to their similarities to the tissue
extracellularmatrix (ECM). Conductive PCL fibreswerewet-spun and
coated by polypyrrole (PPy) and scaffolds were developed using a salt
leaching process applied on wet-spun fibres. The Young’s modulus of
thePPycoatedfibreswashigher than that of the uncoatedfibres.Neurite
outgrowth of PC12 cells was observed on both coated and uncoated
samples and fibroblast cells had a suitable growth and infiltration into
the structure of the scaffolds. The promising results of the cell growth,
infiltration and differentiation on these scaffolds show the benefits of
this fabrication procedure derived from salt leaching and wet-spinning
where fibres form spongy structures with large pores.
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Evaluation of Two Distinct Biomaterials in Critical
Bone Defects in Calvaria of Rats
P. Brassolatti1, P. S. Bossini2, A. M. de Andrade3, G. F. Luna4,
M. A. Napolitano5, L. Almeida-Lopes2, L. R. de Avo´6,
N. A. Parizotto3, F. d. Anibal1;
1Morfology and Pathology, Federal University of Sa˜o Carlos, Sa˜o
Carlos, BRAZIL, 2Research and Education Center for Phototherapy
in Health Sciences (NUPEN), Sa˜o Carlos, SP, Brazil, Sa˜o Carlos,
BRAZIL, 3Physiotherapy, Federal University of Sa˜o Carlos, Sa˜o
Carlos, BRAZIL, 4Post-Graduate Program of Biotechnology,
Federal University of Sa˜o Carlos, Sa˜o Carlos, BRAZIL, 5DMC
Equipment Import and Export- Co. Ltda, Sa˜o Carlos, BRAZIL,
6Medicine, Federal University of Sa˜o Carlos, Sa˜o Carlos, BRAZIL.
Bone defects are referred to as clinical problems1. Thus, new
biomaterials based on hydroxyapatite and PLGA have been exten-
sively studied2,3. The objective was to evaluate the action of two
different biomaterials on critical bone defects. 48 rats (Wistar), di-
vided into CG, BG1-(HA/PLGA/Bleed) and BG2-(HA/PLGA) were
used, subdivided into experimental periods of 15, 30, 60 days. The
bone defect was induced in the medial region of the calvaria with a
trephine drill 8mm in diameter. Histologically, BG1 presented the
best evolution of the repair process with greater presence of newly
formed bone when compared to the other groups studied. Morpho-
metric analysis confirms the histological findings. BG1-15 presented
9.49% of newly formed bone compared to 5.3% presented by CG-15
and 1.5% presented by BG2-15. BG1-30 presented 18.4% of newly
formed bone compared to 17.5% presented by CG-30 and 3.73% by
BG2-30. BG1-60 presented the largest area of newly formed bone
50.9% compared to 18.06% presented by CG-60 and 7.06% by BG2-
60. The difference found between the treated groups may be asso-
ciated with both chemical properties of each biomaterial as well as
the porosity and rigidity. Thus, it is suggested that BG1 has inter-
esting properties that induce the necessary stimuli that contribute to
the evolution kinetics of bone repair. 1 Petrids, X.; Diamanti, E.;
Trigas, G.C.; Kalyvas, D.; Kitraki, E. Bone regeneration in critical-
size calvarial defects using human dental pulp cells in an extracel-
lular matriz-based scaffold. Journal of cranial-maxillo-facial sur-
gery, 43, 483-490, 2015. 2 Torquato, S., Random Heterogeneous
Materials: Microstructure and Macroscopic Properties. Springer-
Verlag, New-York, 2002.
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A Novel 3-D Micro-fibrous scaffold fabricating method
for Engineering Linear Tissues
C. Cui, M. Wang, L. Han;
Drexel university, Philadelphia, PA.
Tissue-engineering scaffolds mimicking the microenvironmental
topography in our body are promising for desirable stem cell responses
and tissue-formation.Microfibers with linear alignment and customized
diameters are particularly useful for forming linear tissues, as aligned
microfibers form channel-like lumen spaces to induce unidirectional
cell spreading and mechanosensing, which are known to promote
linear-tissue cell phenotypes. However, most methods to prepare mi-
crofibers are extremely slow and have limited diameter tunability.
Cellularization of fibrous scaffolds is also challenging, due to inefficient
cell penetration or diffusion in 3-D. Here we present a novel, ‘‘stretch-
and-fold’’ method tomass-produce alignedmicrofibers of customizable
diameter. In brief, a ring of photo-crosslinkable porcine gelatin were
repeatedly stretched and folded for N cycles.Withinminutes, the cycles
increased the length of gelatin ring by 2N folds, decreased the diameter
of the gelatin ring by 2N/2 folds, turning the ring into a bundle of
microfibers. This method leads to a widely tunable fiber diameter, from
micron- to nanometer scale, while maintaining diameter uniformity and
fiber alignment. To verify the efficacy for tissue engineering, human
mesenchymal stem cells (hMSCs) were mixed among the aligned mi-
crofibers, and the microfibers were photo-crosslinked into a 3-D scaf-
fold. Fluorescent images on day 7 showed uniform cell distribution and
unidirectional cell spreading. The stress-fibers of hMSCs, which plays a
central role in mechanosensing and mechanotransduction, were found
to organized along the fibers. Above results demonstrated the great
potential of our stretched and folded, multi-scaled microfibers for
tissue-engineering and regenerative medicine.
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Evaluation of Biocompatibility of Silk Fibroin and Application to
Tissue Engineered Materials for Cardiocvascular System
Y. Nakazawa1, D. Aytemiz1, A. Higuchi1, C. Pinkarn2, R. Tanaka1,
T. Murakami3, S. Nemoto4;
1Biotechnology and Life Science, Tokyo University of Agriculture
and Technology, Tokyo, JAPAN, 2Veterinary Surgery, Tokyo
University of Agriculture and Technology, Tokyo, JAPAN,
3Veterinary Medicine, Tokyo University of Agriculture and
Technology, Tokyo, JAPAN, 4Thoracic and Cardiovascular Surgery,
Osaka Medical College, Osaka, JAPAN.
Introduction: Current commercial material as a cardiovascular
medical device is expanded polytetrafluoroethylene (ePTFE) and in
use a broad treatment spectrum. However, there are still physical and
functional limitations of this material. In order to make ePTFE a more
useful material, modification of the material itself is required because
of current problems such as biodegrability, self-organized dysplasia,
thrombosis and infectivity. We therefore developed on a hybrid ma-
terial prepared by blending a silk fibroin (SF) and Polyurethane (PU)
for the cardiovascular system, and evaluate the biocompatibility and
tissue response with comparison of current materials.
Materials and Methods: Composite of SF/PU sheets prepared by
electrospinningwith several ratio (ww) and insolubilized in proportion to
previous report. Structural analysis and compatibility of material ob-
served by Solid state NMR measurements. SF/PU patches implanted to
rat abdominal aorta and dog descending aorta from 3 to 6 monthes.
Results: SF and PU composite sheets showed cell infiltration that
result will be anticipated the tissue remodeling in long term. These results
indicated that the SF/PU composite sheet have some good functions
supports to use as a cardiac repairing patch. Moreover, the SF/PU=7/3
sheet demonstrated significantly higher tissue infiltration, elastogenesis,
endothelialization, and no neointimal hyperplasia compared with SF/
PU=4/6 sheet. In conclusion, an increase of SF concentration in the SF/
PU patch had effects on the vascular remodeling and physical properties.
Acknowledgment: This project is supports to us by KAKENHI
(15H03020) by MEXT.
482
Biomimetic Surface Modification of Polymeric Scaffolds
for the Development of in vitro tumor Models
C. Williams, P. McKernan, R. Harrison, V. Sikavitsas;
The University of Oklahoma, Norman, OK.
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Traditional chemotherapy regimens put a high degree of emphasis
on the use of historical data to predict a cancer patient’s response to a
proposed therapy. Unfortunately for the patients, this often leads to
continuous rounds of trial-and-error in the search for a compatible
treatment, decreasing their chances for survival. Tumor engineering
seeks to alleviate this issue by growing patient tumors outside of the
body, providing a high throughput avenue for treatment discovery.
Utilizing a variety of techniques for 3D culture, researchers have cre-
ated models that more closely resemble and predict in vivo tumor drug
responses; however, there is still more room for improvement. In par-
ticular, these in vitro models consistently exhibit poor cell proliferation
and distribution, which severely limits their predictive capabilities. To
combat this major issue, we have leveraged our patented biomimetic
surface modification platform for tumor engineering applications. In
particular, we have identified variousmoieties specific to certain tumors
that are integral to cellular adhesion, and have used these to modify our
scaffolds and trick the cancer cells into exhibiting higher rates of ad-
hesion. For instance, in terms of prostate cancer, poly(L-lactic acid)
(PLLA) scaffolds were modified to express n-cadherin, which is a
highly upregulated protein used for cellular adhesion. After cell seed-
ing, we were able to significantly increase PC3 seeding efficiency and
potentially improve cell physiology without compromising the me-
chanical and degradation properties of the underlying PLLA.
483
Novel Heterogeneous Polycaprolactone/human Serum Albumin
Electrospun Membrane for Tissue Engineering with Improved
Properties
A. P. Tiwari, M. K. Joshi, C. H. Park, C. S. Kim;
Bionanosystem Engineering, Chonbuk National University, Jeonju,
KOREA, REPUBLIC OF.
Development of electrospun membrane with improved mechani-
cal properties, proper biodegradation, and excellent biocompatibility
simultaneously is the great challenging task. In this background, we
have prepared the heterogeneous polycaprolactone/human serum
albumin (PCL/HSA) membrane by blending the solution of the dif-
ferent mass weight ratio of PCL to HSA using electrospinning
technique. Physio-chemical and biological properties of the as-
fabricated membranes were evaluated. FE-SEM images revealed that
all PCL/HSA mats were composed of interlinked nano-nets along
with conventional electrospun fibers while nano-nets were not found
for pristine PCL mat. PCL-HSA membranes showed excellent me-
chanical properties (3 fold tensile stress compared to pristine PCL),
improved biodegradation, enhancedmineralization and extraordinarily
supported the cells early adhesion and proliferation compared to pure
PCL membrane. These results indicate that the nano-nets supported
PCL/HSA membranes with the ability to induce progressive cell
growth could be promising in tissue engineering applications.
484
Evaluating the Degradation of Alginate/Chitosan Mixtures
in Growth Plate Injuries
C. B. Erickson1, N. A. Fletcher2, M. D. Krebs2, K. A. Payne1;
1University of Colorado, Anschutz Medical Campus, Aurora, CO,
2Colorado School of Mines, Golden, CO.
Alginate and chitosan are promising yet unexplored biomaterials
for regenerating growth plate cartilage. Growth plate injures can
cause bone bridge formation that can result in traumatic bone growth
abnormalities for children, yet no treatment exists that can restore
growth plate cartilage. The goal of this study was to develop a ma-
terial that would prevent bone bridge formation, and degrade in a
timely manner. We evaluated the ability of Alginate:Chitosan 90:10
with calcium (90:10+C), Alginate:Chitosan 50:50 with calcium
(50:50+C), Alginate:Chitosan 50:50 without calcium (50:50-C), and
Irradiated Alginate (IA) to inhibit bone bridge formation, and de-
grade in a rat growth plate injury model. All animal procedures were
approved according to the University of Colorado IACUC. Alginate/
chitosan mixtures were prepared as above, and injected into proximal
tibial growth plate drill-hole injuries of 6-week Sprague-Dawley rats.
Animals were sacrificed at 28 days, and tibiae were processed for
Alcian-Blue Hematoxylin staining. Groups 90:10+C, 50:50+C, and
50:50-C remained present in the drill track with variable levels of
degradation. Further, repair tissue in these groups showed a mix of
chondrogenic, bony, and fibrous tissue. IA was mostly degraded, and
resulted in fibrous/chondrogenic repair tissue without bony repair.
Results from this study suggest that of these groups, IA degrades
quickly and may enhance growth plate cartilage restoration.
485
3D Electrospun PLGA-Cardiac ECM Hybrid Scaffold
for Cardiac Tissue Engineering
M. Krishnamoorthi1, U. Sarig1, L. Tan1, M. Machluf2;
1Materials Science & Engineering, Nanyang technological
University, Singapore, SINGAPORE, 2Biotechnology and Food
Engineering, Technion Israel Institute of Technology, Israel,
ISRAEL.
Electrospinning is a widely used technique to fabricate polymeric
fibers, which mimics the structural organization of native extracel-
lular matrix (ECM). Despite these mimicking structural properties,
conventional electrospinning only results in 2 dimensional mats ra-
ther than 3 dimensional structures and require further biochemical
modification to improve their bioactivity. Polymeric scaffolds are
generally conferred bioactivity using biomolecules such as collagen,
fibronectin, and laminin. But, more specific organotypic molecules
are required to modify the polymer scaffolds to obtain a native ECM
mimicking structure, as the complex ECM provides a tissue specific
biochemical makeup, and 3D structural organization that governs
eventual cellular functionality. In this study, we combined a PLGA
scaffold and liquid porcine cardiac ECM (L-pcECM), to form a
hybrid scaffold. Wet electrospinning was used to obtain 3D scaffolds
of PLGA. L-pcECMwas obtained by the process of decellularization
of porcine cardiac ECM. The 3D PLGA scaffolds were modified with
L-pcECM using EDC-NHS chemistry. The resulting 3D scaffolds
showed similar morphology, fiber diameter, and pore size as char-
acterized using SEM in comparison to a native ECM. FTIR analysis
presented successful modification of the scaffold with the L-pcECM.
Preliminary cell interaction between the unmodified PLGA scaffold
and human mesenchymal stem cells show improved cell interaction,
viability, proliferation and phenotypic expression. Taken together,
these results indicate that this natural-synthetic composite scaffold
provides a native mimicking cardiac microenvironment to facilitate
stem cell survival and proliferation and may be a potential platform
for cardiac tissue engineering applications.
486
3D Microprinting of Poly(propylene fumarate)
for Drug Delivery
M. Santoro1, C. McCue2, A. I. Son3, K. Hashimoto-Torii3,
M. Torii3, J. P. Fisher1;
1Bioengineering, University of Maryland, College Park, MD,
2Engineering Information Technology, University of Maryland,
College Park, MD, 3Center for Neuroscience Research, Children’s
Research Institute, Washington, DC.
Photocrosslinkable polymers have great applicability in tissue
engineering as resins for 3D printing applications. Photocurable
materials are particularly good candidates for 3D microprinting
(3DMP), a rapidly emerging technology in which a two-photon laser
source is used to fabricate scaffolds with nanoscale resolution1. Yet,
of the extensive library of photocrosslinkable biomaterials currently
developed, only a limited fraction is currently used in 3DMP. In this
work we investigated the possibility to scale down the photochem-
istry of poly(propylene fumarate) (PPF), a biomaterial extensively
used in tissue engineering, for microscale scaffold fabrication via
3DMP. PPFwas synthesized using standard techniques2 and crosslinked
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in the presence of bis-acylphosphine oxide photoinitiator at different
3DMP conditions, resulting in scaffold with microscopic features, as
shown via electron microscopy. Laser power/speed affected PPF
crosslinking and mechanical properties, as measured by infrared
spectroscopy and atomic-force microscopy. Furthermore, delivery
kinetics from drug-loaded PPF scaffolds was tuned by 3DMP condi-
tions, resulting in highly controlled drug release in an animal model.
Together, this work highlights the use of established photocrosslink-
able polymers in 3DMP and its high-throughout characterization of
polymer properties (including degradation and delivery kinetics) on a
microscopic level, avoiding resource-consuming experiments with
larger scaffolds.
References:
1. Xing J, Zheng M, Duan X. Chem Soc Rev, 44, 5031, 2015.
2. Kasper FK, Tanahashi K, Fisher JP, Mikos AG. Nat Protocols,
4, 518, 2009.
Acknowledgments:This research was supported by theMaryland
Stem Cell Research Fund (Grant # 4300811), the Scott-Gentle
Foundation, and the NIH National Center for Advancing Transla-
tional Science (Grant # UL1TR001876).
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Preparation of Chondroitin Sulfate Crosslinked, Thermally
Responsive Hydrogels for Osteochondral Tissue Regeneration
Y. Kim1, J. L. Guo1, J. Lam2, A. G. Mikos1;
1Bioengineering, Rice University, Houston, TX, 2Center for
Biologics Evaluation and Research, Food and Drug Administration,
Silver Spring, MD.
In situ gelling hydrogel constructs have shown great promise for
the repair of bone, cartilage, and other tissue types. Our research
group has developed in situ thermally gelling hydrogels for bone
repair, as well as bi-layered hydrogels that affect the repair of os-
teochondral tissue containing bone and cartilage. Because thermo-
gelling hydrogels have inherent issues with syneresis, or shrinking,
chemical crosslinkers have been utilized to prevent such behavior. In
this study, we aimed to study the feasibility of using chondroitin
sulfate (CS), a sulfated glycosaminoglycan, as the biological cross-
linking agent. Once modified with adipic acid dihydrazide (ADH),
it undergoes crosslinking reaction with (N-isopropylacrylamide)
(PNiPAAm)-based thermogelling macromer. Pendant epoxy group
was chosen as the site of crosslinking, since amine-epoxy reaction
does not require exogenous catalyst, and can occur in mild conditions
without generating harmful by-products.
Carboxylate groups on glucuronic acid repeat units of CS were
modified with ADH using carbodiimide crosslinking chemistry, and
the degree of modification was quantified via 1H-NMR. The results
show that CS can be modified with ADH, and its modification rate
can be easily modulated by changing the amount of carbodiimide in
the reaction. The chemical crosslinking between modified CS and
PNiPAAm-based hydrogel was also verified via simple inverted tube
method, in which the hydrogel underwent, along with thermal ge-
lation at 37 C, irreversible chemical crosslinking. These results
show that CS can indeed be utilized as the chemical crosslinker for
PNiPAAm-based hydrogel.
488
Localized Release of Corticosteroid from Macroporous
Organosilicone Beads Scaffolds
J. Liang, K. Jiang, C. L. Stabler;
Biomedical Engineering, University of Florida, Gainesville, FL.
The local delivery of anti-inflammatory agents provides a prom-
ising approach to improve the efficacy of islets transplantation for
treatment of Type 1 Diabetes. The delivery profile, however, needs to
be carefully designed to ensure the stable release of the agent in a
range that mitigates inflammatory responses while avoiding delete-
rious effect to the graft. In our previous study, Dexamethasone (Dex)
was loaded within PDMS directly to fabricate macroporous scaffolds
(regular scaffolds) for controlled release of the drug. This local release
was found to acceleration islet engraftment via promotion of anti-
inflammatory M2 macrophages [1]. In an effort to provide a more
controlled and extended drug release, porous scaffolds were fabricated
using Dex-microbeads. First, Dex was loaded within PDMS and mi-
crobeads were fabricated by emulsion (size range 75.39– 50.51mm).
Dex-beads were then mixed within PDMS and NaCl to obtain a 85%
macroporous scaffold. The kinetic release of Dex from these new
PDMS beads scaffolds was found to be significantly modulated, re-
sulting in the stable release for over 30 days (within the range from 50
to 150 ng/mL for the 0.5% loaded scaffold). This was in stark contrast
to standard Dex scaffolds, where the majority of the drug was released
within the first 10 days (burst followed by plateau). A scaffold that
provides a more sustained and controlled Dex release should lead to
mitigation of different transplant-associated inflammatory responses
while minimizing deleterious effects associated with a burst and ex-
piration drug release profile.
Reference: 1. Jiang, Kaiyuan, et al, Biomaterials 114 (2017) 71-81.
489
Fabrication of Functional Biomimetic Vascular Scaffolds
for Use in Renal Tissue Constructs
J. Huling, S. Min, I. Ko, A. Atala, J. Yoo;
Wake Forest Institute for Regenerative Medicine,
Winston Salem, NC.
One challenge common to large tissue engineered constructs is the
need for vascularization in vivo and in vitro to facilitate oxygen
delivery. Pre-vascularization is particularly challenging in the kidney
due to the organ’s size and unique vascular architecture. Biofabri-
cation and microfluidics techniques can produce simple branching
vessel-like structures, however they do not replicate the vascular
organization seen in native tissues. In addition, these methods are
often complex and expensive. We propose a simple, cost-effective
and novel method for the fabrication of biomimetic microvascular
scaffolds for pre-vascularization of constructs based on vascular
corrosion castings of kidneys. Vascular corrosion casts are capable of
capturing the entire vascular network of an organ, including glo-
merular capillaries. Starting with these corrosion casts as a template,
we are able to mold microvascular scaffolds that reflect the native
anatomy. The microvascular scaffolds can support endothelialization
and incorporation into hydrogel-based renal constructs. Human re-
nal cells in 3D culture around the vascular scaffold self-assemble
into tubule-like structures, which anatomically and functionally re-
semble segments of the nephron. We believe that these pre-
vascularized renal constructs will be capable of integration after
implantation and may be used to augment the function of diseased or
damaged kidneys.
490
Osteogenic Differentiation of Human Mesenchymal Stem
Cells on Osteopontin Mimetic Peptides Modified
Electrospun Nanofibers
G. Onak, O. Karaman;
Biomedical Engineering, _Izmir Katip Celebi University,
_Izmir, TURKEY.
Osteopontin is one of the major extracellular matrix protein that
plays vital role on mineralization. Osteopontin structure contains
40% of glutamic acid (GLU) and aspartic acid (ASP) sequences.
Although there have been studies that show the individual effect of
GLU and ASP sequences on osteogenic differentiation when those
used to modify the surface of PLGA nanofibers (NF), to best of our
knowledge comparison the effect of GLU and ASP on human mes-
enchymal stem cells (hMSCs) osteogenic differentiation has not been
studied. The objective of this study is to determine the major effec-
tive sequence on adhesion, proliferation, osteogenic differentiation
and mineralization of hMSCs. EEEEE and DDDDD were synthe-
sized manually on Rink Amide resin and conjugated to Ac-PLA by
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Michael addition reaction to produce the PLA-GLU and PLA-ASP
conjugate1. Peptide conjugation was characterized via AFM, FTIR
and XPS. Next, hMSCs are seeded on the surface modified NF and
cultured in osteogenic media for 28 days. Differentiation of MSCs
was evaluated by measuring the alkaline phosphatase activity, aliz-
arin red staining, total calcium content, gene expression levels and
immunofluorescence staining of osteogenic markers of collagen type
I, osteocalcin and osteopontin. Surface characterization of PLA-GLU
and PLA-ASP successfully confirms peptide conjugation on NF and
osteogenic differentiation of hMSC on surface modified NF are un-
derway. The outcomes of this study would help to determine the most
effective sequence on hMSCs on osteogenic differentiation for fur-
ther modification of the synthetic scaffolds.
1. Karaman O. et al, J Tissue Eng Regen Med, 10(2): p. E132-
46(2016).
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Mechanically Tuned Aligned Nanofibers and GDNF to Improve
Nerve Growth Conduits
T. J. Whitehead1, E. A. Mays1, J. Peduzzi2, A. Mazhari3, C. Chen1,
J. M. Cavanaugh1, H. G. Sundararagahavan1;
1Biomedical Engineering, Wayne State University, Detroit, MI,
2Anatomy and Cell Biology, Wayne State University, Detroit, MI,
3Neurosurgery, Wayne State University, Detroit, MI.
Treatments for peripheral nerve injury includes autografts and
nerve growth conduits (NGC). This project enhances existing NGCs
by incorporating aligned nanofibers (topographical) made from a
compliant substrate (mechanical) with growth factor (GF) releasing
microspheres (chemical). We hypothesize that these cues along with
physical therapy (PT) will result in enhanced function recovery.
Polycaprolactone conduits with longitudinally alignedmethacrylated
hyaluronic acid fibers, with or without microspheres containing glial
cell line-derived neurotrophic factor were tested in rat sciatic nerves.
The animals were divided into five groups: fibers, fibers + PT, fibers +
GF, fibers + GF + PT, and autograft control. All animals received
behavior and functional testing prior to surgery and weekly post-
surgery for 60 days. Prior to sacrifice the Compound Muscle Action
Potentials (CMAP) of the gastrocnemius muscles were measured.
Gastrocnemius muscles and sciatic nerves were harvested for his-
tological analysis. All surgical procedures and animal testing was
approved by the Wayne State University Institutional Animal Care
and Use Committee. Weekly testing showed that fibers with GF
enhanced or accelerated functional recovery. By 4 weeks both the GF
groups were performing similarly to the autograft in the footfall test.
Interestingly, starting at week 5, the fibers + PT group was also near
autograft. Von Frey fibers were used to test the sensory perception.
This study indicates that GFs combined with aligned fibers can im-
prove functional recovery following peripheral nerve injury and that
physical therapy can have a positive effect, though it may not have an
additive effect when combined with GFs.
492
Development of an Elastic and Adhesive Sealant
for Surgical Applications
N. Annabi1,2,3, Y. Zhang2,3, A. Assmann2,3,4, E. Shirzaei Sani1,
A. Vegh2,3, G. Cheng2, B. Dehghani2, G. U. Ruiz-Esparza2,
X. Wang2, A. S. Lassaletta, 021155, S. Gangadharan5, A. S. Weiss6,
A. Khademhosseini2,3;
1Chemical Engineering, Northeastern University, Boston, MA,
2Biomaterials Innovation Research Center, Harvard Medical School,
Cambridge, MA, 3Massachusetts Institute of Technology,
Cambridge, MA, 4Harvard University, Cambridge, MA, 5Beth Israel
Deaconess Medical Center, Boston, MA, 6University of Sydney,
NSW, AUSTRALIA.
Conventional surgical sealants have been used for sealing or re-
pairing defects often suffer from low adhesion strength, insufficient
mechanical stability and strength, cytotoxic degradation products,
and weak performance in biological environments. Therefore, in this
study we aimed to engineer a photocrosslinked and highly biocom-
patible sealant with tunable mechanical and adhesion properties us-
ing tropoelastin, as a genetically modified human protein. We tuned
the degree of methacrylation of tropoelastin and prepolymer con-
centration to optimize the physical properties and adhesion strength
of the methacryloyl-substituted tropoelastin (MeTro) hydrogel for
sealing of elastic and soft tissues. Following ASTM standard tests,
the MeTro hydrogels revealed superior adhesive strength and burst
pressure values compared to the commercially available sealants.
The subcutaneous implantation of the engineered MeTro hydrogels
in rats exhibited minimal inflammatory host responses and slow
biodegradation of sealant. The in vivo and ex vivo burst pressure
resistance of bioengineered MeTro sealants was tested on lungs and
arteries in small as well as translational large animal models. Our
results proved MeTro sealant to effectively seal lung and artery
leakages without the need for sutures or staples, presenting a sig-
nificant improvement compared to the commercially available clin-
ical sealants (Evicel and ProgelTM) and sutures only. Combining
these results, we envision that the engineered MeTro sealant has the
potential to be commercialized due to its remarkable mechanical
strength, biocompatibility, biodegradability and strong adhesive in-
teraction between the sealant and the wound tissue without the need
for suturing.
493
Seeding and Recellularization of Porcine Acellular Muscle
Matrix Biomaterials with Adipose-Derived Mesenchymal
Stem Cells and C2C12 Myoblasts
J. N. Schroen, C. T. Pham, T. D. Collins, N. N. Mseis, A. van Eldik,
C. E. Burt, M. M. Stern;
Biology, Winthrop University, Rock Hill, SC.
The ability of skeletal muscle to repair itself via regenerative
mechanisms is limited to instances where tissue damage is relatively
small. When volumetric muscle loss occurs, the regenerative ca-
pacity of skeletal muscle is exceeded. This results in a permanent loss
of muscle volume and function. Current strategies to replace or repair
such damage are inadequate. The goal of this project is to develop
natural biomaterials that facilitate the engineering and/or regenera-
tion of skeletal muscle tissue by providing a myoinductive envi-
ronment to seeded and/or infiltrating cells. We hypothesized that
scaffolds and hydrogels composed of porcine acellular muscle matrix
(PAMM) could be efficiently recellularized and support myogenic
differentiation. Here, we describe the production and characteriza-
tion of PAMM scaffolds and gels. Histological analyses, DNA
content measurement, and scanning electron microscopy show that
porcine skeletal muscle tissue can be effectively decellularized and
processed into both a sheet-like scaffold and a hydrogel. We also
demonstrate that PAMM biomaterials can be recellularized with
adipose-derived mesenchymal stem cells and support the differen-
tiation of C2C12 myoblasts into myotubes. These results demonstrate
the potential for PAMM biomaterials to be employed in tissue en-
gineering and regenerative medicine-based strategies for repairing
volumetric muscle loss.
Cardiovascular
494
Bioprinting of Engineered Heart Tissue
P. Koti1, N. Muselimyan1, B. Holmes1,2, H. Asfour1, N. Sarvazyan1;
1Pharmacology and Physiology, The GeorgeWashington University,
Washington, DC, 2Nanochon LLC, Burke, VA.
For cardiac tissue repair, 3D bioprinting holds great potential
enabling to create multicellular constructs with defined shape and
cell composition. However, materials selection and effective struc-
tures that can be reliably used to bioprint cardiac tissue constructs
remain elusive. Here we present a concerted effort to fine tune
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existing materials and protocols to generate customizable 3D printed
designs which can support cardiomyocyte or fibroblast live cell
printing. To achieve this, variable concentrations of gelatin meth-
acrylate were used to print freeform 3D cell-containing structures
using a BioBots bioprinter. To increase precision, the concentration
of UV cured gelatin methacrylate inks was changed from the stan-
dard 10% to 15%. Printing parameters were monitored and adjusted
to achieve free standing structures before UV crosslinking. Primary
rat neonatal cardiac myocytes and cardiac fibroblasts were used as
main cell sources. To address possible adverse effects of bioprinting-
induced shear stress, bioprinted 10mm wide ring-shaped constructs
were then analyzed using CytoscanTM LDH assays, immunocyto-
chemistry and bioluminescence imaging. Results from these exper-
iments demonstrate that 3D bioprinting can be effectively tuned to
create on demand cardiac constructs with different scaffold porosity,
cell composition, and cell concentration.
495
M1/M2 Macrophage Secretome Differentially Alters Valve
Interstitial Cell Remodeling Behavior within Mechanically
Constrained Microenvironments
S. Sridhar, T. W. Gee, D. Y. Cheung, J. Hua, J. T. Butcher;
Nancy E. and Peter C. Meinig School of Biomedical Engineering,
Cornell University, Ithaca, NY.
There is an increased appreciation for the contributions of mac-
rophages as regulators of tissue and matrix remodeling through their
ability to produce cytokines and chemokines. Their role in altering
valve remodeling and driving disease has not yet been elucidated.
While others have implicated classically activated macrophage (M1)
microvesicles in driving valve interstitial cell (VIC) calcification,
they do not address bulk 3D remodeling behavior of VIC populations
in mechanically constrained environments as well as the contribu-
tions of the M2 secretome. Previously, we showed that boundary
constraints can promote hyperactive remodeling within VIC popu-
lations. Here, we show that VIC remodeling differs greatly in the
presence of secreted factors as a function of macrophage polarization
(M1, M2a, M2c). Porcine VICs were encapsulated within iso-
tropically mechanically anchored type I collagen hydrogels, and
cultured with conditioned media collected from THP-1 derived M0,
M1 (LPS, INFg), M2a (IL4, IL13), or M2c (IL10) macrophages.
Extracellular matrix remodeling and cellular differentiation varied
significantly between conditioned media states. The M2a and c
conditioned media showed increased compaction relative to M0 and
M1 conditioned samples. Additionally, these samples showed in-
creased osteogenic differentiation potential via increases in Runx2
and BMP2/4 expression. Using this novel platform, we can begin to
understand how macrophages can alter VIC homeostasis by driving
fibrosis and calcific remodeling.
496
Tissue Engineering Based 3D Modelling of Cardiomyogenesis
V. M. Thiruvanamalai;
Comparative Biosciences, University of Illinois at Urbana-
Champaign, Urbana, IL.
We report the creation of a reproducible and prototypical in vitro
3D prevascularized cardiac tissue, which encompasses all the in-
dispensable characteristics of a tissue-engineered cardiac graft, such
as consistent and synchronized spontaneous contractility, stable and
responsive electrophysiological properties, vascularization, and a
somatic stem cell source, to address the most chronic problem that is
facing cardiac therapy as of today, i.e., the repair and/or regeneration
of damaged myocardium. Additionally, we have demonstrated that it
is feasible to recreate in vitro a 3D model of mammalian cardio-
myogenesis that has been long-awaited. This 3D vascularized cardiac
tissue can be utilized to address various outstanding questions that
linger in the highly controversial field of adult stem cell-based car-
diac regeneration, and allows us to dissect various molecular
mechanisms that are underpinning the orderly cellular differentiation
and tissue morphogenesis, which are probably difficult to be exam-
ined and/or accomplished in the clinical scenario. The mosaic of
myocardial tissue recreated by means of modular and bottom-up
tissue engineering approaches reiterated not only several crucial
aspects of in vivo neo-vasculogenesis and neo-cardiomyogenesis, but
it enabled us to critically evaluate the controversial aspects of the role
of somatic stem cells (hMSCs) on the induction/differentiation of
embryonic cardiomyocytes, and most significantly, whether hMSCs
hadmultilineage differentiation potential in this milieu, undoubtedly.
Eventually, the outcome from this study may translate to human
personalized medicine by rendering a targeted approach to regulate
the maintenance (physiological) or reparative (pathological) process
of myocardium, and in turn can lead to functional enhancement of a
failing heart.
Matrix & Extracellular Matrix Biology in Regenerative
Medicine
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Integrated Hydrogel Culture System for Co-Culture of Muscle
& Tendon Cells for In vitroModeling of Myotendinous Junction
L. Gaffney, M. Fisher, D. Freytes;
Biomedical Engineering, North Carolina State University, Raleigh,
NC.
Muscle tissue disorders can result from chronic conditions, in-
cluding Duchenne’s Muscular Dystrophy, or acute conditions, such
as volumetric muscle loss resulting from trauma. In many cases, the
myotendinous junction is also affected and is a key target for tissue
engineering therapies. In vitro co-culture systems that allow for the
characterization of the cross-talk between myoblasts and tenocytes
could reveal mechanisms that could be targeted to guide current
tissue engineering strategies towards tissue healing. C2C12 myo-
blasts (ATCC) and tenocytes were seeded in decellularized extra-
cellular matrix hydrogels1 which were self-assembled adjacent to
each other with a controlled gradient transition between the two
tissue specific gels. This platform allows for the characterization of
both myoblasts and tenocytes separately and in co-culture on a
controllable scale to analyze disorders at the myotendinous junction.
This platform is the first step towards the development of new
therapeutic techniques targeted at creating a more favorable envi-
ronment for the regeneration of functional muscle tissue.1. Freytes,
D. O.; Martin, J.; Velankar, S. S.; Lee, A. S.; Badylak, S. F., Pre-
paration and rheological characterization of a gel form of the porcine
urinary bladder matrix. Biomaterials 2008, 29 (11), 1630-7.
498
Tissue-Engineered Submillimeter Diameter Vascular
Grafts for Free Flap Survival in Rat Model
H. Yamanaka1,2, A. Mahara1, S. Suzuki2, T. Yamaoka1;
1Department of Biomedical Engineering, National Cerebral
and Cardiovascular Center Research Institute, Suita, JAPAN,
2Department of Plastic and Reconstructive Surgery, Kyoto
University, Kyoto, JAPAN.
The technological innovation of microsurgery has allowed to
anastomose smaller diameter vessels, but synthetic vascular grafts
with that small diameter, which could replace the autologous vein
grafting, have not been developed. In this study, we studied acellular
tail arteries of rats with 0.6-mm inner diameter and 5-cm length for
free flap transfers. Their inner surfaces were modified with the
peptide ‘(POG)7G3REDV’, which we previously reported to catch
circulating endothelial progenitor cells. Tail arteries of ACI rats were
treated with the high-hydrostatic pressure and then incubated in
peptide solution at each condition; two arteries were at 60C for 1 h
(group A), three were at 37C for 1 h (group B), and three were at 4C
for 24 h (group C). Each graft was transplanted to connect the epi-
gastric flap of Lewis rat to the contralateral femoral artery while the
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flap venous drainage remained intact. All flaps survived at 3 weeks,
whereas three flaps with the axial artery ligated showed total ne-
crosis. All grafts demonstrated immediate patency, but each patency
was 0/2 in group A, 3/3 in group B, and 2/3 in group C at 3 weeks.
Although partial pseudoaneurysms were seen in patent grafts, the
endothelialization was observed in grafts of group B. Since flap
survival does not need long-term patency of the axial artery, our
tissue-engineered vascular grafts would be useful for replacing flap
arterial deficits temporarily.
499
A Bone Ecm-derived Porous Scaffold As Biomaterial For Bone
Tissue Engineering.
A. M. Malago´n Escando´n, A. Castell Rodrı´guez, C. P. Chaires
Rosas, M. Herrera Enrı´quez, K. Jarquı´n Yan˜ez;
Inmunologı´a experimental e Ingenierı´a de tejidos, Universidad
Nacional Auto´noma de Me´xico, Me´xico, MEXICO.
The current approach to the treatment of bone defects involves the
use of scaffolds that provide a biological and mechanically stable
niche to favor tissue repair. Despite the significant progress in the
field of bone tissue engineering, several main problems associated
are attributed to giving a low biodegradation degree, does not pro-
mote osseointegration and regeneration, if the bone is not healing as
well as expected or fails to heal, will not be given a proper ossifi-
cation or new bone formation. The actual approaches of bone tissue
regeneration are directed to the use of decellularized native extra-
cellular matrices, wich are able of retain their own architecture,
mechanic properties, biodegradability and promote new bone for-
mation because they are capable of conserving proteins and other
factors that are founded in physiological concentrations. Therefore,
we propose an extracellular matrix-based bioscaffolds derived from
bovine cancellous bone, which is processed by decellularization,
demineralization, and hydrolysis of the collagen protein, these pro-
tocols have been successfully carried out in other organs and tissues;
the effectiveness of its biosafety has also been previously evaluated
in vivo and FDA approved. In the specific case of bone a more
complex treatment is needed in comparison with other organs and
tissues, because is necessary demineralization and collagen denatu-
ralization. The present work was made in order to obtain a temporal
scaffold that succeed in degradation in an inversely proportional way
to the synthesis of extracellular matrix and the maturation of the bone
by the cells of the host.
500
The Use of Intrarticular Acellular ECM in Knee OA:
A Clinical Study
D. M. Lox;
Sports and Regnerative Medicine Centers, Clearwater, FL.
The Intrarticular Use of Acellular UBM in Knee OA: A Clinical
Study
Purpose: To evaluate the utility of UBM in human knee osteo-
arthritis (OA)
Methods andMaterialsA retrospective random assessment of 14
patients with symptomatic knee OA were treated with Matristem
Micro Matrix. Patients were confirmed to have knee OA using
Kellgren and Lawrence (KL) assessment grades 2-3. Patients were
monitored at 1 week, 1 month 6 months and 1 year.
Results:All patients received one intra-articular of Matristem. No
severe adverse events or side effects were noted in any patient. In
terms of efficacy, all but one patient showed a period of sustained
pain relief (92.8). At one year 8 of 14 patients (62.5) reported no
return of pain. Patients that did experience pain relief of up to one
year tended to have lower VAS scores prior to injection than patients
that experienced pain relief for less than 6 months.
Conclusion: This clinical study of the use of Matristem Micro-
Matrix injection in the treatment of human knee OA reflects a fa-
vorable response in patients, correlating with the animal literature.
Exclusion of known factors impacting the progressive nature of knee
OA such as obesity or more advanced KL score resulted in 100
efficacy. In this study, the small sample size and non-randomized
non-clinical trial warrant further investigation. The use of knee
Matristem for symptomatic human knee osteoarthritis provides a
therapeutic regenerative medicine and tissue engineering application
where prior strategies have been ineffective in altering the progres-
sive degenerative cascade of knee OA.
501
Behavior of Fibroblastic Cells under the Influence
of Variable Biaxial Cyclic Stress Regimes
H. Ghazizadeh1, D. R. LaJeunesse2, S. Aravamudhan1;
1Nanoengineering, North Carolina Agricultural and Technical State
University, Greensboro, NC, 2Nanoscience, University of North
Carolina at Greensboro, Greensboro, NC.
Mammalian cells such as adipocytes and myocytes are constantly
subjected to varying mechanical stimuli during both normal physical
and exercise regimes. Even though mechanical stimuli are a major
factor in determining cell function, the role of complex mechanical
environments have remained unexplored. In this study, we report on
our understanding of applying variable stress on NIH/3T3 fibro-
blastic cells cultured on flexible membrane in a custom-built biaxial
cell stretching system[1]. In order to understand the cell behavior in
the above-mentioned environment, we applied both regular (5%) and
variable (up to 75% variability with mean stress amplitude main-
tained at 5%) biaxial cyclic stress. The normal cellular functions
namely viability, proliferation, adhesion, migration and directional-
ity of actin fibers were studied. It was found that even though via-
bility was not affected by stress, proliferation increased significantly
under regular and decreased marginally under variable stretch re-
gimes. Lastly, the spreading factor, which is an indicator for cell
adhesion and fibronectin distribution increased significantly fol-
lowing variable stretching. These results indicate that variable
stretching, in particular may affect normal cellular functions such as
proliferation and adhesion significantly, which in turn may affect
cell-matrix interactions. Control of such cell-matrix interactions has
wide applicability in tissue engineering and wound healing pro-
cesses.
References: 1. Karumbaiah, L., S. E. Norman, N. B. Rajan, S.
Anand, T. Saxena, M. Betancur, R. Patkar and R. V. Bellamkonda
(2012). Biomaterials.
Acknowledgments: The Joint School of Nanoscience and Na-
noengineering at Greensboro.
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The Effect of Regular and Diet Coca-ColaTM on Cell Adhesion,
Proliferation and Integrin Expression of Human Foreskin
Fibroblasts
K. K. Eckhart;
Masters of Science in Biotechnology, California State University,
Channel Islands, Camarillo, CA.
Objective: Observe trends of Human Foreskin Fibroblasts-1 cells
in different concentrations of Coca-Cola and Diet Coca-Cola initially
coated with fibronectin that may increase proliferation, migration
and modify integrin expression.
Methodology: HFF-1 cells were cultured in DMEM, 10% fetal
bovine serum and grown in 2% Coca-Cola, 4% Coca-Cola, and 4%
Diet Coca-Cola media. HFF-1 cells were seeded on 5ml/ml fibro-
nectin, 10ml/ml fibronectin, 5ml/ml collagen, and 10ml/collagen ini-
tially coated wells (10,000 cells/well) and incubated at 37C, 5%
CO2. Samples were quantified via Calcein-AM staining using Fil-
terMax F5 MultiMode microplate reader. Images were taken using
Olympus IX71 inverted microscope using Cy3 filter at 10x magni-
fication. 24-well plates with Boyden Chamber inserts were coated
with 10ml/ml collagen and 10ml/ml fibronectin. Cells were counted
using Countess II FL from Life Technologies. FACS analysis
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performed using Millipore Guava easyCyte. Statistical significance
by p< 0.05.
Results: Proliferation rates and initial adhesion of HFF-1 cells
were examined on varying concentration of collagen and fibronectin,
revealing that cells in a fibronectin environment had an increased rate
of initial adhesion. Proliferation increased in the presence of 2%
Coca-Cola. HFF-1 cells migrate at a higher rate in the presence of
ECM proteins such as collagen and fibronectin. b1 integrin expres-
sion was slightly increased in the presence of 2% Coca-Cola and 4%
Coca-Cola, suggesting the increase in focal adhesion and HFF-1 cell
spreading due to many ingredients such as phosphoric acid blocking
mineral absorption and therefore allowing cellular proliferation.
503
3-D Physiomimetic Porcine ECM Hydrogels Preserves the
Function and 3-D Morphology of Rodent and Human Islets
K. Jiang1, D. Chaimov1, J. Liang1, S. Patel1, C. L. Stabler2;
1Biomedical Engineering, University of Florida, Gainesville, FL,
2University of Florida, Gainesville, FL.
Clinical islet transplantation is a promising cell-based therapy for
type 1 diabetes. Following islet isolation, the disruption of islet-to-
matrix interaction results in ‘‘anoikis’’-induced apoptosis. Recent
studies have shown that anoikis can be reduced if islets are co-
cultured with an extracellular matrix (ECM). Decellularized tissues
are abundant in cell adhesion motifs and provide an environment that
can recapitulate the peri-islet niche. In this study, we sought to de-
velop 3-D porcine ECM hydrogels using optimized tissue-specific
decellularization protocols to enhance islet survival. Decellularized
porcine bladder and pancreas were generated, with resulting matrices
exhibiting no visible nucleic residue and minimal detectable DNA.
IHC and HPLC-MS-based proteomic analysis found a high presence
of peri-islet proteins and structural collagens in decellularized
bladder and pancreas, respectively. Stable hydrogels reconstituted
from solubilized decellularized tissue (1mg/mL) were formed and
used to encapsulate pancreatic rodent or human islets within this 3-D
fiber network structure. After 3-7 days of culture, islet viability,
function, and morphology were examined. Islets embedded in
bladder and pancreas hydrogel demonstrated an increase of glucose-
stimulated insulin production after culture, when compared to un-
encapsulated controls. Notably, ECM hydrogels also supported
the outgrowth of CD31+ endothelium and F-actin+ fibroblast-
like cells from islets, as well as recapitulated islet adhesion with
increased expression of b1-integrin. This unique morphology could
be beneficial during transplantation, to accelerate engraftment.
Overall, these results demonstrate the benefits of ECM hydrogels
in preserving islet function in vitro, while also supporting a 3-D
morphology.
504
Effect of Soluble RGD Peptide on Vasculogenesis
of Scaffold-Free Micro-Tissues
Z. B. Yaralı, O. Karaman;
Biomedical Engineering, _Izmir Katip Celebi University,
_Izmir, TURKEY.
3-dimensional (3D) tissue formation characteristics of mainly
vascularized tissues requires extensive exploration to investigate the
characteristics of such tissue formation in micro scale. RGD peptide
sequence is the primary integrin binding sequence to effectively
modify biomaterials surface to enhance cellular adhesion and mi-
gration on synthetic surfaces. Immobilized RGD peptide on substrate
promotes cellular adhesion and soluble form of RGD peptides en-
hances cell-to-cell communications. In this study, the effect of sol-
uble RGD peptide on vascularization of Human Umbilical Cord
Stem Cells (HUVECs) in scaffold-free micro-tissues was investi-
gated. Scaffold-free micro-tissues were formed by 3D petri dish1 by
seeding 105 HUVECs in 100ml with control (no RGD), 1mM and
2mM RGD peptide experimental groups containing serum-free
media. Micrographs were taken every day for 7 days and the diameter
of developed micro-tissues was determined by ImageJ. After cul-
turing for 7 days, the cell viability of micro-tissue was assessed using
a live/dead assay. Vascularization of HUVECs in micro-tissues were
assessed by evaluating gene expression levels and immunofluores-
cence staining of key vasculogenic markers of VEGF, Tie-1, Tie-2,
vWf, and PECAM-1. Micro-tissues were formed successfully for
both experimental groups. 2mM RGD peptide significantly en-
hanced the size of the micro-tissues. Vasculogenic differentiation of
HUVECs with different concentrations of RGD peptide is underway.
The findings of these study will enlighten the effect of integrin
binding peptide on vasculogenesis of HUVECs. 1. Dissanayaka WL
et al. Journal of endodontics. 2015;41(5):663-70.
Musculoskeletal
505
Engineered In Vitro Models for the Guidance of Rehabilitation
Regimens that Promote Cartilage Regeneration
after Repair Surgery
T. Iseki1, S. Kihara1, H. Sasaki1, S. Yoshiya2, F. Fu1, R. S. Tuan1,
R. Gottardi1;
1Department of Orthopaedic Surgery, University of Pittsburgh,
Pittsburgh, PA, 2Department of Orthopaedic Surgery, Hyogo college
of medicine, Nishinomiya city, JAPAN.
Microfracture (MFX) to repair focal lesions of articular cartilage
injury is the most common cartilage repair procedure. MFX consists
in the creation of small holes through the subchondral bone, the
defect site is then filled with a clot rich in bonemarrow-mesenchymal
stem cells (BM-MSCs) that form of new fibrocartilaginous tissue. In
general, early passive motion and limited weight bearing are adopted
for rehabilitation after surgery, but it is unclear how these mechanical
regimes affect BM-MSCs differentiation at the defect site and car-
tilage repair. To study this, we devised an in vitro model of cartilage
defect filled with fibrin and BM-MSCs to mimic MFX repair.
Composite constructs were then subjected to loading regimens
simulating different rehabilitation exercise sessions. Weight bearing
(compressive loading) was simulated using the Mechano-Active
Tissue Engineering (MATE) system (MATEsystems, Clackamas,
OR) with dynamic compression at 9N load force, 1.5Hz for 2
minutes followed by 2 minutes pause, repeated for 1h a day total,
over 7 consecutive days. Passive motion (shear loading) was simu-
lated using a rotatory cell culture system (RCCS TM-4;Synthecon
Inc., Houston, TX). Samples were assayed by qRT-PCR, histology,
GAG/DNA content, push-out test (integration of the construct).
Statistical comparisons were done by paired t-test with significance
of p < 0.05. Our results suggest that early passive motion exercise
may be the most effective promoter of chondrogenesis in the early
stages of MFX repair. Ultimately, we aim at identifying the long-
term effects on regeneration of each exercise regime to guide the
optimization of post-op rehabilitation.
Acknowledgments: Ri.MED Foundation, CASIS GA-2016-236,
Commonwealth of Pennsylvania.
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Control of Fiber Size and Tortuosity in Direct-Write
Electrospun Structures for Tissue Engineering
P. B. Warren, Z. G. Davis, M. B. Fisher;
Biomedical Engineering, North Carolina State University,
Raleigh, NC.
Abstract: Direct-write electrospinning (DWE) combines the ad-
vantages of electrospun1 and 3D printed2 scaffolds for fibrous soft
tissue engineering by creating polymeric scaffolds with both submi-
cron diameter fibers3 and macroscopic structure. However, the influ-
ence of process parameters on fiber size and direction is not well
understood. Our objective was to investigate the feasibility of con-
trolling poly-caprolactone fiber formation via DWE by systematically
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varying polymer solution concentration (14, 17.5, 21, 24.5, and
28wt%) and stage translation speed (10-90mm/sec). Preliminary
scanning electron microscopy showed that fiber diameter decreased
with increasing concentration. Tortuosity also appeared to decrease
with increasing concentration. No clear effects for stage speed were
observed. These initial results show the promise of controlling fiber
size and tortuosity for in vitro tissue engineering studies evaluating the
effect of fibrous scaffolds on cellular morphology and collagenous
tissue formation.
Acknowledgments: We thank the North Carolina State Uni-
versity Game-changing Research Incentive Program (GRIP) for its
support.
References:
1. Fisher MB et al. Acta Biomater 9: 4496-4504, 2013.
2. Lee CH et al. Sci Transl Med 6(266):266ra171, 2014.
3. Hochleitner, G et al. Biofabrication 7(3):035002, 2015.
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Cell-based Enhancement of the Tissue Engineered Muscle
Repair Technology Platform
E. L. Mintz, K. C. Smith, E. Ende, J. A. Passipieri, K. J. Lampe,
M. J. McConnell, G. J. Christ;
University of Virginia, Charlottesville, VA.
Skeletal muscle has a remarkable ability to undergo regeneration
post-injury. However, there is a limit to which endogenous mecha-
nisms can recover bulk loss of tissue. One example is volumetric
muscle loss (VML), which can result from trauma, as well as other
congenital and acquired conditions. VML injury is associated with
permanent functional and cosmetic deficits. There are currently no
treatments that can adequately address VML injury. We have de-
veloped a tissue engineered muscle repair (TEMR) technology
platform to enhance endogenous repair by creating a more favorable
microenvironment for regeneration. TEMR consists of muscle pro-
genitor cells seeded on a porcine bladder acellular matrix (BAM) and
conditioned in a bioreactor prior to implantation. TEMR constructs
have been evaluated in two distinct, surgically-created and biologi-
cally relevant rodent VML injury models in the tibialis anterior and
lattisimus dorsi muscles, respectively. In both instances, TEMR-
treated animals exhibited significant, durable, functional recovery
(60-70%), as well as observable muscle regeneration. In pursuit of
more rapid and complete functional recovery from VML injury, we
have begun to incorporate additional cell types into the TEMR
construct to more fully recapitulate the endogenous regenerative
microenvironment. Specifically, satellite cells or human pluripotent
stem cell-derived neurons have been added to the TEMR construct.
Initial investigations have documented that both cell types can adhere
to and survive on the TEMR construct during our bioreactor pre-
conditioning process. Incorporation of these cell types into our ex-
isting technology platform should further improve functional
recovery from VML injuries.
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Antibacterial Effects of Silver Nanoparticle-loaded
3D Bioprinted Construct for Infected Bone Repair
Y. Lee1, P. Chandra2, Y. Choi1, J. J. Yoo2, S. Lee2;
1Department of Orthopedic Surgery, Soonchunhyang University,
Bucheon Hospital, Bucheon-Si, KOREA, REPUBLIC OF, 2Wake
Forest Institute for Regenerative Medicine, Wake Forest School
of Medicine, Winston-Salem, NC.
Osteomyelitis is a common manifestation of invasive Staphy-
lococcus aureus infection, often resulting in extensive bone loss
and destruction. Reconstruction of large bone defects secondary to
Osteomyelitis is still a major challenge, mainly due to chances of
re-infection of bone grafts and rise of Methicillin-resistant Sta-
phylococcus aureus (MRSA). The objective of this study is to use
3D bioprinting for custom fabrication of bone constructs containing
silver nanoparticles (AgNPs); where a sustained release of AgNPs
from the bone constructs would provide antibacterial activity, and
the construct architecture would allow new bone ingrowth. This
bone construct was designed and 3D printed using a combination of
poly(e-caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA)
containing AgNPs (PCL-AgNP and PLGA-AgNP, respectively).
AgNP release kinetic studies showed that almost 100% of AgNPs was
released from PLGA-AgNP in 6 weeks; while for only 4% of the
AgNPs release from PCL-AgNP. A NaOH pre-treatment method was
used to accelerate the degradation of PCL, which resulted in about
30-35% AgNPs release in 2 weeks. Additionally, an in situ hy-
droxyapatite (HA) plus AgNP deposition method to surface-coat the
bone constructs resulted in an enhanced antimicrobial activity in vitro
against Staphylococcus aureus and Pseudomonas aeruginosa. The
combination of differentially degrading PCL and PLGA polymers
containing AgNPs along with surface coating would enable the
sustained release of AgNPs for treating Osteomyelitis infection
during the bone regeneration.
509
Curcumin-loaded PLGA Particles for the Treatment
of Osteoarthritis
L. M. Mancipe Castro, R. Agarwal, A. J. Garcia, R. E. Guldberg;
Georgia Institute of Technology, Atlanta, GA.
Osteoarthritis (OA) affects 27 million adults in the U.S and is the
leading cause of disability in the country. It consists of a painful
progressive articular cartilage degeneration and synovium inflam-
mation that could lead to total joint replacement. Current treatments
of OA are limited to pain management and there is no approved
therapy to prevent OA progression. The anti-inflammatory and
chondroprotective properties of curcumin make it a good candidate
for OA treatment, but its poor oral bioavailability has limited its use.
Therefore, this work aims to develop poly-lactic-co-glycolic acid
(PLGA) curcumin-loaded microparticles (PLGA-Cur) for the intra-
articular treatment of OA in a Medial Meniscus Transection (MMT)
rat model. Particles of 0.26, 1 and 8 mm in diameter were synthesized
using oil-in-water emulsion evaporation method and evaluated for
their in vitro curcumin release profile and residence time in naı¨ve rat
knee joints. Particles with longer residence time in the knee joint and
higher amount of curcumin cumulative release (1 and 8 mm) were
evaluated for their effectiveness at reducing OA progression in a pilot
study (n= 3) using the MMT model. Preliminary results suggest that
1 mm PLGA-Cur particles qualitatively reduced lesion volume
compared to empty particles (control) as shown by Equilibrium
Partitioning of an Ionic Contrast agent microCT (EPIC-mCT). Future
work includes fully powered studies to confirm the effectiveness of
1 mm PLGA-Cur particles to reduce OA progression and dosing
studies. This preliminary work suggests that intra-articular curcumin
delivery could be an effective disease-modifying therapy able to
reduce the progression of OA.
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Combination of Silk Fibroin and Fiber Alignment Cues
in Nanofibers for Tendon Tissue Engineering to Repair
the Achilles Tendon Defects
C. Chen1, S. Chen1, P. Chou1, J. Chen2;
1Chang Gung Memorial Hospital, Taoyuan, TAIWAN, 2Chang
Gung University, Taoyuan, TAIWAN.
In this study, we used silk fibroin/polycaprolactone to produce
random and aligned nanofibrous membranes through electrospinning
while silk microfibrous membranes were purchased. SF could fa-
cilitate cell attachment and proliferation while PCL could impart
favorable mechanical properties and biocompatibility.We embedded
a silk microfibrous membrane at the bottom of the electrospung na-
nofibers to enhance the mechanical strength of the scaffold. TheMTS
test revealed the effect of SF in proliferation of rabbit dermal fibro-
blast (RDFB) while fluorescent cytoskeleton staining and SEM
analysis showed that the aligned nanofiber membranes (APSF)
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facilitated the allied proliferation of cells with extracellular matrix
(ECM) deposition. The quantitative real-time polymerase chain re-
action studies indicated that the APSF facilitated expression of type I
collagen, fibronectin, and biglycan. Tendon reconstruction was
confirmed by the presence of type III collagen on APSF. Subse-
quently, an in vivo animal experiment on New Zealand white rabbits
with Achilles tendon deficiencies were performed to examine tendon
reconstruction. Histological and immunohistochemical staining,
mechanical testing, tissue section staining for tenascin-cytotactin,
collagen type I and type III staining were performed to evaluate the
tendon regeneration potential of the scaffolds. Effects of fiber
alignment in ECM production was verified by histological and im-
munohistochemical staining. In vivo mechanical testing of tendon
tissues grown on APSFm+RDFB indicated the similar Young’s
modulus values to original tendons. In short, the aligned nanofiber
composite membrane scaffold enabled a faster tendon reconstruction
by utilizing the aligned morphology and good mechanical properties.
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3D Displacement Fields in Cartilage under Compression
using Two-Photon Microscopy
M. Motavalli1, J. Myers2, A. Huang2, J. Welter1, J. Mansour3;
1Biology, Case Western Reserve University, Cleveland, OH,
2Pediatrics, Case Western Reserve University, Cleveland, OH,
3Mechanical and Aerospace Engineering, Case Western Reserve
University, Cleveland, OH.
Introduction: The structure and mechanical properties of artic-
ular cartilage are known to vary with depth. Depth dependent me-
chanical behavior has been evaluated using planar (2D) methods
based on optical imaging to track tissue features. It has generally
been assumed that tissue displacements were limited to the imaging
plane. In this investigation, we used two photon microscopy tech-
niques to track the 3D spatial location of labeled chondrocytes under
compression.
Materials and Methods: A biaxial loading apparatus for apply-
ing compressive and shear displacements to a sample was designed
and built. Servo motors applied specified compressive and shear
displacements to a cartilage sample while a load cell measured the
corresponding shear and compressive forces. Osteochondral samples
were cored from a calf femoral condyle. Before imaging, cell nuclei
were labeled with ethidium bromide. Three-dimensional images of
the tissue in uncompressed and compressed states were then obtained
using two-photon microscopy. 3D displacement fields were obtained
from volume images using Imaris software.
Results and Discussion: Cell displacements under compression
did not remain in the imaging plane; they had displacement com-
ponents perpendicular to the imaging plane. We observed that cell
displacements vary spatially suggesting that it should not be assumed
that displacements in this type of commonly used loading device are
planar. Cells close to the articular surface displaced more compared
to those near bone, suggesting that surface andmiddle zones aremore
compliant.
Acknowledgments: This work was funded in part by a grant from
the NIH/NIBIB P41EB021911.
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Contractile hPSC derived Skeletal Muscle Tissues
for Human Disease Modeling
L. Rao1, Y. Qian1, A. Khodabukus1, T. Ribar2, N. Bursac1;
1Duke University, durham, NC, 2Duke University, DURHAM, NC.
Despite established protocols for differentiation of human plu-
ripotent stem cells (hPSCs) into myogenic cells, 3D hPSC-derived
skeletal muscle tissues that are able to respond to electrical and
biochemical stimuli have not been reported. Here we describe en-
gineering of contractile human skeletal muscle tissues using induced
myogenic progenitor cells (iMPCs) generated via paraxial-
mesoderm induction of hPSCs followed by transient overexpression
of Pax7. Under optimized 3D culture conditions, iMPCs form skel-
etal muscle tissues (iSKM bundles) contain aligned multi-nucleated
myotubes that display functional properties akin to native muscle,
including positive force-frequency relationship in response to elec-
trical stimulation as well as forceful contractions in response to
acetylcholine. During 4-week culture, iSKM bundles undergo in-
creased structural and molecular maturation, hypertrophy, and force
generation. When constructed with iMPCs derived from patients
with various muscular dystrophies, the iSKM bundles allowed
quantitative comparisons of histology, contractile forces, and cal-
cium handling between control and diseased cells. The iSKM bun-
dles hold the promise as a platform for personalized modeling of
human muscle disease and screening of candidate therapeutics.
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Engineering of Volumetric Skeletal Muscle Tissue for
Accelerated Restoration of Pelvic Floor Muscle Function
J. Kim, M. Jeon, I. Kim, S. Lee, J. Yoo, A. Atala, I. Ko;
Wake Forest Institute for Regenerative Medicine,
Winston Salem, NC.
Damages in the pelvic floor muscles often cause dysfunction of the
entire pelvic urogenital system. Current treatments for the injury
include physical therapy, autologous muscle flap transfer, and sur-
gical interventions using synthetic and biological materials. How-
ever, none of them entirely address the problems associated with
long-term restoration of normal anatomy and function in the injured
pelvic floor muscle system. Engineering of functional muscle tissue
constructs may provide a solution to this unmet medical need.
However, the current muscle engineering techniques are limited by
the ability to build sizable constructs with timely innervation for
successful graft survival. To this end, this study aims to fabricate and
optimize volumetric 3-D bioprinted skeletal muscle constructs with
innervation capability for repairing pelvic floor muscle injuries.
Bioprinted skeletal muscle constructs that mimic native skeletal
muscle organization were fabricated by using a ‘bioink’ formulation
consisting of fibrin-based hydrogel containing human muscle pro-
genitor cells, and muscle tissue formation capacity was investigated
in a pelvic floor muscle injury in rats. Our results demonstrate that the
bioprinted cells within the engineered skeletal muscle constructs are
able to maintain their viability and formed muscle fibers in vivo,
suggesting that the engineered muscle constructs may contribute to
the restoration of pelvic floor muscle function anatomically and
functionally.
Respiratory, Urologic and Gastrointestinal
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Anastomosis of Tissue Engineered Intestine in Line with Host
Intestine in Rats
Y. Liu, B. Cromeens, Y. Wang, G. Besner;
Center for Perinatal Research, Research Institute at Nationwide
Children’s Hospital, Columbus, OH.
Objectives: The purpose of this study was to anastomose tissue
engineered intestine (TEI) in line with host intestine to examine the
patency and peristaltic function of the TEI.
Methods: Intestine harvested from 2-5 day old transgenic GFP rat
pups was digested to obtain organoids which were seeded onto tu-
bular polyglycolic acid (PGA) scaffolds and implanted into the
peritoneal cavity of six nude rats. After 4 weeks of in vivo incubation,
the TEI was located and anastomosed with host intestine. Four weeks
after anastomosis, the patency and peristaltic function of TEI was
assessed by barium contrast study, and the TEI with adjacent host
intestine was harvested for morphological evaluation.
Results: Four animals survived the anastomosis surgery. One
animal died from intestinal obstruction and another from leakage at
the anastomosis. In surviving animals, the average time for passage
of barium through TEI was 9 – 3 minutes, whereas it was 5 – 2
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minutes for passage through the same length of native intestine
( p< 0.05). Histology revealed TEI lined with neomucosa. GFP
staining demonstrated the presence of positively stained cells at the
site of TEI, which confirmed that the cell source of TEI was from
implanted organoids.
Conclusion: Anastomosis of TEI in line with host intestine
maintained patency and displayed intact but slower intestinal transit
compared to native intestine.
515
An Autonomous Bronchoscope for Drug Delivery into Target
Regions in the Lungs
J. Kim, B. Guenthart, J. D. O’Neill, S. P. Ma, M. Bacchetta,
G. Vunjak-Novakovic;
Biomedical Engineering, Columbia University, New York, NY.
Locally administered therapeutics into injured or diseased lung
regions can increase treatment efficacy and reduce systemic toxicity
by concentrating therapeutic action within a specific region [1, 2].
With existing methods, however, localized drug delivery within the
structurally complex airway tree is technically challenging, time
consuming, and spatially inaccurate because of manual navigation-
path determination and tedious device operation required. To address
these challenges, we developed an autonomous robotic broncho-
scope that can enter predetermined target pathologic sites and release
drugs in the lungs with enhanced spatial accuracy. This device is
integrated with a fiber-optic imaging probe that visualizes the inside
of the lung airways. Using machine learning algorithms, the visual
information obtained is processed to determine a navigational di-
rection in real time. During navigation, the device is steered using
computer-controlled servos attached to the distal tip of the device
through pulling wires. We present the first application of machine-
learning guided technology that could improve the treatment out-
comes of lung disease by enabling precisely controlled and spatially
focused drug delivery into target pathologic sites in the lungs.
References:
1. R. Langer, Drugs on Target, Science, 293, 58, 2001.
2. J. Kim et al., Targeted Delivery of Liquid Microvolumes in the
Lung, P Natl Acad Sci USA, 112, 11530, 2015.
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Re-Epithelialization of Whole Porcine Kidneys with Renal
Epithelial Cells
A. D. Cook, N. Poornejad, E. M. Buckmiller, L. Schaumann,
S. Passey, H. D. Wang, J. J. Wisco, B. L. Roeder, P. R. Reynolds;
Brigham Young University, Provo, UT.
Re-epithelialization of whole porcine kidneys with renal epithelial
cells could result in improved regeneration of human tissues. Pre-
servation of vasculature and uniform cell perfusion are critical cri-
teria for achieving regeneration. Decellularized porcine kidneys were
recellularized with renal epithelial cells by 3 methods: perfusion
through the vasculature under high pressure (VHP), perfusion
through the ureter under high pressure (UHP), or perfusion through
the ureter under moderate vacuum (UMV). Vasculature preservation
and cell perfusion throughout the kidneys were analyzed in this study
by histology, scanning electron microscopy (SEM), confocal mi-
croscopy, and magnetic resonance imaging (MRI). Renal epithelial
cells were detected in the MRI by labeling them with iron oxide. It
became apparent that the cell solution concentration was optimal at
4-5 million cells/ml of culture medium. Higher cell concentrations
resulted in clot formation and reduced homogeneous distribution of
cells throughout the kidney. High pressure perfusion of cells through
the vasculature (VHP) resulted in only a few cells settling in the
capillaries of the glomerulus in the cortex region. Perfusion of cells
through the ureter under high pressure (UHP) resulted in significant
damage to the cell membranes. Perfusion of the cells through the
ureter under moderate vacuum (UMV at 40mmHg) produced the
most uniform distribution of cells throughout the kidneys. We sug-
gest 4-5 million cells/ml of culture medium perfusion through the
ureter under moderate vacuum as the best procedure for complete and
uniform recellularization of porcine kidneys.
517
Engineered Trachea with Mucosal Epithelium
J. Dennis, D. MacKay, N. Liou;
Baylor College of Medicine, Houston, TX.
Goal: The overall goal is to engineer a viable, functional trachea
replacement tissue (‘‘neotrachea’’) for large segmental tracheal de-
fects. The current goal is to develop amethod to line neotracheas with
functional mucosal epithelium.
Methods: Epithelial cells were obtained from rabbit tracheas in-
cubated with 0.1% pronase and 20 units DNAse in Joklik’s medium
and expanded on collagen I-coated plates. For air/liquid differenti-
ation, cells were cultured on collagen type IV-coated 12mmMillicell
inserts in BEGM medium. Sheets were fixed in 2% glutaraldehyde
and o1% smium for transmission (TEM) and scanning electron mi-
croscopy (SEM); the SEM samples were critically point dried. Sheets
were fixed in formalin and either flash frozen or embedded in paraffin
for immunostaining. Sections were incubated in antibodies to poly-
glutamate, pan-cytokeratin, cytokeratin-14, or mucin, followed by
biotinylated secondary antibody and peroxidase-streptavidin, and
visualized with the Vector VIP Peroxidase Substrate Kit.
Results: SEMdata showed that culturedmucosal cells had formed
ciliated cells by 14 days in culture. TEM images confirmed the
presence of ciliated cells, showed mucosal-like cells and a pseudo-
stratified epithelium that included a basal cell-like morphology. Pan-
cytokeratin staining confirmed the epithelial nature of the sheets,
while the polyglutamate localization showed the presence cilia-
specific tubulin. The cyotokeratin-14 results confirmed the presence
of basal cells observed with TEM and, similarly, the mucin staining
confirmed the presence of mucosal cells.
Conclusions: The results demonstrate a methodology for isolat-
ing, expanding and differentiating rabbit tracheal epithelial cells,
in vitro, into sheets containing ciliated, mucosal and basal cells.
518
Modular Bioreactor with a Simple and Intuitive Touch-Screen
Supervisory with Flow/Temperature/pH/Stirring Capabilities
A. Kaasi1,2,3, H. B. Campos1, R. T. Quevedo1, A. L. Jardini4,2,
P. Kharmandayan4,2;
1Eva Scientific Ltd., Sa˜o Paulo, BRAZIL, 2National Institute of
Biofabrication, Campinas, BRAZIL, 3Faculty of Medical Sciences,
UNICAMP, Campinas, BRAZIL, 4UNICAMP, Campinas, BRAZIL.
Bioreactors are a broad category of devices used in the areas of
bioprocessing and tissue engineering/regenerative medicine, to im-
prove, refine or optimize a biological process.
We have developed a modular bioreactor system capable of si-
multaneous control, monitoring and data logging of different param-
eters, through the central Supervisory software (Cairo, Eva
Scientific, Sa˜o Paulo, Brazil), useful for tissue bioreactor purposes.
Scalability occurs in multiples of four, with no limit on the number of
tissue/organ chambers. Flow is controllable at a range of 0.36-
2900mL/min, with a simple configuration of steady state, ramp-based
or pulsatile flow patterns, e.g. for cardiovascular tissue engineering.
Stirring is controllable at a range of 100-1500 RPM, with steady state,
ramp-based or pulsatile programs, with different impeller designs
available for different flow requirements. Temperature is controllable
by ramps or at a steady state at a range of 4 C above ambient up to
50 C. Flow, stirring and temperature all benefit from Monitoring and
Data logging functionalities, within the same Supervisory responsible
for the Control functionalities. The fourth parameter, pH, is not con-
trollable in the present embodiment, but allows Monitoring and Data
logging, like the other parameters, across a pH range of 0-14.
The system is suitable for a wide variety of applications in tissue
engineering. So far, we have tested the system with whole kidney,
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liver and trachea decellularization and recellularization setups, in
addition to cardiac and lung physiological flow setups.
Kaasi & Jardini (2016) Bioreactors.
Reference: Module in Materials Science and Materials En-
gineering. Elsevier. pp. 1-15.
519
In vitro culture of Spermatogonial Stem Cells in Klinefelter
syndrome: a step forward to generate fertility
G. Galdon1, N. Pourhabibi Zarandi1, Y. Lue2, R. S. Swerdloff2,
S. Kogan1,3, H. Sadri-Ardekani1,3, A. Atala4,3;
1Male Fertility, Wake Forest Institute for Regenerative Medicine,
Winston-Salem, NC, 2Division of Endocrinology, Department of
Medicine, Harbor-UCLA Medical Center and Los Angeles
Biomedical Research Institute, Torrance, CA, 3Urology, Wake
Forest School of Medicine, Winston-Salem, NC, 4Wake Forest
Institute for Regenerative Medicine, Winston-Salem, NC.
Klinefelter Syndrome (KS) is characterized by masculine phe-
notype, supernumerary sex chromosomes (47 XXY) and impaired
fertility due to loss of spermatogonial stem cells (SSC) at puberty. To
understand this process and find new therapies it is critically im-
portant to develop a culture system for KS testicular cells.
Our current method of SSC isolation and propagation have been
adapted to neonatal mouse using 40 XY 3-day old mice. Propagated
cells were characterized using qPCR, digitalPCR and Flow Cyto-
metry. The same optimized system was used to isolate and propagate
testicular cells from UCLA 41XXY (KS) mouse model and from
human KS cryopreserved testicular tissue.
Preliminary data culturing KS mouse testicular cells showed
viable testicular cells with 10 folds increase up to 116 days. Char-
acterization of propagated KS testicular cells by qPCR confirmed the
presence of undifferentiated SSC. Preliminary data culturing KS
human testicular cells showed viable testicular cells with 17 folds
increase up to 80 days in culture and presence of spermatogonial cell
at least in first 40 days of culture.
Ongoing work is focusing on full characterization of the cell
populations present in KS testicular cells culture and ultimately
testing their potential to restore fertility.
With this study we were able to overcome the quiescent stage of
neonatal testicular germ cells from both XY and KS mouse to suc-
cessfully expand them in culture while conserving their characteristic
gene expression. Preliminary data proofed the reproducibility of this
method in human KS tissue, which may lead to new therapeutic
options for KS patients.
520
Controlled Delivery of Stem Cell-derived Trophic Factors
To Treat Acute Kidney Injury
H. Yim1, D. Kim1, H. Chung1, B. Shing1, K. Moon1, S. George1,
M. W. Kim1, I. Ko1, A. Atala1, J. Yoo1, K. Su Cho2;
1Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC, 2Wake Forest Institute for Regenerative Medcine, Winston
Salem, NC.
Renal disease is a worldwide health issue. Besides transplantation,
current therapies revolve around dialysis, which is limited to delaying
disease progression throughfilteringmetabolicwastes in blood.However,
dialysis is unable to replace other renal functions, such as synthesizing
erythropoietin. To address these limitations, cell-based approaches have
been proposed to restore damaged kidneys as an alternative to current
therapies. Particularly, recent studies have shown that stem cell-derived
secretomes could enhance tissue regeneration. This study explores a gel-
based delivery system for controlled delivery of trophic factors secreted
from human placental stem cells (hPSC) (conditioned medium: CM) and
evaluates the effect of trophic factors on renal regeneration. In vitro cell
viability and proliferation assays demonstrated that CM treatment sig-
nificantly enhanced cell proliferation when compared with the control
withoutCM.Platelet-rich plasma (PRP)was used as a delivery vehicle for
CM. To test the feasibility of controlled delivery, CM was encapsulated
within the PRP, followed by assessing the release kinetics of CM from the
gel. The release profiles show that CM can be released from PRP in a
controlled manner by altering gel stiffness. An In vivo study using a rat
acute kidney injury model showed that CM delivery using the gel system
into the injured kidney tissue facilitated less renal tissue damage, leading
to rapid functional recovery than that of saline, CM or vehicle only
group. These results suggest that the delivery of hPSC-derived trophic
factors in a controlled manner may contribute to efficient kidney repair
from renal tissue injury.
521
Mesenchymal Stem Cells versus Steroids in Inflammatory Bowel
Disease
N. M. El Akabawy1,2, A. El- Gebaly3, H. Pasha4, R. Zidan5, K. El-
Mosalamy6, A. Atala1;
1WFIRM, Winston Salem, NC, 2Zagazig Faculty of Medicine, Zagazig,
EGYPT, 3Department of Tropical medicine, Zagazig Faculty of
Medicine, Zagazig, EGYPT, 4Department of Biochemistry, Zagazig
Faculty of Medicine, Zagazig, EGYPT, 5Histology & Cell Biology,
Zagazig Faculty of Medicine, Zagazig, EGYPT, 6Histology & Cell
Biology, Zagazig Faculty of Medicine, zagazig, EGYPT.
Introduction: Inflammatory Bowel Disease (IBD) is a chronic
disease without a medical cure, requires a lifetime care. IBD includes
range of intestinal pathologies as Crohn’s disease (CD) and ulcera-
tive colitis (UC). The idea of treatment of IBD patients with MSCs
came into mind accidentally after reporting remission of IBD in a
woman with 20 years CD who was treated with chemotherapy and
autologous bone marrow stem cells for non-Hodgkin’s lymphoma, 6
months later she was free of CD.
Materials andMethods: 72 female albino rats were divided into 4
groups; control, Dextran Sulphate Sodium (DSS) induced IBD, DSS
rats treated with MSCs and DSS rats treated with steroids. Bone
marrow was harvested by flushing the tibias and femurs of 10 healthy
male albino rats. During the duration of the experiment, Living animals
were assisted for weight loss and occult blood in stool. Biochemical
tests for IBD markers, colon length measuring beside histological and
immunohistochemical examinations were done. Flowcytometry and
PCR were done to insure homing of right cells vehicle.
Results: IBD markers were highest at DSS untreated group and
steroid treated group. PCNA immunoreaction marked significant
colonic cell proliferation in MSCs treated group. MSCs succeeded to
restore normal colon length and avoid strictures. Notable avoidance
of weight loss and stool occult blood were recorded.
Conclusion: - Steroids have limited effects on complicated IBD.
- MSCs are capable of homing at sites of bowel inflammations.
- MSCs carry hope for resistant complicated cases of IBD.
Acknowledgment: Egyptian Cultural Affairs and Missions.
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Modeling Early Granuloma Formation In Engineered Human
Lung Tissue Using Mycobacterium Smegmatis
A. Sundarakrishnan1, G. Beamer2, B. B. Aldridge3, D. L. Kaplan1;
1Department of Biomedical Engineering, Tufts University, Medford,
MA, 2Department of Biomedical Sciences, Cummings School of
Veterinary Medicine, Tufts University, Grafton, MA, 3Department
of Molecular Biology andMicrobiology, Sackler School of Graduate
Biomedical Sciences, Tufts University, Boston, MA.
The granuloma of human Tuberculosis (TB) infection is an or-
ganized structure of infected and non-infected macrophages, leuko-
cytes and fibroblasts. Virulent Mycobacterium tuberculosis (Mtb)
containing RD1 and ESAT-6 loci produce human lung granulomas.
In vitro granulomas have been produced using pulmonary blood
mononuclear cell (PBMC) systems and virulent Mtb or avirulent
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mycobacteria. Whether in vitro PBMC granulomas produced using
avirulent bacteria are merely cellular aggregates or whether they
recapitulate key features of Mtb granulomas is unknown. Early
granuloma formation has been studied by adding Mtb infected
PBMCs to an in vitro Transwell model of human lung mucosa
containing epithelial and fibroblast cells. Although this model has
several advantages, it does not accurately mimic the distal lung mi-
croenvironment, where dynamic strain and blood flow are found
in vivo. We hypothesize that mechanical strain and perfusion forces
could significantly affect granuloma formation and maintenance.
Towards elucidating these effects, we have performed preliminary
experiments utilizing THP-1 monocytic cells and avirulent Myco-
bacterium smegmatis (M. smegmatis). THP-1 cells and M. smeg-
matis were encapsulated within silk-collagen-type I hydrogels and
viability was assessed using CellTracker dyes and confocal micros-
copy. At a lower multiplicity of infection (MOI) of 1:1, THP-1 de-
rived macrophages killed most bacteria and at a higher MOI of 10:1,
fast multiplying M. smegmatis resulted in a higher bacterial burden.
Future work will include conducting infections using Mtb within an
established in vitro lung tissue model that recapitulates the distal
human lung microenvironment with strain and perfusion forces.
Skin Regeneration and Immunomodulation
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The Superiority Of The Autografts Inactivated By High
Hydrostatic Pressure To Decellularized Allografts For Dermal
Reconstruction In A Porcine Model
N. Morimoto1, A. Mahara2, C. Jinno3, T. Mitui1, N. Kakudo1,
S. Suzuki3, T. Fujisato4, K. Kusumoto1, T. Yamaoka2;
1Department of Plastic and Reconstructive Surgery, Kansai Medical
University, Hirakata, JAPAN, 2Department of Biomedical
Engineering, National Cerebral and Cardiovascular Center Research
Institute, Suita, JAPAN, 3Department of Plastic and Reconstructive
Surgery, Kyoto University, Kyoto, JAPAN, 4Department of
Biomedical Engineering, Osaka Institute of Technology, Osaka,
JAPAN.
In Japan, the JACE cultured epidermal autograft (CEA) was ap-
proved and covered by public healthcare insurance for use in the
treatment of giant congenital melanocytic nevus (GCMN) in 2016.We
are developing a novel skin regeneration therapy in which the inacti-
vation of nevus tissue via high hydrostatic pressure (HHP) is used in
the dermal reconstruction in combination with CEA. In this study, we
used a porcine skin graft model to explore whether autologous skin
including cellular debris inactivated by HHP or allogeneic skin de-
cellularized by HHP is better for dermal reconstruction. Grafts (n= 6)
were prepared for 5 groups each: autologous skin without pressuriza-
tion group (control group), autologous skin inactivated by 200MPa
group, autologous skin inactivated by 1000MPa group, allogeneic skin
decellularized by 200MPa group, and allogeneic skin decellularized
by 1000MPa group. All of the grafts at 1, 4, and 12 weeks showed
complete engraftmentmacroscopically. Themean areas of the grafts of
the control group and autologous 200MPa group were larger than that
of the allogeneic 1000MPa group at four weeks after implantation.
The thickness of the control group and autologous 200MPa group was
comparable, and that of the autologous 200MPa group was signifi-
cantly thicker than that of the allogeneic 200MPa group. Our result
suggests that the autologous dermis was superior to the allogeneic
decellularized dermis as a skin graft, and that HHP at 200MPa pro-
vided a better outcome than HHP at 1000MPa.
525
Poly(Diol Fumarate) Microparticles Restore Wound Healing
in a Neutropenic Murine Model of Cutaneous Fungal Infection
A. M. Tatara1, E. Watson1, N. D. Albert2, A. G. Mikos1,
D. P. Kontoyiannis2;
1Bioengineering, Rice University, Houston, TX, 2Infectious
Diseases, The University of Texas MD Anderson Cancer,
Houston, TX.
Introduction: Cutaneous fungal infection is a challenge to treat
in immunocompromised patients. We have recently described
poly(decanediol fumarate) (PDF), a biodegradable aliphatic poly-
ester whose degradation products have potential antifungal (de-
canediol) and immunomodulatory (fumarate ester) properties. In
this work, PDF microparticles were loaded with a traditional anti-
fungal therapeutic (voriconazole), characterized, and injected into
a cutaneous wound infected with Aspergillus fumigatus in a neu-
tropenic mouse model to measure subsequent wound healing and
fungal burden.
Materials and Methods: Briefly, microparticles were fabricated
by oil/water emulsion and in vitro drug release was assayed. A 6 cm
diameter wound inoculated with A. fumigatus (or saline in control
animals) was treated with loaded microparticles, non-loaded mi-
croparticles, or saline 72 hours after inoculation (n = 10 mice/group).
Six days after treatment, animals were euthanized. Wound surface
area size, fungal CFU count, and histological presence of fungi were
measured.
Results: Mice treated with loaded microparticles had signifi-
cantly greater rates of wound healing than non-treated mice
(p = 0.002) and no significant differences were observed between
blank and loaded microparticles compared to non-infected controls
(p = 0.497 and p = 0.947). Although wounds treated with micro-
particles had less fungal burden, these results were not significant
(p > 0.05).
Discussion and Conclusion: PDF microparticles can restore
normal rates of wound healing in a neutropenic murine model of
cutaneous fungal infection. As fungal burden was not significantly
reduced, the mechanism of this healing may be due to reduced in-
flammation due to immunomodulatory effects of released fumarate
esters on the Nrf2 stress response pathway rather than direct fungal
toxicity.
526
Identification of Immunosuppressive (IFNgamma-Stimulated)
MSC Morphological Subpopulations Using viSNE, A Tool
for Visualizing Cellular Heterogeneity
R. A. Marklein1, M. W. Klinker1, K. A. Drake2, H. G. Polikowsky2,
J. L. Lo Surdo3, S. R. Bauer1;
1U.S. Food and Drug Administration, Silver Spring, MD, 2Cytobank,
Inc., Santa Clara, CA, 3Bristol-Myers Squibb Co., Syracuse, NY.
Introduction: In many mesenchymal stromal cell (MSC)-based
clinical trials, common markers of MSCs do not adequately predict
in vitro or in vivo responses. Therefore, improved methods to
identify MSC quality attributes are needed. We previously devel-
oped techniques to identify population-based morphological fea-
tures predictive of MSC osteogenic and immunosuppressive
capacity and sought to expand upon these methods by quantita-
tively assessing heterogeneity based on unique morphological
subpopulations (SPs).
Methods: Morphological data from images of *3·105 single
cells was uploaded to Cytobank and viSNE (visual stochastic
neighbor embedding) was performed. SPs were identified for each
IFNg concentration and both SP frequency and total cell numbers
were determined for each MSC sample and correlated with their
overall immunosuppressive capacity.
Results and Discussion: viSNE permitted visualization of high
dimensional morphological data, which allowed for identification of
distinct SPs using a contour density plot. Representative cells from
different SPs illustrate the ability of viSNE to identify distinct
morphological phenotypes. Using viSNE, we were able to identify
morphologically-distinct SPs following IFNg stimulation, which
demonstrated donor and passage-dependent differences in SP fre-
quency and number. The immunosuppressive capacity of MSCs was
significantly correlated with one SP identified used viSNE (SP9) and
MSC samples with greater immunosuppressive capacity possessed
greater numbers of SP9 cells (p< 10-10). This approach could be used
as a predictive measure of MSC immunosuppression and could also
be used as a tool for both identifying molecular markers to enrich for
desired functional SPs, as well as optimizing manufacturing condi-
tions to improve MSC functional characteristics.
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527
Estimation Of Cell Death Related To Skin By High
Hydrostatic Pressure
T. Mitsui1, N. Morimoto1, N. Kakudo1, A. Mahara2,
K. Kusumoto1, T. Yamaoka2;
1Plastic and Reconstructive Surgery, Kansai Medical Univeresity,
Oasaka, JAPAN, 2Biomedical Engineering, National Cerebral
and Cardiovascular Center Research Institute, Osaka, JAPAN.
High hydrostatic pressure (HHP) technology is a physical method
for inactivating cells and tissue. Previously, we have reported that
skin and nevus specimens were inactivated after HHP of 200MPa for
10 minutes. The inactivated nevus could then be used as autologous
dermis for covering skin defects. However, the estimated cell death
by HHP of 180-200MPa or the duration of time needed for skin cell
inactivation remains unclear. In the present study, we evaluated the
time and pressure necessary for complete skin cell inactivation as
well as cell-death pathways. We prepared the following four human
cell types: dermal fibroblasts, adipose tissue-derived stem cells,
malignant melanoma cells, and squamous cell carcinoma cells. We
applied HHP of 150, 160, 170, 180, and 190MPa over three different
exposure durations (1 second, 2 minutes, or 10 minutes). To deter-
mine cell viability, we performed LIVE/DEAD assay immediately
after re-pressurization and WST-8 assay after culturing for 3 hours,
1 day, 3 days, and 7 days. In addition, we performed apoptosis assay
using Annexin V. Results revealed that at HHP >170MPa, cells were
not inactivated after an exposure of 1 second or 2 minutes but were
completely inactivated after an exposure of 10 minutes. Cell-death
pathways were predominantly necrosis. Therefore, HHP >170MPa
for 10 minutes completely inactivated four kinds of human cells.
Stem Cells
528
A Computational Model of the Hematopoietic Stem Cell Niche
Microenvironment
B. Mahadik1, B. Hannon2, B. Harley1;
1Chemical and Biomolecular Engineering, University of Illinois at
Urbana Champaign, Urbana, IL, 2Dept. Of Geography and
Geographic Information Science, University of Illinois at Urbana
Champaign, Urbana, IL.
The bone marrow microenvironment provides a complex set of
extrinsic signals that regulate hematopoietic stem cell (HSC) biology
and consequently the production of the body’s full complement of
blood and immune cells. An artificial marrow would have significant
value for expanding HSCs or to study the onset and treatment of
hematologic diseases. The challenge consists of identifying key
niche elements among the large number of niche parameters influ-
encing stem cell fate. Here we describe a biology-driven computa-
tional approach for defining stem cell kinetics in culture in order to
gain critical insight regarding culture conditions and intercellular
signaling networks and to distill the biological complexity to its
essential elements. Through a combination of experimental and in
silico methods, we examine the balance between self-renewal and
differentiation that drives early and late hematopoietic progenitors.
We investigate the importance of dynamic feedback associated with
cell-secreted biomolecules on lineage specification events in early
progenitor populations and demonstrate that changing this feedback
alters cell fate. Our analysis suggests that accurately modeling the
development of mature phenotypes requires direct contributions
from early progenitor populations via differentiation along with the
traditional intermediary oligopotent progenitors. While consistent
with in vivo results, this suggests a revision of our understanding of
in vitro HSC lineage development and in our approach for engi-
neering optimal culture conditions for HSC biomanufacturing in
targeted clinical applications. Finally, we demonstrate the appli-
cation of the computational model as a predictive tool to identify
culture parameters particularly sensitive for regulating HSC pro-
liferation and myeloid lineage specification events.
529
WITHDRAWN
530
Role of Adipose-Derived Stem Cells on Vasculogenesis
in 3D Co-Culture
V. Suresh1, J. West2;
1Biomedical Engineering, Duke University School of Medicine,
Durham, NC, 2Biomedical Engineering, Duke University,
Durham, NC.
Adipose-derived stem cells (ADSCs), which can differentiate into
adipocytes, chondrocytes, and osteocytes, have been shown to in-
fluence wound healing, however much is unclear about the role these
cells play in neovascularization. Previous work has shown that
ADSCs may be stimulated to express CD31, an endothelial cell
surface marker, using EGM2 media. Clinically, techniques such as
fat grafting have been used to help promote wound healing. How-
ever, understanding the influence of ADSCs on neovascularization
may provide novel avenues for stem cell therapy in treating ischemic
conditions, such as the chronic non-healing wounds seen in diabetic
patients. Utilizing three-dimensional in vitro models may provide
insight into the in vivo cell-cell interactions between ADSCs and
vascular endothelial and support cells. We sought to understand the
relationships between human derived ADSCs and human endothelial
and pericyte cells through co-culture in a cell-adhesive, proteolyti-
cally degradable poly(ethylene) glycol-based hydrogel. ADSCs
cultured in hydrogels alone were stimulated using EGM2-media and
showed increased proliferation and cell spreading, compared to
ADSCs cultured in hydrogels and stimulated with ADSC growth
media. Co-culture of ADSCs and human endothelial cells in EGM2
media showed the formation of tubule-like networks after 7 days.
Additionally, co-culture of ADSCs and human vascular pericyte cells
in EGM2 media showed the formation of tubule networks after
7 days. Our findings suggest that ADSCs contribute to neovascu-
larization and may be stimulated to adopt endothelial cell type
functions in the appropriate environment.
531
A Novel in Vitro Model of Human Urothelium with Barrier
Function Differentiated from Urine-Derived Stem Cells
I. Vasiutin, Q. Wan, D. Zhang, G. Liu, X. Zhang, D. Liang,
L. Guodong, A. Atala, Y. Zhang;
Wake Forest Insitute for Regenerative Medicine,
Winston Salem, NC.
Purpose: An in vitro model of human urothelium can provide a
multipurpose tool for assessing the effect of drugs on urothelial
permeability barrier function and for studying intrinsic alterations in
the urothelium of the patients with dysfunctional bladder diseases,
cancer, and infection. The objective of this study is to fabricate
in vitro biological model of human urothelium with permeability
barrier properties using urine-derived stem cells (USCs), which can
be used to study barrier physiology, disease pathogeneses, and
bladder drug efficacy.
Methods: Human USCs were harvested from 6 healthy individ-
uals and then induced to differentiate into urothelial cells on a per-
meable membrane using five different culture conditions for up to 2
weeks. Non-differentiated USCs were used as a control.
Results: The differentiated USCs expressed urothelial-specific
transcripts and proteins (Uroplakin-III, -Ia) as well as general epi-
thelial cell markers (Ck7, Ck13, Ck20 and AE1/AE3). Urothelially-
differentiated USCs expressed genes and protein markers (ZO-1 and
E-cadherin) of the tight junction. In vitro assays using a fluorescent
tracer on differentiated cells cultured on inserts demonstrated a 99%
decrease in leakage over 3 hours, indicating that the induced USCs
could perform barrier functions similar to those of normal urothelial
cells. In addition, TEM confirmed the ultrastructural phenotypes of
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urothelium differentiated from USCs, including tight junction for-
mation between neighboring cells.
Conclusions: The present study demonstrated that human ur-
othelium differentiated from USCs can efficiently generate ur-
othelium with intact permeability barrier function, which can be used
in vitro to study urothelial abnormalities present in various urinary
disorders.
532
Spheroid Culture Combined with 5-Azacytidine Treatment
Alters the Developmental Potency of Adipose-Derived
Mesenchymal Stem Cells
N. N. Mseis, M. A. Barr, E. R. McAbee, H. L. Hopfensperger,
M. M. Stern;
Biology, Winthrop University, Rock Hill, SC.
Adipose-derived stem cells (ADSCs) are multipotent mesenchy-
mal stem cells located within the microvasculature of adipose tissue.
Although ADSCs can differentiate into several cell lineages, they
cannot match the differentiation potential of pluripotent stem cells
such as ES and iPS cells. The goal of this project is to develop culture
conditions that enable ADSCs to more readily differentiate into the
myogenic lineage for use in tissue engineering and regenerative med-
icine applications aimed at restoring damaged and/or diseased skeletal
muscle tissue. Previous research in our lab suggests that culturing
murine ADSCs as three-dimensional spheroids can induce the expres-
sion of genes associated with pluripotency. We hypothesized that the
combination of culturing ADSCs as three-dimensional spheroids and
treatment with the DNA demethylating agent 5-azacytidine would
1) upregulate the expression of genes associated with enhanced de-
velopmental potency and 2) improve the efficiency of myogenic dif-
ferentiation by ADSCs. Through the analysis of ADSC gene expression
via real-time PCR, we found that culturing ADSCs as spheroids in
combination with treatment with 5-azacytidine impacts the expression
of genes associated with developmental potency and myogenic differ-
entiation. This suggests that these conditions can be used to prime
ADSCs for myogenic differentiation. Future work will include further
optimization of culture conditions to maximize the myogenic potential
of ADSCs. This would allow ADSCs to serve as a plentiful and easily-
obtained source of myogenic cells for skeletal muscle tissue engi-
neering and regenerative medicine applications.
533
Comparison of Donor-Matched Amniotic Fluid and Placental
Mesenchymal Stromal Cells
K. T. Herout, S. Walker, L. Lankford, P. Kumar, D. L. Farmer,
A. Wang;
Surgery, University of California, Davis, Sacramento, CA.
Mesenchymal stromal cells (MSCs) are an ongoing focus of cell
therapy treatments due to their ability to modulate inflammatory
responses, promote angiogenesis, and protect neural tissue. MSCs
can be derived from a number of tissue sources including fetal cells
from both the placenta and amniotic fluid. There is much debate
about the best source of cells to be utilized for stem cell therapy;
however, the significant variability among cells from different do-
nors causes difficulty in accurately characterizing the similarities and
differences among MSCs derived from various tissues. In this study,
MSCs were derived from chorionic villus placenta stromal tissue
(PMSCs) and amniotic fluid (AF-MSCs) collected from the same
donor, and assessed for growth kinetics, ability to differentiate, se-
cretome, and their functional capacity to promote endothelial pro-
genitor cell tube formation when indirectly co-cultured on matrigel.
Our data suggests that PMSCs have greater secretion of immuno-
modulatory cytokines and angiogenic growth factors than AF-MSCs,
but grow less rapidly and have less secretion of neurotrophic pro-
teins. Both cell lines appear to support lasting tube formation at
72 hours, but placental cells show a trend of increasing early tube
formation at 4 hours as well. Despite these differences, overall the
two cell sources are similar, and therapeutic potential will likely be
dependent on the unique clinical need.
534
Non-Invasive Cell Tracking with Brighter and Red-Transferred
Luciferase for Potential Application in Stem Cell Therapy
F. Shu, L. Dou, J. Paxton, T. Long, Q. Song, L. Mutkus, F. Marini,
J. Yoo, A. Atala, J. Jackson, Y. Zhang;
Wake Forest Insitute for Regenerative Medicine, Winston Salem,
NC.
Propose: It is critical to monitor the fate of the grafted cells after
implantation and to examine the progress of the implanted cells over
time for improving the efficiency of cell therapy. The goal of this
study was to determine the safety and efficacy of a novel cell labeling
technology on in vitro biological function of human placental stem
cells (hPSCs) labeled with a red fluorescent protein variant mKATE
and a new codon-optimized luciferase from Renilla Reniformis
(mKATE-renLUC) using a lentivirus vector. Our methodology is
intended to establishing this duel labeling technology for in vivo
bioluminescence imaging to track the implanted stem cells in the
treatment of erectile dysfunction.
Methods: To optimize the transfection protocol, different cell
concentrations of hPSCs, types of vectors (mKATE-renLUC, GFP-
FLUC), and titers of lentivirus were tested.
Results: The cell viability and cell proliferation of mKATE-
renLUC labeled hPSCs were similar to those of non-labelled cells
in vitro. The cell survival and migration of renLUC-labeled hPSCs
were efficiently monitored using IVIS imaging system after these
cells were implanted into corporal tissue using an erectile dysfunc-
tion athymic rat model. The mKATE-labeled cells were brighter than
the GFP-FLUC, which was confirmed within the host penis tissue
five days after injection using a fluorescence microscope.
Conclusions: This study demonstrated that the duel labeling
technology using mKATE-renLUC provides a safe and effective cell
tracking approach with brighter fluorophores and codon-optimized
luciferase for stem cell therapy in the treatment of erectile dys-
function allowing us to monitor injected cell noninvasively in vivo.
Tissue Chips & Tissue Organoid Models
535
Characteristics of Co-cultured Hepatocyte Spheroids
in a Microwell Chip Culture
K. Nakazawa, Y. Ohta, D. Miyamoto;
Department of Life and Environment Engineering, The University of
Kitakyushu, Kitakyushu, JAPAN.
Hepatocyte spheroid (three-dimensional cell aggregate) culture is
a promising technique for tissue engineering and drug screening
studies. In this study, we constructed a co-cultured spheroid, which
combined hepatocytes with other cells, and evaluated the effects of
co-culture on the expression of hepatocyte functions. As a culture
platform for generating homogeneous spheroids, we fabricated a
culture chip which contained the microwells (500mm in diameter) on
a culture substratum, and its surface was modified with poly-ethylene
glycol to create the non-adhesive area. In this study, three kinds of
cells, primary rat hepatocytes (Hep), human endothelial cells (HU-
VEC), and human mesenchymal stem cells (MSC) were used for the
spheroid culture, and the spheroid properties were compared in the
Hep-spheroid, Hep/HUVEC-spheroid, and Hep/MSC-spheroid con-
ditions. The spheroid formation was promoted with the presence of
HUVECs or MSCs. Although the HUVECs scattered within the
spheroids, the MSCs coagulated in the center of spheroid. Further-
more, the abilities of protein synthesis and drag metabolism in the co-
cultures (Hep/HUVEC or Hep/MSC-spheroids) were higher than
those of mono-culture (Hep-spheroid), and especially the functions
of Hep/MSC-spheroids were highest under all conditions. These
results indicate that the co-cultured spheroids are a promising
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technique for the maintenance of hepatocyte functions, and the
combination of cell species is important factor for modulation of cell
functions.
536
Sequential Formation of Vascularized Optogenetic Muscle
Tissue in a Micro Device
T. Osaki1, V. Sivathanu1, R. D. Kamm1,2;
1Department of Mechanical Engineering, Massachusetts Institute of
Technology, Cambridge, MA, 2BioSystems and Micromechanics,
Singapore MIT Alliance for Research and Technology, Singapore,
SINGAPORE.
Capillary networks surrounding muscle tissue play an important
role to not only supply oxygen and nutrients but also to regulate the
myogenesis and repair of surrounding skeletal muscle tissues. In
spite of this crucial role, strategies of engineering vascularized
muscle tissue in vitro have thus far been limited. Therefore, engi-
neering vascularized muscle in vitro is a high priority for developing
transplantable muscle tissues and understanding the pathogenesis of
muscle related disease such as muscular dystrophy and sarcopenia.
In this study, we model the early stages of 3D vascularized muscle
fiber formation in vitro using a sequential molding technique to in-
vestigate interactions between angiogenesis of endothelial cells
(EC) and myogenesis of skeletal muscle cells. Channelrhodopsin-2
induced C2C12 skeletal muscle fiber and 3D vascular structures
(f500mm) were formed at 500mm intervals in collagen gel. After
several days of culture, endothelial cells exhibited angiogenesis,
sprouting into the gel and forming robust capillary networks. Ad-
ditionally, muscle fiber bundle augmented EC sprouting, regulated
by the secretion of angipoietin-1 from muscle cells. Myogenesis was
also upregulated by the vascular networks, improving muscle con-
traction via angiopoetin-1/neuregulin-1 signaling. Moreover, con-
tinuous training of muscle tissue by optical stimulation significantly
induced angiogenesis.We believe this in vitromodel could be used to
help understand the formation of vascularized muscle tissue and
testing the interaction between muscle contraction and angiogenesis
for tissue engineering and regenerative medicine.
537
Organoid Culture of Mesenchymal Stem Cells for Organ
Function Regeneration
J. Hwang;
Department of Biomedical Engineering, Korea University, Seoul,
KOREA, REPUBLIC OF.
Cell therapy using mesenchymal stem cells (MSCs) have been
increasing in several degenerative diseases. Even though ongoing
research is attempting to the application ofMSCs to the clinical trials,
further understanding on their efficacy and optimal condition for
therapeutic effect are required. Tissue engineering is the use of a
combination of cells, engineering and materials methods, and suit-
able biochemical and physicochemical factors to improve or replace
biological functions of tissues. We developed three-dimensional
spheroid cell culture system on the hemispherical concave microwell
chips for tissue regeneration, for cells in 3D may better mimic the
conditions and properties of our body than 2D culture. First, we
reported that tonsil-derived mesenchymal stem cells (TMSC) are
successfully differentiated into parathyroid hormone (PTH)-
releasing cells, demonstrating the therapeutic role in hypoparathy-
roidism. Scaffold-free TMSC spheroids were engineered in concave
microwell plates made of polydimethylsiloxane in control culture
medium for the first 7 days and differentiation medium for next
7 days. Second, we present the therapeutic effect of placenta-derived
mesenchymal stem cells (PD-MSCs) on a rat model with ovariec-
tomy and compare their effects on the ovary dysfunction according to
conventional monolayer 2D culture system and 3D spheroid culture
system, restoring ovary function through increased estrogen pro-
duction as well as gene expressions for folliculogenesis by spheroid
forms of PD-MSCs. These findings suggest new insights into further
understanding of stem cell-based therapeutic mechanisms for organ
function regeneration and should provide new avenues to develop
more efficient therapies using biomaterials and new 3D organoid
culture system.
538
Development of Curved and Branched Blood Vessels Based
Microphysiological System to Model Atherosclerosis
Z. Chen, M. Tang, D. Huang, K. W. Leong;
Biomedical Engineering, Columbia University, New York, NY.
The pathology of many diseases, such as inflammation, athero-
sclerosis, and autoimmune disorders, is intricately linked with the
interaction between immune cells and blood vessels. Tissue con-
structs engineered from human cells have become important in vitro
models for disease modeling and drug screening. In this work, we
aim to develop an in vitro tissue model to study the dynamic rela-
tionship between immune cells and blood vessels. We fabricated
tissue-engineered blood vessels (TEBVs) from human cells, and
engineered a dual-function bioreactor to support long-term culture
and facilitate direct real-time imaging of the TEBVs. This perfusion
and imaging system was combined with two-photon microscopy to
monitor the bioreactions in TEBVs, such as leukocyte adhesion and
trans-endothelial migration within the lumen of the TEBVs. The
addition of inflammatory cytokines activated the TEBV endothe-
lium, which led to the enhanced adhesion and transmigration of
monocytes. We also fabricated branched TEBVs and curved TEBVs
with 3D bio-printing, and corresponding bioreactors to study flow
induced endothelial activation, and the initiation of atherosclerosis in
TEBV. These TEBVs offer a more biomimetic model than conven-
tional systems to study immune cell-blood vessel interactions, ath-
erosclerosis, and potentially cancer metastasis.
539
Hydrodynamically Controlled Fabrication of Three-dimensional
Microvasculature for Engineering Thick Vascularized Cardiac
Tissues
T. Su, M. A. Daniele, P. D. Erb, K. Huang, M. T. Hensley,
A. T. Young, T. A. Allen, A. C. Vandergriff, P. Dinh, J. Cores,
F. S. Ligler, K. Cheng;
North Carolina State University, Raleigh, NC.
A major challenge that hinders the practical application of en-
gineered tissues is the inability to form thick, viable tissues. Current
methods for manufacturing vascularized cardiac tissues fail to pro-
duce large tissue constructs with thickness great than 2mm.1,2 Here,
we report the fabrication of free-standing, human microvessels with
organized heterotypic cell layers using microfluidic method em-
ploying hydrodynamic focusing. These microvessels incorporate
human umbilical vein endothelial cells (HUVECs) on the lumi-
nal surface and human aortic smooth muscle cells (HASMCs) in
the wall, respectively, emulating the natural architecture and func-
tions of small diameter blood vessels. After integration in a three-
dimensional collagen matrix, the microvessel perfusion is examined
by using fluorescent microbeads and the permeability coefficient of
microvessel is quantified by using FTIC-dextran. The angiogenic
sprouting process is monitored at different time points using confocal
laser scanningmicroscopy.Moreover, the response of the endothelial
cells in the microvessels to the mechanical stimuli induced by flow
rate change is investigated. The fabrication of human microvessels
using hydrodynamic focusing allows for the assembly of engineered
tissue constructs in a facile and modular manner. We plan to as-
semble a thick vascularized cardiac tissue (thickness ‡1 cm) by in-
tegrating cardiomyocytes and human microvessels within an
extracellular matrix, and investigate the effect of perfused micro-
vasculature on the growth of cardiomyocytes.
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Cardiovascular
540
Three Dimensional Fabrication of Vasculature with Tropoelastin
R. Wang1,2, A. S. Weiss1,2,3;
1School of Life and Environmental Sciences, University of Sydney,
Sydney, AUSTRALIA, 2Charles Perkins Centre, University
of Sydney, Sydney, AUSTRALIA, 3Bosch Institute, University
of Sydney, Sydney, AUSTRALIA.
The development of synthetic vasculature is one of the most fun-
damental yet unmet challenges in clinical regenerative medicine.
Current vascular replacement therapy solutions have poor long term
patency because they are engineered from materials which cannot
adequately emulate the complex functional interplay between me-
chanical strength, elastic compliance, and biological signalling that is
inherent to natural vascular tissue. Elastin is a protein native to vascular
extracellular matrix and imparts the appropriate mechanical elasticity
and cell signalling properties. Elastin itself is predominantly made
from tropoelastin, which has been demonstrated to be an attractive
material for vascular engineering due to its ability to reduce throm-
bogenicity, promote endothelialisation, and to remain conveniently
solid during fabrication yet reverting to its natural elastic state when
hydrated. Using recombinant human tropoelastin, we have generated a
range of freestanding vascular architectures including straight grafts,
branching grafts, aortas, and simple vascular beds, achieving fine
control over physical design and architecture. Due to the unmet need,
our primary focus is to create small vessels of typically 4mm internal
diameter. Our in vitro studies validated tropoelastin grafts and show
that they support vascular endothelial cell proliferation. Concurrently,
we also demonstrated the robustness of the fabrication process by
combining tropoelastin with polycaprolactone, enhancing elastic
stiffness and burst pressure to emulate the corresponding biological
equivalent, and improving suture retention for surgical handling. Data
will be presented that validate these foundational results in vivo in an
ovine carotid artery interposition model to demonstrate the superiority
of tropoelastin as a material for vascular engineering.
Biofabrication and Bioreactors
541
Application Case Study All-in-one Bio 3d Printer,
Invivo From Rokit Inc
H. Lee;
ROKIT Inc, Seoul, KOREA, REPUBLIC OF.
For about recent a year, approximately 70 customers purchased our
all-in-one 3D printers for mostly their research purposes. For the last a
year, we can feel sudden increasingmovement of tissue engineering and
biofabrication research using bio 3D printers and we are introducing its
applications case studies through the consulting with our customers.
Cell bio-printings with bio-inks is a one big category. Vascularized
kidney, cardiacmyocyte regeneration,Neuron regeneration for dementia
patients, liver function regeneration, Oncology using target therapy, and
pancreatic cell regeneration are proposed for tissue engineering re-
searches using our product of 3D bio printers. All the cases include live
cell as a printing bio-materials and consist with scaffold design.
Second application category is human skin equivalent (HSE). Skin
is relatively easier than other organs for fabrication sue to is structure.
Dermis and epi-dermis are not containing large vascular, so many
researchers are working on this topic, HSE. One third of our customers
were also purchased our 3D bio printers for human skin equivalent.
The final applications for HSE are cosmetics test for substitution of
animal tests and artificial skin for wound healing for burnt patients.
Third application cases are bone and teeth, hard tissue application.
Not just simple or uniform shape of bone-replace scaffold, non-
uniform, which is gradually increasing pore size toward outside. This
structuremay prevent clogging or fouling on the surface and cannot fill
the designed structures. In fact, more than half of the studies related to
bio-implant is recently focused on scaffolds’ internal structure design.
542
Optimization of Hydrogel-based Bioink Printability using
Rheological Parameters: A Systematic Approach
G. Gillispie, J. Copus, A. K. Asari, T. Gao, J. Yoo, A. Atala, S. Lee;
Wake Forest Institute for Regenerative Medicine,
Winston-Salem, NC.
The dearth of suitable bioinks is frequently cited as a major limiting
factor for the advancement of bioprinting technology. It is well known
that the viscosity of a bioink has a direct impact on its printability.
Highly viscous materials maintain their structure, but also have de-
creased cell viability due to high extrusion forces. Complex viscosity is
comprised of two discrete components, storage (G’) and loss (G’’)
modulus and their individual contributions to printability are unknown.
For this study, gelatin and alginate mixed at various concentrations to
obtain hydrogels with a wide range of storage and loss moduli. These
hydrogels were then evaluated for the quantitatively defined values of
extrudability, structural integrity, and extrusion uniformity. While
neither loss nor storage moduli alone were excellent predictors of
printability, a lower loss tangent (G’’/G’) correlated with increased
structural integrity while a higher loss tangent correlated with in-
creased extrusion uniformity. Hydrogels with a loss tangent in the
range of 0.3 to 0.65 exhibited an excellent compromise between
structural integrity and extrusion uniformity. For extrudability, in-
creasing either the loss or storage modulus increased the pressure re-
quired to extrude the bioink. Amathematical model relating the G’ and
G’’ to the required extrusion pressure was derived based on this data.
Using this approach, a variety of different bioink formulations can be
quickly and accurately evaluated for printability. Immediate future
work will incorporate cell viability studies to further define printability
and will examine additional hydrogels to determine the generaliz-
ability this evaluation methodology for the printability of bioinks.
Biomaterial Scaffolds
543
Dual Ionic Cross-linked Interpenetrating Network Of Alginate-
cellulose Beads With Enhanced Mechanical Properties For
Biocompatible Encapsulation
K. Lee1, J. Hong2, H. Roh1, S. Kim3, H. Lee3, S. Lee4, C. Cha2;
1School of Life Sciences, Ulsan National Institute of Science and
Technology (UNIST), Ulsan, KOREA, REPUBLIC OF, 2School of
Materials Science and Engineering, Ulsan National Institute of
Science and Technology (UNIST), Ulsan, KOREA, REPUBLIC OF,
3School of Advanced Materials Engineering, Kookmin University,
Seoul, KOREA, REPUBLIC OF, 4School of Energy and Chemical
Engineering, Ulsan National Institute of Science and Technology
(UNIST), Ulsan, KOREA, REPUBLIC OF.
Spherical hydrogels (‘micro beads’) made from alginate has been
explored and used for biomedical application, delivery of biomolecule
and cell transplantation, although restricted mechanical strength and
short-term structural cohesion. In this study, controlling mechanical
properties andmaintaining the long-term structural integrity of spherical
hydrogels could be achieved by creating interpenetrating networks (IPN)
of alginate and aqueous-soluble cellulose with divalent and trivalent
ions. By using various the aqueous-soluble cellulose, with varying
concentration of cellulose or types of ions, the moduli of the resulting
hydrogels could be controlled in a wide range with a simple yet highly
efficient method of engineering alginate beads. We found that proces-
sing a dual sequential ionic crosslinking scheme to create IPN of alginate
and cellulose with divalent and trivalent ions has synergistic effect to
increase moduli and structural stability of hydrogels. Also the aqueous-
soluble cellulose is found to undergo crosslinking reaction with trivalent
ions more favorably than divalent ions. Especially, the aqueous-soluble
anionic cellulose, containing either carboxylate or sulfonate, is easier to
control mechanical properties than other types of celluloses. As a result,
the IPN alginate-cellulose beads demonstrate enhanced resistance to
harsh chemical environment as compared to alginate beads and
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suitability for biomedical applications by encapsulating microbial spe-
cies and therapeutic agents for controlled release.
Reference:
1. Lee, K, Hong, J, Roh, HJ, Kim, SH, Lee, H, Lee, SK, Cha, C.
Dual ionic crosslinked interpenetration network of alginate-cellulose
beads with enhanced mechanical properties for biocompatible en-
capsulation. Cellulose, in press. 2017.
544
Polyaspartamide-based Crosslinker For Controlling
The Mechanical Properties Of Hydrogels
J. Jang, C. Cha;
Ulsan National Institute of Science and Technology (UNIST), Ulsan,
KOREA, REPUBLIC OF.
Hydrogels are widely used as cell-culture platforms for various bio-
technology applications. To tailor to specific needs, various modification
strategies are employed to tune their properties. Herein, amultifunctional
polymeric crosslinker based on polyaspartamide is developed, which
allows for the adjustment of the type and number of reactive functional
groups to fit different reaction schemes and control the mechanical
properties of the hydrogels. The amine-based nucleophiles containing
desired functional groups are reacted with polysuccinimide to synthesize
polyaspartamide crosslinkers. The crosslinking density and the concur-
rent change in mechanical and properties of the resulting hydrogels are
controlled in a wide range only with the degree of substitution. Fur-
thermore, the polyaspartamide crosslinker linked with cell-recognition
molecules via the same conjugation mechanism (i.e. nucleophilic sub-
stitution) render the hydrogels cell responsive without having to addi-
tional processing steps. This polyaspartamide-based crosslinker is
expected to provide an efficient and versatile route to engineer hydrogels
with controllable properties for biomedical applications.
545
3D Culture NSCs in Conductive Scaffold
S. Wang, S. Guan, T. Liu, X. Ma;
Dalian University of Technology, Dalian, CHINA.
Neural stem cells (NSCs), as a self-renewing and multipotent cell
population, have been widely studied for never regeneration. En-
gineering scaffold is one of the important factors to regulate NSCs
proliferation and differentiation towards the formation of the desired
cells and tissues. Because neural cells are electro-active ones, the
conductive scaffold is required to provide three-dimensional cell
growth microenvironments and appropriate synergistic cell guidance
cues. In this study, two types of conductive scaffolds were obtained
for three-dimensional culture of NSCs in vitro. A PEDOT-HA/Cs/
Gel scaffold was developed by introducing PEDOT-HA nano-
particles into the chitosan/gelatin (Cs/Gel) matrix. HA, as a bridge,
not only was used as a dopant, but also combined PEDOT into the Cs/
Gel via chemical crosslinking. In addition, a poly (3,4-ethylene-
dioxythiophene)/chitosan/gelatin (PEDOT/Cs/Gel) scaffold was
prepared via in situ interfacial polymerization, with a nanostructured
layer of PEDOT assembling on the channel surface of porous Cs/Gel
scaffold. The results demonstrated that these electrically conductive,
three-dimensional, porous and biodegradable scaffolds could not
only promote NSCs adhesion and proliferation but also enhance
NSCs differentiation into neurons and astrocytes with higher protein
and gene expression. They will be the promising conductive substrate
for NSCs research and neural tissue engineering.
546
Comparison of Cell proliferation to 3D Printed Gelatin Scaffolds
by different Cross-linking Methods
Y. Kho1,2, S. Park1, B. Gu1, H. Shin2, C. Kim1;
1Korea Institute of Radiological & Medical Sciences, Seoul,
KOREA, REPUBLIC OF, 2Hanyang University, Seoul, KOREA,
REPUBLIC OF.
Three-dimensional (3D) printing is the powerful techniques in
tissue engineering. Gelatin is highly biocompatible and useful 3D
printing material. However, gelatin scaffold requires a cross-linking
treatment to maintain its structure. N-Hydroxysuccinimide (NHS) is a
cross-linking agent that cross-links gelatin, however it has cytotoxicity.
To improve its cytotoxicity problem, physical cross-linking method
have been studied. We fabricated physically crosslinked 3D gelatin
scaffolds by dried heat treatment (DHT). We have confirmed the
surfacemorphology and chemical properties of 3D gelatin scaffolds by
using SEM and FT-IR. Swelling degree and mechanical property of
each scaffold was identified by water absorption and universal testing
machine. The proliferation of human dermal fibroblasts (HDFs) in 3D
gelatin scaffolds resulted in DHT scaffold 48% higher than chemical
crosslinked 3D scaffold after 7 days of culture.
547
The Promotion of Cell Proliferation Induced By Three-
dimensional Scaffolds with Optimized Porosity
D. Choi1,2, S. Park1, S. Chung2, C. Kim1;
1Korea Institute of Radiological and Medical Sciences, Seoul,
KOREA, REPUBLIC OF, 2Korea University, Seoul, KOREA,
REPUBLIC OF.
Three-dimensional (3D) scaffolds in tissue engineering play an im-
portant role in regenerating defective tissue. In order to achieve these
goal, the 3D scaffold should be highly porous and with an appropriate
pore size, pore interconnectivity, and exhibit a high surface area-to-
volume ratio. In particular, the pore size of the 3D scaffold is one of the
important factors to determining the regeneration of the tissue as well as
affecting the cellular behaviors. 3D printing technology is an appropriate
method to fabricate pore size controlled 3D scaffold. In this study, we
fabricated pore size controlled 3D gelatin scaffolds by using 3D printing
with low temperature processing. The pore size of the 3D scaffold was
designed to be 600*1,200mm. The desired designed pore sizes of the
3D scaffolds were confirmed by the scanning electron microscopy
(SEM) images. The SEM image shows that the pore sizes of the 3D
printed scaffolds were reduced by approximately 20% compared to the
design.To evaluate the cell proliferation, humandermal fibroblast (HDF)
was cultured on the 3D scaffolds with various pore sizes. After 7 days of
culture, the HDF on the 3D scaffold with pore sizes ofmore than 665mm
(G8) showed the higher proliferation rate than that of the 485mm (G6).
These results suggest that the pore size of the 3D scaffold is an important
parameter to be considered in fabricating the 3D scaffold.
548
Three-dimensional PEG Hydrogel to Probe Cytokine Role in
VIC Myofibroblast Activation and Wound Healing Response
M. E. Schroeder1, A. Gonzalez Rodriguez2, K. S. Anseth2;
1Materials Science and Engineering, University of Colorado
Boulder, Boulder, CO, 2Chemical and Biological Engineering,
University of Colorado Boulder, Boulder, CO.
Fibrotic aortic valvular stenosis (FAVS) is a disease marked by
stiffening and reduced function of valve leaflets.Valvular interstitial cells
(VICs) present within the leaflets transition between quiescent fibroblast
and activated myofibroblast phenotypes to regulate homeostasis and
repair local injury. Thewoundhealing response initiateswith recruitment
of fibroblasts, pro-inflammatory cytokines, and growth factors to the
injury. This is followed by increased extracellular matrix (ECM) depo-
sition and contractility. FAVS arises when this process becomes dysre-
gulated. To better understand factors that contribute to FAVS, a
biocompatible 3D poly(ethylene glycol) (PEG)-based hydrogel platform
was employed to investigatewound healing progression and contractility
of encapsulated VICs. Hydrogels were prepared using a photoinitiated
reaction between norbornene-functionalized 8arm 40kDa PEG macro-
molecules and thiol-containing enzyme-degradable crosslinkers at a
modulus of 1kPa to permit cell spreading and interactionswith thematrix
via a cysteine-containing CRGDS adhesive peptide. Exogenously de-
livered cytokines, TGF-b and FGF-2, were introduced over a 10-day
S-136 POSTER ABSTRACTS
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
culture period and the subsequent cell response assessed via contraction,
gene expression (aSMA, CTGF, COL 1a, COL 3a, FN1), and im-
munostaining (aSMA, EdU proliferation). Treatment with FGF-2 re-
sulted in increased proliferation while reducing the myofibroblast
phenotype, as seen by decreased expression of both CTGF and aSMA.
The addition of TGF-b increased the proportion of cells exhibiting the
myofibroblast phenotype, increased ECM remodeling, and led to mac-
roscopic contraction of the hydrogel (*20% reduction in surface area
compared to control). Subsequently, this 3D culture system provides a
unique in vitroplatform toprobe cell-matrix interactions and contractility
with respect to FAVS.
549
A Supercritical Foaming Method to Create Biodegradable
Scaffolds Incorporating Autologous Growth Factors for Bone
Regeneration
L. A. Diaz Gomez1, C. A. Garcia-Gonzalez2, A. Concheiro3,
C. Alvarez-Lorenzo3;
1Bioengineering, Rice University, Houston, TX, 2Tecnologı´a
Farmace´utica, Universidade de Santiago de Compostela, Santiago de
Compostela, SPAIN, 3Dept Farmacia y Tecn. Farmaceutica,
Universidade de Santiago de Compostela, Santiago de Compostela,
SPAIN.
Preparation rich in growth factors (PRGF) is an autologous cocktail
of proteins obtained from platelet-rich plasma useful in tissue engi-
neering due to the contained growth factors (GF) and cytokines that
participate in several healing stages1. PRGF has been included in
biodegradable scaffolds using a different methods such as electro-
spinning or foaming, and able to control cell recruitment, attachment
and proliferation. In this work, highly porous poly(e-caprolactone)
(PCL) scaffolds containing PRGF were designed using supercritical
CO2 green technology and an architecture similar to bone matrix was
tuned. Solvent-free scaffolds with open and interconnected porous
structure were produced avoiding harsh conditions that could degrade
or remove GFs contained in the PRGF. SEMmicrographs revealed the
presence of large pores in the structure of the scaffolds and fluorescent
staining confirmed the homogeneous distribution of GFs. Sustained
GFs release over 15 days had a positive effect on cell attachment and
proliferation of mesenchymal stem cells in the scaffolds containing
PRGF. Live-Dead staining also revealed the cytocompatibility of PCL-
PRGF grafts. Results encourage the exploitation of these scaffolds for
the induction of bone tissue formation with an expected higher efficacy
in terms of GF-delivery, cost and success rate than current GF-
containing devices clinically used.
Acknowledgments: MINECO (SAF2014-52632-R; BES-2012-
051889).
References:
1. Anitua E, et al. Perspectives and Challenges in Regenerative
Medicine Using Plasma Rich in Growth Factors. J Control Release
157, 29, 2012.
2. Vo TN, et al. Strategies for Controlled Delivery of Growth
Factors and Cells for Bone Regeneration. Adv Drug Deliv Rev 64,
1292, 2012.
550
Biofabrication of Scaffolds for Human Induced Pluripotent
Stem Cells
X. Lyu1, H. Bi1, R. Ramos2, E. B. Finkelstein2, K. Ye1, D. Ren2,
S. Jin1;
1Binghamton University, Vestal, NY, 2Syracuse University,
Syracuse, NY.
Collagen scaffolds have excellent biocompatibility to most human
cells, including human induced pluripotent stem cells (iPSCs).
Nevertheless, weak mechanical strength and degradation nature of
collagen hinder the use of collagen scaffolds for iPSC differentiation
that lasts several weeks. poly (ethylene glycol) diacrylate (PEGDA)
is a FDA approved biomaterial. The cytocompatibility of PEGDA
treatment to iPSCs remains largely unknown. In this study, we in-
vestigated whether a physically stable and iPSC compatible collagen
scaffold can be fabricated through PEGDA penetration treatment.
We discovered that not only the content but also the molecular
weight of PEGDA affects the stability and cytocompatibility of the
treated scaffolds. Scanning electron microscopy analysis revealed
the PEGDA treatment affects the diameters of collagen fibrils but not
the pore size of the scaffolds. The determination of the shear storage
modulus of the scaffolds suggested that high molecular weight
PEGDA treatment results in more elastic and mechanically stable
scaffolds and prevents scaffolds from shrinking in extended iPSC
cultures. The Young’s modulus of the PEGDA treated scaffolds
varies from 110 to 5,500 Pa, suggesting the stiffness of the scaffolds
can be finely tuned by PEGDA treatment. Furthermore, we discov-
ered that the stiffness of 2 kDa PEGDA treated collagen scaffolds is
about 2.79 kPa, which is close to the stiffness of human pancreatic
tissues ranging from 1.15 to 2.09 kPa. This study implies that these
collagen-based scaffolds can possess better mechanical cues for
biofabricating pancreatic tissues from iPSCs. It will offer a new
technology for generating various iPSC-derived tissues and organs.
551
Engineered Phage Matrix Stiffness for Osteogenic
Differentiation
J. Kang1, S. Yoo2;
1Korea Maritime and Ocean University, Busan, KOREA,
REPUBLIC OF, 2Pusan National University, Busan, KOREA,
REPUBLIC OF.
Although biochemical cues in extracellular matrices play a critical
role in regulating cellular growth and fate, their physical cues as
stiffness in guiding stem cells has not been well studied so far. Here,
we have demonstrated engineered phage mediated matrix controlling
stiffness for various applications and verified that osteogenic dif-
ferentiation could be controlled by the constructed phage matrix. The
stiffness of matrix was controlled by cross-linking the engineered
phage displaying RGD and HPQ with different concentrations and
compositions of streptavidin and polymer mixture. Our phage ma-
trices, which can be easily functionalized by chemical/genetic en-
gineering, may be used as a convenient tissue matrices platforms for
controlling stem cell expansion and differentiation.
552
Bioactivation of Ti6Al4V Through Developing Micro
and Nano Surface Roughness
P. K. Srivas, K. Kapat, B. Das, P. Pal, P. Dadhich, S. Dhara;
School of Medical Science & Technology, IIT Kharagpur,
Kharagpur, INDIA.
Titanium and its alloys are widely used for biomedical, aerospace
and defence application because of its novel properties like low
density with high strength, excellent corrosion resistance, and bio-
compatibility. As Titanium based metallic implants have been
widely accepted but implant-bone interfacial bonding is still a
challenge due to poor tissue integration with implant. In past decades,
researchers have explored various techniques to minimize this failure
using different surface modifications using physical, chemical
methods and coating with bioactive material to improve interfacial
bonding. As surface roughness or surface physics and surface
chemistry play a critical role for cell proliferation cell attachment and
tissue adhesion. In this study, micro roughness has been generated by
creating different shapes of micro pillars/grooves on Ti6Al4V scaf-
folds to enhance cell adhesion. Further the scaffolds were thermally
treated to generate nano roughness on Ti6Al4V surface. Surface
morphology of developed architecture on Ti6Al4V sample and cell
attachment were evaluated by scanning electron microscopy (SEM).
Human mesenchymal stem cell (hMSC) line has been utilized for
cytocompatibility as well as cell proliferation property of prepared
Ti6Al4V scaffold. MTT and live/dead assay were performed to
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evaluate scaffold cytocompatibility. In vivo study was carried out in
rat model to examine soft tissue adhesion. Preliminary results using
SEM showed significant cell attachment and proliferation while
MTT and live/dead assay indicated non-toxic nature of the matrix. It
was also observed significant difference for thermally treated and
untreated Ti6Al4V scaffold in in vitro and in vivo studies.
553
Natural Rubber Latex as Stem Cells Scaffold for Muscle
Regeneration and Cell Therapy
J. F. Floriano1, R. D. Herculano2, C. F. Graeff1;
1Physics, Sa˜o Paulo State University (UNESP), School of Sciences,
Bauru (SP), Brazil., Bauru, BRAZIL, 2Sa˜o Paulo State University
(UNESP), School of Pharmaceutical Sciences, Araraquara (SP),
Brazil., Araraquara, BRAZIL.
Natural rubber latex (NRL) is a product extracted from rubber
trees, with the most common source of NRL is Hevea brasiliensis.
NRL is a mixing of colloidal rubber particles stabilized by a thin
layer of phospholipids and proteins [1]. NRL has several features that
make it an excellent scaffold and biomaterial to promote the growth
and repair of tissues, skin, and bones, due to its’ characteristics, such
as biocompatibility, angiogenic potential, flexibility, mechanical
stability, surface porosity, permeability and low cost [2]. The present
study aimed to assess the potential NRL use as stem cell scaffold, for
future application in muscle regeneration and cell therapy, evaluating
cell adhesion, proliferation and migration, after the primary culture
of rat stem cells in the biomamembranes NRL surface. By means
confocal microscopy, scanning electron microscopy, immunocyto-
chemistry and immunophenotyping techniques, we evaluated aspects
of cellular interaction with NRL biomembrane surface, such as cell
viability, proliferation, migration and adhesion. Our results demon-
strate high cell viability, excellent cell adhesion, high cell prolifer-
ation and migration rate, besides this it was shown that the NRL
biomembrane made a good provisional extracelular matrix demon-
strating the great potential NRL as stem cell scaffold.
References:
[1] Othman AB, Hepbur C, Hasma H. Influence of non-rubber
constituents on elastic properties of natural rubber vulcanizates. Plast
Rubber Compos Process Appl. 1993;19:185-94.
[2] Floriano JF, Mota LSLS, Furtado EL, Rossetto VJV, Graeff
CFO. Biocompatibility studies of natural rubber latex from different
tree clones and collection methods. J Mater Sci-Mater Med.
2014;25:461-470.
554
Fabrication and Characterization of Sericin Gel and Sponge
for its Biomedical Applications
M. Jang, J. Lim, J. Huh;
Kyungpook National University, DAEGU, KOREA, REPUBLIC
OF.
Silk is naturally occurring biomaterial composed of two bio-
polymers: fibroin and sericin protein. Sericin is hydrophilic protein
that has strong polar side groups and it has been considered as a good
material for biomedical applications due to its excellent biocom-
patibility, biological activities and resistance to oxidation, ultraviolet
light and bacteria. However, sericin gel and sponge have poor me-
chanical properties restricting its applications to biomedical fields. In
this study, sericin gels and sponges were fabricated with various
sericin concentrations and ethanol contents to improve mechanical
properties. Their gelation behavior, rheological properties and
structural characteristics were examined. As the sericin concentra-
tion increased, the rate of gelation of sericin accelerated and gel
strength increased significantly. This occurred up to an ethanol
content of 15%. Above that, the rate of gelation and the gel strength
decreased. There was no change in the gel-sol transition temperature
of sericin with the sericin concentration, although more ethanol ad-
dition resulted in a decrease in the starting temperature of thermal gel
disruption. The crystallinity index of the frozen and thawed sericin
sponge did not change with the sericin concentration, whereas it
increased with increasing ethanol content up to 15% and decreased
above 15%. As the sericin concentration was increased, the me-
chanical properties of sericin sponge were remarkably improved.
Studies in vitro indicated biocompatibility of the sericin sponge.
555
Pamam (generation 4) Incorporated Three Dimensional
Macroporous Scaffold as an Improved Substitute for Bone
Tissue Engineering
S. Maji, T. Agarwal, T. K. Maiti;
Biotechnology, Indian Institute of Technology Kharagpur,
Kharagpur, INDIA.
Introduction: The present study, explored the applicability of
generation 4 PAMAM in three-dimensional gelatin-CMC-nHAp
based macroporous scaffold (P-MGC) for bone tissue engineering
application. We hypothesize that by incorporating amine group ter-
minated PAMAM in the macroporous scaffold, will allow greater
interaction between cells and scaffold, hence increases the overall
biocompatibility of the scaffold.
Methods:The P-MGC scaffold was prepared by high-speed stirring
and freeze-dried to generate macroporosity. FTIR, SEM, and UTM
were used to characterize the physico-chemical properties, while
hMSC differentiated osteoblasts microtissue and HUVEC was used to
assess their viability, proliferation, andRT-PCR based gene expression
profile. Angiogenic activity was performed using CAM assay.
Results and Discussion: The P-MGC scaffold showed augmenta-
tion in mechanical strength and pore size distribution in comparison to
non-PAMAM based scaffold. An enhanced expression of osteogenic
and endothelial genes was also observed in the P-MGC scaffold. Live-
dead staining and alamar blue assay showed an increased adhesion and
proliferation rate of osteoblasts microtissue and endothelial cells.
CAM assay showed high angiogenic activity on P-MGC scaffold.
Conclusion: Our study demonstrated P-MGC scaffold allow en-
hanced cellular adhesion, proliferation and osteoconductive and
angiogenic activity. This suggests that blending of PAMAM (G4)
into matrix provides additional support to bone regeneration and
angiogenesis.
References:
1. Kato D, et al. Biomaterials.24, 4253, 2003.
2. Maji S, et al. Colsurfb. 155, 128, 2017.
556
Aptes Functionalized Filter Paper as a Bioactive Scaffold for
Bone Tissue Engineering Applications
T. Agarwal, S. K. Ghosh, T. K. Maiti;
Department of Biotechnology, Indian Institute of Technology
Kharagpur, Kharagpur, INDIA.
Bioactive, functional scaffolds are required to improve the regen-
erative potential of stem cells for tissue reconstruction and functional
recovery of damaged tissues. Here, we report a filter paper-based
bioactive scaffold platform for bone tissue engineering applications.
The paper-based scaffolds were surface-functionalized with (3-
Aminopropyl)triethoxysilane followed by its coating with collagen.
The prepared paper scaffolds were compatible with general cell culture
andmanipulation techniques. They supported efficient cell attachment,
proliferation of the human mesenchymal stem cells. The paper based
scaffold also supported efficient differentiation of the mesenchymal
stem cells into bone cells. Our study suggests that paper possesses great
potential as a bioactive, functional, and cost-effective scaffold plat-
form for stem cell-mediated bone tissue engineering.
References:
Kim et. al, BMP-2 peptide-functionalized nanopatterned sub-
strates for enhanced osteogenic differentiation of human mesen-
chymal stem cells, Biomaterials, 34, 7236, 2013.
Park et. al, Paper-based bioactive scaffolds for stem cell-mediated
bone tissue engineering, Biomaterials, 35, 9811, 2014.
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557
3D Printing Hydrogel into Media to Increase Nutrient
Availability for Tissue Engineering Constructs
S. Asfari1, J. Coburn2;
1Office of Science and Engineering Laboratories, Food and Drug
Administration, Silver Spring, MD, 2Office Science and Engineering
Laboratories, Food and Drug Administration, White Oak, MD.
3D printing cell-laden materials for tissue engineering models
has developed quickly over the last 10 years. However, printing
organ-level constructs remains a challenge for many reasons, in-
cluding reduced cell viability for long print sessions. We created a
platform to print a crosslinkable alginate hydrogel directly into
media to enhance nutrient transport and viability of cells during
long 3D print sessions. The objective of this experiment was to
optimize the crosslinking process of sodium-alginate and
calcium-chloride when extruded through a 3D BioPlotter (En-
visionTEC, Germany). In addition, we assessed feasibility of
encapsulating cells in the sodium-alginate solution so that they are
incorporated in the crosslinked gel and simultaneously surrounded
by media during printing. An experimental protocol was devel-
oped to test various concentrations of sodium-alginate and
calcium-chloride media. Separate tests were run to investigate the
diffusion of dye out of the hydrogels into the surrounding media to
determine the diffusion coefficient, indicative of nutrient ex-
change potential. Extruding sodium-alginate into calcium-
chloride produced thin, precise strands. To prevent coagulation of
gel around the print nozzle, the surface was coated with a thin
metallic sheet, allowing stable multi-layer, insoluble constructs to
be printed into media. The diffusion rate of dye was calculated,
and supports the theory that nutrient exchange will occur. Future
objectives include incorporating live cells into sodium-alginate
mixtures, and assessing cell viability in extruded hydrogels over
long print durations.
558
An Impedance Based Biosensing Platform for Epithelial Cell
Scaffold Characterization
R. Schramm;
SUNY Polytechnic Institute, Cohoes, NY.
A label free and non-destructive method of assessing the in-
teraction of cell tissue and scaffolds aids in the ability to discern
the effective quality and magnitude of any scaffold modifications.
Impedance cell spectroscopy is a biosensing method that employs
a functional approach to assessing the cell monolayer. The elec-
trical impedance barrier function of a cell monolayer represents
the level of restriction to diffusion of charged species between all
adjacent cells across an entire contiguous cellular monolayer. The
impedance signals from many individual paracellular pathways
contribute to the bulk measurement of the whole monolayer
barrier function. However, the scaffold substrate must be entirely
porous in order to be used with electrochemical cell impedance
spectroscopy (ECIS) and cells must be closely situated to the
electrodes. For purposes of evaluating cell-scaffold constructs
for tissue engineering, non-invasive evaluation of cell properties
while seeded on scaffolds is critical. A Transwell-type assay
makes a measurement across a semi-permeable membrane, using
electrodes placed on opposing sides of the membrane immersed in
fluid. It was found that by suspending a nanofiber scaffold across a
Transwell aperture, it is possible to integrate a fully functional
nanofiber tissue scaffold with the ECIS Transwell apparatus.
Salivary epithelial cells were grown on the nanofiber scaffolds
and tight junction formation was evaluated using ECIS mea-
surements in parallel with immunostaining and confocal imaging.
The trans-epithelial resistance increased coordinate with cell
coverage, culminating with a cell monolayer, at which point
the tight junction proteins assemble and strengthen, reaching the
peak signal.
559
Peptide Polymer Scaffolds for Liver Tissue Engineering
R. Grant1, D. C. Hay1, L. Chow2, A. Callanan1;
1University of Edinburgh, Edinburgh, UNITED KINGDOM,
2Lehigh University, Bethlehem, PA.
In 2-D culture, hepatocytes are flattened, with a corresponding
loss of liver-specific mRNA. In contrast, hepatocytes cultured in 3-D
display round, aggregated morphologies and a gene expression
profile more similar to in vivo1.
Conjugate scaffolds are of interest to tissue engineers because they
are reproducible, require no precious resources (e.g. donated ca-
daveric material) and allow researchers to customise scaffolds2.
Tissue engineering exploits polymer chemistry and molecular bi-
ology to create scaffolds which promote interaction between scaffold
and hepatocyte via the asialoglycoprotein receptor (ASGPR)3, a cell
surface receptor found primarily in the liver4.
We manufactured a novel peptide-polymer conjugate scaffold
exploiting the ASGPR of functional hepatocytes; creating a 3-D
environment which promotes cellular adherence. Scaffolds were
assessed for biocompatibility by culturing hepatocytes on them and
analysing their adherence, survival and enzyme/albumin production.
Directly incorporating peptide sequences which promote the ad-
herence of hepatocytes into scaffolds provides a method of creating
customised microenvironments for liver bioengineering and the
elucidation of cell scaffold interactions. Peptide:polymer scaffolds
represent a viable method of providing a bioactive environment for
hepatocytes.
Acknowledgements: Engineering & Physical Sciences Research
Council [EPSRC] doctoral training partnership, UK Regenerative
Medicine Platform II [RMPII] grant MR/L022974/1 and a Royal
Society of Edinburgh JM Lessells Scholarship.
References:
1. Grant, R., Hay, D. & Callanan, A. Tissue Eng. Part A 23, 650-
662 (2017).
2. Chow, L. W. et al. Adv. Healthc. Mater. 3, 1381-1386 (2014).
3. Vasanthan, K. S et al. Anal. Chim. Acta 890, 83-90 (2015).
4. Takebe, T. et al. Nature 499, 481-4 (2013).
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Assesing Intestinal Organoid Drug Response in a well-defined
Microenvironment
V. Hernandez-Gordillo1, K. Lee2, A. Lampejo1, R. Carrier3,
D. Breault4, L. Griffith1;
1Biological Engineering, Massachusetts Institute of Technology,
Cambridge, MA, 2Biological Engineering, University of Pittsburg,
Pittsburg, PA, 3Chemical Engineering, Northeastern University,
Boston, MA, 4Pediatrics, Harvard Medical School, Boston, MA.
Intestinal organoids have gained relevance as a tool in preclinical
drug discovery, disease modeling and basic research. Forskolin-
induced swelling of organoids derived from Cystic Fibrosis patients
is used in drug-screening. Similarly, intestinal organoids have been
used to investigate intestinal wound repair upon prostaglandin E2
(PGE2) stimulation. Matrigel hydrogels in combination with Wnt-
3A, R-spondin, and Noggin, is the predominant intestinal medium
used in drug discovery. However, Matrigel is ill-defined, varies from
lot to lot, and contains numerous bioactive soluble proteins that could
affect drug response. Exactly how these factors could impact drug
discovery is unknown. Here, we show that a fully-defined synthetic
basement membrane can be used to investigate intestinal organoid
drug response to similar extent to the ill-defined Matrigel hydrogels.
Human-derived intestinal organoids were cultured in the synthetic
matrix and Matrigel and their response upon PGE2 and Forskolin
was compared. The synthetic matrix consists of a multi-arm poly-
ethylene glycol macromer reacted with free thiols groups of a
collagen-derived peptide (which has a high affinity for integrins), and
two small peptides sequences that had affinity for collagen IV, lamin,
and fibronectin. After six days, the organoids were treated with PGE2
and forskolin in serum free organoid medium. Images were taken
POSTER ABSTRACTS S-139
D
ow
nl
oa
de
d 
by
 U
cl
a 
Li
br
ar
y 
U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 L
os
 A
ng
el
es
 fr
om
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
7/
09
/1
9.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
before and after stimulation to measure the organoid diameters
processed with FIJI. Intestinal stem cell embedded in the synthetic
matrix form organoid similar to Matrigel, after six days. Upon for-
skolin or PGE2 stimulation, organoids increased in size on average
1.2 to 1.6 times in the synthetic matrix or Matrigel.
Cancer
561
Nanoconstruct induced Apoptosis Through Downregulation
Of Nucleolin-rtk Pathway In Cancer
H. Lee1, J. Kim2, S. Oh1;
1Korea Institute of Science and Technology, Seoul, KOREA,
REPUBLIC OF, 2Hanyang University (ERICA), Ansan, KOREA,
REPUBLIC OF.
Cell surface nucleolin (NCL) has been shown as a novel cancer
target molecule due to its abundance in various cancers including
gastric, breast, lung and prostate. In this regard, anticancer drugs
targeting NCL have been developed for anti-NCL therapy. Among of
them, AS1411, DNA aptamer, is a representative anti-NCL agent that
induces apoptosis through destabilization bcl2 mRNA. Although
promising, as1411 has been faced with some limitations such as short
circulatory half-life, unexpected immune response, and insufficient
anticancer outcome. These drawbacks have been alleviated by
modification of aptamer, conjugation with nanoparticle and combi-
natorial treatment with other anticancer reagents. Here, we suggested
the combinatorial treatment of cancer cells using nucleolin targeting
aptamer (AS1411) and c-Met aptamer (c-Met apt) simultaneously.
To improve delivery efficacy of two aptamers into gastric cancer
(MKN-45), we introduced a star-shaped gold nanoparticle (AuNS) as
a carrier. AS1411 and c-Met Apt were immobilized onto the surface
of AuNS through gold-thiol chemistry. The bi-functional AuNS, c-
Met-AS1411 AuNS, can alternately bind to c-Met and nucleolin on
the cellular surface, results in induction of anti-cancer pathway via
dual pathway of c-Met apt and AS1411. This nanocomplex showed
increase of therapeutic efficacy compared with free apts and single
apt-functionalized AuNS. Interestingly, mixture of c-Met-AuNS and
AS1411-AuNS could not suppress the cell viability as c-Met-
AS1411-AuNS decreased at the same apt total concentration. The
result indicated that bi-functional AuNS effectively induces apo-
ptosis pathway through interaction of c-Met- and nucleolin-
correlated cell death mechanism.
Cardiovascular
562
AAV-mediated Therapeutic Strategy for Ischemic Heart Disease
S. Yoo;
Pusan National University, Busan, KOREA, REPUBLIC OF.
Recent work in cellular reprogramming of fibroblasts into cardi-
omyocytes has demonstrated therapeutic potential for cardiovascular
disease, in which viruses were utilized as biomaterials for successful
transgene delivery. Retrovirus- or lentivirus-mediated transgene
delivery into the cardiovascular system was majorly used and is not
yet feasible for application to humans. Here, we propose to utilize
AAV-mediated gene delivery as a cardiovascular regeneration
strategy to generate new cardiomyocytes and limit collagen deposi-
tion in the injured heart. This was achieved by inducing synergism of
Gata4, Mef2c, and Tbx5 (GMT)-mediated heart reprogramming and
thymosin b4 (Tb4)-mediated heart regeneration in a myocardial is-
chemia model. AAV-GMT promoted a gradual increase in expres-
sion of cardiac-specific genes, including Actc1, Gja1, Myh6, Ryr2,
and cTnT, with a gradual decrease in expression of a fibrosis-specific
gene, procollagen type I. Vessel growth was enhanced in fibrotic
areas in the AAV-Tb4 co-treatment group compared to the AAV-
GMT or AAV-Tb4 only group; enhanced cell survival was also ac-
companied by AAV-Tb4 co-injection. Histological assessment of
heart also showed decreased myocardial fibrosis and increased wall
thickness in the AAV-Tb4 co-injection group, with consequent im-
proved cardiac function, as shown by echocardiography. Taken to-
gether, the combined AAV-mediated GMT and Tb4 therapy
enhanced the recovery of heart structure and function via enhanced
heart regeneration and blood vessel growth in an acute myocardial
infarction model.
563
Tissue-Engineered Blood Vessels with User-Defined Geometries
S. Pashneh-Tala, C. Sherborne, S. MacNeil, F. Claeyssens;
Materials Science and Engineering, University of Sheffield,
Sheffield, UNITED KINGDOM.
A great need exists for blood vessels for use as vascular grafts in
the treatment of cardiovascular disease. Autologous vessels are of
limited availability/quality and their harvest is invasive. Synthetic
vascular grafts are prone to thrombosis and infection. A tissue-
engineered blood vessel, able to grow, remodel and repair in vivo,
offers an attractive solution to vascular grafting.
Natural vasculature is composed of complex geometries (tapers
and bifurcations) and it has been suggested in a number of studies that
the geometry of the vascular constructs created during surgery has a
strong influence on their performance. The ability to generate tissue-
engineered blood vessels with varied geometries would therefore be
of great potential benefit.
Here we have developed a method for generating tissue-
engineered blood vessels of various geometries. A novel photocur-
able polymer, poly(glycerol sebacate) methacrylate (PGS-M) was
developed for use as a scaffold material to support the growth of the
tissue-engineered blood vessels. PGS-M is highly elastic, degrades
rapidly and displays excellent cytocompatibility. Using a combina-
tion of 3D printing and emulsion templating, porous tubular PGS-M
scaffolds of various geometries, including tapers, bends and bifur-
cations, were produced. These scaffolds were seeded with vascular
smooth muscle cells and cultured in a bespoke, pulsatile flow, bio-
reactor which provided mechanical stimulation to the developing
constructs. The vessels generated displayed cellular organisation
similar to natural vasculature with an extracellular matrix of collagen
and elastin. This method may be adapted to produce blood vessels
with user-defined geometries for tailored clinical applications.
Dental & Craniofacial
564
3D-Printed External Cages Preserve Shape of Human Tissue
Engineered Ear Cartilage In Vivo
B. P. Cohen1, J. L. Bernstein2, A. Lin2, Y. Toyoda2, A. Harper2,
J. A. Spector2, L. J. Bonassar1;
1Biomedical Engineering, Cornell University, Ithaca, NY, 2Division
of Plastic Surgery, Weill Cornell Medical College, New York, NY.
A persistent challenge engineering ear shaped cartilage is con-
traction and deformation during implantation due to weak initial
mechanical properties. Previously, we observed that constructs
contracted up to 60% in vivo. We hypothesize that providing me-
chanical support by encasing the construct in a ‘‘cage’’ during im-
plantation will protect the construct from external forces of
surrounding tissue, preserving shape definition without hindering
tissue development. Human AuCs were isolated from otoplasty
specimens and encapsulated in high density collagen, as either 8mm
discs or an ear. External cages were 3D-printed from polylactic acid
(PLA) to fit constructs, containing large pores to allow nutrient ex-
change with the construct. Discs were inserted into cages and im-
planted subcutaneously in nude mice for 1 or 3 months, and ear
constructs implanted in nude rats for 3 months. After 3 months, PLA
cages remained stable and the encased discs maintained 95% of the
initial diameter. Histology of disc and ear constructs displayed col-
lagen bundling and proteoglycan deposition after 3 months, with disc
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constructs also containing elastin fibers. After 3 months, disc con-
structs showed 47% the compressive stiffness and 59% the proteo-
glycan content of native auricular cartilage. The cages ability to
protect the developing construct indicates that that internal cell
traction accounts for only 5% of construct contraction, and that most
deformation results from external forces. Collectively, these data
indicate the potential for encasing auricular chondrocyte constructs
within 3D-printed external cages to preserve shape and structure
while still allowing for generation of auricular cartilage tissue.
565
Mechanical Evaluation of the SLM Fabricated,
Stiffness-matched, Mandibular Bone Fixation Plates
A. Jahadakbar1, N. Shayesteh Moghaddam1, A. Amerinatanzi1,
D. Dean2, M. Elahinia1;
1MIME, University of Toledo, Toledo, OH, 2Department of Plastic
Surgery, Ohio State University, Columbus, OH.
The standard of the care for the treatment of mandibular segmental
defects is the use of Ti-6Al-4V bone fixation plates and screws to
immobilize the grafted bone and the host mandible. While Ti-6Al-4V
bone fixation plates provide strong immobilization during the healing
period, they may disturb the stress distribution in the repaired man-
dible. The highly stiff Ti-6Al-4V fixation carries a great portion of the
load which was previously borne by the mandible, and stress shielding
may occur on the surrounding cortical bone. Based on the bone re-
modeling theory, stress shielding causes bone resorption in the affected
region and may eventually lead to the failure of the surgical recon-
struction. To address this issue, we have developed a new generation of
the patient-specific, porous NiTi bone fixation plates which benefit
from stiffness-matching of the adjacent bone. Using the CT scan data
of the patient’s defective mandible, the geometry for the required bone
fixation plates is designed and the stiffness of the surrounding regions
is measured. By introducing specific level and type of porosity to the
bone fixation plate, its stiffness can be tuned. Finite Element simula-
tions have verified the reduced level of stress shielding on the re-
constructed mandible, in case of using the proposed bone fixation
plates. Selective Laser Sintering has been used for fabrication of the
porous NiTi bone fixation plates with six different levels of stiffness.
Finite element simulations and mechanical tests have been done to
verify the performance of the fabricated parts resulting from our design
and fabrication method.
566
Clinical study of Dentin DemineralizedMatrix (DDM) combined
with BMP2 for socket preservation after extraction
H. Jang1, S. Jun2;
1Oral & maxillofacial surgery, Korea University, Ansan, KOREA,
REPUBLIC OF, 2Oral & maxillofacial surgery, Korea University,
Seoul, KOREA, REPUBLIC OF.
Objectives: This study compared socket preserving effects be-
tween autogenous tooth derived dentin demineralized matrix (DDM)
combined with recombinant human bone morphogenetic protein-2
(rhBMP-2), DDM only, and xenogenic bone (BioOss collagen).
We hypothesized that DDM+rhBMP-2 would have better bone
forming ability and socket preserving effects than those of others.
Methods: Total 21 participants aged over 19 with one or more of
hopeless teeth were included. The participants were excluded if they
were pregnant, generalized compromised, immune deficient, or
heavy smokers. All participants got informed consent, and were
randomly selected into three groups. The 8 participants got socket
preservation using xenogenic bone, 6 participants got DDMonly, and
the other 7 participants got DDM+rhBMP-2 graft. Three dimensional
(3D) volumetric, radiographic, and histomorphometric changes be-
tween initial and 4 months later were analyzed.
Results: The 3D volumetric analysis showed that DDM+rhBMP-2
group had similar horizontal bone resorption compared to DDM only
or xenogenic bone group. Likewise, cone beam CT results revealed
that DDM+rhBMP-2 group had similar amount of new bone forma-
tion, horizontal and vertical bone loss compared to those of other
groups. Histomorphometric results displayed new bone formation was
found on DDM+rhBMP-2 group comparable to other groups.
Conclusion: Autogenous tooth derived DDM+rhBMP-2 showed
new bone formation and socket preservation comparable to those of
xenogenic bone or DDM only group.
567
Periodontal Ligament Integration with Cementogenesis
Using Modified Fibrin Matrices
C. Park1, J. Oh1, H. Jung1, Y. Choi1, S. Rahman1, S. Kim1, T. Kim1,
H. Shin2, Y. Lee3, F. H. Yu1, J. Baek3, H. Ryoo3, K. Woo3;
1Seoul National Univeristy, Seoul, KOREA, REPUBLIC OF,
2Department of Oral Pathology, School of Dentistry, Kyungpook
National University, Daegu, KOREA, REPUBLIC OF, 3Department
of Molecular Genetics, Seoul National Univeristy, Seoul, KOREA,
REPUBLIC OF.
Objectives:Cementum formation on the exposed tooth-root surface
is a critical process in periodontal regeneration. Although various
therapeutic approaches have been developed, regeneration of integrated
and functional periodontal complexes is still wanting. Here, we found
that the OCCM30 cementoblasts cultured on fibrin matrix express
substantial levels of matrix proteinases, leading to the degradation of
fibrin and the apoptosis of OCCM30 cells, which was reversed upon
treatment with a proteinase inhibitor, e-aminocaproic acid (ACA).
Methodology andResults:Based on these findings, ACA-releasing
chitosan particles (ACP) were fabricated and ACP-incorporated fibrin
(fibrin-ACP) promoted the differentiation of cementoblasts in-vitro, as
confirmed by bio-mineralization and expressions of molecules asso-
ciated with mineralization. In a periodontal defect model of beagle
dogs, fibrin-ACP resulted in substantial cementum formation on the
exposed root dentin in-vivo, compared to fibrin-only and enamel matrix
derivative (EMD) which is used clinically for periodontal regeneration.
Remarkably, the fibrin-ACP developed structural integrations of the
cementum-periodontal ligament-bone complex by the Sharpey’s fiber
insertion. In addition, fibrin-ACP promoted alveolar bone regeneration
through increased bone volume of tooth roof-of-furcation defects and
root coverage.
Significance: Therefore, fibrin-ACP can promote cementogenesis
and osteogenesis by controlling biodegradability of fibrin, implicating
the feasibility of its therapeutic use to improve periodontal regeneration.
568
Attaching a Hydroxyapatite-binding Domain to Anchor BMP2-
derived Peptides onto Bone Graft Materials
A. S. Curry1, N. W. Pensa1, J. L. Bain2, M. Reddy3, S. L. Bellis4;
1Biomedical Engineering, University of Alabama at Birmingham,
Birmingham, AL, 2Dentistry, The University of Mississippi Medical
Center, Jackson, MS, 3School of Dentistry, University of Alabama at
Birmingham, Birmingham, AL, 4Cell, Developmental and
Integrative Biology, University of Alabama at Birmingham,
Birmingham, AL.
Objective: The osteoinductive factor, BMP2, has been passively
adsorbed to commercial bone graft materials to improve osseointe-
gration, however BMP2 disseminates quickly from the graft, re-
sulting in inflammation. Previously we identified a molecular domain
of 7 glutamates (E7) which tightly binds to hydroxyapatite, a com-
mon graft material. We hypothesize a bioactive peptide derived from
BMP2 with an attached E7 domain (E7-BMP2pep) can anchor to
hydroxyapatite, increasing bone regeneration without evoking a
deleterious immune response.
Methods: Osteoblastic cells were treated with BMP2pep, with or
without E7, to measure osteogenic cell signaling. Peptide-coated
hydroxyapatite particles were implanted in rat cranial defects and
evaluated by H&E and immunohistochemistry to analyze bone for-
mation, presence of T cells (CD3), and vascularization (CD34).
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Results: In vitro assays showed that the E7 domain greatly im-
proves peptide anchoring to hydroxyapatite without diminishing
BMP2pep’s capacity to stimulate BMP2-dependent signaling
(pSMAD activation) and osteoblastic differentiation (upregulation of
alkaline phosphatase, ALP). In fact, cells treated with E7-BMP2pep
had equivalent levels of induced ALP expression compared with full-
length rBMP2. In vivo studies of implanted E7-BMP2pep-coated
hydroxyapatite revealed that the peptide strongly stimulated bone
formation, and did not hinder vascularization. Furthermore, there
was minimal T cell infiltration associated with the E7-BMP2pep
group compared with rBMP2-coated samples.
Significance: E7-BMP2pep offers a valid alternative to full-
length rBMP2 because it can prolong osteoblastic signaling at the
graft site by strongly adhering to hydroxyapatite, resulting in
equivalent bone formation compared to rBMP2, without the in-
flammatory response commonly seen with rBMP2 treatment.
569
Polyglutamate Modified VEGF Mimetic Peptides Elicit
a Proangiogenic Response
N. W. Pensa1, A. S. Curry1, M. S. Reddy2, S. L. Bellis3;
1Biomedical Engineering, University of Alabama at Birmingham,
Birmingham, AL, 2Periodontology, University of Alabama at
Birmingham, Birmingham, AL, 3Cell, Developmental and
Integrative Biology, University of Alabama at Birmingham,
Birmingham, AL.
Introduction: Engineering bone graft materials with gradient
release of angiogenic factors such as VEGF is a major research focus,
given the need for neovascularization for efficient bone healing. To
address this issue, we synthesized the VEGF mimetic peptide, QK,
with three different polyglutamate domains (diglutamate, tetra-
glutamate, and heptaglutamate) that selectively release from Ca2+
found within bone grafts based upon the number of glutamate resi-
dues. A mixture of these peptides (‘‘Polyglu-QK’’) was used to de-
velop a proangiogenic gradient on graft materials.
Methods: Solution fluorescence assays were conducted with
FITC-labeled components within Polyglu-QK to quantify release
from bone grafts. Polyglu-QK was evaluated for proangiogenic
bioactivity through endothelial tube formation assays, scratch test,
and activation of signaling proteins.
Results: Individual peptides within the Polyglu-QK mixture are
released in accordance with polyglutamate domain length, creating a
gradient. Additionally, we confirmed that the polyglutamate domain
does not interfere with the bioactivity of QK, as measured by en-
dothelial cell migration, tubule formation, and activation of signaling
molecules (pAkt and p-eNOS). Finally, bone graft materials coated
with Polyglu-QK elicited a greater angiogenic response in endothe-
lial cells compared with grafts passively coated with rVEGF or QK.
Conclusions: Polyglu-QK offers a new approach for gradient
delivery of proangiogenic factors from bone grafting material, thus
facilitating bone tissue neovascularization.
Acknowledgments: NIH R01 DE024670 ; NASA NNX15AJ18H.
Imaging
570
Cell-Based Probes for Real-Time Evaluation of Chondrogenesis
R. Somoza1, D. Correa2, J. Kenyon1, L. Duesler1, A. Caplan1;
1Biology, Case Western Reserve university, Cleveland, OH, 2Dept.
of Orthopaedics, University of Miami, Miller School of Medicine,
Cleveland, FL.
Chondrogenic differentiation constitutes a multistep program mod-
ulated by spatially- and temporally-determined combinations of mor-
phogens. Current assessments of engineered tissues rely on destructive
methodologies applied at the end of the fabrication period, making
impossible to predict failures early in the process. Therefore, devel-
oping a dynamic, multi-modal, non-destructive/non-invasive technol-
ogy toolset to monitor cell differentiation in real-time is important. An
imaging approach is applied to chondrogenic structures serving as
platform for testing the biological effect of specific designed inter-
ventions. It uses cell-based probes to directly interrogate differentiation
events during in vitro chondrogenesis. Native promoters of well-
established cell-differentiation biomarkers are used to create indepen-
dent reporters incorporating a traceable signal (Luciferase), to monitor
in real-time the progression throughout the differentiation program of
Mesenchymal Stem Cells chondrogenesis. This technology will permit
a longitudinal reconstruction of the differentiation program and an
analytical assessment of phenotypic changes of engineered cartilage.
They offer significant advantages to researchers to improve the fabri-
cation algorithms of engineered cartilage, such as: 1) avoid relying on
end-point/destructive assessments to determine success/failures; 2) to
make fine spatio-temporal correlations between specific interventions
and resulting phenotypes; 3) to be able tomake adaptations and tune ups
‘‘on the go’’; and 4) the possibility of defining release criteria for im-
plantation based on established features and events monitored in real-
time. These advantages positively impact both the design strategies and
the testing approaches of engineered cartilage, speeding up the trans-
lation of implantable constructs to treat cartilage defects.
571
Ultrafast Pump Probe Imaging of Melanin For Non invasive
diagnosis of Melanoma
E. Ghadiri, W. S. Warren;
Chemistry, Duke University, Durham, NC.
96 Normal 0 false false false EN-US X-NONE X-NONE /* Style
Definitions */ table.MsoNormalTable {mso-style-name:’’Table Nor-
mal’’; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-
style-noshow:yes; mso-style-priority:99; mso-style-parent:’’‘‘;
mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-
para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-
size:12.0pt; font-family:Calibri; mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;} We integrated the state-of-the-art
ultrafast pump-probe microscopy to distinguish between hyperpig-
mented and malignant melanoma tumor. Multiphoton microscopes are
operating based on two-photon induced fluorescence and second har-
monic generation. Such methods are only useful for imaging exoge-
nous fluorophores (dyes) and genetically expressed markers, but have
more limited utility with endogenous contrast. In ultrafast pump-probe
microscopy, two femtosecond laser pulses with MHz repetition in-
teract with the sample. A variety of different linear and nonlinear
optical interactions of the two laser pulses with the tissue provide
contrast for imaging. This includes refractive-index change (self-phase
or cross-phase modulation), two-photon or single-photon absorption,
or pump-probe features such as excited-state absorption, ground-state
depletion or stimulated emission. Time-resolved pump-probe images
and transient absorption spectrum of melanin in different forms of
synthetic nanoparticles, in tissue biopsy specimens and dissected tu-
mors, are compared. Our results suggest that the excited state dynamics
of melanin in malignant melanoma are significantly different with that
in the hyperpigmented tissue. The nature of underlying photophysical
processes, such as excited state absorption, ground state bleaching are
described. These processes provide chemical information and the
molecular level and are compared for melanin pigments in hyperpig-
mented tissue with malignant melanoma tissue. Therefore, the tech-
nique and the biophysical model provides a reliable quantitative
optical contrast for non-invasive diagnosis of melanoma.
Matrix & Extracellular Matrix Biology
in Regenerative Medicine
572
Superior Elastogenicity And Pro-elastogenic And
Anti-proteolytic Effects Of Phenotype-selected, Adult Stem
Cell-derived Smooth Muscle Cells In A 3-d Collagenous Milieu
S. Dahal, A. Ramamurthi;
Cleveland Clinic, Cleveland, OH.
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Abdominal aortic aneurysms (AAAs) are rupture-prone dilations of
the abdominal aorta that develop from irreversible proteolytic break-
down of the elastic matrix. Towards use in a matrix regenerative cell
therapy for AAAs, we showed in 2D co-cultures that bone marrow
mesenchymal stem cell-derived smooth muscle cells (BM-SMCs)
provide paracrine pro-elastogenic/anti-proteolytic stimuli to AAA
SMCs, and identified a specific phenotype (cBM-SMCs) derived on a
fibronectin substrate in presence of TGF-b and PDGF that is more
elastogenic than even healthy aortic SMCs and show more impressive
paracrine effects versus other generated phenotypes. We presently in-
vestigate the performance of the cBM-SMCs in a 3D collagenous mi-
lieu evocative of the de-elasticized AAA tissue. Rat aortic SMCs, cBM-
SMCs and rat AAA SMCs were cultured standalone or together with
AAA SMCs within compacted collagen gels for 21 days. Elastic matrix
amounts (Fastin assay), fiber formation (TEM, IF), and lysyl oxidase
mediated (Western blot, Amplex Red assay) formation of desmosine
crosslinks (ELISA) within the elastic matrix, besides contractility
(stereomicroscopy) and elastic moduli (Nano-indentation test) of the
constructs were significantly higher and metalloprotease protein syn-
thesis and activity (western blot, gel zymography) were significantly
lower in standalone cBM-SMC cultures and in cBM-SMC/AAA SMC
co-cultures versus controls. Our study strongly supports the utility of
cBM-SMCs for cell therapy aimed at restoring elastic matrix homeo-
stasis in the AAA wall towards achieving growth arrest or regression.
Acknowledgments: This work was supported by funding from
the NIH (HL132856), AHA (16IRG27250113), and NSF (1508642)
awarded to A.R
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Extracellular Matrix Hydrogels for Mediating
Inflammation and EMT
T. J. Keane, Jr., M. M. Stevens;
Materials, Imperial College London, London, UNITED KINGDOM.
Fibrosis is the principal factor leading to progression and end-stage
of many diseases, oftentimes leading to organ failure. Despite ac-
counting for greater than 45% of deaths in the western world, there are
currently no available agents for targeting fibrosis. A common feature
of fibrosis across tissues is inflammation and epithelial injury mani-
festing as pathologic epithelial-to-mesenchymal transition (EMT).
Recent data suggests cryptic fragments of extracellular matrix (ECM)
can moderate the activation state of macrophages and alter EMT gene
expression and mitigate downstream fibrosis. The aim of the present
study was to determine the effect of an ECM derived hydrogel
(ECMH) upon of innate immune cell activation and the progression
EMT. Murine bone marrow derived macrophages were cultured with
ECM hydrogel (with and without polarizing cytokines) and phenotype
was assessed by flow cytometry. Epithelial cells were cultured on
ECMH substrates and EMT was induced by addition of transforming
growth factor beta (TGFb). The effect of ECM on EMT was assessed
by matrix metalloproteinase (MMP) activity, gene expression, and
immunolabeling. Macrophages treated with ECMH had a diminished
pro-inflammatory response without changing expression of anti-
inflammatory markers. Epithelial cells grown on ECMH had reduced
activity of MMPs alongside altered EMT gene expression. Despite
challenge with TGFb, the cells retained expression of epithelial pro-
teins when grown on ECM hydrogels. Results suggest that ECMH
represents a potential therapeutic for pathologic fibrosis as it contains
components that can suppress both inflammation and EMT.
574
Biomimetic Matrices for Enhanced Stem Cell-Mediated
Osteogenesis
M. S. Carvalho1, A. A. Poundarik1, J. M. Cabral2, C. L. da Silva2,
D. Vashishth1;
1Center for Biotechnology and Interdisciplinary Studies, Department
of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy,
NY, 2Department of Bioengineering and iBB – Institute of
Bioengineering and Biosciences, Instituto Superior Te´cnico,
Universidade de Lisboa, Lisbon, PORTUGAL.
New promising solutions for bone tissue reconstruction have been
developed in the last years due to the dramatically increase of the number
of bone-relatedmedical conditions that require clinical interventions. The
biological process of bone regeneration is very complex and is influenced
by multiple factors that regulate osteogenesis, angiogenesis and tissue
remodeling. New technologies that accelerate bone healing response
without compromising the quality of new bone tissue would be useful
tools for clinical applications. Bone non-collagenous proteins, such as
osteocalcin (OC) and osteopontin (OPN) have been implicated in a va-
riety of roles, such as cell attachment to extracellular matrix, osseointe-
gration at the biomaterial/tissue interface and bone toughness. Here, we
investigate the effect of biomimetic OC/OPN-enhanced collagen matri-
ces on human mesenchymal stem/stromal cells (MSC) proliferation,
osteogenic differentiation, angiogenic properties and in vivo bone re-
generation. Our OC/OPN-enhanced collagen matrices demonstrate ac-
celerated, increased and sustained bone formation response, producing
mineralized tissue similar to bone. Additional in vivo studies in a critical
sized-defect rabbit long-bone model reveals bone formation with active
tissue remodeling. Our work shows, for the first time, that selected non-
collagenous proteins can be used in concert with type I collagen matrix,
to create a novel biomimetic matrix for enhanced cellular activity and
bone formation. These findings open avenues for the use of bone non-
collagenous proteins as an alternative to other biomolecules, promoting a
paradigm shift in the design of regenerative scaffolds.
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Bio-molecular Characterization of Common Organs being
used as Tissue Scaffolds
R. C. Hill1,2,3, M. Dzieciatkowska1,3, A. S. Barrett1, K. C. Hansen1,2;
1Biochemistry and Molecular Genetics, University of Colorado-
Denver, Aurora, CO, 2Omix Technologies, Inc., Aurora, CO,
3Biological Mass Spectrometry Facility, University of Colorado-
Denver, Aurora, CO.
Introduction and Objectives: Extracellular Matrix (ECM) rich,
biologically derived scaffolds are quickly proving more efficacious
than their synthetic substitutes in the clinic. Despite the ECM lending
known phenotypic heterogeneity when tissue sourcing is varied,
bioanalytical methods aimed at teasing apart this compositional di-
versity are lacking. To fill this gap in knowledge, we aim to provide a
method to quantify and characterize ECM proteins, Glycosami-
noglycans, and cross-links in organs in order to enhance our under-
standing of tissue engineered bioscaffolds.
Methods: Tissues representing a unique and diverse array of
ECM abundance, composition, and biomechanical properties where
chosen for characterization by a novel collection of mass spec-
trometry techniques, including (1) quantitative proteomics utilizing a
stable isotope labeled polypeptide library for absolute quantitation of
ECM proteins, (2) determination of glycan composition, and (3)
quantitation and characterization of in vivo derived cross-links.
Results and Discussion: To extend the general utility of these
methods, we determined the unique bio-molecular composition of the
ECM within five tissues by (1) quantifying 216 ECM-targeted and cel-
lular proteins, (2) characterizing the glycan composition, and (3) quan-
tifying cross-linking across tissues with varied biomechanical stiffness.
Conclusion: The approaches developed here allows for unprec-
edented bio-molecular characterization of the ECM and can serve as
a catalyst to drive tissue engineering efforts towards the clinic. In
addition, these analytical methods can be used to monitor product
heterogeneity and establish relationships between clinical outcomes
and molecular composition of a scaffold.
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Systematic Review and Meta-Analysis: Efficacy of Volumetric
Muscle Loss Treatments in Animal Models
C. McGann1, J. K. Frankum1, S. M. Greising2, B. T. Corona2,
G. L. Warren1;
1Physical Therapy, Georgia State University, Atlanta, GA,
2Extremity Trauma and Regenerative Medicine, United States Army
Institute of Surgical Research, Fort Sam Houston, TX.
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Background: Volumetric muscle loss (VML) injuries present a
complex clinical problem resulting in chronic loss of muscle tissue
and strength. Our objective was to perform a systematic review and
meta-analysis of the research examining the effectiveness of various
approaches for treating VML injury.
Methods: Our primary question was to investigate if ‘‘In humans
and/or animals with VML injury, is treatment better than no treat-
ment at recovering function’’. In total, we identified 2,230 relevant
publications and 2,196 were excluded based on the review of title/
abstract or full text for not meeting the inclusion criteria.
Results: The overall effect size (ES) was calculated to be 0.78
(95% CI = 0.55-1.00; p < 0.00000001), indicating that the treatments
employed in the 34 studies, on average, resulted in a significant
improvement in function. This overall ES equates to*15% smaller
strength deficit for treated VML compared to untreated (i.e.,
-37 – 1% vs. -44 – 1%). Between-study ES variance was low (Q-
df= 2.8; p = 0.34; I2 = 7.5%) and none of the moderator variables
analyzed (e.g., subject sex, age, and species, thickness and location of
VML injury, treatment type, and study design) explained a signifi-
cant portion of the ES variance among studies.
Conclusion: Overall, our findings indicate that various biomate-
rial, cellular, and rehabilitative treatments applied at the time of
injury in animal models improve muscle function over leaving the
VML injury untreated.
Musculoskeletal
577
Ovine Satellite Cell Inhomogeneity in the Fabrication
of Tissue-Engineered Skeletal Muscle Units
B. L. Rodriguez1, R. E. Armstrong2, M. H. Nguyen2, L. M. Larkin1;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Molecular and Integrative Physiology, University of Michigan, Ann
Arbor, MI.
Volumetric muscle loss (VML) is defined as a loss of skeletal
muscle that overwhelms the body’s innate regenerative capacity and
results in sustained impairment of function. Our work to date has
involved the use of satellite cell populations derived from ovine hin-
dlimb muscle to fabricate tissue-engineered skeletal muscle units
(SMUs) to treat hindlimb VML. However, many studies have shown
that satellite cell populations derived from different muscle sources are
heterogeneous and exhibit differences in regenerative capacity, satel-
lite cell density, and gene expression. Thus, when designing a treat-
ment for craniofacial VML, the optimal starting satellite cell
populationmay not be hindlimbmuscle.We hypothesized that satellite
cell heterogeneity would be reflected in the properties of the resultant
SMUs. Thus, we assessed the development, structure, and function of
SMUs derived from four muscle sources, including two hindlimb
muscles (i.e. soleus and semimembranosus) and two craniofacial
muscles (i.e. zygomaticus major and masseter). Immunostaining for
MyoD coupled with a BrdU assay was used to evaluate myogenic
proliferation of cells 4 days after seeding. Differentiation of myoblasts
was measured with immunostaining monolayers for myogenin on day
6. Following 3D construct formation, tetanic force production was
measured to evaluate functionality. While the masseter group had
significantly fewermyogenin-positive cells/mm2 than the othermuscle
groups on day 6, there were no significant differences in force pro-
duction between groups. Overall, we have demonstrated that it is im-
portant to consider the satellite cell source when fabricating tissue-
engineered skeletal muscle constructs for varied clinical applications.
Supported by:NIH/NIAMS-1R01AR067744-01, 3R01AR067744-
02W1.
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Characterization of Biochemically Induced Rabbit OA Model
J. Park1, H. Kim2, E. Woo1, E. Lee2, D. Oh1;
1Biomedical Engineering, Kyung Hee University, Seoul, KOREA,
REPUBLIC OF, 2Impedance Imaging Research Center, Kyung Hee
University, Seoul, KOREA, REPUBLIC OF.
Biochemical induction of OA using collagenase II has several
advantageous points in a sense that it does not involve surgery to
induce model and the extent of induced cartilage degeneration is
almost uniform. However, concerns still existed for biochemical OA
model, because they induce abrupt destruction of cartilage tissues
biochemically in a short period of time and this might accompany
systemic acute inflammatory response, which is rather a trait of RA
(rheumatoid arthritis) than being a trait of OA disease. Therefore,
instability-induced OA model is widely used than biochemically
induced model. In this study, symptoms exhibited by biochemically
induced rabbit OA model was investigated to verify if they truly
represent OA disease state. Our results showed that cartilages were
rapidly degenerated during short period of time, and they did not
accompanied with RA-like process based on the fact that the carti-
lage tissues on non-induced side remained intact. Also there were no
significant change in CBC (complete blood count) profile showing a
characteristics of OA disease. These study shows that biochemically
induced of cartilage degeneration truly represent reliable and uni-
form OA state.
References:
1. Kikuchi T, Sakuta T, Yamaguchi T. Intra-articular injection of
collagenase induces experimental osteoarthritis in mature rabbits.
Osteoarthritis & Cartilage 6, 177, 1998.
2. Sun MMG, Beier F, Pest MA. Recent developments in
emerging therapeutic targets of osteoarthritis. Curr Opin Rheumatol
29, 96, 2016.
Acknowledgment: This research was supported by National
Research Foundation of Korea (NRF-2015R1D1A1A01059702 and
NRF-2015R1A2A2A04006172).
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N-acetylcysteine Reduces Fibrosis and Improve Both Muscle
Regeneration and Function in Compression Induced Injury
B. Yoseph;
Surgery, Wake Forest Institute for Regenerative Medicine, Winston-
Salem, NC.
Skeletal muscle regeneration from severe injuries is dependent on
the ability of satellite cells to survive, proliferate, and differentiate
within the resultant damaged and toxic microenvironment of the
injured tissue. Inability of the tissue to regenerate efficiently may
result in fibrotic lesions, scar formation and subsequently decreased
functional recovery. The full impact of the injuredmicroenvironment
on the balance between healthy muscle regeneration and pathologic
fibrosis is not completely known. For example, the inflammatory
response and wound repair pathways may be differentially regulated
at the site of injury, which will affect extracellular matrix protein
synthesis, neovascularization, and antioxidant activity. Historically,
antioxidants have been used as a treatment for severe pathologic
fibrotic diseases such as idiopathic pulmonary fibrosis because when
added to standard theraphy they preserve lung capacity. Here, we
show that treatment with the antioxidant N-acetylcysteine (NAC),
decreased fibrosis and enhanced muscle regeneration and functional
recovery in a model of compression injury of skeletal muscle in rats.
This data suggests that NAC treatment post skeletal muscle injuries
may be a viable option for the prevention of long-term fibrosis, scar
formation and muscle dysfunction.
580
Extracellular Matrix Formation and Meniscal Phenotype
in Co-cultures Of Meniscal Cells and Peripheral Blood-derived
Mesenchymal Stem Cells
W. FU, J. LI;
Department of Orthopedics, West China Hospital, Sichuan
University, Chengdu, CHINA.
To establish 2D and 3D co-culture systems of MFC and peripheral
blood MSC and test the effects of cell ratios on matrix formation and
meniscal phenotype. MSC and MFC were co-cultured in various
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ratios. Conventional 2D monolayers and 3D micromass pellet co-
cultures were prepared. Cell morphology was analyzed by confocal
microscopy. The phenotype of meniscal cells was analyzed based on
matrix production were assessed based on deposition of glycosami-
noglycans (GAG). In 2D monolayer cultures, adding MSC to MFC
cultures maintained theMFC phenotype, based on expression of type
I and III collagens, and it increased their matrix formation, based on
GAG deposition. Mixing the cells in equal parts (50:50) led to the
highest expression of type I and III collagen; levels of sulphated
GAG did not vary significantly with co-culture ratio. In 3D micro-
mass pellet cultures, adding MSC to MFC monocultures reduced
pellet size and GAG production: matrix formation positively corre-
lated with the proportion of MFC in the co-culture. Adding MSC
cells to MFC also changed the pattern of collagen expression. Co-
cultures expressed lower levels of type II and III collagen than did
MFC monocultures, though all co-cultures expressed these collagen
types at much higher levels than type I. Only MSC monocultures
expressed type X collagen. In 2D co-cultures, mixing the cells in a
50:50 ratio optimizes the meniscal phenotype and leads to good
matrix formation. In 3D co-cultures, matrix production positively
correlates with the proportion of MFC.
Neuronal Tissue
581
Novel Nerve Conduits with Wall-Encapsulated Cells Improve
Peripheral Nerve Regeneration
A. X. Sun, P. G. Alexander, R. M. Brick, T. A. Prest, H. Shen,
M. DeHart, B. N. Brown, R. S. Tuan;
University of Pittsburgh, Pittsburgh, PA.
Engineered nerve conduits have the potential to aid peripheral
nerve regeneration across functionally debilitating segmental de-
fects. Although incorporation of cells secreting neurotrophic factors
within these designs should confer additional beneficial effects, cell
delivery lacks control, generally limited to injection into the conduit
lumen or surface adsorption after fabrication. We report here a
single-step method to encapsulate cells into the walls of a nanofiber
conduit during fabrication through the use of a composite metha-
crylated gelatin/polycaprolactone scaffold, allowing for strict control
of cell number and spatial distribution away from the lumen. The
resulting structure is flexible, and mechanical testing verifies excel-
lent suture retention strength for implantation. Immunofluorescence
staining in vitro shows that the encapsulated cells respond to the
nanofiber topography with concentric distribution of cells visualized
within the conduit walls. Enhancement of neurite extension, up to
twice the length of controls, was seen in chick embryonic dorsal root
ganglia cultured on these constructs. In vivo implantation of this
novel conduit into a 1 cm sciatic nerve gap in rats confirms this effect
displaying complete bridging of the gap at 6 weeks, with strong S100
Schwann cell staining throughout the regenerated nerve and into the
distal nerve stump, in contrast to the highly limited S100 staining in
the distal portion observed in the acellular control. Given these re-
sults, this new conduit fabrication strategy presents a promising new
avenue in the nerve conduit arsenal to study and maximize the po-
tential of cell application in peripheral nerve repair.
Support: Dept Defense W81XWH-15-1-0600, NIH T32
EB001026.
Production Assistance for Cellular Therapies
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Development Of The Tonsil-derived Mesenchymal Stem
Cell-therapeutics For Hypoparathyroidism Treatment Using
Fibrin Sealant As Injectable Scaffold
S. Jung, H. Kim, H. Kim;
School of Medicine, Ewha Womans University, Seoul, KOREA,
REPUBLIC OF.
The incidence of hypoparathyroidism has been increasing along
with the increasing thyroid surgery. The conventional treatment was
oral calcium administration with vitamin D, however, this treatment
could not mimic the physiologic effect of the native parathyroid
hormone(PTH). We previously reported the possibility of cell ther-
apeutics which was differentiated from the tonsil-derived mesen-
chymal stem cell (TMSC). For stable hormone release, the ideal
scaffold material which facilitates cellular engraftment is mandatory.
The fibrin sealant has got FDA approval and widely used. The pur-
pose of this study was to development the cell therapeutics and to
evaluate its’ feasiblility. As in vitro study, cell viablility test was
performed. As in vivo study, 50 Spraque-Dawley rats was divided
into four groups (2 experimental group and sham group and fibrin-
sealant only injected group). After parathyroidectomy, 106 Cells
were administrated with fibrin sealant at dorsum by subdermal in-
jection in experimental group. Intact PTH, calcium, and phophrous
was measured by venous sampling. The TMSC and fibrin sealant has
feature as gel after injection in vitro. The cell survived more than 4
weeks in vitro. Serum PTH level decreased to non-detectable level as
postoperative 3 days and began to restore at 21 postoperative day.
Immunofluorescence microscopy revealed that PTH and CHGA
positive cells were remained in Cell therapeutic injected area.
TMSC-derived hypoparathyroidism cell therapeutics demonstrated
its validity in PTH level restoration.
Regenerative Medicine Transplantation
583
Tooth Pulp Stem Cells: Treatment of NASH
or Cirrhosis in Swine
K. Yaegaki, H. Ishikawa, 1028159;
Nippon Dental University, Nippon Dental University,
Chiyodaku, JAPAN.
Liver cirrhosis or Nash was by transplantation of hepatocyte-like-
cells derived from human exfoliated deciduous tooth (SHED) stem
cells. SHED was separated by magnetic sorting with CD117 anti-
body. For hepatic differentiation, CD117 + SHED were grown in
DMEM supplemented with insulin-transferrin-selenium-x (ITS-x),
embryo-tropic-factors(ETF) and hepatocyte-growth-factor (HGF)
for 5days: IMDM supplemented with ITS-x, ETF, HGF, dexameth-
asone and oncostatin for another 11 days. Nude rats or Swine were
employed for this study. Carbon tetrachloride (CCl4) or specific meal
was administrated for certain period. Hepatocyte-like-cells (2· 106
cells/animal) were transplanted into the spleen. The vehicle was in-
jected to the positive control group. Non-cirrhosis-models were used
as negative control group. Animals were sacrificed 4 weeks after the
transplantation. Immunocytochemistry observation of the hepati-
cally differentiated cells strongly demonstrated positive staining for
albumin, IGF-1, a-feto-protein, HNF4a and CPS-1. The histopath-
ological analysis, HE and Masson’s trichrome staining, indicated a
significant decrease of fibrous tissue in the transplantation group with
comparing to the positive control group. Healthy liver tissues were
recovered by the transplantation. Moreover, serological test results
revealed signif icance differences between the groups. Serum ALT
levels of the test group dramatically decreased to one third com-
pared to the positive control group. Activities of albumin, bilirubin,
BUN, HA levels were also recovered. The xenotransplantation of
hepatocyte-like cells from human tooth transplanted into the liver
with severe failure demonstrated their capacity to preform posi-
tively because of drastic decreasing fibrous tissues. Together,
hepatocyte-like cells derived from SHED are a potential source for
treating chronic liver injuries such as cirrhosis.
584
ecm Hydrogel Injection For The Treatment Of Stroke
H. Ghuman, M. Gerwig, F. Nicholls, J. Liu, J. Donnelly,
B. Wahlberg, S. Badylak, M. Modo;
University of Pittsburgh, Pittsburgh, PA.
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Stroke is the leading cause of adult disability and a significant
effort is underway to develop therapies to repair the damaged tissue.
Biomaterials composed of mammalian ECM promote constructive
tissue remodeling with minimal scar formation in peripheral tissue
and organs. The biodegradation and functional effect of injecting a
large volume of a 8mg/mL ECM hydrogel into the brain are un-
known. We aimed to determine if biodegradation occurs and if ECM
remodeling will affect the behavioral deficits of animals with stroke
damage. Two weeks post-stroke, Magnetic Resonance Imaging-
defined lesion volume equivalents of ECM was injected into the
lesion cavity of stroke rats. A battery of behavioral tests were per-
formed at pre-treatment, 1, 4, and 12 weeks post-treatment for con-
trol, untreated and ECM-treated groups. Retention, gelation, and
biodegradation of the ECM, as well as host cell invasion and phe-
notype were analyzed at 12 weeks post-injection using immunohis-
tochemistry. Behavioral tests indicated a functional impairment that
was not affected by the injection of a large volume of ECM into the
cavity. ECM showed a robust gelation and retention in the lesion
cavity with a 30% decrease in volume over 12 weeks. A significant
host cell invasion into the ECM hydrogel was seen within the hy-
drogel. ECM hydrogel therefore can be readily injected and retained
within the lesion cavity, while promoting an acute endogenous repair
response, without deleterious effects.
585
Osseointegration with PEKK 3D Technology TETRAfuse
in an Ovine bony defect model
R. Zhukauskas1, S. Horvath2, A. Zhukauskas1;
1R&D, RTI Surgical, Alachua, FL, 2RTI Surgical, Alachua, FL.
Introduction: High performance thermoplastics becoming key
biomaterials for load bearing implants in spine and reconstructive
surgery. A comparative evaluation of osseointegration with smooth
PEEK, titanium-coated rough PEEK and PEKK 3D Technology
(TETRAfuse) was performed in an ovine bony defect model. The
hypothesis was that surface topography influences bone apposition
and implant interlock.
Methods: Total of 36 cylinder shaped implants were randomly
placed into distal femora of six sheep bilaterally for 8 and 16 weeks.
Micro CT, SEM, histology and biomechanics were performed.
Periprosthetic Bone Area (% PBA) and Appositional Bone Index
(ABI) were quantified by accredited pathologist. Peak force (N) was
obtained from push-out test. Statistical analysis was performed using
Tukey, One-way ANOVA.
Results: Microscopy demonstrated new viable bone surrounding
all implants. Periprosthetic bone area increased by 8 weeks and
stabilized thereafter. Bone apposition significantly increased to 3D
PEKK and ti-coated PEEK but decreased to smooth PEEK implants
by 8 weeks. Excellent osseointegration was achieved with 3D PEKK
and ti-coated PEEK implants. Smooth PEEK showed ‘‘spot weld-
ing’’ osseointegration with limited mechanical interlock due to in-
terposing fibrosis. 3D surface allowed for progressive bone ingrowth.
Average push-out peak force (N) significantly increased in 3D
printed and ti-coated groups by 8 weeks (Tukey, One-way ANOVA),
when smooth PEEK showed no overtime increase.
Conclusions: Both, TETRAfuse Technology and rough titanium
coating provides biomechanical advantage of early and persistent
implant stabilization in the cancellous bone. The histological and
biomechanical results demonstrated that material properties and
surface topography determine push-out strength and bone growth
potential.
Regenerative Pharmacology
586
Injectable Hydrogel For osteogenic differentiation Human
Periodontal Ligament Stem Cells
S. Park, H. Lee, M. Kim;
Ajou University, Suwon, KOREA, REPUBLIC OF.
We prepared a covalently bone morphogenetic protein-2 (BMP2)-
immobilized hydrogel that is suitable for osteogenic differentiation
of human periodontal ligament stem cells (hPLSCs). BMP2 cova-
lently immobilized on an inectable hydrogel (MC-BMP2) was pre-
pared quantitatively by a simple biorthogonal reaction between
alkyne groups on BMP2-OpgY and azide groups on MC-N3. In vivo
osteogenic differentiation of hPLSCs in the MC-BMP2 formulation
was confirmed by histological staining and gene expression analyses.
Histological staining of hPLSC-loaded MC-BMP2 implants showed
evidence of mineralized calcium deposits, whereas hPLSC-loaded
MC-Cl or BMP2-OpgY mixed with MC-Cl, implants showed no
mineral deposits. Additionally, MC-BMP2 induced higher levels of
osteogenic gene expression in hPLSCs than in other groups. In
conclusion, the injectable in situ-forming MC-BMP2 hydrogel in-
vestigated here may be used for noninvasive administration of
therapies for debilitating orthopedic conditions.
587
A 3D Printed Bioreactor with Electrospun Scaffold
as a Millifluidic Renal Tubule Model
T. P. Burton1, A. Callanan2;
1Institute for Bioengineering, University of Edinburgh, Edinburgh,
UNITED KINGDOM, 2Institute for Bioengineering, Institute for
Bioengineering, University of Edinburgh, Edinburgh, UNITED
KINGDOM.
Chronic kidney disease is a major global health problem effecting
millions of people, kidney tissue engineering provides an opportunity
to better understand this disease and has the capacity to provide a cure.
Two-dimensional cell culture and decellularised tissue have been the
main focus of this research thus far with promising results 1,2; although,
these methods are not without their shortcomings. We have de-
signed a dual flow bioreactor to be used with electrospun scaffold,
delivering an even shear stress across the surface. Experiments show
that as a result of stokes flow, 2 different media types can be used
without mixing allowing for the co-culture of cell. Adjustment on
the head of the head height of the media reservoir allows for dif-
ferent flow rates to be used in each chamber, allowing for different
shear stresses to be delivered to either side. The bioreactor main-
tained a co-culture of endothelial and epithelial cells, and demon-
strated the influence of fluid induced shear stress. This bioreactor is
an excellent tool as a model of kidney tubules, but has applications
in any area where a dual environment with a controlled shear stress
is needed.
References:
1. Song, J. J. et al. Regeneration and experimental orthotopic
transplantation of a bioengineered kidney. Nat. Med. 19, 646-51
(2013).
2. Takasato, M. et al. Kidney organoids from human iPS cells
contain multiple lineages and model human nephrogenesis. Nature
526, 564-568 (2015).
588
Investigations into Potential Mechanisms of Action
of A Cell-based Treatment for Severe Alcoholic Hepatitis
L. K. Landeen, P. W. Bedard, J. Lapetoda, S. Lin, J. Dammanahalli,
S. L. Riley, R. Ashley;
Research and Development, Vital Therapies, Inc., San Diego, CA.
Only liver transplant extends long-term survival for severe alco-
holic hepatitis (sAH), characterized by decompensated hepatic
function from chronic steatosis, inflammation, oxidative stress, and
cholestasis. The ELAD System is an investigational (phase 3) cell-
based liver treatment using VTL C3A cells, with ancillary delivery
device components, to treat sAH. Numerous studies involving pro-
teomics, metabolomics, gene expression, and in vitro signaling were
completed, elucidating several hypothesizedmechanisms of action in
which C3A cell-secreted factors could provide benefit to this target
population. The C3A cell secretome contains numerous proteins
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associated with immune modulation, regeneration, oxidative stress,
angiogenesis, transport function, hemostasis, and homeostasis. C3A
cells increase expression of anti-inflammatory IL1-receptor antago-
nist (IL-1Ra) in response to pro-inflammatory cytokines, and IL-1Ra
is significantly higher in ELAD-treated vs. control subject plasma.
Amphiregulin activates the EGF receptor, soluble Fas blocks Fas-
mediated apoptosis, and glutathione helps reduce reactive oxygen
species (ROS), all to promote survival in hepatocytes. VEGF and
other unidentified factors protect endothelial cells by blocking LPS-
induced apoptosis and H2O2-or ethanol-induced ROS. Our research
shows that C3A cells produce energy-rich molecules (e.g. creatine
phosphate), consume fatty acids through beta-oxidation, and detoxify
through a dynamic cytochrome P450 enzyme system. Subjects on the
ELAD System have reduced levels of bilirubin, decreased levels of
primary bile acids and increased levels of secondary conjugated bile
acids. Further, C3A cells secrete transport proteins such as albumin,
lipoproteins, and transferrin. Cell-based treatments offer advantages
over monotherapies due to their ability to target multiple cell types
through multiple mechanisms and dynamically respond to their en-
vironment.
Respiratory, Urologic and Gastrointestinal
589
Personalized Models of Distal Airway Epithelial-Stromal
Unit in COPD
S. B. Mahjour;
Medicine, Weill Cornell Medical College, New York, NY.
Background and Objectives: Distal airways (diameter <2mm)
represent the primary site of pathologic changes in chronic ob-
structive pulmonary disease (COPD), the 3rd leading cause of death
in the U.S. Although clinical and pathological characteristics of
COPD are well known, no effective disease-modifying therapies for
targeting distal airway remodeling are currently available, largely
due to heterogeneity of pathologic phenotypes and absence of re-
producible models of human distal airways. The objective of this
study is to establish patient-derived ‘‘personalized’’ organotypic
models of human distal airways, by co-culturing epithelial basal stem
cells (BSC), autologous fibroblasts, endothelial cells isolated from
the same distal lung region of subjects with and without COPD, into
functional, organ-level tissue.
Methods and Results: A protocol was established to isolate-
propagate epithelial basal stem cells, fibroblasts and endothelial cells
from the distal airways of normal and COPD lung donors. Hetero-
geneous cellular and molecular phenotypes in the human distal air-
ways were characterized using immunofluorescence and single cell
RNA sequencing. Patient-specific distal units were reconstructed by
co-culturing BSC and autologous stromal cells using an air-liquid
interface-based airway wall model and a bronchosphere-based 3D
distal airway organoid assay.
Conclusion: Isolated epithelial and stromal cells from distal air-
ways of subjects with and without COPD can be assembled into
functional, organ-level tissue which mimics the architecture of hu-
man distal airways and, in patients with COPD, reproduces several
distal airway remodeling phenotypes. Patient-specific models of
distal airway epithelial-stromal cross-talk established in this study
can be used to identify candidate pathways that mediate disease-
relevant airway remodeling.
590
In vitro Generation of Mouse Colon Crypts
Y. Wang1, D. Gunasekara1, P. Attayek2, M. Reed1, M. DiSalvo2,
D. Nguyen1, J. Dutton2, J. Huling2, M. Lebhar1, S. Bultman3,
C. Sims2, S. Magness2, N. Allbritton2;
1Chemistry, University of North Carolina, Chapel Hill, Raleigh, NC,
2Biomedical Engineering, University of North Carolina, Chapel Hill,
Raleigh, NC, 3Genetics, University of North Carolina, Chapel Hill,
Raleigh, NC.
The lumen of the colon is made up of densely packed invaginated
structures called crypts with a distinct basal-luminal cell organization.
Appropriate maintenance and function of the colonic epithelium plays a
role in a host of medical issues including cancer, drug absorption and
bacterial infections. Unfortunately, primary colon stem cells do not
grow under standard cell culture conditions, making research into these
issues difficult. Recently, 3D organoid culture of colon stem cells has
been shown to produce structures with a crypt-like organization, but
organoids offer limited luminal access for in vitro study. Our lab has
developed a novel platform for the culture of mouse colon crypts in a
way that mimics normal physiology. Molded hydrogels provide the
matrix cues and mechanical properties necessary to form an epithelial
layer in the distinct crypt pattern seen in the mouse colon. Optimized
chemical gradients across the basal-luminal axis maintain stem cells at
the base of the crypts and a layer of continually repopulated differen-
tiated cells at the lumen. This system offers the unique opportunity to
observe the differentiation process of colon stem cells as well as study
the effects of various perturbations to normal physiologic conditions.
Skin & Wound Healing
591
Effective Cutaneous Gene Delivery through Dissolvable
Microneedle Mediated Intradermal Delivery
of Adeno-Associated Viral Vectors
D. S. Ackerman1, G. D. Falo2, D. Ozdoganlar2, E. P. Yalcintas3,
C. Tuzmen1, M. Naganbabu4, G. Erdos5, E. Korkmaz5,
L. D. Falo, Jr.5, J. W. Jarvik1, P. G. Campbell3,
M. P. Bruchez1, O. B. Ozdoganlar6;
1Department of Biological Sciences, Carnegie Mellon University,
Pittsburgh, PA, 2North Allegheny Senior High School, Wexford,
PA, 3Department of Biomedical Engineering, Carnegie Mellon
University, Pittsburgh, PA, 4Department of Chemistry, Carnegie
Mellon University, Pittsburgh, PA, 5Department of Dermatology,
University of Pittsburgh, Pittsburgh, PA, 6Department of Mechanical
Engineering, Carnegie Mellon University, Pittsburgh, PA.
Cutaneous gene delivery has emerged for treatment and prevention of
a broad range of diseases. Virus-mediated gene transfer has proven to be
a more efficient and long-lasting alternative to non-viral gene expres-
sion. Specifically, adeno-associated virus (AAV) has gained much re-
cent attention due to its low immunogenicity and long-term expression.
However, the full potential of AAV-based cutaneous gene delivery has
not been achieved due to (a) limitations in clinical deployment strategies
beyond parenteral injections and (b) a knowledge gap in the ability of
different AAV serotypes to transduce skin cells. Therefore, it is neces-
sary to identify effective AAV serotypes for cutaneous gene delivery
and to provide more effective means for enabling reproducible and
efficient delivery of these vectors to patients. To this end, we first in-
vestigated the transduction efficiencies of six commonly-used AAV
serotypes in in vitro cultured murine skin cells and identified that AAV
serotypes AAV6 and AAV2 result in the highest transduction efficien-
cies in keratinocytes and fibroblasts, respectively. Next, we evaluated
the use of dissolvable microneedle arrays (MNAs) for effective intra-
dermal delivery of those AAV vectors to the skin. MNAs that incor-
porate the AAVs were created from a biodissolvable material
combination Carboxymethylcellulose/Trehalose. Results demonstrate
that MNA-embedded AAVs retained their infectivity. MNAs also ef-
fectively delivered 85% of their content to living human skin within 20
minutes. Importantly, MNA-delivered AAV effectively transduced
murine skin cells in vivo, driving robust fluorescent protein expression at
localized application sites. The findings presented here could signifi-
cantly increase our ability to conduct reliable cutaneous gene therapy.
592
Manufacturing Tissue Based On Mechanical Properties
Its Native State
K. L. Basinger;
Edward P. Fitts Industrial and Systems Engineering, North Carolina
State University, Raleigh, NC.
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Translation of regenerative medicine research from the bench to
the patient is slow-moving as the result of factors such as federal
approval, cost, and most frequently reproducibility. In traditional
manufacturing environments, parts are comparatively measured
based on initial material properties and quality of the final product,
therefore improving reproducibility, which leads to lower costs and
approval of products. This research aims to use a novel device to
expose native biologic tissue to uniform pressure in an orbicular
manner to determine mechanical properties. The orbicular pressure
device (OPD) provides sufficient grip of tissue up to 9 psi, where
attachment sights are not the point of failure in the tissue. Therefore,
yielding true responses of the material and not capabilities of the
device. During initial testing the main response variable was surface
area and measured a 40% increase during seven days while exposed
to pressure in the OPD. However, the OPD has the ability to provide a
complete mechanical mapping of skin, the tissue of this research and
other tissue types in the future. Future experiments aim to measure
stress, strain, and modulus of elasticity, thickness, surface roughness,
tensile strength, and yield strength. These results will provide a more
complete picture of skin to aid in regenerative medicine research as it
transitions to a manufacturing like process and therefore improving
reproducibility.
593
Tissue Engineered Polyurethane/Alginate as a Novel
Wound Dressing
S. Sen1, B. P. Sinha2, T. K. Mandal, Sr2, P. Basak1;
1School of Bioscience and Engineering, Jadavpur University,
kolkata, INDIA, 2Veterinary Pharmacology and Toxicology, West
Bengal University of Animal and Fishery Science, kolkata, INDIA.
Tissue Engineered Polyurethane/Alginate as a Novel Wound
Dressing Sohini Sen 1, Bishnu P Sinha 2, Tapan K Mandal 2, Piyali
Basak 1 1School of Bioscience & Engineering, Jadavpur University,
188 Raja S.C. Mullick Road, Kolkata 700032 2 Department of
Pharmacology and Toxicology, West Bengal University of Animal
and Fishery Science, 37, Khudiram Sarani, Kolkata 700037
Introduction: Burn wound is sensitive issue worldwide. Poly-
urethane has been used as wound healing agent, due to biocompati-
bility, swell ability. Composite scaffolds were fabricated using
polyurethane, alginate, recombinant epidermal growth factor (rEGF).
Cell seeded scaffolds were evaluated for in vivo wound healing.
Materials and Methods: Isophoron diisocyanate based poly-
urethane was blended with alginate, rEGF; lyophilized to get porous
scaffold followed by FTIR, SEM characterization. HUVEC, NIH
3T3 cells were co-cultured onto scaffold. Cell proliferation was es-
timated upto 72 h by MTT assay. Cell seeded scaffolds were applied
on burn wound of Wistar rats. Gross wound healing including his-
topathological findings were recorded 3 to 15 days post wounding
with control.
Results: FTIR, SEM results confirmed its synthesis, porous
structure. In MTT assay, 96% cells were viable with exact mor-
phology on scaffold. Cell seeded scaffold showed highly satisfactory
wound healing response when applied in vivo within 14-15 days.
Discussion: Since cells seeded matrix showed abrupt healing
capacity compared to bare polyurethane/alginate, it may be con-
cluded rEGF incorporated, cell seeded scaffolds can serve as highly
promising wound healing agent.
Acknowledgment:We acknowledge CSIR, GOI for fellowship to
presenting author.
References: Konno T, Watanabe J, Ishihara K. Biomacromole-
cules 5,342, 2004.
Soft Tissue
594
Bioreactor for Joint Segmentation Model to Investigate
Toxicants/Teratogens
Y. Zhong1, J. Berilla2, M. Motavalli3, J. F. Welter3, A. I. Caplan3,
R. S. Tuan4, P. Alexander5, H. Baskaran6;
1Biomedical Engineering, Case Western Reserve University,
Cleveland, OH, 2Civil Engineering, Case Western Reserve
University, Cleveland, OH, 3Biology, Case Western Reserve
University, Cleveland, OH, 4Orthopaedic Surgery, University of
Pittsburgh, Pittsburgh, PA, 5Orthopaedic Surgery, Case Western
Reserve University, Cleveland, OH, 6Chemical and Biomolecular
Engineering, Case Western Reserve University, Cleveland, OH.
In the US, alone or a combination of genetic defects and envi-
ronmental insults cause about 3% of children born each year to have a
major structural birth defect by their sixth birthday. The most com-
mon birth defects are skeletal abnormalities. Investigating such ab-
normalities is typically carried out in an animal model. However, this
suffers from poor translation of the findings to humans. An in vitro
model of human tissue can be hugely beneficial. The goal of this
project is to develop three-dimensional organotypic culture models
to investigate limb development and its susceptibility to toxicants/
teratogens. Towards this, we are developing a biomechanical
stimulus-induced joint segmentation model in a bioreactor system.
The bioreactor system consists of a tissue holder containing micro-
scale anchors for forming a tissue under investigation in straight
channels. The three phases of limb development: cartilage devel-
opment, hypertrophy and joint formation, is modeled in the reactor
system. The first two phases are achieved by exogenous biochemical
factors, whereas the joint formation/segmentation is achieved by a
combination of chemical factors and mechanical stimulus. The me-
chanical stimulus is introduced by an actuator the subjects the tissue
to undergo flexion. In this presentation, we demonstrate the efficacy
of the mechanical stimulus to effect joint segmentation.
595
Mechanical Behavior and Failure of Polydisperse
Semi-Flexible Polymer Networks
M. Tehrani1, Z. Ghalamzan1, A. Jahadakbar2, A. Sarvestani1;
1Mechanical Engineering, Ohio University, Athens, OH, 2MIME,
Toledo University, Toledo, OH.
The classical theories for elasticity of polymer networks are built
upon the assumption of network monodispersity; That is, the network
is comprised from sub-chains of equal length. However, the cross-
linking in polymers and biopolymers is often a random process and
thus, the resultant networks are likely to be polydisperse. The effect
of structural polydispersity on mechanical behavior of polymer
networks is not well understood. The main goal of this research is to
show how network polydispersity controls the mechanical behavior
and ultimate properties of crosslinked filaments subjected to finite
deformation. We propose a continuum micromechanical model
based on the Langevin statistics of individual chains. The mechanical
strength of network is controlled by finite-extensibility of filaments.
Shorter filaments break at relatively smaller stretches. The progres-
sive failure of the filaments continues and eventually determines the
ultimate strength of the network. The predicted stress-stretch be-
haviors are in reasonable agreement with experimental data.
596
Mechanical Properties of Human Liver
R. Grant, J. Hallett, D. C. Hay, S. Forbes, A. Callanan;
University of Edinburgh, Edinburgh, UNITED KINGDOM.
Hepatocytes are known to respond to the mechanical stimuli of
their surrounding microenvironment1. Liver tissue engineering aims
to create a niche environment for the survival and function of he-
patocytes, however little is known regarding the mechanical prop-
erties of the human liver2.
A human liver was obtained approximately 12 hours post-mortem,
kindly donated by the deceased and their relatives. Tensile and
compression testing was conducted on the tissue along the X, Y and
Z axis.
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Results demonstrate that the Z-axis Young’s modulus is 2.5 times
greater than both X and Y for all strain bands represented, indicating
a spatial influence upon the mechanical characteristics of the human
liver, and thus upon the hepatocytes within. This data is of value to
the field of liver tissue engineering when considering the factors to be
addressed when designing niche microenvironments for the optimal
survival and function of hepatocytes.
References:
1. Grant, R., Hay, D. & Callanan, A. Tissue Eng. Part A 23, 650-
662 (2017).
2. Klatt, D. et al. Biorheology 47, 133-141 (2010)
Acknowledgments: This work is funded by an Engineering &
Physical Sciences Research Council [EPSRC] doctoral training
partnership studentship, UK Regenerative Medicine Platform II
[RMPII] grant MR/L022974/1 and the donors and relatives who
make this work possible.
Stem Cells
597
Regulation Of Cell Behavior By Bioactive Materials
for Tissue Engineering
J. Chang;
Biomaterials and Tissue Engineering Research Center, Shanghai
Institute of Ceramics, Chinese Academy of Sciences, Shanghai,
CHINA.
It is known that the chemical composition and nano-structure are
two critical factors of biomaterials which could affect cell behavior
and tissue regeneration. We have designed and fabricated calcium
phosphate and silicate based bioactive ceramics and composites with
different chemical composition and micro structures, and demon-
strated that the chemical signal released from the silicate based
biomaterials and microstructural environment of calcium phosphate
bioceramics stimulated stem cell behavior such as proliferation and
differentiation indicating that ‘‘tissue inducing biomaterials’’ with
certain chemical composition and surface structure may be designed
for tissue engineering applications.
598
Peripheral Nerve Regeneration Using Schwann Cells
Differentiated From Human Tonsil-derived Mscs
in a Charcot-marie-tooth Disease Mouse Model
S. Park1, N. Jung1, S. Myung1, S. Ahn Jo2, I. Jo3, S. Jung1;
1Biochemistry, School of Medicine, Seoul, KOREA, REPUBLIC
OF, 2Pharmacology, College of Pharmacy, Cheonan, KOREA,
REPUBLIC OF, 3Molecular Medicine, School of Medicine, Seoul,
KOREA, REPUBLIC OF.
The hypothesis of this study was that transplantation of Schwann
cells (SCs) into atrophic muscles in lower limbs would enable neu-
romuscular regeneration in a mouse model of hereditary peripheral
neuropathy. We investigated the potential of Schwann-like cells
differentiated from human tonsil-derived MSCs (T-MSCs) for neu-
romuscular regeneration in trembler-J (Tr-J) mice, a model of
Charcot-Marie-Tooth disease type 1A (CMT1A), which involves
hereditary motor and sensory peripheral neuropathies. T-MSCs dif-
ferentiated toward Schwann-like cell with increased expression of
Schwann cells (SCs)-related markers in vitro. In situ transplantation
of T-MSC-SCs into the caudal thigh muscle in Tr-J mice enhanced
motor function proved by a rotarod test and measurement of sciatic
function index. Morphology of the sciatic nerve and skeletal muscle
recovered without the formation of teratomas. The sciatic nerves in
the T-MSC-SCs-transplanted mice revealed regenerative morphol-
ogy in myelin sheaths and axons. Transplantation of T-MSC-SCs
could enable neuromuscular regeneration in patients with CMT1A.
Further studies such as the assessment of neurotrophic factors and
regeneration potential of neuromuscular junctions might provide
more insight into the outcomes of transplantation of T-MSC-SCs for
patients with Charcot-Marie-Tooth disease.
599
A New Molecular Target to evaluate and modify Mesenchymal
Stem cell-Chondrogenesis Towards Articular Cartilage
R. Somoza1, D. Correa2, D. Vail3, A. Khalil3, A. Caplan1;
1Biology, Case Western Reserve university, Cleveland, OH,
2Orthopaedics, University of Miami, Miami, FL, 3Genetics and
Genome Sciences, CaseWestern Reserve university, Cleveland, OH.
Mesenchymal Stem Cells (MSCs) derived cartilage significantly
differs from articular cartilage (AC). We aim to use a novel AC mo-
lecular fingerprint as a platform to evaluate and modify molecular
events during MSC chondrogenesis. We hypothesize that mechanistic
processes during chondrogenesis can be modulated by transcriptional
regulatory elements systematically selected from a robust molecular
analysis of native AC. We performed whole-genome expression
analysis on de-identified AC from young cadaveric knees, or adult
MSC cultures. AC is dissected from de-identified specimens (n= 5)
procured from consented guardians of donors. MSC cultures from de-
identified donors (n= 5) were established and differentiated as previ-
ously described1. Total RNA was prepared using standard procedures
and whole-genome expression analysis was performed using an Illu-
mina platform. MultiExperiment-Viewer was used for data analysis.
The transcriptomal profile of AC was globally distinct from MSC-
derived cartilage with over 500 genes highly expressed in AC and not
expressed during MSC chondrogenesis. Differences were minor dur-
ing initial stages (first 7 days) of chondrogenesis. This suggests that
osteochondral fate of MSC-derived cartilage may be re-routed during
earlier stages. We identified key transcription factors that could be
molecular inductors of AC. A specific molecular phenotype of high-
quality ACwas identified as a gold standard for tissue-engineered AC.
This data will be useful for the design of successful clinical application
usingMSCs and the generation of a robust read-out profile ofACnovel
markers.
Reference: 1. Correa, D. et al. Osteoarthr. Cartil. 23, 443-453
(2014).
600
Engineered Phage Matrices Facilitate Angiogenic
Differentiation Of Adipose Derived Stem Cells
K. Shrestha1, J. Kang2, S. Yoo1;
1Pusan National University, Busan, KOREA, REPUBLIC OF,
2Korea Maritime and Ocean University, Busan, KOREA,
REPUBLIC OF.
Although stem cell niche plays a vital role in stem cell differen-
tiation towards different lineages, an artificial stem cell niche
achieved so far is not successful to fulfill the complex microenvi-
ronment of the stem cell. Here, we demonstrated engineered hybrid
phage matrices that possess cell adhesive and angiogenic peptides
with a suitable scaffold by formulating polyacrylamide hydrogel
incorporating phage in different stiffness to guide adipose derived
stem cells (ASC) and could achieve higher stiffness favoring os-
teogenesis and lower stiffness favoring adipogenesis. In this study,
we present a specific phage based angiogenic matrices by modulating
physical and biochemical cues in differentiation of ASC, providing
convenient artificial stem cell niche.
601
A Phenotype-Specific Gene Circuit to Regulate Chondrocyte
Maturation
B. Wu1, S. Murali2, R. Coleman1,3;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Molecular, Cellular and Developmental Biology, University of
Michigan, Ann Arbor, MI, 3Mechanical Engineering, University of
Michigan, Ann Arbor, MI.
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Mesenchymal stem cells have great potential to be used for car-
tilage repair; however, cartilaginous tissues formed by MSCs typi-
cally have inferior mechanical properties compared to native
cartilage, as these cells tend to mature to hypertrophy in which they
stop producing and start degrading structural matrix macromole-
cules, like aggrecan and type II collagen. Preventing the maturation
of MSC-derived chondrocyte using the growth factors is often
compromised by their short half-life and conflicting effects on het-
erogeneous cell populations. To allow individual cells to resist
maturation as needed, we have developed a gene circuit containing a
tunable promoter (CXpcis) that is designed to activate exclusively in
pre-hypertrophic chondrocytes and inhibit the activity of Runx2, one
of the key drivers of hypertrophy. The Col10a1 basal promoter was
placed upstream of Runx2 short-hairpin RNA. The kinetics of Runx2-
shRNA expression was regulated with the inclusion of different copies
of cis-enhancer upstream of the basal promoter. Human and mouse
chondroprogenitors that stably express CXpcis-shRunx2 circuits or
doxycycline-inducible shRunx2 were assessed for early and late
chondrogenesis markers in monolayer and pellet cultures. The syn-
thetic Col10a1 promoter can specifically target chondrogenic cells
with tunable kinetics by varying the copies of cis-enhancer. Using the
inducible shRunx2 system, we verified that the timing of Runx2 si-
lencing significantly affects chondrogenesis, matrix accumulation, and
hypertrophy, highlighting the necessity of phenotype-specific RNAi
expression in therapeutic applications. CXpcis-shRunx2 circuits al-
lowed cells to grow into larger chondrogenic aggregates, accumulate
a higher amount of proteoglycan-rich matrix, and decrease Runx2
expression over five-week culture period in pellet culture.
602
Dynamic Migration Of Dental Pulp Stem Cell - derived
Chondrogenic Cells In Collagen Hydrogels
L. Yao, N. Flynn;
Wichita State University, Wichita, KS.
The biological approach targets therapy that preserves the interver-
tebral disc (IVD) function by regenerating the degenerated and damaged
nucleus pulposus (NP). Biomaterial hydrogels that mimic the NP ex-
tracellular matrix (ECM) can serve as stem cell carriers for cell trans-
plantation and a matrix for replacement of the degenerative NP. Stem
cells derived from dental pulp have received growing attention because
they have a similar differentiation capability as other mesenchymal stem
cells (MSCs) and they are relatively easy to obtain. Type II collagen, as a
major component of NP, has been fabricated as a hydrogel and studied
for the growth ofNP cells andMSCs. Themigration of transplanted cells
within the collagen hydrogels or NP is critical because migration allows
the cells to replace those lost in degenerated NP. In this study, we
differentiated dental pulp stem cells (DPSCs) into chondrogenic cells.
The cells were grown in type I and type II collagen hydrogels, and the
cell motility in these materials were determined by time-lapse imaging.
We found DPSC-derived chondrogenic cells migrated dynamically in
these hydrogels. Quantification of cell migration revealed the the higher
motility in type I collagen hydrogel than type II collagen hydrogel. Our
study explored the differential cell motility of DPSC-derived chondro-
genic cells in these collagen hydrogels.
We acknowledge Wichita Medical Research and Education
Foundation (WMREF), Regional Institute on Aging and National
Institute of General Medical Sciences (P20 GM103418) of the Na-
tional Institutes of Health for the support of this study.
603
In Vitro Osteogenesis of Periosteal Tissue through
Endochondral Ossification
J. Weber1,2, K. Collavino1,2, S. D. Waldman1,2;
1Ryerson University, Toronto, ON, CANADA, 2St. Michael’s
Hospital, Toronto, ON, CANADA.
Introduction: The cambium is a highly cellular layer of the
periosteum containing progenitor cells which are involved in the
process of fracture repair. Previous work has shown that in vitro
endochondral ossification can be induced from these cells, but is
limited to young animals using tissue adjacent to the growth plate. In
this study, we have explored the potential of adult-derived rib peri-
osteum, not near a corresponding growth plate, as a more clinically
relevant tissue/cell source for bone tissue engineering.
Materials and Methods: Adult rabbit rib periosteum was har-
vested (ACC 563) and 4mm · 4mm explants were cultured in
maintenance, chondrogenic, or osteogenic media for 4 weeks. Peri-
osteal cells were isolated by egression or Ficoll separation, expanded,
and then cultured in osteogenic or chondrogenic media. All cultures
were analyzed by histology.
Results: Untreated explants showed minimal presence of alkaline
phosphatase (ALP), whereas chondrogenically treated explants
showed the presence of proteoglycans and minimal ALP. Osteo-
genically treated explants showed more extensive ALP and proteo-
glycans with mineral deposits in the cambium. Isolated cells
(osteogenic or chondrogenic induced) showed no evidence of ALP or
mineralization, irrespective of isolation method.
Discussion and Conclusion: In vitro endochondral ossification of
rib periosteal explants can be promoted indicating that this site may
be a viable source for bone tissue engineering. The inability of iso-
lated cells to directly become osteogenic indicates that additional
endochondral ossification stimulation is necessary. Further work
with isolated cells will include a chondrogenic pre-culture/template
prior to osteogenic induction.
Acknowledgments: Funding provided by NSERC.
604
SaCas9 Mediated Genome Editing in Mammalian Cells
P. Javidi Parsijani1, B. Lu1, A. Atala1,2;
1Wake Forest Institute for Regenerative Medicine, Winston Salem,
NC, 2Department of Urology, Wake Forest School of Medicine,
Winston Salem, NC.
Introduction: CRISPR/CAS9 system has shown a promising
potential therapeutic application as a genome engineering tool. In
this study, we investigate CRISPR/CAS9 system to correct mutations
in HBB (hemoglobin beta subunit) gene causing Sickle cell anemia
(SCA) and IL2RG (interleukin 2 receptor subunit gamma) causing
Severe Combined Immune Deficiency (SCID-X1).
Materials and Methods: A lentiviral vector (pSin-EF2-IL2RG-
HBB-GFP) for GFP reporter cell line was made including IL2RG and
HBB. The reading frame of GFP could be restored only if Cas9
targets and cuts these genes leading to deletions or insertions. Adeno-
associated viral serotype 6 (AAV6) vectors expressing SaCaS9,
template and locus specific guide sequences were designed. We also
assessed the ability of inserting a larger fragment by adding extra
GFP to the template. We evaluated these systems in HEK293T cells,
GFP reporter cells and human Hematopoietic Stem cells (hHSCs).
Results: SaCaS9, guide and the template delivered in AAV serotype
6 could transduce HEK293T and hHSCs with 40% efficiency with
10% HR for SCA. However, HR rate decreased to 0.3% when foreign
GFP cDNA sequencewas inserted. Similarly inserting an IL2RG cDNA
into the locuswithout removing the previous gene for SCID-X1, showed
low HR efficiency (0.3%) despite an Indel rate of 30%, suggesting that
inserting a larger fragment decreases the efficiency of HR dramatically.
Conclusion: AAV6 can efficiently deliver SaCas9, guide RNA
and template into hHSCs with high rate of HR as long as the template
does not differ much in terms of size or sequence with target se-
quence in the genome.
605
Improving the Osteogenic Potential of Human Adipose Tissue-
derivedMesenchymal Stem Cells using a Cytoskeletal Modifying
Drug for Bone Tissue Repair
R. M. Samsonraj1, A. Dudakovic1, B. Sen2, A. B. Dietz1,
S. M. Cool3, J. Rubin2, A. van Wijnen1;
1Mayo Clinic, Rochester, MN, 2University of North Carolina, Chapel
Hill, NC, 3Institute of Medical Biology, Singapore, SINGAPORE.
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Strategies for tissue regeneration utilize adult mesenchymal stem/
stromal cells (MSCs) that can be obtained from bone marrow- and
lipo-aspirates. Human adipose tissue-derivedMSCs (hAMSCs) can be
harvested in large quantities required for cell-based tissue-engineering
approaches, but are generally considered to be less osteogenic than
bone marrow MSCs. Herein, we tested a new molecular strategy to
improve the osteogenic differentiation ability of hAMSCs using Cy-
tochalasin D (CytoD), a secondary metabolite derived frommolds.We
show that CytoD, which reorganizes actin cytoskeleton, is a potent
osteogenic stimulant as reflected by significant increases in alkaline
phosphatase activity, extracellular matrix mineralization and
osteoblast-related gene expression (e.g., RUNX2, ALPL, SPARC and
TGFB3). RNA sequencing (RNA-seq) analyses ofMSCs revealed that
acute CytoD treatment (24 hr) stimulates a broad program of osteo-
genic biomarkers and epigenetic regulators. CytoD decreases mRNA
and protein levels of the Polycomb chromatin regulator Enhancer of
Zeste Homolog 2 (EZH2), which controls heterochromatin formation
bymediating trimethylation of histone 3 lysine 27 (H3K27me3). These
findings conclude that CytoD is a potent osteogenic stimulant that can
be used to precondition hAMSCs to attain an osteogenic phenotype for
skeletal tissue engineering applications.
606
Regulation of Cell Reprogramming in 3D Microenvironment
Interactions
D. Kim, Y. Arai, Y. Lee, B. Choi, S. Lee;
CHA University, Seongnam-si, KOREA, REPUBLIC OF.
After the introduction of induced pluripotent stem cells (iPSCs),
various methods to reprogram the somatic cells into pluripotent state
have been investigated. Along with transducing agent and supple-
mented chemical substances to improve reprogramming, cell culture
substrates were highly explored. Recent study have been shown that
chemically defined PEG hydrogel enhances reprogramming by
promoting mesenchymal-to-epithelial transition (MET) as well as
epigenetic remodeling. However, cell/microenvironment interaction
on cell reprogramming were not clearly defined. In this study, we
look at various 3D microenvironments to find possible candidate to
improve reprogramming cells significantly, and investigate its in-
teraction that are involved with. Selected microenvironments were
used to encapsulate the reprogramed cells by photopolymerization
system, and analyzed its pluripotency, MET, and epigenetic state.
Throughout many hydrogel systems, hyaluronic acid hydrogel mi-
croenvironment highly improves reprogramming efficiency by reg-
ulating pluripotency, MET, and epigenetic plasticity. These results
show that this facile system may produce more purified repro-
grammed cells using 3D microenvironment hydrogel.
607
Cyclic Forces Induce Rapid Differentiation of human embryonic
stem cells
T. Topal1, X. Hong1, X. Xue2, Z. Fan1, J. Nguyen3, C. Deng1,
P. Krebsbach4;
1Biomedical Engineering, University of Michigan, Ann Arbor, MI,
2Mechanical Engineering, University of Michigan, Ann Arbor, MI,
3Biological and Material Sciences, University of Michigan, Ann
Arbor, MI, 4Dental School, UCLA, Los Angeles, CA.
Mechanical forces play critical roles in human embryonic stem
cell (hESC) fate decisions during development. Investigation of the
intrinsic mechanosensitivity of hESCs is limited by the difficulty in
applying spatiotemporally controlled forces to cells with subcellular
resolution. Here, we used an ultrasound technique, acoustic tweezing
cytometry (ATC), to exert cyclic forces to hESCs by acoustic actu-
ation of integrin-bound microbubbles. We found that ATC-mediated
cyclic forces applied to a subpopulation of hESCs induced global
responses in hESC colonies, including increased cellular contractile
forces, enhanced calcium activities, downregulation of the plur-
ipotency transcription factors Oct 4 and Nanog, and cytoplasmic
YAP localization, leading to initiation of rapid differentiation and
characteristic epithelial-mesenchymal transition (EMT) events that
depend on focal adhesion kinase activation, cytoskeleton tension,
and myosin II activities. These results reveal robust mechan-
oresponses of hESCs to integrin-targeted cyclic forces and efficient
orchestration of integrin and E-cadherin in EMT and differentiation.
Tissue Chips & Tissue Organoid Models
608
Advanced Self-organized Hepatic Microtissue: Liver Organoid
Development That Can Regulate Hepatic Function According To
Hepatic Progenitor Maturity And hASC Co-culture
S. Hong, S. Oh, S. Kim;
Center for Biomaterials, Korea Institute of Science and Technology,
Seoul, KOREA, REPUBLIC OF.
Liver tissue engineering has an attention in regenerative medicine
for the treatment of liver failure and in vitro model for liver toxicity
test. Classically, adherent cells have been expanded as monolayer
cultures; recently, numerous studies have discussed the advantage of
3D cell aggregates, demonstrating that 3D aggregate or spheroid
cultures can improve the differentiation. Most cells are present three-
dimensionally while in contact with the neighboring cells surrounded
by extracellular matrices in a tissue. Mesenchymal cells are directly
involved in the production of ECMs in the natural tissue. In our study,
induced hepatocytes were co-aggregated with hASCs utilizing a bio-
functional matrix for self-organizing tissue. Hepatic phenotypes of
induced hepatic progenitor in immature stage were reduced in 3D
culture compared to in 2D culture. When being co-cultured with
hASCs both in 3D and 2D cultures, the hepatic phenotypes decreased
compared to hepatocyte alone. Interestingly, these features showed
an opposite tendency to enhance hepatic function in response to
increased maturation of the induced hepatic progenitor cells. Fur-
thermore, we have found that conditioned media from hASC in 3D
and 2D cultures can also reduce or increase hepatic function in am-
bivalently depending on the maturity of miHeps. This result provides
clues that liver function of 3D co-cultured miHeps can be regulated
through secreted factors from hASC. Overall, our study provides
insights into the development of a more biologically advanced liver
organoid that can more accurately mimic the physiological charac-
teristics of real human liver tissue through regulation of maturity in
hepatocyte source and co-culture of hASC.
609
Generation and Optimization of Renal Organoids from Whole
Kidney Cells for Drug Screening
L. Chen1,2, H. Guo2;
1Urology, Tongji Hospital, Tongji Medical College, Huazhong
University of Science & Technology,Wuhan, CHINA, 2Wake Forest
Institute of Regenerative Medicine, Winston-Salem, NC.
Introduction:Kidney is the essential organ in the process of drug
metabolism. Renal organoids made from embryonic stem cells and
iPS cells have been reported before. We hypothesize such renal or-
ganoids have approximate characteristics with normal kidney so as to
have the potential applications in drug screening.
Methods: Human renal cells were isolated from unused donor
kidneys and characterized. Whole cells from kidneys were expanded
to form organoids by seeding in Hanging Drop plates. Morphology of
organoids were observed by microscopy and H.E staining. Pro-
liferation curve was generated by ATP measurement. Live/Dead
staining was applied for viability assay. Functional tests were carried
out using ELISA kits for erythropoietin produced in hypoxia con-
dition. Also, the g-Glutamyltransferase activity in normal renal or-
ganoids and drug-treated organoids were compared.
Results: Cells obtained from whole kidney could form solid or-
ganoids. Proliferation curve and Live/dead staining demonstrated
organoids grew well in vitro. In function assay, we found the renal
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organoids assembled from passage 1st kidney cells secreted EPO
protein in hypoxia condition. Additionally, aspirin and penicillin G
were used as nephrotoxic drugs to test kidney function measured by
GGT level which presented amino acid transformation.
Discussion and Conclusions: Human whole kidney cells dem-
onstrate the ability to form functional organoids which may ulti-
mately be developed into an efficient research and clinical
application for drug screening.
610
Biomimetic Cardiac Hypertrophy Model by Engineering
Continuous Beating 3D Cardiac Microtissues
M. Song1, J. Hwang2, Y. Park2;
1Biomedical Science of Brain Korea 21, College of Medicine, Korea
University, Seoul, KOREA, REPUBLIC OF, 2Department of
Biomedical Engineering, College of Medicine, Korea University,
Seoul, KOREA, REPUBLIC OF.
Cardiac hypertrophy is accompanied with a number of heart dis-
eases, including ischemic heart disease, hypertension, valve disease,
and heart failure, which are associated with high morbidity and
mortality. Cardiomyocytes in cardiac hypertrophy respond to he-
modynamic stress, decrease cardiac beating and increase in their size,
resulted in cardiac remodeling. However, underlying molecular and
cellular mechanisms are not well known yet. Recent studies reported
that injured cardiac fibroblast-derived mediators may act in autocrine
and paracrine communications between fibroblasts and cardiomyo-
cytes to induce cardiac remodeling. Here, we investigated a potential
paracrine exosome crosstalk between cardiac fibroblasts and cardi-
omyocytes. We engineered functional cardiac spheroids of human
iPS cell-derived cardiomyocytes with synchronous beating in the
heart by co-culturing human endothelial cells and human fibroblasts
at the approximate ratios of in vivo. Then, we confirmed that these
engineered continuous beating 3D cardiac microtissues could be
utilized as 3D myocardial hypertrophy model by spheroid size, gene
expression level, immunofluorescence staining and the beating rates.
These findings demonstrate that injured cardiac fibroblast secrete
exosomes as paracrine signaling mediators and affect cardiomyo-
cytes, resulted in cardiomyocyte hypertrophy. We suggest that this
biomimetic three-dimensional cardia hypertrophy system is a
promising alternative to an animal experimental model for studying
cardiac disease, as well as a drug screening system for finding ther-
apeutic targets.
611
Development of Human Pancreatic Islet Organoids from iPSCs
K. Ye, S. Jin, H. Bi;
Biomedical Engineering, Binghamton University, State University
of New York (SUNY), Binghamton, NY.
Previously, we reported the generation of islet-like cell clusters
from mouse embryonic stem cells. Building upon these successes,
we herein report the successful biofabrication of human pancreatic
islet organoids from iPSCs. While islet transplantation is promising
for diabetes treatment, it has not been available to a majority of
patients due to the scarcity of donors. The generation of islet or-
ganoids entailing mature beta cells has yet been demonstrated. In
this work, we demonstrated the feasibility of developing human
islet organoids from iPSCs. We showed that a 3D microenviron-
ment is critical to the generation of pancreatic endoderm and en-
docrine. The organoids formed consisted of pancreatic alfa, beta,
delta, and pancreatic polypeptide (PP) cells. A high level co-
expression of PDX1, NKX6.1, and NGN3 in these organoids sug-
gests the characteristics of pancreatic beta cells. More importantly,
most insulin-secreting cells in the organoids did not express glu-
cagon, somatostatin, or PP. The expression of mature beta cell
marker genes such as Pdx1, Ngn3, Insulin, MafA, and Glut2 was
detected in the orgnoids. Insulin-secretory granules, an indication
of deta cell maturity, were detected in these cells. Glucose chal-
lenging experiments suggested that the organoids are sensitive to
glucose levels due to their elevated maturity. In conclusion, we
showed the generation of islet organoids from iPSCs. The further
optimization of the process will enable the biofabrication of islets.
The fabricated islets can be used for diabetes treatment, drug
screening/toxicity validation, and pathological study.
612
In Vitro Characterization of Murine Colonic Epithelial
Stem Cells under Physiological Conditions
J. S. Dutton1, Y. Wang2, R. Kim3, D. B. Gunasekara2,
N. L. Allbritton1;
1Biomedical Engineering, University of North Carolina at Chapel
Hill, Chapel Hill, NC, 2Chemistry, University of North Carolina at
Chapel Hill, Chapel Hill, NC, 3Genetics, University of North
Carolina at Chapel Hill, Chapel Hill, NC.
As links between the gut microbiome and human health continue
to emerge, the establishment of a relevant in vitro model of the gut is
becoming increasingly urgent. To develop a simple in vitro model for
gut research, primary murine colonic epithelial cells were cultured
under conditions physiologically comparable to the in vivo envi-
ronment. These conditions included low oxygen tension and low
glucose concentration. Cells formed monolayers composed of all cell
types observed in vivo including stem cells, proliferative cells, goblet
cells, and enterocytes. After a 24 hour exposure to low oxygen and
glucose, a significant drop in proliferative activity was observed. Cell
survival in these conditions suggests that this model can be used for
the study of interactions between the gut epithelial cells and anaer-
obic bacteria. The successful in-vitro co-culture and analysis of
primary colonic cells with bacteria will represent a significant con-
tribution to gut microbiome research
613
Exploring Normal and Malignant Hematopoietic Stem/
Progenitos Cell-Niche Interactions Using a Novel Bone
Marrow-on-a-Chip Platform
J. Aleman, S. K. George, C. D. Porada, G. Almeida-Porada,
A. Skardal;
Wake Forest Institute for Regenerative Medicine,
Winston Salem, NC.
Under normal conditions, hematopoietic stem/progenitor cells
(HSPC) reside within specific bone marrow (BM) niches. These are
comprised of an array of different cell types located strategically to
provide myriad chemical signals and physical interactions that
maintain HSPC. In human myeloid malignancies, the BM niche is
remodeled by malignant cells, which displace resident HSPC, and
create self-reinforcing malignant niches that drive disease pro-
gression, chemo-resistance, and relapse. We engineered a micro-
fluidic platform, inside of which 4 individual hyaluronic acid-based
niche constructs were patterned in situ. The corresponding niches
contained BM-derived mesenchymal cells (Stro-1 +; MSC), arterial
endothelium (CD146 +NG2 +; AEC), and sinusoidal endothelium
(CD146 +NG2-; SEC). A fraction of the Stro-1 + cells were in-
duced to undergo osteogenic differentiation, to generate osteoblasts
(OB) for the fourth niche. U937 (lymphoma), MOLM13 (leuke-
mia), and normal CD34+ cells were fluorescently tagged and in-
dependently perfused into the system. At day five post infusion,
immunocytochemistry demonstrated the continued expression of
appropriate phenotypic markers by each respective niche. U937
cells exhibited a marked predilection for AEC over the other ni-
ches, and normal CD34+ cells engrafted preferentially within the
SEC and OB niches. Our studies establish the feasibility of re-
creating and testing various BM microenvironments-on-a-chip,
derived from the same donor, and demonstrate that this novel
system can be used to study preferential interactions of normal and
malignant HSPC with distinct niches.
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614
A Complex Model for Studying Human Vascular Disease
in a High-Throughput Microfluidic Platform
N. Raustad1, M. Rogers1, A. Gard1, M. Lech2, P. Keegan1,
C. Williams1;
1Draper, Cambridge, MA, 2Pfizer, Cambridge, MA.
Introduction: Current drug discovery pipelines rely heavily on
simple in vitro cell cultures that fail to recapitulate the complexity of
human tissue. This project aims to develop a complex model of
human vascular biology that incorporates multiple cell types, ex-
tracellular matrix (ECM), and fluid shear stress in a novel, high-
throughput microphysiological system (MPS). Although applicable
across multiple diseases, here we focus on modeling perivascular
fibrosis, a significant healthcare burden for which no FDA-approved
drugs currently exist.
Materials and Methods: Human ECs were co-cultured in Dra-
per’s bilayer MPS with multiple support cell types (smooth muscle
cells or pericytes). The co-cultures were maintained up to 7 days and
assayed for viability, proliferation, permeability/barrier function,
and immunostaining for tissue specific and functional markers.
Fluid shear stress (0.025 - 10 dyn/cm2) was applied using a syringe
pump. As an initial model for disease, pericytes were activated using
TGFb1.
Results: The configurability of the MPS allowed for permutation
of multiple EC and support cell types co-cultured across a range of
ECM compositions and shear stress profiles to differentially control
EC phenotypes as monolayers or microvascular networks. Proof of
concept studies have also demonstrated activation of pericytes on
various ECM substrates for future incorporation into theMPSmodel.
Discussion and Conclusions: The vascular MPS provides a
versatile platform for integrating multiple cell types with key bio-
physical cues. This complex system will provide a more physiolog-
ically relevant in vitro model for human vascular diseases.
615
An in vitro Continuous Primary Intestinal Epithelial Monolayer
for Evaluating Xenobiotic Transport and Metabolism
J. E. Speer1, D. B. Gunasekara1, Y. Wang1, M. I. Reed1,
J. K. Fallon2, B. Zwarycz3, S. T. Magness4,5, P. C. Smith2,
C. E. Sims1, N. L. Allbritton4,5;
1Chemistry, University of North Carolina, Chapel Hill, NC,
2Pharmacy, University of North Carolina, Chapel Hill, NC,
3Medicine, University of North Carolina, Chapel Hill, NC, 4Joint
Department of Biomedical Engineering, University of North
Carolina, Chapel Hill, NC, 5N.C. State University, Raleigh, NC.
Following oral xenobiotic administration, one of the main sites of
absorption occurs in the small intestine, where the compound
is subject to numerous transporters and the effects of metabolism.
For example, cytochrome P450 3A4 (CYP3A4) is the dominant
drug metabolizing enzyme in the human small intestine and P-
glycoprotein (P-gp) is expressed at high levels in the epithelial cells
of the intestine. One approach to the evaluation of intestinal me-
tabolism of xenobiotics is the use of tumor cell lines, such as Caco-2,
MDCK, and LLC-PK1, although these cells lack or have low ex-
pression of CYP3A4. To address such limitations, a cellular mono-
layer derived from human primary small intestinal stem cells was
cultured on a biomimetic scaffold. The measured trans-epithelial
electrical resistance (>100O cm2), lucifer yellow permeability
(<2 · 10-7 cm s-1), and positive tight junction staining (E-cadherin)
indicated a monolayer possessing appropriate tight junctions. The
expected gene expression for transporters and metabolic enzymes
was revealed by RNA seq. Targeted quantitative proteomic analy-
sis via LC-MS/MS provided measurable levels of CYP3A4 and
P-gp. Rhodamine 123 was used as a substrate to evaluate P-gp trans-
port indicating highly active efflux function (Papp, efflux/Papp, influx= 22).
This tissue model is promising as a means to evaluate xenobiotic
absorption andmetabolism, whichwould greatly facilitate screening of
compounds for pharmacologic efficacy or toxicity.
616
Generating Functionally Mature iPSC-Hepatocytes Through
Innovative High-Throughput Bioengineered Culture Platforms
T. A. Petrie, T. Mulhern, R. Maloney, J. Coppeta;
Bioengineering and Bioscience, Charles Stark Draper Laboratory,
Cambridge, MA.
Mature hepatocytes produced from induced pluripotent stem cells
(iPSCs) could afford renewable and precise predictive models for
personalized drug screening. Unfortunately, current iPSCs-derived
hepatocytes largely lack functional metabolic and protein activity. By
combining innovative engineering platforms with biological through-
out discovery strategies, we have designed a streamlined cell differ-
entiation and processing protocol to generate highly functioning iPSC-
derived hepatoblasts and hepatocytes. This process utilizes unique
stage-specific defined biochemical environments within a custom high-
throughput culture platform that incorporates precision pump mecha-
nisms to imitate physiologically-relevant biophysical and biomechan-
ical hepatic parameters, including stage-specific precision flow patterns
and nutrient replenishment schemes. We have reproducibly generated
iPSC-Hepatocytes from 3 distinct iPSC lines that surpass most industry
and academic levels of established functional adult hepatocytes met-
rics, including protein levels of a1aT, albumin, cyp3a4, cyp1a2, and
cyp2b6, NAT2, and UGT1a1 that are within at least 50% of primary
hepatocyte gold standards, while displaying reduced levels of immature
AFP and cyp3a7 levels. Expression levels of most of 30+mature genes
and markers are also at similar levels to primary hepatocytes. We are
currently applying these cells toward specific liver disease tissue-on-a
chip organoid models, including NASH and inflammatory-based dis-
eases, as well as investigating the robustness of this innovative matu-
ration protocol towards larger arrays of IPSC lines. By utilizing
advanced bioengineering hardware to generate biological discovery we
have generated highly functional iPSC-Hepatocytes to advance per-
sonalized hepatic regenerative medicine.
617
Bioproduction of a Universal, Chemically-Defined,
and Xeno-Free Cell Culture Media
Nelson, Jr., Ronald; Zhou, Yu; Wan, Meimei; Criswell, Tracy;
Bishop, Colin; Atala, Anthony; Shupe; Thomas
1Wake Forest Institute for Regenerative Medicine
Introduction: Animal-derived serum supplemented into cell cul-
ture media, while effective in supporting cell proliferation and phe-
notype maintenance in primary cell culture, lacks batch consistency
and cannot be fully chemically defined. These deficiencies result in
variable performance among serum lots. Substituting bioregulatory
serum factors with human sourced factors or small molecule bior-
egulatory factors would allow for the development of standard media
formulations that could simplify clinical manufacturing process de-
velopment and accelerate the translation of regenerative medicine
therapies to clinical deployment.
Materials and Methods: Media formulations were evaluated on
human primary cells, derived from each of the three embryonic germ
layers, using standard cell culture techniques. The performance of pro-
totype media formulations in terms of promoting cell proliferation was
determined using the IncuCyte S3 Live Cell Imager, while immuno-
fluoresence was performed to confirm maintenance of cell phenotype.
Results and Discussion: The first-generation media formulations
proved to be particularly supportive for human primary cells derived
from mesoderm and ectoderm, in some cases outperforming the cell
suppliers recommended media that contained undefined supplements.
These media contained either the undefined but well characterized
supplement, human platelet lysate (HPL) or our bovine pituitary extract
replacement cocktail. Themedia not only increased proliferation rates of
mesoderm and ectoderm-derived cells, but also prevented changes in
immunophenotype. A second-generation media containing defined
substitutes for themost prominent bioregulatory constituents of HPL has
been formulated and is currently undergoing testing. Finally, several
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synthetic molecules have been identified that provide support for human
primary cell proliferation and phenotype maintenance.
Conclusions: These data are being used to inform the develop-
ment of a prototype standardized medium for regenerative medicine
clinical manufacturing. The future vision for the media is to have a
standardized and well defined base medium for cells derived from
each of the three embryonic germ layers. This will provide a stan-
dardized cell platform for the clinical manufacturing of regenerative
medicine therapies.
618
Development of nanoparticles from a biofabricated fructose
polymer
Edmilson Clarindo de Siqueira1, Amanda Mota Vieira1,
Irapuan Oliveira Pinheiro1, Fabio Rocha Formiga1,2
1Programa de Po´s-Graduac¸a˜o em Biologia Celular e Molecular
Aplicada, Universidade de Pernambuco (UPE), Recife/PE, Brazil
2 Programa de Po´s-Graduac¸a˜o em Biotecnologia em Sau´de e
Medicina Investigativa, Instituto Gonc¸alo Moniz, Fundac¸a˜o
Oswaldo Cruz (FIOCRUZ), Salvador/BA, Brazil.
Introduction: A few polysaccharides have been reported for
nanoparticle development in regenerative medicine [1]. Levan is a
biocompatible polyfructan, but its potential has not been fully in-
vestigated. Here, we developed levan-based nanoparticles (LNPs) as
a novel nanobiomaterial.
Methods: Levan was produced by Bacillus subtilis var. Natto
cultivation for 23 h using a 5L-bioreactor (pH 7, 37 C, 950 rpm) and
characterized by thin-layer chromatography, FTIR spectroscopy and
1H NMR/13C NMR. LNPs were produced by nanoprecipitation [2]
and characterized by particle size, zeta potential and transmission
electron microscopy.
Results: The biofabricated levan was formed only by fructose. The
FTIR spectrum showed characteristic bands such as that corresponding
to the glycosidic bond. The 13C NMR spectrum exhibited six strong
resonance signals, with the signal d106.71 (C-2) relative to the quater-
nary anomeric carbon. LNPs sizes varied with the increase in levan
concentration: 226nm, 250nm and 324nm for 0.5, 5.0 and 10.0%,
respectively. The polydispersity of LNPs was found to be narrow at low
polymer concentrations and it widened with increasing levan concen-
tration. The zeta potential varied from-7.9mV to-12.9mV. LNPswere
spherical with negligible aggregation at low polymer concentrations.
Discussion and Conclusions: Levan produced byBacillus subtilis
var. Natto was able to form nanoparticles intended for drug delivery
and tissue engineering with adequate size, charge and morphology.
References:
1. Liu Z. et al. Polysaccharides-based nanoparticles as drug de-
livery systems, Adv. Drug Deliv. Rev., 60, 15, 2008.
2. Fessi H. et al. US Patent 593 522, 1992.
Acknowledgments: E.C.S is supported by a scholarship from
CAPES. Authors are grateful to FIOCRUZ, LPN/DEN/UFPE, DQF/
UFPE and UPE (grant process APQ 2016/N209)
619
Exploiting Macrophages For Vessel Development
E. Moore, G. Ying, J. L. West;
Biomedical Engineering, Duke University, Durham, NC.
Under certain conditions, macrophages can dramatically en-
hance and support angiogenesis. Generally, there are two main clas-
sifications of macrophage phenotypes: M1, thought to be pro-
inflammatory and M2, thought to be pro-tissue healing. We are de-
veloping scaffold materials that offer the opportunity to control
macrophage phenotype locally, thus providing a pathway to exploit
the beneficial actions of macrophages. Our scaffold is a 3D
poly(ethylene glycol)(PEG)- based hydrogel that has beenmodified to
support cell-adhesion (via incorporation of the cell adhesive peptide
RGDS) and to be proteolytically degradable (via incorporation of
GGGPQGIWGQGK, a matrix metalloprotease-2 and -9 sensitive
peptide). This bioactive scaffold supports the spontaneous formation
of blood vessel networks when endothelial cells (ECs) and support
cells are encapsulated into the 3Dmatrix. To investigate the influence
of macrophage phenotypes on vessel formation, macrophages were
stimulated towards a M0,M1 orM2 phenotype and then encapsulated
with ECs into the 3D matrix. We found that M0 + ECs enhanced
vessel volume by nearly two-fold when compared to ECs alone. M2 +
ECs enhanced vessel volume by nearly three-fold while M1 + ECs
reduced vessel volume to one-tenth of the ECs alone. IL-4 and IL-13,
known stimulators of the M2 phenotype, can be covalently im-
mobilized into the scaffold materials for local stimulation of the M2
phenotype. Thus, the bioactive scaffold can be used for local control
of macrophage phenotype in order to enhance vessel formation.
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Microfabrication of Posts to be used with Bioengineered
Muscle Tissues for High Throughput Screening
of Inflammatory Modulators
Sindhoor R. Ambati1, Lewis Gaffney1,2, Patrick Erb1,2,
Seema Nandi1,2, Emily Wrona1,2, Ashlyn Young1,2,
Ashley Brown1,2, Michael A. Daniele1,2, Donald O. Freytes1,2
1NCSU/UNC-CH Joint Department of Biomedical Engineering,
Raleigh NC, Raleigh, NC
2Comparative Medicine Institute, Raleigh, NC
Current platforms make use of bioengineered muscle tissues (BMTs)
that contract around two flexible posts. However, they rely on a single
testing unit per well and the contraction of the muscle cells around
the posts can take up to a week or longer depending on the cell type. The
present project focused on creating multiple smaller posts within the
samewell to increase contraction speed. Overall, the goal was to provide
faster hydrogel contraction and multiple readouts from a single field of
view using a standard microscope. We developed two post designs: 5 or
16 posts within single well in a 24-well plate. Molds are micro-milled
from aluminum and polydimethylsiloxane (PDMS) used to cast the
molds. Prior to seeding, PDMS posts were plasma treated and coated
with bovine serum albumin. Molds were seeded with different hydrogel
gels containing different types of muscle cells.We also tested the effects
of platelet-like particles (PLPs) and dermal fibroblasts on the speed
contraction. All posts were seeded at concentration of 20,000 cells/mL.
Smaller posts required less time to contract. Imaging results found that
both fibrin and collagen served as effective hydrogels, with comparable
tissue formation times. PLP addition was also shown to improve hy-
drogel contraction when combined with fibrin hydrogels. By expediting
preparation of the posts and tissue formation, the newmethodology cuts
downBMT formation 2-3 days. The smaller design also allows us to test
more conditions under a single field in a microscope.
Acknowledgments: We thank the Comparative Medicine In-
stitute’s Summer Interdisciplinary Summer Initiative for their sup-
port throughout the project. Also, we thank the CMI and NC TRACS
(5SOKR141616) for their funding. I would also like to thank the Park
Scholarships for their guidance throughout my undergraduate career.
Undergraduate Poster: U2
Laser triggered thermoplastic shape memory polymeric
particles encapsulating gold nanoparticles
for biomedical applications
Daphne E Schlesinger, Qiongyu Guo, Corey J Bishop,
Randall A Meyer, David P Wilson, Lauren Olasov,
James B Spicer, Jennifer H Elisseeff, Jordan J Green
Department of Biomedical Engineering, Johns Hopkins University
Shape memory polymers (SMPs) are materials that can be mod-
ulated in shape, then returned to their original shape when externally
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stimulated, in an entropy driven process called the shape memory
effect (SME).1 This feature can be utilized in polymer micro and na-
noparticles for biomedical applications, as the optimal shape for a
particle in vivo often changes with respect to time. For example, ellip-
soidal particles resist nonspecific uptake.4 Modulation of shape there-
fore allows for modulation of therapeutic properties.2 This study sought
to optimize SMP particles for rapid shape switching at biocompatible
temperatures. The particles were synthesized via bulk emulsion from
poly(D,L-lactic acid) (PDLLA), encapsulating gold nanoparticles. They
were then cast into a PVAfilm, and stretched in an automated device at a
low temperature of 65C, and a high temperature of 90C.3 Shape re-
version was tested via bulk heating, then by laser irradiation, mediated
by inductive heating of the encapsulated gold particles. The shape
memory particles were also tested in vitro. They were added to mac-
rophages, which were then exposed to short-term bulk heat at 42C, after
which particle uptakewas assessed. The SME is observed in 65C stretch
particles for both bulk heat and laser irradiation, while the 90C stretch
particles maintained their shape. Confocal microscopy of macrophages
exposed to the particles showed an increase in uptake after bulk heat for
particles stretched at low temperatures, over a range of doses. SMP
based particles represent an innovative therapeutic platform, with
promising applications in drug delivery and beyond.
References
1. Wischke, C., Schossig, M., Lendlein, A. (2014). Shape-
Memory Effect of Micro- /Nanoparticles from Thermoplastic Mul-
tiblock Copolymers. Small, 10(1), 83-87. 10.1002/smll.201202213.
2. Yoo, J.W., Mitragotri, S. (2010). Polymer particles that switch
shape in response to a stimulus. PNAS, Early Edition, 1-6. www.
pnas.org/cgi/doi/10.1073/pnas.1000346107.
3. R. A. Meyer, R. S. Meyer, J. J. Green, Journal of Biomedical
Materials Research Part A 2015, 103, 2747.
4. J. A. Champion, S. Mitragotri, Proc Natl Acad Sci U S A 2006,
103, 4930.
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3D Printing Elastin-Like Protein (ELP) with Oxygen-Sensing
Boron Nanoparticles
Hamzah S. Shariff1, Meghan Hefferon2, Daniel Meador1,
Michaela Rikard1, Cassandra Fraser3, Kyle Lampe2,
Shayn M. Peirce1
1Dept of Biomedical Engineering, University of Virginia
2Dept of Chemical Engineering, University of Virginia
3Dept of Chemistry, University of Virginia
Homogenous oxygen delivery when designing 3D printed bios-
caffolds has remained a critical unsolved challenge impeding cellular
viability and effective implantation1. With oxygen diffusion limited to
200mm in vivo, oxygen perfusion to cells imbedded within the scaffold
must be monitored to prevent hypoxia and promote cell growth2,3. In
order to monitor oxygenation over time in 3D bioprinted scaffolds, we
designed a strategy to incorporate oxygen-sensing boron nanoparticles
(BNPs) into a printable bioink. A solution of elastin-like protein (ELP),
a synthetic protein that mimics the properties of the protein elastin, was
mixed with Xantham Gum (XG) at 8% (w/v), to produce a sheer-
thinning, printable hydrogel. The BNPs are dual emissive; they emit
fluorescence and phosphorescence when excited by ultraviolet
light. The fluorescence to phosphorescence ratio (F/P) quantita-
tively indicates oxygen levels, which can be represented as a col-
orimetric map. The BNPs were mixed with the ELP-XG hydrogel
and 3D printed as a ‘‘cross-hatch’’ structured scaffold, which was
immediately crosslinked using tetrakis(hydroxymethyl) phospho-
nium chloride (THPC). Ratiometric images of the bioscaffold with
embedded BNPs revealed different oxygenation levels throughout
the scaffold. The oxygen-sensing capacity in the 3D-printed con-
struct was verified by flowing either oxygen or nitrogen over the
construct, which caused increases or decreases in the F/P ratio,
respectively. We successfully incorporated oxygen-sensing nano-
particles into a 3D-printable ELP-XG bioink and validated the
scaffold’s ability to indicate fluctuations in oxygen levels. Future
work will validate this strategy for monitoring oxygen levels in 3D-
printed constructs containing live cells.
References:
1. Lovett, M., Lee, K., Edwards, A. & Kaplan, D. L. Vascular-
ization Strategies for Tissue Engineering. Tissue Eng. Part B Rev. 15,
353–370 (2009).
2. Volkmer, E. et al. Overcoming hypoxia in 3D culture systems
for tissue engineering of bone in vitro using an automated, oxygen-
triggered feedback loop. J. Mater. Sci. Mater. Med. 23, 2793–2801
(2012).
3. Volkmer, E. et al. Hypoxia in Static and Dynamic 3D Culture
Systems for Tissue Engineering of Bone. Tissue Eng. Part A 14,
1331–1340 (2008).
Acknowledgments: This undergraduate summer research has
been made possible by a grant from the UVA nanoSTAR Under-
graduate Research Fund.
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Fe31 and Photocrosslinkable Tissue Adhesive Intended
for Surgical Wound Healing
Shashank Madhu, Bahram Saleh, Nasim Annabi
Northeastern University, Boston, MA
There is a growing need for sealants in the facilitation of surgical
operations in situations where traditional suturing may prove unsafe,
impractical or ineffective. Fibrin, cyanoacrylates, and aldehyde-based
tissue adhesives offer a greater flexibility in usage, but there are inherent
biocompatibility and toxicity risks involved that restrict the use of these
products in clinical applications. Hydrogels have been proposed as vi-
able alternatives, but it has been a great challenge to develop a hydrogel
which forms rapidly and has strong adhesion on wet surfaces. In this
study, we engineered a double-crosslinked tissue adhesive (DCTA)
comprised of a dopamine-conjugated gelatin methacryloyl (GelMA)
biopolymer. Fe31 ions are used for rapid crosslinking followed by a
long-term acting photocrosslinking mechanism composed of the pho-
toinitiator Eosin Y, co-initiator triethanolamine (TEA) and the co-
monomer poly(N-vinylcaprolactam) (VC). GelMA was formed in a
direct reaction of methacrylic anhydride with gelatin. Dopamine was
grafted onto GelMA using 1-Ethyl-3-(3-dimethylaminopropyl) carbo-
diimide (EDC) and N-Hydroxysuccinimide (NHS) coupling chemistry,
the catechol groups of which can be oxidized to form quinones that are
capable of providing strong adhesion to nucleophile groups on tissue
surfaces. This novel DCTA exhibited an adhesive strength >100kPa
higher than fibrin-based glues when performing lap-shear tests on wet
porcine skin1. TheDCTA also displayed an elastic modulus of >200kPa
that makes it an ideal candidate for gluing flexible soft tissue. This newly
developed adhesive hydrogel is highly promising for internal wound
closure, hemostasis, and preventing infections post surgery.
Acknowledgments: The authors acknowledge the support from
the American Heart Association (AHA, 16SDG31280010), FY17
TIER 1 Interdisciplinary Research Seed Grants from Northeastern
University, and the startup fund provided by the Department of Che-
mical Engineering, College of Engineering at Northeastern University.
Disclosures: The author has nothing to disclose.
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Undergraduate Poster: U6
Heuristic Computational Modeling of Nutrient Role in Fusion of
Cellular Spheroids Useful for Scaffold-Free Biofabrication
David J. Bustamante, Nicanor I. Moldovan
Department of Biomedical Engineering, IUPUI, Indianapolis, IN,
46202
Cellular spheroids are useful as tissue models and as building
blocks for biofabrication. These cellular aggregates are in general
non-perfused, and thus susceptible of nutrient deprivation, with little-
explored effects on their suitability for further 3D assembling. This is
particularly relevant for complex tumor models, developed for drug
discovery and personalized treatments. We modeled the impact of
glucose availability on spheroids fusion rate and on larger-scale
ensuing structure, with emphasis on incorporation of tumor spheroids
among the normal cell spheroids in the constructs. We used a tumor
spheroid model with a bi-dimensional diffusion field for glucose,
implemented in the multiscale modeling platform CompuCell3D.
We also performed fusion experiments with actual tumor cell
spheroids, at normal and low nutrient concentrations. Our fusion
model normal and/or tumor spheroids uncovered an unexpectedly
small dependence on the amount of glucose over an order of mag-
nitude span in the early phase of the process, until either proliferation
(in high glucose), or cell death (in low glucose), modified the size of
the cellular construct. These observations were concordant with the
tumor spheroids experiments. Moreover, simulation of constructs
built from one tumor spheroid bordered by eight other normal cell
spheroids revealed a dynamic structure-destabilizing effect of the
tumoral core, as dependent on the glucose levels. This modeling
approach provides heuristic insights into the behavior of cell spher-
oids, such as the role of nutrients in tissue engineering constructs, and
for better understanding of their biological properties, for basic sci-
ence, biofabrication and pre-clinical applications.
Undergraduate Poster: U7
Enhancing Tissue Adhesives with Small Molecule Additives
KyungMin Yoo1,2, Connor Huntwork2, Surya Banks1,
Aleksander Skardal2 and Mark Welker1
1Department of Chemistry, Wake Forest University
2Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine
Every year, over 50 million people undergo surgeries that require
invasive stitches or sutures to achieve tissue healing. Consequently,
unsightly scars and complications associated with stitches and su-
tures remain a problem. As such, biodegradable tissue adhesives,
such as biopolymer aldehydes and fibrin gels have been employed to
close surgical wounds. Unfortunately, the currently available adhe-
sives have several issues such as cytotoxicity and lack of mechanical
durability. To optimize this system, we developed a novel adhesive
with a base of hyaluronic acid (HA) functionalized with small mol-
ecules. HA is a biocompatible polysaccharide that plays a large role
in connective tissue in vivo, and is widely used as a biodegradable
scaffold for tissue engineering. We synthesized small organic mol-
ecules (10) with varying hydrogen bonding functional groups that
will covalently modify thiolated HA via a thiol-alkyne click reaction.
In this study, a variety of alkyne containing imines, amines and
amides were prepared and characterized by NMR and mass spec-
trometry. The small molecules were modularly added into the HA
hydrogel systems and tested for cytotoxicity as well as shear and
tensile properties to assess the levels of adhesiveness and rigidity.
The integration of catechol functionalized molecules with a bioactive
HA backbone resulted in a 4-6 fold increase in adhesive properties at
minimal concentration while simultaneously reducing cytotoxicity.
Functionalization of HA with catechol groups leads to significant
increase in adhesive properties. Ongoing studies are focused on en-
hancing the mechanical properties by diversifying the functional
groups on the small molecules and amplifying the concentration of
small molecule additives. Successful development of an improved
tissue adhesive would aid wound healing applications and decrease
previous complications.
Acknowledgments: We thank the Arnold and Mabel Beckman
Foundation and Wake Forest University’s Center for Molecular
Communication and Signaling for supporting this research.
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Human Macrophage Response to Pathogens Isolated From
Diabetic Foot Ulcers
Carly B. Deusenbery1, Anamika Bajpai, PhD1, Lindsay Kalan, PhD2,
Jacquelyn S. Meisel2, Brandon Marcinkiewicz, MS1,
Sue E. Gardner, PhD3, Elizabeth Grice, PhD2, Kara L. Spiller, PhD1
1School of Biomedical Engineering Science and Health Systems,
Drexel University, Philadelphia, USA
2Department of Dermatology, University of Pennsylvania, Perelman
School of Medicine, Philadelphia, Pennsylvania
3College of Nursing, University of Iowa, Iowa City, Iowa USA
Diabetic foot ulcers are a major clinical problem exacerbated by
prolonged bacterial infection. Macrophages, the primary innate im-
mune cells, are multifunctional cells that regulate diverse processes
throughout the multiple phases of wound healing. Previously studies
have associated certain wound pathogens with healing outcome in
mice (1). To better understand the influence of pathogen species on
human macrophage behavior, we cultured primary human monocyte-
derivedmacrophages in media conditioned by pathogens isolated from
8 diabetic foot ulcer patients for 24 hours. Gene expression and protein
analysis showed that both pro-inflammatory M1 and wound resolving
M2 phenotypes were upregulated to different extents by 6 species of
pathogens. Interestingly, macrophages individually cultured with each
pathogen induced high levels of expression of CCL22 and MARCO
causing macrophages to most closely align with the M2 phenotypes
compared to the M1 phenotype. Interestingly, Corynebacterium
amycolatum, Corynebacterium striatum, and Pseudomonas aerugi-
nosa conditioned media promoted increased secretion of both the
wound resolving cytokine PDGF-BB and pro-inflammatory cytokines
vascular endothelial growth factor (VEGF), interleukin 1b (IL1b), and
tumor necrosis factor a (TNFa) suggestive of a fibrotic response in
comparison to phenotypic controls unactivated M0 and M1 macro-
phages. Therefore, macrophages respond uniquely to the secretions of
different pathogen species, producing irregular behavior. To correct
this irregularity chronic wound treatments should specifically address
macrophage deficits based on the dominant pathogens to promote
wound healing and skin regeneration.
References:
1. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, Program
NCS, Liechty KW, et al. Longitudinal shift in diabetic wound mi-
crobiota correlates with prolonged skin defense response. Proceed-
ings of the National Academy of Sciences of the United States of
America 2010;107(33):14799-804.
Acknowledgments: We thank the patients who provided us with
diabetic foot ulcer biofilm samples. This work was funded by the
Drexel-Coulter Translational Research Partnership and the Drexel
Neuroinflammation and Gender Research Program, the National
Institutes of Health, National Institute of Nursing Research grant R01
NR009448 to SEG and grant R01 NR015638 to EAG. Authors have
no financial conflicts of interest.
Disclosures: No competing financial interests exist.
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Optogenetics for the Maturation of hiPS-CMs
Christopher Y. Shen1, Stephen P. Ma1, Eugenia C. White1,2,
Olaia F. Vila1, Timothy H. Chen1, Keith Yeager1, Gordana Vunjak-
Novakovic1
1Department of Biomedical Engineering, Columbia University, New
York, NY and 2Louisiana State University Health Sciences Center,
Shreveport, LA
The necessity for in vitro models of the human heart grows as the
burden of cardiovascular disease continues to be the leading cause of
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patient mortality.1 Human induced pluripotent stem cell-derived
cardiomyocytes (hiPS-CMs) are a promising tool due to their po-
tential applications for disease modeling, drug testing, and regener-
ative medicine. However, hiPS-CMs are less mature than their native
counterparts. Electrical stimulation has been used to mature cardio-
myocytes over the past decade; however, such stimulation regimes
are associated with the presence of an electrical field as well as
charge injection, the relative effects of which are not well under-
stood.2,3 Cardiomyocytes expressing channelrhodopsin-2 (ChR2), a
light-responsive ion channel first transduced into mammalian cells in
2005, would allow for optical pacing as a means for stimulation and
maturation.4 ChR2-expressing hiPSCs were created via lentiviral
transduction, and differentiated into cardiomyocytes as previously
published.5 Cardiomyocytes were subsequently digested and seeded
in collagen-fibrin hydrogel constructs. The tissues were stimulated
using a ramped stimulation protocol using a custom Arduino-driven
LED system for fourteen days. The maximum capture rate (MCR)
was periodically evaluated to set stimulation parameters. The
MCR was quantified using custom image processing software and
conduction velocity was analyzed by optical mapping of impulse
propagation. Sarcomeric alignment was quantified through im-
munostaining. Here we show that optically stimulated cardiomyo-
cytes exhibit increased ultrastructural organization, enhanced Ca2+
handling through increased MCR, and improved conduction veloc-
ity.We demonstrate that optical pacing of transgenic hiPS-CMs leads
to functional changes linked to cardiac maturation.
Acknowledgments: We gratefully acknowledge the funding of
this work by NIH (HL076485, EB002520) and NYSTEM (C028119,
C030291).
References:
1. Mozaffarian, D. et al. Heart disease and stroke statistics–2015
update: a report from the American Heart Association. Circulation
131, e29-322 (2015).
2. Sun, X. & Nunes, S. S. Bioengineering Approaches to Mature
Human Pluripotent Stem Cell-Derived Cardiomyocytes. Front. cell
Dev. Biol. 5, 19 (2017).
3. Eng, G. et al. Autonomous beating rate adaptation in human
stem cell-derived cardiomyocytes. Nat. Commun. 7, 10312 (2016).
4. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth,
K. Millisecond-timescale, genetically targeted optical control of
neural activity. Nat. Neurosci. 8, 1263–8 (2005).
5. Burridge, P. W. et al. Chemically defined generation of human
cardiomyocytes. Nat. Methods 11, 855–860 (2014).
Undergraduate Poster: U10
Design, Development and Verification of a Technique
to Manufacture Locally Strain Variant Electrospun Scaffolds
for Ligament Tissue Engineering
Steven Wright, Todd P Burton and Anthony Callanan
Institute for Bioengineering, The University of Edinburgh, Scotland.
Anterior cruciate ligament (ACL) rupture is a burden of sports
people globally, with approximately 130,000 reconstructions each
year in the US alone.1 Current treatment involves an autograft
from either patella tendon or hamstring tendon, with the concomitant
result of donor site morbidity, surgical cost and time as well as
increased risk of infection. Scaffold based alternatives such as hya-
luronan2, silk3, polymer4 have been studied previously but are yet to
replace allografts as the gold standard for ACL reconstruction. The
structure and integration of the scaffold is a key consideration, with
the architecture of the bony plug distinct from the ligament. We have
designed and developed a polymer scaffold to better mimic the local
strain variance seen in native ligaments, with an architecture that
better represents the ACL and gold standard treatment a bone-
patellar tendon-bone autograft. Polymer scaffolds were electrospun
onto a specially designed rotating mandrel, programmed to stop at
precise intervals increasing deposition in certain areas. Analysis of
results from mechanical testing illustrates a significant variation in
both scaffold thickness and consequently strain behaviour along the
scaffold length in agreement with that seen in native ligaments.
Stress-strain behaviour for the scaffold as a whole is shown to be very
similar to scaffolds of uniform thickness with potential for closer
matching behaviour through manipulation of manufacturing pa-
rameters. Thus, the novel technique of strain variant scaffold manu-
facture for ligament tissue engineering has great potential.
References:
1. Everhart, J S et al. Knee Surgery, Sport. Traumatol. Arthrosc.
23, 752–762 (2015).
2. Cristino, S. et al. J. Biomed. Mater. Res. Part A 73A, 275–283
(2005).
3. Altman, G. H. et al. Biomaterials 23, 4131–4141 (2002).
4. Sahoo, S., Ouyang, H., Goh, J. C.-H., Tay, T. E. & Toh, S. L.
Tissue Eng. 12, 91–99 (2006).
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Catechol-functionalized Pectin Hydrogel as Mucosa Adhesive
and Therapeutic Delivery Agent for the Treatment
of Peptic Ulcer
Shih-Yung Liao1, Tzu-Wei Wang2
1Department of Biomedical Engineering and Environmental
Sciences, National Tsing Hua University, Hsinchu, Taiwan
2Department of Materials Science and Engineering, National Tsing
Hua University, Hsinchu, Taiwan
The treatment of peptic ulcer disease is typically mediated by acid
suppressant such as proton-pump inhibitor (PPI) or by mucosal
protective agent such as sucralfate. However, acid inhibitor may not
only attenuate the anti-infection ability but also lead to malnutrition
or vitamin B12 deficiency. Of note is that mucosal protective agent
has problems of weak protectability and short duration of action.
Prolonged treatment with PPIs may accelerate the development of
atrophic gastritis, a risk factor of stomach cancer. To address these
problems, multifunctional pectin hydrogel is developed to serve as
tissue adhesive, acid-resistant wound barrier, and therapeutic drug
controlled delivery vehicle. For future clinical administrations,
multifunctional pectin hydrogel can be delivered through the en-
doscopy route without affecting intragastric pH levels and can adhere
to the ulcer site for a long duration. Pectin was modifiedwith catechol
functional groups to act as tissue adhesive and in-situ gelation hy-
drogel for protecting ulcer wound area against the attack of gastric
fluid. Gelatin nanoparticles were embedded in pectin hydrogel to
function as drug delivery carrier for accelerative ulcer healing. Ca-
techol was successful modified on pectin with desirable conjugation
rate. The hydrogel exhibited sol-gel transition behavior and adhesive
property to underlying tissue surface after oxidation treatment.
Possessing with strong mechanical property and stability in acid
solution, the hydrogel was particularly suitable for surgeons to
manage peptic ulcer. Catechol-functionalized pectin hydrogel dem-
onstrates that it is a promising mucosal protective agent and has
potential of being applied to chronic wounds, gastric and duodenal
ulcers and other mucosa related injury or diseases. Ongoing research
works are to assess the drug release profile and cytoprotective po-
tential of this hydrogel.
Undergraduate Poster: U12
Co-Transplantation of Neural-Progenitor Cells
With Interstitial Cells Of Cajal To Treat Gastroparesis
Suzanne Zhou1, Prabhash Dadhich2, Elie Zakhem1,3
and Khalil N. Bitar1,3-5
1Summer Scholar program, Wake Forest Institute for Regenerative
Medicine, Wake Forest School of Medicine, Winston Salem,
NC, USA
2Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston Salem, NC, USA
3Program in Neuro-Gastroenterology and Motility, Wake Forest
School of Medicine, Winston Salem, NC, USA
4Section on Gastroenterology, Wake Forest School of Medicine,
Winston Salem, NC, USA
5Virginia Tech-Wake Forest School of Biomedical Engineering
and Sciences, Wake Forest School of Medicine, Winston Salem,
NC, USA
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Gastroparesis is delayed gastric emptying without knownmechanical
obstruction. Symptoms and pathologies are heterogeneous among cases;
however, most patients diagnosed have a reduction of gastric neurons
and interstitial cells of Cajal (ICCs) upon histological investigation.
Therefore, this study aims to determine the efficacy of cell therapy, using
ICCs and neural-progenitor cells (NPCs), at restoring functionality to the
diseasemodel. Rat stomachwas harvested following ablation of neurons
and ICCs via chemical treatments to make gastroparesis tissue model
(GTM). Murine small intestine NPCs and ICCs were isolated and
fluorescently taggedwith fluorescent protein. The cells were delivered to
GTM. Cell delivered GTM were evaluated using qPCR and immuno-
histochemistry (IHC), and functionality was analyzed using organ bath
studies. The ICCs and neural cells were successfully depleted after
chemical treatment. The GTM showed a 70% decrease in ANO1 and
83% decrease in beta-III tubulin expression compared to control. NPCs/
ICCs injected tissues showed a 225% increase inANO1 expression and a
384% increase in beta-III tubulin expression compared to control. IHC
confirmed the survival and functional differentiation of ICCs and NPCs
in the diseased tissue model. The contraction and relaxation activity
improved by 84% and 57%, respectively, within seven days, further
confirmed that the NPCs and ICCs were able to re-establish connections
to the smooth muscle cells in the tissue. These findings suggest that cell
therapy using an injection of NPCs and ICCs can be used to treat neu-
rodegenerative disorders of Gut.
Undergraduate Poster: U13
Electrospun Polymer Fibers Infused with Cellulose
Nanowhiskers: A Micromechanics Approach
Carl Bartlett1, Cody Johnson2, Haibin Ning2, and Aaron Catledge1
1Department of Physics, The University of Alabama at Birmingham
2Department of Materials Science and Engineering, The University
of Alabama at Birmingham
Calcium sulfate (CaSO4) and calcium phosphate (CaPO4) bone ce-
ments have low toughness due to the brittle nature of the material. Our
objective is to use amicromechanics approach to develop discontinuous
fiber-reinforced Engineered Cementitious Composites (ECCs)1 with
significantly improvedmechanical strength and toughness. In this work,
we apply the ECC approach for injectable bone cement in order to
improve strain to failure and load-bearing capacity without brittle
fracture. Atomic Force Microscopy (AFM) showed that addition of
cellulose nanowhiskers increased the surface roughness of the fibers,
which is expected to improve the fiber-matrix interfacial strength.
X-Ray Diffraction (XRD) confirmed the presence of cellulose nano-
whiskers within the cement matrix. Nanoindentation generated force-
displacement curves, which revealed increased Young’s Modulus for
fiber-reinforced cements. For the pressed (pore-free) fiber-reinforced
cements, Young’s Modulus increased by as much as a factor of 2
(22.8– 3.2 GPa vs. 11.7– 2.2 GPa), and the elastic recovery decreased
by more than 10%, suggesting the cement is stiffer, but also tougher
than the unreinforced cements. Predictive micromechanical modeling/
simulation was used to demonstrate how factors such as cellulose na-
nowhisker content, fiber aspect ratio, and fiber length, impact the crit-
ical volume fraction needed to induce strain hardening and to serve as a
baseline for initial cellulose nanowhisker concentrations. This model-
ing predicts that the addition of cellulose nanowhiskers will increase the
fiber Young’s Modulus improving the cement matrix. This ECC be-
havior can produce a composite cement with increased toughness while
promoting the formation of natural bone.
References:
1. Li, Victor C, Kanda, Tetsuhi. Engineered Cementitious Com-
posites for Structural Applications. ASCE Journal of Materials in
Civil Engineering, Volume 10, 1998.
The authors would like to acknowledge support from the Uni-
versity of Alabama at Birmingham (UAB) College of Arts & Sci-
ences Interdisciplinary Team Award.
Undergraduate Poster: U14
Bioprinted Blood Brain Barrier Model for Drug Screening
Caroline H. Sane1, Goodwell Nzou2, Anthony J. Atala, MD.3
1Summer Scholar program, Wake Forest Institute for Regenerative
Medicine, Wake Forest School of Medicine, Winston-Salem, NC,
USA
2Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston-Salem, NC, USA
3Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston-Salem, NC, USA
Neurodegenerative disease accounts for one million new diag-
noses1 in the United States every year, with 50 million pre-existing
cases.2 Treatment is limited due the lack of an in vitro model of the
blood-brain barrier (BBB) capable of high-throughput drug screen-
ing. We propose that our bioprinted model incorporating all six hu-
man brain cell types (astrocytes, pericytes, microglia, endothelial
cells, oligodendrocytes, and neurons) will ameliorate this. The pur-
pose of this research is to develop a human-based, physiologically
relevant, bioprinted microvessel BBB model for drug screening.
Viability was determined via Live-Dead analysis. Neuronal matu-
ration markers were localized via immunofluorescent staining. Cells
were printed via the integrated tissue and organ printing system
(ITOP) in fibrin-hyaluronic acid hydrogel. Sectioning was achieved
using a microtome and subsequently stained via H & E analysis.
Live-Dead analysis demonstrated the maintenance of viability for up
to 21 days as well as cellular maturation and differentiation. The
presence of neuronal maturation markers was confirmed. Sectioning
of tissue revealed the presence of an open lumen. Live-Dead analyses
indicate long-term culture applications. Normal protein expression in
the hydrogel was confirmed via immunohistochemistry. Our bio-
printed blood vessel model possesses a lumen resembling blood
vessels of the blood-brain interface and, with high viability and re-
producibility, holds potential as a platform for drug screening.
References:
1. Brown, R.C., Lockwood, A.H., Babasaheb, R. S. Neurodegen-
erative Diseases: An Overview of Enviromental Risk Factors. NCBI.
Environmental Health Perspectives. 2005; 113(9): 1250-1256. doi:
10.1289/ehp.7567. PMCID: PMC1280411.
2. Fei, E. Xiong, Wen-Cheng, & Mei, L. Ephrin-B3 recruits PSD-
95 to synapses. Nature Neuroscience 18, 1535-1537 (2015). doi:
10.1038/nn.4147.
3. Nzou, Goodwell. Human Neurovascular Unit Models for High-
Throughput Neurotoxicity Screening and Drug Discovery. 2017.
Acknowledgments: This summer research position was gener-
ously sponsored by Elias H. ‘‘Butch’’ Pegram Jr.
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Bioengineering of vascular myocardial tissue; a 3D bioprinting
approach
James B. Hu, Daniel A. Hu, Jan W. Buikema, Orlando Chirikian,
Sneha Venkatraman, Vahid Serpooshan, and Sean M. Wu
Division of Cardiovascular Medicine, Stanford University School of
Medicine
Cardiovascular tissue engineering holds significant promise to re-
store the loss of structure and function after heart damage. However,
clinical attempts at myocardial tissue grafting have shown limited
success primarily due to the insufficient vascularization and poor
control over the scaffold structure. Here, we hypothesize that recapit-
ulating physiologic vascular architecture and blood flow in the 3D
bioprinted constructs would allow for optimal cardiac cell function in
3D tissue. Our goal was to determine the effect of vasculature design
and flow on hiPSC-CM and EC viability and function in 3D printed
myocardium. Our results demonstrated the feasibility of printing via-
ble and functional human induced pluripotent stem cell (hiPSC)-
derived cardiomyocytes (CMs) and endothelial cells (ECs) using
gelatin methacrylate (gelMA) as bioink. A reverse engineering ap-
proach was utilized to create the vascular network; hiPSC-CMs were
encapsulated in gelMA and printed into perpendicular mesh network
and the remaining (negative) space was utilized as an interconnected
3D vascular network and perfused with ECs. To form endothelium
onto the printed channels, we subsequently used a custom-printed
bioreactor to perfuse ECs into the microchannels. Optimal flow con-
ditions and design parameters to achieve hiPSC-CM viability,
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contractile function, and maturation were identified. Outcomes of this
research establish the design principles and lead to the creation of the
first 3D bioprinted, patient-specific, vascular myocardium which can
be broadly applicable to other tissues and organs.
Undergraduate Poster: U16
Effects of Bioactive Molecules on Skeletal Muscle Development
In 3d Bioprinted Muscle Constructs
Margaret vanSchaayk1, Ji Hyun Kim2, James J. Yoo2,
Anthony Atala2,3, Sang Jin Lee2
1Summer Scholar program, Wake Forest Institute for Regenerative
Medicine, Wake Forest School of Medicine, Winston Salem, NC,
USA
2Wake Forest Institute for Regenerative Medicine, Wake Forest
School of Medicine, Winston Salem, NC, USA
3Department of Urology, Wake Forest School of Medicine, Winston
Salem, NC, USA
Patients with volumetric muscle loss (VML) experience profound
structural and functional impairment. The current standard of care,
autologous muscle graft, is often limited by unavailability of suitable
host tissue and poor grafting efficacy which prevents functional
restoration of muscle mass. Bioengineered functional skeletal muscle
has potential to fill this clinical void. To engineer skeletal muscle
tissue, several biofabrication techniques have been previously ap-
plied. However, these techniques have faced inadequate fiber
alignment for functionality with clinically-relevant size for treating
VML. To overcome this limitation, we fabricated skeletal muscle
constructs using 3D bioprinting of human muscle progenitor cells
(hMPCs). The constructs showed a high degree of muscle fiber
alignment. To achieve functional recovery in vivo, further develop-
ment of the constructs is needed. In this study, we investigate the
effects of bioactive molecules on muscle development. The condi-
tioned medium factors from the human neural stem cell (hNSCs)
were tested in 2D hMPC culture and 3D bioprinted muscle con-
structs. Muscle development was evaluated after 5 days of differ-
entiation by immunostaining with myosin heavy chain (MHC). Our
results demonstrated that the treatment of Fibroblast Growth Factor-
2 (FGF-2) and Hepatocyte Growth Factor (HGF) significantly in-
creased the development of skeletal muscle. In the future, studying
the synergistic effects of these factors with other factors may produce
an even more pronounced effect on muscle development. This
finding may be beneficial in working toward improving development
of bioprinted muscle constructs which may contribute to functional
restoration in VML injury in vivo.
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